X,AGE,BAGE,BBULKN,BIPIN,BWT,BHT,BBMI,BBSA,CYCPL,DIAG,DIAG2,ECOG2,IPI2,LESION,PCYCN,SPD,TRT01AN,TRT01PN,LDH1,ALBUM,ALKPH,ALT,AST,BANDS,BANDSF,BASOS,BASOSF,BICARB,BMLYMP,BUN,CALCUM,CD16,CD16LY,CD19,CD19LY,CD3,CD3LY,CHLOR,CRCLBSA,CREATN,CSFLDH,CSFLYMA,CTPROT,EOSIN,EOSINF,F13005,F13005LY,F13011,F13011LY,HBDNA,HCRIT,HGB,IGA,IGG,IGM,LYMPH,LYMPHF,MONOS,MONOSF,NAPTT,NEUTR,NEUTSA,NEUTSP,OTHCA,OTHCP,PHOSAT,PLATE,POTAS,PROTUR,PTINR,PTM,PTR,PTT,RBC,SODIUM,TBILI,TPROT,URACID,WBC,BSA,DIABP,HEIGHT,LENGTH,PULSE,SYSBP,WEIGHT,INVET,BMHCANC,BMHCEREB,BMHCPULM,BMHDIAB,BMHHEART,BMHMYCRD,BMHPEPUL,BMHTISS,BMHVASCU,CCI,AGEU,BAGEU,ITTFL,COMPSTUD,BHSCNVYN,BHSCEVYN,BWTU,BHTU,LYMCT1,LYMCT2,AEWITHFL,AGE40,AGE55,AGE60,AGE65,AGE70,AGE75,ANN,ARM,ARM2,ARMCD,BBULKY,BHSCNVC,BIPIC,BMI,BMINV,BSYM,CNTRYCHN,COUNTRY,COUNTRY2,CREACL,CRIRCYN,DIAG3,ECOG,EGORRES,ETHNIC,EXANN,EXINV,EXINV2,EXINV3,FCGAM1,FCGAM2,FEVER,FUPSTRT,GCYC1MIS,HBVAEFL,IPI,IPI3,ITBSAQ,IVIPI,LDH2,LHEPB,LIVERP,LYMCT4,NIGHT,NK,PETYN,PRAD,PSURG,RACE,REG,RSPIRCYN,SAFFL,SEX,SPLP,STRAT1,TRT01A,TRT01P,TRTETMF,TRTSTMF,WGTLOSS
1,74,74,1,4,61.06,180.08,19.13705,1.79,6,0.127855005,1.53424194,2,4,6,6,9422.427,1,1,581.62,23.96,88.84,32.3,79.79,0.001006,0.0016,1.177e-4,0.00317,30.17,0.023,6.69449,2.2786,0,0.117,0,0,0,0.748,101,53.21,87.0372,0.28,0,0,0.078628,0.01,0,0.277,0,0.286,1.26,0.28876,105.1606,0,0,0.0053,0.194897,0.0071,0.599637,0.0475,0,3.065694,0.326846,0.0245,6.9e-4,0.001,1.067734,104.45,3.3,0,1.087,11.572,0.013,23.4,3.163,139.1,10.618,49.88,338.2466,4.3,1.85,72,181.83,0,74,149,63.18,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,NA,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,NA,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
2,59,59,0,4,76.01,177.95,23.80925,1.92,7,0.031184459,0.3737208,1,4,5,7,3552.709,1,1,175.07,40.08,178.42,16.01,21.05,0.003868,0.0033,0.0399241,0.00403,41.44,0.215,0.11351,2.1981,0.138,0.244,0.08,0.077,0.434,0.702,104,76.16,87.696,0.28,3e-5,0.0173,0.140157,0.075,0.24,0.375,0.107,0.227,0.883,0.37895,118.6081,2.181,13.9262,1.7831,0.630595,0.3305,0.229714,0.1047,25.75,4.643269,3.928848,0.6699,0,0,1.246697,298.6,4.21,0,0.9036,14.55,0,24.05,4.24,140.8,20.044,66.98,380.751,7.49,1.87,62,177.95,0,128,113,70.09,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,Y,Y,N,N,High,High,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
3,73,74,0,3,78.13,163.04,28.73347,1.83,7,NA,NA,0,3,1,7,1507.287,1,1,437.56,31.54,117.36,53.83,37.05,1.2e-4,8e-4,0.0200101,3e-5,0,0.001,7.19583,1.9719,0.002,0.098,0,0,0,0.565,103.9,45.07,116.7259,0.04,0,0,0.019792,4e-4,0,0.002,0.005,0.258,0,0.38986,130.0423,1.9782,10.176,0.7726,0.705204,0.0079,0.398847,0,0,4.306007,4.921664,0.6493,0,0,1.206022,140.81,4.11,1,0.9461,12.013,0.0175,29.61,3.802,138,7.593,69.13,333.0799,5.6,1.69,76,162.8,0,66,136,76.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,NA,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
4,40,39,0,2,80.95,179.27,25.45236,1.98,7,0.117691279,1.41145247,2,2,5,7,751.008,1,1,270.38,30.98,151.94,27.31,32.16,0.00163,0.0024,0.0312524,8e-5,32.27,0.049,0.04491,2.3078,0,0,0,0,0.021,0.704,100,175.08,42.5157,0.14,0,0,0.059702,0.0151,0.015,0.309,0,0.001,2.079,0.28907,103.8282,1.2643,0.1305,0.5643,0.742569,0.0083,0.598599,0.0392,0,4.632192,4.552748,0.7876,0.00384,0.001,1.197466,437.1,4.21,0,1.0909,9.653,0.041,28.85,3.308,141.8,5.141,69.9,63.1296,6.11,1.94,85,179.59,0,81,130,80.67,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
5,66,66,0,1,107.9,177.58,34.52478,2.25,6,0.065266842,0.78357546,0,1,1,6,755.408,2,2,219.8,41.17,140.14,63.21,21.92,0,0,0.0399763,9e-5,30.7,0.144,3.94707,2.2544,0.278,0.127,0.133,0.046,1.463,0.631,100.4,217.11,40.6041,0,0,0,0.220662,6e-4,0.812,0.348,0.62,0.245,7.21,0.43894,143.7084,2.7443,15.2026,0.2001,2.410059,0.0689,0.579307,0,0.44,4.694812,7.712457,0.6543,0.00121,0.001,1.065709,350.63,5.12,0,1.0059,12.111,0.0445,28.6,4.59,140,7.993,68.96,388.9997,7.8,2.06,70,179.9,0,64,103,108.75,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,0,131RR,158VV,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
6,75,75,0,4,52.72,158.03,21.36065,1.53,6,0.069833013,0.83932904,0,4,1,6,7165.147,2,2,436.09,31.47,195.98,10.39,26.12,0.08696,0.0045,0.0163955,3e-5,23.04,0.24,4.6,2.3492,0.054,0.08,0.02,0.015,0.447,0.458,97.9,61.63,70.6546,0,0,0,0.109399,3e-4,0.506,0.392,0.002,0,0,0.34022,106.8646,0.9248,8.1758,1.1869,1.431742,0.0093,0.315224,0.0016,0,4.147324,0.592179,0.0093,0.00633,0.001,1.356523,334.81,3.52,1,0.9873,0.286,0.0525,34.97,3.132,142.9,10.206,65.09,288.367,6.4,1.41,65,155.23,0,83,116,48.62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
8,47,47,0,2,82.38,174.02,26.70495,1.96,7,0.018833618,0.22612675,1,2,3,7,8828.176,1,1,1057.86,38.03,40.81,23.1,26.3,0,0,0.0737211,0.00791,0.83,0.017,6.99904,2.3481,0.251,0.307,0.116,0.096,0.597,0.699,93.3,106.2,71.7328,0,0,0,0.199917,0.02,0.253,0.292,0.311,0.386,6.813,0.31444,98.1403,2.57,7.459,0.81,0.938093,0.0117,0.901782,0.0881,0,8.37651,0.272833,0.0324,0.00215,0,1.19354,319.19,4.3,0,1.1066,0,0.0225,23.6,3.917,138.9,6.835,66.94,252.1569,9.41,1.85,70,175.23,0,83,103,81.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
9,64,64,1,2,76.95,150.64,34.04705,1.73,6,0.126737119,1.52112678,0,2,2,6,9132.121,2,2,158.96,43.1,65.75,21.04,13.08,0,0,0,0,8.16,0.083,5.90063,1.9923,0.085,0.158,0.001,0.044,0.55,0.87,105.1,91.88,68.8617,0.03,0,0,0.109915,1e-4,0.43,0.687,0.148,0.293,0.527,0.4187,145.7533,0.94,0,1.183,0,0,0.035984,0,0,3.951007,0.169427,0.0364,0.00112,0,1.14099,210.87,4.29,0,0.9789,11.128,0.0049,0.63,4.912,143,5.015,61.98,228.6222,4.27,1.69,81,146.22,0,78,138,69.01,1,1,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Other,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
10,59,58,0,1,76.92,172.92,25.60814,1.93,7,0.129488892,1.55445291,0,1,3,7,3651.594,2,2,244.08,41.04,96.79,15,24.05,0,0,8.02e-5,2e-5,23.03,0,5.78302,2.3255,0.369,0.339,0.089,0.065,0.917,0.708,105.1,127.65,54.9407,0,0,0,0.299915,0.0141,0.321,0.01,0.796,0.581,0.511,0.39063,134.3753,1.664,10.5782,16.8223,2.259029,0.0125,1.415925,0.039,0,5.201368,5.752652,0.0352,0.11363,0,0.478344,57.47,3.61,0,1.0146,11.565,0,22.94,4.708,140.3,18.801,70.7,315.1559,8.73,1.88,80,169.98,0,72,120,74.69,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
11,70,70,0,4,64.88,171.95,22.31833,1.75,6,0.098705767,1.1830534,1,4,4,6,1681.96,1,1,898.98,40.07,67.05,9.04,14.07,6.27e-4,0,0.0497499,7.8e-4,28.13,0.165,3.21979,2.481,0.149,0.122,0.001,0.002,0.714,0.751,96.4,97.94,53.4527,0.27,1.8e-4,0.0079,0.358751,3e-4,0.407,0.461,0.256,0.233,0.096,0.40848,133.0032,1.8978,10.804,0.3787,1.295604,0,0.438177,0.0034,17.91,3.208882,0.126408,0,4.6e-4,0,1.205661,300.33,4.31,1,1.1351,0.895,0.0217,27.67,4.136,140,5.11,74.02,305.3888,5.59,1.81,92,173.17,0,75,129,64.42,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
12,18,18,0,2,62.41,165.13,22.79549,1.68,7,0.100652012,1.2076312,1,2,2,7,1222.177,2,2,124.04,40.1,44.24,12.95,10.7,0,0,0.0516406,0,3.59,0.11,5.92418,2.3982,0.078,0,0.058,0.009,1.711,0.881,102.9,147.61,56.1766,0.48,0,0,0.210123,0,0.773,0.374,0.795,0.491,5.038,0.34717,117.6841,0,5.3822,2.306,2.665845,0,0.400299,0,0.74,3.787716,0.357435,0,0,0,1.606575,295.78,4.76,0,0.9097,0,0,0.53,4.378,138.1,11.214,70.06,184.1717,6.81,1.69,58,165.09,0,58,103,59.76,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
13,72,72,0,3,80.95,160.03,30.90872,1.86,8,0.181640947,2.17918529,0,3,3,8,5385.532,1,1,339.27,41.02,116.08,10.39,11.72,0,0,0.0297302,0.00684,26.02,0.078,7.10711,2.4201,0.127,0.073,0,0.001,0.103,0.514,106.1,103.62,53.9969,0,1.7e-4,0.0204,0.06984,0.0076,0.27,0.311,0,0,0,0.35701,109.8618,2.2435,8.2038,0.9145,2.004234,0.289,0.342857,0.0821,16.54,2.995378,0.35791,0.7358,0.0056,0,1.29139,201.99,3.9,0,0.9893,10.752,0,0,4.477,143.2,6.871,68.97,237.5694,4.66,1.92,83,162.43,0,68,148,85.48,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
14,44,44,1,2,59.39,167.78,21.07787,1.66,7,0.035550371,0.42717864,1,2,1,7,4516.171,1,1,304.92,42.63,67.83,22.95,19.19,0,1e-4,0.0903531,0.0101,24.1,0.001,0.09692,2.3497,0.122,0.171,0.06,0.071,0.599,0.65,98,88.78,72.2645,0.19,0,0,0.287454,0.0848,0.271,0.394,0.156,0.194,0,0.4004,139.0912,2.5956,14.8384,1.5859,1.144848,0.3745,0.229168,0.1262,0.55,4.295978,5.202887,0.7409,0,0,1.45023,304.09,4.8,0,1.0313,11.628,0,24.74,4.489,134.9,10.077,77.86,202.1821,6.2,1.66,70,169.1,0,79,110,58.47,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,Y
15,69,69,0,2,94.58,169.86,33.27209,2.04,6,0.059144779,0.70960076,0,2,3,6,1140.414,2,2,155.71,43.9,68.56,18.22,16.09,0.003891,0.0037,2.1e-4,5e-5,22.91,0.119,7.04618,2.3931,0.004,0.001,0.009,0.023,0.288,0.705,105,91.69,71.6852,0,1.8e-4,0.0075,0.006533,1e-4,0.26,0.422,0.005,0.001,0,0.43359,142.08690000000001,0.0149,8.1126,0.5461,1.625867,0.0088,0.490531,0,0,5.014893,1.940092,0.0034,0.00305,0,0.908411,300.82,4.04,0,1.0758,0,0.0776,31.98,5.087,145.8,3.501,69.09,166.992,6.79,2.14,80,170.86,0,70,141,101.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
16,66,66,0,2,69.8,149.73,32.01996,1.63,6,0.106129904,1.27334924,1,2,4,6,5965.664,2,2,366.32,41.01,77.79,4.08,14.31,0.001227,0.0022,0.0100462,0,22.93,0.13,4.89456,2.3241,0.159,0.169,0.036,0.042,0.849,0.745,98.1,115.57,47.743,0,0,0,1.576478,7e-4,0.353,0.292,0.48,0.431,5.936,0.43099,138.9765,3.0863,15.5784,0.6286,1.520608,0.0044,0.549572,7e-4,0.7,2.052798,0,0,0,0,0.910258,392.68,3.51,0,0.9839,12.769,0.0335,31.99,4.809,136.9,7,78.02,509.2963,3.92,1.59,77,149.82,0,78,130,70.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
17,55,56,0,3,54.69,151.82,23.12403,1.5,6,0.019061861,0.22887376,0,3,6,6,7483.329,1,1,326.98,43.9,275.39,13.18,13.98,0,0,0.0095127,0.00275,2.87,0.213,4.90567,2.3008,0.08,0.203,0.037,0.044,0.348,0.772,107.1,133.5,42.06,0,0,0,0.168316,0.018,0.019,0.254,0.258,0.444,0.794,0.39997,132.5362,2.4354,7.9652,1.117,2.022962,0.2502,0.437448,0.066,0.47,4.096261,0.085852,0.0191,0,0,1.490806,260.56,4.9,0,0.9848,12.837,0,27.26,4.491,141,6.813,66.12,260.7803,5.96,1.58,56,151.6,0,84,115,56.54,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
18,65,65,1,2,69,163.67,25.6222,1.74,8,0.02047959,0.24576543,1,2,2,8,2259.281,2,2,336.06,43.1,67.9,10.88,22.9,9.11e-4,0,0.0614187,0.00706,29,0.109,4.55282,2.1292,0.004,0.005,0,0,0.036,0.651,96.2,87.93,67.7201,0,1.5e-4,0.0053,0.159866,8e-4,0,0,0.2,0.332,0,0.31157,103.2931,1.1996,1.164,0.7801,0.89973,0.0362,0.300269,0.0046,0.23,4.593723,3.208404,0.7127,0.00149,0.001,1.518516,269.81,4.21,0,1.0998000000000001,12.769,0.0352,37.65,3.265,135.8,10.262,67.59,233.7868,6.09,1.69,66,164.49,0,87,129,65.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
19,66,65,0,2,NA,168.98,NA,NA,7,0.095434555,1.14381799,1,2,4,7,5426.421,2,2,287.03,25.8,50.5,37.94,36.81,0,0,0.1099614,0.00871,24.9,0,0.05883,2.2596,0,0,0.001,0.025,0.035,0.715,99.9,75.24,80.9392,0,0,0,0.500715,0.0296,0,0,0.207,0.317,3.962,0.39672,128.9266,2.8075,15.4285,1.7533,1.556694,0.1989,0.698278,0.0792,14.96,6.89661,6.580801,0.6488,0.00148,0.001,0.793618,426.77,3.21,0,1.0965,11.362,0,28,5.169,137,6,71.58,464.8005,10.61,1.6,61,169.52,0,91,111,62.13,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,NA,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
20,59,58,0,2,61.28,162.07,23.61111,1.65,6,0,0,0,2,5,6,2297.5,2,2,575.54,44.81,52.78,25.98,20.04,0.002622,0.0025,0.0606152,0.00943,29.83,0.146,2.99823,2.3251,0.789,0.404,0.307,0.094,2.766,0.898,103.9,116.46,60.3162,0.11,2e-5,0.0289,0.200642,8e-4,1.214,0.489,1.753,0.636,0,0.41609,145.578,2.6724,12.2458,1.584,3.794251,0.137,0.760043,0.0994,0,3.118966,0,0,0.00138,0.001,1.068351,240.47,3.91,1,0.9915,0.321,0.0469,35.95,4.391,146.2,17.183,71.24,190.6042,7.1,1.69,80,162.73,0,61,121,67.13,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
21,25,25,0,0,72.54,180.07,22.96245,1.93,7,0.092438293,1.10964283,0,0,4,7,20344.977,2,2,269.16,49.9,81.37,34.87,33.42,0,0,0.0500716,0.0051,0,0.367,4.29515,2.256,0.182,0.09,0.138,0.084,1.209,0.691,104.9,77.86,133.1077,0.53,2.7e-4,0.309,0.199929,0.0199,0.754,0.341,0.588,0.271,0.776,0.3917,129.704,0.0123,14.1058,0.011,2.040392,0.2395,0.66995,0.0631,0.14,4.031403,0,7e-4,0.00608,0,1.125082,192.86,4.7,0,0.7341,10.52,0,26.74,4.224,141.1,8.292,72.92,297.121,6.9,1.96,88,183.94,0,61,155,74.82,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
22,62,62,0,2,70.09,155.99,28.67933,1.7,7,0.104001045,1.24775264,2,2,2,7,4444.361,1,1,334.63,40.91,84.61,16.02,27.23,5.57e-4,0,3.612e-4,0,23.46,0.101,4.99898,2.327,0.507,0.495,0.067,0.061,0.874,0.793,99.1,65.6,91.0701,0,2e-5,0,0.100702,0,0.617,0.511,0.274,0.329,0,0.26263,88.9686,2.9956,12.8583,0.9087,0.80042,0,0.679553,0,0,4.329927,0.58576,0.0308,0.00375,0.001,1.381541,699.42,5.2,0,1.0175,13.312,0,30.89,3.877,141.2,10.247,74.67,422.3811,6.81,1.72,73,154.96,0,79,110,70.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
24,35,35,2,1,48.07,167.95,17.15973,1.52,7,0.058074865,0.6970554,1,1,4,7,8711.009,2,2,339.57,18.52,88.67,15.9,21.93,0,0,0,2e-5,29.07,0.083,0,2.349,0.114,0.174,0.009,0.001,0.803,0.808,100,109,56.1777,0,0,0.0051,0,0,0.374,0.355,0.306,0.413,1.818,0.29917,102.5474,1.7745,7.0857,0.4434,0.630639,0.0509,0.549751,0.0687,0,4.986618,6.517307,0.6649,0,0,0.90815,98.22,3.9,0,1.0901,12.76,0.0049,29.02,3.567,141,8.272,1.04,135.8716,6.14,1.51,58,167.41,0,73,107,48.16,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,POL,Poland,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,Yes,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
25,49,49,1,2,103.91,158.16,41.89609,2.01,6,0.096497063,1.15813992,1,2,5,6,5430.206,2,2,159.77,44.73,54.32,20.49,11.43,0,0,0.0470089,7.4e-4,33.23,0,5.39742,2.4221,0.221,0.186,0.019,0.001,0.406,0,102.2,169.46,59.5989,0,3e-5,0.0093,0.111971,3e-4,0.182,0,0.097,0.001,0,0.46641,152.0605,30.0894,15.329,1.2208,0.60251999999999994,0.0073,0.608964,0.0047,0.22,6.104226,5.784201,0.0145,0.00403,0,1.234379,315.01,3.91,0,1.0012,12.127,0,32.51,5.29,138.9,17.066,70.11,196.0794,8.73,2,80,161.89,0,113,119,100.65,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,AUS,Australia,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Other,Y,Y,M,No,OTH,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
26,61,61,2,5,54.08,160.13,20.71357,1.56,8,0.0426004,0.51133712,1,5,4,8,33169.513,2,2,844.64,27,78.58,20.06,16.95,0,0,0.0818467,5e-5,27.21,0,1.90189,2.3816,0,0.081,0,0,0.026,0.679,95.9,99.22,48.7276,0.37,4e-5,0.0211,0.059808,2e-4,0,0,0.207,0.364,0,0.37975,130.6734,0.3973,10.6084,1.6034,1.060939,0,0.692031,0,0.33,6.891587,3.134027,0.0036,0.00112,0,1.037727,334.41,3.89,1,1.0557,0,0.0415,31.96,5.148,130.2,7.995,62.83,196.1132,8.21,1.63,74,160.57,0.1,68,130,53.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHE,Switzerland,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
27,43,43,1,1,64.53,170.13,22.43398,1.74,6,0.024745143,0.29625179,1,1,6,6,15915.27,1,1,595.72,40,61.97,22.83,84.03,0.001368,0.0017,0.0226831,7e-5,23.19,0,5.50105,2.2705,0.066,0.164,0.091,0.081,0.252,0.566,99,120.72,56.1557,0,1.2e-4,0.0045,0.099539,6e-4,0.319,0.458,0.001,0,0,0.31203,113.6963,2.1763,7.0318,0.3138,1.001891,0.0123,0.698443,0.0335,19.17,3.260358,0.520872,0.0205,5.3e-4,0,1.355648,94.54,1.13,1,1.2076,10.979,0,28.96,3.626,134.3,7.661,63.39,226.0167,4.53,1.82,81,173.51,0.1,95,120,65.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
28,72,73,0,2,63,169.18,22.59774,1.72,6,0.079556358,0.95504182,0,2,3,6,1951.42,1,2,269.6,18.41,73.08,32.17,24.62,0.001736,6e-4,0.0703428,0.00198,27.02,0.002,5.62347,2.1082,0.412,0.231,0.074,0.027,1.227,0.767,92.1,76.69,61.0033,0.3,1e-5,0.0129,0.20137,6e-4,0.677,0.429,0.458,0.276,1.205,0.33392,103.0424,2.0939,8.0392,0.0106,2.143355,0,3.387827,0.0337,28.11,8.782009,4.312834,0.5154,0.00193,0,1.2386,511.97,4.16,0,1.098,11.953,0,24.08,3.706,129.6,3.098,54.11,296.235,11.77,1.8,67,167.96,0,108,90,64.81,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,AUS,Australia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Other,Y,Y,F,No,OTH,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
29,58,58,0,2,52.01,148.46,23.6148,1.45,8,0.157559464,1.89040277,0,2,5,8,4640.071,2,2,361.28,0,137.85,85.39,86,1.01e-4,0,0.0150069,6e-5,29.5,0.001,4.19518,2.2596,0.126,0.212,0.032,0.061,0.386,0.636,93.8,121.76,43.1047,0.45,1.3e-4,0.0228,0.019313,0,0.405,0.475,0.006,0.113,0,0.22696,72.8734,1.8649,8.3804,0.9123,0.418823,0.0598,0.499167,0.0749,16.6,3.175556,5.561507,0.6197,0.00161,0,1.516891,272.72,3.7,1,1,13.707,0,31.44,3.167,137,3.097,55,256.7861,4.53,1.56,55,149.1,0,69,106,55.64,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,North America,Y,Y,F,Yes,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
30,59,59,0,3,70.87,166.94,26.14744,1.8,6,0.008382566,0.10041094,0,3,4,6,14024.059,2,2,638.77,65.11,64.02,7.15,14.9,0.002983,0.0033,0.0624076,0.00496,0,0.002,5.35372,2.4427,0.434,0.369,0.046,0.045,0.842,0.576,105.9,78.02,88.3239,0.01,0,0,0.300305,0.0103,0.469,0.32,0.302,0.23,2.203,0.47951,152.759,1.8811,12.2464,0.8211,3.492937,0.1986,0.498438,0.0044,0,3.648322,0,0.0355,0,0,1.019569,450.76,4.77,0,1.0176,12.216,0.021,34.83,5.598,143.8,10.061,73.99,452.4828,8.21,1.76,90,168.06,0,81,135,70.04,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
31,74,74,0,3,47.58,161.01,18.72596,1.49,6,0.069577887,0.8331285,1,3,5,6,2481.719,2,2,335.31,37.9,77.61,12.93,18.05,0,0,0.0400206,6e-5,30.07,0.151,5.51432,2.3825,0.068,0.006,0.213,0.122,1.224,0.845,104.9,78.14,51.5535,0,0,0,0.13082,2e-4,0.541,0.417,0.511,0.359,5.114,0.39279,133.1507,1.7242,11.1623,1.622,1.6014,0.0062,0.300817,7e-4,0,3.612893,0,0,0.00215,0,1.480751,196.38,3.91,0,0.9485,0.297,6e-4,24.94,4.453,137.1,7.562,75.14,184.9661,5.89,1.4,61,159.77,0,73,114,45.65,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,< 55,>= 60,>= 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,High,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
32,78,78,1,5,104.16,176.77,33.30251,2.21,6,0.016182069,0.19423651,1,5,5,6,13887.879,1,1,311.88,37.92,45.99,8.84,14.09,0,0,0.019918,0,26.92,0.159,5.90386,2.3781,0.222,0.176,0.025,0.017,0.889,0.787,103,69.85,85.7409,0,0,0.0124,0.01918,0,0.45,0.294,0.471,0.461,6.336,0.37865,127.915,1.4065,0.8476,0.0069,2.291745,0,1.407636,0,0,5.581631,0,0,0,0,0.055057,242.04,3.13,1,1.0779,0,0.0128,34.82,4.328,144.9,8.595,56.74,315.1235,9.6,2.11,81,178.08,0.1,80,136,108.23,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
33,72,72,1,5,64.06,154.98,26.02848,1.62,7,0.043838496,0.52527989,2,5,6,7,33599.848,1,1,448.39,0,57.69,27.74,25.87,0.002795,0.0017,0.0100872,0,25.06,0.138,3.59369,2.4009,0,0.002,0,0,0,0,102.9,82.62,60.7547,0.26,0,0,0,0,0,0,0,0,3.453,0.28081,95.0614,0.0057,4.74,0.3959,0.369969,0,1.061163,0,0.29,4.476045,2.5758,0.0029,0.00312,0,1.230113,182.58,3.12,1,1.1988,0,0.0332,26.04,3.336,136.1,3.409,0,184.7712,5.61,1.6,91,152.47,0,92,141,62.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,High,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,Y,Y,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
35,56,56,0,1,72.04,178.17,22.78781,1.91,6,0.04119671,0.49441944,0,1,2,6,1363.753,1,1,549.01,47.09,68.62,43.47,181.07,0,0,0.0998519,0.00406,0.81,0.232,8.57187,2.3607,0.723,0.412,0.497,0.179,1.864,0.711,91.2,80.91,82.2306,0.31,9e-5,0.0078,0.00996,0,0.833,0.292,0.904,0.384,1.648,0.49649,171.7605,1.7502,6.5114,0.2304,3.511452,0.0039,0.658874,0.0035,0.51,5.620912,0,0.0045,0.00563,0,1.193996,126.95,4.81,0,0.9378,11.641,0.0383,31.99,5.251,139,14.111,72.04,408.8022,8.08,1.81,68,175.32,0,80,118,69,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
36,64,64,0,4,67.81,158.07,26.69929,1.68,8,0.237031019,2.84353815,1,4,5,8,1942.376,1,1,528.08,32.01,122.09,29.02,21.03,7.41e-4,0.0018,0.1010263,0.00494,25.69,0,0.0266,2.7034,0.139,0.096,0.081,0.041,1.232,0.706,100.9,76.19,73.3708,0,8e-5,0.013,0.130172,0.0138,0.491,0.009,0.576,0.313,0.265,0.34959,110.2005,0.9963,10.492,1.0944,3.221879,0.1817,1.028907,0.0051,0,4.201625,6.211785,0.5809,0.00252,0,0.868907,442.51,4.19,1,1.0917,11.409,0,33.96,4.645,140.9,6.981,69.92,184.0723,8.81,1.61,71,158.13,0.1,85,120,65.76,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
37,31,31,0,2,82.53,174.95,26.1776,1.98,6,0.041949134,0.50259069,1,2,6,6,8847.78,2,2,229.37,7.2,49.09,12.13,17.74,0,0,3.98e-5,3e-5,26.57,0.001,3.60062,2.3112,0.134,0.178,0.061,0.072,1.01,0.809,108.2,133.38,61.8787,0.13,1.4e-4,0.0207,0.159555,2e-4,0.619,0.557,0.277,0.275,0,0.41463,143.4388,2.5214,14.1529,1.3933,1.346118,0.0024,0.678348,0.0047,0.65,6.132825,4.96943,0.5653,0,0,1.455593,264.54,4.2,0,1.1545,11.242,0.0242,24.91,4.549,142,3.481,57.9,248.0155,9.2,1.93,70,172.91,0,78,121,78.12,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
38,61,61,1,2,48.03,154.16,19.65115,1.43,6,0.050647965,0.60891831,0,2,5,6,3901.36,2,2,106.11,27.05,97.79,17.95,13,0.001525,0.0028,0.0099533,7e-5,23.01,0.039,8.93723,2.4562,0.038,0.136,0.026,0.048,0.213,0.699,99.9,60.56,81.1723,0.33,1.8e-4,0.0283,0.029663,8e-4,0.216,0.359,0.003,0.096,4.556,0.36937,123.8018,1.0989,12.8407,1.1094,0.59134,0.1781,0.3997,0.0767,0.76,6.10666,0.575129,0.6526,0.00112,0,1.063282,183.93,4.8,1,0.8787,11.343,0.0292,0,4.505,134.2,3.859,75.82,282.3176,6.53,1.38,52,154.03,0,99,94,47.28,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
39,84,84,0,2,43.47,154.92,17.89579,1.38,7,0.170294092,2.04406587,0,2,4,7,72.13,2,2,219.19,40.94,109.76,16.93,24.18,0.002527,0.0036,2.561e-4,9e-5,26.29,0.015,5.81532,2.3957,0.398,0.165,0.048,0.023,1.003,0.705,104,33.88,74.513,0,0,0.0116,0.187456,0.0342,0.596,0.386,0.351,0.21,0,0.40976,133.8026,2.5774,12.5323,1.1057,1.867149,0.3529,0.399507,0.0807,16.47,1.750856,0.4316,0.0161,6.7e-4,0,1.269201,107.55,5.51,0,0.9942,12.3,0,32.12,4.317,139.9,13.366,70.94,227.7109,3.7,1.3,70,152.79,0,85,114,35.9,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
40,50,50,3,3,81.64,170,28.40387,1.96,7,0.083711995,1.00609385,1,3,3,7,23776.991,2,2,898.6,36.09,77.57,44.85,32.33,0.00219,0.0024,0.0111559,0.00403,25.98,0,11.37859,2.4,0.101,0.119,0,0,1.081,0.823,100.1,103.61,84,0,1.1e-4,0,0.336256,0.0408,0.288,0.002,0.862,0.58,0,0.40917,131.7197,0.8699,6.8007,0.5284,1.976156,0.27,1.347987,0.1366,0,6.19448,4.969912,0.6259,0.00216,0.001,1.389388,468.74,4.91,1,1.0183,7.301,0.0444,27.38,4.805,141.1,3.486,73.07,285.4392,9.45,1.92,81,172.79,0,97,136,85.78,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
41,49,48,0,2,66.85,170.13,23.68675,1.77,7,0.192196474,2.30759937,1,2,2,7,2487.716,2,2,496.81,37.02,100.91,16.84,11.69,0.001453,0.0019,0.0200109,0,0,0.099,3.3087,2.3273,0.234,0.093,0.076,0.013,0.995,0.012,96.9,85.8,87.5029,0,1.3e-4,0.0056,0.099844,0,0.5,0.222,0.291,0,0.566,0.37148,126.6545,2.305,9.7001,0.6522,4.241674,0,1.334656,0,30.46,8.042854,2.063644,0.0112,0.00315,0,1.282548,278.5,4.6,0,1.0065,0,0,26.73,4.378,139,10.22,74.86,190.179,15.32,1.78,91,172.02,0,80,131,69.88,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
42,65,66,0,3,72.41,162.82,27.1649,1.8,8,0.082785561,0.99419193,1,3,6,8,4947.936,1,1,426.14,39.04,60.15,36.72,51.79,0,0,0.0198602,0.00399,34.57,0.059,4.60462,2.1896,0.004,0.096,0,0.001,0.053,0.698,100.9,58.38,98.0321,0.05,4e-5,0,0.199925,0.0137,0,0.298,0.13,0.239,0.413,0.2836,93.1334,1.9989,7.6161,0.5057,0.964957,0.181,0.399365,0.031,0.05,4.998535,2.775104,0.7326,0,0,1.098118,253.17,4.11,2,1.0944,10.725,0.0042,27.98,3.603,137.1,6.106,67.94,327.0659,6.87,1.8,68,159.65,0,82,127,70.4,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,NA,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
44,65,65,2,2,65.03,160.06,25.36989,1.68,7,0.113863849,1.365096,0,2,1,7,6006.116,2,2,586.4,37.03,321.66,16.89,28.16,0,0,0.0499879,0.00116,30.23,0.001,7.88026,2.3442,0.376,0.227,0.051,0.027,1.102,0.703,96.9,92.44,60.5639,0,1.6e-4,0.0145,0.02198,6e-4,0.578,0.333,0.476,0.339,0,0.3549,116.9343,2.4015,7.0997,0.6987,1.107853,0.1795,0.820786,0.0993,24.31,4.644362,12.160575,0.031,0,0,1.259782,456.78,5.28,1,1.22,14.485,0.0181,33.01,4.398,138.5,11.916,61.97,202.6812,7.03,1.68,90,159.9,1,104,130,64.84,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,Yes,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
45,60,60,0,4,56.93,156.76,23.07115,1.56,6,0.061552606,0.73885686,0,4,3,6,2341.186,2,2,495.37,35.06,174.3,23.04,19.1,5.6e-4,5e-4,0.1017088,9e-5,30.04,0.105,4.30132,2.452,0.19,0.134,0.048,0.038,1.074,0.79,100.9,125.91,43.9802,0,1.6e-4,0.0093,0.489917,7e-4,0.527,0.358,0.521,0.425,3.614,0.38404,122.7871,2.5408,5.7165,0.5364,2.259931,0.0074,0.532433,0.0018,0.4,2.898361,0.079412,0,0.00135,0,1.131418,335.06,4.16,0,1.0403,10.846,0.0179,33.89,4.515,139.4,5.109,69.97,175.6358,5.5,1.6,80,157.98,0,67,132,57.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
46,73,73,0,3,58.58,157.87,23.50665,1.59,8,0.086666532,1.04014059,1,3,1,8,679.424,1,1,514.6,40.92,68.31,13.16,25.93,0,0,0.0610806,7e-5,24.96,0.15,9.67898,2.2575,0.503,0.339,0.162,0.099,1.173,0.742,98,58.89,78.9658,0,0,0,1.01896,0.0299,0.619,0.39,0.477,0.305,3.215,0.38958,124.1403,2.2392,7.9163,0.5109,1.149474,0.0076,0.200371,0,11.08,2.885998,0.233834,0,0,0,1.00186,479.24,4.2,0,0.9116,0,0,26.36,4.484,137.9,5.075,73,380.6393,4.57,1.44,69,154.97,0,77,112,54.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
47,74,74,0,2,54.95,164.95,20.30584,1.58,6,0.058237414,0.69907786,1,2,2,6,1890.425,2,2,207.13,34.01,106.85,13.14,17.07,0,8e-4,0.09978,0.01007,30.72,0.26,0,2.2082,0.125,0.178,0.044,0.061,0.364,0.017,104.1,67.7,68.078,0,8e-5,0,0.299971,0.0447,0.022,0,0.21,0.271,2.447,0.37086,134.4905,4.2424,11.8091,0.9606,1.496844,0.3096,0.598845,0.1092,0.09,2.693873,0.244913,0.529,0.0068,0.001,0.23295,222.66,3.81,0,1.0157,0.434,0.0156,26.76,4.226,137.3,11.977,74.9,288.6272,6.11,1.5,70,163.73,0,88,142,53.42,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
48,42,43,0,2,78.9,182.36,24.00495,2,7,0.09049458,1.08571355,1,2,3,7,812.834,2,2,418.92,44,102.81,29.34,28.2,9.79e-4,0,0.0199218,0.00606,33.52,0.08,0,2.5811,0.305,0.251,0.129,0.111,1.079,0.416,98.1,122.07,57.7142,0.06,3e-5,0,0.099536,0.0203,0.696,0.431,0.291,0.002,0.714,0.39301,135.332,1.6243,10.171,0.6592,0.839898,0.2634,0.398778,0.0921,31.91,4.040583,7.859207,0.6245,0.00397,0.001,1.227947,287.89,5.12,1,0.988,12.713,0.0457,27.08,4.316,140,6.826,76.05,336.1848,5.59,1.99,85,182.52,0,110,152,79.35,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
49,45,46,0,3,65.01,166.97,23.73411,1.73,8,0.004774013,0.05703461,1,3,5,8,3183.746,1,1,2545.17,41.92,73.12,11.97,26,0.001372,0.0011,0.020035,0.0023,0.2,0.017,4.70551,2.4602,0.37,0.352,0.222,0.155,1.031,0.756,95.1,91.68,75.0639,0,3e-5,0,0.643012,0.0196,0.532,0.405,0.368,0.293,0,0.34386,118.493,1.7393,10.0853,0.5755,1.259662,0.0129,0.349284,0.0039,0.73,4.368405,0.044759,0.0228,0,0,1.098456,467.2,4.41,0,1.1006,0.098,0.0346,30.91,4.311,139.3,8.558,61.96,287.2899,6.73,1.65,68,165.75,0,87,109,60.28,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
50,66,66,0,3,58.98,162.51,22.59271,1.62,6,0.053216678,0.63901616,1,3,1,6,1877.329,2,2,941.21,21.19,53.74,18.34,26.02,5.7e-5,0.0028,0.0769551,9e-5,27.72,0.146,4.28186,2.1266,0.946,0.465,1.183,0.327,1.987,0.742,96.9,54.62,89.2332,0.21,0,0.0045,0.292433,0.0115,1.375,0.503,0.664,0.315,3.666,0.27732,89.7516,1.8359,5.4529,1.2832,1.303894,0.0344,0.299774,0.0018,10.91,4.589713,0.472369,0.0133,0.00248,0,0.968702,291.77,2.56,0,1.1072,10.091,0,0,3.858,140.8,9.372,48.18,231.9722,6.39,1.52,67,158.19,0,87,137,53.3,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
51,27,27,0,2,73.95,160.15,28.26693,1.79,7,0.107774382,1.29186691,0,2,4,7,6837.859,1,1,187.72,40.03,152.86,14.77,14.05,0.001753,0.0014,0.0375008,2e-5,28.01,0.08,4.06229,2.2992,0.003,0.001,0.055,0.022,0.806,0.562,102,175.58,46.0633,0.05,2.4e-4,0.0026,0.099665,0,0.572,0.323,0.251,0.115,0,0.35967,123.5159,3.2561,14.6748,0.4001,1.356663,0.0052,1.353106,0.0507,0,7.560605,2.60605,0.0178,0,0,1.330222,469.75,4.69,0,1.1614,10.989,0.0055,26.75,4.16,141.1,7,78.16,266.6446,9.46,1.8,70,162.93,0,96,107,75.93,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
52,64,65,1,4,50.99,169.12,17.86871,1.58,8,0.088442187,1.06234961,2,4,6,8,6449.845,1,1,1945.44,33.98,79.94,15.01,49.62,0,7e-4,0.0084693,0.00296,28.93,0.001,4.28382,2.3334,0.068,0.362,0,0.079,0,0,95.8,176.83,2.2255,0,0,0,0.071468,8e-4,0,0,0,0,2.282,0.30083,96.7206,3.8994,13.304,0.9105,0.308315,0.0059,0.499906,0.0648,32.2,3.8066,3.72396,0.6509,0.00376,0.001,1.351265,156.62,3.36,0,1.6943,14.688,0.0326,26.69,4.254,135,11.043,68.96,303.9869,4.6,1.62,64,171.91,0.1,95,115,55.48,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,Yes,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
53,67,67,1,2,81.07,159.89,32.32176,1.87,6,0.019016949,0.22807964,2,2,2,6,1264.098,2,2,240.94,32,47.49,31.03,17.89,0,0,2.987e-4,5e-5,25.44,0.159,7.17961,2.0593,0.08,0.004,0.111,0.112,0.797,0.776,0,84.92,72.8819,0.35,0,0.0024,0.076104,5e-4,0.246,0.281,0.471,0.438,0.08,0.29525,105.2107,2.7492,12.6114,1.2948,2.02269,0.0675,0.698148,0.0659,0,4.10919,0.174826,0.006,0.00315,0.001,1.080414,166.13,3.71,0,0.96,10.272,0,34.03,4.052,3.5,14.68,65.99,217.5758,6.86,1.8,78,157.09,0,70,119,78.29,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
54,83,83,0,2,69.94,156.16,28.63495,1.7,6,0.031740309,0.37992159,0,2,6,6,2082.451,1,1,188.25,30.99,96.4,18.25,22.93,0.002152,0.002,0.0272516,0.003,23.44,0.08,6.0634,2.1731,0.396,0.308,0.058,0.041,0.971,0.819,102.2,71.25,54.8693,0.02,0,0,0.351764,0.0118,0.551,0.448,0.363,0.317,0,0.34321,121.0956,1.0631,9.0195,0.2003,1.072521,0.0073,0.905947,0.06,0.47,5.111079,3.992022,0.0117,0.00646,0.002,1.042511,174.56,3.29,0,1.2905,11.87,0.0035,30.46,3.784,139,13.621,70.93,231.9826,8.43,1.72,80,157.04,0,81,150,67.93,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
55,70,70,0,2,96.17,169.25,33.30929,2.07,6,0.103762167,1.24515139,1,2,3,6,2820.157,2,2,260.76,36.02,57.84,14.84,33.91,0,0,0,0,0,0,5.99909,2.16,0.229,0.166,0.135,0.117,1.4,0.875,104.1,100.04,70.6961,0.16,0,0,0.100474,0,0.716,0.469,0.582,0.429,0.996,0.39382,127.9046,1.0469,6.6942,0.4802,0.798763,0,0.81312,0,0.58,5.019048,0.277545,0,0.0029,0,1.027609,218.04,4.7,1,1.0778,0.457,0,27.38,4.5,140.8,14.058,58.66,392.897,7.32,1.99,79,167.39,0.1,73,139,90.06,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,Yes,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
56,74,74,1,3,72.56,182.97,21.96418,1.94,7,0.089311566,1.06967003,0,3,6,7,5982.877,2,2,931.23,42.03,91.16,17.87,23.93,1.46e-4,0,0.0759512,0.00188,1.4,0,7.4995,2.5257,0.294,0.15,0.097,0.059,1.306,0.8,97.9,40.35,149.1151,0.05,1.3e-4,0.0089,0.03988,9e-4,0.574,0.312,0.724,0.461,0,0.47442,150.2925,0.9115,0,0.3049,1.700132,0.074,0.812593,0.0371,0.04,22.229656,2.39703,0.7299,0.00215,0.001,0.980864,456.8,4.7,0,0.9916,0.456,0.0249,24.34,5.242,134.7,10.236,55.37,279.617,22.22,1.92,76,183.33,0,91,125,74.59,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
57,61,61,1,3,79.96,163.07,29.40309,1.86,8,0.236627524,2.83939973,2,3,6,8,15285.217,2,2,854.86,34.09,163.77,41.08,33.74,0.003415,0.004,0.0297373,0,31.09,0.024,2.642,2.3219,0.002,0.003,0.001,0.017,0.473,0.512,96.9,71.07,91.6959,0,3e-5,0.0142,0.078266,0,0.273,0.43,0.064,0,0,0.33675,109.6857,1.4286,0.0372,0.8993,1.040392,0,0.66994,1e-4,31.96,13.215399,4.779983,0.3443,0.00158,0,1.518145,412.14,4.49,0,0.966,0.791,0,0.9,4.011,140,5.15,59.85,303.3601,10.88,1.95,71,165.01,0,84,137,87.93,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,Yes,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Other,Y,Y,F,No,CASA,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
58,65,65,0,4,81.66,170.9,27.77667,1.95,6,0.031179866,0.37386532,0,4,3,6,1990.836,1,1,882.43,36.03,127.23,16.97,25.19,0.001434,0.0023,0.0114247,0.00101,29.11,0.224,8.95765,2.2793,0.286,0.237,0.142,0.119,0.873,0.625,104.1,87.6,68.0472,0.38,1e-5,0.0234,0.159756,6e-4,0.496,0.381,0.338,0.243,2.045,0.33121,120.088,2.1024,8.2817,0.6396,1.39089,0.1568,0.227959,0.0039,27.75,5.757569,2.446847,0.6649,0.00107,0,0.838887,289.61,3.71,0,0.9432,0,0.0604,24.25,4.596,136.1,5.3,70.29,409.6011,7.18,1.93,79,169.85,0,84,131,80.25,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
59,57,56,0,1,84.72,156.58,35.0129,1.84,7,0.034013163,0.40777428,0,1,2,7,1693.059,2,2,230.36,35.93,164.26,22.1,21.03,0,0,0.03002,0.0099,29.43,0,4.76287,2.3969,0.025,0.061,0.087,0.091,0.582,0.803,99.1,122.31,61.0067,0.09,1.9e-4,0.0112,0.099684,0.0221,0.364,0.385,0.243,0.342,0.96,0.40982,135.5514,0.0256,0.0319,0.3781,0.906794,0.1631,0.584078,0.049,0,6.517472,3.361573,0.0208,0.00499,0.001,1.033951,201.18,4.2,0,1.2314,0.402,0.0338,31.21,4.47,135.9,6.921,66.85,196.7708,8.51,1.83,80,158.11,0,105,120,82.56,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
60,41,41,0,2,60.17,169.94,21.10871,1.69,6,0,0,1,2,2,6,3693.857,2,2,619.47,46.94,65.03,27.31,59.09,8.78e-4,2e-4,0.1004602,0.00957,24.98,0.363,3.16207,2.4201,0.27,0.223,0.097,0.061,1.176,0.837,101,93.97,77.8402,0,0,0,0.48963,0.0349,0.649,0.547,0.587,0.502,0,0.39291,133.9669,0,0,0.5072,0.991456,0.2143,0.459171,0.0656,0,3.085053,4.527435,0.0386,0,0,0,215.44,3.88,1,0.991,0.2,0.0847,28.76,4.56,141.1,17.318,73.08,446.0588,5.59,1.63,94,169.29,0,108,138,58.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
61,35,35,1,1,100.78,171.95,34.60496,2.13,7,0.102430977,1.23028336,1,1,1,7,5043.853,2,2,156.63,39.02,43.46,14.69,12.93,0,0,0,0,31.92,0.201,0.10178,2.2916,0.088,0.022,0.027,0.001,0.426,0,103,85.68,106.3999,0,0,0,0.040856,2e-4,0.079,0,0.191,0.12,2.203,0.41032,139.8576,1.3819,10.297,0.3962,1.872985,0,0.640605,0,0.23,4.003029,0,0,0,0,0.96068,204.45,3.09,0,1.0056,11.307,0,29.34,4.593,143,6.013,77.02,377.475,6.14,2.09,81,170.03,0,70,129,106.12,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
62,44,44,0,1,96.09,169.46,32.91016,2.05,7,0.079291898,0.95083101,0,1,4,7,3824.417,1,1,210.16,44.92,65.54,13,19.95,0,0,0.0269724,0,24.12,0.159,9.64582,2.3402,0.792,0.489,0.366,0.156,1.33,0.621,99.1,105.66,79.5925,0.02,1.1e-4,0.0157,0.501116,0.0047,0.998,0.468,0.474,0.252,0,0.4435,154.2183,0.4727,6.3259,1.2466,0.931763,0,0.640162,0,24.91,5.102211,0,0,0.00815,0,0,166.73,4.8,0,0.1187,0.003,0.0125,0,5.259,140,12.83,76.02,440.1605,6.81,2.08,80,168.02,0,72,137,99.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,Y,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
63,78,78,0,4,72.04,162.19,27.33291,1.77,8,0.057939389,0.69529771,1,4,3,8,5082.458,2,2,557.21,39.01,85.13,21.94,21.45,0.001693,7e-4,7.42e-5,1e-5,24.21,0.001,11.79342,2.4998,0.06,0.073,0.084,0.091,0.504,0.699,104,70.06,69.959,0,0,0.001,0.095106,6e-4,0.335,0.432,0.154,0.218,0,0.37741,121.7579,2.0539,12.223,0.4502,0.789286,0.1278,0.452937,0.0039,0.56,2.409752,0.2262,0.0134,0,0,1.132429,149.65,4.31,0,1.1256,10.157,0.0341,32.99,4.269,143,5.997,65.98,231.6943,3.76,1.64,76,162.05,0,70,128,70.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
64,63,63,0,3,60.09,155.13,24.28821,1.59,8,0.117973528,1.41545159,1,3,6,8,780.769,2,2,216.52,44.98,70.71,24.97,39.65,0.001966,0.0029,0.1057069,0.00237,28.21,0.2,0.06022,2.5735,0.185,0.091,0.252,0.197,1.817,0.813,88.6,85.64,60.7778,0.11,0,0,0.447907,0.043,1.076,0.481,0.753,0.429,0.001,0.39886,140.9634,3.3717,23.546,1.5238,2.241721,0.2359,2.422304,0.1178,0.12,5.105634,0.092324,0.0043,1e-5,0.001,1.227242,180.16,3.71,0,0.839,0,0.0192,0.57,4.469,142.4,13.641,77.03,347.8591,9.79,1.55,58,150.22,0,65,120,55.18,1,0,0,0,0,0,0,1,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
65,37,37,0,2,NA,NA,NA,NA,6,0.104750883,1.25584199,1,2,5,6,3646.383,1,1,509.97,35.1,161.35,65.27,87.48,5.42e-4,0,0,0,22.66,0.296,10.29402,2.3008,0.065,0.179,0.16,0.234,0.707,0.825,104,203.23,36.2974,0,0,0,0.014616,0,0.468,0.549,0.236,0.281,7.697,0.36455,120.037,2.8962,11.5959,1.3247,0.552106,0,0.380347,0,30.5,2.136367,0.223684,0,0,0,1.042216,183.62,3.71,1,0.9821,13.332,0.0042,26.47,3.949,143.1,11.08,72.53,239.0753,3.72,1.76,68,169.39,0,64,112,60.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,NA,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
66,62,62,1,2,53.3,158.89,21.09034,1.53,7,0.054762832,0.65667384,0,2,2,7,11322.124,1,1,367.54,33,69.16,78.2,58.22,0.002204,0.001,0.0904737,9e-5,24.1,0,0,1.8667,0.336,0.209,0.212,0.131,0.581,0,102,120.05,48.5137,0.06,4e-5,0.0113,0.070001,8e-4,0.397,0.23,0.146,0.086,0,0.32056,114.7929,3.71,30.8185,3.9713,2.010318,0.045,2.895261,0.1003,27.08,11.551278,0,0,0,0,1.178235,303.19,3.3,0,1.0529,11.621,0.0717,27.64,4.344,139.9,2.503,68.49,160.4889,11.5,1.56,72,162.11,0,81,106,55.72,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
67,73,73,0,2,74.23,162.18,27.99553,1.81,7,0.198047299,2.37991754,1,2,2,7,417.697,NA,1,132.63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,NA,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,NA,Rituximab plus 6 CHOP cycles,NA,NA,N
68,59,59,3,3,59.09,153.28,25.14764,1.57,7,0.157551672,1.89190088,0,3,5,7,20617.597,1,1,427.79,40.36,116.83,26.75,45.81,2.36e-4,3e-4,0.0297048,4e-5,6.72,0.36,3.43809,2.3491,0.211,0.234,0,0.001,0.044,0.594,104.1,70.11,79.5907,0.32,5e-5,0.0118,0.119499,4e-4,0.01,0.304,0.005,0.157,0.848,0.36487000000000003,117.5,2.432,15.4822,0,0.080167,0,0.660208,0.0037,0.57,6.615302,2.057679,0,0.00416,0.001,1.228125,252.03,4.59,0,0.8297,11.773,0,0.09,4.8,140.1,9.935,69.97,315.0321,6.79,1.7,87,154.23,0,88,136,64.87,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
69,43,43,1,2,58.37,164.15,21.10214,1.62,6,0.008945161,0.10704581,1,2,6,6,11660.024,1,1,185.92,15.78,69.06,32.94,32.39,0,0,0.0200342,0,27.64,0.171,7.78274,2.1562,0.244,0.146,0.143,0.089,0.878,0.604,107.1,99.86,65.9162,0.33,1e-5,0.0096,0.04953,0,0.588,0.367,0.317,0.11,1.576,0.33045,104.9786,2.6583,11.0981,1.7086,1.233824,0,0.560396,2e-4,0.59,7.470063,5.097426,0.6248,0,0,1.223068,235.77,3.32,0,0.9736,10.409,0.0599,0.31,4.097,143.1,6.839,71.09,136.0086,9.19,1.69,86,163.95,0.1,91,103,59.16,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VV,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
70,73,73,2,3,59.96,156.7,24.54548,1.6,6,0.021842759,0.26195245,0,3,4,6,15919.974,2,2,1366.08,45.02,217.28,20.42,38.14,5.97e-4,0,2.143e-4,0,29.03,0,12.35707,2.7785,0.302,0.264,0.013,0.016,0.274,0.583,97.9,95.98,53.9822,0.06,1.1e-4,0.0091,0.030648,0,0.301,0.26,0.078,0.227,0,0.44085,141.116,2.0031,8.3463,0.6174,0.769185,0,0.747956,8e-4,0.57,5.066503,5.166822,0.7212,0.00363,0.001,0.10295,240.77,3.99,0,1.183,0.105,0.0416,36.01,5.368,132.2,13.321,75.94,95.2041,5.54,1.58,62,155.24,0.1,109,105,55.34,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
71,76,76,0,4,65.27,176.4,21.47364,1.82,6,0.078164001,0.93692237,1,4,6,6,5174.443,1,1,1595.8,35.96,159,34.85,61.09,0,0,0.0894995,9e-5,23.6,0.09,5.50757,2.3113,0.172,0.142,0.056,0.05,1.568,0.858,0,57.97,79.2736,0.04,7e-5,0.0058,0.100491,7e-4,0.758,0.509,0.694,0.505,3.261,0.33587,114.5639,2.1806,9.2015,0.8605,1.040268,0.0054,0.599895,0,25.42,3.702399,0,0.0147,0,0.001,1.23544,296.45,4.77,0,1.096,0,0.0083,0,3.544,138,6.032,68.31,329.001,6.5,1.83,59,176.34,0,94,97,67.13,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
72,63,63,0,1,64.52,159.73,25.530639999999998,1.67,6,0.139253531,1.67054536,0,1,3,6,302.591,2,2,90.48,25,54.98,12.06,0,0.001683,0.0012,9.66e-5,0,1.94,0.151,3.39238,1.9433,0.162,0.065,0.096,0.042,1.563,0.85,102.1,105.43,49.1402,0,0,0,0.099682,0,1.112,0.614,0.407,0.303,3.147,0.39574,130.566,2.1772,9.9963,3.3688,1.684543,0,0.300124,0,0.24,3.09741,3.620577,0,0,0,1.218453,374.31,3.32,0,0.9922,0,0,28.81,5.069,137,5.168,59.73,3.3449,4.48,1.74,80,160.12,0,77,130,69.03,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
73,39,40,1,2,76.97,173.47,25.70997,1.93,6,0.027680748,0.33216613,1,2,2,6,2514.654,1,1,498.26,40.6,164.8,13.85,9.87,0.002379,9e-4,0.0399649,0.00909,0,0.174,6.6167299999999996,2.2191,0.19,0.139,0.11,0.085,1.072,0.806,106.8,125.52,61.9089,0,7e-5,0,0.040328,8e-4,0.487,0.313,0.489,0.392,0,0.50339,160.2628,1.977,7.0991,0.7256,2.080464,0.1192,0.697723,0.003,0,12.816833,5.702698,0.7287,0.00202,0.001,1.067176,239.6,4,0,0.9979,10.046,0.0136,31.73,5.961,144.2,10.85,61.03,200.041,15.21,1.87,82,171.94,0,74,130,77.22,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
74,67,67,0,3,75.97,171.92,25.50713,1.91,6,0.045724674,0.54932515,1,3,3,6,7791.062,2,2,1148.93,37.68,164.21,22.85,36.88,0.044183,0.0023,0.0099492,6e-5,22.73,0.1,10.88734,2.286,0.234,0.145,0.048,0.036,0.368,0.48,105.1,70.44,83.9999,0,1.5e-4,0,0.199881,0.009,0.137,0.183,0.206,0.228,0.863,0.36182,112.5153,3.8528,10.4511,1.3513,1.524135,0.1629,1.760812,0.0808,0.33,4.040338,2.595745,0.567,0.00329,0,1.165697,140.45,4.28,0,1.0082,13.298,0,31.08,4.458,141.9,11.909,57,463.1595,8,1.74,75,170.03,0,97,109,73.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
75,63,64,1,2,60.91,154.96,25.21691,1.6,6,0.077774522,0.93335333,0,2,2,6,17152.315,2,2,369.86,40.1,75.08,9,30.18,0,0,0.0372556,0,2.88,0.079,5.32069,2.5197,0.321,0.225,0.003,0,0.867,0.727,104,71.61,80.1942,0.15,0,0,0.147126,0,0.444,0.347,0.363,0.328,5.26,0.35777,128.7395,0.0081,0,0.3084,1.259259,0,0.45653,0,0,3.647236,0,0,0.0019,0,1.149407,254.22,4.05,0,0.9934,12.163,0,38.41,4.158,139.1,10.901,64.03,351.3904,5.31,1.64,93,156.34,0,107,153,59.94,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,>= 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
76,65,65,0,1,41.32,150.52,17.65284,1.31,7,0.117721784,1.41408127,0,1,3,7,1152.084,2,2,170.16,45.96,60.18,6.72,16.02,0,2e-4,0.0795943,0.00847,26.07,0.063,4.99075,2.5259,0.352,0.28,0.019,0.022,1.002,0.744,105.9,89.7,44.0237,0.21,7e-5,0.0091,0.110042,0.0203,0.575,0.387,0.465,0.309,0,0.38611,116.0091,2.072,7.92,0.4461,1.610192,0.3195,0.053036,0.0601,0.27,1.92951,0,0.024,0.0037,0.001,1.390039,374.46,4.61,0,0.8861,0.143,0.0254,28.52,4.397,144,3.466,66.04,293.6377,3.51,0.21,80,148.94,0,99,130,37.92,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
77,56,56,0,2,54.9,159.91,21.03648,1.56,7,0.071895007,0.86313393,0,2,4,7,4659.036,1,1,145.94,46.13,62.97,16.34,15.73,7.67e-4,0.0014,0.0531798,3e-5,2.31,0.169,0.04426,2.5099,0.168,0.176,0.026,0.048,1.005,0.841,103.1,82.74,61.9614,0.2,6e-5,0.0123,0.643825,7e-4,0.551,0.493,0.367,0.373,2.99,0.44346,139.0794,3.9739,16.9884,3.0037,0.879884,0,1.468589,0.0122,0,6.199372,0.619118,0.0191,0,0,0,228.14,3.9,0,0.919,0.473,0.0309,30.08,4.267,138.1,10.251,72.92,615.9887,8.09,1.58,68,160.06,0,64,106,57.87,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
78,49,49,0,0,106.25,175.04,35.59357,2.23,7,1.024901542,12.36642993,0,0,5,7,1006.67,2,2,246.19,36.54,50.69,15.63,22.03,0,0,0.0350179,1e-5,29.01,0.03,4.6433,2.2498,0.435,0.134,0.092,0.038,1.043,0.603,106,78.53,123.9388,0.09,2.3e-4,0.091,0.336049,4e-4,0.611,0.303,0.274,0.14,2.701,0.41277,143.9617,1.0157,6.8393,0.2391,3.616245,0,1.004006,0,17.74,5.296398,0,0,0,0,1.272761,220.49,4.3,1,0.9183,0,0,0,5.096,142,5.797,75.95,231.4129,9.11,2.36,80,176.16,0,72,125,111.22,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NA,N,Outside-China,USA,United States,< 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,Y,Y,N,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
79,50,50,1,2,66.91,169.74,22.82347,1.74,7,0.060642367,0.72780994,1,2,1,7,3201.565,1,1,1473.86,41,215.8,39.47,61.19,0.00196,8e-4,0.0199731,0,25.99,0.001,6.85779,2.3029,0,0.061,0.115,0.148,0.559,0.751,101.2,112.79,57.3905,0.11,0,0.0056,0.110091,7e-4,0.011,0.182,0.376,0.431,0.433,0.38973,129.381,1.9962,12.8858,2.4184,0.699812,0.2285,0.3901,0.0534,0.27,4.536904,0,0.0319,0,0,1.230681,260.22,4.4,0,1.0478,11.571,0.0727,24.54,4.549,137.1,6.655,69.96,142.9957,7.15,1.62,64,169.84,0,72,120,63.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
80,55,56,1,1,67.92,164.29,24.783080000000002,1.74,7,0.065894157,0.78991639,2,1,3,7,15682.143,1,1,187.24,43.03,83.74,19.92,16.91,0,0,4.99e-5,0,24.86,0.083,6.78398,2.3019,0.003,0.032,0.018,0.004,0.473,0.586,102.2,113.06,59.0805,0,5e-5,0.0091,0.069314,0,0.057,0.149,0.277,0.272,0,0.43076,150.4014,1.7687,9.1923,0.7725,0.933854,0,0.160914,0,0.2,5.327762,0.405852,0.01,0.00223,0,0.868236,417.67,3.9,0,1.0075,9.891,0.0178,0.69,4.687,136.1,10.083,66.13,221.5115,6.73,1.57,84,164.91,0,71,119,64.47,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
81,62,62,0,2,71.7,165.03,26.08562,1.82,6,0.096113352,1.15333475,0,2,1,6,2591.862,2,2,574.51,41.99,66.35,16.85,33.75,1.7e-4,6e-4,0.0697915,0.00603,32.04,0.009,4.68803,2.628,0.105,0.167,0.049,0.059,0.237,0.716,100,67.26,88.7281,0.34,1e-4,0.0285,0.159869,0.0198,0.238,0.456,0.124,0.274,3.983,0.37959,117.1071,1.9508,11.4776,0.7565,1.210676,0.2591,0.501321,0.0865,0.07,3.213645,0.267725,0.0409,7.1e-4,0,0.959307,308.74,4.68,1,1.0029,11.848,0.0209,27.01,4.266,138.1,5.108,73,214.0618,5.67,1.81,74,165.01,0,80,109,66.84,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,Y,ASIAN,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
83,37,37,1,3,71.56,163.85,26.09479,1.8,6,0.090422443,1.08420646,2,3,4,6,6073.062,2,2,293.21,37.02,224.96,53.88,25.89,0,0,3.255e-4,5e-5,26.98,0.145,6.03336,2.4016,0.206,0.119,0.334,0.194,2.782,0.903,100,70.21,108.4953,0.04,2.2e-4,0.0061,0.004318,3e-4,1.178,0.517,2.091,0.679,0,0.41611,145.5486,0.013,7.1586,0,3.117309,0.2338,0.658595,0.001,0.72,6.149937,5.440419,0.0168,0,0,0.839996,174.76,4.1,1,1.0995,12.045,0,27.96,4.541,142,6.67,60.99,290.8917,11.5,1.63,72,162.43,0.1,76,136,66.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
84,61,61,1,2,64.83,160.1,24.44743,1.68,7,0.062646834,0.75127228,1,2,2,7,4155.536,1,1,528.5,38.99,140.91,16.19,28.09,0,0,0.0499261,0.00686,27.09,0.065,4.63189,2.4701,0.11,0.074,0.011,0.027,0.712,0.416,104.1,123.96,50.9146,0.27,7e-5,0.005,0.069496,0.0505,0.278,0.007,0.241,0.165,0.477,0.43855,144.9285,1.2653,12.4011,1.3835,1.82694,0.2102,0.660237,0.1169,0,17.875923,5.69108,0.8088,0,0,1.197858,315.43,3.99,1,1.1942,11.01,0.0097,30.12,5.24,140.7,21.493,78.92,213.1403,20.47,1.71,74,159.79,0,72,131,63.15,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
86,62,63,0,1,82.27,174.93,27.05931,1.98,7,0.080162234,0.96161017,0,1,3,7,670.919,2,2,227.76,46.04,43.98,140.73,21.95,0.001719,6e-4,0.0296904,0.00212,35.75,0,11.42028,2.2161,0.115,0.117,0.037,0.046,0.89,0.738,103,98.79,67.8039,0.09,2.2e-4,0.0103,0.299876,0.033,0.73,0.66,0.083,0.001,0,0.45556,153.509,2.2371,6.3286,0.2848,1.521425,0.2385,0.484374,0.0678,28.09,6.092873,6.000874,0.683,0.00619,0,0.173005,564.39,3.91,0,1.052,0.725,0,27.31,4.896,139.9,3.555,71.47,231.9809,8.75,1.87,81,174.08,0,101,149,77.54,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
87,24,24,1,0,68.12,168,24.03446,1.78,6,0.019824054,0.23831772,2,0,1,6,10120.054,2,2,171.33,41.43,83.06,12.91,10.88,0.001447,0,0.0100431,0,0,0.2,4.00689,2.0135,0,0,0.116,0.057,0.945,0.699,103,269.44,34.769,0,3e-5,0.0196,0.099387,0,0.55,0.353,0.348,0.215,0.342,0.33042,111.7732,1.9708,10.5889,0.6724,2.34932,0.0093,0.700799,0,0.15,10.722243,0.245702,0,0,0,1.269553,405.11,3.89,0,0.9971,11.12,0.0324,28.96,3.818,140,8.021,61.79,0,12.18,1.75,81,165.08,0,70,116,67.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
88,82,82,1,4,56.92,163.04,21.47965,1.6,6,0.039440661,0.47296383,1,4,5,6,14788.791,1,1,209.22,30.03,68.19,20.31,25.29,0.002293,0.0014,9.65e-5,6e-5,29.81,0.002,5.91437,2.2249,0.201,0.223,0.035,0.042,0.813,0.705,106.9,33.34,102.7836,0.13,0,0,1.711288,0.0337,0.26,0.134,0.49,0.419,0.076,0.3457,119.7608,2.4075,12.9366,1.2765,1.044636,0.1861,1.279465,0.0661,0.62,4.530939,3.459615,0.0166,0.00177,0.001,1.195182,471.43,4.3,0,0.9065,11.61,0.0204,22.28,3.382,144,6.957,66.18,248.0158,7.34,1.53,73,161.91,0,96,151,54.46,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
89,66,66,0,4,58.09,164.9,21.85691,1.63,6,0.035565376,0.42671245,1,4,6,6,13229.36,1,1,506.19,7.37,300.25,43.5,167.3,0.001042,9e-4,0,0,26.98,0.1,6.62374,2.2938,0.56,0.384,0.347,0.18,1.046,0.585,98,77.61,70.8674,0.54,2.4e-4,0.4207,0.11081,7e-4,0.984,0.513,0.298,0.199,1.371,0.37463,128.4609,2.733,12.1988,0.1005,0.949997,0.0066,0.299861,0,0,5.81265,4.998245,0.0381,0,0,0.819273,232.5,4,1,1.1053,10.931,0.0556,36.55,4.058,137,20.907,66.91,273.1525,7.6,1.59,65,161.04,0,81,125,54.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,Y,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
90,25,25,1,2,90.13,173.91,29.68492,2.05,8,0.049284609,0.59110855,0,2,5,8,6240.489,2,2,304.85,43.93,128.47,28.02,20.06,0,3e-4,0.0289079,0.01009,22.34,0.049,3.6924,2.9402,0.275,0.057,0.371,0.164,1.354,0.65,0,103.38,89.1709,0.1,0,0,0.090159,0.0126,0.771,0.425,0.375,0.001,0,0.4514,149.3289,2.7746,14.4111,2.764,1.697772,0.2117,0.647499,0.0827,0.46,4.250968,3.602362,0.7201,0.00369,0,1.274626,320.81,5.01,1,1.0732,11.974,0,25,5.206,136,20.658,82.08,400.0631,7.41,2.05,94,173.91,0,113,147,89.38,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HR,158VF,Y,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
92,57,57,0,2,99.81,188.12,27.6437,2.29,6,0.109043246,1.30749797,1,2,6,6,308.188,2,2,198.07,43.1,761.36,64.82,36.14,0.004127,0.0034,0,5e-5,26.4,0.261,9.02385,2.3024,0.087,0.124,0.112,0.08,0.973,0.74,92.8,88.87,81.3757,0,0,0,0.199943,0.0099,0.416,0.372,0.528,0.505,0.645,0.41801,149.9023,2.6812,9.9727,0.198,0.551012,0,0.251103,0,31.99,3.399913,1.758491,0.032,0,0,1.354637,110.88,4.2,0,0.9743,11.174,0.0338,0,4.501,135.2,22.99,72.91,333.7846,6.1,2.32,95,185.41,0,97,165,103.18,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
93,57,57,1,2,63.19,152.72,26.90534,1.63,7,0.049345371,0.59290058,1,2,3,7,4422.829,2,2,216.55,32.08,57.14,12.3,17.04,0,0,0.0435353,0.00403,26.25,0,3.30293,2.2703,0.322,0.333,0.023,0.011,0.648,0.756,101.9,88.59,70.699,0.09,5e-5,0.0081,0.039889,0.0207,0.473,0.523,0.166,0.2,2.916,0.42954,147.6091,2.4009,7.6143,0.4003,0.303007,0.18,0.369005,0.0782,0.23,5.774447,2.599551,0.672,0,0,1.050165,318.65,3.69,0,0.9982,0.056,0.0125,25.08,5.094,137.9,12.466,63.11,327.5046,4.91,1.47,65,150.32,0,77,99,60.91,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
94,56,56,1,1,58.06,158.72,22.85153,1.58,7,0.117444976,1.40990639,1,1,1,7,2182.146,1,1,195.21,44.08,40.2,90.23,27.11,3.88e-4,0,0.0680991,0.01442,29.09,0.034,6.10165,2.2933,1.588,0.338,0.275,0.062,2.476,0.739,103,104.23,61.9254,0,0,0,0.290648,0.1128,1.452,0.392,0.903,0.271,0,0.51912,197.964,1.7968,10.5957,0.1156,2.111086,0.451,0.648864,0.1372,0,3.390807,6.054907,0.6648,5.3e-4,0,0.907893,144.45,4.11,0,1.043,0.061,0,29.89,6.369,143,15.754,71.04,398.7889,6.21,1.58,80,159.78,0,52,130,58.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
95,50,50,1,2,111.55,160.99,48.04885,2.12,8,0.045327534,0.54430656,0,2,5,8,7374.588,2,2,490.54,37.91,70.94,21.03,19.99,0.002667,0.0016,0.0502779,3e-5,24.18,0.001,3.19944,2.3517,0.174,0.131,0.026,0.042,0.305,0.003,97.1,113.05,76.0162,0.24,3e-5,0.0154,0.260086,5e-4,0.206,0.299,0.106,0.174,1.292,0.40694,131.5913,2.4989,23.191,0.501,1.269668,0.0062,0.549809,0.0031,0.02,4.893861,3.920578,0.5704,8.8e-4,0.001,1.161144,482.68,3.81,0,1.1077,10.414,0.0043,29.51,4.605,140.8,17.986,69.07,243.92,7.32,2.06,87,162.76,0.1,74,163,109.24,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158VF,N,Y,N,N,Low,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
96,66,65,1,3,69.04,164.93,25.91892,1.74,7,0.260859544,3.13134276,2,3,3,7,10204.916,1,1,258.49,35.64,71.4,89.24,39.14,0,0,0,0,28.12,0,13.12897,2.3947,0.215,0.216,0.201,0.123,2.403,0.961,98,67.05,97.1259,0.13,0,0.0087,0.099415,0,1.276,0.638,1.142,0.661,0,0.33787,114.0196,3.2995,12.6071,0.9487,0.722379,0,0.400238,0,0.48,3.187563,0.489493,0.025,0,0,0.940172,152.6,3.71,1,1.4263,12.09,0,29.72,4.408,132.8,9.307,66,374.9645,5.33,1.8,76,163.93,0.1,84,119,66.29,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,High,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
97,45,46,1,3,86.9,180.23,26.71034,2.07,6,0.030168862,0.36138661,2,3,4,6,18552.212,2,2,359.55,17.41,78.06,14.72,44.88,0.003919,0.0035,0.0099719,0,0,0.121,5.54614,2.2804,0.043,0.022,0.108,0.106,0.765,0.68,100.9,83.56,81.2701,0.28,6e-5,0.0164,0.09006,0,0.246,0.229,0.461,0.404,0,0.29776,100.0807,1.3625,15.8887,2.2836,1.373065,0.0024,0.450614,0,0.26,5.647584,0,0,0,0,1.247401,232.98,3.7,0,1.0004,0,0.0453,27.53,3.928,140,15.83,75.83,267.7427,7.4,2.1,84,181.77,0,77,120,84.77,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
98,70,70,0,5,63.1,170.13,21.93339,1.74,6,0.045722203,0.54878108,1,5,5,6,5247.426,2,2,423.37,21.69,80.74,24.75,29.68,0.001088,0.0022,0.0899259,4e-5,25.09,0.001,8.94477,2.1498,0.08,0.064,0.001,0,0.612,0.496,101.9,88.58,55.9333,0.31,0,0.0213,0.100579,0,0.238,0,0.379,0.259,0,0.37234,103.8986,1.7637,5.0085,1.5002,1.662556,0,1.893799,0,0,10.914989,0.089057,0,0.0035,0.001,1.130125,330.76,4,1,1.0062,13.409,0.0207,42.7,3.811,136.9,3.407,60.95,133.5608,15.21,1.7,84,164.24,0,78,121,58.03,0,0,0,0,0,0,0,1,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
99,61,61,1,3,71.78,149.87,32.63657,1.66,7,0.026553225,0.31881049,2,3,2,7,5306.89,2,2,683.1,34.19,92.69,14.11,20.81,7.24e-4,0.0013,0.0101118,0.00384,3.79,0.179,4.63576,2.4781,0.191,0.092,0.068,0.044,0.824,0.416,102.2,64.59,90.0666,0.15,2e-5,0.0087,0.122233,0.0237,0.522,0.358,0.284,0.001,2.184,0.3728,118.8489,0,9.2876,0.3683,1.253918,0.2699,0.501582,0.0941,39.07,4.316728,4.972833,0.0354,0.00252,0,1.061246,418.28,4.59,1,0.9869,10.607,0,24.96,4.15,137.9,5,65.99,228.1903,7.8,1.72,95,149.62,0,68,160,69.94,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
100,53,53,1,1,104.99,181.4,31.45524,2.25,6,0.138452483,1.65943054,1,1,2,6,6757.888,2,2,169.57,34.09,37.69,15.1,18.87,0.001858,0.001,0.0238795,6e-5,3.47,0,5.3759,2.121,0.002,0.038,0.006,0.028,0.016,0.644,97.9,105.95,70.6048,0,0,3e-4,0.109828,2e-4,0.238,0.439,0,0,0,0.36924,113.6704,1.6986,4.8948,0.2969,0.800963,0.0022,0.640325,0.0029,0.51,4.976154,2.398858,0,0,0,1.060313,201.6,3.88,0,0.9493,0,8e-4,29.04,4.201,132.2,4.079,50.81,202.9377,5.47,2.25,81,180.83,0,84,140,104.22,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
101,68,68,1,4,85.21,170.74,29.3844,1.98,7,0.118630165,1.42271481,1,4,3,7,5967.929,1,1,261.22,26.01,106.1,21.05,16.86,0,0,0.0586906,1e-5,0,0.05,13.54885,2.0579,0.056,0,0.026,0.015,0.28,0.012,104,61.49,101.8043,0.05,2.3e-4,0,0.040229,0,0.015,0,0.113,0.179,0,0.31044,89.9932,2.5497,5.8863,1.7455,1.84092,0.0066,0.698533,1e-4,0,7.711498,4.832447,0.0368,0,0,1.37256,274.27,4.2,1,1.4902,11.862,0,47.82,3.303,140,7.534,52.86,137.8434,13.99,2,0,170.06,0,88,100,83.44,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low-Intermediate,High,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,N,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
102,51,52,0,1,111.54,187.6,31.23412,2.35,6,0.060293424,0.72367101,0,1,3,6,3482.618,1,1,932.61,46.97,35.57,13.6,21.99,0,0,3.133e-4,1e-5,0,0.136,4.39436,2.3516,0.005,0.166,0.012,0.067,0,0.002,101,130.02,65.8889,0,1.7e-4,0.0028,0,0,0,0.283,0,0.048,4.154,0.46007,147.0538,2.1486,9.4398,0.7193,1.220161,0.0028,0.698298,0.0346,32.43,3.521582,0.355675,0.0269,0.00704,0,0.841814,230.48,3.8,0,0.9262,0,0.01,28.25,4.648,138.9,10.27,71.98,374.9094,4.78,2.25,79,187.44,0,64,120,110.23,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
103,49,49,0,3,55.13,162.71,21.10481,1.59,8,0.091963059,1.10449363,0,3,2,8,810.475,1,1,428.26,39.04,313.54,15.88,15.92,0.002464,0.0022,0.0998909,0.00601,22.57,0.148,4.28714,2.6459,0.099,0,0.069,0.034,0.627,0.004,105,103.77,60.1191,0.18,2.1e-4,0.0311,0.15983,0.0097,0.149,0,0.327,0.14,0.542,0.4507,139.0195,1.5588,10.4871,1.5706,6.319542,0.0131,1.649537,0.0538,0.6,3.99576,0.692753,0.1794,0.00501,0.001,1.269092,373.47,4.3,1,1.0501,15.469,0,33.02,4.408,139,37.694,77.08,370.8513,10.08,1.55,80,161.06,0,103,135,54.93,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,0,131RR,158FF,N,Y,N,N,Low-Intermediate,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
104,59,59,0,1,78.24,160.99,30.36328,1.85,7,0.074607138,0.89732971,0,1,3,7,301.389,2,2,213.89,43.99,91.15,27.23,22.86,0.001768,8e-4,0.0539424,0.01002,29.25,0.201,3.70709,2.4386,0.727,0.334,0.477,0.144,2.412,0.676,107.1,99.81,81.7283,0,1.2e-4,0,0.256736,0.0669,1.362,0.471,0.953,0.269,0,0.42978,144.9495,1.7908,14.2944,1.2756,3.265599,0.2836,0.63943,0.111,30.24,4.953432,1.674656,0.0309,0,0,1.030713,221.88,4.31,0,1.0388,0.924,0,0.2,4.642,142.1,10.28,77.04,368.5132,9.82,1.84,71,159.78,0,61,115,80.21,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
105,71,71,1,2,88.1,155.18,39.60629,1.92,6,0.079693812,0.95608017,1,2,5,6,2676.587,1,1,260.09,45.09,159.35,54.44,29.21,6.41e-4,0,2.767e-4,7e-5,25.52,0.049,4.20002,2.4482,0.27,0.294,0.111,0.132,0.371,0.52,100.6,85.44,77.5673,0.18,0,0,0.049498,6e-4,0.203,0.374,0.219,0.272,5.471,0.44581,147.4208,3.826,13.0028,0.8327,1.350806,0.1437,0.479951,0.0015,0.16,4.27037,0.679323,0.6524,5e-5,0,1.251425,308.02,4.31,1,0.996,0,0.0251,0,4.492,136.2,193.742,83.98,636.1159,6.11,2.01,80,158.16,0.1,81,157,94.23,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Other,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
106,76,76,1,3,67.02,157.88,26.68419,1.68,7,0.207994674,2.49103295,1,3,3,7,5278.098,2,2,234.35,43.99,58.84,13.92,0,0.001247,0,0.0300106,0,0,0.121,5.36601,2.588,0.295,0.13,0.075,0.056,1.235,0.758,0,65.96,70.8423,0,2.8e-4,0.0185,0.108109,4e-4,0.589,0.416,0.511,0.347,0,0.46475,161.7692,1.1491,6.5669,0.4068,1.67712,0,0.601157,0.0011,25.07,4.095997,0.69524,0,0,0,0.969087,149.68,4.09,0,0.9496,0,0,27.52,5.135,138,8.455,71.98,261.5218,6.06,1.78,80,156.19,0,78,130,69.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
107,43,44,0,1,51.91,157.84,20.84629,1.52,8,0.086630829,1.03863828,0,1,2,8,879.426,2,2,178.99,45.08,154.58,13.12,13.18,0,0,0.0099159,8e-5,27.85,0.08,5.3022,3.131,0.199,0.105,0.047,0.011,0.91,0.543,104,103.95,56.1335,0,1e-4,0.0223,0.059896,7e-4,0.619,0.423,0.222,0,1.006,0.46732,148.2787,1.0095,4.0092,1.3307,2.002479,0.0133,0,0,0,4.395198,0.658895,0.0139,0.00198,0,1.524529,313.81,4.9,1,0.9545,10.21,0,0,5.597,138.9,15.872,70.08,315.0445,8.63,1.63,70,160.9,0,72,101,55.97,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,N,N,N,WHITE,Other,Y,Y,F,No,CASA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
108,67,68,0,2,71.46,152.07,30.4926,1.66,6,0.061656748,0.74014551,0,2,1,6,478.343,1,1,137.48,49.86,294.13,20.58,11.66,0.00137,0.001,0,0,25.94,0.091,5.58769,2.3937,0.171,0.17,0.009,0.022,0.812,0.697,107,100.27,56.6975,0,0,0,0.003909,0,0.283,0.133,0.388,0.327,3.669,0.50983,159.9795,4.3594,12.74,1.3252,0.899138,0.0048,0,0,0.73,4.908894,0.402129,0.0333,0.00149,0,1.211135,530.84,4.6,0,0,9.908,0.0307,30.15,5.064,145.1,15.394,79.91,285.7945,4.6,1.81,95,153.86,0,78,158,75.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
109,73,74,0,2,61.74,162.9,24.16506,1.66,7,0.146271654,1.7580823,0,2,4,7,1081.498,2,2,162.36,37,81.12,31.84,22.08,0.001177,0,0.0300002,0.005,24.91,0.041,4.86559,1.9552,0.439,0.343,0.149,0.088,1.082,0.709,103.9,83.94,55.7625,0,0,0,0.765045,0.0405,0.707,0.482,0.488,0.282,0,0.33573,125.4168,2.57,10.7758,0.7243,1.683176,0.1378,0.400318,0.0051,0,2.520732,0.488407,0,0,0,0.985174,203.18,3.39,1,0.9617,9.43,0.0217,36.29,3.911,138.1,10.296,59.47,204.689,5.4,1.67,75,163.07,0,65,149,60.83,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,Y,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
110,61,61,0,3,69.9,170.11,24.02536,1.8,7,0.059123433,0.70899162,2,3,5,7,3990.24,1,1,505.63,39.97,67.09,19.19,14.99,0.001521,0.0021,0.0385638,0,24.07,0.08,6.78987,2.3774,0.138,0.053,0.321,0.155,2.495,0.9,103,72.23,89.2644,0,4e-5,0,0.00351,0,1.186,0.522,1.15,0.558,0,0.33604,104.8279,1.8476,9.9929,1.0721,1.801031,0.0075,1.130849,0.0748,0.55,7.79441,2.700635,0,0,0,1.209061,248.06,4.5,0,0.9983,0,0.0541,27.92,4.559,141,8.48,68.43,333.2476,13.15,1.81,45,169.33,0,65,85,69.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
111,58,58,0,2,110.85,185.38,31.15434,2.34,6,0.142967735,1.71510391,1,2,1,6,3175.98,2,1,353.95,39.97,213.02,53.95,42.5,0,0,0.0150308,7e-5,0,0.086,4.75446,2.4433,0,0.055,0,0,0.097,0.71,0,109.61,73.8906,0,0,0,0.20066,6e-4,0.009,0.006,0.14,0.313,2.935,0.34323,108.9936,1.9339,10.8603,0.61,1.26577,0.0025,0.580396,0.0021,0.81,3.69709,0.658204,0.0098,0.00394,0,1.019625,170.77,4.92,0,1.0024,12.221,0,29.3,3.833,138.9,7.519,73.01,356.1149,6.47,2.28,81,185.41,0,67,131,110.31,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
112,62,62,1,3,67.84,167.73,24.09984,1.74,7,0.099419079,1.19317033,1,3,2,7,11944.406,1,1,444.49,40.09,198.2,14.2,12.81,0.001267,0.0012,2.113e-4,0.00595,1.85,0,6.0698,2.8729,0.21,0.03,0.111,0.049,1.57,0.756,105.8,83.25,70.9398,0,6e-5,0.0075,0.21731,0.0429,0.925,0.516,0.372,0.079,0,0.38413,127.9462,2.5992,8.2987,8.3104,2.493734,0.3748,0.529288,0.0994,20.03,3.998431,5.510242,0.6897,0.00466,0,1.469712,353.03,4.19,0,1.0392,11.243,0.0013,20.71,5.067,141.9,8.019,75.96,362.2947,8.34,1.74,83,170.99,0,90,141,70.95,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
113,52,52,1,2,77.45,175,25.30133,1.93,6,0.085909483,1.03082102,0,2,3,6,5482.137,2,2,185.8,44.53,195.81,120.24,19.02,4.32e-4,2e-4,0.0399064,0,1.1,0.227,4.54827,2.3701,0.574,0.213,0.166,0.03,1.958,0.774,0.4,112.65,68.9703,0,1e-5,0.0178,0.020748,0,0.871,0.368,0.825,0.31,0,0.46324,146.2741,0.8496,0.1278,0.4802,6.955109,0.1496,1.336017,5e-4,0,9.227235,0,0,0.00281,0.001,1.417361,476.15,4.3,0,0,0.826,0,34.98,5.44,143,20.695,72.96,323.7178,21.51,1.95,70,175.08,0,85,124,80.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
114,71,71,1,3,73.91,178.01,23.35888,1.92,7,0.059484334,0.71363692,1,3,1,7,9361.321,1,1,1290.58,25.97,77,15.78,27.42,0,0,0,0,0,0,2.85638,2.151,0.47,0.428,0.392,0.278,1.262,0.767,92.7,83.16,69.6084,0,0,0,0.149756,3e-4,0.873,0.525,0.52,0.425,0,0.24576,81.7467,2.7928,8.8522,0.8607,1.335489,0,1.098246,0.0022,26.46,3.599511,0.482594,0,0,0,1.259834,264.8,4.01,1,0.9861,12.84,0,25.08,3.81,132.2,9.917,62.92,297.8347,5.27,2.03,79,178.01,0.1,109,140,80.97,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
115,61,61,0,3,88.64,177.94,28.60368,2.06,6,0.064026215,0.76808139,1,3,2,6,1110.204,1,1,143.54,34.83,224.92,57.23,26.82,0.004281,0.0039,8.81e-5,0,1.68,0.134,0,2.4063,0,0.002,0.08,0.134,0.196,0.716,100,104.96,69.903,0,1.1e-4,0,0.120742,0,0.168,0.438,0.055,0.222,2.58,0.34064,102.1617,0,3.9731,0.3694,0.744777,0,0.200347,0,34.1,3.343574,4.998267,0.0111,0,0,0.072179,235.55,3.6,0,1.1036,10.169,0,0,4.118,142,9.04,71.05,285.3048,4.18,2.2,67,178.17,0,80,160,90.25,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,>= 60,< 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
116,47,48,0,2,69.44,164.97,25.00317,1.76,7,0.045312467,0.54370805,0,2,5,7,4514.972,1,1,268.74,40.1,95.83,12.98,17.14,0.003109,0.0039,0,0,28.06,0.068,9.61127,2.7037,0.247,0.162,0,0,0.489,0.649,108.1,102.59,77.8468,0.06,3e-5,0.019,0.102268,9e-4,0.232,0.275,0.216,0.209,0,0.40474,138.2982,3.5831,9.8973,0.0081,1.319347,0.0498,0.233431,0,0,4.591441,3.528684,0.4975,0.0053,0,1.194141,516.75,4.4,1,0.9631,0.748,0.0425,21.58,4.852,142,8.203,68.98,361.0663,7.68,1.81,69,164.99,0,83,120,65.11,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,N,NA,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,NA,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
117,48,48,0,4,64.41,171,21.87616,1.73,6,0.073997937,0.88731633,0,4,4,6,3553.525,2,2,289.33,34.03,101.94,9.92,15.41,0,0,0.0204349,0.00399,0,0,6.48893,2.4739,0.308,0.154,0.355,0.184,1.46,0.775,0.2,92.41,72.5613,0,2.9e-4,0.0252,0.120034,0.0098,0.908,0.468,0.67,0.308,0,0.32977,108.0083,0.0105,0.1248,0.5764,2.042894,0.0069,0.499778,0,0,5.56056,0.336355,0.022,0,0,1.441208,277.28,4.34,0,0.9935,11.444,0.0239,0.73,4.177,128.5,7.695,72.92,237.9406,10.08,1.81,77,172.18,0,76,107,67.56,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
118,56,55,2,2,101.54,175.77,31.30768,2.16,7,0.020410014,0.24532532,2,2,4,7,18550.224,2,2,347.08,36.23,76.94,9.79,27.69,3.59e-4,6e-4,0.0309308,7e-5,20.86,0.191,4.30075,2.4273,0.136,0.123,0.02,0.007,0.701,0.65,0,70.08,123.4997,0,0,0,0.100605,0.0088,0.368,0.291,0.215,0.171,2.242,0.35234,125.266,0.5985,4.9878,0.52,1.557854,0.2061,1.168696,0.0951,0.66,5.757793,3.989738,0.7127,0.00103,0,1.110443,380.62,4.84,1,0.9899,16.404,0,31.61,4.148,136,17.089,0,363.1336,8.72,2.25,77,176.82,0,100,126,99.46,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
119,72,72,0,1,85.94,168,30.49958,1.95,6,0.099323203,1.19013374,0,1,4,6,364.959,1,1,302.95,40,177.05,29.16,17.93,0,0,0.0474225,0.00192,26.98,0.069,8.48816,2.3646,0.546,0.404,0.144,0.112,0.975,0.753,103,114.24,53.0057,0,2e-5,0,0.193552,0.0014,0.622,0.504,0.339,0.277,1.418,0.42988,146.4534,1.861,10.9923,0.2343,0.59985,0.0052,0.569863,0.0402,0,4.099161,2.32023,0.6801,0.00345,0.001,0.045425,241.37,4.01,0,1.0536,11.771,0.0478,26.89,5.464,139,13.397,69.96,404.4314,5.5,1.93,76,164.96,0,74,111,82.58,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
120,65,65,1,3,81.91,167.08,28.61919,1.92,6,0.07099438,0.85077731,0,3,6,6,10999.162,2,2,898.39,38.95,106.97,39.94,28.14,0.002021,0.0018,0.0239152,4e-5,2.05,0.362,6.20825,2.4397,0.321,0.286,0.01,0,0.981,0.809,98,100.56,67.0343,0,0,0,0.09759,9e-4,0.428,0.385,0.418,0.386,0.265,0.41494,134.5116,3.2928,14.6254,0.5253,1.698746,0.0102,0.91893,0.0522,10.98,9.199929,0.686401,0.014,0,0,1.120097,285.91,4.01,0,1.0005,10.43,0.0139,0,4.799,138,19.62,68.91,438.2784,10.31,2.02,87,169.96,0,85,131,88.17,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
121,59,59,1,2,81.93,187.89,23.52861,2.1,6,0.078252761,0.93931424,0,2,2,6,6070.015,1,1,210.93,41.01,54.21,21,43.18,0.002281,0.0023,0.0200239,2e-5,24.06,0.159,19.39487,2.3077,0.133,0.182,0.043,0.071,0.495,0.71,104.9,64.29,132.9249,0.15,0,0,0.190822,0,0.343,0.439,0.244,0.285,1.288,0.39185,131.9965,1.6956,10.5559,0.7806,1.30838,0.0119,0.499669,0,0.81,3.409457,0,0,0,0,1.25969,128.53,3.7,0,1.062,10.489,0.0357,33.23,3.902,140.1,15.399,67.08,254.689,4.99,2.17,91,190.6,0,74,140,82.72,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
122,60,60,0,3,48.99,158.76,19.29122,1.5,7,0.051401828,0.61791976,2,3,3,7,2094.62,2,2,225.71,1.58,95.77,13.17,19.08,0,0,0.0820586,0,30.04,0.001,0.46839,2.2015,0.126,0.19,0.09,0.11,0,0,100.9,72.78,75.1027,0,0,0.0067,0.039218,0,0,0,0.055,0.276,1.067,0.32617,106.1535,4.3278,13.0021,2.5884,0.337896,0,0.611461,0,0.01,6.905058,4.126812,0,0,0,1.388972,323.28,4.39,1,1.0905,0.591,0,27.41,3.438,138.9,11.435,0,285.5667,8.43,1.47,62,157.96,0,87,95,47.15,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
123,61,61,0,3,67.26,156.49,27.74775,1.67,6,0.1886663,2.26288456,0,3,1,6,3205.044,2,2,228.27,40.01,72.84,5.31,0,0.116551,0.0224,3.03e-4,1e-5,28.98,0.025,7.0412,2.3292,0.165,0.149,0.005,0,0.901,0.765,108.8,73.81,83.9998,0.16,0,0,0.089229,4e-4,0.381,0.32,0.473,0.338,1.906,0.39536,126.4663,1.8419,9.9193,0.5005,0.987581,0.0111,0.498494,0.0137,0,4.442926,6.65945,0.5605,0.00715,0.001,1.160605,410.78,4.44,0,0.891,11.914,0.0195,31.33,4.3,140.9,10.207,71.97,273.1318,6.45,1.62,62,153.66,0,72,110,62.89,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
124,56,56,0,2,77.58,164.98,28.81116,1.85,6,0.069081757,0.82825881,0,2,5,6,1730.456,2,2,349.81,41.91,53.48,10.82,10.64,2.11e-4,0,0.0399566,0,25.91,0,7.15588,2.071,0.241,0.238,0.263,0.232,0.808,0.651,101,94.46,70.6875,0.3,4e-5,0.0114,0.099386,0,0.678,0.446,0.217,0.223,0,0.32511,118.7887,0.0143,0,0.5488,1.210554,0,0.373205,0,0,3.703011,0,0,0,0,0.959624,125.85,3.89,0,1.0292,0,0.0455,30.12,3.5,140.7,5.999,60.72,160.4084,5.49,1.84,69,164.08,0.1,88,151,72.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
125,60,60,0,2,46.1,149.57,21.21199,1.39,8,0.096094659,1.15386824,1,2,3,8,582.052,2,2,171.55,42.29,94.44,27.64,17.13,6.47e-4,0,0.1321666,0.00971,33.07,0.001,1.47247,2.3974,0.116,0.198,0.003,0.003,0.379,0.717,101,58.49,86.1115,0.07,0,0.0201,0.393264,0.0171,0.19,0.376,0.072,0.222,3.435,0.38405,130.3205,5.5954,16.2344,0.7368,1.15835,0.0629,0.603248,0.0395,12.38,2.744104,0,0,0.00174,0,1.450548,156.51,4.29,0,0.8558,0,0.0159,0,3.923,139,13.363,74.2,349.4861,4.68,1.24,61,146.92,0,80,90,45.39,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
126,79,79,1,2,44.37,161.77,17.60342,1.43,6,0.045036907,0.54104254,0,2,1,6,2799.384,1,2,335.24,34.37,82.88,10.23,21.02,0,0,0.0082745,0,21.96,0.152,3.70362,2.248,0.018,0.004,0.164,0.137,0.682,0.726,102,45.62,78.7308,0.09,9e-5,0.0112,0.100364,0,0.484,0.454,0.132,0.154,0,0.27207,90.9475,2.1959,8.1826,0,0.99995,0,0.839907,0,0.11,3.074826,0.35177,0.0032,0,0,0,79.77,4,1,1.3179,0,0,25.93,3.167,134.7,5.167,64.96,291.2393,5.73,1.5,77,164.99,0,78,140,46.18,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
127,69,69,0,2,50.16,152.26,21.55739,1.45,6,0.023465381,0.28176425,0,2,1,6,1353.292,2,2,788.07,41.96,154.73,19.97,22.04,0.079166,0.0039,0.0240002,0.00409,28.8,0.049,6.41981,2.4464,0.813,0.245,0.12,0.022,2.957,0.81,97.1,61.6,73.7477,0.14,0,0,0.322651,0.0509,1.846,0.502,1.037,0.304,0,0.35705,122.7888,2.9034,16.9487,1.878,4.287213,0.3712,0.693928,0.0886,0.04,4.183606,5.424473,0.035,0.00167,0,1.297193,218.48,5.01,1,0.9562,12.458,0.0135,16.9,3.781,136.9,9.982,68.99,480.7298,8.98,1.56,80,152,0,77,141,51.49,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,NA,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,NA,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
128,76,76,1,3,52.11,151.97,22.37357,1.47,7,0.03856259,0.46255747,1,3,4,7,13104.87,1,1,629.29,33.73,88.95,10.84,25.09,0.003103,0.0033,0.0219667,0.00899,27.42,0.109,7.4996,2.3275,0,0,0.026,0.05,0.041,0.627,0.4,42.89,80.0098,0,5e-5,0.0012,0.140247,0.0213,0,0.267,0.061,0.114,0,0.2502,87.6128,1.743,11.5059,1.2682,1.059954,0.2406,0.539484,0.1163,28.99,10.789911,3.246296,0.7362,0.00351,0.001,1.228635,555.81,3.7,1,1.298,13.072,0.0173,26.07,3.3,137.1,5.181,71.03,30.121,9.82,1.47,73,151.7,0,74,118,52.02,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
129,58,58,1,1,69.93,152.1,30.47408,1.67,8,0.139999796,1.68203928,0,1,3,8,2134.73,2,2,154.68,46.59,66.37,46.7,18.42,0.003006,0.0019,0.0399731,0,20.19,0.052,12.24579,2.1095,0.172,0.183,0.054,0.06,0.614,0.48,106.8,115.65,53.2826,0,2.1e-4,0.0077,0,1e-4,0.339,0.259,0.218,0.208,0,0.4087,138.6514,1.48,3.4935,0.3032,0.919095,0.0079,0.400129,0.0413,0.23,5.061025,2.183487,0.0382,0.00367,0,1.069196,230.23,4.09,1,1.0278,9.883,0.0137,30,5.001,144,5.002,73.04,362.9116,6.29,1.69,59,150.01,0,81,120,70.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
130,67,67,1,1,90,169.92,31.61326,2.01,7,0.044606469,0.53590182,1,1,2,7,7861.598,1,1,156.61,41.3,49.38,14.77,20.09,0.003184,0.0022,0,0,32.32,0.071,6.15904,2.1983,0.434,0.296,0.065,0,2.035,0.883,98.9,88.29,79.7692,0,2.6e-4,0.0288,0.038929,0,1.039,0.511,0.957,0.442,0,0.40296,133.6167,5.2906,32.2558,1.5966,1.002395,0.0087,0.016165,0,30.03,3.697373,0.365867,0,5e-4,0,1.270826,413.32,4.59,1,1.0639,14.047,0,29.96,4.409,139,10.282,77.1,339.24,4.99,2.11,79,168.93,0,89,125,93.21,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
131,79,79,0,4,77.72,158.12,30.48995,1.79,6,0.131492143,1.57820471,0,4,5,6,10012.967,2,2,1239.63,33.45,30,11.9,19.13,0.004196,0.0286,0.0199638,0,3.85,0.001,22.15777,2.4552,0.772,0.485,0.141,0.084,1.41,0.643,105,33.47,144.328,0.15,0,0.0146,0.267306,0.0048,0.953,0.414,0.353,0.182,1.103,0.39935,122.0387,0,0.085,0.0026,2.435057,0.1772,1.130014,0.0971,0,3.391549,0.018717,0.0352,0,0,1.595405,229.58,5,1,1.107,14.075,0,29.48,4.826,141.1,8.558,62.23,466.1384,6.8,1.97,76,160.17,0,62,135,84.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
132,56,56,0,2,NA,170.05,NA,NA,6,0.07143479,0.85707016,2,2,3,6,1814.998,1,1,165.07,36.44,71.92,43.78,24.74,0.002267,0.0021,1.318e-4,0,28.2,0.11,5.80804,2.0623,0.162,0.11,0,0,1.153,0.746,106.3,129.8,55.7523,0.03,0,0,0.039626,0,0.508,0.375,0.487,0.204,2.052,0.35937,122.477,1.7955,11.8437,0.4195,1.818925,0.0387,0.409795,8e-4,0.23,2.898138,1.967937,0.0122,0,0,0.925066,253.28,3.84,0,1.0921,11.962,0,26.74,4.294,143.8,13.694,64.48,209.419,4.9,1.92,96,166.06,0.1,75,149,78.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,NA,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
133,27,27,0,1,59.91,153.25,25.70916,1.58,6,0.144441632,1.73120755,0,1,3,6,5158.119,1,1,171.81,42.07,164.74,11.97,18.95,0.002597,0.0024,1.81e-5,0,25.67,0.239,4.96889,2.5023,0.068,0.095,0,0,0,0.376,110.2,141.37,56.5332,0,8e-5,0.0145,0.500442,1e-4,0,0.251,0.002,0.002,1.256,0.37961,125.5728,2.0387,8.2363,0.3399,1.988044,0.0081,0.570416,0.0055,0,5.093698,3.909463,0.0373,0,0.001,1.165097,229.71,4.5,1,0.4963,10.63,0.0367,27.73,4.011,143.1,7.992,74.35,485.0562,7.63,1.59,69,151.78,0,76,130,57.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
134,65,65,1,4,62.93,161.05,24.15213,1.65,6,0.086885241,1.04404035,1,4,3,6,11823.229,1,1,898.86,40.95,76.86,8.73,21.95,0,0,4.63e-5,5e-5,26.52,0.198,3.60411,2.3773,0.58,0.415,0.212,0.156,1.239,0.79,101.1,72.69,77.8768,0,1e-4,0.0137,0.019161,0.0184,0.787,0.486,0.546,0.463,0,0.43043,143.9694,1.309,10.2096,0.4601,1.231493,0.1512,1.138634,0.0503,0.06,7.67793,6.634904,0.6704,0.003,0,0.830305,205.08,5.03,0,1.0072,11.691,0.0057,24.78,4.994,137,10.813,64.06,363.2907,9.77,1.71,80,163.03,0,99,142,66.53,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
135,46,47,1,1,87.99,175.29,28.03411,2.03,8,0.073536383,0.88224785,NA,1,5,8,14002.577,1,1,402.99,33,72.29,27.91,29.8,0.001722,0.0015,0.0429587,4e-5,23.02,0,0.06244,2.3959,0.208,0.289,0.154,0.162,0.363,0.003,101.9,155.22,46.979,0.08,1e-5,0,0.100087,0,0.432,0.428,0.004,0,0,0.30706,101.4126,0.8482,0.1099,0.7256,0.627826,0,0.16101,0,16.31,3.509851,2.657597,0,0.00418,0,1.030834,242.06,3.29,0,0.9428,0,0.0541,0,3.775,144.2,7.819,65,220.0468,4.42,1.96,79,174.84,0,86,130,83.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,NA,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
136,76,76,0,4,59.28,161.65,22.48003,1.62,6,0.039803387,0.47705034,1,4,4,6,4056.53,2,2,241.84,38.97,73.95,48.44,54.92,0.002543,0.001,0.0061201,0.00205,30.59,0.175,3.59564,2.1861,0.039,0.002,0.066,0.04,0.77,0.813,100,87,58.3885,0.11,7e-5,0,0.040437,5e-4,0.337,0.282,0.351,0.359,0,0.34839,109.6071,1.8973,19.3221,0.8941,1.525416,0.1741,0.57607,0.0031,0,4.300081,0.088404,0,0,0,1.13014,176.26,4.31,1,1.1283,15.74,0,49.74,4.434,134.3,13.348,73.03,214.0582,5.97,1.56,79,161.06,0,99,107,54.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,NA,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
138,50,50,0,2,57.91,160.16,22.7176,1.6,6,0.042798056,0.51399632,0,2,2,6,350.587,2,2,321.12,21.51,84.85,23.72,25.08,0.001052,8e-4,0.0087572,1e-5,22.77,0.081,4.71201,2.3938,0.131,0,0.125,0.029,2.217,0.906,0.4,99.2,71.276,0.03,2.2e-4,0.0123,0.00634,4e-4,0.852,0.419,0.911,0.407,0.809,0.38312,119.4119,2.3629,9.9693,0.5241,1.786894,0.0078,0.304054,0.0011,0,4.573104,0.018207,0.0095,9e-5,0.001,1.239251,245.52,4.9,0,0.8613,0.413,0.0237,28.97,4.143,138.9,15.316,68.05,243.885,7.07,1.6,68,158.34,0,68,115,58.1,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
139,73,73,1,2,58.99,159.83,23.1437,1.6,6,0.142334963,1.71011464,0,2,6,6,12118.779,1,1,307.1,47.59,105.68,15.98,15.16,0,0,0.0651305,9e-5,23.73,0.002,14.18608,2.7535,0.284,0.265,0.15,0.115,0.811,0.005,103,42.22,93.0418,0.2,0,0,1.907958,0.0307,0.78,0.529,0.098,0,0,0.39994,126.2698,1.0922,0,0.7725,1.497531,0.1502,0.411418,0.0577,0,6.044484,3.678321,0.0198,0.00451,0,0.757109,365.99,4.71,0,0.9381,0,0.0158,32.75,4.188,142.7,8.499,75.43,410.3097,10.63,1.61,60,156.16,0,56,122,55.02,1,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
140,71,71,0,4,60.28,160.16,23.4372,1.64,7,0.158493522,1.89995127,0,4,2,7,1189.125,1,1,224.92,41.03,146.35,20.44,25.95,0.002864,0.0021,0.0352823,6e-5,0.89,0,4.46812,2.6899,0.851,0.567,0.475,0.271,1.348,0.669,102,73.93,69.8187,0,1e-5,0.0016,0.0901,5e-4,0.626,0.417,0.733,0.427,0.603,0.34543,97.0738,1.7082,10.652,0.201,2.933989,0.189,0.898702,0.0552,0.34,3.188078,6.704841,0.0364,0,0,1.289291,336.11,4.43,0,1.0486,0.56,0.0055,0.04,3.92,136,11.985,75.84,388.9993,7.53,1.81,59,160.37,0,75,120,66.05,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
141,73,73,0,2,47.33,145.81,23.03055,1.38,7,0.15464171,1.85288182,0,2,3,7,417.832,NA,1,149.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,NA,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Other,Y,Y,F,No,CASA,NA,Rituximab plus 6 CHOP cycles,NA,NA,Y
142,69,69,0,1,45.15,161.79,17.25646,1.44,8,0.136912107,1.64271636,0,1,1,8,255.268,1,1,568.9,41.02,725.71,22.02,27.32,0.004205,0.0049,0.0101546,0.004,30.79,0.082,5.3651,2.3487,0.004,0.131,0,0,0,0.004,99,45.01,101.2753,0.21,0,0.0083,0.199924,0.0117,0,0.004,0,0,0,0.36176,119.9063,2.4982,11.7839,1.6849,0.308077,0.2255,0.087152,0.0653,0,3.602888,8.945896,0.8571,0,0,1.32226,301.32,4.21,0,1.123,13.826,0,31.69,3.837,140.9,7.932,63.96,196.5961,5.01,1.46,85,162.09,0,103,131,45.12,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
143,62,62,2,2,45.6,159.81,17.8979,1.44,6,0.046072931,0.55364395,1,2,6,6,33212.392,1,1,625.14,33.95,58.88,8.44,14.98,0,0,0.011701,3e-5,25.09,0.05,5.37221,2.3012,0.221,0.296,0.01,0.04,0.458,0.687,99.1,74.47,61.9566,0.48,0,8e-4,0.099476,0,0.29,0.461,0.209,0.296,0,0.29513,97.7452,0,0,0.4072,0.878831,0,0.870654,0.0028,0.74,8.928208,0.704526,0.0375,0.00674,0.001,1.042698,360.99,3.42,0,0.894,11.626,0,26.98,3.702,138,7.005,57.05,309.0914,10.42,1.55,76,159.07,0,100,138,48.36,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
144,70,70,0,4,52.57,157.86,21.10911,1.52,8,0.083403705,1.0003605,2,4,2,8,789.981,1,1,1390.34,40.91,734.79,9.01,18.06,0.003085,0.0034,0.0297962,0.01353,0,0.002,4.28826,2.1904,0,0,0.019,0.001,0.644,0.709,104,70.15,61.8767,0.01,0,0,0.120236,0.0654,0.044,0,0.389,0.36,0,0.29777,97.142,1.1061,11.0558,0.0096,1.777424,0.3629,0.654982,0.1449,0.6,5.397014,4.288526,0.7875,0,0.001,0.978078,326.82,4.81,1,1.0665,10.654,0.0328,22.83,3.43,134.1,10.263,73.06,214.0941,8.17,1.53,69,159.46,0,76,127,53.92,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
145,74,74,0,1,90.01,169.93,31.64794,2.02,7,0.110796284,1.33092831,0,1,6,7,6342.706,NA,2,219.63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,HUN,Hungary,NA,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,NA,GA101 plus 8 CHOP cycles,NA,NA,N
146,64,64,1,2,52.09,175.98,17.62896,1.61,7,0.055183224,0.66285301,1,2,4,7,27917.429,2,2,840.68,26.82,91.05,24.97,90.22,5.55e-4,0,0.0519138,5e-5,28.92,0.001,2.49013,2.0714,0.734,0.479,0.307,0.239,0.933,0.629,98.9,89.22,56.3646,0.05,7e-5,0.0116,0.098939,4e-4,0.872,0.552,0.257,0.227,0,0.27008,89.208,4.4367,24.615,1.7168,1.040342,0.0035,0.819413,0.0699,0.08,9.575714,0.20578,0,0.00261,0,1.518369,408.53,3.51,0,1.2622,11.93,0,32,3.247,138,11.506,50.55,208.8275,9.45,1.66,72,176.15,0,70,144,54.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
147,60,60,0,2,80.73,160.14,30.60434,1.84,6,0.033585208,0.40233301,0,2,2,6,2055.496,2,2,191.54,40.03,61.19,26.31,27.64,7.9e-4,0.0022,0.0697931,1e-4,29.5,0.11,12.51117,2.2608,0,0,0,0,0.551,0.717,108.1,88.5,76.0038,0.17,0,8e-4,0.069947,8e-4,0.312,0.382,0.1,0.091,1.427,0.39102,126.741,0,0,0.363,0.908156,0.2439,0.460203,0.0895,0,5.62892,0.510183,0.0378,0.00658,0,1.064063,188.08,3.51,0,0.9814,10.608,0.0442,28.18,3.907,144,7.361,3.61,189.3302,7.21,1.71,65,159.75,0,71,113,74.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Other,Y,Y,M,No,OTH,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
148,73,74,0,3,44.93,138.5,22.65495,1.28,6,0.073503082,0.8811386,1,3,4,6,315.568,2,2,227.62,37.03,71.25,16.93,21.09,8.54e-4,0,0.0099329,1e-5,0,0.138,0.01849,2.1898,0.239,0.096,0.047,0,1.548,0.8,99.9,41.23,82.212,0,1.5e-4,0,0.189122,9e-4,0.927,0.512,0.468,0.214,0,0.37513,116.0299,2.5532,12.5032,1.298,1.841705,0.0106,0.598565,0.0043,0.84,1.797327,0,0,0,0,1.261033,232.22,4.31,0,0.9003,0,0.0604,27.35,3.896,139.1,10.222,73.93,272.3415,3.71,0.73,69,0,0,64,138,46.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
149,61,61,0,2,58.02,154.34,23.9677,1.55,6,0.100648834,1.20902537,0,2,5,6,1384.659,2,2,125.5,31.01,69.79,13.17,13.13,0.001027,0.0021,0.0067576,1e-4,1.66,0.164,5.71967,2.0599,0.148,0.157,0.202,0.162,0.772,0.737,101.1,103.84,57.8657,0,0,0,0.499974,0.0117,0.375,0.408,0.335,0.306,1.064,0.34688,108.6866,1.4183,11.3006,1.2373,0.667809,0.006,0.399468,0.065,17.99,3.206085,3.134133,0.0057,0.00297,0,1.193196,225.77,3.9,0,1.0035,11.99,0,29.71,3.795,136.1,2.93,54.61,243.9354,4.67,1.59,52,154.11,0,65,106,59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
150,68,68,1,2,93.09,175.88,29.53973,2.09,8,0.027581824,0.33105087,0,2,1,8,12326.515,2,2,441.34,40.25,73.19,41.26,23.81,0,0,0.0324811,0,26.6,0,15.37542,2.4971,0.289,0.396,0.189,0.131,0.726,0.657,98.9,62.59,123.0577,0,1.3e-4,0.014,0.279677,0,0.655,0.524,0.158,0.2,5.281,0.38586,125.415,3.178,9.4973,1.1659,0.2644,0,0.849,0.0022,0,6.304903,0.145739,0,0,0,1.133994,219.3,4,0,0.9938,9.763,0.0463,32.47,4.695,139,6.562,73.93,619.9208,6.78,2.23,85,178.52,0,76,149,100.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
151,50,51,1,1,82.06,169.99,28.54539,1.95,8,0.053212001,0.6397794,0,1,6,8,6093.538,1,1,237.57,39.96,68.53,18.82,24.09,0.001904,0.003,0.0567865,0,31.03,0.911,5.91338,2.3287,0.256,0.122,0.08,0.057,1.257,0.629,101,59.7,144.422,0.42,2.3e-4,0.0245,0.130737,9e-4,0.597,0.369,0.377,0.157,3.206,0.41852,140.8872,2.6344,12.7796,0.37,1.89995,0.0901,1.099533,0.0903,0.51,2.49886,5.961903,0.6278,9.5e-4,0,1.420528,179.6,4.6,0,1.0572,14.535,0,27.21,5.098,138,6.669,77.02,403.5293,5.61,1.96,71,168.06,0,68,119,80.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
152,64,64,0,4,50.65,159.88,20.2079,1.51,6,0.022704931,0.27233106,0,4,6,6,4510.16,1,1,159.55,37.91,54.4,9.02,11.66,0.004207,0.003,0.1182825,7.1e-4,26.04,0.22,4.98402,2.3893,0.166,0.239,0.008,0.026,0.292,0.754,107,69.92,74.1456,0.29,1.1e-4,0.0117,0.103535,0,0.137,0.421,0.179,0.306,0,0.41326,135.0077,1.1056,7.2007,1.3261,1.317343,0.0107,0.282444,0,0.81,3.608833,0.70184,0,0.00153,0,1.198437,189.25,4.2,0,1.0915,13.306,0,31.97,4.356,140.7,22.216,42.66,487.6851,6.95,1.51,62,158.93,0,96,119,49.07,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,3,0,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
153,65,65,0,1,81.87,159.84,31.64733,1.86,6,0.084036825,1.00911473,1,1,3,6,5250.965,1,1,362.33,46.81,91.53,15.77,16.82,0,0,0.0212548,0.00184,24.07,0.127,4.81924,2.2717,0.32,0.155,0.316,0.338,1.311,0.774,107,131.84,54.766,0.35,2e-4,0.6598,0.546134,9e-4,0.822,0.466,0.543,0.377,0,0.40503,128.3043,4.1519,6.4016,2.7416,1.560221,0.0093,0.81124,0.0045,0,20.566512,5.932909,0.0027,0.00847,0.001,1.063272,684.8,4.1,1,0.97,11.199,0,36.23,4.542,143.1,5.186,72.92,202.3327,18.81,1.88,98,161.64,0,98,167,85.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,DEU,Germany,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
154,62,62,0,1,78.09,158.85,30.86541,1.81,6,0.058997325,0.70792974,1,1,3,6,4160.793,1,1,221.86,40.1,59.94,7.91,13.36,0.004723,0.0022,0.0269157,0.0038,31.06,0.074,14.31542,2.3483,0.176,0.159,0.044,0.044,0.771,0.634,100,107.08,60.0244,0.18,1.7e-4,0.0071,0.393016,0.0184,0.137,0,0.451,0.297,2.803,0.3543,121.1046,0.0033,6.9306,0.3945,1.969456,0.2513,0.573963,0.0843,0,3.208908,5.068784,0.0034,0.0021,0,1.248744,239.65,4.99,0,1.1181,13.703,0.0058,24.93,3.873,141,12.22,58.81,344.9905,6.78,1.8,89,155.98,0,70,145,75,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
155,81,81,1,2,87.87,162.77,33.3084,1.92,6,0.048788462,0.58570921,1,2,5,6,10090.087,2,2,302.18,25.08,45.74,22.05,21.31,5.39e-4,7e-4,0.0311195,0.01223,27.94,0.002,3.80301,2.2844,0,0.128,0,0,0,0.01,93.1,76.97,73.909,0.01,3e-5,0.0116,0.099325,0.053,0,0.013,0,0.132,0,0.3601,118.3171,2.5152,0.1189,0.6301,0.698306,0.3918,0.48384,0.127,0.67,7.139542,6.819967,0.7379,5e-4,0,0.224815,225.23,4.31,1,1.0704,11.961,0,25.63,4.475,129.3,6.803,0,333.0657,9.19,1.98,81,166.98,0,91,130,89.55,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
156,63,63,1,3,66.82,169.99,23.01316,1.76,7,0.121911172,1.46165402,0,3,2,7,6474.177,2,2,202.17,37.51,87.63,26.75,27.45,6.34e-4,7e-4,0.030015,4e-5,0,0.078,0.09033,2.3785,0.233,0.076,0.082,0.057,1.264,0.736,92.7,155.23,35.4132,0.22,1.1e-4,0.169,0.020852,0.001,0.84,0.565,0.304,0,1.803,0.36836,123.0121,1.7927,6.0925,0.0021,2.184664,0.0112,1.005027,0.0564,0.37,6.003697,0,0,0.0035,0,0.171413,315.14,4.68,0,1.0446,12.833,0.0029,29.88,3.969,140.9,10.238,70.94,0,11.88,1.73,80,169.5,0.1,68,126,69.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,NA,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,Y
157,51,51,1,2,81.18,177.97,25.81306,2,7,0.049361788,0.59216682,1,2,4,7,20124.95,2,2,624.7,44.92,55.85,22.95,30.29,0,0,0.0174576,0,23.51,0.001,5.70716,2.7133,0.373,0.322,0.317,0.274,0.643,0,102.1,86.4,82.5927,0.23,3e-5,0,0.029793,0,0.568,0.375,0.159,0.139,0,0.39563,139.9075,2e-4,0.0944,1.6091,1.192267,0,0.631249,0,0.1,10.913284,3.95882,0.0094,0,0,1.237562,317.24,3.94,0,1.0218,10.598,0,29.91,4.54,137,8.551,77.8,237.9944,11.16,2.16,85,176.18,0,101,155,87.33,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
158,48,48,0,3,67.88,162.79,24.8846,1.75,6,0.040010582,0.4799682,0,3,5,6,2541.058,2,2,453.8,39.66,99.17,22.64,18.09,0,0,0.0999788,0.00985,28.04,0,4.7964,2.2925,0.198,0.117,0,0,0.577,0.545,98.1,128.75,64.6007,0,0,0,0.732608,0.0404,0.026,0,0.338,0.25,0,0.42468,131.1201,4.0272,14.5857,0.8788,1.48997,0.2342,1.033441,0.0945,0,2.898045,3.897658,0.6781,0,0,0.985135,329.42,3.99,0,1.0512,0.463,0.0628,29.09,4.893,144.8,9.209,68.83,279.3252,5.23,1.91,69,168.01,0,77,130,79.04,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
159,49,49,0,2,64.8,169.84,22.54014,1.73,6,0.071482492,0.85775084,0,2,1,6,752.337,2,2,192.45,43.05,65.79,28.14,58.89,0,0,3.139e-4,0,25.37,0,5.89776,2.2299,0.005,0.084,0.015,0.039,0.662,0.846,103.1,116.72,50.9272,0,1e-5,0,0.059679,4e-4,0.253,0.32,0.432,0.66,0,0.41945,143.0207,1.8785,7.3931,0.3184,1.000863,0.0026,0.528119,0,22.85,5.768514,0.460464,0.0145,0,0,1.185492,178.13,3.59,1,1.0351,12.054,0.0197,24.3,4.603,141,20.02,70.34,161.0353,7.21,1.71,89,170.82,0,80,144,63.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
160,72,72,1,2,66.91,168.92,23.12685,1.74,8,0.116714289,1.40232199,0,2,1,8,3175.707,2,2,344.59,47.44,82.53,25.82,18.05,0,0,0.0099811,0,20.64,0.085,3.5902,2.4448,0.127,0.123,0.087,0.056,0.729,0.739,99.1,72.15,71.6884,0.03,4e-5,0,0.207744,0,0.383,0.357,0.309,0.302,3.489,0.46043,151.8492,1.7279,7.4345,0.7587,1.04086,0,0.819567,0,0.54,14.323485,0,0,7.7e-4,0,1.229174,353.62,4.09,0,1.0994,0,0.0078,26.74,4.754,138,11.987,71.72,275.1366,15.08,1.74,91,169.81,0,77,129,72.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,1,131RR,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
162,44,45,0,2,81.79,169.24,27.76555,1.94,8,0.072544964,0.87087322,1,2,4,8,2097.363,2,2,207.35,43,97.55,20.42,20.05,0,0,0,0,3.17,0.147,0,2.3835,0.163,0.139,0.146,0.098,0.984,0.648,0.3,155.53,45.3305,0.47,1e-4,0.0219,0.099699,9e-4,0.675,0.475,0.256,0.147,3.505,0.40837,142.6938,2.2254,9.7965,0.3825,1.073845,0.0083,0.177816,0,25.87,1.377458,0,0,0,0,1.19595,207.38,3.91,0,1.0991,0,0.0525,0.26,4.6,138,8,67.09,243.1758,2.8,1.91,83,170.88,0.1,68,141,87.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,Y
163,57,57,1,2,100.41,179.99,30.95096,2.2,7,0.037808842,0.4536988,2,2,1,7,822.539,2,2,235.55,43,55.19,24.94,15.6,0,0,6.38e-5,0,3.25,0.181,4.99882,1.9342,0.252,0.118,0.127,0.087,1.181,0.726,100,121.27,69.7429,0.03,0,0,0.179731,0,0.536,0.339,0.472,0.28,0,0.43067,140.7859,1.7584,0.1365,0.2994,1.609397,1e-4,0.792891,2e-4,0.01,6.777344,2.76055,0,0,0,0.80961,400.15,3.8,1,0.9672,12.104,0.031,31.45,4.911,139.4,6.504,66.81,231.9847,9.19,2.08,86,178.03,0,67,150,97.72,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
164,67,66,0,3,79.99,178.01,25.02937,1.99,6,0.039936148,0.47894071,0,3,3,6,766.106,1,1,110.01,44.9,55.04,15.67,10.68,0,0,0.0200349,3e-5,3.69,0.118,8.5316,2.4529,0.112,0.186,0.02,0.031,0.373,0.698,96.9,82.51,83.9997,0.15,0,0.007,0.166803,8e-4,0.013,0.005,0.301,0.442,4.661,0.47995,163.8431,0.0048,0,0.7511,0.566744,0,0.620222,0.0018,0.24,7.697949,0,0,0,0,0.327683,318.17,3.91,0,0.8494,0.812,0.0697,34.54,4.843,140.8,54.84,68.03,206.6841,8.4,1.95,71,178.59,0,79,118,80.38,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
165,47,48,1,2,71.08,165,25.63742,1.78,7,0.095426396,1.14566473,0,2,2,7,6749.885,1,1,216.31,41.06,91.23,19.81,16.04,1.24e-4,5e-4,0.1037815,4e-5,28.05,0.262,8.57186,2.682,0.052,0.081,0.035,0.027,0.856,0.871,103.1,109.49,69.9014,0.39,2e-5,0.0203,1.643269,0.0159,0.527,0.51,0.336,0.368,0,0.37604,121.8267,1.2653,0.0091,0.5786,1.097227,0,0.412259,0,0,2.049278,0,0,0,0,1.321845,166,4.5,0,0.9958,10.602,0,32.54,4.006,136.1,8.97,60.43,273.8181,3.72,1.79,88,167.99,0.1,71,135,72.43,0,0,0,0,0,0,0,0,1,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
166,73,73,1,2,69.03,156.4,28.18588,1.69,7,0.07793675,0.9356577,1,2,2,7,4343.417,2,2,410.76,34.93,0,17.82,19.85,0.00147,0.0011,0.1363509,0.00223,21.99,0.099,6.0996,2.6722,0.306,0.127,0.207,0.085,1.995,0.809,102.8,50.68,97.307,0,4e-5,0,0.253084,3e-4,1.105,0.46,0.796,0.344,2.595,0.33079,117.6676,1.4891,0.066,0.0099,3.673846,0.0092,0.501048,0.0011,17.17,6.627527,5.506591,0.0063,0.00673,0,1.02762,417.1,3.91,0,1.1233,0.819,0.0044,0,3.863,135,4.441,68.04,148.9525,12.45,1.75,91,158.56,0,79,156,70.06,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
168,50,50,0,0,NA,NA,NA,NA,6,0.028463096,0.34132377,0,0,5,6,4071.098,1,1,275.01,46.86,64.93,27.54,20.95,0,0,0.0199227,5e-5,3.52,0,39.74798,2.5763,0.444,0.19,0.161,0.092,1.521,0.554,105,96.05,81.1709,0,0,0,0.270745,9e-4,1.163,0.459,0.44,0.165,0,0.39266,137.7677,2.197,13.1223,1.6186,1.394529,0.0454,0.45928,0.0049,0,3.502032,0,0.0233,0.00255,0,1.259343,150.77,3.61,0,0.8891,0,0.0293,26.87,4.463,142.2,11.016,73.97,505.8199,6.1,1.74,77,162.01,0,80,130,70.14,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,NA,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),NA,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,NA,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
169,63,63,0,2,88.52,171.92,30.59416,2.01,7,0.056129791,0.6737855,1,2,5,7,7913.214,2,2,906.32,41.23,47.1,17.85,79.01,0,0,0.0099211,0.00799,25.44,0,3.79508,2.2616,0.185,0.338,0.101,0.17,0.39,0.761,90.6,85.98,78.6986,0.37,0,0.0094,1.241551,0.0404,0.182,0.42,0.206,0.43,0,0.33324,130.4887,3.2003,14.3333,2.5847,0.33429,0.0902,0.700111,0.0973,0,4.125841,0.605994,0.512,1e-4,0,0,160.87,3.9,0,1.1921,0,0.0232,23.79,3.952,138.1,12.063,80.02,265.9464,5.3,1.92,75,171.04,0,79,109,87.27,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
170,36,36,0,1,58.84,163.84,22.17899,1.64,6,0.044067408,0.52802554,1,1,5,6,1459.491,1,1,522.62,32.72,123.81,19.1,25.11,0.001186,0.001,0.0079033,5e-5,0,0.105,6.79286,2.5308,0.046,0.036,0.151,0.148,0.502,0.391,94.9,120.71,54.9726,0.29,1.8e-4,0.0259,0.010065,0,0.478,0.452,0.001,0,0,0.35709,117.0842,1.8863,0.1218,0.7748,1.52788,0.0083,0.293125,0,0.02,7.092371,6.160122,0.74,0,0.001,1.044527,198.58,3.01,0,0.9736,0,0.0233,28.4,4.498,136,20.058,64.96,349.2725,10.04,1.79,81,166.07,0,64,135,60.59,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
171,74,74,1,3,104.95,183.37,31.05436,2.32,8,0.089303398,1.07211611,1,3,5,8,4919.351,1,1,849.51,39.93,75.13,28.98,51.18,0.001872,0.001,0.0200383,9e-5,25.69,0.038,3.02814,2.3479,0,0.002,0,0,0,0.453,100,71.02,90.1922,0,0,0,0.007243,3e-4,0,0,0,0.153,0,0.41122,128.3913,0.8797,0.0724,0.4603,0.497608,0.012,1.28994,0.0402,17.97,5.887235,7.139807,0.7767,0,0,1.256077,189.91,3.69,1,1.022,0.54,0.0618,30.08,5.052,137.1,14.384,56.92,308.5919,9.01,2.37,100,185.16,0,95,161,109.59,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,NA,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,NA,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
172,49,49,0,5,51.94,164.97,19.04318,1.57,6,0.021808307,0.26186166,2,5,4,6,2845.9,2,2,1134.16,0.48,60.89,25.96,100.29,0.003184,0.0029,0,0,25.01,0.001,5.71678,1.9303,0,0,0.001,0.044,0,0.001,98.9,94.91,71.6643,0,1e-4,0.0012,0.019881,1e-4,0,0,0,0.002,0.105,0.2438,78.4134,0.7574,7.6659,0.5115,0.649809,0,0.399352,0,16.02,6.777588,2.237871,0.0206,0.00302,0,0.08603,283.88,4.3,0,1.3022,11.878,0,31,3.248,140,6.878,45.03,268.3551,8.22,1.62,71,164.01,0,96,125,54.98,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
173,62,62,1,5,42.79,151.77,18.45428,1.35,6,0.074777555,0.89819115,1,5,4,6,3742.17,1,1,261.9,26.99,54.62,8.36,16.95,0.002284,0.0024,0,2e-5,30.2,0.027,3.91388,2.0721,0.036,0.007,0.069,0.064,0.976,0.838,103,86.18,54.8017,0.22,1.8e-4,0.0242,0.04984,9e-4,0.807,0.676,0.249,0.28,1.831,0.28093,93.3037,2.4617,12.1924,1.9298,1.222045,0.1512,0.300295,0.0054,0.79,5.597007,1.946483,0.0355,0.00119,0,1.272036,241.66,4.5,0,1.0399,10.383,0.7968,36.36,3.219,140.1,6.052,72.03,422.1926,7.85,1.33,61,151.88,0,80,112,45.3,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
174,67,67,0,3,61.75,155.86,25.22964,1.62,7,0.046554632,0.55898077,1,3,4,7,510.095,2,2,210.66,34.03,77.94,27.22,33.58,0,0,4.66e-5,0,19.95,0.101,5.32781,2.2763,0.072,0.118,0,0,0,0.004,96.1,61.38,85.367,0.15,2e-4,0.024,0,0,0.005,0.247,0,0.001,1.463,0.3587,122.0255,1.0593,8.9037,0.7715,0.970773,0.0105,0.400242,0.0053,0,1.689972,0,0,0.00444,0,0.961145,240.44,4.89,1,0.8968,8.59,0.008,42.09,4.107,129.6,7.995,69.94,336.0364,2.99,1.64,70,155.95,0,73,117,62,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
175,51,51,1,1,71.57,165.82,25.87021,1.78,6,0.076228986,0.91617213,1,1,5,6,6481.204,2,2,269.36,39,89.09,7.39,12.98,0,0,1.885e-4,4e-5,3.14,0.15,2.49965,2.3392,0.156,0.072,0.093,0.059,0.983,0.651,107.3,121.7,58.2721,0.23,0,0.0011,0.119341,8e-4,0.523,0.358,0.324,0.144,1.583,0.42061,138.7966,1.3937,10.8316,0.6589,1.09781,0.0033,0.570427,0.0037,0,13.025302,4.590599,0.0173,0.09888,0.001,1.431282,291.32,4.2,0,1.1923,11.909,0,36.66,4.76,139.1,3.089,69.07,267.9333,15.61,1.79,79,164.07,0,81,121,69.85,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NA,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
176,72,72,1,4,44.99,156.63,18.47499,1.42,7,0.059798991,0.71774325,1,4,5,7,18088.316,2,2,337.42,38.09,81.58,21.04,18.31,0.001052,0.0019,0.0082531,0,24.5,0.041,2.40064,2.3499,0.121,0.087,0,0,0.54,0.006,97.8,70.67,52.4876,0.15,0,0.0052,0.159533,0,0.175,0,0.184,0.141,0,0.34852,110.3786,2.005,8.9874,3.8256,1.559601,0.0074,1.128504,0.0647,0,7.502418,8.370638,0.7447,0,0,1.130014,183.58,3.89,0,1.0012,0.301,0.0088,26.8,3.807,133,10.986,62.91,261.7998,10.52,1.34,81,154.94,0,79,131,44.32,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
177,35,35,1,2,55.71,163.82,20.81035,1.6,6,0.100966922,1.21168938,1,2,3,6,8195.042,1,1,162.3,30.55,151.93,12.92,15.45,0.001291,0.0015,1.58e-5,0.00277,30.92,0.158,3.20817,2.0532,0.089,0.007,0.251,0.181,1.084,0.815,103.1,120.64,57.8334,0.06,1e-4,0,0.199945,0.018,0.523,0.38,0.628,0.424,3.144,0.27694,96.9879,0.8568,9.2429,0.3316,1.302003,0.1022,0.433196,0.0495,0,5.387987,7.984903,0.5922,0,0.001,1.155669,87.63,3.23,0,1.0207,13.346,0.0321,25.26,4.325,138.9,2.876,56.64,328.9269,7.61,1.59,59,164.94,0,85,110,58.43,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
178,58,58,1,3,70.39,174.05,24.09049,1.86,6,0.060448819,0.72540652,1,3,4,6,6969.588,2,2,1256.37,40.74,53.12,28.19,31.07,0.001976,0.0022,0.0399669,0.00397,27.01,0,9.97882,2.376,0.002,0.034,0.011,0.047,0.031,0.471,93.8,90.03,76.9625,0.5,0,0,0.070009,0.0261,0,0.001,0.106,0.221,0,0.39678,140.8431,1.4904,11.5958,0.5061,1.995437,0.1968,0.799265,0.0998,33.04,8.110327,4.265156,0.6836,0.00204,0.001,1.298349,320.13,4.31,0,0.9938,12.74,0,0.29,5.134,138,9.73,77.01,312.2464,11.14,1.85,79,172.04,0,82,125,67.81,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,>4,>1,NA,NA,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Other,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
179,26,26,0,1,81.1,167.9,29.40319,1.93,6,0.084818938,1.01824127,0,1,4,6,740.001,1,1,290.6,39.93,119.55,22.85,28.92,0,5e-4,0.10071,0.00285,28.05,0,11.87489,2.3501,0.327,0.192,0.182,0.106,0.79,0,102.2,118.84,76.9716,0.76,0,0.0103,0.631947,0.0307,0.424,0,0.257,0.148,0,0.42843,144.9284,1.3624,11.8199,1.0782,2.0246,0.0082,0.440007,0.0026,0,7.172188,4.291073,0.0188,0,0,1.178125,266.3,4.51,1,0.9589,0,0.032,0.75,4.782,141.3,7.996,75.88,309.5179,12.4,2,70,166.94,0,77,120,79.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
180,64,65,1,3,54.93,154.05,22.92161,1.51,6,0.058201133,0.69846469,0,3,2,6,2176.294,1,1,262.5,35.43,75.61,16.19,18.97,0.001338,7e-4,0.099505,0.00278,24.92,0.219,0,2.2981,0.217,0.116,0.062,0.046,0.694,0.581,99.9,76.12,65.4122,0,0,0,0.109876,8e-4,0.436,0.356,0.184,0.001,3.528,0.38493,114.1942,1.5396,0,0.1476,1.587949,0.2114,0.93783,0.0488,0,2.802298,0,0.0304,0,0,1.237802,481.46,4.49,0,0.8971,10.829,0.0112,31.79,4.407,137.9,14.706,43.93,285.4247,6.59,1.42,70,154.93,0,61,119,52.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,GBR,United Kingdom,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,High,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
181,60,60,0,2,76.91,174.53,25.01411,1.91,6,0.171924419,2.06284865,0,2,2,6,1249.158,2,2,242.46,41.07,32.27,13.89,21.09,0,0,0.0117121,0,0,0.05,6.20326,2.3567,0.13,0.07,0.044,0.035,0.833,0.799,95.9,61.62,117.2823,0,5e-5,0.0082,0.100652,0,0.365,0.323,0.303,0.343,4.301,0.49592,157.5336,0.3964,0,0.5185,1.199077,0,0.43634,0,30.44,6.886728,0.177426,0,0,0,0,240.23,3.61,1,1.0644,0,0,24.27,5.413,139.4,5.518,70.95,291.7434,9.55,1.98,76,175.9,0,71,131,79.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
182,53,53,1,2,75.98,167.54,26.15447,1.87,6,0.059923354,0.71970485,1,2,5,6,3959.791,1,1,293.03,28.99,49.01,80.97,82.59,0.001401,0.0016,1.717e-4,0,20.65,0.06,5.2026,2.1506,0,0,0.054,0.084,0.031,0.588,99.6,95.71,70.9145,0.36,0,0.0214,0.003703,0,0,0,0.107,0.341,1.833,0.31093,97.9511,2.4708,9.5736,0.5182,0.243742,0.0124,0.299844,0.0019,0.1,3.008799,0.237457,0.0066,0.00697,0.002,0.870524,138.9,3.8,2,1.1828,9.788,0,40.91,3.54,141.7,6.81,66.01,231.1461,4,1.82,58,167.45,0,77,109,76.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,UNKNOWN,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
183,62,62,1,4,56.94,157.94,22.69497,1.58,7,0.085827346,1.03142311,0,4,6,7,10592.18,1,1,478.32,34.01,81.13,15.07,15.71,6.18e-4,0.001,0.0132075,0.00948,33.08,0.056,5.37768,2.3729,0.499,0.223,0.12,0.05,1.59,0.71,104.8,70.18,85.4505,0.3,0,0.0138,0.070002,0.0831,0.699,0.36,0.731,0.351,0.745,0.38543,130.1729,0.9782,11.0176,0.4205,1.871321,0.4279,0.488606,0.1274,0,5.107648,3.779221,0.6257,0.00101,0.001,1.420418,315.77,4,0,1.0427,0.227,0.0052,0,4.25,143,8.02,63.92,231.1681,8.14,1.63,88,158,0,109,131,58.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
184,51,51,0,3,71.03,175.57,23.48085,1.85,8,0.040895114,0.49049075,1,3,6,8,16763.225,1,1,797.93,47.11,93.98,18.85,36.79,0,0,0.0532582,0.00202,27.62,0,5.09297,2.5299,0.066,0,0.091,0.04,1.548,0.922,100.1,64.48,107.0042,0,0,0,0.625089,0.0281,0.963,0.529,0.675,0.492,0,0.41241,141.7297,4.5899,20.0786,2.4378,1.608785,0.1281,0.300261,0.0046,26,4.304597,4.830813,0.5816,4.9e-4,0,1.300024,235.25,4.39,0,1.1017,0.11,0.0234,26.85,4.975,139.9,21.723,73.94,321.1082,5.91,1.85,75,173.1,0,74,116,68.89,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
185,51,52,0,1,63.13,170.06,21.93565,1.74,6,0.099523952,1.19519321,2,1,2,6,2503.244,2,2,216.09,28.07,57.06,17.83,28.01,0.00118,0,0.0087315,5e-5,1.79,0.021,7.11971,2.1758,0.432,0.284,0.37,0.199,1.996,0.784,95.9,73.74,84.6503,0.18,6e-5,0.0111,0.029642,2e-4,1.018,0.41,0.959,0.442,0,0.31245,110.4113,4.0681,12.1673,1.8811,1.842188,0.1805,1.00428,0.0628,27.32,1.603337,0.175092,0,0.00314,0,0.90352,154.09,0,0,1.1786,11.557,0.0016,27.39,4.016,137,4.999,59.43,220.0397,4.33,1.78,82,170.08,0,83,113,66.36,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
186,67,67,1,4,90.99,182.81,27.71294,2.1,8,0.019723422,0.23664526,2,4,3,8,6393.706,1,1,404.96,34.87,165.03,46.07,34.22,0.0027,0.002,0.0218176,0.00988,27.33,0.151,4.68615,2.3726,0.069,0.008,0.154,0.075,0.905,0.537,96.6,72.3,94.5785,0,0,0,0.002794,0.0242,0.534,0.335,0.347,0.184,0,0.30969,111.4942,0.6888,7.8941,0,1.660004,0.3303,1.446852,0.1809,0,4.971424,10.92105,0.804,0.00711,0,1.170448,217,4.2,0,1.0427,12.101,0.0061,22.92,3.593,133.9,10.228,57.03,382.0376,9.99,2.16,84,181.94,0,94,153,90.07,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131HH,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
187,65,66,1,2,68.96,162.5,25.71994,1.74,8,0.022062098,0.26490795,0,2,5,8,11235.446,2,2,378.76,37.93,77.12,68.49,28.1,2.7e-4,0,0.0439954,0.00793,23.99,0.051,6.74122,2.4632,0.04,0.063,0,0,0.251,0.634,101,72.41,81.0709,0,0,0,0.402555,0.0333,0,0.002,0.248,0.246,0,0.33551,108.9388,1.4641,10.4794,1.981,0.999743,0.0062,0.969199,0.0695,0.2,8.493613,7.499841,0.66,1.9e-4,0,0.930964,619.52,4.81,0,1.0298,12.916,0,30.86,3.775,137,8.565,70.04,231.9937,10.92,1.79,80,161.83,0,85,132,66.91,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
188,52,52,0,2,64.19,152.73,27.60957,1.64,8,0.139528978,1.67468325,2,2,4,8,2446.141,2,2,110.76,36.9,80.18,13.17,4.89,0.002274,5e-4,0.011552,2e-5,32.04,0.2,3.90457,2.2056,0.443,0.203,0.395,0.177,1.354,0.016,105.1,84.73,80.9614,0.43,1.4e-4,0.0165,0.323194,0.0039,0.723,0.377,0.538,0.15,0,0.36351,134.3923,3.0477,13.9372,2.4813,1.971921,0.1918,0.199371,0,31.77,4.328581,4.215013,0,0,0,1.344058,227.94,4.2,1,0.9707,13.587,0,28.37,4.296,140,2.907,76.62,253.5,6.7,1.72,70,152.07,0,75,110,67.27,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NA,N,China,CHN,China,>= 50 ml/min,N,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
189,46,46,0,3,48.04,147.92,22.31218,1.41,7,0.147052996,1.7659822,1,3,5,7,251.045,1,2,158.71,35.99,58.2,9.86,18.94,0.00359,0.0034,0.0996837,0.01559,26.99,0.183,6.01737,2.7858,0.183,0.177,0.139,0.14,1.15,0.801,107,95.21,63.7328,0,1e-5,0.0191,0.675336,0.1289,0.609,0.534,0.4,0.283,3.884,0.40227,142.743,0.6926,0.0868,0.5998,1.361232,0.1963,0.356318,0.1217,0.28,3.179606,4.973224,0.0408,0.00183,0,1.06655,405.9,4.88,0,0.8997,0,0.0273,29.99,4.725,142.1,7.009,73.97,437.109,6.3,1.52,61,148.77,0,74,115,54.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NA,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
190,47,47,0,3,85.72,168,29.66368,1.95,6,0.042769996,0.51353227,0,3,3,6,9462.392,1,1,736.88,47.28,103.12,10.25,16.03,0,0,0.0300179,0.00181,28.91,0.2,4.63963,2.401,0.254,0.201,0.61,0.295,1.309,0.647,108.9,107.12,68.0717,0,0,0.0065,0.203834,0,1.082,0.564,0.365,0.212,0,0.41415,130.774,0.013,3.6174,0.2284,2.634902,0.0139,0.386419,7e-4,0.36,3.948416,3.159115,0.006,0.00104,0,0.938775,183.47,4.01,0,0.9892,0.88,0,23.14,4.733,144.1,15.048,71.52,244.4821,6.99,1.97,79,167.91,0,86,112,79.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
191,42,42,1,1,73.01,173.8,24.22098,1.89,6,0.131347537,1.5757554,0,1,2,6,4695.449,2,2,319.74,41.89,90.92,14.01,13.8,0,0,1.753e-4,0,25.69,0,4.60245,2.5248,0.172,0.116,0.063,0.028,1.564,0.838,100.1,91.15,88.0865,0,4e-5,0,0.446301,1e-4,0.843,0.59,0.495,0.292,0,0.36119,116.0037,0.0024,0,0.3691,3.061906,0.0088,0.800126,0.0033,0.62,4.329827,5.991859,0.5885,5.8e-4,0,1.0888,334.13,4.6,1,1.1867,12.601,0,25.95,4.327,134.7,11.975,73.93,440.1813,8.4,1.92,91,171.18,0.1,75,133,77.74,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
194,64,64,1,3,64.27,154.77,26.87673,1.64,6,0.066318089,0.79564588,1,3,1,6,1997.994,2,2,370.09,23.71,87.93,11.91,21.07,0,0,0.1191142,0.00385,28.9,0.078,0.11298,2.377,0.007,0.188,0,0.001,0,0,99.1,82.64,64.3318,0.46,3e-5,0,0.288291,7e-4,0,0.004,0,0,0,0.31778,104.226,1.7094,6.7293,0.7239,1.092973,0.0115,0.680669,0,0.44,9.40191,2.226268,0.0216,0.00305,0,1.319164,281.08,4,0,0.979,0,0.0035,25.81,4.429,129.1,10.226,64.25,239.7668,15.27,1.67,71,152.46,1.8,78,103,65.09,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
195,45,45,0,2,65.02,173.38,22.32156,1.79,7,0.051631253,0.61919929,1,2,5,7,7317.122,2,2,876.74,44.04,308.73,38.59,27.62,0,0,0.0416428,7e-5,26.09,0.057,3.92744,2.4258,0,0,0,0,0,0.64,102.9,107,67.8868,0,0,0,0.251128,0.0309,0,0.103,0,0.141,0,0.38125,136.1847,3.5828,13.9895,3.0018,0.725679,0.0081,0.369223,0.0498,0.61,3.996681,0,0.0159,0.003,0.001,1.097909,258.2,4.43,0,1.092,0.831,0.02,27.01,4.88,141,13.684,71.95,215.5325,5.6,1.79,83,171.95,0,72,132,65.34,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
196,50,50,2,4,80.13,166.93,28.71115,1.9,7,0.05668616,0.68094416,0,4,6,7,37742.174,1,1,1670.74,27.07,74.47,8.49,16.03,0.0025959999999999998,0.0031,0.0773847,0.01209,26.02,0.158,3.76332,2.1053,0.354,0.244,0.218,0.155,0.528,0,96.7,105.79,70.9065,0,8e-5,0.0087,0.00355,0.0316,0.271,0.01,0.25,0.216,0.303,0.31602,93.6756,1.7356,6.8286,0,0.988309,0.24,1.138437,0.1433,0.04,5.321969,4.590043,0.747,0.00321,0.001,1.259715,279.78,3.89,0,1.0527,14.06,0.0511,37.3,3.51,136,10.25,65.05,180.1869,7.44,1.73,74,168.99,0.1,0,128,80.04,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
197,69,69,1,2,52.5,151.72,23.32348,1.46,7,0.077062819,0.92545935,0,2,1,7,2777.714,1,1,349.31,49,280.47,11.68,18.49,8.03e-4,2e-4,0.0399998,5e-5,3.63,0.08,4.63365,2.3773,0.305,0.167,0.083,0.044,0.939,0.554,105,65.03,67.8061,0.33,0,0,0.129742,4e-4,0.441,0.17,0.315,0.162,1.347,0.27659,89.2867,0.0182,10.4086,1.1124,1.702285,0.0134,0.142677,0.0037,0.17,2.895292,2.815166,0,0.00437,0,1.503216,194.26,4.45,0,0.9375,13.58,0.0553,33.07,3.853,140,17.038,75.96,297.7444,4.5,1.49,67,154.17,0,76,136,52.75,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Other,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
198,68,68,0,1,69.83,164.95,25.30653,1.75,6,0.080289379,0.96393719,1,1,2,6,4293.522,2,2,239.96,41.84,61.12,10.93,13.18,0,0,0.0906166,2e-5,1.99,0.002,4.75411,2.4505,0.338,0.214,0.269,0.116,0.996,0.513,103,94.47,56.856,0.09,0,0.0021,0.753149,1e-4,0.731,0.44,0.233,0.092,1.083,0.3999,133.0892,0.0112,3.8418,1.174,1.34149,0,0.799847,0,12.68,4.40119,0.058312,0.0283,0.00582,0,1.227824,224.24,3.99,1,0.9007,12.047,0,27.38,4.583,139.9,6.828,69,208.4979,6.79,1.9,64,169.87,0,70,120,78.85,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
199,63,64,1,4,80.08,168.95,27.91632,1.92,6,0.125224702,1.50173165,0,4,2,6,9346.832,2,1,789.27,31.51,155.33,39.72,55.73,5.3e-5,0.0016,0.0542835,0.00504,1.88,0.166,8.97228,2.4496000000000002,0,0.024,0.001,0.027,0.572,0.86,100,54.73,122.7674,0.21,0,0.0047,0.00993,0.0156,0.41,0.55,0.134,0.282,0,0.39537,123.3249,0.7037,0,0.3065,0.799485,0.1361,0.376054,0.0817,22.67,3.169118,0,0.5302,0,0,0.964246,87.5,4.78,0,1.0944,10.401,0.0252,24.91,4.503,132.1,5.175,51.07,421.0252,4.4,1.96,69,170.1,0,103,120,80.18,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
200,58,58,0,2,47.41,161.07,18.52097,1.5,6,0.105651631,1.26646162,2,2,1,6,1816.386,2,2,267.82,31.01,91.39,13.9,15.29,0.002082,0.0014,0.0101641,0,26.7,0.151,5.00253,2.1662,0.333,0.186,1.601,0.523,1.408,0.478,103,97.4,44.2994,0,0,0,0.052464,4e-4,0.57,0.004,0.714,0.298,2.726,0.29459,100.1016,0.0098,7.9827,0.6392,3.12339,0.0071,0.829338,0.0049,0.72,13.076063,0.621449,0.0224,0,0,1.45343,452.25,2.82,0,0.9007,13.514,0.0298,32.47,3.447,175.9,8.921,65,261.9343,20.02,1.46,60,162.95,0,81,99,45.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,2-3,ABNORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,Y,N,High-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
201,71,71,0,2,79.98,191.28,21.55252,2.08,6,0.059080865,0.70953655,1,2,1,6,1036.711,1,1,374.34,30,943.05,20.89,19.15,0.00101,0,0.019882,0,2.83,0.151,4.25037,2.2718,0.176,0.15,0.205,0.136,0.868,0.538,109.2,74.82,77.7669,0,1.7e-4,0,0.189953,0,0.449,0.131,0.345,0.256,1.887,0.44838,141.406,1.7981,10.5904,0.0104,1.394677,0.0807,0.52599,0,0,6.802367,0.250273,0.0116,0.00451,0.001,0.84099,328.98,4.3,0,1.0112,0,0.0096,30,4.813,142.1,22.3,70.75,273.9524,12.26,2,69,190.43,0,70,109,78.19,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
202,54,53,2,2,53.15,168.07,18.57858,1.6,6,0.019018471,0.2284447,2,2,3,6,13104.16,1,1,701.34,32.97,108.57,12.98,17.11,0.001481,9e-4,0.0300064,0.0051,26.27,0.07,1.95569,2.1202,0.128,0.245,0.042,0.089,0.045,0,0,96.07,64.8958,0.01,5e-5,0.0014,0,0.0076,0.006,0.009,0.128,0.261,3.193,0.3503,120.6097,3.5707,9.8893,0,0.625262,0.2021,0.174336,0.042,0.46,9.600705,6.70256,0.59,0,0,0.96252,345.67,3.51,0,1.092,0.784,0,28.67,4.104,134.8,9.995,46.73,210.6164,8.9,1.59,71,167.87,0,69,130,55.53,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
203,29,28,0,1,53.94,163.02,19.6714,1.57,7,0.119452303,1.43331974,0,1,4,7,3957.809,1,1,298.47,37.97,242.87,10.89,13.78,0.003245,0.0029,0.0099628,2e-5,0,0.101,3.04708,2.033,0.12,0.127,0.013,0.042,0.393,0.538,104.5,112.63,59.5843,0,1.1e-4,0.017,0.100283,0,0.021,0.002,0.265,0.299,0.979,0.34278,112.3584,2.0593,9.3351,0.8001,1.305842,0.0084,0.698575,0.0056,0.67,6.564307,3.678422,0.591,0.00258,0,0,322.62,3.59,0,1.1161,13.711,0.0193,39.99,4.699,144.2,8.316,70.06,294.0919,8.3,1.61,71,165.05,0,68,113,56.93,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
204,48,48,0,2,55.09,160.92,21.48454,1.58,6,0.054758272,0.65658836,0,2,5,6,5901.63,1,1,665.48,31.99,305.92,55.28,61.26,0.003212,0.0023,0.0502464,0.00197,31.56,0.15,4.20854,2.2749,0.001,0.058,0,0.003,0,0,105.1,103.88,60.0414,0.22,0,0,0.00307,0,0,0,0,0,0,0.34476,109.54,1.6146,14.7927,1.1525,0.598534,0,0.499241,0.0034,0,3.284956,3.200206,0.0301,0,0,1.554763,204.09,4.4,0,1.0951,11.627,0.0401,29.51,4.021,139.9,6.78,77.01,190.4149,4.92,1.64,79,159.84,0,71,125,55.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
205,61,62,1,2,59,158.01,23.36872,1.6,7,0.06125722,0.73505964,1,2,5,7,9371.369,1,1,1764.27,32.76,63.99,9.95,20.08,0.001532,0.0017,2.645e-4,6e-5,23.18,0.049,11.14285,2.0752,0,0,0.093,0.069,1.262,0.958,99.3,115.62,50.4169,0.02,3e-5,7e-4,0.142566,0.0118,0.544,0.503,0.631,0.636,1.231,0.40312,128.9187,1.9317,10.6115,1.6024,0.596681,0.0106,0.982491,0.0684,0.25,9.398415,4.968846,0.6696,0.00756,0.001,0.070952,235.67,3.9,0,1.0438,13.331,0.0055,35.63,5.204,140.1,6.83,61.97,0,11.55,1.69,70,156.98,0,77,97,54.67,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
206,37,37,0,2,89.76,176.56,28.00057,2.07,6,0.042775547,0.5136697,2,2,1,6,3739.117,2,2,343.84,38.97,126.72,26.74,26.9,0,0,0.0259114,7e-5,0,0.119,4.32816,2.2244,0.127,0.088,0.381,0.278,0.529,0,103,142.96,61.9109,0.04,5e-5,0.0103,0.03465,0.0051,0.269,0,0.22,0.117,0,0.36929,111.5633,2.5169,5.708,1.5069,0.995153,0.0125,1.138922,0.0662,30.93,6.124666,4.011723,0.6602,0.00337,0.001,0.910861,218.18,3.89,1,1.8241,13.886,0.016,32.02,4.016,135.1,6.942,58.1,327.3331,11.51,2.13,68,181.91,0,117,120,101.19,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
207,66,66,1,1,79.06,159.87,30.80053,1.81,6,0.076767874,0.92087755,1,1,4,6,8960.095,2,2,163.18,40.03,80.02,16.04,20.9,0.001872,0.002,0.0199894,0.00798,26.99,0.135,3.60317,2.0399,0.242,0.122,0.21,0.127,1.306,0.751,104.9,99.99,65.0044,0.11,0,0,0.140336,0.0332,0.828,0.414,0.408,0.287,1.794,0.41754,139.9881,2.2088,10.7949,0,3.423427,0.2243,0.725125,0.1338,0.01,9.515723,3.900619,0.6304,3.7e-4,0,1.294036,222.08,4.71,0,0.5604,0.057,0.0172,26.38,4.505,145.3,39.946,66.9,1208.2146,14.2,1.68,71,159.82,0,79,119,75.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
209,69,69,0,2,71.44,157.5,29.39671,1.74,6,0.028133571,0.33723216,1,2,2,6,3023.896,2,2,298.14,42.05,104.2,14.86,17.03,0.00212,0.0011,0.0502383,8e-4,24.93,0.152,9.61847,2.45,0.112,0.126,0.001,0.004,0.041,0,93.7,75.16,77.9048,0.23,2.4e-4,0.0246,0.313068,0.011,0.019,0.009,0.001,0,0.523,0.39037,121.5309,3.798,10.179,0.5011,1.291244,0.0057,0.400025,0.0587,0.11,7.945928,7.931841,0.3433,0.00687,0.001,0.763548,314.39,3.39,0,0.9853,10.501,0.0166,22.9,3.832,142.1,5.102,71.05,137.0011,11.26,1.7,79,157.72,0,72,146,67.85,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
210,64,64,0,2,74.98,184.17,22.59446,1.98,6,0.10348765,1.24004659,0,2,2,6,1027.786,1,1,334.21,48.84,97.44,44.4,23.87,1.89e-4,4e-4,0.0813621,1e-4,29.11,0.118,11.30258,2.4517,0,0,0,0.001,0,0.699,105,66.64,98.1218,0.36,1.1e-4,0.0033,0.110062,2e-4,0,0.334,0,0.001,1.079,0.42958,149.9169,0.5118,5.7946,0.0066,1.12448,0.0051,0.648179,0.0036,0.23,4.30869,5.731568,0.0324,0.00149,0,1.198779,192.94,3.94,0,1.1093,0,0.0477,36.05,4.768,131.9,6.894,75.87,306.5782,5.69,1.99,69,186.41,0,64,111,79.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
211,44,44,0,2,68.06,168.36,24.22349,1.76,8,0.038282448,0.45934785,1,2,6,8,6793.539,1,1,1023.13,35.47,82.54,18.16,24,0.002142,0.0034,0.0101018,0.00834,27.9,0.031,1.82777,2.3004,0.722,0.563,0.066,0.095,0.74,0.004,93.8,148.26,47.8075,0.09,1e-5,0.0086,0.308014,0.1313,0.4,0.006,0.342,0.231,0,0.33074,111.7261,3.59,19.4974,0.632,0.598516,0.2006,1.196163,0.1723,0,7.347783,6.616389,0.8354,0,0,1.160534,301.8,4.25,0,1.0001,13.433,0.0141,33.71,4.608,141,8.016,71,333.3047,9.35,1.78,61,169.87,0,81,110,65.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
212,59,59,0,2,79.94,172.98,26.39097,1.95,6,0.118723426,1.42523019,0,2,6,6,4213.871,2,2,502.43,26.9,44.47,10.69,21.05,8.94e-4,5e-4,0.0457855,0.00392,0,0.001,6.68203,2.0918,0.158,0.178,0,0,0.293,0.689,104.9,67.58,101.0349,0,0,0.0028,0.401547,6e-4,0.015,0.006,0.259,0.376,3.38,0.26775,86.9913,3.3538,10.208,1.2963,1.000032,0,0.602543,0.0033,0,1.586589,0,0,0.00244,0,1.314841,222.01,3.43,0,0.9733,10.523,0.0076,43.88,3.824,137.1,4.679,61.9,287.1671,3.44,1.84,79,173.99,0,78,131,80.73,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
213,50,50,0,3,55.14,163.01,20.80418,1.59,6,0.028610921,0.34414848,1,3,4,6,2122.601,1,1,410.63,40.4,78.26,12.28,17.13,0.002251,0.0028,0.0400154,1e-5,3.87,0.067,4.4446,2.3275,0.141,0.119,0.001,0.019,0.058,0.567,104,73.32,85.8596,0,5e-5,0,0.117195,7e-4,0.008,0,0.133,0.274,1.748,0.34719,108.8592,2.5359,10.8608,1.0519,1.291271,0,1.332751,0.0031,0.15,5.405122,0.543756,0.627,0.00191,0,1.618079,332.16,4.17,0,1.1637,12.103,0.0164,28.27,4.095,139.1,18.166,46.74,617.0736,8.4,1.59,80,162.56,0,129,121,53.47,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
214,82,82,1,5,66.19,152.05,28.98169,1.64,7,0.036967322,0.44341018,2,5,2,7,4992.804,1,2,482.7,25.82,66.31,11.92,10.08,1.9e-5,6e-4,0.0698987,0.00849,20.94,0.077,4.26261,2.1285,0.356,0.344,0.048,0.001,1.054,0.78,98,73.13,53.038,0.15,1.1e-4,0.0194,0.039767,0.015,0.643,0.462,0.303,0.288,0.496,0.36306,114.3468,1.5635,5.5293,0.5906,1.130233,0.1996,0.672953,0.0844,16.14,4.315514,0,0.0086,0.00235,0,1.135103,529.56,4.15,0,1.1076,10.571,0,0.41,4.1,135.2,9.977,64.67,190.0296,7.31,1.63,79,150.73,0.1,71,119,64.32,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
215,26,26,1,0,78.86,162.74,29.37605,1.83,6,0.058661589,0.70387447,1,0,2,6,6286.019,1,1,168.66,39.05,94.92,30.11,48.19,0,0,0,0,29.42,0.152,10.41383,2.4536,0.005,0.074,0.042,0.085,0.301,0.694,100.9,156.4,53.0302,0,0,0,0.070014,0,0.145,0.356,0.103,0.221,0,0.28254,105.8644,0.0099,11.9734,0.4229,1.206818,0.0102,0.548709,2e-4,0,9.611401,0.606491,0.0384,0,0,1.420087,148.63,4.51,0,0.9859,0,0.0443,28.15,3.306,140.9,2.928,70.5,356.9308,11.43,1.86,87,161.72,0,104,147,78.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
216,61,61,1,2,61.71,158.48,24.45626,1.64,8,0.159556677,1.91792767,1,2,2,8,6249.92,2,2,1098.93,36.73,124.45,15.07,20.07,0,0,0.0400341,0,27.81,0.05,13.4403,2.2758,0.08,0.051,0.016,0.04,0,0,104.9,52.73,97.0149,0.25,5e-5,0,0.060423,5e-4,0.001,0.003,0,0,0,0.36169,111.07470000000001,2.4683,12.5649,1.1982,0.769864,0,0.360304,0,0.21,4.246303,0.434901,0.0334,0.00436,0,1.206661,323.12,5.01,0,0.9924,11.814,0.0364,27.35,4.09,143.1,3.252,71.91,234.2695,6.12,1.64,88,157.42,0,70,127,61.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
218,64,64,2,2,69.89,162.12,26.27192,1.74,7,0.055048905,0.66192168,1,2,3,7,28468.822,1,1,217.3,37.95,164.86,49.44,30.75,0.002024,0.0016,0.0238045,0.00289,3.57,0.105,6.67529,2.372,0.155,0.191,0.014,0.034,0.518,0.745,98.8,104.2,58.3447,0,3e-5,0.0013,0.07842,0.0098,0.27,0.367,0.248,0.334,2.191,0.31419,106.0187,0.8793,11.3447,2.4885,1.193864,0.0123,1.155819,0.1065,23.94,3.944087,4.301295,0.0301,0,0.001,1.23256,320.65,4.29,0,1.0002,12.297,0,31.71,3.881,140,8.692,66.5,226.0126,6.3,1.81,78,161.91,0.1,85,134,70.18,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
219,50,50,1,3,71.47,176.02,23.57753,1.87,7,0.032189988,0.38639509,1,3,1,7,4772.265,1,1,393.26,37.25,93.97,14.69,24.11,9.08e-4,6e-4,0.0702454,7e-5,26.79,0.141,0,2.2755,1.122,0.458,0.296,0.105,2,0.746,101,122.39,51.1796,0,1e-5,0,0.01977,0,1.458,0.464,0.812,0.275,1.221,0.3643,123.3644,1.7194,0.0557,0.8605,0.998745,0.001,0.701373,0.0451,0.16,3.904919,0.528198,0.007,0,0,1.300725,380.03,3.8,0,0.991,0.263,0,44.12,4.48,140.1,6.754,60.61,130.1123,6.06,1.75,80,175.32,0,70,109,62.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
221,60,60,1,2,89.57,168.06,31.59001,2,7,0.048747169,0.58465439,0,2,2,7,5404.867,2,2,430.53,41.98,97.95,43.15,33.21,0,1e-4,0.0300005,0.00314,28.74,0.111,13.77926,2.5333,0.06,0.165,0.012,0.044,0.219,0.663,102.2,106.44,72.981,0,0,0,0.009828,5e-4,0.266,0.347,0.006,0.198,0,0.44558,151.7723,0.002,10.9074,0.0099,0.80185,0.0131,0.479657,0.003,30.2,6.707738,3.725753,0.6796,6.6e-4,0,0.12947,242.76,4.61,0,1.118,10.606,0,24.58,5.788,136,10.214,69.98,365.8231,7.1,2.04,80,168.08,0,80,137,88.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Other,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
222,63,63,1,4,92.36,160.65,34.60521,1.97,7,0.098514135,1.1833395,1,4,4,7,5000.271,1,1,705.39,48.03,70.9,15.01,61.18,2.32e-4,6e-4,0.039942,1e-5,24.97,0.116,6.2849,2.3061,0.238,0.307,0.032,0.063,0.035,0.014,107.1,70.44,103.0922,0,0,0.0077,0.199901,5e-4,0.094,0.363,0,0,5.204,0.39279,127.9728,1.5243,9.0866,0.5006,1.090144,0.0581,0.598803,0.0645,17.33,2.599873,3.522869,0.0227,0.00282,0,1.062707,63.83,4.5,2,1.0904,11.503,0.0094,25.79,4.041,141.1,3.971,76.58,374.5715,5.41,2,77,163.07,0,80,120,93.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
223,37,37,1,3,74.05,159.92,28.65512,1.77,8,0.130030308,1.5597253,1,3,5,8,4305.835,2,2,229.05,36.02,75.03,65.26,25,0.003145,0.0028,2.82e-5,9e-5,0,0.001,5.89889,2.0935,0.032,0.037,0.059,0.071,0.577,0.629,93.5,133.02,52.0666,0.39,0,0.0243,0.194264,0.0194,0.353,0.32,0.188,0.154,0,0.34994,119.6449,2.3943,10.2956,0.1142,0.577131,0.003,0.752702,0.0879,18.08,17.935619,0.580096,0.5372,0.00339,0,1.583018,588.96,4.31,0,0.0084,12.26,0,0,4.227,140.8,6.823,64.71,168.9972,14.43,1.84,75,159.83,0,115,107,73.08,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
224,60,60,1,2,53.47,160.67,20.57431,1.55,7,0.105802719,1.27042691,1,2,2,7,11185.553,1,1,790.08,35.79,146.66,49,50.16,0,0,0,0,26.29,0.097,6.38514,2.3977,0.003,0.091,0.011,0.029,0.057,0.675,102,83.64,64.6816,0,5e-5,0,0,0,0.059,0.372,0.007,0.15,3.552,0.30978,94.9355,2.4478,12.0972,0.6418,0.513456,0,0.389765,5e-4,0.34,6.67666,5.232545,0.6448,0.00147,0,1.327794,203.05,4.42,1,1.0042,11.069,0.0207,32.51,3.782,137,7.996,63.94,254.7695,7.69,1.5,65,157.8,0.1,87,117,49.24,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
225,65,65,0,2,77.56,174.04,25.8329,1.92,6,0.094181575,1.12988285,1,2,6,6,11062.708,2,2,438.37,38.96,65.69,23.74,23.83,0,0,0.0199302,0.00961,30.11,0,23.51501,2.1153,0.136,0.161,0.031,0.024,0.818,0.661,94.4,101.16,61.9295,0.24,1.4e-4,0.0101,0.29476,0.0488,0.527,0.384,0.248,0.196,4.125,0.31135,107.9447,2.6795,8.988,1.5089,1.031003,0.1796,0.751778,0.1176,0.27,3.924544,2.897907,0.6634,0.00272,0,1.29134,257.91,4.09,0,1.2913,13.106,0,25.73,4.506,137,8.499,66,267.7541,5.96,1.92,84,172.91,0,78,120,75.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,0,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
226,73,73,0,2,51.75,153.97,21.79302,1.48,7,0.107777873,1.29434292,2,2,2,7,253.82,2,2,623.83,34.17,147.8,19.72,34.97,0.002831,0.0022,0.0470108,0.01314,30.54,0.15,4.99475,2.2625,0.229,0.273,0.15,0.112,1.15,0.759,105,73.92,61.9844,0,1.1e-4,0,0.028514,0.0272,0.919,0.583,0.253,0.113,0,0.41938,131.9284,0.8514,9.0607,1.6722,1.002576,0.3245,0.979204,0.1505,0.57,4.66283,7.614282,0.7406,0,0,1.407338,382.01,4.5,0,1.1829,13.042,0.0192,28.3,4.677,139,8.263,44.12,356.0728,7.89,1.46,84,153.58,0,103,116,51.96,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,Y,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
227,66,67,1,4,69.87,157.89,27.59324,1.7,7,0.038287215,0.45955075,1,4,5,7,18222.353,2,2,698.12,37.87,66.39,9.04,19.02,0,0.0015,0.0198779,0,26.96,0.28,5.36754,2.2573,0.1,0.186,0.11,0.16,0,0,102.2,69.08,85.7589,0.68,0,0.016,0.069914,0,0,0.009,0,0,0,0.40721,132.0181,1.0378,2.6812,0.5006,1.362742,0,0.52001,0,0.04,5.259829,0.59496,0.0338,0.00679,0.002,1.000472,340.09,4.72,0,1.2114,12.487,0,33.22,4.507,135.1,8.561,49.74,285.0384,7.31,1.65,75,157.74,0,99,119,64.37,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
228,51,51,1,1,78.11,159.87,30.58187,1.81,7,0.024073345,0.28909654,0,1,3,7,6449.868,1,1,1113.47,41.92,144.95,9.74,10.53,0.001612,5e-4,0.0199174,0.00592,0,0.21,0,2.4591,0.067,0,0.15,0.104,0.932,0.682,0,152.24,53.0077,0.33,4e-5,0.0159,0.110002,0.0113,0.523,0.255,0.338,0.217,0.778,0.39122,135.9431,1.7916,7.787,1.2365,2.14024,0.225,0.398621,0.0037,0.46,7.679847,7.90015,0.7368,0,0,0.939447,375.47,3.85,0,0.9887,11.273,0.0184,39.78,4.383,140,4.707,80.05,162.209,9.09,1.83,93,159.98,0,77,133,79.41,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
229,62,62,1,1,59.03,168.18,21.49295,1.65,6,0.02376096,0.28517443,1,1,1,6,2567.688,2,2,249.68,30.97,94.91,24.31,29.02,0,0,0.0502376,0,23.77,0.212,4.60316,2.1203,0.237,0.185,0.295,0.152,1.263,0.666,97.4,80.09,70.9814,0.08,6e-5,0.0171,0.036757,0,0.784,0.431,0.353,0.14,0.459,0.31895,112.0923,2.2961,15.7706,1.381,4.239193,0.0018,0.598462,0,0.06,4.107141,0,0,0.00621,0,1.065488,318.46,4.37,0,0.9931,11.869,0.0051,33.27,3.667,140,4.24,67.09,458.2647,9.16,1.66,80,170.03,0,98,122,60.95,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
230,54,54,0,4,53.91,180.03,16.41935,1.65,7,0.024381355,0.29291785,1,4,6,7,4531.879,1,1,1410.47,38.97,0,30.02,33.94,1.71e-4,7e-4,0.0163376,8e-5,20.86,0.131,9.6393,2.432,0.271,0.233,0.122,0.129,0.975,0.791,95.5,56.98,109.0843,0.46,8e-5,0.0029,0.099709,0.0099,0.439,0.376,0.581,0.416,4.263,0.39564,131.8249,1.0976,5.7152,0.7143,1.280904,0.0085,1.99563,0.0704,19.49,4.085278,0,0,0.00827,0.001,1.117638,219.58,4.49,0,1.1883,11.754,0.0321,25.98,4.359,134.3,8.516,65.98,261.7231,8.91,1.69,81,180.61,0,85,134,54.54,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
231,60,60,1,3,74,161.91,28.07256,1.77,7,0.03487914,0.41880694,0,3,4,7,20440.29,2,2,327.98,40.71,76.92,15.85,18.06,0.001943,9e-4,0.0099424,8e-5,0,0.177,2.60014,2.3453,0.295,0.189,0.313,0.23,0.829,0.757,101.1,79.26,76.032,0.43,0,8e-4,0.309044,8e-4,0.663,0.557,0.229,0.186,0,0.3938,130.0548,2.4765,11.24,2.4813,1.053904,0.1292,0.625693,0.0778,0,5.29173,2.689999,0.5316,0,0,1.066984,279.96,3.6,0,0.9954,0.172,0.0206,0.63,3.971,140,10.249,76.04,385.1166,6.58,1.67,70,162.92,0,64,109,71.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,High,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,N,N,N,WHITE,Other,Y,Y,F,No,CASA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
232,66,66,1,3,54.06,174.99,18.07255,1.63,8,0.054359364,0.65244646,1,3,2,8,13221.295,1,1,1317.89,38.45,94.23,10.97,29.06,0.001498,0.0024,0.0401089,0.0071,29.95,0.066,6.20528,2.3009,0.22,0.272,0.013,0.045,0.081,0.015,102.1,52.19,97.5405,0,0,0,0.099825,0.0389,0.077,0.134,0.092,0.175,0,0.38032,134.0801,0.0162,10.8962,0.5389,0.996098,0.2006,0.84681,0.0925,0.34,5.069811,0.42582,0.7364,0,0,1.370389,246.48,3.81,0,1.0456,0,0.0597,29.7,5.001,144.9,6.152,72.97,309.0593,7.1,1.64,81,173.64,0,86,149,53.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
233,29,29,1,3,96.33,153.46,40.894,1.93,8,0.038444328,0.46179718,1,3,4,8,22355.44,2,2,512.98,41.97,120.82,13.14,17.08,0.001346,0.0029,0.0085783,9e-5,26.22,0.076,7.13309,2.4933,0.083,0.104,0.007,0.001,0.318,0.589,101.9,122.33,75.1113,0,2e-5,0,0,8e-4,0.153,0.348,0.094,0.173,0,0.35448,123.4044,1.5521,0.1333,0.8159,0.560003,0.0413,0.701143,0.0858,0,15.575048,1.933219,0.6444,0.00133,0,1.337098,302.46,4.88,0,1.0452,12.545,0.0301,28.54,4.636,138.9,6.81,73.06,356.1962,12.69,2,64,152.43,0,91,119,97.76,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
234,62,62,1,2,81.96,174.97,27.05259,1.96,6,0.034525419,0.41502724,1,2,2,6,15716.357,2,2,1030.49,37.19,109.85,30.75,29.12,7.5e-5,0.0017,0.0300223,0,0,0.041,11.79913,2.1557,0.003,0.006,0.018,0.017,0.058,0.623,98.8,93.68,72.197,0.19,0,0,0.112055,0,0.136,0.252,0.092,0.214,3.216,0.33186,112.0436,0,0.0856,0.3966,1.039718,0,0.799304,0,0,5.701482,3.421017,0.0132,0.00502,0.001,0.969021,197.03,5.11,0,1.0088,0.095,0.0293,34.31,3.844,135.2,6.023,63.92,279.5255,8,1.93,58,175.94,0.1,89,111,78.86,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,Yes,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
235,73,73,0,5,60.99,164.97,22.83211,1.66,7,0.019083776,0.22905794,1,5,5,7,3873.125,2,2,2725.52,37.1,83.11,15.63,20.06,0.001954,0.002,0.0499571,7e-5,0,0.002,4.59417,2.1461,0.017,0.002,0.001,0,0.254,0.532,102.2,83.88,61.9028,0,0,9e-4,0.100214,3e-4,0,0,0.225,0.241,5.005,0.33096,108.5697,2.7143,15.8851,8.3716,1.395643,0.011,0.598997,0.0052,0.31,3.671901,0.228832,0,0.00142,0,1.197533,275.73,4.16,0,0.9815,11.157,0,29.84,3.954,134.7,8.322,70.91,214.0217,6.57,1.64,88,166.02,0,76,125,62.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
236,57,57,0,3,46.11,170.03,16.42142,1.54,7,0.017885998,0.21461236,2,3,5,7,4495.216,1,1,1593.11,40.07,69.17,32.18,189.2,0,0,0.0428251,0.0095,2.72,0.001,0,2.3335,0.281,0.157,0.114,0.075,0.922,0.616,92.3,56.99,93.8316,0,0,0,0.395856,0.0495,0.4,0.27,0.448,0.248,2.667,0.31323,100.9653,2.4196,10.9977,1.4009,2.280169,0.3412,2.138288,0.1194,0.29,13.377882,4.242065,0.6834,0.00184,0.002,1.253244,536.66,4.11,2,0.9693,13.038,0,35.65,3.995,137.2,5,67.92,350.9558,18.86,1.43,80,169.96,0,89,129,45.5,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,< 55,>= 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
237,73,73,1,2,84.01,163.06,31.00326,1.92,7,0.152933158,1.83667224,2,2,3,7,10567.076,2,2,301.18,40.97,61.2,21.04,17.11,0,2e-4,0.0995252,9e-5,28.06,0.101,6.28704,2.1714,0.143,0.027,0.034,0,1.216,0.765,100.9,107.19,63.5774,0,4e-5,0,0.101083,4e-4,0.653,0.363,0.355,0.22,4.628,0.31101,104.3627,1.4097,12.6763,0.0035,2.407242,0.0041,1.380168,0.0391,30.5,13.77715,5.786613,0.0337,6e-4,0,1.144338,277.73,3.52,1,1.0125,13.535,0,33.04,3.973,141.9,9.07,80.72,297.0142,18.64,1.93,77,162.72,0,72,136,82.55,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,>= 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
238,48,48,1,2,63.16,169.5,22.60726,1.72,6,0.057358785,0.68882257,1,2,5,6,8188.114,1,1,141.87,41.07,71.37,15,13.78,3.17e-4,0,0.027454,7e-5,26.76,0.121,0.04258,2.4432,0.212,0.119,0.122,0.07,1.159,0.59,97.1,89.53,72.9492,0,1.2e-4,0,0.126678,8e-4,0.619,0.291,0.474,0.236,4.89,0.37963,132.1319,1.6243,8.9061,0.7306,3.088781,0.2331,0.498565,0.0056,16.82,2.710094,0.304694,0,0.00373,0,1.090416,401.74,4.35,0,1.2052,0,0.035,27.09,4.222,137,5.16,73.97,231.9936,5.91,1.69,61,168.05,0,89,111,63.19,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
239,36,36,1,2,45.55,150.4,19.90393,1.38,6,0.023193925,0.27836668,1,2,2,6,1861.745,1,1,178.46,38.95,66.59,24.95,16.17,0.001558,0.0016,0.0081207,1e-5,27.08,0.136,3.98781,0.2911,0.175,0.125,0.152,0.087,1.114,0.787,106.5,125.19,53.6101,0.1,0,0,0.125142,6e-4,0.516,0.386,0.431,0.347,0.78,0.32741,108.3427,1.0891,9.1958,1.1255,1.293868,0.013,0.300955,0.0027,0,4.203345,0.211744,0.0303,0.003,0,1.131293,178.87,4.17,0,1.0066,13.045,0.0245,30.72,3.925,146.2,3.449,63.99,286.9615,6.5,1.45,79,151.74,0,75,111,46.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
240,81,81,1,3,54,157.74,21.014,1.55,6,0.105685482,1.26650994,1,3,2,6,3936.629,2,2,217.55,29.04,87.87,15.04,15.93,0.001753,0.003,0.1261395,0.01252,32.34,0.09,7.49483,2.3221,0.156,0.135,0.001,0.033,0.18,0.775,104,49.44,68.9063,0.17,5e-5,0.0283,0.45893,0.0432,0.388,0.591,0,0.001,0,0.21293,67.4536,2.4991,10.3997,0.6996,0.702736,0.1899,0.501061,0.0662,0,2.690637,0,0.0143,0.00541,0.001,1.299632,316.68,3.8,1,1.1076,11.475,0.0325,32.3,3.034,135.9,11.293,70.9,279.6675,3.8,1.51,66,157.84,0,85,132,52.78,1,0,0,0,0,0,0,0,1,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
241,72,73,0,2,86.37,165.03,31.23948,1.96,6,0.053058313,0.63616216,1,2,1,6,588.501,1,1,301.85,45.06,264.64,24.28,21.94,0.003477,0.0043,0.0598168,0.00509,22.24,0.06,6.42176,2.2258,0.22,0.362,0.059,0.087,0.315,0.704,103,112.96,53.5234,0,0,0,0.099685,0.0246,0.022,0.328,0.23,0.314,0,0.35646,113.8055,3.5346,10.686,0.7603,1.677665,0.201,0.139685,0.0538,0.37,3.912973,3.011488,0.4575,0,0,1.065153,120.04,4.1,0,1.0947,12.146,0.0051,35.62,3.748,135.9,8.572,76.01,84.7572,7.1,1.99,74,163.94,0,73,118,87.81,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,Yes,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
242,78,78,0,4,75.07,169.81,25.72254,1.86,6,0.058436041,0.70090081,0,4,1,6,5069.179,2,2,285.01,38.3,52.73,37.1,23.72,3.19e-4,6e-4,0.0158737,9.1e-4,25.04,0.001,5.74924,2.3341,0.069,0.006,0.001,0,0.036,0,92.1,50.08,97.2331,0.38,1.3e-4,0.0128,0.252029,0.0068,0.147,0.284,0.002,0,2.072,0.42014,138.1367,2.9535,8.3451,2.7861,1.610381,0.1449,1.20131,0.0765,0,6.893478,5.839745,0.4757,0.00392,0.001,0.755684,270.96,3.31,1,0.9499,11.945,0.015,38.8,3.989,140,5.169,63.93,273.885,9.12,1.73,61,169.75,0,75,111,76.84,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
243,60,60,0,3,80.06,176.07,25.19671,1.96,6,0.025882289,0.31018928,2,3,3,6,20439.457,2,2,6868.15,35.98,65.68,23.85,85.41,0,0,0.1028607,0.00798,26.39,0.079,0,2.5026,0.216,0.133,0.036,0.012,0.986,0.881,0,91.75,74.1502,0.02,0,0,0.150037,0.0099,0.367,0.382,0.649,0.502,0,0.3529,110.6067,5.1393,17.5152,1.2378,1.827508,0.1758,0.83999,0,0.74,2.393418,0,0,4.4e-4,0.001,0.772965,419.01,4.99,0,1.1223,0.746,0,30.96,4.592,131.4,8.944,73.04,446.6043,6.21,1.94,66,179.37,0.1,110,99,80.14,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
244,86,86,0,4,84.47,160.19,32.51736,1.89,7,0.095760867,1.14926352,1,4,3,7,1396.801,1,1,666.63,40.47,245.58,33.66,81.07,0.00121,0.0011,0.0416116,0.00606,27.97,0,10.35757,2.3389,0.176,0.079,0.04,0.029,0.858,0.697,105.1,10.82,178.2416,0.28,0,0.0061,0.409135,0.0124,0.67,0.492,0.176,0.024,2.723,0.39706,128.5555,4.5885,18.7655,1.393,0.89722,0.1817,0.429313,0.0783,42.45,4.542296,2.887251,0.147,0.00146,0.001,0.969606,233.02,4.61,1,0.9406,0.307,0,0,4.206,135.2,45.123,67.96,454.8554,7.2,1.93,95,159.72,0,100,141,82.59,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
245,60,60,0,3,75.03,175.45,24.24617,1.94,6,0.086451275,1.03740473,0,3,3,6,4117.647,1,1,340.22,34.03,98.76,16.06,32.81,0.00162,0.0023,0.1301671,8e-5,28.39,0.001,7.70425,2.3052,0.259,0.147,0.116,0.075,0.934,0.707,102.9,109.72,56.9982,0.03,0,0,0.14992,2e-4,0.491,0.454,0.325,0.236,0,0.37458,128.982,3.7918,16.8723,1.5964,2.36118,0.143,0.68815,0.0091,0,4.549859,0.690608,0.5898,2.3e-4,0.001,1.423715,155.21,4.59,1,1.0282,0.857,0.0429,0,4.287,139,17.659,73.98,327.6593,8.19,2.02,75,175.61,0,87,101,80.46,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
246,63,63,0,3,82.1,155.02,33.539,1.8,8,0.083244277,0.99836607,1,3,5,8,4776.588,2,2,339.71,43.96,122.14,14.99,16.88,0,0,0.0103163,0.00277,24.04,0.091,6.29648,2.4075,0.182,0.176,0.049,0.059,0.772,0.661,100.1,70.62,97.6219,0,0,0,0.234311,6e-4,0.412,0.284,0.292,0.275,2.656,0.40466,144.9854,5.1667,14.2936,1.6113,0.639686,0.0062,0.056047,0,23.96,4.238879,4.20665,0.7789,0.00363,0,2.151945,678.33,3.79,0,1.0842,13.452,0,36.28,4.575,139.4,8.029,83.52,321.1634,5.47,1.86,71,155.09,0,87,131,82.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
247,68,68,1,4,64.47,171.71,22.87165,1.76,6,0.061360706,0.73625039,0,4,3,6,8033.714,2,2,343.64,49.72,209.44,52.84,18.95,6.28e-4,0.0017,0.0399771,0,0,0.229,3.99856,2.8225,0.104,0.062,0,0,0.288,0.458,100.3,66.52,97.0789,0.52,0,0.0176,0.009982,0,0.013,0,0.186,0.189,1.729,0.44223,159.1217,2.3722,10.2063,0.6549,2.877682,0.0022,1.120666,0,0,7.705104,0.111972,0,0,0,1.247142,363.56,4.99,1,0.9794,11.412,0.0478,30.31,4.533,135.1,17.253,79.21,421.4761,15.08,1.67,72,171.17,0,77,120,63.93,1,0,0,1,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
248,47,47,1,1,57.08,162.83,21.47914,1.62,6,0.068155535,0.81568152,0,1,4,6,7470.11,2,2,131.13,42.91,30.07,8.73,9.06,5.71e-4,6e-4,0.0224607,0,0,0.125,5.40779,2.1637,0.089,0.058,0.239,0.158,1.199,0.824,105,105.43,53.0415,0,0,0,0.042101,0,0.78,0.507,0.42,0.386,0,0.37562,130.4745,2.5198,7.9004,1.7498,0.800184,6e-4,0.273491,0,0,5.504777,0,0,0.00103,0.001,1.192296,385.95,3.92,0,1.092,0.895,0.0824,1.01,4.499,139.9,9.736,69.04,142.5748,5.24,1.64,88,160.19,0,87,162,56.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
249,65,65,0,3,80.97,162.16,30.34704,1.89,6,0.04861976,0.58385499,0,3,2,6,1565.381,1,1,369.61,45.91,175.74,20.15,13.17,0.130445,0.0035,0.0501036,0,21.98,0.172,6.48727,2.4711,0.253,0.18,0.336,0.202,0.989,0.699,97.7,92.63,67.3643,0,0,0.0076,0.099654,0,0.805,0.468,0.235,0.206,3.101,0.38764,125.9231,0,8.2187,0.6474,1.640127,0.0103,1.156876,0.0052,0,10.592234,3.680203,0.0356,0.00384,0.001,0,292.2,4.78,1,0.999,12.966,0,32.08,4.42,140.1,11.989,72.9,231.9252,11.75,1.87,69,162.76,0,69,116,79.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
250,70,70,1,3,78.16,168.93,27.36944,1.88,6,0.075748336,0.90987093,1,3,3,6,2786.779,2,2,471.88,43.93,84.44,22.06,40.31,0,0,0.0292359,0,29,0.001,2.49929,2.4724,0.693,0.459,1.637,0.421,2.033,0.759,104,83.35,68.0727,0.14,4e-5,0.0212,0.278685,0,1.034,0.465,1.057,0.447,0,0.31734,103.3781,3.8008,14.2701,1.6975,1.456449,0,0.41178,0,0.38,2.505509,0,0,0,0,1.392097,247.86,3.99,0,1.2098,11.693,0,32.99,4.089,143.1,11.088,69.91,333.3534,4.3,1.89,87,168.1,0,72,151,74.94,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
251,28,28,1,2,87.14,170.06,29.40948,1.99,7,0.106399789,1.27575888,0,2,2,7,9307.347,2,2,822.19,40.93,75.03,27.6,16.9,0,0,0.0995452,0,28.48,0.1,4.9956,2.4265,0.005,0.003,0.093,0.127,0.522,0.017,101,138.67,68.5232,0.23,0,0.0212,0.400274,0,0.357,0.341,0.004,0,3.605,0.34471,101.6007,2.1539,8.2782,1.0424,1.900843,0,0.599616,0,12.96,5.692412,0,0,0.00278,0,1.607539,475.91,4.29,0,0.9625,10.711,0,0,3.81,143.9,5.12,70.99,175.7467,10.1,1.9,75,170.17,0,91,116,92.86,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
252,67,67,0,4,58.99,154.03,25.40106,1.56,7,0.053081224,0.63729376,1,4,6,7,2558.654,1,1,495.05,42.99,91.11,107.67,42.88,7.11e-4,0,0.0099307,7e-5,22.62,0.042,3.60411,2.4489,0.118,0.319,0,0.001,0.01,0.642,101,82.62,62.9286,0.03,1.6e-4,0.0084,0.050043,4e-4,0,0.265,0.008,0.31,0,0.39499,129.839,1.4067,4.4211,0.9606,0.300723,0.0043,0.709509,0.0725,30.78,6.515384,0.641978,0.0241,0.00127,0,1.299731,475.35,4.2,1,0.9333,14.212,0,32.53,4.59,140,5.801,59.28,320.9609,7.21,1.53,79,154.94,0,75,123,58.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,4,>1,NA,NA,N,Y,N,N,Low-Intermediate,High,Q3 ITT,High,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
253,64,65,1,4,70.11,160.11,27.1258,1.72,8,0.171871337,2.06382047,1,4,2,8,7064.73,2,2,313.4,27.04,89.85,11.09,15.38,0,0,0.0315983,0.00199,24.91,0.152,3.51373,2.2403,0.111,0.028,0.011,0,0.432,0.41,97.1,79.84,78.3279,0.25,1.5e-4,0.0292,0.471738,0.0134,0.008,0,0.207,0.194,0,0.32496,96.975,1.2034,11.0179,1.2398,1.938257,0.1163,1.293695,0.0046,0.79,5.107961,2.723886,0.0016,0,0,0.968716,431.43,3.89,0,1.0049,13.547,0,36.39,4.191,137.1,11.928,68.6,610.3224,8.54,1.65,68,160.07,0,80,130,69.92,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
254,52,53,1,2,48.63,156.12,19.93193,1.46,7,0.06100769,0.73169002,1,2,3,7,8038.052,2,1,248.75,42.03,65.2,14.08,19.86,0.001948,0.0016,0.0104546,3e-5,21.98,0.14,12.80333,2.2993,0.079,0.115,0.001,0.001,0.359,0.687,93.9,104.41,46.9053,0,5e-5,0.0131,0,0,0.19,0.368,0.19,0.316,0,0.33283,106.1009,3.1883,12.1006,1.583,1.20604,0.1441,0.053617,0.0086,0.2,2.875636,0.671033,0.0162,0,0,1.769831,255.56,4.5,0,0.8279,9.993,0.0186,30.98,3.725,140.9,8.455,75.38,269.3131,3.39,1.43,72,156.28,0,84,113,46.16,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
256,65,65,0,2,89.87,171.4,29.75247,2.02,7,0.0942555,1.13089698,1,2,5,7,5682.702,1,1,286.68,39.03,89.93,18.27,27.2,0.001485,0,0.0300211,0,27.02,0.08,4.22209,2.35,0.237,0.137,0.081,0.051,1.407,0.852,0.1,100.36,69.3999,0,0,0.0076,0.070019,0,0.584,0.378,0.864,0.516,1.891,0.28558,94.8617,2.3143,14.0213,3.706,1.901008,0.0053,1.03895,0.004,0.31,5.291903,4.807507,0.0077,0.00541,0,1.097523,197.83,4.14,1,1.0054,12.472,0,0.76,3.672,136.9,9.563,68.6,148.9727,7.53,2.08,61,170.11,0,87,109,86.33,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
258,71,71,1,3,83.22,167.73,29.74606,1.93,6,0.05517536,0.66241589,1,3,6,6,6078.351,2,2,309.86,39.06,70.1,45.11,27.71,0,0,0.1353474,0.00353,0,0,0.01917,2.1601,0.069,0.112,0.026,0.041,0.682,0.802,103,118.34,51.4545,0,3e-5,0.0198,0.091408,6e-4,0.391,0.414,0.256,0.372,0,0.47666,146.9368,2.5213,11.1347,0.8944,0.880261,0,0.751711,0.0019,0.17,4.435761,0.079661,0.007,0.00205,0,0.959732,274.58,4.05,0,1.0601,8.583,0,23.1,5.043,138.1,17.089,66.06,362.8138,6.24,1.99,73,166.07,0,86,149,85.5,0,1,0,0,2,0,0,0,0,0,3,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,3,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Other,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
260,56,56,1,4,63.13,172.98,21.0919,1.76,7,0.018147403,0.2177474,1,4,2,7,4885.554,1,2,501.67,36.35,265.67,25.18,87.61,0.00248,0.0043,0,0,27.09,0.2,4.27215,2.1015,0.125,0.088,0.057,0.043,1.113,0.849,98,92.63,73.9606,0.3,0,0.0105,0.039616,0,0.65,0.487,0.46,0.32,0,0.31223,107.2484,2.0629,12.4337,0.7013,0.826248,0,1.146536,0.0652,17.1,2.602569,0,0,0,0,1.145619,78.53,4.39,1,0.9394,0.634,0,31.16,3.292,137,12.025,70,136.1726,4.53,1.73,61,171.96,0,76,98,61.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
261,28,28,0,0,60.15,169,21.03566,1.67,6,0.101608535,1.2200866,0,0,3,6,793.72,1,1,159.12,36.92,112.19,15.02,10.65,0.002664,0.0013,0.0703495,9e-5,26.8,0,4.09796,2.2964,0.268,0.134,0.251,0.165,0.741,0.498,108,202.48,36.4438,0,0,0,0.161102,0.0079,0.403,0.346,0.213,0.034,0,0.38921,125.2919,0.994,9.0097,0,1.097036,1e-4,1.409319,0.0052,0,3.209944,4.338961,0.0336,0.00222,0,1.096016,384.43,3.23,0,0.8243,0.03,0.0711,26.95,4.726,141,6.734,66.04,119.7168,5.96,1.63,51,172.96,0.1,64,41,66.81,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
262,61,61,0,1,91.44,173.9,30.61943,2.03,7,0.096107632,1.15260504,0,1,6,7,6192.764,2,2,552.76,41.06,132.93,34.12,26.71,0,0,0.500632,0.00693,28.05,0.001,4.29627,2.3738,0.12,0.067,0.027,0,0.772,0.609,100,82.19,87.4972,0,1.7e-4,0,0.229525,8e-4,0.41,0.341,0.277,0.182,2.02,0.41111,133.1618,2.0561,11.0087,1.159,1.701806,0.0041,7.303208,0.0873,23.95,5.600365,5.320665,0.5653,0.00201,0,1.194758,331.44,4.21,0,1.051,11.785,0,26.82,4.34,137.1,3.453,61.19,321.719,9.64,2.07,72,175.01,0,82,116,90.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,NA,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
263,48,48,0,2,88.07,187.25,24.97682,2.17,6,0.04352215,0.5224072,0,2,6,6,5260.689,2,2,703.03,44.03,84.63,12.39,32.81,0,0,0.0800184,0.00298,28.84,0.199,5.90022,4.5049,0.321,0.225,0.194,0.131,1.376,0.771,99.9,65.97,149.2962,0.21,0,0.0087,0.200584,2e-4,1.015,0.485,0.454,0.272,2.995,0.44317,138.7101,2.0983,12.5913,0.5276,1.699891,0,0.769597,0,0.12,7.968412,0,0,0.00204,0.001,0.938529,320.83,4.5,0,1.0505,0.567,0.0392,0,5.403,140.1,8.426,82.08,362.7432,11.78,2.15,78,189.69,0,88,109,91.38,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low,High-Intermediate,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
264,58,58,0,2,76.04,179,23.62009,1.96,6,0.024786234,0.29772584,0,2,5,6,8039.884,1,1,550.86,41.66,62.94,28.17,20.04,0,0,0.0300211,9e-5,26.27,0,6.67242,2.1067,0.008,0.008,0.09,0.09,0.773,0.748,106,65.46,103.5779,0,1e-4,0,1.13397,0.0183,0.34,0.362,0.348,0.336,0,0.431,147.8122,2.3601,7.1152,1.1578,1.20267,0.0013,1.512311,6e-4,0.09,5.161321,0,0.0136,0,0,1.019465,167.23,3.88,0,0.9977,0.762,0,32.53,5.164,139.1,6.94,70.01,317.6017,8.41,1.96,69,178.92,0,64,119,76.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
266,71,72,1,3,65.06,157.13,26.17443,1.65,6,0.167917868,2.0169265,1,3,2,6,12334.367,2,2,377.09,41.26,68.6,9.95,11.2,0,0,0.0298226,0,2.18,0.104,5.39491,2.3274,0.447,0.273,0.079,0.041,1.645,0.826,101,63.23,83.1066,0.25,1.4e-4,0.018,0.179875,1e-4,0.825,0.412,0.622,0.422,5.135,0.38489,122.4355,3.5567,10.8555,0.7629,1.900167,0.005,0.321306,0,0,3.10977,3.803185,0.0149,0.00255,0,0.969989,119.23,4.3,1,0.9967,14.721,2e-4,25.96,4.02,142.1,8.914,65.05,129.0027,6.32,1.59,59,156.2,0,70,102,63,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
267,67,68,1,2,128.82,207.77,28.87879,2.57,7,0.059154614,0.71020481,0,2,3,7,12940.528,2,2,491.14,41.75,79.17,33.93,29.06,0,0,0.0303972,0,0,0.108,7.99523,2.3934,0.247,0.249,0.035,0.014,0.849,0.577,0,68.72,123.3054,0,2e-5,0,0.33492,0,0.483,0.359,0.316,0.223,0,0.35509,120.9559,1.901,2.8156,0.5232,1.296664,0,1.022623,0,0.76,7.326764,0.210252,0,0.00387,0,0.967239,498.07,4.3,0,0.9866,13.436,0,0.71,4.039,133.2,5.988,73.92,118.9989,11.89,2.51,87,201.92,0,71,145,123.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,GBR,United Kingdom,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
268,63,63,0,3,46.01,153.93,19.33969,1.42,8,0.17763338,2.12726222,0,3,3,8,3245.695,1,1,287.56,37.92,75.19,11.05,18.01,2.82e-4,0,0.0198529,0.00403,24.98,0.2,1.34787,2.1248,0.586,0.346,0.052,0.034,1.072,0.708,104,54.46,83.8691,0,0,0.0022,0.029621,0.0292,0.666,0.47,0.358,0.223,0,0.38473,123.3966,2.0649,16.1408,2.6126,1.557925,0.2704,0.501384,0.078,10.73,3.640363,0.035742,0.016,0,0,1.062095,295.77,3.76,0,0.8127,0.034,0.0196,25.62,4.391,141.9,8.583,71.75,58.4535,5.81,1.41,83,155.13,0,89,107,49.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
270,69,69,1,1,95.5,172.92,31.62535,2.08,6,0.172369386,2.07042436,0,1,3,6,10088.44,1,1,441.57,49.53,68.71,24.49,16.93,0,0,0.0596572,0,23.33,0.002,6.38206,2.4504,0.205,0.19,0.004,0.001,0.484,0.44,104.9,86.96,79.2368,0,0,0,0.199916,0,0.261,0.254,0.201,0.152,2.382,0.43615,148.1321,1.9082,0.009,0.3944,1.432062,0,0.411641,0,16.31,2.634881,0.177572,0,0.00163,0,0.90917,247.54,4.09,0,1.1497,9.25,0.0418,25.93,5.504,138.9,6.669,73.04,322.5235,4.61,2.08,86,172.94,0,70,130,97.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,I,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
271,68,68,1,5,37.83,154.99,15.90236,1.3,6,0.08245012,0.99003447,1,5,6,6,14215.352,1,1,1697.31,17.79,93,9.02,31.16,0,0,0.0269796,0.01,19.98,0.101,4.12941,2.1013,0.033,0.08,0.076,0.124,0.054,0.616,93.1,71.48,53.0188,0.36,1e-5,0.0095,0.231545,0.0869,0.022,0.368,0.007,0.194,2.488,0.28955,93.118,2.7403,11.4924,0.6597,0.717802,0.3022,0.469285,0.1603,0.36,2.766674,0,0.0227,0,0,1.246516,205.26,4.41,0,1.1031,11.674,0.0047,44.91,3.302,135.2,11.062,54.62,262.4856,3.73,0.6,72,154.92,0,91,117,16.74,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
272,60,60,1,1,53.04,162.41,20.06666,1.54,6,0.12502939,1.49989825,1,1,6,6,9012.044,2,2,301.61,46.81,74.99,13.9,18.98,2.82e-4,0.0019,0,0,2.04,0.001,7.3411,2.7865,0.178,0.215,0,0.001,0.417,0.381,99.9,44.54,118.5323,0.09,0,0,0.040861,0,0.265,0.196,0.12,0.174,3.879,0.3632,131.1106,2.3549,17.9392,1.4229,1.45175,0.045,0.799427,0.0023,0.73,17.282799,2.457877,0.0405,0,0,1.38384,220.19,4.2,0,0.92490000000000006,9.941,0,31.98,4.231,137,5.138,79.22,354.5217,15.75,1.63,70,163.77,0,62,139,58.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
273,75,75,0,5,49.64,157.2,19.67781,1.47,7,0.059308213,0.71130167,2,5,4,7,4336.267,1,1,711.97,33.1,59.42,8.5,13.88,0.002779,0.002,0.0101832,3e-5,2.35,0.211,5.00348,2.4272,0.005,0.089,0.121,0.155,0.297,0.776,96.1,45.93,81.0877,0,6e-5,0.0192,0.100442,0.0145,0.138,0.419,0.092,0.344,0.14,0.29013,85.8609,1.0331,0.0389,0.2442,0.700109,0.1638,0.641692,0.0928,30.26,9.498897,0.48709,0.0141,0.00604,0.002,1.420582,279.73,4.4,1,1.0638,0.58,0,30.43,3.753,137.1,2.95,49.7,223.2979,9.1,1.57,71,157.97,0,89,137,52.63,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,Y,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
274,80,80,0,5,64.46,163.91,24.05722,1.69,7,0.195324638,2.34506127,1,5,5,7,4999.171,1,1,560.85,36.09,239.78,24.4,51.72,0.003784,0.0032,0.0242311,8e-5,27.06,0.001,4.39087,2.4905,0.1,0.192,0,0.001,0.025,0.747,0.3,62.58,70.9237,0,2.2e-4,0.013,0.090176,0.0368,0.076,0.42,0,0.195,0,0.36574,112.1208,4.3123,15.0146,1.0103,0.699942,0.0112,1.000555,0.0759,18.2,4.973382,5.243671,0.489,0,0,1.359746,258.32,4.22,0,1.0578,11.923,0,21.89,4.104,134.8,6.88,69.92,368.9393,7.22,1.85,78,166.16,0.1,91,131,68.88,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NA,Y,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
275,66,66,0,4,53.42,156.87,21.62788,1.51,6,0.052523453,0.63071623,2,4,4,6,9655.883,2,2,788.27,44.06,77.54,14.99,15.5,0,0,0.0999848,0.00947,29.19,0.132,5.71685,2.5226,0.053,0.07,0.088,0.086,0.365,0.424,99.3,88.1,52.5398,0,0,0,0.599945,0.0443,0.045,0.001,0.276,0.299,0.396,0.36255,117.4,0.0168,1.3846,0.0053,1.249748,0.1193,0.300252,0.0055,0,4.997996,7.836266,0.702,0.00189,0,1.109711,589.34,4.51,0,0.9095,0.131,0.0826,0.4,4.051,140.1,6.891,62.29,89.5666,5.59,1.41,61,155.81,0,89,110,51.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
276,65,65,1,4,98.91,172.08,32.29234,2.07,8,0.046678704,0.56093246,3,4,6,8,33420.003,2,2,861.68,36.23,301.62,29.69,20.09,0.001688,7e-4,1.079e-4,0,28.03,0.1,5.37261,2.4029,0.173,0.088,0.164,0.112,0.884,0.691,0,103.46,75.0855,0.03,0,0.0084,0.099097,2e-4,0.776,0.5,0.196,0.097,0.666,0.2823,97.2776,3.857,14.5022,1.2068,1.00306,0,0.400207,0,27.71,12.013689,3.51688,0.0042,0,0.001,0.156047,368,2.99,0,1.0368,8.715,0,26.45,3.631,139,3.422,70.91,531.1443,12.68,2.05,79,171,0,97,112,95.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,Y,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
277,60,60,2,4,96.59,192.28,24.87487,2.29,6,0.039686195,0.47622308,0,4,5,6,35021.061,2,1,721.19,41.91,70.1,8.61,13.4,0,0,0.0317115,0.00171,25.75,0.002,5.33417,2.718,0,0.001,0,0,0,0,99.9,63.95,119.747,0.34,1e-5,0.0066,0.188182,7e-4,0,0,0,0,2.062,0.40841,127.9004,1.9081,5.1739,1.6019,0.631229,0.0122,0.433159,0.0055,0,7.620129,2.834093,0.4939,0,0,1.060924,654.79,4.8,0,0.9776,0.843,0.0462,29.95,3.82,143.1,5.649,59.27,416.6534,9.68,2.13,86,191.99,0,81,128,90.48,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,>1,NA,NA,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,N,N,N,WHITE,Other,Y,Y,M,No,OTH,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
278,62,62,0,3,102.24,180.07,30.07159,2.2,6,0.040465463,0.48536695,0,3,5,6,1622.4,1,1,345.2,45.06,83.96,62.14,74.31,0,0,0.0200304,0,24.92,0.089,2.89385,2.1644,0.361,0.207,0.136,0.08,1.421,0.773,100.6,82.91,97.9467,0.08,1.3e-4,0.0189,0.014051,1e-4,0.822,0.458,0.556,0.322,0.045,0.39521,139.0644,3.7651,12.3254,0.7701,1.448193,0.0064,0.542177,0,28.05,4.091517,0,0,0,0,0.965101,118.64,3.9,0,1.3074,0.71,0.0533,30.58,4.196,137,22.959,79.62,351.0603,6.81,2.19,76,177.95,0,82,138,100.48,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
279,62,62,1,3,79.06,155.87,32.86044,1.81,6,0.02731016,0.32759697,2,3,5,6,10112.019,1,1,410.85,35.69,196.32,30.35,38.44,3.7e-4,8e-4,0.0300181,3e-5,3.92,0,12.14644,2.1574,0.231,0.092,0.57,0.29,1.299,0.647,108.1,136.68,40.7817,0.2,2.5e-4,0.0248,0.267792,0,0.945,0.487,0.427,0.189,0,0.40061,133.9495,1.293,8.0627,1.5026,1.002473,0.0028,0.150453,0.0016,0,1.613348,0,0,0.00612,0,1.182218,230.11,4.71,0,0.9944,10.606,0.0728,23.29,4.387,143.9,9.084,58.79,108.3757,3.37,1.81,70,155.09,0,83,123,77.07,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,2-3,ABNORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
280,53,53,0,3,73.04,170.07,25.03167,1.88,6,0.209589256,2.51878615,0,3,6,6,5473.287,2,2,1870.68,39.04,727.08,44.25,59.05,0,5e-4,0.070051,0.01005,23.56,0.151,5.50121,2.4286,0.491,0.46,0.184,0.219,0.804,0.699,105.1,167,41.4187,0.42,0,0.0135,0.089249,0.0398,0.585,0.538,0.281,0.247,0.877,0.37537,110.1822,2.2149,21.001,1.127,0.799898,0.2905,0.595128,0.0906,0.32,4.528213,0,0.0019,0,0.001,0.09041,146.36,4.21,0,0.9936,14.003,0.0247,36.67,3.871,140.2,6.048,79.18,58.5872,7.69,1.93,81,170.01,0,97,133,76.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
281,49,49,1,2,63.11,168.07,23.04756,1.71,6,0.049790833,0.59825962,1,2,5,6,16161.868,2,2,445.86,42.94,111.73,14.06,11.03,6.1e-5,0,0.0199174,6e-5,0,0.049,2.49906,2.3222,0.16,0.197,0.092,0.061,0.888,0.698,0,88.19,82.2051,0.04,0,0,0.191373,5e-4,0.476,0.385,0.402,0.269,2.225,0.30911,89.6217,2.8974,12.3006,1.1322,1.694275,0.1741,0.447137,7e-4,0.18,2.606828,0.057052,0.0032,0.00379,0.001,1.051188,360.32,4.15,0,0.9996,0.242,0,30.28,3.766,134.1,6.944,70.62,215.0048,5.01,1.65,67,170.7,0,81,99,63.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
282,67,68,1,4,69.99,164.04,25.72531,1.75,6,0.084990926,1.01947341,0,4,4,6,2501.716,2,2,186.73,39.77,67.1,7.09,11.45,0.003882,0.0027,0.0200055,0.01003,0,0.001,4.27801,2.2519,0.637,0.258,0.306,0.195,1.604,0.723,96.7,137.01,33.9056,0,0,0.0052,0.140432,0.079,0.738,0.35,0.841,0.371,0,0.32268,103.0339,2.1912,13.3555,0.2834,1.671123,0.2356,1.000003,0.1002,0,9.146683,2.100282,0.6177,0,0,1.169887,574.1,4.18,0,1.182,11.821,0.0392,31.61,3.548,139.1,3.053,79.74,139.7682,11.79,1.83,61,164.11,0,87,125,68.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158VV,N,Y,N,N,Low-Intermediate,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
283,58,58,0,2,54.94,150.03,24.21912,1.5,8,0.211119724,2.53237346,0,2,3,8,1161.597,1,1,227.69,42.03,256.48,27.92,22.87,0.003028,0.002,0.0080336,4e-5,27.39,0.149,4.12327,2.4546,0.145,0.099,0.121,0.092,0.885,0.576,92.8,99.6,53.3364,0.05,7e-5,4e-4,0.199929,0,0.588,0.364,0.272,0.002,1.016,0.35769,120.2522,2.0698,14.6736,1.3424,0.80705,0,0.111011,0,0.78,4.114362,0.411557,0.0218,6.2e-4,0,0.983395,257.54,4.7,0,0.9195,13.86,0,0,4.186,140.1,11.125,72.91,243.936,5.09,NA,NA,NA,NA,NA,NA,NA,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
284,53,53,1,1,63,159.85,24.48631,1.65,6,0.1087489,1.30712089,1,1,5,6,4611.082,1,1,224.98,44.76,62.97,9.88,17.74,0,0,0.0998753,3e-5,0,0.101,6.91946,2.4213,0.692,0.376,0.549,0.312,1.012,0.647,100.1,120.03,50.0731,0,0,0,2.724297,0.0156,0.783,0.502,0.333,0.197,0,0.40768,139.0021,0.0086,7.0596,0.0107,1.68602,0.0056,1.287276,0.0025,0,5.356909,0.447844,0.0125,0.00689,0.001,1.074603,193.52,4.09,0,0.9802,11.3,0.0274,33.34,4.402,137.4,8.025,66.17,267.1521,9.85,1.57,80,158.19,0,58,137,59.96,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
285,59,59,0,1,88.3,168.92,31.56664,2,6,0.142146279,1.70540808,0,1,1,6,831.462,2,2,196.11,45.92,53.72,21.74,22.12,0.001932,4e-4,0.0118012,3e-5,28.09,0.226,4.00732,2.377,0.241,0.149,0.134,0.088,0.991,0.643,103,78.28,79.5426,0.15,2e-5,0.0175,0.253637,7e-4,0.804,0.452,0.271,0.103,1.003,0.45269,157.7669,2.9765,15.1916,0.8232,1.319947,0,0.571405,0.0035,0,6.231848,3.756641,0.0363,0,0,0.969524,304.95,3.6,0,1.0066,0.28,0,22.37,5.098,143,4.999,80.63,231.9946,6.65,2.12,82,171.92,0,58,140,90.63,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
286,64,64,1,3,77.3,161.88,29.59765,1.82,7,0.031926725,0.3838298,0,3,5,7,5015.952,1,1,206.46,47.93,102.35,38.88,20.06,6.73e-4,4e-4,0.0401215,6e-5,22.99,0.197,9.62991,2.209,0.107,0.061,0.06,0.069,0.8,0.75,108.8,71.38,98.8146,0.35,0,0,0.120799,0.0138,0.422,0.388,0.262,0.263,5.021,0.46623,154.7194,1.5374,10.4086,0.4718,1.708926,0.2102,0.773744,0.0741,0.36,3.778647,0,0.0374,0,0,1.328846,140.12,4.61,0,0.9364,0,0.0536,27.26,5.979,139.1,5.129,73.97,278.9532,6.69,1.71,73,161.83,0,74,124,74.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
287,70,70,0,2,66.39,168.07,22.91317,1.76,7,0.097609796,1.17048442,1,2,5,7,843.465,1,1,171.15,41.86,55.81,15.39,13.89,0,0,0.0417797,0.0031,3.81,0.2,4.27848,2.2991,0.342,0.165,0.587,0.27,1.898,0.693,96.5,71.53,79.5904,0,0,0.0072,0.099415,0.0141,1.02,0.463,0.843,0.383,3.827,0.40283,139.0694,3.2148,14.6393,1.4395,1.69074,0.1567,0.800137,0.0035,0.5,4.770644,0,0.0076,0,0,0.969132,320.56,3.9,0,1.0266,14.595,0,0.16,4.609,137,10.918,70.04,273.4634,7.59,1.81,85,167.41,0.1,79,131,69.85,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
288,59,58,0,3,74.06,167.29,26.33263,1.82,6,0.060871165,0.73040449,0,3,4,6,9135.412,2,1,278.14,42.05,100.92,154.33,21.01,0,0,0.0399495,0.01001,27.11,0,4.70876,2.4216,0.288,0.244,0.021,0,0.9,0.774,105,83.47,88.1033,0,8e-5,0,0.12215,0.0353,0.338,0.271,0.554,0.516,1.585,0.5073,167.981,4.0931,11.2033,0.7192,1.526148,0.1831,0.809657,0.08,0.31,6.800669,2.457237,0.0366,0,0,1.213308,270.23,5.36,1,0.9736,10.275,0,30.35,5.482,143.1,15.27,71.44,338.4059,9.98,1.83,79,167.3,0,59,121,70.08,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
289,71,71,1,2,78.22,166.9,27.37334,1.89,6,0.033031313,0.3955903,1,2,1,6,6994.758,1,1,228.46,39.95,96.77,15.35,19.91,0.00399,0.0099,3.333e-4,7e-5,27.87,0.118,0.09979,2.3004,0.098,0,0.137,0.078,1.001,0.727,101.1,96.6,63.7692,0.02,0,0,0.049637,0.0047,0.583,0.348,0.356,0.224,0,0.41494,134.8035,0.3866,7.9485,0.6807,1.225415,0.1395,0.359138,0.0888,0,1.926088,3.010342,0.0197,0.00349,0.001,0.978292,208.27,3.89,0,1.1177,14.856,0,32.05,4.381,141.5,9.018,66.98,222.2699,3.2,1.69,79,167.01,0,54,135,75.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
290,67,67,0,3,102.47,183.74,29.10043,2.29,7,0.079204342,0.95041818,1,3,6,7,6728.386,2,2,529.93,26.76,74.83,10.31,16.98,0,0,2.234e-4,3e-5,29.02,0.13,7.49808,2.3521,0.001,0.123,0,0,0,0.74,101.9,68.98,93.5847,0.18,4e-5,0.0078,0.292707,0.0091,0,0.393,0,0.165,0,0.35903,112.6058,1.9858,11.1667,1.291,0.196807,0,0.360098,0.0048,0,2.571077,0.489462,0.0298,0,0,1.000779,124.26,3.61,1,0.9322,10.561,0.0118,38.92,4.408,138.1,10.282,66.17,411.9442,3.27,2.39,85,182.72,0,95,123,106.54,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
291,54,54,0,1,61.76,164.02,23.34506,1.67,7,0.060632321,0.72738085,1,1,6,7,4818.181,2,2,235.84,37.03,75.21,23.86,24.99,0.001028,6e-4,3.093e-4,9e-5,29.38,0.101,7.60186,2.2713,0.073,0.058,0.045,0.051,0.642,0.739,103,103.57,60.8149,0.02,2.6e-4,0.0076,0.140512,0.0099,0.246,0.322,0.338,0.373,0,0.4,138.5855,0.8082,9.9216,0.329,1.001561,0.0114,0.710403,0.0768,0.05,3.930288,0.184753,0,0,0,1.297288,183.55,3.8,1,1.0698,12.497,0.0224,28,4.572,140.1,10.283,74.46,122.5711,7.1,1.59,69,162.15,0.1,75,103,58.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,Y,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
292,54,54,0,2,75.77,180.07,23.51904,1.95,7,0.068779017,0.82485106,1,2,4,7,1158.826,1,1,345.2,33.09,100.11,25.28,26.35,0.428251,0.0745,1.09e-5,0.00287,25.34,0.039,5.28897,2.2254,0,0,0.025,0.065,0.023,0.13,102.1,110.81,59.2812,0.43,0,0.0099,0,0.0279,0.126,0.352,0,0,0.416,0.37927,123.9553,2.5035,15.6612,1.4008,0.876951,0.2977,0.310314,0.1645,0,2.873226,0.685364,0.7404,0.00354,0.001,1.199071,146.85,3.4,0,0.978,0,0.0319,28,4.303,140,5.332,69.04,249.8605,4.37,1.88,86,180,0,63,139,77.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
293,55,55,0,1,56.27,163.05,20.95116,1.61,7,0.122143069,1.46453948,0,1,2,7,1769.453,1,1,186.58,37.88,88.86,23.88,18.1,0.004303,0.002,0.0198816,0,26.08,0.159,3.21102,2.3103,0.14,0.089,0.092,0.084,0.887,0.736,97.2,135.75,42.0902,0,1.7e-4,0.0102,0.254791,3e-4,0.435,0.309,0.496,0.482,2.803,0.28618,97.2061,1.9628,13.9697,1.1847,1.190073,0.0085,0.89996,0.0048,0,3.614424,4.015867,0.0087,0.00425,0.001,1.162709,216.93,3.39,1,1.0987,12.29,0.0285,28,3.56,136.9,4.021,76.26,161.8676,5.41,1.62,65,164.92,0,85,120,62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,AUS,Australia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
294,75,75,1,3,67.95,169.85,23.14546,1.78,8,0.010529552,0.12596562,1,3,2,8,1240.167,1,1,191,38.01,76.27,19.78,10.86,0.1172,0.003,0.0300086,0.005,34.57,0.12,3.59492,2.4478,0.163,0.075,0.048,0.039,0.808,0.664,89.2,78.24,61.9756,0,1.7e-4,0.0173,0.399521,0.0455,0.529,0.496,0.226,0.001,0,0.3728,122.581,2.3281,7.211,0.0032,1.04612,0.1928,0.451458,0.0828,30.24,5.637316,8.936714,0.3379,0,0,1.225319,256.24,4.2,1,1.3025,10.998,0.076,0.38,4.004,133.5,32.315,66.06,267.6751,7.39,1.69,80,167.95,0,72,129,65.06,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
296,72,73,1,3,82.98,169.97,28.57604,1.95,8,0.089544132,1.07582677,0,3,5,8,10457.505,2,2,202,31.03,57.6,13.16,21.01,0,0,1.834e-4,0.00406,31.04,0.156,5.56376,2.3011,0.242,0.311,0.092,0.083,0.726,0.704,105.1,104.21,57.7963,0.12,6e-5,0.0138,0.401997,0.0308,0.401,0.384,0.305,0.347,0,0.31788,107.8454,2.1743,11.2969,1.0877,0.598976,0.1426,0.341117,0.0276,0.08,2.769836,0.083191,0.0125,0,0,1.389396,77.56,3.8,0,1.1095,10.429,0.0416,26.09,3.792,143,11.998,61.24,327.2128,4.53,1.94,63,170.84,0,95,120,85.74,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
297,71,71,1,3,NA,NA,NA,NA,7,0.045107799,0.54121277,1,3,4,7,1425.378,2,2,897.9,26.9,95.78,28.3,39.46,0.002368,0.0029,1.443e-4,7e-5,23.43,0.062,3.21004,2.2607,0.136,0.181,0.001,0.004,0.058,0.497,103,73.4,69.875,0,1.1e-4,0.0091,0.070016,0.0074,0.07,0.317,0.045,0.161,1.878,0.30829,108.5538,0,13.0068,0.5068,0.536666,0.0092,0.118874,0.0491,0.29,3.070603,0.21046,0.5947,0.0029,0.001,1.629189,175.03,3.71,0,1.1011,11.631,0.0215,29.87,3.608,137.1,10.236,74.87,315.6149,3.97,1.57,85,148.99,0,81,123,66.2,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),NA,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,NA,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
298,41,42,0,2,46.08,170.05,16.23469,1.51,7,0.096600567,1.15917599,1,2,6,7,1123.051,1,1,354.81,37.08,47.74,65,19.11,0,0,0,0,3.39,0.001,4.41767,2.2975,0.086,0.088,0.111,0.077,0.567,0.653,100.1,97.93,59.8479,0.08,1.8e-4,0.0186,0.009983,5e-4,0.379,0.304,0.191,0.263,0.731,0.29086,87.4871,2.8615,10.5046,2.6041,0.805401,0,1.100585,0.0023,0.57,7.240485,3.425077,0.0055,0,0,1.192061,314.37,3.8,1,1.061,13.476,0,37.1,4.031,138,5.177,3.28,160.4808,9.79,1.31,80,169.81,0,75,124,43.29,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
299,69,69,0,1,76.24,168.06,27.10003,1.87,6,0.038399346,0.46050894,0,1,1,6,631.624,2,2,150.09,36.1,287.83,41.52,29.22,0,0,0.0519688,5e-5,3.42,0,4.96958,2.3517,0.163,0.132,0.048,0.051,1.263,0.856,102,47.84,123.9788,0,0,0,0.220003,5e-4,0.642,0.561,0.576,0.444,1.314,0.44127,152.6157,2.5733,5.2713,0.2478,1.898054,0.0669,0.250804,0,0.45,3.346916,0,0,0,0,0,163.43,3.91,0,1.1099,0,0.0798,30.58,5.191,140,12.765,71,367.5981,5.88,1.96,59,165.04,0,64,106,73.92,1,0,0,1,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
300,63,63,0,3,67.81,174.95,22.65313,1.81,6,0.027332335,0.32783825,0,3,1,6,555.132,1,1,668.45,37.04,63.93,12.94,18.77,0.001737,0.0017,0.0605848,7e-5,9.9,0.12,4.29106,2.0517,0.207,0.161,0.039,0.04,0.638,0.495,97.2,112.94,49.3547,0,2.8e-4,0.0073,0.040501,0,0.344,0.364,0.259,0.179,0,0.34377,103.8261,2.608,11.7956,3.1869,0.69948,0.138,0.936758,0.0639,0.5,4.38827,0.402958,0,0.00175,0,1.030028,255.69,4.41,0,0.932,11.889,0.0384,34.47,3.644,142,2.972,48.23,226.0223,5.97,1.69,77,173.21,0,91,142,65.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
301,67,67,2,2,59.95,161.82,22.96524,1.63,7,0.041080203,0.49317369,1,2,2,7,16920.512,1,1,414.69,40.09,245.65,9.03,13.14,3.47e-4,5e-4,0.053599,4e-5,29.94,0,0,2.3925,0.239,0.235,0.153,0.136,0.299,0,98.8,84.43,61.8211,0,9e-5,0,0.399837,0.0166,0.222,0.254,0.103,0.001,0,0.34599,106.5828,3.1737,13.9019,3.0966,1.556912,0.2376,0.400346,0.0485,0,8.248391,6.192742,0.6209,0,0,1.069369,536.3,4.49,0,1.0268,10.684,0,27.88,4.134,136.9,6.068,70.69,289.8578,11.15,1.58,66,157.87,0,65,128,54.68,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
302,46,46,0,0,41.39,159.8,15.85224,1.37,8,0.072216321,0.86602897,0,0,3,8,519.848,2,2,147.86,43.99,73,15.08,17.06,0.003212,0.0033,0.0099317,0.00738,29.38,0.11,5.11899,2.1011,0.216,0.336,0.403,0.569,0.486,0.404,105.3,76.18,61.9789,0,0,0.001,0.080093,0.0703,0.483,0.454,0.038,0.127,4.488,0.31886,111.6673,2.0669,5.4794,1.7161,0.599248,0.3886,0.317071,0.1672,0,3.802216,6.728466,0.8103,0,0,1.132095,177.67,4.4,0,0.8991,15.306,0,34.93,3.879,141.9,6.854,63.9,195.413,5.09,1.44,70,159.94,0,50,133,41.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
303,50,50,0,1,71.61,162.06,26.88221,1.75,7,0.072458065,0.86818175,1,1,3,7,564.219,2,2,221.56,36.03,141.58,22.02,24.17,0.002434,0.0019,0,5e-5,23.81,0.019,5.11741,2.3739,0.046,0.066,0.001,0,0,0,104,102.45,68.5232,0,7e-5,0,0.199911,3e-4,0,0,0.002,0.001,0,0.42011,137.6938,1.7038,9.4175,0.7117,0.997477,0.0056,0.399427,0,0.66,3.44689,7.320505,0.7292,0.00643,0,1.29034,480.52,5.45,0,0.9991,12.12,0.0503,31.08,4.782,143.3,6.039,67.95,160.3412,4.81,1.77,71,163.94,0,72,120,75.68,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,Y,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
304,70,70,1,3,59.97,165.05,22.46,1.65,6,0.051236556,0.61460995,0,3,1,6,5233.177,1,1,688.09,43.98,38.63,19.18,24.12,0,0,0.0697329,0.00109,2.45,0,6.94817,2.3532,0.35,0.241,0.591,0.493,0.949,0.64,101.1,88.51,51.0765,0.09,7e-5,0,0.49484,0.0378,0.774,0.474,0.288,0.202,0,0.42048,142.7495,1.2043,13.7455,0.6167,1.157149,0.1778,0.400265,0.0032,0,5.703511,0,0,8.9e-4,0,0.844231,183.44,3.42,0,0.976,13.759,0.0336,18.58,4.487,142,10.274,72.94,130.9662,7.38,1.52,76,162.9,0.1,80,145,56.56,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
306,55,55,0,3,102.03,167.98,36.18862,2.08,6,0.185831336,2.22878269,1,3,6,6,2091.43,2,2,206.08,40,202.28,32.01,16.88,0.00263,0.0027,0.0346503,0.00497,3.65,0.087,5.8224,2.1103,0.125,0.126,0.066,0.062,0.809,0.858,102.4,111.6,76.7289,0,1.1e-4,0,0.119473,0.0206,0.582,0.596,0.299,0.381,2.559,0.37125,127.5832,5.1633,14.28,2.5013,0.914438,0.0113,0.80061,0.1194,20.02,3.996788,0,0,0.00417,0.001,1.227066,345.48,4.4,0,1.1075,11.101,0,24.32,4.42,140.7,25.611,69.04,545.8633,5.96,2.11,85,171.41,0,76,121,105.51,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
307,68,68,0,2,45.67,161.85,17.89318,1.44,6,0.017885352,0.21467538,1,2,2,6,776.012,2,2,210.9,31.62,57.29,7.21,16.9,0.002428,0.0037,0.028379,1e-4,3.32,0.028,6.06709,2.2088,0.155,0.163,0.103,0.093,0.814,0.794,100.1,72.24,67.1864,0.16,0,0.0099,0.220009,7e-4,0.358,0.354,0.335,0.35,0.041,0.279,93.167,2.3006,17.5564,1.3876,0.635744,0,0.41017,0.0017,0,6.002522,0,0,0.00323,0,1.063787,337.85,4.2,1,1.2923,14.693,0,41.9,3.152,138.1,0.574,64.07,247.2787,7.34,1.26,70,157.94,0,76,106,36.54,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,Y,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
309,78,79,0,2,63.08,174.72,21.48316,1.75,7,0.064746614,0.77643352,0,2,4,7,1313.348,2,2,222.69,32,74.63,17.06,21.03,0.002721,0.0033,1.568e-4,0,26.31,0,4.65353,2.2259,0.049,0.035,0.022,0.022,0.613,0.702,102,60.04,74.6999,0.31,1.8e-4,0.0189,0.119105,0.001,0.616,0.545,0.002,0,3.209,0.41473,139.8259,0,0,0,1.682401,0.1407,0.531721,0.0053,0,5.394323,0.140697,0,0,0,1.190615,232.38,4.61,0,1.0074,0,0.0294,25.95,4.03,137.1,3.477,58.01,60.6228,8,1.7,63,171.99,0,76,122,62.53,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
310,75,75,0,2,105.74,182.54,32.45202,2.29,7,0.136177208,1.63399199,1,2,2,7,623.126,2,2,216.69,38.39,59.31,22.03,24.62,0,0,3.647e-4,0,0,0.078,16.40626,2.3115,0.115,0,0.372,0.15,2.108,0.882,100,56.45,105.873,0.07,3.4e-4,0.0262,0.009993,5e-4,1.355,0.517,0.727,0.35,0.949,0.42999,149.0897,3.3471,11.3925,2.336,1.497165,0.002,0.181361,0.0032,12.13,2.500279,0,0,0,0,0.915485,107.11,3.91,1,1.0335,0.26,0.0149,30.31,5.339,137.1,11.953,65.08,350.9704,3.61,2.36,80,182.08,0.1,60,128,104.22,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
311,36,36,1,0,110.67,178.86,35.06076,2.29,6,0.056106557,0.67271819,0,0,5,6,11609.015,1,1,298.43,32.5,53.72,45.51,27.06,0.001728,7e-4,2.285e-4,0.0019,30.03,0.085,9.29319,2.0712,0.264,0.162,0.356,0.169,1.645,0.797,0.5,135.07,73.2717,0,0,0.012,0.92199,0.0616,1.014,0.512,0.562,0.241,5.624,0.45476,144.964,0.4732,0.0581,0.0102,1.495072,0.187,1.087384,0.1161,0.52,4.191463,3.520046,0.0324,0.00162,0.001,0.939372,216.89,4.41,0,1.0307,8.581,0.0073,0.1,5.289,138,10.414,56.13,505.9356,8.01,2.28,81,177.89,1.1,89,123,105.18,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
312,72,73,1,2,90.68,180.7,27.54561,2.11,6,0.077623277,0.93062193,0,2,2,6,9193.596,2,2,184.91,39.94,117.95,10.14,14.06,0,0,0.1141433,5e-5,1.49,0.081,5.36779,2.2369,0.378,0.152,0.156,0.077,1.463,0.743,100,69.04,97.8926,0,0,0,0.149301,1e-4,0.873,0.43,0.471,0.2,5.843,0.43004,134.4989,2.7282,7.4373,0.2003,3.681494,0.0035,1.455246,0,0.46,14.315974,0,0,0,0,1.196401,568.48,4.62,0,1.0084,11.185,0.01,30.88,4.606,139.9,10.911,67.02,297.8987,21.6,2.08,70,182.32,0,63,120,95.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
313,68,68,0,0,84.62,176.59,26.84063,2,6,0.513664405,6.1176735,0,0,1,6,114.351,1,1,NA,67.16,116.7,15.02,15.94,5.7e-5,0.0012,0.050245,6e-5,28.23,0.171,3.91781,2.6781,0.225,0.177,0,0,1.012,0.876,95.9,113.07,59.1614,0.2,6e-5,8e-4,0.264716,8e-4,0.73,0.62,0.319,0.319,0.832,0.51535,173.8984,2.5013,8.6339,0.3775,1.368563,0.2042,0.459944,0.0602,29.95,3.276402,5.071822,0.0369,0.00223,0.001,0.764712,190.65,4.7,1,1.0323,10.603,0.0126,28.94,5.595,142,6.806,72.89,318.657,4.53,1.92,70,177,0,72,117,79.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,NA,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
314,50,50,0,3,58.51,178.94,18.80126,1.73,6,0.023885519,0.28648883000000003,0,3,4,6,5108.844,2,2,202.61,41.06,55.81,50.47,28.89,5.05e-4,0,0.0236617,0,25.94,0.21,3.45263,2.2083,0.468,0.307,0.142,0.072,2.472,0.95,0,50.82,140.5116,0,1.5e-4,0,0.098068,0,1.162,0.572,1.236,0.658,0,0.38454,131.2289,3.8863,12.1631,1.762,2.826622,0.0019,1.287205,0,0,7.169724,0.079132,0,0.00276,0,1.159066,280.02,3.72,1,1.1915,0.75,0.0101,1.08,4.268,137.1,18.299,73.41,178.5759,13.05,1.69,66,180.73,0.1,59,105,59.16,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
315,55,54,1,3,58.11,163.05,21.73217,1.62,7,0.023196901,0.27795249,1,3,6,7,22394.894,1,1,162.78,29.09,45.87,14.99,15.58,0.002444,0.0038,0,0,30.98,0.031,14.96647,2.1223,0.113,0.291,0.028,0.063,0.702,0.836,0.1,88.23,75.0322,0.03,0,0,0.008596,5e-4,0.504,0.582,0.203,0.295,0,0.27882,99.1877,2.2467,10.1617,1.1286,0.391644,0.0028,0.588917,0.0562,0.38,5.681261,4.77417,0.0253,0.00376,0.001,1.088047,379.48,3.59,0,1.0694,11.41,0.0594,37.9,3.493,133.8,9.58,59.54,371.726,5.89,1.59,58,164.91,0,76,93,56.45,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
316,66,66,0,3,67.88,172.01,23.12,1.8,6,0.024500327,0.29452806,1,3,2,6,5370.811,1,1,477.07,31,49.19,26.8,41.21,0.001838,0.0027,0,1e-5,27.69,0.19,5.39653,2.4347,0.295,0.319,0.019,0.049,0.044,0,93.8,80.13,69.597,0,3e-5,0.0059,0.100151,0.0155,0.023,0.163,0.087,0.112,0,0.34362,108.9203,2.4268,0.1,0.4206,0.952834,0.2502,0.320564,3e-4,0.6,6.348412,0.027284,9e-4,0.00443,0.001,0.230204,531.63,3.88,0,1.1405,11.921,0.0163,30.34,4.056,136.1,6.448,62.81,33.9989,9.08,1.76,59,170.13,0,73,110,63.87,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,NA,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
317,59,59,0,3,57.06,164.34,21.036740000000002,1.63,8,0.046293475,0.5554598,0,3,3,8,1813.824,1,1,2673.74,35.09,71.97,46.51,29.04,0.001004,0.0021,0.0198948,0.00271,2.72,0.197,5.30701,1.9945,0.285,0.192,1.724,0.886,1.281,0.697,97.2,122.39,44.99,0.1,6e-5,0,0,1e-4,1.392,0.719,0.18,0,0.887,0.26454,94.6253,1.8935,18.3898,0.7271,1.601559,0.2243,0.873532,0.093,0,2.898134,3.60005,0.0277,0.00128,0,1.357732,259.72,4.9,0,1.0999,0,0,26.06,3.451,139.6,6.357,73.99,167.633,4.8,1.62,85,161.62,0,84,131,53.15,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
318,47,47,1,3,62.94,163.02,23.87708,1.67,7,0.017760404,0.21328912,2,3,4,7,16843.014,1,1,168.11,36,87.97,38.85,35.12,0,0,0.0099167,0,27.07,0.097,4.31442,2.0463,0.001,0.007,0.001,0.03,0.012,0.677,100.1,112.67,66.3598,0,0,0.0057,0,0,0.006,0.33,0.007,0.178,0,0.37408,125.9968,3.4092,12.8885,0.7798,0.993722,0.1368,0.450977,0.0019,0.02,4.132043,0.683281,0.0099,0.001,0,1.298944,155.07,4.01,1,0.9542,13.785,0,33.22,4.597,135.9,20.866,65.99,380.1913,5.6,1.8,60,166.09,0.1,80,110,64.95,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,High,Q2 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
319,60,60,1,3,51.52,167.97,18.50421,1.58,6,0.036424557,0.4367174,1,3,6,6,3807.754,2,2,390.11,36.01,55.1,16.06,26.81,0.003926,0.0037,0.0087646,0.00497,26.98,0.001,6.08798,2.3553,0.163,0.306,0,0.029,0,0.514,102.3,115.53,47.2214,0,5e-5,0,0.070006,0.0323,0,0,0.074,0.291,0,0.43534,142.7931,1.4452,10.9034,1.8499,0.314886,0.1795,0.400393,0.0556,0,5.50129,2.989619,0.5126,0,0.001,1.587907,394.08,4.37,0,1.0321,14.803,0,32.74,5.158,134,15.4,73.05,397.9129,5.94,1.52,74,166.97,0,111,109,47.17,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,0,NA,NA,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
320,75,76,1,4,61.05,158.73,23.70415,1.64,7,0.192884505,2.31463937,1,4,5,7,15717.739,2,2,210.55,30.2,125.2,15.83,18.07,0.001093,0.0032,0.1103323,0.0013,25.59,0.112,0.09353,2.0401,0.069,0.088,0.001,0.015,0.032,0.219,99,105.96,44.2037,0,0,0,0.060276,0.0163,0,0,0.213,0.338,1.315,0.29682,91.3164,2.3572,11.38,0.5447,0.501119,0.0293,0.299604,0.0044,0,2.522807,0,0.0121,0,0,1.189765,197.06,3.12,0,1.1649,15.105,0,35.81,3.314,142,10.661,55.08,327.1121,3.78,1.7,66,158.04,0,81,115,61.55,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
321,28,29,0,4,44.88,156.06,17.95877,1.41,7,0.088164418,1.05908321,2,4,6,7,18686.04,1,1,1116.36,41.97,48.48,9.06,29.99,0.001025,3e-4,2.424e-4,3e-5,34.21,0.175,4.96186,2.2499,0.469,0.373,0.356,0.256,0.845,0.494,97.7,65.38,99.0168,0.14,0,0,0.230705,0.0098,0.525,0.353,0.303,0.24,3.152,0.31126,101.9466,1.9457,11.4927,2.1408,0.873621,0.0525,0.380942,0.0597,0,3.803333,4.672787,0.6498,0,0,1.292994,435.52,4,0,0.9257,0.824,0,0,3.871,137.9,11.911,70,492.5927,5.2,1.44,54,157.15,0.1,92,114,45.28,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low-Intermediate,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
322,61,62,0,2,69.91,163.07,26.07525,1.75,6,0.029007441,0.34842163,0,2,1,6,164.977,2,2,203.43,45.01,56.59,27.18,25.03,0,0,2.015e-4,0,25,0.001,8.8984,2.1744,0.169,0.148,0.28,0.148,1.258,0.654,102,77.51,93.4978,0.01,1.1e-4,0.0224,0.149693,0,0.589,0.393,0.473,0.239,2.976,0.49049,163.2531,0.9591,0.0353,0.6797,1.388761,4e-4,0.238125,0,0.28,4.31356,0,0,0,0,0,131.08,4.04,0,1.0002,11.584,0,33.59,5.091,143.1,13.416,66.04,349.9274,5.41,1.72,89,163.06,0,0,150,69.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
323,61,61,1,1,44.99,152.06,19.51387,1.39,6,0.051090064,0.61259643,0,1,3,6,3311.796,1,1,182.61,47.19,286.07,22.83,25.93,0.002886,0.0035,2.854e-4,4e-5,28.09,0.206,4.29579,2.4638,0.153,0.138,0.017,0.026,0.638,0.685,106.2,88.38,66.3648,0,0,0.0018,0.068573,0.0086,0.419,0.478,0.174,0.142,0,0.34643,107.8782,2.3737,17.8791,1.0542,1.299477,0.2653,0.300286,0.0601,0.56,3.752665,0.387641,0.0238,0,0.001,1.223933,152.58,4.81,0,1.0361,12.001,0,36.27,3.452,172.1,13.697,75.96,539.3759,5.75,1.41,68,154.06,0,67,107,45.95,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
324,62,62,1,2,71.81,161.76,27.11864,1.74,7,0.097882276,1.17440135,1,2,1,7,932.572,2,2,486.39,45.09,90.11,16.03,18.02,0.223187,0.0036,0,0,0,0,17.36803,2.3002,0,0.101,0,0.047,0,0.757,106,84.69,73.5401,0,1.9e-4,0.0133,0.059973,0,0,0.332,0.008,0.28,0,0.41068,145.8827,1.7545,10.195,0.8979,0.927732,0.0697,0.239658,0.0014,0,4.589123,0.486968,0.0174,0,0,1.228844,144.31,4.31,0,0.9999,10.601,0.097,35.45,4.362,143.8,18.803,68.97,217.7013,6.5,1.84,77,164.97,0,69,123,73.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
325,41,41,1,0,80.21,155.29,33.40805,1.79,7,0.043650072,0.52401004,1,0,4,7,4801.577,1,1,183.41,46.03,54.3,14.08,16.18,0.002032,3e-4,0.0200021,8e-5,25.98,0.069,3.57889,2.5507,0.162,0.095,0.031,0,1.157,0.85,102.1,163.27,46.7898,0.28,1.7e-4,0.0254,0.070007,5e-4,0.822,0.54,0.319,0.279,3.383,0.37209,125.1316,3.9958,13.424,2.0788,1.136403,0.0343,0.462851,0,0.16,6.797654,3.908781,0.0275,0.00401,0,1.165057,264.48,4.3,1,1.1075,0.618,0.0706,28.21,4.702,140.9,8.463,78.18,233.6728,8.72,1.77,76,155,0,96,122,77.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
326,24,24,0,0,60.19,179.39,19.29532,1.76,6,0.048170636,0.57832052,0,0,1,6,482.803,1,1,346.07,41.95,76.85,10.18,32.51,0,0,0.0155765,0.00324,3.46,0.139,1.3212,2.3731,0.487,0.24,0.392,0.162,2.035,0.707,103,112.62,80.9722,0.24,6e-5,0.0186,0.199998,0.0848,1.305,0.526,0.708,0.22,0,0.44568,155.3024,3.3558,17.9948,0.9276,1.437761,0.2895,0.468869,0.0748,12.21,2.991317,0,0,0,0.001,0.87173,376.4,4.39,0,0.1888,11.842,0,29.34,4.568,144.9,5.997,72.08,198.1039,6.19,1.64,78,175.22,0,68,113,55.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
327,36,36,0,1,82.8,165.09,28.90316,1.91,6,0.020814299,0.24982958,0,1,3,6,9353.854,2,2,179.36,38.98,153.62,21.56,21.53,7.29e-4,8e-4,1.226e-4,0,22.39,0.228,5.32287,2.5257,0,0,0.007,0.001,0.712,0.788,99.1,80.09,98.133,0,1.3e-4,0.0012,0.110076,1e-4,0.478,0.504,0.187,0.143,0,0.35482,128.794,1.0314,0.0784,1.0476,1.051448,0.0046,0.399428,0,33.95,6.005701,4.647882,0.0287,0.00408,0,0.145608,444.38,4.29,0,1.0388,11.165,0.0085,23.28,4.502,136,8.556,69.08,237.4719,7.75,1.87,67,171.1,0,69,115,88.66,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
328,60,60,1,3,89.55,170.14,30.11571,2,6,0.095886699,1.15112871,2,3,1,6,10708.757,1,1,2555.84,32.95,137.62,36.66,21.06,0.045725,0.0043,0,7e-5,26.23,0.337,3.62203,2.4795,0.001,0.006,0.026,0.04,0,0,100.3,99.14,70.6789,0.09,0,0.0125,0.00235,9e-4,0,0,0.001,0,1.584,0.39861,130.7557,2.2985,13.3021,1.6786,1.281015,0.2085,0.700565,0.1171,0.72,11.830004,9.048723,0.7926,0,0,1.077731,308.95,4.09,0,0.9431,16.426,0,0.75,3.941,135.1,17.955,63.92,394.1673,14.7,2.09,81,170.86,0.1,104,112,94.51,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,NA,<1,2-3,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,N,N,N,ASIAN,Eastern Europe,NA,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
329,66,66,0,1,66.97,180.13,20.70958,1.87,7,0.085789154,1.02795444,0,1,2,7,2510.795,1,2,458.92,31.99,97.82,11.93,44.86,0.003036,0.0028,0,7e-5,28.07,0,5.21223,2.3883,0.111,0.213,0.04,0.057,0.454,0.579,102.9,94.44,63.5991,0.21,0,0.0211,0.017866,0.0101,0.358,0.412,0.086,0.125,1.024,0.35054,113.6582,4.3468,21.0417,1.4859,0.490916,0.2279,0.272996,0.0049,20.93,4.67987,4.882498,0.0278,4.6e-4,0.001,1.25974,143.31,4.01,0,1.3853,13.435,0.0136,30.36,3.35,136.4,6.806,69.98,446.0672,5.26,1.8,92,177.88,0,80,120,66.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
330,56,57,1,2,47.23,157.29,19.0563,1.46,7,0.187187963,2.24700885,0,2,5,7,19492.518,2,2,493.55,34.86,55.41,15.09,19.03,0.001183,1e-4,0,0.0019,29.15,0,6.79391,2.5015,0.137,0.511,0,0.017,0,0.005,102.7,114.34,49.3433,0,7e-5,0,0.351081,0.0393,0,0,0.002,0.351,0,0.37198,129,2.2381,9.1954,0.9971,0.396446,0.1051,0.589381,0.085,0,10.197772,4.160507,0.6894,0.00169,0.001,1.390298,359.09,3.51,2,0.9947,13.551,0,32.97,4.107,138.1,3.045,62.05,255.3153,8.49,1.36,95,155.98,0,86,104,47.87,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
331,76,77,0,3,76.06,162.16,28.6838,1.82,6,0.078821764,0.94533309,1,3,1,6,1946.43,2,2,270.38,26.85,44.53,38.66,42.36,0,0,0.0200093,4e-5,0,0,15.59845,2.1392,0.136,0.1,0.123,0.074,0.731,0.709,102,67.7,71.6165,0.3,1e-5,0.0049,0,0,0.493,0.417,0.19,0.103,2.187,0.33498,98.8339,3.1578,7.2921,0.6001,1.699369,0.0032,0.229863,0,0,3.052585,0,0.0185,0,0,1.036396,226.67,3.71,0,0.9507,8.979,0.0123,31.12,3.662,136.9,5.987,60.81,243.5647,4.84,1.79,90,162.87,0,94,138,80.38,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Other,Y,Y,F,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
332,64,65,1,2,61.34,162.13,22.82126,1.65,6,0.131753401,1.58139328,2,2,2,6,10929.797,2,2,390.91,32.07,109.99,16.01,11.1,1.21e-4,0.0021,0.0297877,9e-5,27.02,0.105,4.30512,2.3254,0.16,0.057,0.189,0.072,0.944,0.524,96,79.51,66.082,0,5e-5,0.0208,0.129901,0.0392,0.74,0.439,0.2,0,0.53,0.31466,99.9761,2.9016,11.2398,1.1581,2.537394,0.0133,0.501462,0.0674,16.04,11.919987,3.512104,0.5745,0,0.002,1.067195,571.06,4.2,0,0.9092,0.716,0,28.09,3.604,139.1,5.49,74.48,255.2331,15.39,1.58,71,162.6,0,80,80,59.92,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
333,72,72,0,2,61.1,159.91,24.11551,1.64,6,0.053983338,0.64741721,2,2,3,6,1162.601,1,1,141.96,47.74,75.22,33.68,19.94,0.001638,0,0.0200039,1e-4,24.17,0.079,8.26299,0,0.2,0.303,0.081,0.064,0.861,0.739,99,43.45,99.709,0.03,0,0,0.139914,5e-4,0.362,0.308,0.472,0.417,1.664,0.39145,139.0712,1.0972,10.5426,0.1335,0.769611,0.0062,0.400118,0.0022,0.1,3.307679,0.598767,0.0043,0.00558,0,1.36523,108.79,3.71,0,1.0056,0.657,0.0101,29.04,3.766,135.8,10.237,73.04,208.0458,4.48,1.58,81,158.81,0,74,141,62.93,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
334,55,55,1,1,73.66,168.09,25.88753,1.82,6,0.177377642,2.12671296,0,1,3,6,2576.79,2,2,311.16,42.58,59.07,18.05,15.89,9.3e-5,0,0.0115574,0,24.85,0.125,9.1797,1.9718,0.302,0.122,3.642,0.912,1.669,0.718,105,192.41,36.6538,0,1.4e-4,0,0.200017,9e-4,1.239,0.581,0.463,0.206,0,0.43931,151.6945,8.3492,15.8978,5.2294,2.866742,0.0353,0.527079,0.0792,14.93,1.561732,0.513817,0,0.00284,0.001,1.353082,176.18,4.71,1,0.92490000000000006,10.328,0,0.33,5.009,140,6.021,74.06,365.7682,3.98,1.88,83,170.01,0,67,115,77.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
335,69,69,0,1,46.65,152.02,20.49113,1.42,6,0.071266279,0.85641504,0,1,1,6,185.404,1,1,298.05,44,46.69,7.97,18.01,0.002205,0.0038,0.0104312,3e-5,28.01,0.254,11.57428,2.1728,0.344,0.223,0.286,0.163,0.857,0.538,106.7,51.73,70.9274,0.06,0,0,0.140375,9e-4,0.827,0.513,0.077,0,0,0.36722,127.9517,0.013,12.5275,1.3095,1.979722,0.222,0.282306,0.0503,0,1.512256,0.33073,3e-4,0.00262,0.001,1.452927,172.76,3.9,0,0.8293,11.402,0.0645,29.56,4.221,146.4,10.274,69.02,243.7889,2.37,1.27,76,147.96,0,64,122,42,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,< 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
336,47,47,1,3,59.93,152.44,25.51709,1.56,6,0.157790212,1.88956854,0,3,5,6,8491.818,2,2,606.14,36.55,84.11,9.02,14.96,0,0,0.0677769,8e-5,28.04,0.001,0.02484,2.1995,0.216,0.146,0.001,0,0.602,0.494,100,112.31,62.6456,0,0,0,0.972377,0.0024,0.129,0,0.338,0.244,0,0.38957,114.5362,2.0922,9.5989,0.3112,1.389622,0.0067,1.742455,0.0337,0.21,8.119144,1.970443,0.0243,0,0,1.138896,731.97,4.58,0,0.9218,11.967,0,33.54,3.917,139.9,7.451,73.91,122.4471,12.98,1.56,84,152.01,0,124,101,56.99,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
337,66,66,1,3,86.17,176.17,27.6476,2.03,8,0.070207308,0.84217215,1,3,5,8,11944.552,2,2,341.92,39.63,70.93,10.92,22.86,0,0,0.0541207,0.00295,25.02,0.17,0,2.3012,0.001,0,0.17,0.074,1.295,0.818,101,111.7,51.1205,0.3,1.4e-4,0.0115,0.099231,4e-4,0.661,0.415,0.528,0.352,0.037,0.42444,142.4262,0.0169,7.1767,1.6051,2.529698,0.01,0.452874,0.0019,0.64,7.419894,2.460778,0.0222,0,0,1.202666,305.78,4.4,1,1.0014,0,0,22.95,4.013,139.1,6.896,64.59,320.9375,11.9,2.13,66,179.6,0,81,127,90.91,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High,High,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
338,59,59,1,2,49.76,147.5,22.50767,1.41,6,0.033049616,0.39711244,0,2,2,6,8660.864,1,1,419.42,34.17,84.56,37.38,32.15,2.54e-4,5e-4,0.0198626,8e-5,0,0.147,2.66727,2.2969,0.032,0.079,0,0,0.051,0.566,101,97.93,55.5904,0,1.7e-4,1e-4,0.028536,0,0,0,0.155,0.238,0.305,0.38022,119.9709,2.1801,14.9248,3.7032,1.067671,0.0126,0.623103,0.0031,17.26,5.900524,2.742686,0.0193,0,0.001,1.00015,329.58,4.01,0,1.0686,12.269,0.0184,27.91,4.559,135.2,13.65,67.92,76.145,9.04,1.45,56,146.45,0,50,104,53.89,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
339,57,57,2,3,51.67,160.93,19.5235,1.52,6,0.012215699,0.14681042,1,3,6,6,26194.316,1,1,705.84,41.7,145.07,23.98,26.01,0.002815,0.0019,2.954e-4,0.00278,1.36,0.101,2.70039,2.3492,0.065,0.125,0.064,0.082,0.309,0.656,97.8,111.92,48.5851,0,4e-4,0.0163,0.052472,0.0273,0.248,0.435,0.157,0.202,0,0.35095,113.8901,1.083,7.6411,0.82,0.997112,0.2636,0.1996,0.0931,0,1.553687,3.592194,0.6475,0,0,0.245923,88.03,3.2,0,1.1216,0.877,0.0676,40.79,3.925,144,10.213,71.99,130.7229,2.82,1.57,82,162.91,0.1,64,120,52.29,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
340,37,37,1,2,61.86,161,23.84495,1.65,6,0.036942728,0.44344134,1,2,2,6,1524.118,1,1,201.24,43.15,56.24,19.98,21.38,0.001266,0.0011,0.0099267,3e-5,0,0.119,11.3158,2.7058,0.155,0.106,0.062,0.053,0.867,0.683,104.1,98.54,74.2446,0,0,0,0,5e-4,0.494,0.307,0.291,0.181,4.293,0.38822,129.2488,0.9438,0.0225,0.6231,1.50883,0.0798,0.7309,0.051,0.07,3.680388,0.335463,0.0218,0.00407,0,1.228003,168.37,4.81,1,1.0063,11.896,0,32.33,4.18,140.5,10.614,63.97,249.8979,7.62,1.7,84,160.04,0,71,126,63.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
341,53,53,0,1,62.8,162.04,23.89181,1.66,6,0.100804273,1.20937142,1,1,3,6,2225.992,2,2,431.23,27.06,53.81,15.95,21.01,0,0,0,0.00192,0,0,5.50125,2.2097,0.004,0.094,0.001,0.054,0,0.02,0.4,116.84,52.5159,0,0,0,0,0.0014,0,0.327,0,0.001,2.065,0.3201,111.0825,0.7471,8.3028,0.3727,0.621181,0.1523,0.560619,0.079,0.45,7.194692,4.88249,0.6556,0,0,0.9698,306.22,4.01,2,1.0679,12.708,0.032,25.63,4.286,136.9,5.151,58.04,160.164,8.66,1.7,77,163.95,0,104,139,63.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
342,67,67,1,1,69.98,167.13,25.33316,1.78,8,0.191015087,2.29484976,1,1,4,8,5496.483,1,1,183.06,30.02,200.83,9.99,17.07,0.004151,0.0043,0.0163639,0.00685,29.34,0.104,4.79484,2.2586,0.078,0.13,0,0,0,0,103,109.09,53.5932,0,0,0,0.785103,0.1398,0.014,0.003,0,0,0,0.30005,114.4946,1.0597,10.1125,8.2955,0.774649,0.4527,0.372764,0.1487,0.46,3.775856,8.232186,0.7394,0,0.001,1.183405,206.88,4.1,0,1.2055,11.036,0,27.35,3.851,139.1,3.431,56.29,274.5338,7.18,1.74,68,165.31,0,78,117,67.81,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
343,56,56,1,4,57.23,163.82,21.65487,1.6,7,0.055175616,0.66168985,0,4,6,7,13876.364,1,1,1632.94,37.98,119.63,13.06,66.04,0.001823,8e-4,1.573e-4,7e-5,22.48,0.049,3.47042,2.9163,0.175,0.311,0,0,0,0,101.4,68.96,88.9319,0,0,0.0105,0.049512,0,0,0.2,0,0.001,0,0.33028,109.332,2.9699,13.7017,1.4747,0.400671,0,0.395491,0,18,10.020135,8.657876,0.6302,0,0,1.455993,460.48,5.23,1,1.1979,15.077,0,0.69,3.957,133.7,3.413,72.07,363.1613,9.29,1.6,62,164.25,0,95,109,54.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
344,75,75,1,3,65.98,NA,23.91188,1.71,6,0.034749429,0.41696762,0,3,1,6,3577.923,2,2,1028.96,42.1,79.93,41.68,51.09,0.001209,7e-4,0.0305124,9.7e-4,25.86,0.074,24.37432,2.2743,0.476,0.189,0.451,0.166,1.739,0.556,98.3,53.27,96.7888,0.14,3e-5,0.0168,0.179596,0.0175,1.255,0.489,0.44,0.124,0,0.40961,140.892,2.0112,12.057,1.1085,2.634374,0.2438,0.308075,0.0504,0,7.293286,5.162007,0.5689,0.00739,0.001,1.331017,290.71,4.31,0,0.9777,15.495,0,23.06,4.331,139,10.209,67.91,247.9273,13.54,1.61,66,161.99,0.1,77,120,60.18,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,NA,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VV,N,Y,N,N,High,High,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
345,63,63,1,3,75.06,162.95,28.22941,1.79,7,0.056303702,0.67539681,1,3,1,7,12099.384,1,1,265.56,30.98,95.17,12,15.23,7.1e-4,0.0013,0.0114212,0.00389,22.51,0.044,2.49937,2.0568,0.123,0.23,0,0.039,0,0.651,108,87.54,70.7621,0,1e-5,0,0.100601,8e-4,0.008,0.29,0,0.204,0,0.3989,130.8482,2.5298,13.3971,0.6957,0.216398,0.137,0.409791,0.013,0.18,3.617905,0.499462,0.6454,0,0,1.051571,249.92,4.01,0,1.1123,9.311,0,31.66,4.801,140,6.985,67.95,208.9624,4.31,1.87,82,161.82,0,99,130,74.76,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
346,58,58,1,2,72.06,180.11,22.33048,1.92,6,0.240722462,2.88726443,0,2,6,6,7917.865,2,1,391.77,41.33,75.39,15.02,16.01,7.37e-4,5e-4,0.0265866,8e-5,0,0.109,6.20598,2.2289,0.729,0.461,0.096,0.067,1.112,0.733,99.8,103.14,59.7939,0,5e-5,0,0.118748,0.0103,0.673,0.453,0.367,0.311,0,0.43093,135.6169,4.4309,12.3004,0.4995,2.048292,0.1698,0.620146,0.0524,0,5.169646,6.220539,0.6652,0.01173,0,1.029617,154.14,4.78,0,0.9697,12.949,0,31.94,4.681,142,8.586,55.01,180.6468,7.81,1.84,0,178.14,0,76,0,67.25,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
347,67,66,1,3,75.98,167,27.03518,1.85,6,0.101808207,1.22131066,0,3,6,6,10237.168,2,2,696.71,39.91,161.11,24.11,22.25,5.57e-4,1e-4,0.1736411,0.00237,24.99,0.07,0.07521,2.3753,0.11,0.076,0,0.001,0.738,0.71,100.1,77.64,85.2264,0.31,7e-5,0.011,0.399212,0.0076,0.283,0.283,0.329,0.304,0.927,0.40268,137.5393,0.0063,5.9411,0.3005,1.231028,0.0081,1.46788,0.0578,14.28,8.29071,0.571066,0.0271,0.00247,0.001,1.034082,307.89,4.16,0,1.0906,11.451,0,0.2,4.321,140,3.968,70.05,338.9718,13.52,2,80,169.58,0,76,135,82.54,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,Y,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
349,49,49,1,1,79.05,166.91,28.65948,1.89,6,0.054388406,0.6520985,1,1,5,6,12320.309,1,1,131.98,46.51,49.13,13.88,13.98,0.002246,0.0024,0.0400663,0.00681,25.94,0.14,4.12486,2.3656,0.253,0.245,0.019,0,1.003,0.711,102.8,120.07,70.6079,0,0,0,0.169994,7e-4,0.394,0.265,0.542,0.322,3.368,0.44453,153.8313,2.3228,12.6111,0.8071,0.882082,0.149,0.680445,0.0292,31.96,3.182698,2.957158,0,0.00333,0,0.973407,256.72,3.81,0,1.0646,11.618,0.0136,33.66,5.142,140.6,13.672,77.01,338.8909,5.41,1.93,80,166.99,0,88,135,83.57,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
350,56,56,0,2,69.83,178.28,22.30596,1.87,6,0.065627031,0.787283,0,2,4,6,2168.992,1,1,397.81,36.99,59.91,270.65,49.61,0,0,5.73e-5,3e-5,24.99,0.002,2.49981,2.4666,0.276,0.21,0.264,0.156,2.154,0.917,100,78.86,75.5769,0,4e-5,0.012,0.26864,8e-4,1.173,0.551,1.129,0.59,2.918,0.39252,127.4068,5.5692,14.6088,2.9763,1.198168,0.0063,0.359398,0,27.26,3.493436,0,0,0,0,0.839946,235.31,3.7,0,0.9814,0,0.0333,0.17,4.616,141.9,11.285,80.03,236.6382,5.46,1.74,79,175.57,0,65,130,65,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
351,44,44,0,1,77.18,172.97,25.19678,1.93,7,0.063505,0.76223984,0,1,2,7,4167.153,1,2,293.33,43.18,52.66,24.95,19.96,6.38e-4,1e-4,0.0574919,0,20.88,0.129,4.99744,2.2446,0.065,0.055,0.156,0.159,1.104,0.749,98.1,98.51,84.9226,0,0,0.0184,0.099986,0,0.614,0.49,0.428,0.342,0,0.41706,138.6345,0,0,0.0056,2.333994,0,0.601625,2e-4,22.17,6.733045,2.895342,0.0156,0.0072,0,0.100443,166.17,3.54,0,1.1278,0,0.0727,22.97,4.983,139.1,9.34,71.79,244.1103,9.5,1.99,81,173.94,0,73,130,83.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
352,59,59,0,3,72.06,167.59,25.61648,1.84,6,0.058312902,0.69948878,0,3,1,6,9055.331,2,2,390.82,49.23,74.77,12.92,37.84,0,0,0.0399974,6e-5,27.46,0.119,3.57553,2.3783,0.094,0.091,0.042,0.046,0.859,0.755,106.3,73.87,88.8601,0.28,3e-5,0.0115,0.199911,8e-4,0.609,0.512,0.175,0.129,3.859,0.50154,172.9606,1.0227,11.1935,0.0092,1.100812,0.0075,0.107866,0,21.65,5.31381,0,0.0382,0.00122,0,1.032686,196.78,3.69,1,0.9472,13.88,0.031,34.32,5.254,145,11.988,73.03,591.4042,5.12,1.79,80,165.05,0,66,140,70.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
356,70,70,0,3,88.08,163,32.97507,1.98,7,0.046158292,0.55386914,2,3,6,7,5189.405,1,1,421.15,37.99,92.1,31.01,33.9,0.002345,0.0012,0.0800088,7e-5,29.53,0.085,4.20638,2.1208,0.262,0.212,0.162,0.109,1.143,0.734,103,109.71,57.8593,0,0,0.0015,0.230494,0.0099,0.474,0.292,0.613,0.423,0.828,0.24484,85.9295,1.077,9.2954,2.5669,1.320695,0.0051,0.599775,0,0.22,3.999445,4.469648,0,0.0019,0.001,1.353149,220.09,3.8,1,1.2385,14.539,0,29.5,2.603,139.1,6.019,65.49,333.0133,7,1.93,79,162.19,0.1,79,125,86.88,0,0,0,0,0,0,0,0,1,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
357,61,62,1,2,68,154.96,28.23022,1.65,7,0.071054114,0.85167012,1,2,4,7,8314.974,2,2,141.5,39,76.93,12.93,11.27,6.75e-4,0,9.54e-5,9e-5,22.02,0.07,0.0684,2.2959,0.297,0.27,0.076,0.071,1.005,0.831,100.9,120.2,57.8781,0.09,0,0,0.030244,0.0159,0.729,0.541,0.349,0.389,0,0.42083,143.5116,3.4351,10.1896,1.2247,0.692701,0.0114,0,0.0036,0.2,2.598476,0,0,0,0,0.834639,194.77,4.51,0,1.0037,11.621,0,30.95,4.799,142.7,10.038,72.03,265.963,3.36,1.69,75,154.03,0,90,113,64.43,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
358,59,59,2,3,105.16,175.72,33.63009,2.23,6,0.082327445,0.98814701,0,3,5,6,15447.218,1,1,162.09,36.46,44.55,16.06,15.7,0.001811,0.0021,0,0,22.41,0.185,5.89476,2.2929,0.084,0.084,0.051,0.074,0.843,0.741,100.9,77.26,103.2132,0.08,0,0.0015,0.102603,0,0.336,0.151,0.375,0.379,0,0.34566,105.0888,1.3901,9.9217,0.3079,1.289301,0,0.79405,0,18.19,2.825523,0,0,0.00315,0,0.93048,454.56,3.3,1,1.0056,0,0,25.91,3.963,140,6.056,72.95,226.1904,4.54,2.37,80,179.69,0,65,141,111.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
359,69,69,0,3,78.03,175.01,25.28078,1.96,7,0.17606991,2.11236187,1,3,3,7,6833.476,1,1,446.13,27.07,199.24,19.26,59.04,0.001826,0.002,2.8e-4,0.00104,25.37,0.002,4.88016,2.3499,0.176,0.198,0.001,0.034,0,0,99,77.47,81.3423,0.24,0,0.0223,0,0.0122,0,0,0,0.002,5.497,0.40937,129.4924,3.3624,13.86,1.5976,1.501351,0.2584,1.509445,0.1014,0.66,7.418478,4.100338,0.0406,0,0.001,1.099447,318.12,4.76,0,0.9157,12.08,0.0183,28.78,5.029,136,13.618,63.86,323.1636,11.28,1.88,84,174.73,0,95,124,76.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
360,69,69,0,4,64.42,163.08,24.32202,1.69,6,0.131962732,1.58371672,2,4,4,6,949.731,2,2,151.55,39.97,175.19,9.05,18.05,3.99e-4,0,0.0270427,0.00792,22.44,0,4.91475,2.4054,0,0,0,0,0.405,0.785,0.4,100.55,50.6587,0.11,0,0.0048,0.110012,0.001,0.136,0.416,0.12,0.146,0,0.39443,135.2955,3.2496,10.3891,1.4004,1.198083,0.0844,0.40824,0.0041,0,2.917454,1.723293,0,0.00157,0.001,0.770818,145.9,3.7,1,1.2792,0.145,0.0434,33.16,4.056,137,14.736,78.78,244.2332,5.69,1.72,79,162.94,0,96,130,64.7,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
361,63,63,0,2,66.46,160.12,25.71335,1.7,8,0.134113327,1.60943925,2,2,6,8,9879.305,1,1,478.08,39.99,65.35,8.47,10.92,0.002304,9e-4,0,0,28.23,0.144,5.37499,2.2774,0.013,0.063,0,0,0.049,0.02,103,127.86,44.2055,0,0,0,0.200556,0,0.021,0.009,0.05,0,0,0.40318,120.9838,1.0976,4.4452,1.3837,1.397412,0,0.312479,0,0.14,1.507048,0,0,0.00251,0,1.356963,228.44,4.28,0,0,10.255,0,23.73,4.525,143.1,4.073,51.04,255.7951,3.69,1.59,80,159.83,0,85,139,65.82,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
362,75,75,0,3,50.06,173.37,17.90561,1.57,6,0.072575781,0.87146295,0,3,2,6,1621.504,2,2,203.11,35.05,76.07,13.18,12.72,0,9e-4,0.1020368,0.01348,0,0.331,2.99832,2.2947,0.174,0.237,0.311,0.421,0.925,0.651,103.9,64,65.8991,0.12,0,0.0048,0.07668,0.0343,0.57,0.424,0.383,0.322,1.076,0.37106,117.9547,0.9307,5.3621,0.0111,1.725827,0.2463,0.809932,0.108,25.09,8.541981,5.544195,0.8004,0,0,0,347.38,2.38,1,0.9709,13.153,0.0235,33.69,3.708,139.6,5.195,59.02,209.975,14.32,1.57,42,174.73,0,63,102,50.96,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
363,68,68,0,2,77.89,161.83,29.75618,1.83,8,0.062447648,0.74938345,0,2,2,8,3642.74,1,1,252.52,43.99,203.14,15.07,28.8,0.001182,5e-4,2.313e-4,0,32.91,0,3.3998,2.0781,0.336,0.53,0.069,0.091,0,0,101.9,84.8,62.8222,0.34,2e-5,0.0156,0.043066,5e-4,0,0.006,0,0.002,4.531,0.3042,115.0743,2.3568,10.305,0.2515,0.120835,0.0845,0.220364,0.0033,0.2,2.971227,3.840865,0.0244,0.00196,0,1.22804,195.58,4.6,0,1.0709,12.713,0,30.18,3.297,142,14.705,76.57,305.6425,3.89,1.94,71,161.76,0,92,140,72.33,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
364,69,70,0,3,70.02,163.87,26.37732,1.76,6,0.13205164,1.5840286,1,3,1,6,1960.777,1,1,302.06,43.83,124.59,5.94,18.28,3e-6,0,0.0770319,0.00251,28.66,0.001,4.67661,2.5435,0.575,0.46,0.14,0.093,1.4,0.717,103.1,86.43,61.0083,0.11,4e-5,0.0144,0.099361,7e-4,0.6,0.292,0.834,0.395,0,0.39788,120.7975,2.4426,7.2537,0.9157,0.860147,0.0077,0.343159,0.0044,0.37,4.751362,0.533704,9e-4,0.00388,0,1.543226,467.16,4.11,1,0.9592,10.651,0,33.25,4.03,136.9,15.698,73.08,164.5744,5.99,1.75,75,164.95,0,71,130,70,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
365,58,58,2,4,76.99,180.11,24.02095,1.98,7,0.056521528,0.67793167,0,4,5,7,12813.823,1,1,2359.04,0,77.24,15.76,53.67,0.001422,0.0016,0,9e-5,30.9,0.001,4.70912,2.3632,0,0.107,0,0,0.01,0.59,92.1,87.55,86.0108,0,5e-5,0.0203,0.099703,0.0049,0,0.009,0.012,0.262,1.101,0.26549,83.5327,2.8635,10.2018,0.1496,0.847043,0.2272,1.259879,0.1134,30.26,11.090202,5.718337,0.7093,0,0,1.291294,710.9,4.26,1,1.6439,17.839,0.0022,31.78,3.503,134.4,2.11,66,333.0836,11.9,1.96,80,182.72,0,97,103,75.94,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
366,65,65,1,3,104.18,170.15,35.37457,2.11,6,0.04369264,0.5244826,0,3,2,6,12660.146,1,1,211.39,38.66,224.88,28.79,18.3,0.293419,0.0062,0,0,22.91,0.947,12.482,2.2525,0.147,0.127,0.33,0.176,1.367,0.757,104.1,102.48,71.725,0.06,8e-5,0.0264,0.010079,0,0.614,0.349,0.723,0.447,0,0.42104,139.3729,1.622,12.7904,0.4294,1.122104,0.0128,0.498976,0.0043,29,5.509177,2.793015,0.6294,0.00259,0,0.773564,269.09,4.39,0,0.9406,13.221,0.0188,24.74,4.673,139,13.69,52.85,212.4832,8.49,2.07,90,165.08,0,95,160,93.24,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
367,77,77,0,1,55,163.82,19.8362,1.58,6,0.02048743,0.24597045,0,1,5,6,2073.728,1,1,343.42,39.04,196.68,13.14,21.67,0.001339,0.0032,2.801e-4,0.00505,27.41,0.12,4.18435,2.3495,0.23,0.32,0.003,0.024,0.116,0,100.1,55.77,81.1321,0.12,0,0.0164,0.08224,0.0362,0.028,0.264,0.083,0.131,4.835,0.35579,100.9415,6.4573,19.496,0.561,1.85141,0.314,0.821218,0.1628,17.34,2.9133,0.41504,0.72,0,0.001,1.218655,201.04,4.7,1,1.1329,13.449,0.0304,0.04,3.695,137,10.253,76.06,431.8909,6.79,1.6,61,167.36,0,92,149,55.25,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
368,62,62,0,4,48.93,155.86,20.30678,1.45,7,0.046064391,0.55335858,2,4,3,7,1835.278,2,2,312.68,29.87,288.11,22.07,58.54,0.001338,0,0.0300091,0,32.92,0.052,5.33269,2.4763,0.003,0.003,0,0,0,0,103,88.84,57.095,0.24,2.1e-4,0.0171,0.041014,0,0,0,0,0,0,0.38331,121.0074,2.3528,13.626,1.0233,1.041045,0,0.540677,0,0.08,5.041986,4.868509,0.0055,0.00149,0.001,1.639107,232.6,4.91,0,0.9246,0.294,0.0354,27.39,4.303,141.9,9.507,70.01,258.5266,6.6,1.52,81,157.24,0,66,121,53.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,NA,N,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
369,57,57,1,3,98.15,187.5,27.34573,2.26,7,0.071578356,0.85923767,1,3,3,7,20487.285,1,1,156.07,54.61,61.95,20.96,19.87,6e-4,0,0.0074011,0,27.29,0.002,0.02568,3.0475,0.128,0.118,0.112,0.065,1.084,0.757,104,114.27,75.0634,0.2,4e-5,0.0077,0.340738,3e-4,0.411,0.296,0.54,0.385,1.077,0.51581,173.6853,3.1117,10.6742,0.2995,3.002347,0.0077,0.642164,0,0.18,10.924685,3.936101,0,0,0,1.368783,473.53,4.11,0,1.0879,0.424,0.0396,30.36,5.894,140,13.611,86.93,303.4273,19.33,2.1,74,186.18,0,65,131,94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
370,35,36,1,2,64.03,170,22.31084,1.73,7,0.065619811,0.78702385,1,2,4,7,5642.277,1,1,1580.3,42.08,910.45,57.24,58.11,0,0,0.1048957,9e-5,26.65,0.001,6.69274,2.5213,0.257,0.115,0.08,0.064,0.875,0.679,97.1,92.67,77.1477,0.55,0,0.0047,0.069865,1e-4,0.289,0,0.599,0.413,0,0.38498,102.1969,3.7852,10.5901,0,1.795726,0.07,0.816337,0.0034,0.11,3.944743,3.105695,0.6994,2.5e-4,0.001,1.250332,416.25,5.57,0,1.0732,12.542,0.0574,27.21,4.766,134.4,10.294,75.85,247.8721,10.5,1.66,76,167.26,0,99,120,59.42,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,2,>1,131HH,158VF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
371,58,58,0,2,56.45,160.01,22.58954,1.58,6,0.034078137,0.4078587,0,2,1,6,3240.169,1,1,177.65,46.05,63.81,73.39,61.29,0,0.0016,0,0,26.56,0,6.28547,2.3774,0.465,0.364,0.126,0.056,1.247,0.711,107.9,106.36,61.9686,0.39,0,0.0179,0.069832,3e-4,1.063,0.596,0.247,0.098,0,0.40415,143.2796,3.9865,17.3323,1.7821,2.072585,0.1091,0.258266,0.003,0.74,6.877317,0.140317,0,0.00366,0,1.274678,230.32,4.45,0,1.0549,13.554,0,35.49,4.033,141.9,14.194,77.02,420.1368,9.3,1.55,67,158.96,0,82,122,54.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
372,64,64,0,4,60.02,165,22.03369,NA,6,0.20319911,2.43526157,1,4,5,6,2657.47,2,2,211.91,38.04,45.64,15.94,17.81,0.001345,3e-4,2.389e-4,1e-5,25.62,0.068,5.30481,2.3547,0.039,0.064,0,0.001,0.375,0.604,100.9,92.23,53.0069,0.5,1.1e-4,0.0192,0.199941,6e-4,0.176,0.131,0.107,0.208,1.394,0.37942,130.6763,0.0086,6.8553,0,0.545065,0.0137,0.47872,0.0036,26.51,7.193,5.460951,0.0354,0,0,1.068052,268.9,3.8,1,0.805,0.628,0.046,31.25,4.547,140,5.119,68.95,363.3877,8.8,1.62,80,162.43,0,87,128,55.62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
373,70,70,0,2,62.95,149.86,27.76326,1.58,8,0.106543672,1.27820723,0,2,3,8,4656.649,1,1,790,44.99,108.74,30.59,22.02,5.47e-4,2e-4,0.1039008,0.00507,27.23,0.049,5.29443,2.2067,0.328,0.403,0.013,0.034,0.339,0.629,102,100.93,47.8484,0.32,6e-5,0,0.00285,0.0099,0.006,0,0.351,0.488,2.48,0.4528,144.9021,2.0573,12.8955,1.1342,0.918069,0.2052,0.549358,0.1113,0,2.702467,0.417523,0.0237,0.00223,0,0.935186,246.39,4.14,1,1.0267,15.311,0,36.97,5.119,138,9.177,79.24,315.8351,4.6,1.42,82,145.99,0,87,132,59.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
374,74,74,1,3,57.8,155.94,23.85543,1.56,7,0.04281468,0.51362461,0,3,5,7,21952.857,1,1,744.91,50.11,74.76,16,18,0,0,0.0194402,9e-5,22.12,0,4.40578,2.7753,0.24,0.132,0.067,0.051,0.914,0.737,91.3,58.96,79.4777,0,0,0.0026,0.059793,0.001,0.474,0.374,0.467,0.316,0,0.42303,128.8394,1.5683,9.2054,0.4734,3.573514,0.2526,0.342559,0.0531,0.78,7.103165,0.481721,0.6458,0,0,1.135326,515.91,4.56,1,0.974,12.693,0.0118,28.25,4.544,135.9,7.135,79.22,300.0464,9.88,1.51,60,155.07,0,68,121,54.09,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
376,63,63,0,2,52.95,169.04,18.51089,1.6,6,0.045381214,0.54444739,0,2,6,6,8291.18,2,2,285.46,42.94,87.38,12.94,20.04,3.37e-4,0,0.0102568,6e-5,3.1,0.149,5.21206,2.2646,0,0.113,0.001,0.048,0,0.718,105,78.23,69.9328,0,2e-5,0.0119,0.099824,0,0.048,0.522,0,0.208,2.94,0.40933,133.7488,1.3164,0.1021,0.3969,0.511669,0,0.450359,0,0.55,3.094742,0,0,0,0,0.24269,188.18,4.71,0,1.0424,0.599,0.01,25.21,4.114,142.8,5.038,71,386.6873,4.5,1.61,91,171.16,0,66,134,55.26,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
378,62,63,1,4,78.03,171.11,26.46683,1.92,6,0.052396526,0.62844454,1,4,6,6,16517.897,1,1,425.6,43.99,201.38,15.07,38.05,0.002852,0.0024,1.99e-5,0.00501,29,0.118,4.12312,3.02,0.838,0.509,0.454,0.222,2.186,0.819,98.1,78.2,83.9991,0,1.1e-4,0.0268,0.100713,0.0583,1.002,0.468,1.382,0.574,0.974,0.37939,128.9459,4.6824,18.5055,1.9477,1.319804,0.3703,0.500739,0.1508,0.71,4.919234,7.866004,0.6096,0,0,1.164053,176.97,4.6,0,1.0907,10.631,0.0394,22.13,4.176,138,8.105,80.13,368.867,7.3,2.05,73,173.34,0,78,129,80.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
379,67,67,0,2,79.99,180.16,24.47237,2.02,8,0.104959687,1.2597529,1,2,2,8,3024.07,1,1,193.23,41.01,53.35,22.07,21.07,0,0,0.0066931,7e-5,23.97,0.069,4.61631,2.3015,1.15,0.459,0.455,0.156,1.611,0.588,105.9,56,123.9543,0.09,0,0.0083,0.551864,0.013,1.105,0.452,0.435,0.001,0,0.46786,161.1901,4.033,18.5106,0.4431,3.247147,0.2528,0.400193,0.0037,0.32,3.951299,3.960734,0.0262,0.00352,0,1.062329,217.28,4.62,1,1.0292,0.669,0,22.98,5.047,143.8,10.898,81.82,446.0994,7.1,2.01,86,180.12,0,88,157,83.47,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
380,58,58,0,2,67.21,156.06,26.98887,1.66,6,0.098237074,1.1780654,1,2,5,6,4807.105,1,1,431.2,30.01,66.44,8.69,9.78,0,0,0.0193537,0.00279,27.07,0,5.31783,2.1465,0.377,0.135,0.405,0.143,2.583,0.903,92.3,90.71,77.2918,0.03,0,0.0021,0.100297,0.0099,1.547,0.654,0.894,0.381,2.026,0.39113,130.713,1.2089,6.3294,0.425,1.907228,0.0085,0.559961,0.0473,0.57,7.400396,4.568215,0.54990000000000006,0,0,1.09917,430.63,4.1,0,1.0628,0.445,0,30.1,4.456,140,2.29,73.06,190.3983,10.5,1.77,63,156.24,0,55,83,66.58,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
381,53,53,1,2,85.31,158.52,34.04635,1.88,6,0.088441049,1.06256198,1,2,5,6,8397.282,2,2,675.46,32.82,56.39,24.94,43.17,0,6e-4,0,0,21.96,0.101,5.37894,2.1127,0.332,0.343,0.03,0.056,0.593,0.641,0,139.61,46.4098,0.07,1e-5,0.0126,0.016272,0,0.435,0.374,0.245,0.288,1.9,0.28754,89.3584,0.7081,0.0937,0.5934,1.093025,0,0.501247,0.0021,0.69,5.267338,0.389744,0.6377,0.00329,0,1.321704,430.05,4.09,1,1.022,0.936,0.0083,27.62,3.811,135.9,11.95,70.77,214.1373,5.9,1.88,59,160.47,0,71,119,88.53,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
382,49,49,0,3,71.72,169.93,25.00688,1.83,6,0.025036844,0.30026135,1,3,3,6,6638.19,2,2,162.97,40.02,58.94,12.39,21.94,0,0,0.0200311,0,0,0,4.29306,2.377,0.351,0.309,0.218,0.159,0.867,0.695,101,100.11,65.3207,0.33,8e-5,0.023,0.153195,0,0.659,0.493,0.281,0.244,0,0.2962,94.1768,2.5795,12.7459,0.5286,1.291695,0.004,0.47082,0,0.83,4.910485,0.277488,0,0,0,1.113052,183.04,3.1,0,0.9798,10.282,0,28.02,3.786,141.9,6.713,73.09,279.0324,6.85,1.99,70,171.97,0,89,121,75.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
383,51,52,0,4,59.99,158.72,24.44922,1.62,7,0.043300256,0.51928804,0,4,6,7,6342.959,2,2,1909.65,36.21,248.25,175.32,79.4,0.001646,6e-4,0.0996952,0.005,26.97,0,7.11793,2.5729,0.05,0.008,0.013,0.001,0.742,0.658,0.3,88.29,71.6307,0.11,6e-5,0.0224,0.0874,0.0022,0.303,0.354,0.238,0.221,0,0.40956,131.3717,1.0027,4.0617,0.9808,0.909484,0,0.466834,0.0425,0.81,12.574938,3.602839,0.6047,0.00334,0,1.289029,569.94,5.75,0,1.1124,13.821,0,0,4.122,138.9,21.052,69.94,208.4635,12.49,1.65,61,156.97,0,96,92,58.27,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ZAF,South Africa,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Other,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
384,76,76,0,3,102.15,174.17,33.25457,2.13,6,0.061020734,0.73285748,0,3,3,6,887.578,1,1,1116.13,35.1,99.81,71.35,186.05,0,1e-4,0.0300127,6e-5,22.39,0.09,0,2.2276,0.299,0.223,0.198,0.139,0.677,0.418,96,72.39,87.1297,0.33,1.7e-4,0.0146,0.050945,6e-4,0.521,0.495,0.006,0,3.991,0.33669,112.6799,2.1878,10.8928,0.3196,1.90073,0.0833,0.799446,0.0496,0.09,3.712461,2.594909,0.0112,0.00646,0.001,0.831247,208.02,4.28,0,1.2132,10.975,0,30.07,4.017,136.1,6.177,73.01,451.6894,7.63,2.04,85,173.37,0,75,130,98.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,>= 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
385,60,60,1,1,59.03,164.09,22.22037,1.65,6,0.158811671,1.90483669,0,1,3,6,3021.623,1,1,228.56,44.27,113.47,17.86,12.97,0.001393,0.0022,0.0650459,0.00285,25.18,0.124,10.42403,2.4713,0.32,0.28,0.092,0.09,0.808,0.719,94.2,71.52,88.4976,0.26,0,0.0029,0.127995,0,0.651,0.544,0.243,0.221,0.083,0.37556,117.8665,1.6919,9.8512,2.4995,1.765932,0.0096,0.334957,5e-4,0,3.126065,0.541895,0.6559,0.00308,0,1.167351,317.3,4.81,0,0.9968,0,0.0388,30.36,3.589,139,6.166,69.03,314.4239,6.39,1.62,64,164.68,0,68,100,64.49,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
387,43,43,1,3,85.35,182.84,25.71006,2.06,6,0.043817553,0.52495396,1,3,2,6,5250.12,2,2,186.92,38.43,208.07,35.86,18.88,0.001227,0.0014,0.0260106,0,25.1,0.215,0.035,2.3582,0,0,0,0,0.579,0.696,97.1,152.74,49.5245,0,0,0,0.08006,0,0.398,0.361,0.093,0.001,1.651,0.37665,126.05,3.3915,15.2548,6.6615,2.480299,0,1.694564,0,0.17,6.096175,0,0,0,0,1.18833,148.37,3.49,1,0.9611,0,0,28.98,4.226,138.1,32.309,70.07,261.9241,9.45,2.01,80,185.39,0.1,93,145,90.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
388,70,70,0,1,156.95,210.34,37.84753,2.84,7,0.108221657,1.29767906,0,1,5,7,3830.351,1,1,191.41,39.04,82.6,22.07,22.08,0.002168,0.0021,0.0297221,7e-5,1.07,0.16,8.56947,2.4589,0.039,0.055,0.001,0.042,0.011,0.013,102.9,96.59,89.281,0.25,0,0.0062,0.193771,0.0162,0.006,0,0.008,0.221,1.919,0.42006,136.4814,2.112,9.0355,1.0529,0.997568,0.105,0.601245,0.061,0.58,6.147149,5.290161,0.0231,0,0.001,0.775057,245.42,4.89,0,1.1254,0,0,30.94,5.13,140,7.86,74.24,344.7026,9.22,2.62,79,204.79,0,53,130,130.23,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
389,60,60,0,4,89.93,175.24,29.55374,2.07,6,0.031135688,0.37346241,1,4,5,6,4120.937,1,1,170.12,34,98.64,50.4,81.1,0.00317,0.0036,0.0400491,0,0,0.151,4.39789,2.0677,0.226,0.061,0.634,0.36,1.225,0.599,103.9,93.99,70.8319,0,0,0.0111,0.199958,3e-4,0.981,0.506,0.308,0.141,0,0.40951,133.9064,2.6517,8.7836,1.1083,1.240247,0.0102,1.519889,0.0456,0.28,7.969907,3.528349,0.0238,0,0,0.679985,186.14,3.99,0,1.163,9.822,0.0151,28.46,4.597,139,20.147,65.08,333.0044,12.2,2.31,57,174.88,0,72,115,90.31,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
390,44,44,1,2,55.94,159.86,21.87386,1.57,6,0.043505227,0.52207353,1,2,2,6,22568.243,1,1,686.69,42.25,72.93,10.98,19.16,2.91e-4,0.0026,0.0998992,0.00509,24.05,0.134,3.39417,2.2772,0.145,0.042,0.139,0.119,0.73,0.662,100,120.23,49.2227,0.25,0,0.007,0.160717,0.0144,0.321,0.15,0.324,0.256,2.917,0.43889,140.5274,1.9922,9.3206,1.5177,1.904806,0.1317,0.6503,0.0048,0.07,3.196435,0,4e-4,0,0,0.572655,277.81,3.91,0,1.1825,0.821,0.0225,31.28,4.998,141.9,10.994,70.65,380.6901,6.2,1.53,75,157.45,0,72,131,52.53,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,High,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
392,26,26,2,3,90.93,178.09,28.60319,2.09,8,0.054251461,0.65151237,1,3,6,8,32738.965,1,1,343.12,32.16,117.44,21.02,23.88,0.00176,0.0018,0.0227938,0.00221,24,0,5.68962,2.3964,0,0.123,0,0.01,0,0.713,100,143.64,63.3578,0.09,0,0.0013,1.163429,0.0311,0,0,0.13,0.422,2.27,0.31185,97.861,0.803,0.0695,0,0.336397,0.203,0.82085,0.0065,21.84,4.29123,3.361694,0.6293,0,0,1.255552,248.36,3.7,1,0.9534,11.097,0.0076,29.91,4.001,133.7,5.191,59.1,598.4226,5.96,2,70,178,0,130,116,86.2,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
393,63,63,1,2,59.21,158.12,23.39165,1.59,7,0.09813739,1.17731776,1,2,6,7,9202.218,2,2,165.42,32.42,57.7,10.12,10.12,0,0,0,0,28.95,0.116,4.71138,2.3025,0.183,0.122,0.21,0.112,2.192,0.892,91.5,77.54,68.9767,0,0,0.0071,0,0,1.453,0.628,0.91,0.491,6.443,0.33608,112.6248,3.0265,10.8769,1.5188,0.998793,0.0061,0.349817,0.0022,0,6.00024,0.559457,0.0074,0,0,1.345734,228.64,3.89,0,0.9318,12.822,0,29.56,4.125,140.1,7.998,62.01,231.6004,5.8,1.53,85,158.93,0,64,117,60.22,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,< 55,>= 60,< 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
394,69,69,0,0,85.54,169,30.89452,1.97,6,0.085058373,1.01958493,1,0,4,6,6162.726,1,1,231.96,38.95,76.98,15.92,18.05,0.00147,0.0021,0.0074146,0.00378,24.08,0.088,15.37312,2.1787,0.802,0.359,0.034,0,1.238,0.607,99,96.6,64.4499,0.11,4e-5,0.0034,0.273402,0.0151,0.646,0.281,0.48,0.223,0.876,0.37989,130.3191,1.9045,15.2737,0.7372,1.759726,0.134,0.389115,0.0056,0.38,4.362193,0.4061,0.6111,3e-4,0,1.141166,416.51,4.38,0,1.0429,0,0.0621,0,4.816,134.1,3.524,78,347.613,6.52,1.9,59,166.96,0,92,96,80.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
396,52,52,1,4,68.96,170.33,23.17567,1.8,7,0.066690013,0.79964432,1,4,3,7,16793.678,2,2,495.78,41.1,200.59,108.39,33.56,0.001255,6e-4,0.0300184,0,2.04,0.069,2.31288,2.208,0.446,0.338,0.118,0.096,1.214,0.792,96.7,88.73,81.3291,0,9e-5,0.0146,0.129887,6e-4,0.61,0.426,0.564,0.376,0,0.39500999999999997,130.3042,1.093,10.4615,0.7115,1.193176,0.0095,1.300235,0.0593,0,4.304594,4.897259,0.0303,0.00234,0.001,1.13151,213.24,5.13,1,1.119,12.918,0,47.97,4.992,137,13.682,72.07,223.5485,7.11,1.81,95,169.85,0,71,161,67.83,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,3,0,131RR,158FF,N,Y,N,N,Low-Intermediate,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
398,47,46,1,3,47.75,157.86,19.18271,1.47,7,0.044310946,0.53276095,1,3,3,7,4946.653,1,1,311.7,44.11,81.05,21.08,14,0,0,0.018252,0.00709,26.92,0.198,0,2.4494,0,0.007,0,0,0.047,0.699,106.7,96.86,66.0701,0,1.9e-4,0.0053,0.100333,0.0242,0.137,0.301,0,0.002,2.045,0.38718,131.2057,2.1004,10.9211,0.7594,1.28006,0.1482,0.300222,0.0813,0.59,2.88384,0.629623,0.6044,0,0,1.130026,154.03,4.3,1,0.8862,0.052,0.0583,31.04,4.5,145,19.19,65.06,784.6245,3.96,1.46,86,158.15,0,108,153,48.37,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
399,70,69,1,3,75.89,183.99,22.45643,1.98,7,0.058023687,0.69649794,1,3,5,7,6113.419,2,2,775.03,36.16,67.24,45.28,62.23,0,0,0.0071542,1e-4,32.71,0.068,2.53468,2.1705,0,0.069,0.03,0.099,0,0.31,101,83.24,78.205,0.76,1.3e-4,0.0419,0.198981,0.0097,0.003,0.398,0,0,4.479,0.38024,133.146,0.7317,9.8914,0.6972,0.718625,0.2263,0.994972,0.0822,10.89,4.764041,6.415706,0.671,0.00567,0.001,1.191158,109.49,3.41,0,1.0837,12.246,0.0201,0.36,4.035,136,10.271,60.69,2.6712,7.01,1.94,72,184.81,0,70,131,75.07,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
400,74,74,0,4,69.31,160.98,26.25562,1.72,6,0.055619116,0.66855011,1,4,1,6,582.167,1,1,445.95,29.93,112.61,13.29,27.72,0.004243,0.003,0,7e-5,33.09,0.002,6.02012,2.2582,0.425,0.258,0.09,0.044,1.463,0.812,102.2,69.91,84.93,0,0,0.0153,0.059842,9e-4,0.982,0.55,0.47,0.283,0,0.25416,84.5839,5.1571,27.1399,2.8613,2.510601,0.1796,0.539477,0.0397,0.34,4.521339,2.320425,0.0217,9.8e-4,0.001,1.227727,196.33,4.2,0,1.1096,0.661,0.2604,0.57,2.608,143.8,4.012,72.96,493.1793,7,1.67,71,160.92,0.1,79,119,72.87,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
401,53,53,1,3,52.04,147.98,23.62481,1.46,6,0.104635437,1.25579533,1,3,5,6,5419.889,2,2,610.74,14.73,80.32,10.15,15.13,0.002065,0.0036,0.0399057,0.00238,0,0.061,7.33521,2.0578,0,0,0.097,0.093,0.736,0.765,109,179.64,31.3442,0.42,3e-5,0.0314,0.16004,6e-4,0.23,0.005,0.424,0.429,6.661,0.32481,98.7645,0,0.0078,0.2944,2.370345,0.0128,0.972018,0.0046,0,5.551236,7.274199,0.625,1.9e-4,0,0.966995,209.28,3.9,0,0.9599,12.675,0,32.08,4.06,138,3.025,0,206.324,9.98,1.4,75,145.87,0.1,89,109,47.51,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Other,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
402,51,50,0,3,55.66,155.18,23.04388,1.55,6,0.104735722,1.25932672,1,3,4,6,4553.252,1,1,219.19,41.13,81.13,14.93,38.31,0,0,0.0201686,1e-5,24.97,0.13,6.15358,2.2133,0.253,0.288,0.179,0.153,1.176,0.827,102,103.88,56.7299,0.34,5e-5,0.0078,0.010323,8e-4,0.837,0.555,0.412,0.387,0,0.33965,105.5631,1.4879,7.8856,0.702,0.540478,0.0038,0.344003,0.0028,0,3.950702,5.202354,0.5537,0,0,1.420511,344.7,4.62,0,0.9852,0.498,1e-4,27.52,3.945,139,10.003,72.61,333.3052,5.11,1.43,68,155.16,0,76,140,50.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
403,49,49,0,2,54.04,163.1,19.58872,1.58,7,0.059397254,0.71193961,1,2,2,7,5576.294,2,2,190.91,42.93,51.44,15.1,25.11,0,6e-4,0.0299523,1e-4,25.03,0.069,4.41307,2.7136,0.275,0.291,0.043,0.048,0.459,0.597,93.9,61.9,96.3715,0.22,2.7e-4,0.2677,0.004706,0.001,0.21,0.153,0.188,0.297,1.885,0.2665,82.4671,3.973,10.5997,0.706,0.712961,0.0085,0.272656,0.0038,0.74,6.302766,0.073719,0.5594,0.03109,0.001,1.062236,218.71,4.54,0,1.0865,11.193,0.0035,1.05,3.985,136.9,6.836,69,274.8426,6.49,1.58,80,162.08,0,90,135,50.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
406,49,50,0,1,57,166.01,21.08582,1.63,6,0.081453528,0.97720089,1,1,2,6,1410.317,1,2,170.83,22.79,566.71,16.89,13.36,0,8e-4,0.1586077,0.00606,24.16,0.201,3.84072,2.1754,0.19,0.066,0.156,0.062,1.935,0.83,101.9,122.33,51.0098,0.31,3e-5,0.0196,0.15062999999999999,0.0049,0.948,0.5,0.595,0.242,4.062,0.28905,91.1692,2.858,9.3037,0.7676,1.80051,0.2273,0.700019,0.0043,0.57,7.228675,0.383799,0.0413,0.00347,0.001,1.490421,684.98,4.1,0,0.9839,12.103,0,25.93,3.218,138,3.045,58.04,200.033,9.11,1.61,80,169.95,0,81,108,61.61,1,0,0,0,0,0,0,1,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
407,37,36,1,1,72.06,176.02,23.89733,1.88,7,0.058801324,0.70516596,1,1,3,7,10604.009,1,1,334.3,41.94,66.47,21.58,31.12,2e-4,0.0016,0.0503186,4e-5,26.62,0.138,4.40093,2.3023,0.321,0.3,0.089,0.089,0.982,0.762,104,106.86,70.3596,0.05,0,0,0,0,0.461,0.281,0.503,0.413,0,0.33472,112.821,3.8708,15.7674,2.2256,1.130023,0,0.657264,0.0015,0.34,5.294555,0,0.0121,0,0,1.183948,188.47,3.7,0,0.9717,0.157,0,0,4.168,142,3.413,73.08,152.0396,7.3,1.93,108,180.16,0,79,190,73.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
408,68,68,0,3,43.94,163.99,16.26511,1.44,6,0.059238432,0.71083817,2,3,3,6,1132.175,1,1,135.75,40.96,90.71,12.39,17.14,0,0,1.9e-6,7e-5,27.2,0.056,12.8381,2.2497,0.137,0.104,0.034,0.007,1.547,0.858,105,58.96,78.8184,0.15,6e-5,0.006,0.031981,7e-4,0.713,0.431,0.696,0.444,1.966,0.24316,87.3344,3.6082,14.1245,1.9578,1.311014,0.1663,0.380122,0.0054,0,6.757902,4.410085,0.6459,0,0,1.649145,452.95,4.71,0,1.058,10.949,0.0449,26.18,3.197,141.1,2.397,71.06,377.5736,9.39,1.45,77,161.72,0,78,131,42.12,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),<18.5,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High,High,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
409,40,40,0,3,74.52,173.61,25.10262,1.89,6,0.123467034,1.48358623,0,3,6,6,3024.23,1,1,561.38,38.97,88.96,15.09,11.09,0,0,0,0,22.31,0.2,3.21087,2.2099,0.001,0,0.001,0,0.578,0.808,109.9,106.41,70.656,0,7e-5,0.0092,0.200568,0,0.509,0.536,0.159,0.228,0,0.36493,126.8882,1.2613,7.8262,0.0065,1.040199,0,0.270536,0,0,2.707711,0,0,0.00134,0,1.130062,191.34,4.09,0,0.9081,0,0.033,33.82,4.39,143.9,6.82,64.07,156.4842,3.74,1.9,90,174.81,0,96,117,79.39,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
410,48,48,1,2,47.12,155.12,19.61379,1.44,7,0.057988615,0.69599391,0,2,1,7,11234.54,1,1,237.9,35.97,54.99,7.86,12.99,5.46e-4,0.001,1.278e-4,0,25.96,0.002,4.96095,2.3532,0.028,0.184,0,0.001,0.364,0.837,102.2,104.18,55.1892,0,0,0,0.120415,1e-4,0.358,0.539,0.133,0.325,0,0.3209,105.012,1.2009,12.012,0.4477,0.39353,0,0.449341,0,0,2.816451,0.447721,0.0401,0.00151,0,1.03002,233.53,3.93,0,0.9703,11.975,0,23.57,4.116,140,7.308,69.04,130.688,3.89,1.45,87,157.24,0,86,119,46.4,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
411,39,40,1,0,74.65,169.3,26.23541,1.85,6,0.090195998,1.0805577,0,0,1,6,NA,NA,2,128.91,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.92,68,169.85,0,70,112,70.53,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,NA,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,NA,GA101 plus 6 CHOP cycles,NA,NA,N
412,68,68,0,1,57.98,157.86,23.12145,1.58,6,0.062738162,0.75228322,2,1,5,6,1543.927,1,1,109.09,41.07,69.02,9.71,14.84,0.00369,0.0034,0.0199429,2e-5,27.01,0,5.71073,2.4281,0.056,0.045,0.001,0.001,0.5,0.637,98.9,70.2,70.6785,0.05,0,0.0052,0.00598,0,0.233,0.352,0.194,0.066,0.46,0.40082,131.3034,0.9751,8.4131,1.1866,1.137502,0.0084,0.290672,0.0034,0.51,5.777232,0,0,0,0,1.138867,239.01,3.32,1,1.0072,9.305,0.056,0.73,4.229,143.1,6.815,68.97,190.5385,6.87,1.48,74,155.27,0,77,124,54.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
413,18,18,0,2,89.03,185.02,26.09483,2.14,7,0.008228457,0.09894803,1,2,4,7,2936.683,2,2,461.45,43.96,67.02,22.02,19.88,0.002235,8e-4,0.0200022,0,3.62,0.07,4.60405,2.1434,0.001,0,0.231,0.217,0.693,0.656,100.5,191.7,62.8354,0.18,0,0.0018,0.080834,0,0.375,0.429,0.208,0.129,0,0.4091,130.5247,2.7184,12.2694,1.283,1.387008,0,0.480068,0.0011,0,13.876599,6.103326,0.0154,0,0,1.308852,518.63,3.08,0,0.92490000000000006,0,0,36.63,4.238,142,13.688,76.04,96.3663,12.32,2.16,80,185.12,0,77,128,94.15,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
414,46,45,0,3,86.21,175.79,27.61073,2.02,7,0.021361033,0.25597822,1,3,6,7,6447.315,1,1,413.14,42.99,64.04,21.08,24.01,4.59e-4,0.001,0.0157616,0.00602,30.23,0.17,5.37973,2.4164,0.041,0.134,0.089,0.154,0.119,0.027,101.1,95.41,80.3624,0.19,2.1e-4,0.0313,0.120639,0.0098,0.235,0.452,0,0,1.003,0.37516,122.261,2.8039,14.1115,0.4324,0.771377,0.2896,0.295901,0.0813,0.56,2.721198,3.388631,0.7022,0.00237,0,1.286896,303.55,4.09,0,1.1086,15.928,0,28.87,4.39,139.9,8.59,71,537.4602,3.89,2.01,90,173.94,0,101,149,83.03,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
416,77,77,1,2,69.94,160.89,27.34208,1.73,7,0.110274207,1.32437538,0,2,4,7,9373.44,1,1,431.33,33.67,163.44,17.05,26.04,0,0,0.0997366,1e-4,26.98,0,13.55567,2.2208,0.222,0.245,0.391,0.425,1.29,0.747,98,72.69,72.3302,0.01,4e-5,0.0019,0.120296,4e-4,0.842,0.521,0.459,0.282,0,0.40045,142.234,2.9315,11.0808,0.4549,0.903622,0.0661,0.818405,0.0044,0.54,14.394009,4.591823,0,0.00212,0.001,1.209799,312.85,3.89,0,1.0922,11.498,0.0705,28.75,4.268,133.8,22.134,70.95,181.2524,13.67,1.76,90,163.76,0,95,149,71.46,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HH,158VV,N,Y,Y,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
417,74,74,1,3,84.13,162.45,31.03233,1.91,6,0.067109753,0.80454885,1,3,5,6,3985.541,1,1,429.52,37.05,103.31,9.01,24.07,0.00112,0,0.0250953,7.9e-4,24.79,0.084,12.48483,2.291,0.095,0.207,0.081,0.125,0.329,0.731,105,88.75,62.4974,0.21,2e-4,0.0259,0.070018,3e-4,0.255,0.43,0.216,0.356,3.756,0.32699,109.0019,1.9531,0,0.0104,0.480902,0.1924,0.520017,0.0794,0.81,2.819078,4.646951,0.5626,0.00168,0,0.879836,104.3,3.8,0,0.9468,0,0.012,34.28,3.266,141.9,10.491,67.02,190.152,4.1,1.86,75,164.19,0,65,119,84.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
418,49,49,1,2,96.04,210.59,22.37064,2.35,6,0.065742585,0.78821914,0,2,1,6,2608.985,2,2,700.58,37.54,129.41,22.95,19.65,0,0,0.0399217,0.00676,1.64,0.05,0,2.3546,0.083,0.052,0.111,0.09,0.623,0.585,100,114.85,70.6628,0,5e-5,0,0.28464,0.0241,0.418,0.361,0.25,0.191,0,0.47573,169.3648,2.719,13.8463,0.6083,0.848018,0.0111,0.693417,0.0684,0.3,7.005863,5.004031,0.7069,0.00145,0,0,180.24,3.29,0,1.1808,11.976,0,35.46,5.297,137,147.222,75.89,261.0522,7.83,2.45,77,216.46,0.1,98,111,106.48,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
419,74,74,0,2,55.19,160.8,21.60859,1.59,6,0.029163617,0.34959528,0,2,6,6,1938.678,2,2,665.5,44.01,237.26,79.18,111.93,6.5e-4,0,0.0465868,7e-5,24.03,0.089,5.37686,2.3502,0.821,0.533,0.152,0.057,1.822,0.749,98.9,70.34,60.0568,0.11,4e-5,0,0.079442,1e-4,1.301,0.553,0.536,0.239,3.083,0.34576,114.1548,3.8939,12.0067,1.7925,2.143339,0.0032,0.700655,0,0.61,6.507131,0.679051,0.0105,0.00647,0.002,1.343836,204.48,4,1,1.1995,12.328,0.0947,38.21,3.978,136.9,21.092,74.19,148.631,11.75,1.51,71,159.71,0.1,73,111,52.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
421,80,80,0,2,55.28,170.11,19.68092,1.63,6,0.061956181,0.74341929,1,2,2,6,1974.117,1,1,243.68,25.97,66.87,9.77,12.61,0,0,0.0701446,8e-5,21.94,0.122,7.69794,1.8945,0.503,0.429,0.296,0.198,1.559,0.833,102.1,78.87,44.2723,0.03,0,0,0.100434,0,0.907,0.503,0.863,0.548,0,0.33461,118.1217,2.9021,11.8068,0.0036,0.802206,0,0.315154,0,0,5.673425,0,0,0.00344,0,0.877231,385.97,3.6,0,0.9804,0.462,0.079,25.97,4.452,140,6.804,51.39,128.2068,6.7,1.71,77,172.98,0,75,125,56.98,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
422,54,54,1,2,45.29,159.82,17.90364,1.45,6,0.0235801,0.28266415,1,2,2,6,6986.251,2,2,192.59,32.97,61.87,11.51,25.84,0,0,0.0795081,0.00793,29.22,0.319,2.49975,2.3968,0.123,0.145,0.126,0.116,0.794,0.735,104,63.53,86.885,0,7e-5,0.0064,0.390409,0.033,0.489,0.448,0.304,0.371,1.123,0.26066,91.8359,1.1068,10.2963,1.9962,1.033479,0.0094,0.541983,0.0036,17.17,2.74445,0,0,0,0,1.067548,174.23,4.4,0,1.0047,13.733,0,26.36,3.389,137.5,10.232,69.2,196.5818,5.32,1.5,56,161,0,102,108,47.24,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
423,20,20,1,2,74.95,158.74,29.34044,1.75,6,0.048017224,0.5762605,1,2,3,6,6483.436,2,2,269.34,42.07,53.69,26.19,18.09,1.67e-4,0,0.0298117,0.0101,25.69,0.111,0,2.0804,0.32,0.319,0.056,0.059,1.029,0.833,104.4,159.01,61.6775,0.12,1.4e-4,0.0014,0.100498,0.0266,0.523,0.415,0.537,0.518,3.365,0.40571,135.3203,2.524,3.2293,0.7267,1.624571,0.1628,0.429635,0.0098,15.38,3.144638,0.546428,0.0382,0.00237,0,1.227186,188.26,3.99,1,1.0495,13.104,0,40.39,5.065,140.8,12.011,62.42,380.1112,5.62,1.85,73,159.92,0,99,110,71.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,NA,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
424,46,46,1,2,59.08,157.54,24.15082,1.59,7,0.093415041,1.1211869,1,2,3,7,9717.241,1,1,311.54,37.48,55.83,13.05,24.9,0.003621,0.0035,0.030005,4e-5,0,0.089,5.90318,2.1656,0.59,0.588,0.13,0.12,0.542,0.016,101,104.99,61.9904,0,1.3e-4,0.0237,0.249856,9e-4,0.384,0.355,0.148,0.2,0,0.363,130.1361,1.3093,11.5982,1.383,0.632501,0.0052,0.467408,0.0048,0.72,4.548711,0.216059,0.1731,0.00283,0,1.130104,198.54,3.29,0,0.9917,0,0,17.32,4.477,143,2.065,70.05,247.4583,5.68,1.59,66,156.56,0,76,111,60.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
425,78,79,1,4,54.99,167.95,19.53599,1.61,7,0.059995075,0.72050115,1,4,5,7,3207.864,1,1,311.23,31.02,86.01,8.52,17.01,0.024359,0.0049,2.954e-4,0,3.5,0.08,5.63212,2.3512,0.177,0.191,0.039,0.049,0.771,0.714,93.5,51.79,81.2143,0.23,1e-4,0.0084,0.187811,0,0.594,0.474,0.18,0.183,0,0.40266,127.9379,1.8496,10.1811,2.3362,0.890909,0,0.636337,0.0054,0.84,3.228692,5.19966,0.0201,0.00959,0.001,1.445667,230.01,4.28,0,0.9981,13.424,0,23.29,4.493,140.8,11.932,62.15,368.9703,5.57,1.53,77,167.97,0.1,89,104,53.5,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,High,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
426,61,61,0,2,67.88,160.98,25.96939,1.71,7,0.131312805,1.57670819,0,2,3,7,1329.762,1,1,196.28,37.98,171.45,97.34,50.95,0.002933,0.003,2.792e-4,2e-5,27.29,0.128,4.99979,2.327,0.004,0,0.082,0.055,0.419,0.001,104.1,83.18,84.95,0,2.6e-4,0.0271,0.103079,0.0065,0.024,0,0.257,0.244,0,0.3549,122.9588,2.2483,7.7007,1.043,1.198783,0.1518,0.567723,0.0535,29.79,2.444638,2.732842,0.5565,0,0.001,1.088487,105.45,4.54,1,1.1042,10.378,0.0114,23.07,4.284,141.1,11.957,65.98,352.365,4.19,1.63,89,160.91,0,72,141,64.57,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,NA,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,NA,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
427,75,75,0,5,NA,157.22,NA,NA,6,0.065917877,0.79174867,0,5,5,6,5962.01,2,2,488.52,38.57,66.2,20.68,34.34,0.00197,0.0032,0.0501189,0.00219,27.93,0.111,4.09685,2.6202,0.216,0.311,0.177,0.233,0.859,0.859,99.1,83.84,58.2416,0.1,6e-5,0,0.099407,0.0067,0.426,0.471,0.498,0.58,0,0.41637,129.5345,3.1783,14.1193,3.5713,0.630238,0.0083,1.405559,0.0542,0.13,5.684741,3.118691,0.0011,7.4e-4,0.001,1.103788,377.56,4.09,0,1.0744,0,0.0849,31.76,4.827,136.4,8.592,72.05,367.0921,7,1.57,60,157.71,0.1,99,111,62.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),NA,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,NA,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
428,55,55,1,2,73.91,174.74,24.15208,1.87,6,0.0885673,1.06350785,0,2,3,6,7548.397,2,2,782.96,41.93,47.95,28.99,34.69,9.4e-4,0.0017,0.0399584,0.00601,0.64,0.031,11.02943,2.4356,0.303,0.273,0.155,0.106,0.737,0.627,88.4,78.16,82.3189,0.21,0,0.0125,0,7e-4,0.578,0.493,0.204,0.177,3.113,0.37945,130.0024,3.2405,9.7662,1.2106,1.011161,0.0114,0.573957,0.0582,0.4,7.154629,0.094945,0.0227,0.00332,0,1.171272,212.42,4.23,1,0.9578,12.237,0,24.68,3.462,138,10.218,74.15,291.246,9.49,1.81,69,170.88,0.1,65,109,64.22,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
429,56,56,1,1,66.92,172.1,22.82152,1.8,6,0.024829605,0.29788075,0,1,1,6,3054.03,1,1,237.36,36.93,76.84,12.13,16.9,0.001155,0.0025,0.0503625,0.00141,1.2,0.337,2.49956,2.3224,0.521,0.183,0.133,0.042,1.549,0.789,0,94.46,68.6365,0.11,1.6e-4,0.0227,0.256508,0.0158,0.799,0.421,0.616,0.316,0,0.40717,119.1708,2.3507,9.7071,0.8984,2.430919,0.1091,0.749857,0.0046,0.78,6.783693,0,0.0394,0.00158,0,1.298354,417.68,4.99,1,0.9799,13.118,0,28.63,4.107,140.1,5.674,67.33,273.8501,9.76,1.69,60,170.14,0,79,90,60.13,1,0,0,0,1,0,0,1,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
430,54,54,0,1,54.03,157.86,21.55842,1.53,6,0.037161548,0.44638906,0,1,2,6,854.271,2,2,366,28.12,207.08,16.11,44.92,0.001821,0.0032,0.068919,0.00497,25.47,0.14,2.79979,2.3653,0.046,0.008,0.068,0.058,0.743,0.725,0.2,76.38,62.7352,0.17,0,0.0034,0.322908,0.0263,0.489,0.495,0.18,0.201,0,0.28568,93.5461,2.0485,8.2576,0.6498,0.837908,0.0707,0.49839,0.0687,0.42,3.997821,0.224463,0.6307,0.00234,0.001,1.488259,213.98,4.28,0,0.968,11.141,0.0065,29.48,3.111,138.1,4.46,60.77,226.0169,5.67,1.57,79,162.19,0.1,78,130,54.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,NA,NA,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,NA,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
431,73,73,0,2,80.19,180.18,24.25664,1.99,6,0.114424458,1.37573503,1,2,4,6,1481.159,1,1,149.26,43.92,76.81,35.08,20.04,0,0,0.0591495,5e-5,29.11,0.058,10.08431,2.2391,0.426,0.286,0,0,0.486,0.012,109.2,44.61,140.8434,0.45,0,0.0036,0.070007,2e-4,0.233,0,0.141,0.001,1.819,0.44482,144.3999,1.7411,7.2585,0.9999,1.541632,0.0113,0.372116,0.057,0.21,4.16212,0.440378,0.5255,0.00447,0,1.11651,128.7,4.37,0,0.9066,16.056,0.0508,32.55,4.359,143.1,9.661,67.98,457.6078,8.29,1.93,89,177.94,0,61,126,78.14,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
432,73,73,1,2,64.87,158.99,25.84951,1.66,6,0.05495406,0.65917448,1,2,4,6,4521.47,1,1,277.12,43.97,88.01,20.32,36.04,0.002149,0.002,0.0443563,0.00324,25.91,0.199,2.65238,2.4428,0.439,0.247,0.119,0.092,1.035,0.637,0.3,68.07,76.0147,0,0,0,0.668933,0.1037,0.406,0.328,0.501,0.275,2.343,0.45182,153.6893,2.8098,10.8073,1.3768,1.334971,0.3063,0.549921,0.0878,30.2,3.606368,12.138469,0.6694,0.0021,0.001,1.291069,389.37,3.79,0,1.0346,13.948,0.014,25.1,5,131.1,8.583,77.32,603.4007,6.19,1.71,76,157.82,0,81,140,61.95,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
433,59,58,0,5,48.01,155.89,20.17559,1.46,6,0.029727459,0.35713928,0,5,6,6,16478.259,2,2,492.14,40.43,63.4,7.86,9.28,1.18e-4,5e-4,0.0313306,2e-5,26.38,0.075,4.99608,2.7603,0.135,0.007,0.031,0,1.444,0.723,102,82.9,70.8265,0,0,0.0018,0.156511,0,0.67,0.389,0.351,0.117,0,0.39822,122.6452,1.6208,15.7521,0.9024,3.666467,0.0081,0.41017,0,0.69,6.967046,0,0,0.05511,0.001,1.155592,478.75,4.81,0,1.0571,13.607,0,27.31,4.355,143.8,3.482,75.84,257.7931,13.61,1.48,61,153.71,0,86,86,48.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
434,29,29,0,3,76.99,175.01,25.14497,1.91,7,0.036735604,0.44162828,1,3,6,7,6679.56,1,1,528.18,41.56,65.36,21.81,35.64,0,0,0.0592475,0.00296,24.06,0.107,0,2.0799,0,0,0,0,0.058,0.799,100.9,169.6,48.9741,0.06,3e-5,0.0019,0.199893,0.0049,0,0.212,0.253,0.428,5.15,0.37391,135.0407,1.6013,9.0771,0.4544,0.779076,0.199,0.35856,0.0493,0.07,2.594006,4.023692,0.4434,0,0,1.032491,155.17,3.91,0,1.1103,13.106,0,35.89,4.868,137,11.966,66.53,200.0077,4.51,1.85,69,170.1,0,101,119,70,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,Y,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
435,70,70,2,3,49.29,153.79,21.45315,1.45,7,0.0247892,0.29750262,1,3,6,7,15564.481,1,1,5685.3,27.61,45.22,8.05,18.04,0.003364,0.0044,0.0198333,5e-5,2.94,0.246,2.80838,2.4262,0.331,0.214,0.379,0.207,1.462,0.724,101,78.58,49.0943,0.13,0,0.0057,0.080024,9e-4,1.166,0.574,0.365,0.155,3.752,0.23046,75.3363,0,7.0561,0,3.173862,0.049,2.467984,0.08,26.89,6.904488,10.924074,0.5904,0.00384,0.001,1.218305,352.3,3.69,1,0.8519,0.884,0,0,3.457,139,3.621,61.21,278.6299,16.71,1.41,80,152.57,0,96,110,47.12,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
436,64,64,0,3,93.05,181.09,28.81471,2.12,6,0.061678415,0.73978346,0,3,6,6,1251.254,2,2,189.28,28.34,41.64,30.05,18.9,0.003429,0.0024,1.68e-4,6e-5,0,0.101,4.95931,0,0.108,0.183,0.052,0.069,0.495,0.66,104.1,120.24,54.6577,0,5e-5,0,0,0,0.402,0.479,0.126,0.224,0.645,0.36993,125.3631,1.9553,14.3447,0.8956,0.90747,0.004,0.904886,0.0865,0,1.833926,0.186802,0.0079,0,0.001,1.000259,120.66,3.2,0,1.1431,12.918,0.0142,36.39,4.307,136,8.311,69.09,398.02,3.59,2.25,64,178.18,0,75,108,89.3,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
437,59,59,1,2,96.04,174.02,30.5398,2.09,7,0.134122597,1.60869818,2,2,2,7,4544.556,1,1,539.56,34.88,108.28,33.21,28.84,0,0.0018,0.0103788,9e-5,28.05,0.13,4.93871,2.3496,0.164,0.099,0.047,0.035,0.542,0.01,102.2,92.68,91.0537,0.28,0,0,0.051092,2e-4,0.228,0.325,0.104,0,0.413,0.32474,107.5383,1.8737,13.7,2.603,2.033221,0.0661,0.904604,0.0396,26.98,7.093421,4.405696,0.0235,0.00246,0.001,1.157009,254.06,4.71,1,1.0824,11.411,0,0,4.082,138,7.009,65.99,475.0648,12.21,2.16,65,174.04,0,81,113,104.81,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
438,74,74,0,3,63.83,154.94,26.02841,1.62,6,0.175059952,2.10199468,0,3,4,6,5040.194,1,1,383.85,43.03,51.73,15.05,16.87,0,0,0.0644566,0.00502,24.87,0.064,7.85878,2.3679,0.126,0,0.11,0.055,0.831,0.609,101,76.12,59.2036,0,1.5e-4,0.0101,0.040108,6e-4,0.617,0.399,0.191,0.001,0,0.43004,145.3893,2.7422,7.9161,0.6983,1.190537,0.0416,0.149563,0.0407,25.38,3.393246,0.393896,0.3684,0.00753,0.001,1.03554,234.35,3.67,1,0.8765,11.843,0.0171,0,4.908,139,14.803,74.96,280.163,4.61,1.61,80,153.86,0,95,134,59.65,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,High,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
439,61,61,0,4,59.94,160.08,23.41949,1.62,7,0.114531423,1.37640313,2,4,5,7,5655.396,2,2,208.42,30.55,49.15,33.34,29.32,3.67e-4,7e-4,0.0399122,0.00177,27.78,0.034,7.84135,2.1608,0,0.162,0,0.013,0,0.012,91.3,81.54,66.353,0.25,0,6e-4,0.039911,5e-4,0,0.008,0,0.146,0,0.32486,114.5901,1.0055,6.0007,0.7544,0.01471,0.0086,0.19243,0.0047,24.05,4.318649,2.989471,0.0275,0,0,1.480504,308.13,4,1,1.0646,12.28,0,29.45,4.513,135.9,5.606,50.63,220.0045,4.49,1.52,75,158.79,0,94,108,55.99,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,NA,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,NA,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
441,64,65,1,3,80.04,164.97,29.73423,1.87,6,0.072980233,0.87718404,0,3,3,6,9388.459,2,2,463.74,33.02,75.15,26.75,41.36,0.002056,0.0031,3.117e-4,4e-5,28.41,0.106,9.50169,2.2765,0.447,0.22,0.171,0.113,1.933,0.808,103.9,82.66,82.7392,0.07,1e-5,0.0196,0,0,1.037,0.461,0.891,0.429,0,0.37981,124.7234,2.0081,13.1678,1.1223,0.994981,0.0054,0.778868,0.0092,15.37,4.382797,0.039557,0,7.2e-4,0,0.870949,105.88,3.8,0,1.0353,0,0.0018,28.11,4.703,140.1,10.281,75.88,210.4276,6.88,1.92,91,166.08,0,94,140,81.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
442,65,65,1,3,53.89,167.96,19.66684,1.59,7,0.069308307,0.83158844,0,3,4,7,3205.249,2,2,350.76,36.96,314.17,17.98,20,0,0,0.0199634,0.00501,30.91,0.11,0.09479,2.3754,0.002,0.007,0,0,0.082,0.821,101.1,77.92,63.0361,0.39,2.4e-4,0.0965,0.003869,0.0201,0.212,0.487,0.154,0.318,2.449,0.2877,91.9678,2.8722,10.6981,3.5796,0.699475,0.2266,0.794082,0.1312,0.25,1.429422,3.247991,0.7172,0,0,0.033029,139.84,4.7,0,1.0535,12.866,0.0012,29.51,3.812,135.1,12.543,73.99,313.941,2.76,1.55,56,165,0.1,71,124,51.7,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,AUS,Australia,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
443,43,43,1,1,62.47,147.53,29.35585,1.56,7,0.0562364,0.67474143,0,1,6,7,16413.148,2,2,291.77,34.98,61.96,15.06,27.58,0.004021,0.0033,0.0298312,0,25.32,0.001,4.29209,2.2143,0.156,0.092,0.282,0.175,1.41,0.78,100,102.04,61.9534,0,6e-5,0.0121,0.069744,0,0.745,0.446,0.521,0.326,0.549,0.24723,93.7831,0.9271,10.0551,0.9765,1.005678,0,0.591159,0.0012,27.12,6.804559,4.312825,0.4418,0.00247,0,1.263569,147.13,3.01,0,1.0068,11.891,0,0,3.152,131.1,3.361,65.47,100.5601,9.46,1.59,79,145.99,0,70,129,59.54,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
444,60,60,1,4,71.57,169.93,24.9858,1.82,8,0.181932945,2.17954721,2,4,5,8,4889.15,1,1,509.09,41.07,119.89,13.23,13.01,0,0,0.0420263,0,25.93,0.001,4.92788,2.3921,0.186,0.146,0.093,0.079,0.602,0.626,102.1,99.92,65.0304,0.37,0,0.0102,0.580165,0.0028,0.26,0.265,0.277,0.295,1.548,0.28996,107.7965,1.1093,9.8559,1.9895,1.387987,0,0.987964,0,0,4.284417,7.139245,0,0.00373,0.001,1.130042,84.4,3.33,0,0.9969,14.588,0,30.2,3.973,135,5.141,68.97,178.8708,6.21,1.83,80,169.04,0,95,129,69.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
445,68,68,1,3,122.48,181.73,36.94156,2.35,7,0.021241423,0.25466205,0,3,5,7,8427.127,1,1,1553.05,39.05,63.92,24.54,25.82,1.89e-4,0,0.0210704,3e-5,2.06,0.262,3.69587,2.4686,0.295,0.209,0.135,0.091,1.257,0.78,98.1,73.81,107.0137,0,1.3e-4,0.0132,0.1007,0,0.634,0.428,0.522,0.315,1.523,0.42458,145.9715,1.0767,9.4858,0.8273,2.149625,0,0.72914,0,24.48,7.4486,0,0,0,0,0.151477,252.62,3.8,1,1.1136,0,0.0044,0.18,4.971,142.6,8.531,73.99,350.9598,10.06,2.31,74,178.17,0.1,68,139,113.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Other,Y,Y,M,No,OTH,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
446,68,68,2,2,48.95,148.11,22.09142,1.41,6,0.134723857,1.61780035,1,2,4,6,19596.135,1,1,200.53,37.33,84.13,15.09,20.04,0,0,0.0298499,2e-5,22.61,0.108,0.08686,2.3823,0.242,0.194,0.13,0.095,1.929,0.957,104,72.45,65.7981,0.05,0,0,0.110355,5e-4,0.75,0.524,1.133,0.631,1.86,0.35934,107.6691,3.0294,8.9671,0.8951,1.00043,0,0.116407,0,0,1.708597,0,0,0.00193,0,1.22258,136.76,4.19,0,1.0346,0.485,0,29.24,4.295,140,10.86,68.97,61.7511,3.1,1.36,72,149.57,0,79,124,49.11,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,< 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
448,82,82,1,4,82.62,156.09,35.00966,1.83,6,0.046377594,0.55688504,1,4,2,6,3904.423,2,2,383.85,34.85,97.14,75.45,31.44,0.074713,0.0045,0,2e-5,1.98,0.135,7.26837,2.1321,0.002,0,0.06,0.053,0.462,0.66,0.3,74.32,64.3539,0.23,1.3e-4,0.0257,0.061344,0.001,0.243,0.259,0.104,0.18,2.169,0.33198,116.9772,0.4873,6.3124,0.4802,1.131739,0.1888,0.499768,0.0904,0.53,6.391134,6.175457,0.3395,0.00577,0,1.023455,232.65,3.5,0,0.9942,0.666,0.0431,19.36,3.421,138.7,8.401,62.82,148.2352,8.71,1.89,87,155.83,0,81,150,84.19,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
449,84,84,0,5,76.63,163.09,28.59517,1.82,6,0.080711425,0.96825769,1,5,4,6,1626.392,2,2,638.89,33.84,49.51,11,23.17,0,0,2.158e-4,9e-5,28.06,0.08,9.19088,2.1905,0.241,0.221,0.063,0.065,0.511,0.69,100,59.12,61.0076,0.19,0,0,0.070005,4e-4,0.426,0.449,0.142,0.179,0.826,0.2623,87.5909,0.8135,9.3068,0.5019,0.894741,0,0.680499,0,0.48,4.409512,1.648157,0,0,0,1.173878,223.16,4.48,0,0.9081,0,0.0757,22.43,3.417,140,5.118,65.47,231.9954,5.21,1.8,77,162.97,0.1,94,136,76.83,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HH,158FF,N,Y,N,N,Low-Intermediate,High,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
450,68,68,0,2,56.91,156.18,22.94305,1.56,6,0.114845862,1.37918234,2,2,3,6,3202.166,2,2,257.34,35.1,88.79,11.92,25.03,0,0,0.0298775,1e-5,33.02,0,4.97837,4.7614,0.138,0.155,0.026,0.033,0.039,0,93.1,70.54,68.0046,0.4,0,0,0.235995,0,0.117,0.153,0.007,0,1.021,0.28805,87.8546,0.9967,8.3309,1.2589,0.600065,0,0.172715,0,0.88,3.222173,0.508581,0.0032,0.00532,0.001,1.057681,533.83,5,0,0.9624,0.531,0,0.38,2.928,144.1,8.578,68.95,271.4252,4.58,1.57,61,156.65,0.1,98,116,59.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
451,67,68,0,4,65.01,172.83,21.79927,1.78,6,0.024422028,0.2929954,1,4,2,6,3776.359,1,1,384.41,33.12,55.97,13,17.15,0.23665,0.0027,0.0881871,0.00487,26.45,0.002,3.21297,2.2553,0.172,0.252,0,0.001,0.016,0.453,103.1,79.73,70.9185,0,2e-4,0.0085,0.188665,7e-4,0.224,0.395,0,0.002,0,0.39896,133.0012,1.4246,0.1133,0.3986,0.514938,0.0051,0.35699,0.0056,0,3.998352,0.012029,0,0.0012,0,1.167427,304.2,4.01,1,0.9303,13.883,0.0089,38.69,4.666,137,10.513,59.84,267.2562,5.07,1.78,95,171.85,0,94,167,65.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,AUS,Australia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
452,56,56,0,2,92.45,186.73,26.14375,2.21,6,0.021577922,0.25912783,1,2,1,6,6779.208,1,1,674.47,35.45,63.5,26.73,21,0.001777,0.0011,0.0504484,0.01002,0,0.152,4.68191,2.5238,0.173,0.128,0.081,0.057,0.765,0.603,96.1,60.34,141.5914,0.4,1.6e-4,0.0109,0.10998,0.025,0.375,0.326,0.277,0.202,4.289,0.38743,128.9161,0,7.2878,0,1.460151,0.2541,0.799791,0.0605,0,14.84395,16.609883,0.645,4.8e-4,0,0,400.11,4.31,0,0.9318,0,0.0733,22.27,3.944,139,14.095,75,206.9545,16.12,2.08,56,185.02,0,63,119,88.25,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
454,69,69,1,2,62.97,166.99,22.91934,1.7,6,0.087801509,1.05314777,0,2,1,6,5480.846,2,2,441.14,35.07,71.88,17.8,25.19,0,9e-4,0.0998558,0.01006,28.95,0,3.99929,2.4027,0.193,0.14,0.2,0.112,1.049,0.728,93.2,60.34,90.1954,0.01,0,0.0126,0.095317,0.0444,0.667,0.497,0.284,0.166,0.187,0.34679,116.0254,0.0025,0.0176,0.7115,1.867414,0.341,0.687425,0.1093,27.67,6.433082,0.456218,0.0288,0,0.001,1.004273,167.46,4.2,0,1.0002,0,0,26.1,3.571,136.4,8.206,62.17,364.3903,9.29,1.78,61,173,0,91,116,72.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,< 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
455,75,75,1,4,92.29,174.97,29.16912,2.07,7,0.021988762,0.26393623,1,4,1,7,1383.963,1,1,548.59,42.08,384.25,54.86,38.65,0.003696,0.0046,0.060429,9.6e-4,24.92,0.081,12.92701,2.3262,0.015,0.001,0.02,0.001,0.861,0.647,106.8,37.54,192.6598,0.1,0,0,0.885221,0.041,0.349,0.27,0.315,0.207,2.556,0.34118,116.0071,2.789,10.5775,1.4638,2.915379,0.2676,1.049947,0.0932,24.28,7.303162,8.04579,0.6304,0.00227,0.001,1.111254,348.65,4.11,1,1.1044,0.401,0.0893,29,3.463,139.9,5.107,69.95,208.7797,11.97,1.96,80,175.06,0,90,142,93.81,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,Yes,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,NA,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
456,71,71,1,4,76.06,171.95,25.42928,1.89,8,0.102658685,1.22971254,2,4,6,8,12100.502,2,2,236.27,0,83.43,59.82,20.92,0.001497,0.0013,4.51e-5,0,22.28,0.001,7.04579,2.0963,0.675,0.219,3.937,0.58,2.567,0.623,97,51.95,104.6667,0,0,0,0,0,1.574,0.441,0.983,0.206,0.327,0.37064,113.9977,1.5012,9.2353,0.4442,3.144056,0,5.990728,0.0022,0.18,7.33626,0,0,0,0,0,205.44,3.4,1,1.297,11.201,0,26.01,3.994,139,5.04,64.32,274.1287,14.78,1.81,90,170.08,0.1,84,140,72.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,NA,158VF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
457,75,75,0,2,64.51,177.95,20.9752,1.8,6,0.108744866,1.30429787,2,2,2,6,5175.238,1,1,175.13,40.99,68.85,29.01,23.94,0,0.001,5.01e-5,6e-5,26.93,0.346,12.98449,2.2133,0.196,0.085,0.118,0.042,1.691,0.699,105,55.04,97.0834,0,0,0,0.300655,0.0222,0.667,0.199,0.727,0.306,0.525,0.44566,154.1184,0,11.3906,0.4603,2.667916,0.1788,0.498431,0.0392,0,1.425306,2.579329,0.041,0.00346,0.001,0.969263,120.25,4.6,0,0.4964,7.729,0,31.89,4.743,143,20.203,70.04,563.7664,4.39,1.78,74,175.9,0,55,125,62.52,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
458,38,37,0,2,81.95,171.55,28.33121,1.96,6,0.048926152,0.5873995,1,2,6,6,3623.683,2,2,377.7,44.91,70.61,16.89,23.85,0,0,0.0400138,7e-5,24.41,0.084,0,2.2997,0.181,0.154,0.072,0.058,0.945,0.807,101.1,86.78,97.1344,0,0,0,0.120312,0,0.578,0.413,0.487,0.354,2.189,0.40957,136.0559,0.3972,8.1763,0.4195,1.649727,0,0.761249,0.0013,0,4.435713,0,0,0,0,1.000655,207.41,3.7,0,1.0728,12.345,0,37.99,5.254,141.1,8.542,71.03,330.5186,6.99,1.91,79,169.98,0,91,111,78.83,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
459,48,48,1,4,70.92,171.97,24.05875,1.83,6,0.041332401,0.49567878,1,4,4,6,10086.607,1,1,739.63,47.04,123.97,12.93,16.91,0.001427,5e-4,0.0498035,0.00332,1.32,0.108,5.71273,2.349,0.205,0.134,0.188,0.14,1.181,0.786,97.1,85.87,83.0675,0.11,3e-5,0.0052,0.009826,2e-4,0.617,0.44,0.521,0.384,4.159,0.28034,98.2866,1.2099,0.0175,0.9448,1.060885,0.0061,0.299746,0.0309,0,9.11317,3.991718,0.6556,0,0,1.130069,226.02,4.81,0,1.1069,0.961,0.0164,0,3.306,144,7.999,70.06,249.7678,9.61,1.8,71,170.15,0.1,79,121,68.97,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
460,58,58,0,2,51.45,156.56,20.85986,1.5,6,0.041769543,0.50088571,0,2,2,6,4971.324,2,2,455.42,42.88,80.47,7.87,15.36,0,0,0,0.01007,27.18,0.156,6.31307,2.225,0.224,0.156,0.142,0.079,0.841,0.66,101.6,81.93,73.7091,0,2.1e-4,0.0042,0.200013,0.049,0.396,0.187,0.341,0.294,1.415,0.32613,109.2487,1.7065,12.2958,1.5776,1.957152,0.2609,0.449576,0.0893,0.6,2.989025,3.209581,0.6403,0.0034,0,1.517269,274.36,4,0,1.0547,13.541,0,33.43,4.427,139,8.587,71.86,211.8072,5.01,1.65,70,162.2,0,85,112,56.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
461,55,55,1,2,83.56,170.65,29.07256,1.96,7,0.073244297,0.87980614,1,2,2,7,7470.483,1,1,237.19,40.44,63.74,18.12,21.95,7.98e-4,0.001,0.0102718,0,29.97,0.089,5.70185,2.0591,0.242,0.18,0.133,0.099,0.773,0.554,96.1,98.49,72.3225,0,0,0.0046,0.22002,0,0.686,0.513,0.118,0,4.067,0.29606,96.975,4.5035,11.9367,1.2584,1.84684,0,0.739774,0.002,0.6,2.702293,3.062208,0.0179,6.1e-4,0,2.310321,289.95,4.49,0,1.0614,10.599,0.0376,23.67,3.271,136,11.008,72,273.1669,4.7,1.91,69,168.05,0,84,115,82,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
462,29,29,0,4,59.37,182.59,18.50468,1.76,6,0.035071125,0.42052392,1,4,4,6,5502.814,1,1,167.84,41.03,113.08,14.72,21.02,5.86e-4,0,0.0099696,0,30.1,0.168,4.71156,2.3244,0.355,0.356,0.117,0.098,0.728,0.588,99.3,107.9,72.5068,0,4e-5,0.0124,0.100022,7e-4,0.417,0.334,0.285,0.243,0.212,0.38633,127.9982,3.5335,11.7869,0.7987,0.699436,0.0135,0.818367,0.0039,0.13,5.4937,3.073436,0.0158,0,0,1.21545,197.56,3.88,0,0.9953,10.336,0,25.4,4.481,135.9,10.269,73.39,264.3326,6.69,1.65,78,180.49,0,77,107,59.12,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
463,64,64,0,2,112.05,175.33,38.76077,2.3,7,0.095386266,1.14440911,0,2,2,7,1394.302,1,1,606.79,43.09,50.37,9.7,15.69,0.002298,0.0019,0.10085,0.00407,30.09,0.053,3.90107,2.2247,0.807,0.49,0.137,0.093,1.209,0.707,0.2,100.59,79.3988,0,0,0.0064,1.204235,0.0425,0.706,0.39,0.5,0.341,2.453,0.39904,136.451,0.9119,8.635,1.7822,1.573624,0.1199,0.712728,0.0816,0.53,3.410384,5.089003,0.5758,9.9e-4,0.001,1.275312,148.11,4,1,0.8611,0.249,0,0,4.235,139.1,25.985,59.08,439.4341,5.94,2.19,89,174.74,0,101,171,109.78,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
464,70,70,1,3,106.35,181.75,32.29344,2.25,6,0.055216919,0.66225419,0,3,3,6,11376.215,1,1,931.29,42.95,81.2,13.85,22.08,0,0,0.1416883,0.0069,25.99,0.108,4.30051,2.4442,0.326,0.141,0.09,0.043,1.059,0.74,96.9,69.62,99.0085,0.37,0,0,0.27003,0.006,0.477,0.323,0.545,0.308,0,0.39894,143.9138,3.0953,13.4278,1.9941,2.435469,0.0793,1.927293,0.0822,0.14,8.320066,1.961046,0.0382,0,0,0,211.75,3.9,0,1.0066,12.046,0,36.6,4.498,136.1,8.667,73.95,261.7879,11.28,2.21,70,180.2,0,67,108,105.32,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
466,24,24,0,2,73.14,165.17,26.22454,1.83,7,0.08982868,1.07737594,0,2,5,7,3416.755,2,2,191.52,37.39,280.56,24.93,17.98,0.00108,8e-4,0.039958,0,24.66,0.069,4.77656,2.3622,0.201,0.16,0.16,0.152,1.171,0.844,101,124.64,71.8493,0.21,4e-5,0.0157,0.299919,4e-4,0.841,0.599,0.335,0.25,0,0.35374,110.2935,1.2795,9.4572,0.7502,0.882289,0.0043,0.611563,0,0.12,3.511342,0,0,0.00228,0,1.452402,343.12,4.1,0,1.05,9.789,0,26.05,4.201,141.1,14.399,72.9,445.2989,6.51,1.77,60,164.99,0,93,120,73.92,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
467,71,71,0,4,80.41,170.16,27.49974,1.93,7,0.087107161,1.04405358,0,4,1,7,6449.924,2,2,738.68,39.07,464.57,28.95,67.89,0.003529,0.004,4.01e-5,0,24.54,0.099,8.90486,2.5265,0.051,0.056,0.084,0.065,1.101,0.751,93.9,58,97.0727,0.22,1.6e-4,0.0174,0.090065,3e-4,0.503,0.279,0.417,0.32,4.949,0.3999,125.1419,1.4703,7.1128,0.6446,1.389522,0.0135,0.464725,0.0022,29.97,3.235931,2.732742,0.0019,0.00284,0,0.940249,144.01,4.5,0,1.1084,0.914,0,0,4.236,138.9,15.809,74.17,303.5251,6.29,1.93,60,173.71,0,68,116,80.26,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,<LLN,N,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
468,60,60,0,1,72.92,168.02,25.44342,1.83,7,0.08643667,1.03735711,1,1,1,7,1408.62,2,2,237.28,44.08,74.8,9.93,13.97,0,0,0.0539428,0,31.05,0.067,7.17431,2.361,0,0,0.133,0.097,0.589,0.006,100.9,82.6,87.6104,0.22,2.2e-4,0.0282,0.010114,0,0.267,0,0.163,0.001,0,0.4309,150.7825,0.0064,6.3848,0.5881,1.512725,0,0.449693,0,21.95,8.857084,0.693607,0.0234,0.00278,0,0.940136,283.88,3.43,0,0.9987,11.995,2e-4,28.09,5.06,139,8.023,71.09,169.0986,10.36,1.87,96,170.11,0,78,147,78.91,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,POSITIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
469,28,28,0,3,50.09,157.23,19.47955,1.48,7,0.10411658,1.25120734,2,3,6,7,3949.037,1,1,430.39,34.07,394.61,12.17,17.16,0.00113,6e-4,0.0099338,0,26.82,0.229,3.55427,2.3676,0.171,0.131,0.114,0.087,0.831,0.654,103.9,153.43,41.2766,0.32,0,0.0272,0.090489,0,0.402,0.35,0.39,0.305,3.855,0.29019,98.0563,1.9026,12.0815,0.7181,0.994969,0.0019,0.172909,0,32.84,4.702503,0,0,2.1e-4,0,1.590568,267.53,3.9,0,1.0985,11.002,0.0348,0,4.188,138,9.207,68.01,362.4808,6.36,1.55,65,155.85,0,91,106,51.46,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,N,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
470,51,51,1,2,65.06,157.99,25.96829,1.67,6,0.022146563,0.26571381,1,2,2,6,1684.862,2,2,197.8,34,70.19,57.62,36.06,0,0,0.0290371,0,26.92,0.1,3.93721,1.9897,0,0,0.077,0.111,0.293,0.658,99,145.46,50.0154,0,0,0,0.069287,0,0.225,0.428,0.008,0.132,1.755,0.36833,124.0507,1.8431,0,0.3724,0.540118,0,0.451466,0,0.66,11.897694,0.380951,0,0,0,1.139884,386.09,3.69,0,1.1016,0,0.0268,31.1,4.094,140.3,4.024,3.71,255.9313,10.9,1.74,80,158.4,0,101,135,66.59,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
471,24,24,0,3,NA,174.97,NA,NA,6,0.122764989,1.47253239,1,3,6,6,3876.029,1,1,1023.03,38.93,75.19,36.19,28.9,0.003086,0.0014,0,0,2.54,0.049,8.20505,2.2732,0.108,0.088,0.149,0.09,0.831,0.678,103.1,211.04,50.9293,0,0,0,0.100694,5e-4,0.491,0.431,0.281,0.194,0,0.35241,117.9722,0.0112,0.1085,1.9923,1.301086,0.0044,1.090718,0.0024,0.59,5.491128,3.508656,0.0064,0,0,1.299707,82.79,3.1,0,1.0235,0.672,0,24.45,3.944,143.1,6.082,61.97,308.5575,8.08,2.03,80,176.15,0.1,104,114,90.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,NA,Low-Intermediate,Elevated,N,Yes,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
472,81,81,1,3,71.79,170.92,24.22091,1.85,7,0.105374938,1.26598613,1,3,1,7,2991.126,1,1,428.23,37.03,278.82,17.08,25.03,0.361963,0.0093,0.0597891,0,28.02,0.079,7.48269,2.2078,0.433,0.223,0.081,0.057,1.015,0.601,101,58.35,87.3616,0.03,6e-5,0.0026,0.049754,0,0.687,0.494,0.262,0.001,2.994,0.4028,122.4694,1.9383,10.9153,0.5018,2.869968,0.0114,1.247465,0.0031,0.59,3.570181,0.421775,0.03,0.00163,0,1.097963,269.92,4.91,0,1.2052,14.644,0.026,35.71,4.676,140.7,13.688,49.35,285.4248,8.92,1.88,79,170.02,0,70,102,74.92,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
473,48,48,0,2,64.82,162.71,24.68846,1.69,6,0.027715517,0.33272298,0,2,2,6,3236.694,1,1,397.2,44,89.2,10.25,13.73,0.021269,0.0049,0.0202066,9e-5,1.61,0.095,6.87204,2.4834,0.186,0.092,0.041,0.017,0.194,0,106.9,97.08,70.7904,0.16,1.1e-4,0.0173,0.141258,8e-4,0.15,0.003,0.107,0.001,2.551,0.38649,118.7288,4.1641,13.3455,1.5845,1.059459,0.0131,0.248965,0.0055,0.73,3.805796,3.783419,0.005,0.18286,0.001,1.27247,161.52,5.12,0,0.9387,12.931,0,26.93,4.304,140.7,6.987,70.07,382.1485,6.24,1.66,71,162.4,0,73,131,62.95,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,NA,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,NA,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
474,57,57,1,2,69.95,179.07,22.58493,1.9,6,0.041061271,0.49302795,1,2,5,6,12027.732,2,2,371.17,29,78.31,25.9,51.74,5.1e-5,9e-4,0.0401365,0,25.9,0.168,11.95121,2.1728,0.368,0.369,0.15,0.094,1.231,0.832,102,75.83,89.3538,0,0,0,0.135716,0,0.968,0.645,0.311,0.256,2.239,0.32799,111.0027,2.222,8.8227,0.6113,0.515492,0,0.929637,0.0018,0.51,6.050341,0.619592,0.0301,0.00156,0,1.176179,207.58,3.8,0,0.9942,9.451,0,23.46,3.836,134.6,5.127,50.98,233.9691,7.19,1.9,86,178.72,0,66,149,70.33,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
475,49,49,0,1,58.99,162.95,22.53659,1.63,7,0.130076145,1.56172612,1,1,3,7,393.41,1,1,292.8,41.56,101.55,26.96,21.92,0.002753,0.0035,0.0189444,0.00229,30.99,0.14,9.29823,2.3995,0.281,0.176,0.15,0.107,0.881,0.399,105,100.43,69.4693,0,0,0,0.08928,3e-4,0.456,0.224,0.354,0.184,0,0.4321,153.0352,2.3032,14.5401,0.8559,1.403433,0.1499,0.360319,0.033,38.81,2.898314,3.561985,0.7209,0.00383,0.001,1.22777,110.26,3.88,0,1.143,0.867,0.0481,0,5.691,143.8,22.911,73.61,975.7611,5.72,1.79,73,162.71,0,83,109,62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
476,45,44,0,1,79.87,175.07,26.13558,1.94,6,0.026664042,0.31956023,0,1,1,6,1537.145,1,1,144.12,43.94,46.94,67.65,23.98,0,0,0.0769632,0.00502,25.48,0.084,0,2.3747,0.673,0.253,15.199,0.919,3.048,0.86,100,115.26,68.0652,0,0,0.0055,0.018871,0.001,2.118,0.568,1.296,0.519,4.353,0.41375,137.2658,1.4181,0.0743,0.7809,2.219874,0.01,0.599398,0.0022,0.02,7.127704,0,0.0267,0,0,0.356757,322.75,4.19,0,0.9558,0,0,0,4.257,140.9,10.261,51.79,161.8719,10.36,1.84,101,176.32,0,65,120,80.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
477,34,34,0,1,42.29,149.25,19.02014,1.34,8,0.164754316,1.97800364,1,1,5,8,14717.973,2,2,336.86,34.01,74.66,10.45,21.97,0,0,0.062236,0.00216,27.49,0.119,0,2.2712,0.001,0.001,0.028,0.036,0.472,0.632,0.4,157.62,34.2902,0.09,0,0.0049,0.100005,0.007,0.078,0.213,0.252,0.233,0,0.37779,122.2156,2.1874,10.5253,1.6198,0.999886,0.0013,0.500788,0,0,6.909523,3.395191,0,8.9e-4,0,1.140958,311.23,2.65,0,1.0411,0.312,0,37.97,3.987,141.9,2.079,68.49,260.3878,8.39,1.41,80,147.99,0,83,140,43.69,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
478,62,62,1,1,69.83,163.09,26.19239,1.75,6,0.026641023,0.31918059,1,1,5,6,10626.585,1,1,335.77,39.02,53.07,14.92,16.81,0.002159,0.0011,0.0488536,0.00344,22.61,0.05,3.9018,2.3917,0.171,0.23,0.044,0.053,0.643,0.659,100,71.71,93.1566,0.53,0,0.019,0.153276,0.0049,0.449,0.445,0.19,0.193,0.899,0.40098,137.3395,0.0096,4.0843,1.8177,0.902031,0.0062,0.598379,0.0589,28.2,5.099723,6.051645,0.5929,0,0,1.040299,259.02,4.5,1,0.9801,12.291,0,0.36,4.416,141,6.883,62.28,289.9939,6.7,1.84,91,163.52,0,71,150,67.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
479,64,63,2,4,125.7,179.14,40.21765,2.33,6,0.009438066,0.1131496,0,4,4,6,32959.205,1,1,915.88,42.55,120.07,15.04,24.2,0.001371,0,0.0361706,9e-5,0,0.172,0.1069,2.363,0.24,0.21,0.027,0.044,0.541,0.792,96.1,98.58,74.8582,0.55,0,0.0067,0.381598,5e-4,0.404,0.489,0.233,0.334,0,0.36805,118.9042,0.0061,0,0.4014,0.928285,0.0601,0.398998,0.0028,0.26,1.796901,2.8134,0.0122,0,0,1.167739,227.74,4.1,1,0.9846,11.648,0,29.1,4.354,140.1,39.691,58.07,309.7825,3.69,2.19,65,177.87,0.1,95,148,109.63,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
480,48,48,0,1,69.82,167.96,24.77597,1.8,8,0.166036712,1.99079296,0,1,3,8,3207.115,2,2,277.08,47.08,240.44,59.95,50.47,0,0,0.0296531,3e-5,26.49,0,3.89107,2.2519,0.018,0.002,0.23,0.209,0.696,0.579,102.9,122.33,56.5162,0.07,0,0.0111,0.101357,0.0103,0.387,0.238,0.252,0.225,0,0.31378,113.1587,2.657,12.9878,1.1412,0.858182,0.1428,0.459807,0.0681,0,4.208908,4.3479,0.6544,0,0,1.259358,222.06,3.89,1,0.9713,12.207,0,30.87,3.386,141,7.729,77.52,200.0461,6.78,1.69,65,166.09,0,78,114,66.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
481,65,65,0,5,44.87,153.79,19.12647,1.39,7,0.025715647,0.30875903,1,5,3,7,307.96,2,2,249.07,27.95,93.18,21.07,24.78,0.002867,0.0041,0.0399379,4e-5,27,0.276,6.01939,2.1867,0.005,0.077,0.027,0.077,0.015,0.658,102.1,51.82,78.4173,0.35,0,0,0.336757,0.0098,0.122,0.404,0,0.14,3.009,0.4223,137.7293,0,6.8944,0.4479,0.313847,0.0026,0.259863,0.0057,0,2.410329,4.025713,0.0105,0,0,1.05135,250.89,4.1,0,1.0585,10.305,0.0578,39.22,4.468,137,6.744,59.17,405.0934,3.68,1.41,59,152.07,0.1,110,112,43.29,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,High,Q1 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,N,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
482,64,64,0,2,83.46,174.71,27.5365,2,7,0.039329867,0.47150949,1,2,1,7,414.586,2,2,1393.74,40.06,283.06,101.46,233.13,0.001891,0.0025,0.1101754,0.00505,28.97,0.061,4.74608,2.3973,0.035,0.03,0.048,0.051,0.295,0.019,0.2,102.13,61.001,0.45,2.7e-4,0.0167,0.059993,0.0198,0.318,0.366,0,0,1.046,0.38723,131.4837,3.7989,9.7733,0.568,1.538161,0.2297,0.523436,0.0865,0,6.360966,5.201789,0.6725,0.00518,0.002,1.272064,257.6,3.7,0,1.0998000000000001,13.29,0.023,27.46,4.045,141,10.298,66.99,327.1059,10.98,2,96,172.99,0,91,139,80,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
483,55,55,1,1,44.1,165.01,16.42272,1.44,6,0.048381341,0.5812199,1,1,2,6,3825.575,1,1,552.23,33.7,97.92,24.92,30.83,0.003701,0.0033,0.0298463,4e-5,27.91,0.208,6.28575,2.1269,0.096,0.057,0.316,0.236,1.364,0.851,97.8,67.32,80.2646,0.4,0,0.0137,0.073377,8e-4,0.873,0.538,0.389,0.253,0,0.27496,91.391,2.1042,11.4952,1.1807,2.267331,0.2308,0.396882,0.0056,0.17,4.400177,0.56913,0,0.00489,0.001,1.223875,314.98,3.91,0,1.0224,0.238,0.0379,29.87,2.933,139.9,6.745,64.02,72.6364,6.47,1.44,79,165.08,0,75,121,41.51,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
484,26,26,0,2,51.26,178.17,16.55206,1.62,6,0.017998684,0.21576248,2,2,3,6,6296.016,1,1,218.49,39.98,48.05,22.07,16.89,0.002183,0.0019,0.0200324,0.01005,28.82,0.2,0.10258,2.2288,0.2,0.122,0.019,0.016,0.508,0.495,104.9,132.67,48.6317,0.1,2.4e-4,0.0132,0,6e-4,0.032,0,0.335,0.274,1.145,0.45321,147.744,1.6058,12.6562,1.8367,2.17299,0.2603,0.666396,0.1386,0.26,3.631193,2.728373,0.0348,0.0059,0.001,1.389433,219.35,4.2,0,1.1024,14.456,0,34.88,5.084,141.8,9.032,69.91,302.6483,6.99,1.56,60,174.74,0,58,108,45.79,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
485,65,65,1,3,56.62,160.11,22.46809,1.59,6,0.118317602,1.41976562,1,3,2,6,7297.781,1,1,163.81,31.09,44.17,17.9,18.98,0,0,0.0401245,5e-5,22.61,0.068,0.0033,2.3198,0.209,0.128,0.029,0.006,0.611,0.401,103,66.44,76.8321,0.51,5e-5,0.0283,0.031462,0,0.257,0,0.211,0.089,0,0.36871,114.5861,0.014,0.0063,0.4338,2.791768,0.0136,0.400473,0.001,0.12,1.54373,0,0,0,0,1.020023,398.26,4.91,0,0.9322,0.542,0,31.94,4.36,139,6.012,55.76,368.3322,3.97,1.56,66,159.96,0.1,80,129,54.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
486,74,74,1,1,59.95,153.18,25.35611,1.59,6,0.098587781,1.18218334,0,1,1,6,1888.365,1,1,166.41,33.75,582.48,65.87,50.42,0.002492,0.0025,1.526e-4,0.00607,28.98,0.114,4.4097,2.3013,0,0,0.016,0.028,0.044,0,105.8,80.52,61.8778,0.49,0,0.0261,0.299692,0.0438,0.021,0,0.001,0,0,0.45565,151.9328,0,0.0463,0.0085,1.179001,0.2677,0.449615,0.0804,0,5.269727,5.62036,0.5759,0,0,1.310279,278.04,4.1,0,0.8747,0,0.003,23.53,5.237,138.1,9.53,67.91,293.9976,7.45,1.52,79,152.07,0,68,112,59,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NORMAL,UNKNOWN,Stage I-II and Extranodal Involvement,No,1,1,131RR,158FF,Y,Y,Y,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
487,65,65,1,4,65.06,163.92,24.65378,1.72,7,0.013006935,0.15616281,1,4,6,7,16676.313,1,1,909,30.99,104.22,18,34.19,0,0,1.19e-5,0.00505,28.53,0.101,5.51289,2.0364,0.086,0.247,0.055,0.094,0.348,0.749,98.1,51.43,108.0878,0.42,3e-5,0.0054,0.100126,8e-4,0.017,0.363,0.208,0.358,2.037,0.28015,80.5364,0.7514,9.618,1.0508,0.441045,0.1054,0.398712,0.0652,0.73,3.895208,5.42125,0.7364,0,0,1.518663,243.16,4.9,1,1.0387,14.264,0,29.31,3.303,139,5.032,58.9,305.7821,4.41,1.67,59,163.96,0,86,106,60,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
488,61,61,0,3,52.93,152.07,23.02248,1.48,6,0.01723755,0.20669833,0,3,1,6,298.596,2,2,121.57,42.04,95.69,11.92,13.75,0.001554,0.0024,0.0099468,0,32.08,0.155,9.98979,2.3594,0.214,0.152,0,0,0.87,0.697,108.7,71.9,76.9743,0.24,1.4e-4,0.0109,0.099731,0,0.584,0.475,0.284,0.154,0,0.47801,158.5264,2.101,8.9535,1.8524,5.977248,0.0136,0.292,0,6.1,6.995597,0,0.007,0,0,1.35909,474.12,5.22,1,0,11.19,0,0.82,4.83,144.7,8.54,62.37,353.1838,9.97,1.46,68,150.27,0,78,119,48.92,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
489,78,78,1,3,106.26,175.03,34.58214,2.22,6,0.100525894,1.2060499,2,3,6,6,19297.094,1,1,313.04,23.9,214.98,28.94,25.18,0.004231,0.0039,0.0117129,7e-5,0.96,0.08,3.56158,2.1055,0.268,0.247,0.032,0.023,0.728,0.648,101.3,94.91,61.825,0.22,0,0,0.09976,0.0141,0.417,0.331,0.221,0.239,3.61,0.38857,117.8419,2.2439,9.4053,0.0041,1.30735,0.0127,0.810874,0.0759,28.21,6.620666,0.058956,0.0037,0.09945,0.002,0.937356,262.28,4.7,0,1.0978,13.341,0,24.09,4.23,135.8,16.192,62.25,327.1232,9.2,2.04,69,170.12,0.1,76,117,97.05,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,NA,1-3,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VV,Y,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,NA,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
490,44,44,0,3,66.96,173.4,22.49033,1.78,6,0.135025532,1.62054227,1,3,3,6,3306.313,1,1,244.66,32.08,170.23,19.12,15.56,0.001345,3e-4,0.0498095,0.00315,24.1,0.001,6.00323,2.3261,0.105,0.097,0.101,0.098,0.591,0.657,101,79.89,91.426,0.12,1.3e-4,0.0074,0.19905,7e-4,0.405,0.352,0.195,0.21,0,0.32145,107.9324,0.0082,9.191,2.5811,1.080308,0.0848,0.934775,0.0628,0,12.900612,3.984153,0.6737,4e-5,0,1.349659,405.42,4.62,1,1.156,11.468,0.0157,32.07,4.19,134.8,5.029,55.62,307.3294,15.09,1.91,76,172.07,0,95,109,66.84,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
493,45,45,1,3,80.15,173.93,26.27153,1.94,6,0.148393603,1.78048113,1,3,4,6,5826.273,2,2,909.2,37.44,93.64,18.94,27.1,9.41e-4,0.0017,0,0,30.99,0.001,5.34362,2.377,0.195,0.245,0.104,0.055,1.386,0.865,103,73.04,98.725,0.38,0,0.0203,0.039342,0,1.262,0.631,0.318,0.316,0,0.39321,140.2239,2.4788,9.4336,0.5678,0.648134,0.0998,0.530168,0.0054,32.15,7.504482,6.045026,0.451,0.00345,0.001,1.083677,220.31,4.01,1,0.9317,0,0.006,23.42,4.374,137,3.986,67.01,480.1037,7.3,1.92,69,171.93,0.1,102,129,75.51,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,2-3,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
494,68,68,0,2,60.52,151.85,25.99935,1.6,7,NA,NA,1,2,4,7,713.299,1,1,348.1,42.09,80.73,21.06,19.94,0.003323,0.002,0,0,24.62,0.101,4.70164,2.5247,0.228,0.128,0.206,0.094,2.014,0.793,95,85.61,69.9556,0,4e-5,0.0201,0.077595,0,1.308,0.548,0.622,0.245,0,0.33803,125.1833,1.7152,10.2016,1.1101,1.498764,0.1326,0.446407,0.0081,0.17,7.356974,5.092247,0.6301,0.0018600000000000001,0,1.080385,474.34,4.29,0,0.8544,0,0.0359,0,3.791,137.9,11,72,440.5525,10.47,1.56,79,150.23,0,93,119,64.44,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,NA,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,Y
495,26,26,0,1,55.17,169.98,19.25392,1.62,6,0.039806087,0.47814315,1,1,4,6,6097.587,2,2,333.51,28.84,174.04,36.7,88.07,0,0,0.029896,0,24.98,0.199,3.10121,2.3112,0.036,0.096,0.044,0.057,0.291,0.637,97.1,121.58,61.8504,0,0,0,0.178589,3e-4,0.004,0.005,0.196,0.301,0,0.24283,74.6266,5.0797,18.9406,1.0873,0.547983,0,1.186859,0.0786,0.17,7.55729,2.796825,0.0082,0.00117,0,1.194156,520.87,3.71,1,1.69,17.317,0,30.49,2.561,136,7.301,74.01,181.6316,9.81,1.61,69,167.99,0,102,0,51.57,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
496,31,31,0,2,89.81,167.94,31.6553,1.99,6,0.04394439,0.52710896,1,2,5,6,520.091,1,1,397.99,42.09,70.95,9.76,21.93,0,0,0.1095674,0.00609,28.45,0.079,4.39554,2.5766,0.205,0.164,0.062,0.057,0.542,0.567,97.1,138.5,53.951,0.13,1.9e-4,0.0269,0.339017,0.0176,0.017,0,0.435,0.412,0,0.39854,139.0451,1.8231,11.3776,0.6466,1.847394,0.1205,0.791234,0.06,0,4.859879,0.098049,0.0246,0,0.001,1.244641,296.97,0,1,0.9898,0,0.0407,30.71,4.494,139.5,6.94,70.97,392.6944,7.81,2.09,88,168.86,0,92,135,94.13,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
497,64,64,0,1,58.8,154.99,24.45278,1.58,8,0.152302622,1.82410931,0,1,2,8,3171.911,2,2,439.52,36.95,80.72,28.06,20.03,0,0,0.0101359,0.00116,0.99,0,27.64712,2.3831,0.688,0.525,0.107,0.113,0.861,0.718,104,45.99,129.8784,0,6e-5,0,0.060777,4e-4,0.449,0.373,0.472,0.385,0,0.38993,133.907,1.5274,9.3663,0.9608,0.400114,0.001,0.308797,0,0.48,4.501327,6.419493,0.5106,0,0,1.047596,264.45,3.91,0,1.0014,0.546,0.0478,31.95,5.203,140.7,5.074,76.06,368.8851,5.27,1.6,90,153.22,0,63,146,61.63,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,>= 75,II,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
498,67,67,1,3,70.12,165.02,25.1282,1.78,6,0.089211358,1.06972837,1,3,1,6,2001.729,2,2,625.37,43.05,53.44,5.71,11.65,6.1e-5,0,0,0,23.98,0.255,10.17358,2.3265,0.296,0.267,0.066,0.042,0.912,0.799,101.4,71.28,87.6391,0,7e-5,0.0015,0.058622,1e-4,0.553,0.461,0.257,0.247,0,0.46329,150.1858,0,4.4602,0.0029,1.281555,0.2031,0.570391,0.0884,0.88,2.947448,4.374173,0.0396,4.6e-4,0,1.191637,30.48,4.59,0,1.0413,13.493,0.0037,28.78,4.72,144.9,21.941,68.98,607.9575,5.01,1.7,68,163.89,0,74,109,67.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,NA,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
499,63,63,0,3,76.04,160.67,29.79488,1.77,7,0.021324504,0.25603034,1,3,3,7,3020.39,2,2,260.21,37.04,180.51,20.78,35.2,0,0,0.0118314,3e-5,24.63,0.161,6.41736,2.3419,0.078,0.07,0.118,0.106,0.847,0.728,108.1,84.42,64.7221,0,0,0,0.221518,0,0.376,0.36,0.472,0.375,0,0.36576,112.844,1.5248,9.8939,0.7487,1.324439,0.0062,0.599502,0.0038,17.19,2.816138,0,0.0111,0,0,1.065838,329.46,4.21,0,1.0144,11.486,8e-4,31.21,4.536,138,6.867,68.03,237.9236,5.09,1.84,80,163.97,0,79,152,79.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,>1,131RR,158VF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
500,60,60,0,2,62.99,167.8,22.21203,1.69,6,0.140085284,1.6818963,0,2,6,6,2639.343,1,1,114.52,34.26,31.15,8.88,0,0.002462,0.0029,2.647e-4,0,27,0.122,6.80077,2.3202,0.08,0.002,0.05,0.035,1.152,0.807,106.9,67.58,92.9267,0,1e-5,0.002,0.370242,6e-4,0.608,0.443,0.5,0.386,0,0.42956,138.836,2.0449,7.4483,0.0115,1.600607,0.0781,0.569878,0.058,0.15,2.561661,0,0,0.00297,0,1.019564,274.14,3.66,0,0.8241,0,0.0749,0,4.841,143.9,11.985,69.9,457.9985,4.6,1.71,84,171.12,0,76,109,64.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
501,48,48,0,2,78,172.96,25.88748,1.92,6,0.019659887,0.2359225,0,2,3,6,184.654,2,2,788.48,41.09,94.71,179.2,71.47,0,0,0,8e-5,26.64,0,5.29736,2.2752,0.161,0.127,0.013,0.001,0.875,0.841,94.3,115.43,68.9987,0.05,4e-5,0.0113,0.308266,0.0201,0.349,0.388,0.426,0.417,2.335,0.39598,130.3908,0.4172,7.2801,0,0.918201,0.1496,0.3806,0.0864,0.42,5.167593,3.349492,0.656,0,0,1.257667,376.79,4.37,1,1.2969,12.232,0.0302,24.26,4.399,142,4.438,69.92,303.1855,5.69,1.92,58,174.03,0,85,111,78.17,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
502,31,31,1,0,56.02,164.07,20.90276,1.61,7,0.043535494,0.52260658,1,0,6,7,11906.327,1,1,339.54,39.09,62.73,25.89,27.03,0.001778,0.0021,1.054e-4,0,23.4,0.231,5.54367,2.3011,0.066,0.147,0.005,0.027,0.731,0.829,0,126.85,52.0016,0.36,5e-5,0.0269,0,0,0.418,0.507,0.309,0.333,0.541,0.33736,115.9418,1.7591,13.2001,1.9973,0.999754,0.0086,0.459092,0.0134,0,3.603039,0.727271,0.0202,0.00335,0,1.09216,149.01,3.61,2,0.9903,12.112,0.0086,36.03,4.131,138,5.011,63.99,309.3128,6.31,1.66,79,161.94,0,80,109,55.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
503,69,69,1,0,79.99,163.01,29.06657,1.88,6,0.0855377,1.02561292,1,0,1,6,1596.233,2,2,119.16,44,106.74,30.18,21.03,0.004219,0.0045,9.98e-5,0.00293,31.31,0.218,10.90127,2.4431,0.004,0.041,0,0,0,0,104.1,116.56,56.5176,0,4e-5,0,0.171264,0.036,0,0,0,0,1.732,0.43386,144.9336,3.0072,11.0858,0.6336,1.011193,0.3683,0.323395,0.1346,0,3.129826,5.103222,0.7299,0,0,0.93917,166.86,4.1,1,1.0163,13.591,0.0423,34.24,4.45,144,9.006,68.69,630.4373,4.88,1.9,86,163.97,0,41,139,85.96,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
504,82,82,0,4,59.08,164.95,21.65069,1.65,6,0.01482618,0.17788655,1,4,5,6,1365.238,2,2,351.26,38.96,39.03,10.98,16.85,0,0,0.0200028,3e-5,25.17,0.1,4.60306,1.9588,0.47,0.296,0.114,0.074,1.402,0.751,102.2,57.49,63.9614,0.31,0,0,0.099513,5e-4,0.768,0.38,0.511,0.297,1.68,0.34752,112.1921,3.634,18.314,1.8414,1.098204,0.0063,0.574,0.0395,0.31,1.242983,0,0,0.00698,0.001,1.32156,87.08,4.3,0,1.077,12.771,0,28.65,3.602,140,12.82,74.93,294.5881,3.09,1.71,71,166.46,0,67,119,61.63,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158VV,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
505,74,74,2,3,98.98,171,32.28336,2.1,7,0.104880563,1.25974689,0,3,2,7,33433.382,1,1,687.43,42.93,48.6,19.75,19.05,0,0,0.1299562,0.00401,0,0.089,3.70138,2.4783,0.108,0.181,0,0,0.148,0.706,93,83.11,69.0207,0,7e-5,0,0.421669,0.0022,0.241,0.424,0.009,0.283,0,0.40971,128.9254,1.2704,0.0593,0.0074,0.574763,0,0.858978,0.0027,32.98,8.247686,0.298529,1e-4,0,0,0,434.58,3.34,0,0.8946,0,0.0366,21.44,4.496,138,4.974,64.21,113.7205,9,1.96,78,169.96,0,66,128,93.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
506,80,80,1,4,76,180.26,23.57328,1.95,7,0.051342468,0.6159971,1,4,6,7,19023.045,2,2,307.62,38.89,53.13,15.1,15.6,7.7e-5,0,0.0198318,0,29.05,0.108,15.19369,2.403,0.229,0.237,0.043,0.044,0.366,0.569,96.1,53.16,92.7811,0.05,6e-5,0.0092,0.089532,0,0.247,0.403,0.049,0.117,1.929,0.3681,124.1067,0.4091,9.0793,1.1236,0.312461,0,0.399701,1e-4,27.66,2.786983,0.347674,0,0.00444,0,1.229412,144.28,4.1,0,1.0901,11.889,0.0459,22.96,3.939,140.1,6.973,64.96,395.7325,4.5,2,84,182.24,0,97,148,74.81,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,Y,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,N,Y,N,WHITE,Other,Y,Y,M,No,OTH,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
507,65,65,0,3,80.54,178,25.00942,2.01,8,0.083844518,1.00647702,1,3,3,8,2800.802,1,1,181.81,40.97,51.55,12.91,18.01,0.003187,0.0013,0.0676704,8e-5,30.98,0,5.61421,2.4975,0.396,0.227,0.083,0.036,1.259,0.787,98.1,46.03,117.5499,0.19,0,0.0056,0.939506,0.0299,0.561,0.309,0.636,0.386,0,0.45017,158.6176,1.5053,0.1138,0,1.465353,0.2084,0.333371,0,33.06,5.195544,3.975137,0.0386,0.00149,0.001,1.249325,274.79,3.5,0,0.9392,0,0,0.29,4.591,133.1,11.624,73.92,279.662,8.51,2.04,84,177.94,0,88,147,82.58,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,IV,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
508,57,56,0,1,63.52,169.85,22.59136,1.72,6,0.092891691,1.11451807,0,1,1,6,2223.165,2,2,144.6,48.01,136.44,30.94,17.65,0,0,0.0276336,0,23.94,0.002,0.02666,2.36,0.111,0.061,0.149,0.096,0.848,0.717,103.1,111.93,52.1085,0.28,3e-5,0,0.039865,0,0.551,0.437,0.253,0.237,0,0.44067,154.1732,2.9957,12.1981,1.2884,2.540333,0.0013,0.499975,0,0,3.778238,0.510413,0,0.00228,0,0.646139,252.36,4.6,0,0.9943,0,0,29.52,4.481,144.7,10.806,85.64,100.3876,6.1,1.84,69,170.05,0,82,116,65.89,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
509,73,73,0,2,41.17,143.87,20.06469,1.25,6,0.078250343,0.93905354,0,2,3,6,1066.905,2,2,1132.53,40.03,50.45,8.04,17.92,0.002437,0.0019,0.010169,0.00297,30.94,0.097,4.41399,2.6381,0.532,0.42,0.151,0.106,1.197,0.789,98,54.08,63.9392,0.18,0,0.0043,0.050458,0.0098,0.948,0.561,0.355,0.308,0,0.34903,120.1053,0.9526,11.2935,3.2104,1.311161,0.1497,0.258499,0.0092,27.29,3.829652,5.431632,0.656,0,0,1.057216,116.59,4.71,0,1.0184,13.073,0.0168,28.85,4.035,138,11.949,73.06,280.8705,5.5,0.6,60,113.76,0.1,104,128,41.14,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
510,41,41,1,3,39.84,170.14,12.01921,1.41,8,0.094409987,1.13312943,2,3,5,8,3942.522,1,1,790.7,33.13,90.29,50.11,64.37,0,0,0.0998786,0.00275,23.94,0.031,7.87943,0.7054,0.156,0.119,0.171,0.175,0.701,0.699,99.1,101.15,53.5824,0.42,1.2e-4,0.0156,0.01027,0,0.449,0.41,0.264,0.199,0,0.34015,112.7566,2.0417,11.004,0.9455,0.60375,0.0055,1.209917,0.0602,0,4.896633,1.739361,0.5596,0.00309,0,1.130066,252.64,3.8,0,1.0901,10.002,0.0469,29.61,4.269,141.9,10.976,71.02,243.6459,7.81,1.41,69,172.45,0,61,99,41.15,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
511,55,55,0,2,93.08,168.4,33.01315,2.01,6,0.121751059,1.45995127,0,2,3,6,4149.172,2,1,175.58,44.03,63.67,39.01,23.35,0,5e-4,0.0300127,4e-5,28.51,0.152,3.93142,2.373,0.069,0,0.054,0.04,0.452,0,101,86.96,79.4613,0.35,0,0.0039,0.169989,0,0.117,0,0.263,0.183,2.28,0.43162,148.3589,1.2807,10.8161,0.7802,2.500447,0.0116,0.702988,0.0019,24.06,4.902345,7.100079,0.5927,0.00237,0,1.322609,332.79,4,0,0.9207,11.474,0,26.01,4.741,141,6.494,79.01,136.3348,7.45,2.03,69,169.8,0,76,133,87.85,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,N,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
512,35,35,1,2,59.58,160.11,23.33066,1.62,6,0.107946939,1.29603142,2,2,1,6,1230.831,2,2,203.57,33.15,124.41,23.34,16,0.003016,0.0014,0.0300146,7e-5,28,0.107,2.46687,2.1284,0,0,0,0.001,0,0,95,315.92,32.1469,0.4,1.3e-4,0.0169,0.029555,0.001,0,0,0,0.002,1.037,0.37938,120.5913,1.3926,6.8082,0.4008,2.412386,0.2251,0.530524,0.0519,0.68,10.590934,4.286781,0.0168,0,0,1.227321,304.12,4.09,0,1.0898,11.893,0.0045,34.01,4.596,137.1,5.989,65.29,255.0695,12.3,1.62,72,158.89,0,110,100,59.93,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
513,49,50,1,4,56.39,158.16,22.43436,1.57,7,0.059666343,0.71607168,1,4,5,7,10629.781,1,1,896.7,39.05,69.06,14.06,51.69,0.002672,0.0019,0.0066962,9.2e-4,3.57,0.121,4.88866,2.1168,0.217,0.258,0.043,0.107,0.016,0.016,99.9,81.13,76.9437,0.12,0,5e-4,0.140309,0.024,0.023,0.31,0.001,0.002,0.828,0.37622,127.9873,2.8379,10.192,0.4501,0.525476,0.1509,0.228484,0.0708,0.09,2.067364,0,0.0333,0,0,0.779591,120.87,4.01,1,0.9919,0.303,0.033,30.06,4.127,140.1,9.053,64.07,303.2186,3.27,1.62,82,159.95,0.1,79,129,58.52,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,Yes,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,N,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
514,74,74,0,4,72.59,158.09,28.20954,1.75,6,NA,NA,1,4,4,6,3233.13,1,1,795.38,38.03,205.26,53.21,232.67,0,0,0.0250655,0,0,0.134,5.70167,2.3768,0.005,0.087,0.021,0.056,0.271,0.725,97.5,57.16,88.7105,0.02,0,0,0.059974,0,0.005,0.239,0.264,0.375,3.911,0.37678,115.4689,2.386,10.9897,1.8015,1.123267,0.0072,0.769946,0.004,0.64,6.733931,0,0,0,0,0,529.77,3.52,0,1.1617,0.547,0.0186,28.6,4.131,136.1,15.31,72.92,255.2738,9.85,1.7,52,160.07,0,70,104,75.03,1,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,NA,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
515,59,59,0,3,63.16,170.02,22.06968,1.74,6,0.05653529,0.67814563,0,3,2,6,1156.74,2,2,358.59,38.95,50.12,7.88,13.92,0.001725,5e-4,0.0298745,1e-5,22.96,0.151,4.88195,2.0498,0.189,0.253,0.08,0.135,0.016,0,103.9,91.73,66.8265,0,1.4e-4,0.0204,0.139365,7e-4,0.006,0,0.008,0.115,2.524,0.34541,108.3875,0.7466,0,0.5385,0.991993,0.0067,1.033449,0.003,0,6.571202,0.029834,0.0068,7.7e-4,0,1.062023,244.41,4.19,0,0.9964,12.504,0.0605,31.99,4.174,142.1,6.836,71.49,220.0548,8.7,1.78,66,170.95,0,75,120,66.84,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
516,63,63,0,1,56.94,162.05,21.74022,1.6,6,0.029146542,0.34962738,0,1,4,6,316.256,2,2,197.36,34.97,94.03,18.35,22.94,0.001296,0,0.0890704,2e-5,22.15,0.109,6.3135,2.3202,0,0.045,0.019,0.044,0.054,0.702,104,68.72,81.3748,0.16,2.1e-4,0.0016,0.006813,0,0.014,0.222,0.224,0.387,0.048,0.34193,114.4634,1.0138,9.217,1.4864,1.090097,0,0.371599,0,0.43,7.960736,0,0,1.5e-4,0,0.991038,208.68,4.19,1,0.9691,11.975,0.04,32.36,3.217,140,6.129,62.28,155.0155,9.6,1.62,80,164.04,0,77,118,58.82,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
517,58,58,0,2,57.81,158.02,23.06278,1.59,7,0.119789659,1.43924805,2,2,2,7,5897.093,2,2,282.69,34.26,113.81,18.69,23.95,6.75e-4,0,0.0995142,0.00192,27.03,0.002,4.27431,2.3209,0.17,0.192,0.018,0.04,0.245,0.485,102.9,87.64,75.9439,0,9e-5,0,0.089027,0.0159,0.007,0.001,0.106,0.162,2.41,0.4096,137.3904,0.7677,3.7491,0,1.372133,0.1234,0.792448,0.0052,0.46,7.965611,4.887851,0.0351,0.00511,0,0.927569,203.75,3.59,1,0.9853,9.015,0.0416,0.32,4.238,139,10.272,69.04,395.1633,11.99,1.65,65,158.9,0,89,131,60.2,0,0,0,0,0,0,0,0,1,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158VF,Y,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
518,64,65,0,2,61,163,22.91335,1.65,6,0.029360004,0.35168582,1,2,5,6,1387.193,1,1,550.14,38.07,75.27,23.97,49.42,4.32e-4,0,0.0431029,0,23.94,0.078,3.43971,2.3187,0.163,0.126,0.077,0.049,1.001,0.84,95,61.62,73.373,0,2.4e-4,0,0.294534,1e-4,0.651,0.497,0.355,0.276,0.688,0.3614,120.4409,1.2705,0,1.2345,1.22887,0,0.600923,0.0023,0.21,4.531608,0,0,0.00253,0.001,1.164382,400.54,4.68,1,1.0453,0.955,0.022,40.34,3.505,134.4,7.058,56.91,0.2107,6.87,1.66,79,166.99,0,98,112,61.55,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
519,71,72,1,4,85.15,177.92,26.71161,2.04,6,0.109514133,1.31386956,0,4,1,6,9414.924,2,2,188.78,38.06,71.66,18.08,21.93,6.7e-5,0.0012,2.2e-6,8e-5,21.94,0.1,3.89668,2.1112,0,0,0.001,0.012,0,0,99.1,67.62,80.3021,0,1e-5,0,0.09963,9e-4,0,0,0,0,0,0.33965,117.5044,1.3576,0.1202,0.5833,0.800517,0.1801,0.040434,0,0,1.607908,0,0,0.0017,0.001,0,83.8,3.9,0,0.997,9.904,0.0154,26.89,4.246,137.1,7.375,57.95,267.8901,2.11,2.05,77,178.11,0,76,117,85.8,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,2,>1,131HH,NA,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
520,69,69,1,2,65.04,159.99,24.78137,1.66,7,0.087017264,1.04412541,2,2,2,7,10306.921,1,1,207.8,39.92,83.33,9.02,20.99,0.00429,0.0043,0.0400391,2e-5,0,0.104,6.60012,2.442,0.033,0.075,0.088,0.079,0.49,0.533,103.1,72.33,70.726,0,0,0,0.037963,0,0.269,0.333,0.12,0.197,0.477,0.3316,114.274,3.2941,11.8012,1.2721,0.924529,0.0138,0.80041,0.0494,22.1,7.299223,4.073928,0.0169,0.00514,0,1.068034,273.99,4.22,0,1.1348,13.669,0,19.8,3.705,139.1,16.103,69.63,184.7167,9.69,1.67,57,158.94,0,64,95,60.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HR,158VV,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
521,65,64,1,1,63.05,164.22,22.93897,1.68,6,0.059817734,0.71778148,2,1,2,6,6449.336,2,2,276.35,25.88,30.03,16.12,15.97,0,0.0012,0.022814,0.00358,25.01,0,8.33365,2.1722,0,0.065,0.019,0.08,0.139,0.801,93.8,94.72,66.0953,0.34,0,0.0112,0.020439,8e-4,0.011,0.385,0.187,0.408,5.09,0.36338,120.6893,1.5869,0.0155,1.0697,0.301537,0.0012,0.770418,0.1118,0.34,5.80513,1.833916,0.0409,0.00819,0,1.064512,179.74,3.3,0,1.0912,11.079,0.0143,26.1,4.354,138.9,5.808,64.05,342.8774,6.31,1.65,59,164.65,0,48,91,62.16,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
522,68,69,1,3,50.97,162.87,19.36845,1.54,7,0.080557351,0.9672189,2,3,6,7,15712.165,2,2,1088.55,39.02,130.19,33.1,19.91,6.04e-4,8e-4,0.0300135,8e-5,28.15,0,0.02906,2.5785,0,0.074,0.007,0.045,0.505,0.775,0,88.46,53.9724,0,0,0,0.010026,0,0.198,0.315,0.224,0.295,0,0.36233,106.2468,1.1029,4.9761,0.287,0.62969,0,2.464683,0.0736,0.33,11.89856,5.703473,0.0344,0,0,1.193779,242.09,3.13,1,1.2056,0,0.0201,26.65,4.88,139,10.948,72.93,269.4524,11.12,1.48,80,163.1,0.5,102,139,53.08,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
523,61,61,0,2,79.21,182.71,24.22089,2,6,0.072318366,0.86952228,0,2,3,6,3900.628,1,1,201.19,43.03,77.08,16.06,25.97,0.003581,0.0033,0.0198598,1e-5,3.83,0.089,4.999,2.2386,0.319,0.416,0.038,0.068,0.5,0.711,103,106.83,61.9493,0.11,0,0,0.090007,0,0.268,0.444,0.127,0.199,0,0.41725,140.977,2.8647,12.4383,0.6462,0.990565,7e-4,0.526307,5e-4,0.74,3.364889,0.490722,0.0178,0,0,1.197192,350.67,3.52,0,0.977,0.662,0.0682,0.9,4.616,138,7.317,71.02,286.8703,4.85,1.87,88,182.91,0,96,149,72.83,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
525,68,68,0,2,52.44,153.17,22.4029,1.48,7,0.081497135,0.97839603,1,2,3,7,2483.073,1,1,187.04,28.92,136.28,18.83,13.77,8.64e-4,6e-4,0,0,28.08,0.03,7.84222,2.2091,0.122,0.162,0.001,0.001,0.471,0.711,102.2,59,79.7801,0.22,1.1e-4,0.0077,0.070013,0,0.329,0.417,0.1,0.177,2.214,0.31243,102.5643,2.1812,16.4986,0.6776,0.443397,0,0.349406,0,0,4.196033,0,0,0.0072,0.001,1.34389,420.47,4.67,0,1.0452,11.638,0.0245,34.82,4.188,139,5,62.58,214.1202,5.23,1.49,70,154.46,0,84,120,53.41,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
526,74,74,0,5,62.06,165.09,22.48164,1.7,6,0.050925189,0.61163322,1,5,1,6,1124.011,1,1,356.09,42.64,154.81,18.22,24.16,0,3e-4,0.0198665,2e-5,0.75,0.149,5.90095,2.3022,0.38,0.202,0.139,0.088,0.998,0.56,95.3,43.21,111.8638,0.16,1.5e-4,0.0134,0.100679,4e-4,0.724,0.391,0.255,0.002,0,0.49156,159.1995,3.3746,11.0184,2.3623,1.680313,0.006,0.441025,0.0045,0,7.303046,0,0.0352,0.0014,0,1.226477,244.52,4.97,0,1.0094,12.387,0,34.07,5.783,137.9,8.576,63.59,224.2094,9.1,1.74,69,163.03,0,74,122,60.48,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
527,66,66,1,0,61.07,168.05,22.26597,1.69,7,0.082248472,0.98690784,1,0,5,7,2130.386,1,1,314.84,35.02,395.56,22.98,25.95,0.003187,0.0037,1.84e-5,6e-5,29.91,0,0,2.3911,0,0,0.001,0.004,0.228,0.554,101.2,97.88,53.9539,0.32,1.8e-4,0.0199,0.159979,0.0172,0.177,0.327,0.054,0,0,0.40554,129.5126,1.5405,9.3378,1.4925,0.802395,0.1925,0.475753,0.0438,0.48,4.901785,5.541173,0.656,0.00131,0.001,0,279.63,3.5,1,1.0099,0.76,0.0125,1.02,4.723,140.1,10.611,68.7,267.2154,8,1.73,61,167,0,79,106,62.47,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
528,20,20,1,2,63.07,180.27,19.47634,1.8,7,0.030857495,0.37061746,1,2,2,7,2811.26,1,1,571.52,38.64,106.36,63.01,35.98,0.001791,0.0012,0,3e-5,28.13,0.091,3.92869,2.3758,0.003,0.069,0.026,0.061,0.428,0.759,100.9,152.5,51.5628,0,2e-5,1e-4,0.002189,9e-4,0.14,0.321,0.245,0.378,0,0.33334,114.1065,1.2232,12.1944,0.6598,0.621687,0.1911,0.201214,0.0037,0.29,3.079634,0.504653,0.6098,0,0,1.174234,153.99,4.09,0,1.1266,0,0.0721,33.3,3.993,138,6,65.99,297.0603,3.95,1.7,90,178.18,0,100,117,61.01,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
529,68,68,2,2,81.97,183.51,24.37426,2.07,6,NA,NA,0,2,6,6,14316.201,2,2,340.89,33.96,99.39,23.22,24,0,0,2.056e-4,5e-5,26.34,0.002,6.7824,2.35,0.359,0.289,0.115,0.115,0.868,0.792,100,73.99,79.4191,0.08,0,0.0206,0,6e-4,0.489,0.495,0.334,0.364,1.392,0.39817,126.63720000000001,3.3019,9.5382,0.5012,1.260121,0.1799,0.295726,0,0,3.005933,0,0.0191,0.00401,0,1.157281,150.08,4.81,0,1.0616,11.012,0.0173,1.11,4.11,139,12.105,70.06,326.904,4.4,1.92,78,183.96,0,80,121,84.4,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,NA,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
530,61,61,0,2,84.17,182.84,25.60381,2.07,6,0.094949009,1.14086334,0,2,4,6,778.713,1,1,198.43,37.95,108.09,29.33,29.02,0.039328,0.0046,0.0103659,0.0084,22.69,0.068,5.37665,2.8018,0.589,0.382,0.27,0.136,1.493,0.735,108,51.76,155.5487,0.05,8e-5,0,0.300422,0.1282,0.856,0.488,0.622,0.345,3.73,0.36217,129.0798,3.3333,10.3892,0.3883,1.296447,0.3242,0.410162,0.1293,36.65,5.409885,3.271199,0.6633,0,0.001,0.933438,417.76,4.51,1,0.9782,11.796,0.0012,0,4.048,135.2,5.19,76.02,438.9935,7.34,2.16,94,183.83,0,77,150,85.89,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
531,57,57,1,1,80.58,167.69,29.0942,1.92,6,0.057828673,0.69365493,0,1,6,6,13500.181,1,1,276.32,39.03,69.03,16.82,18.67,0.121656,0.0033,0.0400655,6e-5,21.01,0.16,4.41164,2.3704,0.834,0.31,0.152,0.085,3.585,0.861,100.9,136.72,51.0668,0.06,6e-5,0,0.175848,0.001,2.261,0.576,1.266,0.414,0,0.38954,137.5849,4.273,13.9555,1.2533,1.544449,0.0083,1.589436,0.0732,0.47,5.502718,6.189897,0.683,0.00578,0.001,0.938373,439.76,3.7,1,1.1082,0.831,0.0299,32.5,4.849,139,21.019,72.92,371.1993,8.81,1.98,75,165,0,79,120,79.41,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
532,59,59,0,2,59.19,168.04,21.0823,1.67,7,0.15879599,1.90378015,2,2,3,7,6811.06,2,2,687.74,32.91,99.28,27.66,183.1,0,0,0.0195182,0.01007,32.01,0.002,9.29177,2.4025,0.415,0.256,0.335,0.199,1.572,0.867,103.9,82.26,70.7323,0.1,1e-5,0,0.200389,0.0449,1.147,0.644,0.544,0.384,4.506,0.39034,127.9999,2.5138,12.8373,1.8525,1.171625,0.2106,0.669491,0.1237,12.86,2.628026,0.636628,0.0299,0.00538,0.001,1.461749,278.97,4.51,0,1.1392,13.464,0.0206,32.95,4.377,139.9,21.175,71.08,931.2241,4.4,1.69,71,165.65,0.1,77,118,60.21,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
533,19,20,1,1,74.86,174.81,24.38767,1.91,7,0.040987253,0.49136235,1,1,4,7,6476.336,2,2,204.63,42.93,69.03,22.01,13.84,0,0,0.0204032,0,0,0.04,2.70151,2.3007,0.117,0.092,0.058,0.04,0.643,0.556,0,122.28,71.1716,0.06,0,0,0.046321,0,0.482,0.465,0.126,0.001,0,0.37551,126.1941,3.4423,13.6072,3.6622,1.025815,0,0.961544,2e-4,0,13.996126,0,0,0.00195,0,1.191555,452.06,3.99,0,1.0851,10.751,0,38.41,4.5,140.8,5.47,66.95,260.6022,12.47,1.91,89,174.08,0,78,116,75.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
534,39,39,1,2,69.93,161.87,26.24077,1.75,6,0.022807597,0.27327473,1,2,5,6,5438.781,2,2,283.52,31,75.5,32.35,29.37,6.78e-4,7e-4,0,0,30.07,0.198,3.41715,1.1323,0.387,0.251,3.251,0.653,2.662,0.879,100,158.84,50.1034,0.21,0,0.0247,0.015039,0,1.608,0.579,0.95,0.427,1.425,0.22673,75.8306,1.2622,3.8862,1.5171,1.209343,0,1.09596,0,0,5.725198,0,0,0.00382,0.001,0.171706,137.31,4,0,1.2311,13.323,0.0213,29.82,1.448,139,8.566,49.54,362.0719,9.15,1.71,56,161.67,0,71,108,68.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
535,73,73,0,3,87.16,166.99,31.63205,1.98,6,0.097348881,1.1670844,0,3,3,6,743.727,1,1,268.15,39.99,114.39,45.55,36.83,7.16e-4,8e-4,0.0498957,7e-5,21.92,0.146,3.70041,2.177,0.322,0.396,0.096,0.073,0.859,0.744,102.2,111.56,53.0507,0.03,0,0.0018,0.099507,7e-4,0.713,0.565,0.243,0.23,0,0.38732,131.8238,4.9316,13.225,0.5581,1.476507,0.0085,0.575266,0.0042,0,3.403246,5.427662,0.0416,0.00469,0,0.759719,258.81,4.4,0,1.2458,11.976,0.0605,34.45,4.549,141.1,8.912,71.02,244.3954,6.4,1.92,83,166.96,0,66,154,89.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HR,158VF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
536,74,74,1,5,57.04,158.77,22.82863,1.57,7,0.04178875,0.50129839,1,5,4,7,5048.769,1,1,2425.79,20.67,64.17,7.11,16.13,1.76e-4,6e-4,0.0501029,0.00201,25.06,0.111,11.2587,2.1771,0.087,0.124,0.018,0.045,0.37,0.672,98,52.72,79.9809,0.22,2.7e-4,0.021,0.099797,8e-4,0.373,0.405,0.009,0.166,1.803,0.10377,64.3237,0.014,0.0325,0.984,1.290659,0.1559,0.865423,0.0501,0.76,4.974797,3.208748,0.6974,0.00238,0,0.890405,226.75,3.11,0,0.9522,14.627,0.0192,28.28,0.566,137.1,6.063,0,315.1979,8,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
537,34,34,1,1,43.28,148.74,19.2716,1.34,7,0.07176792,0.86057876,2,1,2,7,3750.649,1,1,378.61,44.06,93.23,18.05,18,3.46e-4,9e-4,0.0102254,0.00497,2.11,0.248,4.55041,2.4663,0.118,0.06,0.137,0.113,0.907,0.771,103,167.88,35.4161,0,2e-4,0,0.009846,0.0295,0.75,0.537,0.208,0.19,1.671,0.3546,118.6057,2.5428,10.5173,0.0087,0.994484,0.2361,0.443057,0.1001,0,1.990166,3.145241,0.6239,3.1e-4,0,1.259788,217.09,4.38,1,0.8675,9.824,0,27.16,4.57,143,5.491,68.53,243.2526,3.6,1.35,60,149.01,0,87,122,47.55,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
538,73,73,0,2,51.15,154.92,21.56304,1.47,6,0.095226375,1.14318431,1,2,2,6,1733.604,1,1,177.3,38.84,89.97,10.34,14.08,0,1e-4,0.0502403,9.7e-4,26.92,0.117,3.60098,2.378,0.221,0.08,0.062,0.026,1.003,0.781,101,69.58,60.1383,0,1.7e-4,0.0192,0.109851,4e-4,0.714,0.557,0.236,0.173,0.669,0.3954,127.9158,5.1174,14.4615,2.1409,2.140466,0,0.410085,0,12.38,5.10905,0.42481,0.01,0.00164,0,1.036278,368.8,3.55,1,1.0115,0,0,24.85,4.559,141.1,3.845,76.98,231.5539,8.17,1.49,80,155.84,0,74,109,50.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,NA,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
540,69,68,0,2,68.96,169.91,23.87463,1.81,7,0.051827743,0.62193266,1,2,4,7,160.624,2,2,300.35,27.74,85.05,20.97,29.64,0.001721,0.002,0.0299961,0.00175,27.93,0.125,3.93624,2.3629,0.043,0.003,0,0,0.672,0.665,89.1,84.1,70.892,0,0,0.001,0.156798,8e-4,0.361,0.328,0.133,0,0.726,0.32196,105.0944,3.5847,21.06,1.2787,2.509787,0.0122,0.809829,0.0033,17.04,5.916174,0,0,0.00518,0,1.224853,241.19,3.39,0,1.0543,12.194,0.0273,25.52,4.321,139,11.998,73,125.8284,10.6,1.85,74,169.87,0,92,119,75.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,>= 60,>= 65,< 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,Y,Y,Y,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
541,40,40,1,2,64.08,168.06,22.37528,1.72,6,0.035345955,0.42417524,0,2,2,6,553.837,1,1,361.74,40.38,66.06,7.9,11.06,3.21e-4,5e-4,0.0596677,6e-5,30.18,0.13,2.38711,2.2292,0.164,0.145,0.017,0.017,0.455,0.588,93.1,115.56,59.6277,0.33,1.9e-4,0.0229,0.317093,8e-4,0.255,0.32,0.175,0.27,2.28,0.34168,121.9539,1.6884,15.1954,2.4362,1.361697,0.0079,0.757684,0.0557,0.33,4.21277,0.58251,0.0387,0.00173,0,1.255679,154.59,4.39,0,0.9025,12.468,0.0259,24.98,3.691,142,4.245,66.82,285.036,6.14,1.63,69,167.15,0,51,120,61.64,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
542,58,58,1,1,89.74,187.68,25.55937,2.15,6,0.037887393,0.4548272,0,1,3,6,3231.822,2,2,190.97,45.08,18.87,23.89,14.98,0,0,0.0185111,0.00321,25.88,0.091,3.25258,2.2586,0.129,0.095,0.027,0.036,0.831,0.878,99,106.56,67.1173,0,1.9e-4,0.0134,0.019866,4e-4,0.332,0.45,0.466,0.511,3.104,0.45267,155.707,2.4892,7.9059,0.2671,1.143028,0.006,0.561173,0.0419,0,3.209539,0,0.0113,0,0,0.721754,216.4,3.51,0,1.0096,10.926,0,25.05,4.698,139.1,9.964,66.14,382.2107,5.6,2.15,83,190.96,0,76,140,94.96,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
543,78,78,0,3,72.58,160.12,27.77771,1.74,8,0.059962371,0.71974419,1,3,2,8,1776.167,2,2,203.12,45.61,47.02,19.79,17.86,0,0,0.0239847,0.00301,3.36,0.001,4.30105,2.172,0,0,0,0,0,0.724,107,79.26,54.9922,0.02,0,0.004,0.351796,0.0297,0.006,0.42,0,0.229,2.589,0.35976,113.4015,2.9086,11.0207,0.2948,0.591798,0.1801,0.550008,0.0902,0.63,2.820024,6.799382,0.7368,0,0,1.452522,393.06,4.21,0,0.9982,12.305,0,27.28,4.284,138.9,9.228,59.33,226.0077,3.79,1.74,80,162.16,0,80,144,76.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
544,60,60,0,1,61.02,175.68,20.57025,1.75,6,0.040797603,0.49018456,1,1,2,6,6026.72,1,1,649,43.3,263.9,18.78,37.11,0.003081,0.003,1.948e-4,0,2.51,0,4.99872,2.3532,0.205,0.181,0.014,0.001,0.907,0.722,105.1,101.14,56.8884,0,3e-5,0,0.009882,0,0.584,0.523,0.371,0.236,0,0.36416,131.7227,3.1908,13.0063,0.8061,0.82092,0.0018,0.951593,0,0.37,5.600828,4.938366,0.5447,0,0.001,1.269618,221.62,4,1,0.958,10.477,0.0409,25.93,3.696,141,3.937,73.93,267.2425,7.99,1.61,76,175.53,0.1,96,111,60.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
545,52,52,0,2,84.77,166.37,29.94209,1.94,6,0.056466261,0.67796746,2,2,3,6,931.18,2,2,261.22,37.2,113.47,17.81,17.06,0,0,0.0199059,0.00234,24.94,0,3.90389,2.274,0.004,0.058,0.028,0.053,0.48,0.756,104.1,93.09,78.5828,0.12,6e-5,0.016,0.19026,0.005,0.253,0.335,0.243,0.287,0.605,0.39267,131.3822,2.6042,8.7464,0.8854,1.001368,0.0673,0.399062,0.0016,0,7.688686,0,0,0.00101,0,0.78858,174.34,4.14,0,1.0427,11.815,0,23.94,4.541,139,10.291,65.99,100.4158,9.63,1.89,90,165.06,0,71,126,85.41,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,NA,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
547,55,55,0,3,63.92,165.09,23.03652,1.7,8,0.093426083,1.12052267,0,3,2,8,710.118,1,1,498.59,39.02,89.87,14.82,24.82,0,7e-4,0.0370075,0,26.66,0.073,4.55926,2.3577,0.032,0.105,0.005,0.022,0.084,0.692,104,73.13,85.8215,0,0,0,0.259927,3e-4,0.382,0.592,0,0,2.659,0.3501,124.5794,2.6858,20.0815,2.252,1.284102,0,0.509515,0,0.67,3.076155,2.044069,0.0155,0,0,1.259777,195.7,3.69,0,1.0983,0,0.039,25.01,4.269,142.1,15.089,71.95,220.3958,4.7,1.61,90,163.09,0,96,120,59.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
548,69,69,1,2,72.2,166.96,26.19281,1.82,7,0.05367049,0.6445839,1,2,2,7,9732.763,2,2,168.48,40.82,97.73,9.97,12.9,0,0,0.0911983,0.00697,29.11,0.024,2.49983,2.3242,0.502,0.18,0.53,0.159,1.414,0.709,0,54.43,105.4933,0,0,0.0027,0.201095,0.029,1.014,0.428,0.407,0.242,2.47,0.38363,125.3854,1.867,0.1163,0.3962,3.441514,0.1714,1.38046,0.0799,0.68,6.555594,2.632846,0.5129,0,0,0.933599,500.99,3.82,0,1.0346,0.144,0.0104,24.47,4.163,137.1,4.041,71.41,284.9349,11.2,1.77,58,163.44,0,60,106,70.09,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
549,73,73,1,3,53.97,163.78,20.54573,1.56,6,0.07349196,0.88186325,0,3,2,6,8418.891,2,2,415.91,31.05,65.35,30.51,46.25,0.002597,0.0017,0,0,26.01,0.2,3.92664,2.1452,0,0,0.094,0.101,0.732,0.803,101.1,65.5,73.6911,0,0,0,0.039795,0,0.266,0.354,0.337,0.344,0.002,0.34199,106.2257,0,6.3921,7e-4,1.658504,0.0129,0.981747,0.0018,0.68,2.104603,3.988757,0.0093,0.00593,0,1.049939,167.77,3.99,0,0.866,14.134,0,24.5,2.756,138,9.901,59.15,255.4891,4.53,1.56,71,162.93,0,79,110,54,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
550,64,64,2,2,100.2,177.28,30.79649,2.16,8,0.042520362,0.51094873,1,2,2,8,16738.804,2,2,274.94,38.95,84.21,14.07,12.58,0.003113,0.0014,0.0584581,6e-5,26.03,0.05,5.90754,2.2385,0.24,0.242,0.001,0.001,0.3,0.549,104.1,77.57,95.9609,0,5e-5,0,0.100671,1e-4,0.353,0.352,0.049,0.128,2.572,0.39312,130.5727,2.545,10.6762,1.4809,0.995046,0,0.719534,0.0043,0.82,7.373447,4.971675,0.7378,0.0046,0.002,0.201699,301.79,4.36,0,1.2054,13.294,0.0531,33.98,4.551,142.9,5.983,66.06,262.858,8.51,2.1,80,180.7,0,88,111,109.51,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
551,72,72,0,1,67.05,172.1,22.59413,1.77,7,0.16516046,1.98179024,1,1,5,7,3156.298,1,1,174.12,38.96,84.24,24.53,27.37,0.001045,0.0014,2.677e-4,7e-5,28.08,0,5.33948,2.4503,0.093,0.006,0.015,0.001,0.816,0.763,106.8,65.45,84.9736,0.57,1e-4,0.0219,0.099819,0.0034,0.553,0.451,0.231,0.217,0.493,0.37635,138.3131,4.4436,16.2051,0.7148,1.460355,0.0128,0.549457,0.0354,0.69,3.12854,6.411853,0.6674,0,0.001,1.181118,103.04,4.1,0,1.1276,11.061,0,28.79,4.425,139,8.207,70.03,744.9192,4.68,1.89,80,173.83,0,70,148,67.88,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,< 65,>= 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
552,41,41,0,3,64.95,168.87,23.12149,1.73,8,0.068369513,0.82201886,1,3,6,8,1005.16,1,1,228.25,36.99,223.68,52.87,45.77,7.18e-4,6e-4,0,0,26.91,0.129,0,2.522,0.151,0.166,0.047,0.07,0.594,0.762,97.1,104.27,68.1746,0,1.9e-4,0.0184,0.02981,0.0098,0.391,0.481,0.272,0.27,0,0.4361,138.2778,1.7625,11.9943,1.1661,0.701524,0.1497,0.47568,0.0598,0.61,4.88721,4.408193,0.039,0,0,0.919887,195.66,4.71,0,0.836,0,0.0097,30.34,4.731,139.9,17.071,66.57,573.8184,6.69,1.72,95,167.94,0,79,136,64.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
553,59,59,1,4,72.92,165.18,26.62524,1.81,6,0.094399471,1.13283321,1,4,5,6,16757.287,1,1,928.94,22.08,96.62,41.99,36.87,0.002336,0.0026,8.09e-5,7e-5,24.08,0,6.78865,2.0835,0.002,0.122,0.037,0.081,0.506,0.851,104.9,80.62,73.6724,0.34,5e-5,0.0147,0.08631,0.035,0.241,0.473,0.198,0.408,2.771,0.33175,114.6864,1.0893,0,0.6342,0.439547,0.0077,0.36004,0.0754,0,8.189675,3.200038,0.6384,0.00337,0.001,1.249262,303.05,3.02,1,0.9615,11.413,0.0291,28.27,4.292,139.9,13.686,59.25,79.1535,8.9,1.86,77,165.01,0,84,130,69.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,NA,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
554,71,71,1,4,70.06,179.08,22.23457,1.91,6,0.09087943,1.09019603,2,4,6,6,33057.036,2,2,333.05,41.74,88.93,18,17.83,0.001842,0.0016,2.794e-4,5e-5,25.67,0.068,4.06207,2.2444,0.108,0.112,0.051,0.09,0,0.305,0,65.24,76.3215,0,0,0,0.070015,2e-4,0,0.009,0.085,0.164,0,0.39606,128.9923,2.0087,11.8004,0.7152,1.296218,0.004,0.448107,0.0029,0,7.798656,4.110974,0.0215,0,0,0.71129,344.82,4.28,0,1.0549,12.226,0,25.53,5.417,133.9,10.285,80,78.4767,8.07,1.88,93,178.4,0,110,132,68.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
555,76,76,0,4,47.54,162.17,18.22801,1.49,7,0.05047173,0.60470132,1,4,3,7,2873.055,2,2,591.47,42.09,254.02,7.15,12.98,0.002251,0.0022,0.1194897,9e-5,29,0.045,6.48342,2.3757,0.523,0.268,0.209,0.078,1.29,0.624,100,56.66,71.644,0,0,0.0029,0.586349,0.0066,1.063,0.474,0.359,0.097,0.919,0.35112,112.7953,1.2695,11.518,0.0071,2.364972,0.0115,0.350233,0.0035,16.96,5.408024,0.35456,0.6326,0.00679,0,1.017228,253.99,4.3,1,0.9915,12.153,1e-4,28.87,3.861,144.1,7.147,69.97,255.8675,10.53,1.51,69,160.06,0,86,123,46.09,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High,High,Q2 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
556,67,67,NA,2,74.01,165.01,26.31565,1.82,6,0.038086173,0.45787509,0,2,NA,6,2728.956,1,1,442.58,39.93,258.36,13.05,15.81,0.003551,0.0031,0.037508,7e-5,22.98,0.129,0,2.3729,0.532,0.294,0.074,0.044,0.912,0.586,100,122.84,53.3854,0.08,5e-5,0,0.19169,9e-4,0.659,0.409,0.305,0.194,0,0.37287,116.0023,1.4591,13.6584,1.4276,1.003851,0.0102,0.199462,0.0027,0.39,3.998411,4.882452,0.5209,0,0.001,0.901721,344.34,4.11,0,1.1986,10.607,0.101,33.93,4.408,139,8.588,78.98,166.3961,5.81,1.89,75,168.74,0,72,123,82.95,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,NA,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
557,74,74,0,1,63.16,158.17,25.62982,1.65,6,0.094027243,1.12666619,0,1,1,6,245.708,1,1,342.2,47.3,52.23,44.65,41.18,0.001588,0.003,0.0200263,0,0,0.141,15.07128,2.5003,0.176,0.308,0.066,0.073,0,0,108,60.5,77.9008,0,0,0,0.100113,6e-4,0,0.001,0.003,0.185,0,0.40947,145.9515,2.4591,11.7095,0.9412,0.6993,0.0058,0.698961,0.0012,0.06,3.697786,0,0,0.0076,0,0.115094,148.36,3.33,1,1.0166,14.405,0.016,27.21,4.517,137.9,6.032,71.05,165.4246,5.7,1.64,102,157.48,0,69,158,59.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
558,67,67,0,2,38.2,150.11,17.86833,1.28,8,0.080065685,0.960327,0,2,2,8,412.572,1,1,307.47,40.02,87.77,9.9,17.14,0,0,0.0200047,0.01008,59.9,0.139,4.70498,2.2709,0.328,0.235,0.321,0.218,1.587,0.693,104,68.66,61.9307,0,0,0,0.300161,0.0661,0.732,0.382,0.842,0.369,2.232,0.32943,109.4524,3.2144,15.8799,1.9423,1.866866,0.387,0.320139,0.1505,0.55,1.701699,4.195781,0.7499,0.00229,0.001,1.143115,123.2,4.09,1,1.2082,13.596,0.0159,29.72,3.562,138.9,8.507,69.92,236.9009,3.33,0.23,72,149.86,0,63,120,9.92,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,>= 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
559,69,69,0,2,65.05,171.98,22.72652,1.77,8,0.039785375,0.47772926,1,2,2,8,618.299,1,1,314.52,38.39,180.8,23.94,26.28,0.00311,0.0023,0.0399442,1e-5,22.82,0.201,0.08866,2.3296,0.216,0.139,0.186,0.15,0.586,0,100.9,74.46,64.8893,0.07,1.2e-4,0.0254,0.2166,0,0.452,0.366,0.167,0,3.121,0.37018,130.4775,1.7964,11.4393,3.9386,2.006723,0.0081,0.969781,0.0053,31.06,5.00834,5.459558,0.4653,0.00191,0,1.065289,182.22,4.21,0,0.9145,0,0.0171,0.18,4.052,137.7,7.991,66.03,268.2207,8.7,1.8,90,170.91,0,115,133,65.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,N,Y,Y,WHITE,Other,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
562,44,44,0,1,68.07,175.36,22.63047,1.82,7,0.05699798,0.68376705,0,1,4,7,1195.46,1,1,361.4,41.96,82.41,27,17.87,4.13e-4,0,0.0260783,0.00989,0.06,0.122,5.6172,2.2745,0.165,0.133,0.267,0.165,1.625,0.897,97.9,111.95,64.5018,0.04,6e-5,0.0177,0.001077,0.0257,1.002,0.575,0.626,0.462,4.314,0.4249,143.583,3.2852,10.3821,0.4202,1.258966,0.1663,0.360323,0.0885,0.06,3.563876,7.530458,0.7705,0,0.001,1.134863,181.11,3.72,1,0.9939,0.438,0.0081,40.94,5.125,139,8.013,66.93,361.6654,5.21,1.81,76,175.37,0,72,136,64.9,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
563,63,63,1,2,54.97,157.12,22.01419,1.54,6,0.023254761,0.27923956,1,2,6,6,11991.328,2,2,649.34,33.27,60.11,13.98,13.12,0,0,0,0,24.09,0,4.49842,2.1792,0.18,0.175,0.367,0.275,1.228,0.786,104,71.32,72.4278,0.14,0,0.0087,0.041017,0,0.742,0.477,0.494,0.359,0.561,0.26848,79.8443,2.9036,14.1269,1.7911,0.87823,0,0.53258,7e-4,0.79,5.090743,0,0,3.1e-4,0,1.272695,445.12,4.6,0,0.9892,11.727,0,28.14,3.309,139.9,4.061,71.07,160.5144,5.71,1.5,50,157.07,0,90,100,54.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
564,64,64,0,3,80.38,169.87,27.76639,1.94,6,0.05730337,0.68810049,0,3,6,6,1933.958,2,2,248.79,37.98,100.2,11.97,16.86,6.3e-5,0.001,0.0416311,0.00491,27.98,0.101,3.26589,2.2772,0.179,0.191,0.068,0.086,0.627,0.719,100,97.84,62.8575,0.11,1.2e-4,0.0113,0.197064,0.006,0.411,0.398,0.225,0.305,0,0.3631,117.7264,1.0171,3.6867,0.0077,0.615956,0.1382,0.220042,0.0682,0,2.891718,0.27074,0.0064,0.00231,0.001,1.236587,176.44,4.16,0,1.0063,0.516,0.0291,31.71,3.942,139.1,11.29,69.06,273.0916,4.3,1.93,79,168.03,0,83,131,79.06,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
565,61,61,1,3,68.98,175.88,22.48481,1.84,6,0.055016837,0.65982791,1,3,6,6,29338.395,2,2,249.88,42.92,31.48,27.57,24.19,0,0,0.1450687,0.00505,0,0,0,2.178,0.714,0.529,0.199,0.193,0.508,0.009,100.9,86.19,66.4928,0,0,0,0.099477,2e-4,0.284,0.251,0.251,0.262,1.063,0.31703,113.2066,6.4579,12.6388,5.9891,2.30061,0.0072,1.695675,0.0014,0,5.660258,0,0,0,0,1.195733,255.04,3.59,0,0.976,0.81,0.0608,28.01,3.27,138.1,6.655,70.52,382.7075,9.3,1.91,67,175.56,0,74,119,70.27,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
566,78,78,0,5,54.98,168.66,19.47106,1.61,7,0.294550272,3.5202017,1,5,5,7,2507.003,2,2,296.2,32.23,79.22,20.32,21.03,9.42e-4,0.0018,0.019971,0,25.92,0.138,12.14815,2.2483,0.3,0.271,0.617,0.924,0.707,0.596,99.1,37.98,97.1119,0,0,0.0052,0.165183,0,0.358,0.3,0.299,0.317,0,0.36301,115.3692,0,0,0.7431,1.001937,0.0061,0.349296,0,19.8,2.800237,0.124002,0.0261,0.00684,0,0.962797,304.37,3.9,0,1.2712,13.073,0,32.53,4.103,139,8.011,3.06,220.0191,4.3,1.56,71,169.85,0,75,140,53.46,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
567,61,61,1,2,69.04,169.82,24.2439,1.77,6,0.0101592,0.12189478,1,2,4,6,4669.221,1,1,536.7,36,82.2,11.96,13.75,0,0,0.0187395,8e-5,25.39,0.078,1.53649,2.351,0.28,0.185,0.166,0.113,0.916,0.758,99,68.61,90.1604,0.21,1e-4,0.0176,0.073044,3e-4,0.569,0.453,0.365,0.274,0,0.43971,143.979,2.0073,8.6802,1.3243,1.29085,0.0094,0.549927,0.0021,0.05,4.269441,4.004548,0.0193,0.0074,0,0.182298,217.65,4,0,1.0494,13.369,0,30.24,5.195,139.3,11.234,68.46,276.4191,7.69,1.7,59,169.99,0,80,106,69.01,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
568,75,75,0,3,88.65,174.85,28.72087,2.02,8,0.071302582,0.85489103,1,3,4,8,2053.874,2,2,135.11,33.01,80.5,9.97,12.91,0.004143,0.0041,0.0279912,0.00705,25.98,0.143,2.61123,2.3597,0.359,0.279,0.067,0.062,0.756,0.305,100.1,75.19,78.38,0,0,0,0.15997,0.0313,0.559,0.377,0.169,0,0,0.4445,148.3598,2.0108,5.9105,0.5372,1.617565,0.3091,0.35652,0.0974,0,4.262861,2.897161,0.0378,0.00132,0.001,0,213.36,3.8,2,1.0064,11.537,0,24.35,4.785,141.1,13.684,61.07,505.7431,7.03,1.96,86,174.77,0,80,130,83.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
569,64,64,1,2,66.6,162.12,25.7106,1.72,7,0.26331061100000003,3.15847236,0,2,4,7,3151.047,1,1,353.42,42.07,61.81,15.01,19.96,0.002372,0.001,2.008e-4,0,20.99,0.107,14.79347,2.4265,0.089,0.138,0,0,0.189,0.685,109.5,93.54,63.646,0.13,0,0.0049,0.099524,0,0.094,0.393,0.099,0.18,4.719,0.4109,144.9891,1.6062,8.8257,0.8022,0.847441,0.0126,0.300211,0,0,1.939219,0,0,0,0,0,118.03,3.91,0,0.8947,0,0.0134,0,4.461,140,5.992,66.92,236.0569,3.68,1.76,89,164.07,0,62,150,69.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
570,69,69,0,1,112.92,168.17,40.89772,2.22,6,0.07812819,0.93815763,1,1,2,6,3819.855,1,1,377.37,45.04,47.45,7.25,16.16,0,0,0.0300159,6e-5,28.91,0.001,1.90154,2.3954,0.071,0.118,0.035,0.069,0.048,0.66,101,109.64,69.8928,0.09,0,0.0072,0.060489,4e-4,0.3,0.494,0,0.119,0,0.48758,159.1359,1.5593,0.067,1.4625,1.467721,0,0.568117,0,27.07,5.977125,5.199534,0.0191,0,0,1.137536,243.29,3.4,1,0.9092,11.611,0.049,23.91,4.825,141.1,11.973,61.49,321.8091,6.71,2.12,80,170.93,0.1,87,149,116.15,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,UNKNOWN,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VV,N,Y,N,N,Low,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
571,68,69,1,1,72.08,169.92,25.64794,1.83,6,0.050026157,0.60052052,0,1,5,6,10359.914,2,2,234.91,38.08,55.06,7.92,8.55,0,0,0.0297684,9e-4,24.01,0.198,12.75851,2.2499,0.068,0.005,0.107,0.068,0.448,0,100.4,72.48,76.9936,0,0,0,0.042567,0,0.352,0.285,0.002,0,6.379,0.39074,131.2741,1.804,11.3852,0.2557,1.524279,0,0.438355,0,26.99,16.659833,0,0.0064,0.00199,0,0.648022,217.65,3.51,0,0.9378,12.065,0.0145,0,4.499,139,2.922,72.95,190.1998,17.18,1.85,61,169.77,0,67,130,71.75,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
573,59,58,2,3,72.58,167.19,25.92657,1.79,6,0.090951565,1.09200557,2,3,4,6,20111.616,1,1,897.32,0,89.27,12.3,27.59,0.002002,0.0018,3.332e-4,9e-5,0.65,0.23,4.28217,2.1403,0.197,0.194,0.072,0.073,0.483,0.016,0.1,84.81,75.4042,0,0,0,0.010635,3e-4,0.255,0.186,0.146,0.001,0,0,53.3914,2.7557,11.8098,2.4605,1.099755,0.0118,1.029966,0.1,0,10.205547,2.737158,0.5195,0.00247,0.001,1.228528,309.55,4.09,0,1.3081,12.139,0,25,0,137,7.997,62.19,279.6172,9.29,1.83,72,167.45,0,123,114,71.81,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Other,Y,Y,F,No,OTH,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
574,54,54,0,4,50.94,156.19,20.68941,1.49,6,0.053743783,0.64428446,0,4,5,6,9616.188,1,1,385.38,31.78,51.83,4.41,11.98,0,0,0.0185579,0,27.54,0.15,5.39403,2.1965,0.028,0.1,0.003,0.024,0.308,0.695,106.2,109.72,53.9986,0.1,0,0.0104,0.201436,1e-4,0.023,0.006,0.223,0.318,4.149,0.34315,108.9539,2.068,10.7928,0.644,0.909305,0,0.372216,0,0.39,3.455535,0.452011,0,0,0,1.290192,219.83,3.11,1,0.9764,10.603,0.0574,30.41,4.281,141.1,6.498,52.97,291.8051,4.49,1.5,79,157.46,0,98,116,51.79,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
575,55,54,0,2,86.94,170.14,30.30972,2,6,0.156616271,1.88164337,1,2,2,6,459.215,1,1,147.76,43.78,140.62,11.02,1.8,0.001519,0.0014,0.0111519,7e-5,25.03,0.101,2.26534,2.3289,0.304,0.162,0.142,0.101,1.378,0.746,104,79.15,97.7842,0,0,0,0.88274,7e-4,0.689,0.389,0.514,0.307,0,0.42957,153.4487,1.6821,10.3991,1.1092,2.737371,0.0111,0.612611,0.0036,0.32,3.118492,2.619211,0.0032,0.00417,0,1.029209,217.59,4.18,0,1.0081,12.32,0,31.93,4.91,137.9,11.022,79.99,481.6576,7,1.93,80,169.84,0,99,125,81.75,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
576,73,73,0,4,55.22,157.87,22.23438,1.56,6,0.091008375,1.09239259,0,4,6,6,313.512,2,1,835.31,36.87,101.1,18.59,22.91,0.001431,0.0013,0.0186668,7e-5,24.96,0.132,3.04148,2.2076,0.053,0.006,0.022,0.027,0.393,0,107.7,54.98,69.9736,0.28,0,0.0067,0.078809,2e-4,0.228,0.273,0.032,0.001,1.5,0.39497,124.3515,1.1141,9.363,0.6842,1.791994,0.0139,1.099554,0.0397,0.58,6.201296,3.971552,0.0196,0,0,1.259885,230.4,4.59,0,1.0867,0.396,0.0086,31.15,4.309,137.9,10.256,67.9,148.9143,10.85,1.45,74,155.13,0,78,119,53.31,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Other,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
577,61,61,1,3,67.05,164.94,24.72363,1.71,6,0.037001843,0.44429639,0,3,5,6,4188.084,1,1,280.6,42.67,938.13,56.65,30.06,0,0,0.0596163,0.00504,29.93,0.395,0.06964,2.5042,0.235,0.12,0.153,0.103,1.799,0.862,109.6,69.09,89.4585,0,0,0,0.55109,0.0135,0.742,0.41,1.008,0.515,0,0.40411,138.8558,2.8583,12.1989,8.3063,10.797622,0.2124,0.630914,0.0711,0.38,4.593062,1.994534,0.0359,0,0,2.559669,191.02,4,0,0,0,0.0447,0,4.515,142,13.681,72.01,302.3403,9.89,1.66,16,162.95,0,97,99,64.05,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
578,60,59,0,3,77.33,175.01,25.33934,1.92,7,0.102585256,1.23104599,0,3,5,7,2637.559,1,1,673.92,40.04,260.81,29.71,36.78,0.002114,0.003,0.0567294,0.00352,2.23,0.062,6.86561,2.3218,0,0.029,0,0.001,0.151,0.699,95.8,87.04,75.3497,0.19,0,0.0127,0.200704,0.0396,0.179,0.42,0.005,0.089,0,0.3969,118.9039,2.0136,8.2017,0.4063,1.140272,0.1872,0.5001,0.053,0.32,4.516403,0.402264,0.6708,0.00204,0,0.969663,463.77,4.29,0,0.9444,13.305,0.061,26.62,4.36,136.1,6.877,65.98,220.0473,7.35,1.87,62,171.14,0.1,65,94,69.81,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
579,73,74,0,4,93.73,170.94,31.35807,2.04,6,0.057499784,0.68923872,0,4,5,6,1792.337,2,2,362.64,39.03,161.05,15.56,14.94,0,3e-4,0.0415951,9.4e-4,27.63,0.149,3.79932,2.2955,0.003,0,0.106,0.036,1.281,0.822,119.3,115.44,52.2306,0.27,1.3e-4,0.0104,0.040685,0,0.843,0.526,0.272,0.144,1.975,0.32453,97.7185,1.1715,1.5832,2.4404,2.740267,0.0089,0.418292,0.0025,0,3.018062,0,0.0177,0.00726,0.001,1.128737,253.87,4.64,1,1.099,11.368,0.0174,30.89,3.748,145,5.102,61.95,173.7929,5.79,2.03,78,172.04,0,79,115,89.68,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
580,69,69,0,1,67.93,161.06,26.13115,1.7,7,0.244975046,2.93827015,0,1,1,7,288.167,2,2,182.51,42.06,82.37,23.88,21.93,8.1e-5,0,0.0399109,3e-5,27.2,0.145,3.67223,2.2957,0.001,0,0.011,0.01,0.503,0.479,106.8,107.75,53.0089,0,8e-5,0,0.453492,0,0.21,0.307,0.172,0.112,0,0.44228,147.8667,2.3593,12.509,1.5896,1.797798,0,0.390388,0,17.68,3.891082,11.027185,0.026,0.00572,0.001,1.229182,127.28,4.81,0,1.103,12.094,0,0.57,4.929,137.7,6.67,80.91,377.0846,5.41,1.62,67,160.13,0,63,105,65.08,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
581,55,55,1,3,67.86,159.1,26.77528,1.71,8,0.100323887,1.2046712,1,3,4,8,6577.064,2,2,247.39,43.68,117.06,11.09,14.05,0,0,0.0079427,5e-5,28.07,0.032,0.11308,2.2499,0.205,0.195,0.004,0.004,0.606,0.602,104.1,70.64,89.8838,0.05,7e-5,0.0178,0.17948,3e-4,0.394,0.475,0.199,0.154,0,0.41445,140.115,0.0098,8.4899,0.8047,1.056433,0.0126,0.45927,0.0025,0,6.101136,4.000588,0.0129,0,0,1.48229,304.09,4.81,0,1.0544,14.451,0.053,35.03,5.055,143,6.839,71.88,465.3664,8.28,1.69,79,159.98,0,80,115,70.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Other,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
582,62,62,1,1,122.73,192.88,31.71871,2.48,6,0.11784167,1.41468115,0,1,6,6,15481.399,1,1,601.63,44.04,374.25,294.43,56.72,0.001644,0.0034,2.187e-4,2e-5,26.52,0.123,4.95804,2.2033,0,0.002,0,0,1.116,0.9,101.1,174.4,53.9687,0.11,1.7e-4,0.0159,0.029768,6e-4,0.447,0.427,0.54,0.464,4.392,0.48847,162.6627,0.005,0.0318,0,0.929115,0.1417,1.275021,0.0887,35.75,10.786912,3.562519,0.4807,0.00149,0,0,224.32,4.62,1,1.0819,0.679,0.06,0.14,5.337,138.1,11.985,67.09,305.9736,13.07,2.34,65,192.89,0,65,97,113.55,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,NA,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
583,79,79,1,5,81.61,161.88,30.79868,1.87,6,0.110809106,1.33110855,1,5,5,6,14313.089,2,2,3229.68,27.09,66.8,24.08,46.73,0.003587,0.002,0.0099594,1e-5,0,0,6.5088800000000004,2.3279,0.528,0.537,0.035,0.062,0.369,0.017,91.5,68.82,70.7864,0.22,0,0,0.060124,0,0.246,0.336,0.098,0.152,0,0.29628,89.0949,2.8146,10.1834,0.9078,0.431691,0,1.501564,0.0043,0.34,6.207171,0.130709,0,0,0,1.093396,327.27,4.2,0,1.1839,10.145,0.033,34.15,3.55,138.1,10.214,66.19,303.5567,8.31,1.87,67,157.97,0.1,89,115,73,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,Yes,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
584,56,57,0,2,82.18,182.91,24.84109,2.05,7,0.11606953,1.3938637,1,2,2,7,2515.317,1,1,381.29,41.09,93.33,50.05,20.04,0,0,0,0,20.95,0.089,8.79538,2.3422,0.48,0.396,0.11,0.112,0.653,0.535,101,52.24,149.9312,0,1.1e-4,9e-4,0.100764,0,0.365,0.341,0.221,0.189,1.915,0.4378,146.7487,0.0017,9.062,0.3975,0.838512,0.0016,0.50985,0.0013,0.52,4.70041,0.058758,0,0.0015,0,1.318596,260.21,4.68,0,0.8602,15.267,0,23.19,4.522,138.4,20.705,72,303.7699,7.57,2.05,83,182.7,0,70,123,79.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,< 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
585,49,49,0,3,79.91,191.74,21.63274,2.09,7,0.09827588,1.17845968,0,3,3,7,4198.482,1,1,203.5,41,54.18,21.06,16.09,0.889486,0.0233,0.0300045,0,0,0.08,11.40684,2.3747,0.145,0.097,0.132,0.08,0.86,0.646,99.7,66.3,115.148,0.19,4e-5,0.0016,0.129072,0,0.425,0.308,0.451,0.255,0,0.29942,103.4882,1.6542,12.0979,1.1394,2.021529,0.0067,0.389798,0.0019,46.41,4.296291,0.0234,0,4.7e-4,0,1.62956,453.73,4.4,0,1.1033,11.898,0.0563,0.35,3.588,137.1,8.006,70.92,289.4395,8.01,2.08,70,191.07,0,69,130,77.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,China,CHN,China,>= 50 ml/min,NA,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Eastern Europe,NA,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
586,57,57,0,2,44.95,167.92,16.03873,1.48,7,0.106610889,1.27849911,0,2,4,7,6772.798,1,1,755.86,36.94,47.03,7.83,10.39,0,0,1.967e-4,6.7e-4,29.45,0.121,4.53937,2.1502,0.287,0.394,0,0.002,0.11,0.722,102.9,70.39,76.0217,0,0,0,0.099973,6e-4,0.004,0,0.314,0.537,4.651,0.31056,109.0142,1.587,8.3187,0.4007,0.196536,0.002,0.398457,0.0576,0,3.445487,0.247682,0.6303,0.00184,0,1.485661,295.66,4.1,0,1.0974,12.025,0,32.29,4.019,140.7,5.104,59.7,149.9578,4.4,1.51,84,168.06,0,86,149,46.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,< 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
587,63,63,1,1,106.77,165,40.15452,2.15,6,0.112578302,1.35073856,0,1,5,6,2804.217,2,2,228.21,43.99,163.59,21.83,20.03,0,0,0.0998458,0.01019,24.09,0.092,7.28536,2.2914,0.131,0,0.367,0.174,1.289,0.772,102.1,95.44,84.9841,0.41,0,0.0071,0.439818,0.0499,0.769,0.415,0.392,0.218,0,0.43042,148.7188,6.431,16.2509,1.8719,1.856841,0.2501,0.238986,0.0602,0,4.789703,0.574972,0.0209,0.00612,0,0.025938,253.09,4.5,0,0.8561,0,0.0552,28,4.692,139.9,10.281,75.82,279.5619,8.1,2.31,84,169.86,0,82,141,121.13,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
588,64,65,0,4,75.91,165.05,27.54627,1.84,7,0.066824909,0.80165667,1,4,3,7,3897.854,2,2,146.98,44.07,225.47,29.74,28.95,0.002046,6e-4,0.0770062,5e-5,26.91,0,7.6061,2.6232,0.087,0.176,0.101,0.148,0.035,0.672,102.9,76.8,75.8184,0.34,0,0.0038,0.15995500000000001,0,0.267,0.497,0.001,0.201,4.394,0.34956,118.8377,2.5648,6.7905,0.0068,0.361629,0,0.420896,0,0,4.327493,3.908484,0.6994,0.00198,0.001,1.197783,184.61,4.19,0,1.0359,9.788,0,28.97,3.761,138.9,20.654,69.21,343.6632,4.6,2,52,165.09,0.1,64,118,78.27,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NA,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
589,35,35,0,3,83.43,166.94,30.09191,1.94,8,0.08865718,1.06265581,0,3,2,8,667.189,1,1,1015.39,48.8,90.71,20.17,20.94,0.001762,0.001,1.72e-4,5e-5,26.22,0.151,4.00759,2.3952,0.112,0,0.201,0.074,1.646,0.515,100,142.33,62.1973,0.24,1.5e-4,0,0.099488,0.0196,0.906,0.383,0.381,0,0,0.42032,131.23,0,5.2558,0.0091,2.943959,0.2543,1.050882,0.0827,24.61,4.533079,3.088178,0.5311,0.00631,0.001,1.000736,379.99,4.84,0,0.9197,0,0.0163,23.74,4.819,137,6.805,79.08,303.0931,8.19,1.98,95,169.47,0.1,81,146,89.2,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
590,58,58,0,2,58.62,162.15,22.37083,1.63,6,0.070178591,0.84221989,2,2,4,6,503.47,1,1,416.99,39.54,258.64,29.81,34.13,0.003181,0.0023,0,4e-5,25.93,0.173,6.21,2.5274,0.276,0.169,0.128,0.079,0.818,0.528,95.8,88.44,66.2072,0,3e-5,0.0019,0.010033,6e-4,0.42,0.223,0.343,0.201,0,0.31905,108.3226,3.7081,15.1925,1.1241,2.329594,0.2545,0.440086,0.0807,0.74,2.434032,3.990329,0.0405,0.00434,0.001,0.128787,247.99,3.73,0,1.0402,15.55,0.0172,26.9,3.708,139,16.004,72.03,231.0772,4.92,1.62,66,164.96,0,58,114,58.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
591,55,55,1,2,69.98,164.15,25.92864,1.76,7,0.083115066,0.99825192,0,2,3,7,1609.414,1,1,415.42,36.93,80.12,34.04,27.97,4.54e-4,8e-4,0.0191065,0.00498,28.99,0.205,12.68946,2.1262,0.067,0.002,0.038,0.054,0.471,0.537,105.8,83.77,78.4451,0,6e-5,0.0253,0.199907,0.0127,0.199,0.317,0.162,0.127,2.931,0.39438,133.1787,0.4109,5.2704,0.4188,2.681437,0.2703,1.09964,0.1209,0.64,8.190222,0.417305,0.6048,0,0.001,1.425421,217.64,3.91,0,1.1057,11.867,0.0211,28.33,4.392,141.9,8.388,58.86,333.0122,11.9,1.85,81,165.03,0,92,123,65.02,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
592,61,61,1,4,64.99,172.03,21.87818,1.76,6,0.026950506,0.32356629,1,4,4,6,3006.431,1,1,1186.17,31.99,92.23,14.73,25.05,0.002562,0.0023,3.04e-5,4e-5,0,0.001,13.5567,2.2325,0.186,0.318,0,0,0,0.791,103.1,66.64,87.8903,0.16,0,0.0073,0.003799,5e-4,0,0.008,0.089,0.4,1.983,0.28345,93.2352,0.5091,7.0512,0.3429,0.299833,0.057,0.40035,0.0581,0.31,5.69387,0,0.5034,0,0,1.397897,432.91,4.02,0,1.2292,10.291,0.0402,38.55,4.223,142.9,15.399,53.08,389.8218,6.69,1.9,80,173.55,0,114,115,67.12,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
593,74,74,0,2,79.91,174.06,26.33996,1.96,6,0.100340089,1.20394694,0,2,1,6,9704.245,2,1,269.43,39.98,62.82,25.04,62.29,0,0,0.0103736,0,28.5,0,10.66659,2.3836,0,0.008,0,0,0,0,108,52.44,104.8231,0,0,8e-4,0.099758,0,0,0,0,0,4.727,0.37265,113.5267,1.7332,8.1106,0.3557,1.005054,0.0111,0.582007,0.0039,0.68,8.009404,0.55887,0.0217,0,0,1.133569,190.21,3.79,0,0.9115,0,0.0783,29.43,4.227,137.9,8.563,68.05,270.9226,8.23,1.92,79,173.23,0,70,139,75.42,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,NA,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,NA,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
594,55,55,1,3,40.09,146.49,18.52339,1.27,6,0.074265736,0.89194256,1,3,2,6,26229.314,2,2,698.19,32.96,38.73,6.8,20.08,0,0,0.0297721,0.00343,25.95,0.179,5.47375,2.321,0.182,0.159,0.014,0.015,0.573,0.445,93.1,68.82,65.6248,0,8e-5,0.0072,0.007362,0.0075,0.388,0.323,0.176,0.171,0,0.37847,111.5513,2.0505,9.9971,0.8921,1.3206039999999999,0.2101,0.269741,0.0053,0,5.688228,4.469518,0.7751,0.00152,0,0.936753,326.73,4.21,0,1.0081,14.595,0.0197,32.05,4.034,142.9,7.325,60.01,0,7,0,72,144.45,0,76,120,35.55,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
595,68,68,1,2,65.03,165.04,23.52605,1.72,7,0.02277616,0.27321455,0,2,2,7,11813.428,1,1,199.58,44.96,79.97,25.96,20.08,3.75e-4,9e-4,2.805e-4,8e-5,0,0.031,9.26421,2.2821,0.175,0.202,0.184,0.117,0.709,0.594,105.4,74.38,76.9905,0,1.3e-4,0.0087,0.039336,7e-4,0.445,0.351,0.207,0.214,5.65,0.39665,132.1485,1.8808,10.6968,1.2039,2.841097,0.2304,1.633035,0.0656,0.66,18.442626,4.590486,0.6076,0,0,1.069791,215.64,4,0,0.7416,10.168,0,27.06,4.668,145,3.468,71.99,243.1148,25.62,1.8,82,168.09,0.1,96,184,69.2,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
596,46,47,1,2,77.73,164.91,28.07379,1.84,6,0.107653371,1.29111868,1,2,2,6,8305.436,1,1,610.35,39.97,97.97,16.92,25.9,0.196486,0.0041,0.0492167,0.00408,12.63,0.171,16.31521,2.4027,0.171,0.131,0.143,0.133,0.505,0.458,105,105.85,66.4525,0.26,3.3e-4,0.0242,0.045262,0.0183,0.421,0.321,0.008,0,0,0.38386,123.5857,2.5146,8.5654,1.8982,1.31077,0.1753,0.857151,0.0798,0.65,5.534977,3.155577,0.0264,0,0.001,1.158746,242.04,3.38,1,1.0316,0.887,0.0351,26.07,4.462,140.1,13.09,67.96,315.8154,8.23,1.8,70,167.92,0.1,107,131,76.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
597,68,68,0,1,79.99,164.92,29.7176,1.9,7,0.047001745,0.56421976,2,1,1,7,4992.851,2,2,476.22,30.97,53.29,10.88,17.99,0,0,0.0121437,2e-5,0,0,3.90394,2.0805,0,0.008,0,0,0,0.702,103.9,70.37,89.8109,0,0,0,0.040353,0,0,0.221,0,0.183,0,0.43236,135.4257,1.2555,0.0309,1.5942,0.765467,0,0.437137,0,0.69,6.001372,2.701422,0,0,0,0,536.73,5.3,0,0.9084,10.767,0,23.69,4.908,141.4,5.997,54.08,148.3859,6.3,1.93,95,165.02,0,80,135,73.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
598,77,77,0,4,56.94,150.2,24.59722,1.51,7,0.060265928,0.72305051,1,4,2,7,4199.543,1,1,571.9,39.09,199.78,16.51,21.05,0.001835,0,0.0942259,0.00353,25.61,0.124,7.34986,2.125,0.14,0.036,0.22,0.17,1.126,0.895,94.9,72.82,57.7707,0.24,1e-5,0,0.100011,9e-4,0.583,0.481,0.49,0.502,0,0.31085,97.3298,5.0881,11.3816,1.295,1.069372,0.1801,0.348603,0.0465,0,2.405349,3.477386,0.66,0,0,1.000162,230.26,4.29,0,1.0064,0.677,0.0852,36.09,3.233,135,5.116,69,190.7134,3.6,1.49,66,149.76,0,92,127,55.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
599,56,56,1,4,82.03,179.06,25.51137,2.02,6,0.056845342,0.6817252,1,4,5,6,2590.825,1,1,878.31,40.04,214.46,21.01,37.05,0.001357,0.0011,0.0300174,0.00192,27.05,0.147,0.08526,2.3625,0.205,0.236,0.032,0.016,0.975,0.759,101.1,95.44,73.2436,0.23,5e-5,0,0.216461,0.0132,0.456,0.339,0.447,0.359,0,0.45078,152.0187,2.8466,12.1947,0.4016,1.983117,0.1804,0.530314,0.0034,17.24,4.762664,0,0.0017,7.6e-4,0,1.092537,236.52,4.36,0,0.9746,7.975,0.0083,28.92,5.199,129.5,17.636,70.06,315.4004,6.72,1.98,89,181.61,0,71,131,89.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,2,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
601,67,68,1,2,77.95,166.94,27.59247,1.88,8,0.124620907,1.49596344,0,2,2,8,16411.424,1,1,247.18,36.93,72.59,15.08,19.82,0,0,0,3e-5,22.95,0.159,3.55951,2.0744,0.058,0.082,0.012,0.001,0.571,0.683,105,82.24,62.2533,0.18,1.5e-4,0.0163,0.019675,4e-4,0.374,0.442,0.159,0.143,3.244,0.41692,143.2687,2.4763,9.2821,0.3801,0.55221,0.0118,0.10515,0.0033,16.3,6.200428,3.346037,0.0261,0,0,0.77613,108.64,3.64,0,0.936,11.724,0.0047,0.75,4.796,140.9,11.107,59.13,211.8171,7.36,1.88,61,166.03,0.1,81,100,74.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,Y
602,71,71,0,2,63.18,157.99,25.02732,1.63,6,0.053127597,0.63762775,1,2,1,6,5771.945,1,1,260.03,40.98,48.79,14.87,31.09,0,0,0.0289219,9e-5,31,0.155,3.96892,2.277,0.164,0.078,0.059,0.03,0.66,0.02,99,109.87,48.0478,0,0,0,0.230504,9e-4,0.424,0.275,0.11,0,0,0.351,119.4029,2.151,12.2819,1.0989,1.831805,0.1629,0.296645,0.0336,0.33,2.801064,4.288825,0.0352,2e-4,0,1.613089,199.72,3.25,1,1.0375,10.666,0,28.17,3.575,140,5.165,70.54,301.3343,4.11,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
604,70,70,0,5,57.45,157.03,22.47589,1.57,7,0.044960743,0.53895943,1,5,5,7,8257.04,1,1,352.13,39.02,86.9,6.15,15.88,0,0,0.0451503,0,23.09,0.041,15.92525,2.3652,0.072,0.13,0.011,0.029,0.029,0.587,97.7,85.65,56.5501,0,0,0,0.043242,0,0,0,0.157,0.312,0,0.36312,120.5384,0.6963,0.1226,0.3183,1.030603,0,0.79966,9e-4,0,6.760447,2.998546,0.0399,0,0,0.807804,426.82,4.67,0,0.9956,11.702,0.0545,34.15,4.702,126.3,10.279,68.44,161.139,9.33,1.51,73,154.09,0,81,121,50.95,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HR,158FF,N,Y,N,N,High,High,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
605,73,73,1,2,99.81,171.94,33.92217,2.11,6,0.03048271,0.36538015,0,2,2,6,4223.497,2,2,696.69,39.15,56.39,24.94,42.38,0,0,0.0300037,9e-5,23.97,0.088,6.43708,2.3755,0,0.027,0.081,0.127,0,0,104,48.04,124.3757,0,0,0.0104,0.020891,1e-4,0.009,0.291,0,0,1.105,0.41586,137.0019,1.8773,5.6303,0.6059,0.771591,0.0103,0.410337,0.0033,0.25,2.466847,0,0.0052,0.00218,0,1.031157,149.46,3.8,0,1.0696,11.991,0.0592,23.95,4.464,139,11.988,66.19,475.9317,3.82,1.96,70,168.95,0,58,139,94.99,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
606,56,56,1,3,62.99,163.36,23.67848,1.68,6,0.052055658,0.62526414,1,3,2,6,2767.975,2,2,405.62,30.03,64.08,28.97,25.14,0,0,0.1005478,0.00404,2.46,0.196,5.58198,2.2238,0.004,0,0.042,0.066,0.769,0.694,103,110.34,52.4907,0.17,1e-4,0.0233,1.394657,0.0134,0.55,0.409,0.196,0.15,3.485,0.37297,130.6034,1.8818,7.458,1.1443,2.040535,0.0095,0.93066,0.0033,16.04,5.969149,0,0.0072,0,0,0.158302,135.57,3.31,1,0.9155,8.754,0.0524,0,4.252,139.2,14.704,72.25,247.2123,10.5,1.64,85,164.04,0,96,141,68.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VV,N,Y,N,N,Low,High,Q2 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
607,72,72,0,4,89.1,158.19,35.52814,1.91,6,0.042980734,0.51520864,0,4,3,6,9288.328,2,2,208.88,37.76,84.83,79.08,21.2,0,3e-4,0.1736261,0.008,1.67,0.088,0.10609,2.757,0.228,0.006,0.183,0.062,1.068,0.018,98.9,92.08,68.973,0.19,0,0.0083,0.200254,8e-4,0.773,0.398,0.366,0,0,0.45319,160.6425,3.0973,13.1498,3.7186,5.935347,0.2511,1.920204,0.0817,0,9.472466,5.068667,0.0376,0.00295,0.001,1.098551,274.35,4,0,0.9001,0,0,27.51,4.946,139,14.198,66.99,231.975,18.84,1.97,80,162.09,0,60,108,95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
608,28,27,0,1,66.15,172.48,22.87153,1.81,6,0.059580128,0.71465954,1,1,4,6,6290.939,1,1,347.42,37.09,55.13,23.08,48.86,0.001382,0.0011,0.0553831,0,28.04,0.001,12.36803,2.3248,0.187,0.162,0.115,0.118,1.152,0.69,96.4,131.05,61.8271,0.17,0,0,0.100343,5e-4,0.672,0.527,0.343,0.183,0,0.42018,145.5316,3.2878,15.6046,1.1475,1.10911,0,0.581529,8e-4,0,4.009914,0,0,0.00321,0,1.062305,181.11,3.88,0,1.2169,10.378,0,25.87,4.47,137,7.01,74.98,275.8756,7.2,1.82,71,169.99,0,74,98,64.87,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
609,73,73,1,3,64.97,178,21.13976,1.83,6,0.135005091,1.62006553,0,3,2,6,2003.487,2,2,429.58,33.44,100.93,15.01,18.98,0.001026,0.0012,0.0422502,0.00539,0,0.103,12.44084,2.3361,0.334,0.208,0.11,0.046,1.451,0.803,92.9,54.3,89.5429,0.28,0,0.0213,0.179405,0.007,0.661,0.374,0.625,0.318,1.566,0.40331,124.7973,0.2319,0.0553,0,2.417504,0.1801,0.679294,0.0769,0,4.261152,0.564387,0.016,0,0,0.766465,121.12,4.59,0,1.0513,8.876,0.0169,34.98,4.173,137,5.301,68.44,235.8429,6.81,1.84,94,178.83,0,77,113,68.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
610,77,78,1,5,95.76,164.93,35.01859,2.01,6,0.037391252,0.44909823,1,5,6,6,16063.66,1,1,7259.52,31.08,116.24,36.44,37.09,0,2e-4,3.114e-4,2e-5,25,0.159,6.56119,2.3033,0.048,0.114,0.016,0.057,0.413,0.803,0,61.45,93.9539,0.2,0,0.0166,0.008413,6e-4,0.236,0.523,0.087,0.242,3.628,0.29163,97.4925,2.1531,10.4337,0.6982,0.498133,0.0058,0.287283,0.0451,13.21,6.519302,0.31298,0.0406,0.00105,0,1.427716,236.13,3.81,0,1.2023,10.35,0,25.71,3.708,127,5.988,71.06,472.145,7.57,2.08,65,165.1,0.1,70,150,104.14,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
611,34,35,0,2,53.55,163.86,19.73954,1.58,6,0.038056465,0.45651091,1,2,3,6,5714.942,1,1,210.71,44.09,230.27,24.33,34.62,0.003792,0.0034,0.0299133,0.01026,24.96,0.233,0,2.306,0.432,0.183,0.665,0.297,1.947,0.798,102.2,95.8,70.9418,0.09,1.2e-4,0.0112,0.039679,0.0451,1.125,0.413,1.084,0.456,1.065,0.41977,144.7802,2.1308,14.4288,1.4418,2.354854,0.3356,0.340901,0.0772,0,2.57152,0.581765,0.6996,0,0.001,1.062341,194.21,4,0,0.9615,0.539,0.0451,29.4,5.203,134.9,8.018,73.07,509.741,4.6,1.48,76,160.17,0,85,109,45.16,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,Y,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
612,37,36,0,0,70.07,163.18,25.72339,1.75,7,0.034747351,0.41703837,1,0,1,7,3312.897,1,1,727.01,45.07,55.05,36.57,59.05,0.00251,0.0023,0.0199925,0.0035,0,0.191,3.71798,2.5435,0.17,0.125,0.086,0.084,0.485,0.022,104,129.93,60.8758,0.16,1.4e-4,0.0049,0.129535,0.0204,0.151,0.104,0.226,0.214,0,0.45446,145.2255,1.0846,19.5112,0.3082,2.110987,0.2602,0.356582,0.087,0.75,4.43297,3.679712,0.7592,6.4e-4,0.001,1.162968,232.34,6.42,1,0.9823,10.408,0.0102,24.39,5.164,139.8,3.778,81.66,279.6173,8.3,1.73,92,159.92,0,75,140,65.39,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
613,61,61,0,3,75.15,167.39,26.83871,1.84,6,0.024779718,0.29731053,0,3,4,6,10090.559,2,2,346.03,41.96,44.7,15.7,13.72,0,0,0.0083377,6e-5,25.01,0,6.21232,2.3033,0.426,0.347,0.353,0.256,1.111,0.787,102.9,96.04,64.74,0.25,1.8e-4,0.0153,0.139842,2e-4,0.61,0.448,0.496,0.417,0,0.35992,111.5035,2.4013,9.8944,0.7712,1.147071,0,0.322853,9e-4,0,3.704694,0.046219,0,1.1e-4,0,1.30173,126.19,3.71,0,1.0904,12.192,0.0154,1.05,3.961,140,9.293,70.48,186.2058,5.87,1.88,90,166.97,0,78,149,70.09,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
614,55,55,0,3,53.74,162.44,20.69489,1.57,6,0.030968765,0.37143455,0,3,1,6,609.446,2,2,581.7,45.94,71.54,19.08,20.93,2.66e-4,0,0.0599948,0.00337,22.97,0.048,0.10659,2.3754,0.317,0.126,0.447,0.235,1.18,0.75,101,75.82,82.3941,0.29,1.5e-4,0.0087,0,0,0.491,0.379,0.626,0.316,0,0.46534,159.1104,2.8291,10.1369,1.1245,3.436701,0.159,1.098756,0.0683,0,8.188806,7.147259,0.8108,0,0.001,0,221.02,4.67,2,1.0999,0.696,0.0324,34.8,5.159,134.5,13.035,80.67,270.3261,12.52,1.53,67,165.09,0.1,80,119,54.94,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
615,77,77,1,3,84.14,184.89,24.33609,2.06,7,0.101011697,1.21085071,0,3,4,7,2437.479,2,2,317.66,21.41,180.23,26.46,21.93,0.002334,0.0025,0,0,1.02,0.062,5.5919,0.9284,0,0.027,0,0,0,0.62,0.5,86.27,64.9416,0.18,6e-5,0,0.00451,0,0,0.15,0.001,0.141,0,0.37691,118.0796,2.3897,2.7241,5e-4,0.919273,0,0.599465,0.002,0.62,5.560901,9.453889,0.6993,0.0035,0.001,0.800473,250.7,4.31,0,1.2916,14.57,3e-4,36.02,4.151,135.3,11.968,61.23,223.0064,8.76,NA,NA,NA,NA,NA,NA,NA,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
616,75,75,0,3,56.48,146.84,25.72339,1.5,8,0.060216707,0.72298192,2,3,6,8,1394.964,1,1,2802.69,24.73,148.66,14.99,25.88,0.003521,0.0027,0.0399538,0.00603,22.4,0.001,4.63968,2.1991,0.515,0.408,0.001,0.001,0.322,0.004,101,67.24,68.0054,0,5e-5,0,0.178106,0.0287,0.017,0,0.199,0.231,1.011,0.38043,122.4422,2.2344,8.7369,0.0105,2.434344,0.3141,1.300567,0.1675,0.43,9.628331,3.12343,0.6756,0.00767,0.002,1.089453,429.35,4.21,0,1.0711,0.783,0.0066,0.24,4.738,136.1,2.918,64.92,92.3746,16.72,1.45,79,146.03,0,92,130,54.04,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,>= 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
617,78,78,0,3,41.28,153.12,17.60645,1.35,8,0.087915239,1.05526607,1,3,2,8,1106.228,2,2,383.84,37.09,47.78,7.88,19.82,0.001759,0.002,0.0199619,0,0,0.151,6.40946,2.4052,0.837,0.487,0.201,0.138,1.592,0.818,101.1,40.09,89.2545,0.09,0,0.0123,0.005028,0,0.915,0.523,0.753,0.419,0,0.40446,139.8309,4.2358,17.8609,2.2052,1.489973,0,0.439372,0,0,3.069744,0.513638,0.0081,0,0,1.003135,244.14,3.74,0,1.102,11.753,0,33.63,5.11,135.2,16.949,70.01,392.358,5.02,1.37,86,153.45,0,103,121,41.2,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
618,33,33,0,4,72.91,175.01,24.01148,1.89,7,0.098815841,1.18526385,2,4,6,7,12009.541,1,1,724.61,27.91,81.73,22.08,50.94,0,0,0.0218261,0.00335,26.5,0.001,0,2.3011,0.264,0.192,0.11,0.064,0.997,0.794,92.1,187.02,46.878,0.11,1.2e-4,0.012,0.098858,0.0297,0.469,0.339,0.546,0.362,0,0.35355,111.9348,2.4655,10.7275,2.5461,2.062445,0.1496,1.581346,0.1038,18.96,5.867511,0.332117,0.0328,0,0,1.173617,322.33,4.1,1,1.1289,11.282,0,1.09,5.148,134.2,10.272,66.03,325.1836,9.34,1.93,88,172.99,0.1,96,134,75.06,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
619,75,75,0,3,65.06,161.11,24.92915,1.67,7,0.136399174,1.63635379,0,3,5,7,2624.785,2,2,276.24,41.91,63.24,12.12,16.87,0,0,0.0194497,7e-5,27.81,0.101,0.10526,2.528,0.003,0.098,0.033,0.07,0,0.496,100.1,74.34,61.9352,0,0,0.0014,0.029419,0,0.029,0.417,0,0.092,4.941,0.38491,126.0293,1.4571,10.8314,1.6052,0.240475,0,0.322197,0,0.12,3.905109,0.300808,0,0.00341,0,1.130005,239.12,4.69,0,1.0509,12.723,0,28.18,4.232,137,11.157,69.99,327.0979,4.4,1.73,89,162.98,0,89,110,71.57,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
620,57,57,0,3,78.12,180.13,23.66347,1.98,7,0.043509366,0.52257897,1,3,2,7,648.203,2,2,127.37,36.96,63.7,13.82,14.06,0,0,0.146069,6e-5,25.75,0.112,5.70219,2.4226,0.612,0.222,0.185,0.066,1.739,0.672,101.1,99.21,67.0654,0.12,0,0,0.299976,8e-4,0.825,0.006,0.755,0.338,0,0.39934,132.846,2.9519,3.7855,0.928,2.844901,0.0099,0.539905,0,31.98,6.997278,0,0,5e-4,0,1.461664,238.82,4.64,0,1.0224,10.772,0.0221,23.97,4.558,142.1,13.438,68.98,306.9339,11.48,1.9,71,178.62,0,55,99,73.91,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,GBR,United Kingdom,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
621,59,59,1,3,57.66,170.14,20.41435,1.66,6,0.14678273,1.76130839,2,3,1,6,2219.544,2,2,353.45,40.09,106.38,15.83,26.96,0.002338,0.0025,0.0081855,0,0,0.121,4.99962,2.1818,0.066,0.102,0.008,0.012,0.339,0.681,102.2,95.7,59.1989,0.1,1e-4,0.0068,0.071124,0,0.221,0.319,0.008,0.167,2.298,0.35825,124.8982,0.3904,5.6611,2.2744,1.485179,0.0077,0.311485,0,0.22,1.990541,0.042999,0.0267,0,0,0,97.35,4.81,0,1.179,11.616,0,24.18,4.259,143.1,9.596,63.09,269.8014,3.86,1.66,100,171.95,0.1,83,152,58.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
622,47,47,0,4,56.01,175.95,18.16433,1.66,6,0.036556459,0.43858182,1,4,3,6,2812.493,1,1,738.69,27.02,34.48,26.46,25.09,0,0,0.0311609,0,2,0.063,5.06285,2.0764,0.466,0.296,0.093,0.051,0.871,0.686,99.1,88.06,71.4091,0.48,0,0,0.069572,0,0.405,0.182,0.374,0.315,0.548,0.32226,104.3827,4.4213,8.3041,2.3587,2.006196,0,0.450153,0,0,5.698161,0.356729,0,0.00458,0,1.084879,303.65,3.6,0,1.0515,12.62,0.0315,33.52,3.871,135.1,7.792,57.31,162.222,8.43,1.77,81,178.09,0,88,111,57.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
623,59,59,0,1,63.17,169.53,22.13029,1.7,7,0.100749389,1.20805706,2,1,5,7,5124.523,2,2,221.41,36.47,109.98,18.6,34.93,0.002373,0.0036,0,0,0,0.001,5.41509,2.0358,0,0.098,0,0,0,0.727,104.9,88.45,64.2022,0,0,0,0.054283,0,0,0,0.144,0.367,1.432,0.21889,85.7818,1.2046,14.8567,0.9983,0.556363,0,0.810604,0,13.28,5.566935,0.112005,0,0.05133,0.002,1.602361,144.67,4.19,0,1.1311,14.904,0,26.15,3.259,93.4,10.283,57.02,221.1226,7,1.84,61,168.03,0,96,97,65,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
624,58,58,1,3,75.68,168.99,26.70921,1.87,6,0.08093815,0.97201189,1,3,5,6,10347.356,2,2,670.6,39.49,89.82,30.59,59.05,0,0,0.1337463,4e-5,0,0.15,8.22838,2.4805,0.001,0,0.025,0.035,0.56,0.713,99.9,73.86,86.8639,0.28,0,0,0.001341,0,0.019,0,0.347,0.375,1.127,0.29355,105.5438,2.5973,9.1373,0.72,1.295286,0,1.303217,0,0,9.849549,4.468691,0.5679,0.00244,0,1.027242,524.5,3.71,1,1.2311,6.258,0.0325,42.22,3.271,136,8.405,70.48,288.39,11.96,1.77,70,169.91,0.1,83,109,74.83,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Other,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
625,59,60,0,4,110.7,170.05,40.23791,2.2,7,0.107843891,1.29453367,0,4,6,7,3809.768,2,2,308.05,49.22,240.17,24.26,42.67,0,0,0.0608387,4e-5,22.98,0.689,0,2.3526,0.297,0.229,0.029,0.032,0.588,0.681,89.4,90.15,94.257,0.14,0,0,0.223955,0,0.237,0.242,0.316,0.318,0.247,0.45332,142.6386,1.8038,9.8646,0.7678,1.387779,0,1.210313,9e-4,16.08,4.263937,0,0.0183,0,0,1.000684,212.77,4.2,0,0.9944,12.696,0,39.39,4.695,136,17.031,70.99,392.0413,7.1,2.32,89,171.44,0,99,124,107.29,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
626,73,73,1,4,59.93,153.98,25.26267,1.58,6,0.087096137,1.0442691,0,4,5,6,29371.559,1,1,340.9,36.33,85.62,13.07,10.66,0.002509,0.0016,0.009924,1e-5,29.01,0.069,4.80105,2.2021,0.173,0.073,0.02,0.001,1.227,0.773,103.4,73.47,67.9036,0.06,2e-4,0.0058,0.040077,8e-4,0.657,0.44,0.521,0.27,0,0.39355,123.1675,4.2067,14.0728,0.545,1.112605,0.0071,0.400202,0.0039,0.63,3.396737,0.640669,0.0159,0.00141,0.001,0.877898,329.91,3.91,0,0.9606,0.943,0,30.31,3.843,146,4.017,65.99,314.4733,5.05,1.53,60,151.81,0,67,120,58.35,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
628,54,55,1,4,57.22,166.83,20.64818,1.64,6,0.029039342,0.34781242,1,4,5,6,6336.021,2,2,1191.74,30.09,223.59,55.01,233.63,0,9e-4,0.0504992,0.00504,0,0.091,5.34994,2.343,0.265,0.227,0.064,0.053,0.599,0.006,102.2,100.63,66.8388,0.21,0,0.015,1.213322,0.0129,0.085,0,0.437,0.285,2.925,0.43203,132.5152,3.0008,14.0903,0.5077,3.188415,0.01,0.829367,0.002,0.25,3.065723,0.338569,0,0.00431,0.002,1.001513,171.53,3.39,0,1.2013,12.113,0,28.83,5.094,137.9,13.938,68.93,630.4117,6.87,1.69,61,164.99,0.1,90,113,59.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,Yes,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
629,74,74,0,3,113.12,184.55,33.98973,2.34,7,0.677273753,8.12504553,1,3,3,7,4809.026,1,1,270.08,36.46,77.53,21.06,20.99,0,0,0.0399341,6e-5,27.97,0.068,4.14037,2.3769,0.701,0.419,0.042,0.001,1.227,0.077,91.3,52,114.9956,0,0,0.0075,0.399001,4e-4,0.702,0.386,0.411,0.106,0,0.44031,138.9615,0.7488,8.6755,0.4682,1.597059,0.0805,0.69949,0.0021,30.35,2.004038,4.290082,0.0364,0.00133,0,1.186575,145.82,4.71,0,1.015,10.31,0,0,4.798,140.1,8.582,72.09,352.9772,4.23,2.3,84,181.62,0.1,79,131,111.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,NA,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
630,60,59,1,2,50.93,158.98,20.03111,1.52,7,0.052407253,0.62827756,0,2,5,7,5363.178,2,2,417.08,42.94,67.17,13.89,14.83,0,0,0.0198868,0.0028,26.57,0.14,4.98273,2.1946,0.199,0.093,0.199,0.135,1.557,0.756,98.8,121.32,44.2727,0,1.5e-4,0.0074,0.070005,9e-4,0.657,0.367,0.685,0.314,0,0.43185,131.6518,2.211,14.4292,0.7029,2.603053,0.2303,0.430704,0.0055,0.53,2.919304,0,0,0.0053,0,0.870629,222.05,4.35,0,0.9871,0.691,0.0118,34.88,4.456,139.1,3.418,64.07,379.1299,6.05,1.52,72,162.01,0,78,111,54.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
631,71,71,0,1,45.35,143.11,22.99158,1.33,6,0.046313523,0.55561037,0,1,3,6,814.107,1,1,NA,46.18,218.21,12.98,14.92,0.002865,0.0036,0.0538904,7e-5,29.97,0.191,9.08573,2.2804,0.381,0.27,0.012,0,0.732,0,107.7,78.25,53.9959,0.23,8e-5,0.0121,0.099872,0.0098,0.382,0.147,0.282,0.111,1.089,0.35351,129.2486,4.1869,11.4599,0.5115,1.474003,0.2184,0.15649,0.0285,0,4.090143,0.601757,0.0346,0,0,1.259966,269.09,3.5,0,0,0.83,0.0436,27.4,3.931,140.1,4.759,67.84,245.0282,5.82,1.23,70,130.67,0,60,127,41.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,NA,NA,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,NA,N,No,NA,Y,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
632,46,46,1,2,64.9,159.71,24.4667,1.68,8,0.070118732,0.8408231,1,2,6,8,10423.432,1,2,624.91,40.17,45.56,16.2,21.06,0,0,0.0400351,4e-5,3.17,0.081,0.05527,2.2285,0.082,0.116,0.132,0.176,0.477,0,103.9,103.25,64.5156,0,0,0.0148,0.00598,0,0.297,0.292,0.135,0.001,0,0.39993,135.1637,1.8999,9.9907,1.6612,1.059143,4e-4,0.055045,0,0.38,2.030448,0,0,0,0,1.000595,191.05,3.21,0,0.9237,0.596,0.0278,0,4.923,140.7,10.233,61.83,287.4479,3.55,1.64,80,158.51,0,80,139,65.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
633,53,53,1,4,69.04,170.89,23.68464,1.82,7,0.022538683,0.27009998,2,4,3,7,19287.847,2,2,1073.27,34,81.92,34.68,34.03,0.001126,2e-4,8.72e-5,6e-5,28.1,0,3.6016,2.3511,0,0.001,0.016,0.044,0.051,0.561,102,105.93,69.6357,0.19,0,0,0.009878,0,0.139,0.386,0,0,0,0.37218,128.8013,4.4308,12.7736,2.709,0.758205,0,0.799678,0.0716,0.03,11.892766,2.774022,0.0223,0.00302,0.001,1.630275,469.31,4.93,0,1.2044,11.281,0.045,0,4.499,136.9,13.174,57.02,279.9317,12.2,1.72,58,171.21,0,92,86,68.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
634,70,70,0,4,56,160.12,21.82981,1.58,7,0.12426213,1.4903934,2,4,6,7,1729.754,1,1,385.62,27.76,67.63,14.99,22.85,2.7e-5,0,0,0,28.93,0.087,0.04078,0,0.013,0.001,0.112,0.113,0.787,0.702,92.3,80.28,56.3677,0.16,1.7e-4,0.009,0,0,0.135,0,0.662,0.554,0,0.40486,123.7945,2.5701,9.8687,1.1492,1.356014,0.0035,0.41382,0.005,0.03,5.45522,0,0.0117,0.00588,0.001,1.170604,206.97,4,0,1.0131,12.063,0,28.21,3.993,134.1,6.856,60.71,298.6926,7.53,1.56,81,160.94,0.1,89,121,56.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
635,46,47,0,1,57.02,155,23.37898,1.56,6,0.042301334,0.50799036,1,1,2,6,1311.746,1,1,415.92,34.08,75.13,19.18,22.75,0,0.0012,0,2e-5,24.78,0.051,1.78428,2.2772,0.144,0.14,0.117,0.091,0.639,0.606,97.2,108.71,53.0262,0.44,0,9e-4,0.201398,8e-4,0.478,0.445,0.173,0.085,2.451,0.32932,107.8452,3.1212,15.1913,6.6884,2.027021,0.1534,0.498434,0.078,0.6,3.638904,4.864164,0.0359,0.00313,0,0,346.84,4.2,0,1.091,13.699,0,34.94,3.842,137.9,10.297,66.51,153.3067,6.28,1.52,79,152.82,0,92,120,54.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
636,67,67,0,4,61.02,158.94,24.24325,1.64,7,0.122916965,1.47419447,0,4,5,7,1439.71,2,2,314.24,43.97,261.31,44.19,36.17,0,0,0.0131197,0.00347,29.91,0.091,6.84738,2.2997,0.117,0.116,0.001,0.008,0.758,0.829,104,86.88,72.8859,0,0,0,0.040762,0.0097,0.023,0.002,0.61,0.656,0,0.3594,116.9838,4.1574,14.5106,0.6332,1.036639,0.2849,0.256865,0.1025,0.53,2.029469,3.059276,0.6786,0,0,1.517962,169.38,4.82,0,1.3824,14.818,0,30.41,4.257,140,7.197,76.91,264.853,3.55,1.61,79,157.91,0,88,125,62.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,Y,Y,N,N,High,High,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
637,56,56,1,2,53.17,164.96,19.26872,1.56,7,0.056624986,0.67939923,1,2,1,7,2637.336,2,2,224.61,33.03,89.58,10.93,20.94,0,0.0017,9.34e-5,0.00397,29.09,0.121,0,2.3115,0.155,0.143,0.082,0.081,0.59,0.721,100,92.04,56.5177,0,2e-4,0.0195,0.034247,0.037,0.446,0.44,0.106,0.219,0,0.36405,113.1128,1.4565,13.5969,1.502,0.905286,0.3365,0.47113,0.1095,0,1.153344,0.629549,0.5707,0,0.001,1.487726,147.09,3.76,0,1.0361,18.051,0,36,4.416,139,18.058,68.36,300.3636,2.09,1.65,80,167.53,0.1,92,120,58.01,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
638,40,40,1,3,81.94,170.19,27.74341,1.97,8,0.036419497,0.43754136,0,3,2,8,4592.854,2,2,347.53,36.91,110.68,42.2,23.41,0,0,0.0399466,0.01005,2,0.075,0,2.3185,0.146,0.186,0.138,0.157,0.697,0.015,104,79.92,122.9587,0.39,0,0,0.09107,0.0319,0.391,0.213,0.209,0.099,0,0.33226,106.4004,1.3581,9.318,1.4603,0.718441,0.2657,0.339946,0.0048,0.69,8.446101,3.420013,0.0272,0.00334,0.001,0.305499,195.06,4.69,0,0.9876,11.093,0,0.35,3.749,138,8.474,72.01,190.2346,9.64,2,89,172.01,0,91,119,81.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,Y,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
639,69,69,0,2,75.03,172.29,24.90944,1.88,7,0.049402744,0.59344068,0,2,5,7,415.726,2,2,154.08,44.01,144.98,28.18,14.93,0.004296,0.0038,3.469e-4,7e-5,24.07,0.169,4.99992,2.3251,0.277,0.221,0.1,0.082,0.633,0.565,0.4,86.61,71.6115,0,1.5e-4,0.1116,0.097838,0.0097,0.589,0.455,0.132,0.118,0,0.43041,143.056,2.6763,12.5331,0.9224,1.220333,0.1588,0.408103,0.0464,0.37,2.50616,0.446489,0.009,0.00671,0.001,0.040923,98.72,4,0,1.0148,12.569,0.009,31.42,4.687,138.9,22.994,71.57,315.657,3.77,1.8,63,168.1,0,71,110,72.58,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
640,82,82,0,3,56.01,156.19,23.12049,1.55,8,0.052511166,0.63069375,1,3,6,8,1474.187,2,2,636.38,27.06,129.36,51.78,85.58,0.003014,0.013,1.069e-4,0.0011,23.75,0,0,2.2177,0.218,0.292,0,0.021,0.414,0.797,102,52.06,65.4873,0.32,7e-5,0.0154,0,0.0113,0.021,0.15,0.329,0.526,1.733,0.37208,120.3733,1.8411,12.521,0.6959,0.329162,0.2698,0.299869,0.1412,10.79,2.052959,6.896015,0.7691,0.00093000000000000005,0.001,1.035783,409.1,4.88,1,1.1762,11.407,0.0043,31.97,4.859,137.1,5.3,66.99,300.678,3.27,1.49,80,155.98,0,96,141,54.28,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
641,69,69,1,3,83.77,175.7,26.83887,2,6,0.206293164,2.47747369,0,3,3,6,8294.966,1,1,318.02,39.91,82.84,7.07,18.94,0,0,2.525e-4,0,24.85,0.001,9.66514,2.3913,0.159,0.286,0,0,0.562,0.85,105.1,61.28,95.9149,0.29,0,0.008,0.148867,0,0.149,0.347,0.306,0.432,0,0.30287,110.0485,1.8097,11.2986,0.6793,0.302929,0,0.700791,5e-4,0.33,5.504985,2.428208,0.034,0,0,1.000878,173.44,4.51,1,1.16,0,0,25.28,4.107,137,5.141,75.64,307.349,5.6,2.01,71,175.1,0,59,112,81.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
642,68,68,1,2,50.91,151.03,22.80855,1.46,7,0.052656269,0.6327435,1,2,3,7,6341.764,2,2,1216.4,6.43,73.96,5.11,8.26,0,0,0.0300228,5e-5,0,0.025,0,2.1775,0.179,0.163,0.008,0.001,0.532,0.603,98.1,78.8,58.4099,0.22,0,0.0019,0.199998,1e-4,0.256,0.211,0.172,0.158,3.351,0.33456,106.2931,0,0.0899,0.3783,1.428425,0,1.216332,0.0055,0.34,4.547583,0.349266,0,0,0,0.770752,385.44,3.79,0,1.0964,10.713,0,33.63,4.27,139.1,8.027,62.82,235.8147,6.62,1.54,90,153.44,0,105,148,54.81,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
643,69,69,0,3,75.09,165.08,26.48943,1.85,6,0.132374388,1.5903284,0,3,1,6,614.634,1,1,117.07,40.96,76.15,9.89,18.02,0.003236,0.0038,0.046403,0,27.94,0.14,3.98557,2.2499,0.626,0.492,0.451,0.278,1.175,0.018,102,71.69,83.432,0.23,0,0.0274,0.255333,0,0.78,0.402,0.34,0.223,0,0.40272,123.9513,1.4533,11.1959,0.484,1.459444,0.0093,0.480107,0,0,5.066947,0,0.0061,8.2e-4,0,1.301187,351.16,4.51,1,1.0204,11.892,0.0178,25.34,3.803,136,12.662,76.71,328.0332,8.82,1.85,69,164.26,0,65,131,77.97,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
644,64,64,0,2,100.93,166.07,36.62763,2.09,7,0.126840182,1.52191125,0,2,4,7,1997.743,1,1,244.69,42.38,101.5,14.09,18,0.902421,0.0304,0.0285014,0,29.71,0.1,12.80815,2.3735,0.129,0.171,0,0,0.393,0.41,101.9,70.53,101.419,0.24,0,0,0.100224,1e-4,0.213,0.379,0.097,0.001,0,0.45696,154.5506,2.6351,11.4155,0.707,0.62058,0.005,0.277862,4e-4,0,3.609455,13.193868,0.7488,0.0037200000000000002,0,1.028596,183.94,4.29,0,0.9814,12.591,0.0358,0.28,5.736,139.6,11.907,75.02,309.9665,5.22,2.24,77,165.06,0,68,139,103.32,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Other,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
645,69,68,1,4,97.73,171.13,32.31352,2.07,7,0.021724452000000002,0.26034576,0,4,3,7,12965.146,1,1,607.36,20.69,76.86,76.84,36.83,0.001421,0.0024,2.68e-4,0.00289,0,0.081,0.08492,2.1913,0.064,0.098,0.058,0.074,0.77,0.801,98.7,73.12,83.047,0.05,0,0.0218,0.043341,0.001,0.544,0.535,0.25,0.319,0.279,0.41475,138.3756,2.4131,9.3621,1.4001,1.020525,0.2015,0.700548,0.0891,0.78,7.967388,5.136924,0.0262,0,0,0,312.48,3.17,0,1.1899,0,0.023,31.02,4.814,141,5.577,51.82,178.904,9.69,2.01,73,172.91,0,96,128,96.71,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
646,63,63,1,2,98.13,169.93,33.27516,2.09,8,0.038255796,0.45919006,0,2,4,8,3402.535,1,2,682.78,41.77,204.19,15.04,25.98,0.002488,0.0018,5.64e-5,0.0049,28.9,0.043,5.32217,2.5472,0.076,0.086,0.007,0,0.347,0,100.4,112.84,69.3525,0.08,9e-5,0.0021,0.201483,0.0418,0.271,0.284,0.002,0,1.286,0.40807,141.2876,3.2087,10.603,1.0974,3.07577,0.1809,0.96123,0.0898,16.42,5.633042,6.193412,0.0316,0,0,1.22458,345.24,4.82,0,1.0097,11.41,0,29.16,4.275,138,8.51,76.09,368.9504,9.33,2.03,90,167.99,0,90,131,99.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
647,62,62,0,2,75.08,171.04,26.17933,1.9,7,0.060852419,0.72999555,0,2,6,7,4411.892,1,1,179.55,38.83,57.94,7.9,15.92,0,0,0.0198646,0.00222,2.09,0.131,4.5896,2.4422,0.435,0.459,0.003,0.024,0.362,0.018,99.9,95.15,70.732,0.11,2e-5,0.0107,0.07954,7e-4,0.268,0.41,0.141,0.168,2.096,0.43994,140.2239,1.2133,9.2109,0.7113,0.817637,0.0069,0.400041,0.0034,0.44,2.432595,0,0,0.00249,0,1.00247,256.11,4.2,1,1.0612,0,0.0565,32.11,4.753,138.9,8.539,71.93,377.7305,3.84,1.8,81,171.19,0,61,115,79.15,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
648,54,55,2,3,66.9,175.04,21.66231,1.81,7,0.067642464,0.80972456,1,3,1,7,12257.549,1,1,345.07,41.97,81.86,14.09,31.24,0.002868,0.004,1.897e-4,0,29.88,0.109,10.25303,2.3822,0.038,0.078,0,0,0,0,103.6,65.42,107.7728,0.07,0,0.0135,0.038108,0,0,0,0,0,0,0.43629,126.0166,0.0106,0.1005,0,1.303975,0.0087,0.305842,0,0,6.098054,5.167465,0.7193,0,0,1.099667,382.32,4.51,0,1.1132,18.684,0,38.13,4.629,139,5.99,67.06,329.6117,8.68,1.91,61,174,0.1,68,127,67.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NA,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
649,57,57,1,3,70.01,184.11,21.49191,1.94,8,0.119884715,1.43877597,1,3,3,8,19553.572,1,1,639.6,33,98.85,314.58,95.7,0.001508,0.0035,0.0200096,0.00713,27.17,0.06,5.79165,2.0028,0,0,0,0.001,0,0,105.1,82.89,76.0411,0.66,1.9e-4,0.0151,0.013353,0.0256,0,0,0,0,1.825,0.31371,114.4102,1.499,8.8241,0.431,0.718649,0.2478,1.158502,0.1723,25.01,5.359142,7.7267150000000004,0.8605,0.00769,0.001,1.095835,279.11,4.39,1,1.0907,10.328,0,26.61,3.876,139.1,2.802,64.68,121.7753,6.53,1.94,60,184.73,0,80,108,69.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,Y,Y,N,N,High,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
651,72,72,1,2,77.64,171.03,26.17835,1.91,8,0.061088631,0.7325404,1,2,1,8,4093.226,2,2,277.23,45.98,129.28,15.05,14.06,0.001162,9e-4,0.0299799,0.00405,28.79,0.116,0,2.3292,0.278,0.153,0.02,0.001,0.815,0.588,98.1,70.71,77.8767,0,1.1e-4,0.0091,0.117472,1e-4,0.498,0.346,0.248,0.181,4.185,0.3564,116.7133,6.2154,13.6041,0.6696,2.030946,0.2463,1.015962,0.0908,0,1.981038,5.62152,0.6641,0,0,1.062303,194.71,4.19,0,1.3908,15.232,0,46.65,4.283,140.1,6.669,77.92,437.5787,4.91,1.9,90,167.92,0,76,121,75.89,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,NA,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,OTHER,Eastern Europe,Y,Y,M,NA,EE,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
652,67,67,0,3,72.97,159.43,28.38574,1.76,7,0.084726915,1.0161539,1,3,1,7,674.129,1,1,509.06,38.98,190.88,17.02,24.14,0.002662,0.0021,0.0268805,0.00284,26.92,0.352,6.31713,2.5227,0.52,0.415,0.198,0.151,0.809,0,0.4,83.4,70.6108,0.38,1e-4,0.0103,0.139891,0.0405,0.381,0.216,0.335,0.227,0,0.35642,110.1463,1.8818,12.9773,0.4956,1.049231,0.2548,0.44037,0.0041,0.71,6.535978,8.301898,0.6405,0,0,1.132152,224.52,3.89,0,0.8786,8.582,0.0175,23.9,3.971,137.6,13.371,79.15,196.2438,9.88,1.78,75,162.64,0,79,113,74.81,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
653,52,52,1,1,82.26,179.62,25.33082,2.02,6,0.083981645,1.00766528,1,1,4,6,4700.57,2,2,121.34,35,66.75,34.78,23.34,2.66e-4,1e-4,0.0099667,4e-5,0,0.001,5.36175,2.1231,0.064,0.122,0.128,0.155,0.526,0.666,91.1,106.89,79.0104,0,0,0,0.049709,8e-4,0.237,0.357,0.197,0.319,0,0.37404,130.3792,1.739,0,0,0.699895,0.0123,0.350148,0.0026,25.1,5.504093,0.676373,0.0052,0,0,0.909554,301.3,3.86,0,0.9954,0.797,0.0361,0,3.929,128.2,6.499,52.08,249.4915,6.47,2.06,60,178.16,0,75,119,81.04,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
656,34,34,1,2,107.92,177.88,34.62156,2.26,7,0.087723377,1.05092739,1,2,2,7,5411.162,1,1,1730.69,34.06,237.69,30,50.44,0.002735,0.0029,3.054e-4,3e-5,22.62,0.078,4.2264,2.1323,0.328,0.238,0.124,0.115,1.178,0.833,93.7,119.03,77.2398,0.17,1.8e-4,0.0145,0.021313,9e-4,0.662,0.496,0.515,0.392,0,0.39694,115.7911,1.2037,7.6547,0.3861,0.390047,0.0105,0.799396,0.0592,0,5.080118,3.199959,0.6207,0,0,1.193983,247.02,4.01,0,1.1055,14.584,0,34.99,5.1,138.1,17.322,65.99,329.9538,6.19,2.07,81,175.04,0,88,123,104.16,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
657,62,62,1,3,50.1,162.03,19.36412,1.53,6,0.018339744,0.21974163,1,3,4,6,6835.299,1,1,162.1,36.07,75.21,37.06,25.02,0.001825,0.001,0.0200015,3e-5,0,0.2,5.3973,2.3012,0.475,0.36,0.154,0.16,1.082,0.746,0.5,78.23,65.798,0.06,0,0.0013,0.200362,1e-4,0.614,0.486,0.477,0.354,3.84,0.33609,118.8683,1.2566,10.0129,0.0066,0.598484,0.0022,0.206938,0,0,4.69036,0,0,0.00109,0,1.131081,285.28,4.1,0,1.1541,0.394,0.0475,63.39,3.872,137.1,8.585,75.28,226.0026,5.8,1.48,73,159.98,0,96,131,48.34,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
658,27,27,1,2,53.95,158.17,20.82372,1.54,6,0.066389049,0.79771269,0,2,4,6,3809.101,2,2,849.53,40.98,105.81,22.06,17.87,0.003428,0.0045,1.123e-4,0,28.04,0.178,11.99581,2.3248,0,0.075,0,0,0,0.735,107.1,120.22,68.0001,0.14,0,0,9.8e-4,1e-4,0,0.217,0.102,0.368,0,0.38904,123.176,1.5831,9.9471,0.5444,0.629296,0.0025,0.412783,0.0024,0.46,4.3855,0,0,0.00238,0,1.130029,294.12,4.67,1,1.0451,14.791,0.032,27.22,4.693,140,9.335,73.9,173.3058,6.9,1.59,69,158.16,0.1,120,121,56.96,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,Y,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
659,18,18,1,1,90.19,175.84,28.9377,2.07,6,0.01012482,0.12140354,0,1,4,6,16843.652,1,1,269.21,44.04,90.32,48.11,42.69,0.002272,0.0012,0.0399229,0.00116,25.69,0.07,0,2.908,0.349,0.112,0.148,0.063,2.109,0.824,101,176.08,53.1185,0.01,0,0.0116,0.236457,0.0291,1.294,0.551,0.672,0.258,0,0.44987,146.9871,4.659,20.1467,7.3258,1.679942,0.1574,0.312325,0.0012,16.94,3.777469,0.427884,0.0141,0.00658,0.002,1.132473,473.33,4.15,0,1.0214,0.41,0.1042,0.48,5.112,141.9,17.018,90.8,333.6008,6.85,2.16,89,177.84,0,108,121,88.53,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
660,70,70,1,2,57.02,168.93,19.82383,1.65,7,0.098619977,1.18201159,1,2,3,7,2463.241,1,1,229.48,41.04,291.8,17.06,39.43,0.001444,0.0026,0.009951,0.00724,27.93,0.14,4.4989,2.5579,0.136,0.141,0,0,0.025,0,103.1,74.4,65.1313,0,0,0,0.159865,0.0599,0,0,0.053,0,0,0.43347,138.3494,3.4596,14.8216,0.6312,1.735556,0.2509,0.499249,0.1214,0.75,3.098918,5.0058,0.5712,0,0,1.217223,107.29,4.01,0,1.1011,13.358,0,41.43,4.8,140.1,10.282,83.15,438.6506,5.2,1.65,69,165.07,0.1,60,126,59.21,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
661,58,57,1,1,68.98,169.87,24.03456,1.77,6,0.219805028,2.6392342,1,1,1,6,5673.829,1,1,140.47,40.63,7.7,10.76,7.85,0,0,0.0399759,4e-5,27.61,0.161,4.40169,2.3521,0,0,0.015,0.001,0.554,0.07,102.2,111.17,64.8242,0,3e-5,0,0.179397,0.0018,0.212,0.004,0.173,0,1.574,0.51728,162.8923,3.7526,18.7534,1.1514,1.884018,0,0.70082,0.0038,17.45,3.938371,0.172489,0.0191,0,0,0.8456,335.1,3.88,1,1.0059,14.453,0,30.68,6.416,141,7.995,84.73,162.4379,7.04,1.8,86,172.23,0,70,132,72.55,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,WHITE,North America,N,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
662,69,69,1,4,68.95,168.91,23.68901,1.77,6,0.04038666,0.4845625,0,4,1,6,6826.613,2,2,244.34,45.01,77.03,8.02,12.92,3.09e-4,0,0.0285029,8e-5,0,0.07,4.20986,2.466,0.433,0.372,0.061,0.041,0.737,0.661,100.1,67.31,83.0132,0,0,0.0043,0.036878,1e-4,0.453,0.306,0.223,0.247,0,0.4507,140.9847,1.5149,0.0981,0.9921,0.912587,0.008,0.501433,0.0038,0.2,8.183004,6.884228,0.6252,0,0,0.726401,449.08,4.71,1,0.9646,10.247,0.0424,33.06,4.787,136.1,15.389,74.12,261.8762,8.81,1.66,80,166.36,0.1,98,119,64.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,Yes,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
663,64,65,0,1,95.82,174.95,30.94275,2.09,7,0.046297515,0.5550721,1,1,5,7,13422.531,1,1,352.01,38.97,63.82,21.91,18.8,0,0,0.0597638,0,30.13,0,9.9268,2.0758,0.07,0.06,0.032,0.051,0.608,0.677,106,85.96,84.9169,0,0,0,0.360287,0,0.365,0.391,0.242,0.242,1.096,0.34843,126.4,1.8047,8.7847,0.9117,1.002961,0,0.659081,0,0,4.487803,0.017087,0,0,0,1.252775,46.68,3.81,0,1.05,13.004,0,31.47,4.221,137.1,28.39,68.99,112.9504,6.3,2.14,74,174.83,0,37,140,99.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
664,70,70,1,3,75.27,175.81,24.73095,1.93,6,0.036210911,0.43474762,1,3,2,6,472.767,2,2,232.61,42.09,77.56,23.12,15.84,0,0,0.0511086,6e-5,0,0.081,9.13683,2.3443,0.089,0.129,0.032,0.061,0.493,0.728,97.3,62.59,89.2977,0,0,0,0.039672,7e-4,0.364,0.471,0.113,0.251,0.368,0.39133,129.8786,1.2433,5.4649,1.1058,1.160014,0.0034,0.36989,0.002,0.34,5.143449,0.360123,0,0.00697,0,0.793315,470.58,4.89,1,1.2222,0,0,29.61,4.098,137.9,8.033,67.91,205.6984,5.71,2,52,174.98,0,59,134,79.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
665,71,71,0,3,91.25,167.04,33.17609,2,6,0.060821907,0.7306936,0,3,1,6,2549.322,2,2,227.01,41.08,78.12,15.02,21.08,0.003051,0.0038,0.0998478,0.00496,29.46,0.124,0,2.2322,0.192,0.124,0.001,0.001,0.794,0.616,98.1,92.43,64.7131,0.27,2.2e-4,0.0059,0.600584,0.0135,0.433,0.372,0.283,0.185,0,0.46148,162.5227,1.5007,6.2957,0.7252,2.586773,0.2061,0.380114,0.003,29.96,5.501405,6.516604,0.6687,0,0,1.207563,516.68,4.06,1,1.1233,11.211,0,0.3,4.907,141,15.95,72.98,219.2472,9.09,2,80,166.94,0,87,130,89.69,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,AUS,Australia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
666,71,71,0,4,67.04,167.86,24.97676,1.72,6,0.080656427,0.96686395,0,4,6,6,8245.734,2,2,438.88,27.98,432.09,36.86,51.69,0.130139,0.0196,0,3e-5,25.95,0.138,4.2902,2.3502,0.169,0.127,0,0,1.346,0.868,100,93.91,65.5082,0,8e-5,3e-4,0.199991,5e-4,0.667,0.397,0.53,0.438,0,0.31835,109.5543,4.3344,14.6239,0,2.280982,0.1785,0.481628,0.0053,26.95,1.797467,2.898509,0.0201,0,0,1.125158,255.32,4.43,1,0.9982,13.579,0.0187,30.94,3.915,135.8,10,71.67,243.9448,4.12,1.71,69,165.07,0,79,107,65.1,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
667,57,57,0,2,47.85,167.66,17.63024,1.53,6,0.044092891,0.52870207,0,2,6,6,1026.613,2,2,243.73,39.59,108.97,13.83,16.08,0.001551,0.0016,0.0200211,0.00906,33.95,0.097,13.87959,2.1644,0.272,0.184,0.072,0.013,0.852,0.463,102.3,103.03,60.5023,0,7e-5,0,0.637711,0.1699,0.543,0.401,0.107,0,1.135,0.41047,131.2341,1.2053,4.837,0.3375,1.940414,0.4235,0.548783,0.1598,0,4.321588,5.289838,0.7799,0.00138,0.001,1.420457,221.02,4.28,0,1.0261,12.396,0.0622,28.01,4.509,142.9,10.718,72.99,214.0474,8.76,1.62,75,169.95,0.1,81,88,51.86,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
668,58,58,0,2,81.92,174.99,27.10595,1.99,6,0.08173041,0.98148216,0,2,5,6,3945.657,2,2,488.68,36.6,101.13,14.9,32.4,0,0,0.0117124,0,19.61,0.001,5.92083,2.3231,0,0,0.001,0.001,0.184,0.748,105,148.51,53.9434,0.38,1.1e-4,0.0184,0.030234,0,0.019,0.277,0.093,0.243,3.399,0.32362,111.0211,1.1936,5.691,1.6245,1.001841,0,0.52024,0,0.69,7.152835,0.113481,0,0,0,1.420373,364.23,3.9,0,1.1098,0.11,0.0045,28.34,4.346,143.9,7.656,65.04,356.8358,8.21,1.96,82,174.74,0,91,129,80.95,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,>4,>1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,Yes,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
669,25,25,0,1,71.01,159.96,27.55045,1.75,8,0.104617671,1.2552871,1,1,1,8,755.756,1,1,228.12,40.03,136.98,12.09,16.01,0.003642,0.0044,0.0081491,0.00184,27.41,0.152,6.19297,2.3763,0.021,0,0.128,0.1,1.257,0.628,101.9,147.66,53.1559,0,0,0,0,8e-4,0.722,0.409,0.393,0.214,1.568,0.37926,123.5428,1.353,9.9036,0.7718,2.418456,0.3101,0.400238,0.0056,18.08,3.995123,6.615306,0.7429,0.00308,0,1.379693,314.28,3.81,0,0.8912,0.602,0.0231,0,4.597,145,4.016,74.03,243.9287,6.32,1.82,70,160.17,0,30,106,76.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
670,51,51,2,2,75.68,182.44,22.99196,1.98,6,0.050608269,0.60852407,2,2,4,6,9860.73,1,1,315.52,37.87,66.91,29.78,30.58,9.08e-4,0,3.387e-4,0,0.87,0.072,3.37876,1.9916,0.005,0.156,0,0.005,0.083,0.744,103,106.63,72.2106,0,1e-4,0,0.044334,1e-4,0,0,0.294,0.574,5.558,0.38385,138.5217,3.3555,12.477,0.8919,0.895352,0.0075,0.499611,0.0037,0.26,4.309735,0.673812,0,0,0,0.050491,199.87,4.51,0,1.136,0,0.0208,37.82,4.529,139,9.235,73.07,240.9294,5.3,2.04,69,184.74,0,75,102,82.5,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158VF,Y,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
671,78,78,0,3,58.09,152.03,24.46928,1.53,8,0.093301929,1.11983763,1,3,5,8,12162.664,1,1,353.39,27.04,280.59,27.1,37.92,9.71e-4,8e-4,0.0099481,0,24.53,0.001,5.50014,2.525,0.227,0.208,0.022,0.016,0.956,0.802,100.1,55.15,70.8938,0.13,0,0,0.501334,0,0.416,0.334,0.427,0.324,0,0.35986,119.3346,3.8629,25.8558,5.2713,1.223965,0,0.898278,0,30.79,3.652695,6.584255,0.0256,0.003,0,1.00645,205.66,3.9,0,1.0067,0.893,0,0,4.414,134.7,21.308,73.7,231.0471,5.8,1.43,64,149.44,0.1,62,130,53.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
672,57,57,0,3,106.03,180.56,32.7365,2.26,7,0.104269415,1.25305183,0,3,3,7,9698.773,2,2,540.96,45.08,84.23,312.81,81.27,1.75e-4,5e-4,0.2061894,8e-5,0.17,0.054,2.46797,2.3275,0.254,0.115,0.313,0.178,1.409,0.739,96.2,87.36,107.9222,0,0,0.0017,0.068585,0,1.017,0.524,0.394,0.213,1.517,0.50993,172.8206,4.0048,17.5228,0.6135,1.199823,0,1.075447,0.0036,0.62,5.928939,2.167523,0.0162,0.00225,0,0.022865,223.94,4.49,0,1.1821,0.055,0,30.55,5.741,139.9,5.143,76.03,363.7499,9.79,2.12,80,181.36,0,57,132,102.83,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
673,63,63,0,4,57.85,155.13,24.16138,1.58,6,0.03141656,0.37706606,1,4,4,6,7917.444,2,2,1965.5,39,57.06,11.95,23.86,6.45e-4,1e-4,0.0111306,0.00501,27.07,0.111,4.9981,2.1427,0.288,0.13,0.095,0.047,1.228,0.402,98.9,61.82,85.1908,0.19,0,0.0129,0.050334,0.0409,0.879,0.364,0.354,0.142,0,0.32466,107.4332,0,0.1317,0,3.430346,0.3887,1.115833,0.1708,0,7.415766,6.723677,0.6101,0.00784,0.002,0.911451,270.38,3.8,1,1.0195,0.026,0.0068,30.13,3.417,140,6.008,51.91,340.7124,10.6,1.56,64,155.28,0,76,109,57.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
674,68,68,1,3,59.95,180.09,19.0386,1.76,6,0.095236793,1.14279981,2,3,4,6,9374.682,2,2,1301.67,27.96,146.31,42.11,74.15,0,0,0.0102809,9e-5,25.34,0,6.90215,2.365,0.32,0.37,0.198,0.157,0.771,0.808,0,46.15,103.1537,0.18,2e-4,0.0046,0.169853,0.0199,0.461,0.41,0.34,0.369,3.44,0.34998,115.4221,2.4631,12.218,0.8585,0.301674,0.0071,1.000047,0.1,0.82,5.695777,8.337172,0.8809,0.00286,0,1.224446,242.05,4.31,1,1.0182,10.901,0,25.58,3.802,128.8,13.466,71.44,204.6761,7.92,1.76,70,178.76,0,77,104,58.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
675,78,77,0,1,68.71,154.97,29.05261,1.69,6,0.152432735,1.82801034,1,1,4,6,3200.073,1,1,254.12,34.71,97.41,10.13,16.17,0,0,0,5e-5,0,0.087,5.32757,2.0766,0.246,0.386,0.11,0.074,0.665,0.819,102.9,81.8,55.9362,0,0,0,0.100531,7e-4,0.23,0.375,0.414,0.592,0,0.29491,96.9925,3.6147,14.835,1.0183,0.720885,0,0.411624,3e-4,0,3.902749,0,0,3.3e-4,0,0.169847,246.89,3.53,0,1.032,0,0,28.95,3.585,138.1,7.991,73.05,196.1619,4.66,1.7,71,151.62,0.1,80,119,63.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
676,59,59,0,2,80.12,166.96,29.09507,1.92,7,0.053134139,0.63704048,0,2,2,7,1789.772,2,2,186.05,43.01,159.33,31.23,21.68,0.057185,0.0039,3.276e-4,0.00303,28.24,0.251,6.20841,2.428,0.002,0,0.043,0.048,0.572,0.496,116.8,83.06,76.9138,0.21,9e-5,0.0116,0.160981,0.0411,0.243,0.284,0.17,0,1.961,0.41914,140.1728,3.2721,14.2393,1.1244,2.383577,0.1981,0.378834,0.0689,16.24,5.696783,5.214925,0.0331,0.00212,0.001,1.351407,334.02,5.11,0,0.9525,13.481,0.0102,0,4.55,144.9,5.491,69.91,274.1444,7.81,1.91,74,163.96,0,78,135,77.85,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
677,63,63,0,2,55.96,164.95,20.70283,1.61,6,0.019848209,0.2379902,0,2,2,6,1816.085,1,1,307.19,46.94,62.9,23.37,72.87,0.001186,0.0013,0.0281536,0.00796,21.83,0.08,8.04754,2.1742,0.141,0.32,0.06,0.152,0,0.008,106.8,80.63,71.8118,0.39,1.4e-4,0.0198,0.119182,0.0395,0,0.419,0,0.083,1.204,0.39401,135.3856,1.0429,0.1082,0.2882,0.339509,0.2859,0.068073,0.0814,29.97,2.896305,0.091255,0.496,9e-4,0,1.065084,216.17,4.4,0,1.0307,0.081,0.9166,0,3.956,142.1,6.812,62.99,302.9783,4.31,1.51,62,164.99,0,67,104,55.19,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,Yes,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
678,70,70,0,3,91.77,181.57,28.61397,2.12,6,0.078480193,0.94202416,1,3,5,6,1994.905,2,2,418.53,38.12,84.15,16.05,17.14,0.001509,0.0017,0,0,26.75,0.039,3.74481,2.4913,0.361,0.366,0.109,0.079,1.071,0.711,102.9,92.04,70.9998,0.27,3e-5,0,0.490442,0.0059,0.482,0.264,0.594,0.359,0,0.40837,145.3305,2.5136,8.8366,0.7715,1.393398,0.0069,2.276795,0.0111,0.24,3.345261,4.955889,0.5613,8.8e-4,0.001,1.138918,366.26,3.99,1,1.0599,11.398,0.0443,45.78,4.227,139.9,10.271,73.02,279.1293,6.43,2.2,99,178.93,0,87,152,90.79,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
679,61,60,0,2,78.1,177.87,24.63818,1.96,7,0.083162458,0.99754785,1,2,6,7,3860.47,1,1,NA,40.08,331.88,30.1,32.34,0,0,0.0220136,8e-5,23.38,0.081,4.29862,2.3019,0,0,0,0.013,0,0.645,103,101.78,72.219,0.23,6e-5,0.0133,0.256415,8e-4,0,0.008,0,0.21,6.546,0.38537,132.0951,1.1938,0.096,0.0053,0.858031,0.0123,1.489095,0.0903,0.24,6.686557,5.701123,0.5168,0,0,0.965637,282.54,4.5,0,1.305,0.819,0.0784,35.97,4.559,136,8.562,68.92,226.1191,8.82,1.92,75,180.11,0,70,119,82.61,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,< 65,>= 70,>= 75,II,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,NA,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
680,77,77,0,2,44.09,151.53,19.2675,1.38,6,0.042788165,0.51389097,0,2,5,6,5954.398,2,2,248.11,39.18,108.98,9.75,19.97,0.002375,0.0031,0.040101,7e-5,25.19,0.13,0,2.2272,0.193,0.124,0.112,0.074,0.724,0.603,0.5,71.87,52.0484,0.17,0,0.0154,0.044535,0.007,0.44,0.328,0.25,0.224,0,0.37607,129.7819,1.0783,0.0954,0.003,1.52994,0.2322,0.640897,0.0598,0.37,6.52155,3.992445,0.029,0.00464,0.001,0,256.87,4.71,1,1.0227,12.363,0,37.82,4.177,138,11.973,65.04,113.7713,10.02,1.39,77,149.92,0,80,147,42.08,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
681,75,76,0,1,103.19,162.46,40.85871,2.08,6,0.102746974,1.23274658,0,1,2,6,2846.757,2,2,309.54,42.98,56.27,11.99,16.97,0,0,0.0189433,0,29.31,0,12.19005,2.2313,0.031,0.008,0.101,0.065,0.95,0.789,102.9,63.22,88.651,0,0,0,0.139814,0,0.457,0.382,0.351,0.252,1.524,0.31838,110.1463,1.8787,9.1829,0.5816,1.446725,0,0.398996,0,0.5,4.264461,1.961452,0,4.2e-4,0,1.019746,101.82,3.91,1,1.0935,10.443,0,17.96,3.933,136,9.4,66.82,249.6532,6.44,2.02,80,162.69,0,77,160,100.55,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,POSITIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
682,74,74,1,2,50.02,157.82,20.30531,1.49,7,0.0580238,0.69545365,1,2,2,7,2055.049,1,1,190.45,34.05,263.91,22.05,43.47,4.69e-4,0.0014,0.0199003,2e-5,29.64,0.208,3.3864899999999998,2.3292,0.208,0.176,0.197,0.161,0.599,0.499,97,53.48,81.0154,0.47,0,0.0042,0.399525,0.01,0.49,0.387,0.182,0.001,0,0.32253,103.1335,4.1445,16.8916,1.4397,1.440227,0.054,0.350996,0.0549,0,3.194111,6.051162,0.0285,0.00671,0.001,1.226224,139.74,3.99,1,0.8156,12.985,0.0189,36.73,3.922,137,8.549,62.42,208.4553,6.19,1.49,100,157,0,91,132,50.15,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
683,41,41,0,2,58.08,167,21.08003,1.65,7,0.05954106,0.71502013,1,2,5,7,328.622,1,1,305.19,39.93,74.48,20.17,16,4.12e-4,3e-4,0.0997288,0.00968,29.14,0.031,5.87739,2.3412,0.468,0.214,0.357,0.155,2.005,0.684,98.1,87.31,83.0795,0,0,0,0.199968,4e-4,1.308,0.592,0.727,0.176,2.51,0.39995000000000003,132.6716,2.9691,14.3966,0.5582,1.680555,0.1444,0.440142,0.005,0.16,2.794025,0.471629,0.0133,0,0,1.195461,329.09,4.15,0,0.9992,0,0.0607,28.4,4.483,136.9,6.882,79.25,298.1968,5.6,1.63,65,167.89,0,71,118,61.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
685,74,74,0,2,104.18,167.02,37.48535,2.08,8,0.050096725,0.60110136,0,2,5,8,1427.029,2,2,156.92,42.04,85.46,20.76,14.1,0.001544,0.0018,0.0506598,2e-5,3.24,0.09,5.19773,2.472,0.14,0.183,0,0,0.425,0.496,100,72.88,80.5395,0.02,9e-5,0.0133,0.39995000000000003,9e-4,0.272,0.319,0.065,0.084,2.76,0.46105,148.3693,2.2186,7.4069,0.3702,0.300358,0,0.544525,0,0.64,4.649042,0.405938,0.0216,0.00206,0,0.807689,197.33,4.2,1,1.0079,11.725,0,28.92,4.89,137.9,15.288,66.86,499.884,6.55,2.06,93,167.12,0,75,159,103.51,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,DEU,Germany,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
686,67,67,0,2,83.54,171.95,29.01064,1.98,6,0.074602208,0.89490489,1,2,1,6,4094.528,1,1,334.29,46,61.83,32.19,31.06,0.001678,0.001,0.0612528,7e-5,2.55,0.159,5.47362,2.3799,0.129,0.1,0.06,0.026,1.348,0.807,103.1,78.41,78.8321,0,1.4e-4,0.015,0.200009,8e-4,0.654,0.429,0.521,0.386,0,0.43909,151.1171,0,5.7006,0.0073,2.040171,0.0108,0.467402,0,0.49,4.001015,0.452301,0.6134,0,0,0.839653,140.71,3.89,0,0.9905,0,0.0878,25.04,5.115,144,13.015,73.93,273.9084,6.29,1.91,81,169.95,0.1,76,136,81.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
687,70,69,1,4,51.44,145.95,24.09159,1.42,7,0.028374537,0.34074087,0,4,1,7,1668.855,1,1,1288.15,42.06,125.86,11.38,17.01,0.003898,0.0037,0.04127,0.00595,22.76,0.147,7.3311,2.4851,0.348,0.191,0.049,0.044,0.771,0.016,99.9,92.33,56.3288,0,2e-5,0,0.201523,0.0099,0.436,0.328,0.221,0.001,0,0.42409,139.0464,2.7001,13.6072,0.924,2.040155,0.2391,0.794184,0.1604,0,3.943494,8.915573,0.77,0,0.001,0.039759,305.68,4.51,1,1.0016,12.973,0.0482,33.83,4.925,139,17.066,73.97,231.9942,6.53,1.35,79,145.04,0,87,131,49.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HH,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
688,60,60,1,2,77.8,169.83,27.13369,1.89,7,0.026869155,0.32255322,1,2,2,7,3178.654,1,1,1636.52,42.06,359.87,31.05,59.1,0,0,0.0614169,0,26.5,0.091,0.00181,2.2927,0.345,0.252,0.17,0.113,1.412,0.704,98,102.34,62.9405,0.15,1.4e-4,0.0155,0.323209,0,0.834,0.405,0.481,0.277,0,0.35743,119.2442,1.2583,13.6056,0.3314,2.66297,0,1.741118,0,0.7,9.346459,0.393408,0.0027,0.00328,0,0.228827,355.84,3.64,1,1.0438,12.171,0,29.02,3.952,140,6.962,78.96,160.0653,18.65,1.91,89,169.17,0,71,142,77,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
689,53,53,1,2,91,171.16,30.03792,2.05,7,0.037075688,0.44500978,0,2,3,7,4798.436,2,2,215.69,39.02,129.3,39.54,20.13,0,0,0,6e-5,25.93,0.043,0.09881,2.3012,0.154,0.087,0.089,0.035,1.196,0.813,97.8,112.87,74.7437,0,1.7e-4,0,0.299635,0.018,0.633,0.363,0.453,0.322,0,0.38125,118.5386,4.2861,14.3312,2.261,2.094461,0.2283,0.902213,0.0476,0.63,5.100647,0.580274,0.6406,0.00182,0,1.130049,218.12,4.11,1,1.1976,14.885,0,25.93,4.364,140,11.957,83.59,399.1204,9.37,2.06,79,170.12,0,99,131,92.57,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
690,39,38,1,2,44.97,160.04,17.62696,1.43,7,0.1991134,2.38241331,0,2,5,7,11907.046,2,2,451.61,42.55,249.74,10.93,19.9,0,0,0.0279707,0,27.92,0.035,5.21428,2.4608,0.033,0.072,0.024,0.047,0.496,0.765,91.1,122.73,42.822,0,0,0,0.249946,0,0.233,0.384,0.292,0.314,0,0.30892,107.6668,2.5986,9.5896,0.3111,0.510449,0,0.969269,0.0043,0,2.766528,0.10402,0.0052,0.00201,0,0.057434,255.99,3.6,0,1.007,9.548,0.013,36.89,4.009,132,9.291,76.58,160.0876,3.82,1.41,58,161.08,0,81,42,42.59,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
691,81,81,0,4,49.12,155.96,20.50805,1.46,7,0.032518915,0.38933881,1,4,4,7,2799.147,2,2,680.31,33.72,67.19,11.06,28.13,0.002965,0.0024,0.0200174,0.00684,0.94,0.031,3.92694,2.0755,0.122,0.215,0,0,0,0.005,97.2,70.58,53.9258,0.32,9e-5,0.0062,0.100763,0.0204,0,0,0,0.199,0,0.34195,115.3363,0,7.8202,0.4595,1.217781,0.2589,1.414877,0.1444,0.64,4.658483,3.421098,0.7047,0.00165,0,0.664966,377.25,4.46,0,1.042,11.533,0.0362,30.58,4.204,132.3,7.999,54.97,270.0574,7.32,1.38,64,157.18,0,96,108,50.29,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,NA,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
692,76,76,1,5,72.59,175.08,24.10446,1.9,7,0.019065932,0.22855658,0,5,5,7,13091.625,1,1,899.78,34.02,80.18,28.91,25.9,5.09e-4,0.0017,0.0392574,0.01472,2.56,0.141,6.79266,2.0998,0.58,0.295,0.195,0.103,1.422,0.724,100,68.75,83.0572,0,1.8e-4,0.0143,0.060599,0.05,0.983,0.56,0.335,0.156,0,0.35997,122.6255,2.2664,9.9585,0,1.647188,0.3894,1.101539,0.17,0.17,2.771144,5.172301,0.5807,0.00105,0.001,1.076578,120.69,3.8,1,1.0216,8.363,0,32.47,4.461,139.1,26.544,71.06,388.9995,5.01,1.83,63,174.79,0,92,116,72.92,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
693,60,60,1,2,73.05,161.65,28.63738,1.78,7,0.05021865,0.60253295,1,2,5,7,32876.362,2,2,592.26,36.14,73.15,23.75,45.46,3.49e-4,0.001,3.552e-4,0.00191,3.17,0,5.75393,2.4492,0.27,0.275,0.159,0.108,1.753,0.854,101.9,103.62,65.0911,0.16,0,0.0052,0.689806,0.045,1.203,0.558,0.625,0.389,1.136,0.24358,93.7533,4.4204,14.3962,2.4969,0.727264,0.0078,0.733595,0.0797,0.65,5.974887,0.100367,0.0376,5e-5,0,1.327502,664.81,0,0,1.0991,10.129,0.065,26.94,3.994,141,5.112,68.62,319.2659,8.24,1.75,66,160.97,0,90,121,72.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,2,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
694,55,55,0,1,87.04,181.17,26.18428,2.06,6,0.053767535,0.6459394,0,1,3,6,1865.825,2,2,377.45,48.88,179.97,18.83,20.02,0,0,0.1027103,0.00109,29.22,0.263,3.59984,2.4999,0.269,0.268,0.112,0.1,0.932,0.841,105.9,106.63,70.894,0,1.7e-4,0.0023,0.35049399999999997,0.0156,0.672,0.553,0.413,0.463,0,0.42306,140.2689,1.2742,0.1019,0.8024,0.745447,0.0134,0.131083,0,29.97,2.802978,0.198495,0.0379,5.5e-4,0,1.000172,187.47,3.89,0,0.9706,10.192,0.01,0,4.898,140.1,18.089,70.29,220.0555,4.41,2.03,52,183.05,0,64,101,88.78,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
696,77,77,1,3,78,180.07,24.05626,1.98,7,0.061782787,0.74107109,1,3,1,7,1057.789,2,2,932.03,47.1,254.74,18.54,26.93,0.002424,0.0024,0.1296449,0.00553,27.01,0.002,9.28971,2.502,0.401,0.423,0.124,0.138,0.611,0.606,103,74.55,61.9192,0.1,1.6e-4,0.0174,0.098093,0.0161,0.409,0.366,0.165,0.224,3.09,0.46415,153.8307,2.2097,14.8792,0.6826,0.931464,0.228,0.259814,0.0991,0.7,2.83526,6.578099,0.7945,0.00129,0,1.215465,234.8,4.5,0,1.0288,10.419,0.0161,0.66,5.24,137,23.98,76.09,344.027,5.1,1.92,100,179.49,0,84,188,75.67,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
697,70,70,1,4,73.04,163.7,26.27245,1.79,6,0.089235641,1.07011602,0,4,6,6,14120.334,1,1,209.13,35.91,59.16,14.05,17.32,0,0,0.0199687,5e-5,30.79,0.081,9.51144,2.2341,0.113,0.094,0.026,0.03,0.184,0,0.3,97.08,51.3317,0,1.3e-4,0,0.273424,8e-4,0.22,0.008,0.081,0.002,0,0.33215,103.0454,0,0,0.3261,1.002846,0,0.650339,8e-4,0.03,4.728551,0.100376,0,0,0,1.066404,251.3,3.61,0,0.9336,11.523,0.0233,24.03,4.163,136,8.706,60.61,130.9596,6.83,1.84,70,167.92,0.1,84,131,79.34,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VV,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
698,79,79,1,5,72.1,170.14,24.92271,1.84,6,0.068501641,0.82006312,1,5,4,6,7477.823,2,2,1094.67,40.99,90.73,23.82,43.68,0.001924,0.0011,0.015771,9e-5,27.16,0.08,0.0544,2.441,0.099,0.209,0,0,0.007,0.013,102.2,59.88,77.1887,0.17,0,0.0037,0.395939,6e-4,0.017,0.341,0.003,0.001,0,0.43958,135.4661,1.1567,11.2935,1.1661,1.293594,0.0062,0.699954,0,0.75,3.995543,4.699843,0.0369,0.00164,0,1.146828,238.82,4.1,0,0.9979,12.333,0.038,0,4.222,146,10.141,63.91,362.1882,6.39,1.8,81,168.99,0,81,147,76.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Other,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
699,62,62,1,1,90.19,166.07,33.24161,2,6,0.06114904,0.73353756,0,1,2,6,2682.595,2,2,624.56,34.1,16.54,23.33,25.85,0,0,0.0300181,0.00385,23.64,0,6.38183,2.1763,0.114,0.123,0.043,0.059,0.373,0.639,99.4,64.63,102.5874,0.02,2.3e-4,0,0.040113,4e-4,0.054,0.23,0.211,0.292,0,0.37094,131.4532,0,9.4965,0.6899,1.228388,0.2259,0.520014,0.058,10.57,9.238043,12.682649,0.7951,0,0,0.088877,193.03,3.91,0,1.4815,11.52,0.0202,0,4.711,138.9,7.005,59.98,416.0926,8.76,1.92,53,164.96,0,69,88,87.82,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HH,158FF,N,Y,Y,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,North America,NA,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
701,67,67,0,2,52.14,170.04,18.66087,1.61,6,0.021619917,0.2594865,0,2,2,6,2158.918,2,2,167.82,41.1,55.94,19.81,9.93,4.97e-4,1e-4,3.048e-4,0,26.01,0.07,6.5209,2.2965,0.118,0,0.543,0.17,2.234,0.744,101.9,60.22,87.1026,0,0,3e-4,0.140209,0.0024,1.226,0.46,0.75,0.196,0,0.37789,122.1304,2.2969,16.4901,3.3724,3.03633,0.2323,0.269482,0.003,23.16,6.197542,0.283805,0.0203,0,0,1.041965,195.14,3.39,0,0.9597,11.611,0.0423,0.06,4.517,124.6,10.276,73.92,0,10.5,1.55,60,169.76,0,63,109,51.44,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,1,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
702,51,51,0,1,54.72,163.03,20.64334,1.58,7,0.018902333,0.2268362,1,1,2,7,313.202,2,2,294.56,31.06,79.13,40.49,40.15,0,0,0.0279622,0.00407,21.91,0.119,2.73238,2.1972,0.276,0.317,0.078,0.11,0.433,0.021,93.1,136.66,37.3772,0,5e-5,0,0,7e-4,0.39,0.438,0.036,0.002,0,0.36094,122.7768,3.9686,16.8512,0.6121,0.799985,0.0125,0.50039,0.0496,0.35,4.44082,0.322771,0.0328,0.00419,0.001,1.189198,215.35,3.02,0,0.9525,12.761,0,33.04,4.447,135.3,8.524,67.1,59.0809,5.35,1.55,87,164.95,0,78,138,55.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
703,60,60,0,2,104.95,174.96,34.47969,2.19,6,0.172076975,2.06565295,1,2,4,6,2581.637,1,1,242.77,33.98,139.7,18.56,28.55,0,0,0.020003,5e-5,22.11,0.155,9.09974,2.2922,0.479,0.293,0.249,0.196,0.935,0.004,104.9,72.28,91.0541,0,0,0,0.004357,1e-4,0.894,0.452,0.225,0.001,0,0.31803,104.3242,1.1007,7.2089,1.1699,1.288369,0.0868,0.678975,0.066,0,5.320816,10.219308,0.8309,0,0,1.155549,88.99,5,0,1.0797,12.803,0,29.55,4.106,141.1,13.681,63.96,602.3772,7.58,2.32,80,173.08,0,79,136,101.63,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
704,38,38,1,3,65.03,163.04,24.51077,1.69,6,0.075853983,0.910899,0,3,2,6,18672.982,1,1,1237.42,31.48,82.38,34.63,29.23,0.003908,0.0043,1.317e-4,0,24.06,0.2,5.48119,2.5594,0.072,0.003,0.078,0.045,1.238,0.715,102.1,94.02,78.6524,0.27,0,0.0123,0.005578,0,0.837,0.415,0.382,0.199,0,0.35913,114.3657,1.5511,6.991,1.051,1.192515,0,0.580384,0,0,11.314156,6.373556,0.591,0.00603,0.001,1.032135,309.95,4.1,1,1.0884,14.111,0,32.88,3.939,143,5.111,71.81,226.1811,11.76,1.77,90,163.06,0.1,92,120,63.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,High,Elevated,N,Yes,< 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
706,57,57,1,2,105.23,179.07,32.65855,2.22,6,0.026849915,0.32227985,2,2,3,6,3268.799,2,2,234.11,38,73.19,13.82,16.98,9.77e-4,0.0011,0.0563053,0,28,0.207,4.99139,2.5009,0.152,0.098,0.085,0.045,1.521,0.868,102.1,124.12,65.2283,0,0,0.003,0.230194,2e-4,0.851,0.483,0.64,0.423,0,0.38426,126.7322,5.1304,12.2024,1.2007,1.63929,0.004,1.03168,0.0027,0.32,3.119245,0,0,0,0,1.223989,140.07,2.74,1,0.947,12.313,0.0223,22.82,4.613,138,32.446,69.04,571.9438,6.37,2.08,76,179.09,0.1,120,120,104.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
707,64,64,1,2,100.71,173.97,32.89128,2.14,6,0.109815694,1.31714378,0,2,1,6,888.857,1,1,192.55,41.93,80.41,23.89,16.9,0.003271,0.004,0.0099253,5e-5,0,0.121,5.43368,1.9782,0.091,0,0.249,0.148,1.155,0.663,92.9,110.28,68.0737,0,0,0,0.450573,3e-4,0.727,0.392,0.446,0.217,2.686,0.35123,133.0756,2.9033,6.2994,0.4806,2.109603,0.11,0.220115,0.0041,10.81,1.732858,0,0.5095,0.00679,0,0,182.73,3.6,1,1.0451,12.023,0,29.16,4,140,5.151,57.05,150.7039,4,2.21,88,174.72,0,86,130,103.36,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
708,70,71,0,1,69.9,166.99,24.33463,1.8,6,0.0417322,0.50105302,0,1,3,6,1528.251,2,2,166.83,46.58,86.57,8.84,26.74,0.004241,0.0033,0.0314216,8e-5,24.76,0.425,0,2.7937,0.098,0.094,0.037,0.051,0.842,0.71,100.4,64.73,84.9458,0.29,8e-5,0.0078,0.089537,5e-4,0.412,0.388,0.316,0.243,0,0.44451,146.8806,1.4156,9.3115,0.7997,1.476333,0.0061,1.090286,0.0302,31.57,13.280306,6.917541,0.6241,0,0,1.066578,124.54,4.21,0,0.8788,0.314,0,28.32,4.855,142.1,5.168,72.31,374.8523,15.14,1.83,81,164.93,0.1,73,113,74.85,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
709,66,66,0,3,65.01,159.96,25.0273,1.68,7,0.117356713,1.40854635,0,3,4,7,3953.376,2,2,650.65,27.35,144.17,28.91,27.24,0,0,0.0599686,0.00269,22.32,0,261.60572,2.273,0.003,0.004,0.001,0.001,0.58,0.495,104.1,60.97,106.1539,0.16,7e-5,0.0042,0.401335,0.029,0.362,0.333,0.163,0.001,1.379,0.30585,90.7526,0.0136,9.0592,0.4991,1.395469,0.1289,0.75146,0.0471,0.56,7.796507,0.413457,0.5334,0.00847,0.001,1.24869,710.15,4.6,0,0.9743,11.85,0.0564,29.73,3.466,137,3.407,63.93,397.4725,11.49,1.73,60,160.71,0,74,104,67.42,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
710,46,46,0,2,85.67,157.88,34.60982,1.87,8,0.108835048,1.30708416,1,2,6,8,4604.841,2,2,244.38,38.24,66.91,15.05,13.73,0.001713,0.0014,0.0107603,0.0011,25.03,0.085,1.85135,2.2577,0.18,0.066,0.187,0.086,1.1,0.665,100.2,176.71,42.2856,0,1.2e-4,0.0075,0.299612,0.0466,0.445,0.007,0.482,0.277,0,0.35149,123.0323,5.1478,15.1042,3.597,1.002148,0.1367,0.461339,0.0919,0,7.603529,5.617563,0.7029,0,0,1.475147,706.6,4.11,0,1.0005,11.048,0,29.96,4.024,140.8,8.424,75.89,256.8933,10.57,1.87,79,160.19,0,83,130,86.34,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
711,73,73,1,3,77.67,173.98,25.82619,1.92,7,0.091536768,1.09862115,1,3,3,7,2988.07,1,1,277.36,36.03,80.93,27.37,21.71,5.55e-4,3e-4,5.75e-5,0,22.53,0,5.04893,4.707,0.108,0.192,0,0,0.149,0.724,101,68.79,83.0087,0,1.1e-4,0.0042,0.009868,0,0.24,0.476,0.086,0.181,0,0.3642,114.5477,1.8085,6.9166,0.8947,1.199687,0,0.64902,0,0.72,5.400356,3.021557,0,0,0,0,244.17,3.66,0,1.0097,0.142,0.0379,22.55,3.603,139.9,11.069,53.99,416.0155,8.4,1.96,71,172.95,0,91,133,77.11,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NA,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,Y
712,74,74,0,2,82.34,168.02,29.60923,1.95,7,0.076926122,0.92363147,0,2,6,7,2786.137,1,1,1622.13,44.01,280,32,16.89,1.36e-4,8e-4,0.0199664,0.01054,0,0.002,8.45436,2.2972,0.145,0.084,0.026,0.008,0.943,0.761,103,78.31,80.2685,0.2,1.5e-4,0.0202,0.1401,0.0196,0.491,0.425,0.308,0.23,0,0.45018,145.7583,2.8999,17.0504,0.7533,1.842051,0.2602,0.719064,0.0909,0.54,10.032653,2.769659,0.6916,0.00427,0.001,0.849328,323.11,4.3,0,1.0684,13.624,0.0132,27.39,4.829,139,10.255,63.05,415.0874,9.61,1.91,90,168.99,0,86,129,87.18,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
713,40,40,0,3,76.47,165.75,28.00985,1.86,7,0.050831717,0.6114848,0,3,3,7,1641.225,1,1,1292.01,38.99,117.6,10.75,36.15,0,7e-4,0,2e-5,21.91,0.001,4.39123,2.3339,0.075,0.033,0.133,0.099,0.861,0.774,99.9,137.21,59.0062,0,0,0,0.09935,9e-4,0.562,0.513,0.181,0.199,2.18,0.39779,127.9677,1.8162,12.5625,0.3844,1.597283,0.004,0.651446,0.0594,0.81,6.978574,10.66186,0.8267,0.0042,0.001,0.822294,239.01,4.7,0,1.2147,12.437,0,25.91,4.362,136.5,10.868,66.51,394.8969,11.59,1.78,74,169.8,0,129,95,79.47,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
714,78,78,0,5,58.99,158.01,23.2486,1.58,7,0.042264748,0.50752181,2,5,5,7,9755.565,2,2,282.97,31,50.37,9.02,18.89,0.001551,0.0015,0,0,26.38,0.136,6.51369,2.1958,0.126,0.13,0.127,0.122,0.676,0.708,99,65.65,70.921,0,0,0,0.130503,6e-4,0.154,0.198,0.358,0.423,1.365,0.32503,107.7657,3.4355,10.9981,0.6691,0.699278,0,0.45101,0.0028,0.54,3.927279,0,0,0.00328,0,1.130016,158.51,3.88,0,1.0172,0.724,0.0037,30.84,2.996,135.9,17.065,66.19,278.2685,6.2,1.48,69,157.74,0,94,140,55.8,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
715,58,58,0,4,45.32,144.92,22.4947,1.34,7,0.055470523,0.66646873,2,4,6,7,2767.538,1,1,286.68,33,225.22,17.09,19.88,8.49e-4,0.0022,0,0,24.74,0.002,12.15008,2.3213,0.128,0.125,0.006,0.037,0.408,0.698,102,69.5,75.7798,0.04,0,0,0.171747,5e-4,0.023,0.009,0.224,0.319,2.759,0.34673,115.2837,1.8436,12.8514,1.4386,0.800154,0,0.973667,0.0016,0,7.206937,0.459562,0.0191,0.00608,0,1.294644,344.83,5.28,0,1.2022,19.115,0,42.69,4.504,126,8.581,69.93,274.0585,8.76,0,59,90.99,0,73,95,36.51,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
716,60,60,0,3,112.28,174.89,39.74083,2.28,6,0.101139042,1.2128713,2,3,5,6,9140.999,1,1,494.75,39.94,95.11,18.01,36.86,0,0,0,0,26,0.08,5.49987,2.5019,0.171,0,0.192,0.101,3.052,0.915,105,72.23,104.9873,0.03,0,0.0212,0.1107,0,1.808,0.592,1.197,0.461,3.608,0.3861,128.955,2.6734,14.828,1.0744,2.117767,0.0017,0.437176,0,0,4.251138,0.047741,0.0037,0,0,1.109524,238.1,4,0,0.9079,0.544,0.0089,34.15,4.301,141,6.85,78.83,398.2379,6.33,2.3,66,176.59,0.1,84,129,115.83,0,0,0,0,2,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
717,68,68,0,1,71.6,148.59,33.02928,1.65,6,0.108072674,1.29688645,0,1,2,6,2467.452,1,1,135.76,36.94,81.72,33.7,24.85,8.79e-4,0,0.0200035,0,0,0,6.95207,2.2411,0.132,0.124,0,0,0.758,0.79,101.1,106.96,57.905,0,0,0,2.677803,7e-4,0.483,0.445,0.208,0.232,1.138,0.30464,102.4331,0.0145,0.0679,0.4018,1.618916,0,0.550017,0,0,4.009402,0.441362,0,0.0029,0,1.358483,179.05,4.61,1,1.0905,11.879,0,31.12,3.77,139.9,9.663,62.49,304.7093,6.51,1.67,82,147.93,0,67,140,70.2,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
718,66,66,0,2,83.76,173.82,28.23228,1.97,8,0.137676069,1.65190947,1,2,2,8,2991.37,2,2,168.95,38.08,76.96,28.96,12.97,2.92e-4,0.001,3.175e-4,2e-5,31.99,0.169,8.75949,2.1902,0.251,0.127,0.273,0.098,1.957,0.844,97,88.26,72.3813,0.05,2.3e-4,0.0245,0.10051,5e-4,1.352,0.548,0.618,0.32,0,0.40051,135.1997,1.9213,11.4641,1.0837,1.389774,0.0112,0.449079,0.0082,0.19,4.997547,4.932203,0.7094,0.00287,0.001,1.513066,214.76,2.95,1,1.0353,12.391,0.0524,34.47,4.598,142.1,9.001,58.1,338.5514,6.24,1.89,72,172.91,0,91,119,79.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
719,66,67,0,1,60.17,165.09,21.635,1.67,6,0.163596487,1.96419439,0,1,3,6,1487.821,1,1,442.75,43.88,232.27,11.93,12.38,0,0,0.0299507,0.00495,19.95,0,3.75637,2.3423,0.155,0.161,0.001,0,0.872,0.651,101,128.06,44.2055,0.14,0,0.0026,0.099188,0.0063,0.367,0.256,0.458,0.254,0,0.34438,102.8942,5.1666,10.5979,1.1053,1.256629,0.0098,0.273169,0,15.14,7.083515,4.936598,0.7241,0,0,1.098556,446.93,5.42,0,0.9984,11.046,7e-4,0.75,4.158,142,6.416,75.4,337.6685,8.5,1.77,68,167.48,0,67,120,66.57,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
720,64,64,0,2,87.06,177.88,27.20526,2.05,6,0.016521842,0.19790317,0,2,3,6,8256.526,1,1,428.7,37.01,86.13,39.74,51.74,0.001073,5e-4,0.0320995,6e-5,2.27,0,8.07877,2.3797,0.085,0.164,0.02,0.06,0.304,0.758,0,108.63,67.8824,0,0,0,0.110087,3e-4,0.078,0.37,0.188,0.408,0,0.39631,127.9948,0.0169,4.6033,0,0.801587,7e-4,0.225623,0,0.07,5.202605,0,0,0.00457,0,1.130082,263.78,4.19,0,1.0664,0.975,0.0339,31.97,4.696,134.8,12.087,68.97,305.7866,6.38,1.89,70,176.26,0,94,139,90.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
721,60,60,0,2,93.26,164.96,33.78817,2.01,6,0.045834471,0.55032017,0,2,1,6,3042.026,1,1,227.3,46.02,67.96,52.2,40.06,6.24e-4,5e-4,0.0769663,9e-5,31.34,0.212,8.43176,2.3022,0.259,0.318,0.31,0.193,0.889,0.79,104.9,109.56,75.0507,0.08,0,0.0036,0.450289,0.0068,0.251,0.012,0.649,0.59,3.815,0.37129,119.1837,0.2494,7.1109,0.48,1.405438,0.13,0.698153,0.003,0,5.054221,0.585405,0.0057,0,0,1.162056,242.02,3.4,1,0.9453,14.438,0.0483,28.52,3.98,138.9,8.594,67.99,333.0012,8.89,1.83,76,163.53,0,83,105,84.13,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
724,71,71,1,1,150.83,182.93,52.02491,2.57,7,0.074881042,0.89742087,1,1,5,7,10088.06,1,1,271.6,40.07,161.16,47.03,26.19,0,0,0.0376852,0.00797,30.99,0.148,12.85199,2.9146,0.175,0.136,0.006,0.001,0.703,0.661,101,77.38,106.2827,0,9e-5,0,0.436842,0.0054,0.262,0.229,0.316,0.256,0,0.38502,115.8607,0.1821,7.0118,1.0696,1.301806,0.0112,0.800241,0.005,0.19,2.109034,4.882463,0.0081,0.0057,0.001,1.287303,268.7,4.7,1,1.1069,0.271,0.0532,0.03,4.298,138.9,9.757,70.11,1438.0332,5.09,2.66,80,182.93,0.1,69,149,160.43,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
725,66,66,1,5,57.91,149.58,25.32533,1.52,7,0.195561646,2.34863257,1,5,5,7,8336.766,2,2,298.65,37.99,136.36,14.18,16.8,0.001358,0.0016,0.019858,0,27.6,0,6.1403,2.4386,0.281,0.225,0.019,0.007,0.552,0.135,102.2,69.1,76.9944,0.12,0,0.0084,0.102604,9e-4,0.35,0.179,0.11,0.101,1.501,0.33954,112.3066,2.4633,9.2808,1.4289,0.49706,0.0089,0.30015,0.0011,0,3.690468,0,0,0,0,1.556936,98.85,3.9,1,0.8901,8.944,0,40.53,3.924,140.1,5.996,56.93,285.2314,5.31,1.51,85,150.53,0,97,148,55.58,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
727,36,36,1,3,62.15,179.98,19.37688,1.78,7,0.095390901,1.1439036,1,3,2,7,9347.28,2,2,674.23,34.32,114.63,23.27,43.15,0.002385,0.0028,0.0611072,6e-5,28.48,0.048,7.87197,2.4965,0.04,0.004,0.001,0.008,0.047,0.618,102.1,79.82,91.0059,0.52,0,0.0136,0.019182,9e-4,0.076,0.288,0.046,0.123,0,0.39906,124.3087,1.2785,8.4708,0.0075,0.931658,0.0082,0.271221,0.0047,0.22,6.595242,7.428247,0.7181,0.00323,0,0.78613,305.99,4.66,1,1.01,10.716,0.0368,27.6,4.837,138.1,5,62.01,125.912,8.1,1.74,71,182.82,0,96,106,60.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,NA,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,NA,Y,M,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
728,71,71,0,4,59.17,167.91,21.32879,1.65,7,0.064803018,0.77636939,2,4,6,7,10089.743,2,2,426.06,0,160.41,86.45,26.98,0.001421,0.0011,0.0100227,1e-5,24.49,0.001,11.4307,1.979,0.292,0.273,0.107,0.108,0.818,0.799,99.8,78.87,74.8831,0,0,6e-4,0.006621,0,0.479,0.423,0.289,0.328,1.026,0.00406,64.3531,2.6391,9.3332,2.4961,1.03668,0,0.481709,0,0.25,12.902094,0.558042,0.016,0.00157,0,1.290922,278.65,4.29,1,1.2089,10.237,0.0411,25.96,3.051,134.2,8.529,52.95,210.7909,15.02,1.61,70,168.08,0,100,104,60.43,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HR,158VF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
729,57,57,1,4,63.02,160.12,23.73718,1.66,8,0.120301248,1.4436209,2,4,6,8,16776.056,1,1,916.56,24.92,437.73,26.14,52.15,0.001446,9e-4,0.0198832,3e-5,24.97,0.09,0.03504,2.3738,0,0,0,0,0,0.757,100,89.71,68.2467,0.29,8e-5,0.006,0.006011,0,0,0.016,0,0.217,0,0.33088,93.5794,2.4452,9.1814,0.6991,0.298191,0.0078,0.529098,0.0648,10.79,3.704226,5.067903,0.6995,0,0,1.050424,341.54,4.61,0,1.1118,12.207,0,28.53,4.312,138.1,4.447,55.93,255.1728,4.85,1.78,72,162.76,0,80,142,69.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
730,62,63,1,2,66.27,165.06,24.28418,1.72,7,0.040317853,0.48327718,1,2,3,7,11202.3,2,2,592.12,35.69,129.44,16.18,24.64,0,0,0.0219531,0,31.77,0.378,10.51408,2.3664,0.002,0,0.059,0.021,0.72,0.538,97.1,66.46,86.5697,0.12,8e-5,0.0064,0.009876,0,0.491,0.28,0.163,0.001,0,0.26644,86.3317,1.2335,9.8036,1.0245,1.436869,0.006,0.559823,0.0033,19.28,10.875954,3.590399,0.0067,8.1e-4,0,1.262675,229.5,3.41,0,1.1174,10.311,0,0,3.277,142.1,5.999,60.47,306.987,12.42,1.77,84,168.08,0,73,145,66.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
731,67,67,0,4,59.17,158.14,23.86382,1.59,6,0.125556823,1.50829405,1,4,6,6,12253.028,2,2,947.65,30.07,54.9,9.77,14.03,0.001656,4e-4,0.0300212,0.00198,0,0.201,7.91395,2.3002,0,0.008,0,0,0.042,0.457,98.9,64.74,79.3201,0.2,5e-5,0.0207,0.200883,0.0302,0.237,0.306,0,0,0,0.41455,131.2601,1.2881,6.7978,0,1.402016,0.0097,0.619141,0.0024,0.44,3.950365,0,0,0.00541,0,1.000343,346.33,3.99,0,0.874,0,2e-4,25.41,4.868,143.1,16.281,55.13,407.0328,6.2,1.6,59,158.74,0,70,110,58.08,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,China,ITA,Italy,>= 50 ml/min,NA,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,NA,NA,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
732,64,63,0,3,63.83,162.16,24.22039,1.67,7,0.204275296,2.45150988,1,3,2,7,1480.906,2,2,550.41,41.03,103.3,28.91,42.87,7.33e-4,2e-4,0.0499662,8e-5,28.59,0.1,5.70949,2.0864,0.278,0.124,0.038,0.03,0.792,0.512,110.8,83.29,68.0483,0,4e-5,0,0.299757,0.0104,0.61,0.382,0.18,0.001,1.912,0.39739,131.5794,3.2011,22.8943,1.1738,2.287671,0.1429,0.957168,0.0707,0,3.601859,0.626812,0.0342,0.00159,0.001,1.466264,181.25,4.01,0,0.9812,12.004,0,0,5.419,138.7,17.092,72.26,423.4461,7.25,1.81,92,162.79,0,64,142,68.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HR,158VF,N,Y,N,N,Low,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
733,48,48,2,2,75.06,157.97,30.79889,1.76,7,0.132683131,1.59134307,0,2,4,7,19125.994,2,2,227.21,42.07,159.08,25.16,15.01,0,0,0,0,20.29,0,16.41111,2.4227,0.142,0.097,0.07,0.065,0.619,0.02,102,136.84,55.3501,0.44,0,0.0012,0.179796,0,0.464,0.318,0.111,0,1.122,0.46142,144.9514,2.3394,11.4628,1.0369,0.837749,0,0.005792,0,0.18,3.276946,0,0,3.3e-4,0,1.197788,216.66,4.61,0,0.9943,0.719,0.0423,39.54,5.094,142,8.603,71.93,333.4005,3.77,1.77,81,159.85,2.3,99,163,71.95,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
734,49,49,0,2,128.53,183.27,39.6871,2.38,6,0.110098145,1.32144648,0,2,5,6,16337.798,2,2,712.36,43.9,71.16,31.66,26.93,0,0,0.0259137,1e-4,28.73,0.189,3.90177,1.8932,0.094,0.143,0.15,0.139,0.55,0.717,104,175.48,56.6986,0.29,5e-5,0.0075,0.201328,0.002,0.439,0.415,0.188,0.306,2.089,0.46654,162.7169,2.2713,9.5525,1.2247,0.798527,0.0122,0.229388,0.0023,17.03,3.600962,0,0,0,0,1.162259,104.84,4.3,1,0.9529,10.017,0.0312,42.75,5.291,137,14.885,71.05,368.8072,4.28,2.38,60,184.26,0,81,94,116.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
735,63,63,1,2,52.51,150.56,22.91343,1.46,6,0.025513591,0.30632798,1,2,1,6,2557.329,2,2,163.06,32.04,107.95,18.87,17.99,0.293625,0.0045,0.0200262,0.00781,32.12,0.002,6.0933,2.3036,0.154,0.178,0.066,0.088,0.578,0.764,104,110.14,47.613,0.22,2.2e-4,0.008,0.184056,0.0203,0.423,0.546,0.159,0.194,3.88,0.29445,96.6851,1.2545,14.9986,3.1752,1.269639,0.3274,0.220628,0.0696,31.46,2.606243,4.954689,0.0415,1.6e-4,0.002,1.809195,169.84,3.8,0,1.1261,12.372,0,0.61,4.011,142,8.005,57.08,208.7152,3.94,1.45,86,151.48,0,98,148,54.83,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
736,67,67,1,4,77.78,171.03,26.13495,1.9,7,0.087665183,1.05136423,0,4,4,7,9708.887,2,2,320.44,41.96,164.4,48.22,37.58,0,0,0,5e-5,26.91,0.164,7.83817,2.4688,0.179,0.139,0.101,0.098,0.866,0.691,97.8,71.24,78.7124,0.42,5e-5,0.0284,0.502578,0.0215,0.743,0.569,0.134,0,0.932,0.38337,123.9509,0.9184,5.5037,1.3,1.020584,0,0.823637,0.0517,26.66,5.910983,0.695025,0.0088,0,0.001,1.483882,289.12,4.69,0,0.9191,10.802,0.009,0.54,4.624,137.9,3.45,63.02,625.6424,8.09,2,55,171.99,0,72,106,80.45,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,Yes,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
737,47,47,1,3,57.04,167.05,20.57378,1.64,6,0.022324545,0.26732932,1,3,2,6,9601.482,1,1,346.09,27.09,117.39,16.86,25.8,6.67e-4,8e-4,0.0400144,3e-5,25.98,0.111,0.02816,2.2496,0.112,0.08,0,0,0.614,0.546,101,104.24,61.989,0.43,0,0.0168,0.019574,6e-4,0.103,0,0.31,0.224,0.566,0.33276,88.6482,1.9471,8.8324,0.2454,1.489966,0.1532,0.991979,0.0627,33.44,7.196124,6.922138,0.6692,0.00603,0,0.796301,244.33,4.53,2,1.0324,0.153,0.0316,23.86,3.991,135,4.03,66.51,120.3207,12.44,1.66,62,170.15,0,80,100,61.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,DEU,Germany,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,Y,Y,N,N,High,Low-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
738,56,55,0,3,89.83,162.41,33.501,1.95,8,0.072945268,0.87535274,0,3,3,8,1071.379,1,1,428.31,36.1,45.64,22.09,23.92,0,0,0.0232239,3e-5,1.37,0,6.39846,2.2486,0.126,0,0.274,0.136,1.715,0.834,98.8,109.09,61.9403,0.06,3e-5,0.0114,0.00998,0,1.067,0.487,0.629,0.383,0.799,0.34951,118.4419,0.6918,11.1918,0.6594,2.203779,0.0075,0.602699,0.0048,0,2.620535,0.148959,0.0058,0,0,1.269501,351.48,3.32,0,1.1925,0,0.0087,31.26,4.043,138,15.323,69.94,408.2364,4.8,1.92,60,161.63,0,68,95,86.89,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
739,52,52,1,1,114.54,171.14,41.10259,2.26,6,0.115502548,1.38605448,0,1,1,6,6384.234,1,1,209.9,43.24,168.66,43.34,31.18,0.001403,0,0.0184829,4e-5,27.17,0.105,5.71732,2.3797,0.198,0.082,0.18,0.107,1.07,0.7,101.1,108.99,86.4025,0,1e-4,7e-4,0.139589,2e-4,0.687,0.379,0.376,0.232,0,0.41117,140.8086,0.8645,12.9897,0.7255,1.020373,0,1.2849410000000001,0.0131,0,6.104421,6.817411,0.0198,0,0,1.230941,256.61,4.48,1,0.9878,11.079,0,26.01,4.835,141,15.35,76.96,348.6312,8,2.09,92,171.96,0.1,101,134,110.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
740,62,63,1,2,80.44,167.97,29.04188,1.9,6,0.141314138,1.69661621,0,2,5,6,2157.322,1,1,219.52,45.94,96.69,27.15,24.12,0,0,0.050055,0.00174,22.45,0.112,5.89511,2.3278,0.085,0.132,0.033,0.03,0.372,0.706,104.1,76.49,89.0886,0,0,0,0.010187,5e-4,0.27,0.406,0.152,0.194,3.751,0.42948,144.2236,1.3646,7.0588,0,1.391579,0.2582,0.800221,0.1197,0.76,3.823059,0.519246,0.0245,0.00965,0.001,0.943864,88.74,4.41,0,1.0487,0.259,0,31.22,4.267,140,13.5,76.01,309.9925,6.23,1.99,67,169.9,0,72,116,85.79,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
741,55,55,0,2,88.06,164.95,31.64521,1.94,8,0.177218217,2.12366019,1,2,2,8,3565.191,2,2,154.27,38.96,51.68,12.11,10.65,0.001924,0.0021,0,0,24.72,0,3.08629,2.689,0,0,0.001,0,0.034,0.559,97.3,205.42,38.2477,0,3.1e-4,0.0317,0.136238,1e-4,0.021,0.007,0.006,0.002,0.749,0.36282,119.1762,2.1748,12.4893,1.4571,0.881993,0.006,0.358835,0.0022,30.97,4.007194,4.654893,0,0,0,0.961538,464.89,3.78,1,1.2072,0.204,0.0441,31.69,4.3,142,5.108,69.06,179.6944,5.04,1.88,73,168.09,0,68,137,93.07,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
742,63,63,1,1,105.1,162.2,40.42407,2.08,7,0.034287837,0.41156233,1,1,2,7,6136.983,2,2,147.1,44.12,49.01,15.62,17.01,7.79e-4,0,0.0102827,0,25.02,0.066,5.06342,2.6601,0.031,0,0.033,0.004,0.246,0.011,108.2,85.82,88.0069,0,0,0,0.001245,0,0.03,0,0.051,0.001,0.567,0.45656,151.86,3.6163,11.907,3.9628,1.162862,0.0084,0.28213,0.001,27.94,7.615169,3.526442,0.0291,0.00398,0,1.420221,367.83,5.02,0,0.9595,10.702,0.0091,1.02,4.993,141.1,9.996,80.09,439.1485,9.99,1.96,69,160.72,0,78,129,100.18,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,N,Y,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
743,80,80,1,3,89.29,162.18,34.05734,1.94,7,0.042313903,0.50754754,2,3,3,7,18140.263,1,1,NA,29.86,108.76,22.82,33.94,6.68e-4,0.0021,1.51e-4,0.00207,23.45,0.001,8.91199,2.2764,0.172,0.229,0.001,0,0.678,0.744,101,58.71,90.1717,0.17,0,0.0185,0.742973,0.0405,0.444,0.512,0.191,0.164,0,0.28384,108.1679,2.1893,10.4067,1.3553,1.198744,0.2704,0.258777,0.0969,25.29,1.838888,4.100629,0.0414,8e-5,0.001,1.213043,37.58,4.5,0,1.0025,0,0.0062,25.85,3.292,138.9,8.546,59.05,243.9594,4.28,2,70,162.53,0,55,143,87.73,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,NA,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
745,77,77,0,1,68.07,164.93,25.31109,1.74,7,0.079802429,0.95774072,1,1,1,7,200.422,1,1,210.52,41.07,94.19,14.77,17.03,4.04e-4,0,0.0435656,0.01004,26.99,0.072,0,2.3112,0.251,0.116,0.052,0.018,0.796,0.735,101,96.92,51.0049,0,4e-5,0.0037,0.066881,0.0452,0.525,0.411,0.29,0.194,0.145,0.40792,127.5846,2.9966,5.0165,0.2006,1.423317,0.0929,0.378202,0.0849,0,6.009673,6.190315,0.023,0,0,0,219.7,4,0,1.1053,11.68,0,42.78,4.012,141,6.83,64.22,194.7937,10.52,1.69,69,163.07,0,50,111,68.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,>= 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,NA,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
746,56,56,0,4,59,158.89,23.26877,1.59,8,0.138903285,1.66576969,0,4,4,8,2271.671,1,1,231.43,45.01,93.71,7.87,11.57,0,0,0.0184047,3e-5,25.4,0.086,6.49831,2.5684,0.076,0.053,0.145,0.135,1.003,0.828,103.1,72.82,79.5263,0.07,0,0,0.190559,0.0127,0.564,0.458,0.312,0.305,0,0.39093,120.733,1.382,6.7199,0.7807,1.390682,0.0021,0.175873,0.0595,0,3.026842,2.891672,0.6768,0.00271,0,1.166315,449.23,4.46,0,0.9127,9.869,0.0336,22.44,4.504,142,6.012,80.06,221.6467,4.89,1.65,105,160.94,0,102,155,60,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
747,69,69,0,2,54.94,156.09,22.22018,1.54,8,0.101064746,1.21307424,0,2,4,8,4922.642,2,2,249.74,41.14,145.82,12.27,13.8,0.002345,0.0017,0.0300016,0.00957,0,0.129,0,2.4999,0.281,0.151,0.524,0.163,3.178,0.961,0.5,104.62,44.2035,0.33,3.1e-4,0.0261,0.079854,0.0207,1.844,0.704,1.181,0.472,2.925,0.41638,135.091,1.8539,9.695,0.7093,1.69954,0.1791,0.500522,0.0048,26.6,10.580838,3.902293,0.0046,0.00314,0,1.373065,442.83,4.1,0,0.9087,11.403,0,0.68,4.54,140.8,8.203,64.05,163.3557,14.54,1.56,67,157.82,0,65,119,56.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
748,25,25,1,3,67.9,163.81,25.51324,1.72,8,0.061037667,0.73261641,1,3,5,8,3849.435,1,1,2877.38,39.05,308.74,135.75,202.33,5.15e-4,0.0016,0.0199859,2e-5,25.33,0.151,2.49954,1.9049,0.069,0.102,0.11,0.122,0.467,0,97.3,152.72,56.5198,0.17,3e-5,0.0036,0,0,0.128,0.003,0.065,0.001,4.13,0.2844,102.5922,2.0425,9.376,3.5316,0.760313,0.0572,0.520003,0.0048,17.02,10.955319,5.553185,0.6697,0,0,1.865867,384.61,3.13,0,1.6216,12.484,0.0213,23.73,3.843,140,5.156,61.3,208.1556,12.45,1.75,81,167.92,0,71,132,72.53,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
749,65,65,2,5,60.98,164.16,22.65719,1.66,6,0.021480847,0.25759113,2,5,6,6,21292.208,2,2,1955.16,33.97,165.47,23.87,170.75,0,0,0.0300172,1e-4,23.52,0.071,13.54324,2.0994,0.275,0.319,0,0.018,0.452,0.74,103,90.65,60.1148,0.29,7e-5,0.025,0.050729,5e-4,0.182,0.324,0.225,0.269,0,0.38532,125.3506,2.3121,12.1093,0.8131,1.11293,0.0449,0.489131,0.0052,0.27,6.193682,0.317015,0,0.00384,0,0.765918,233.55,3.5,0,0.9928,11.906,0.0321,27.4,3.94,134.1,25.834,71,260.2409,8.84,1.65,61,164.94,0,75,116,64.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
750,68,68,0,3,58.52,157.98,23.19954,1.58,7,0.096512586,1.15794726,1,3,5,7,1996.056,1,1,242.53,42.47,136.87,13.82,16.1,0,0,0,0,26.07,0.201,10.76594,2.3756,0.091,0.006,0.21,0.144,1.493,0.818,104.9,84.69,63.0876,0,0,0.0047,0.099236,9e-4,0.837,0.605,0.446,0.208,0,0.31871,110.0385,1.3894,10.028,0.7717,1.882514,0.1411,0.300993,0.0047,27.05,3.901808,4.095141,0,0.00416,0,1.351611,328.96,4.28,0,0.9903,0.712,0,22.35,3.998,143.9,5.529,71.02,255.9013,6.99,1.67,54,156.96,0,70,2,60.56,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
751,46,46,0,2,99.04,175.64,30.86119,2.14,6,0.067223238,0.80657387,0,2,1,6,8049.713,1,1,692.13,44.01,51.85,29.02,63.48,0.001982,0.0033,0.0200314,0.00331,30.23,0.098,2.82981,2.5744,0.181,0.141,0,0,0.49,0,100.9,82.6,94.2324,0,4e-5,0.0019,0.140469,0.0318,0.07,0.001,0.184,0.099,0,0.35854,125.1469,1.4876,11.0916,1.2012,2.435453,0.3211,0.602121,0.0756,29.05,5.539522,7.329584,0.6514,0,0,1.199429,131.35,3.85,1,1.1495,12.918,0,28.94,4.488,140,10.601,74.15,279.6508,9.88,2.09,73,176.08,0.1,75,111,92.94,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
752,52,51,0,0,81.94,168.82,28.80043,1.94,6,0.047337063,0.56890122,0,0,5,6,8292.103,2,2,310.14,42.06,35.98,19.77,25.16,8.96e-4,5e-4,0.0087668,0,23.73,0.08,5.6787,2.3484,0.112,0.085,0.117,0.096,0.887,0.775,103,104.6,68.0777,0,0,0,0.100419,9e-4,0.505,0.453,0.289,0.275,1.379,0.39436,129.2084,2.6808,9.5067,1.5914,1.495909,0.0138,0.809706,0.0131,0,6.807467,0,0,0,0,1.544215,244.35,4.68,0,0.9996,11.872,0,26.13,3.987,139.4,6.675,75.82,280.7907,9.11,1.99,80,169.86,0,82,125,83.07,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
753,77,77,0,4,64.9,164.24,24.01954,1.72,7,0.029791539,0.35680671,1,4,5,7,1123.486,2,2,865.86,44,49.06,8.89,14.24,0.00151,0.0015,0.0399412,0.00493,28.5,0.056,0.10567,2.3512,0.191,0.205,0,0.001,0.016,0.433,105,83.24,53.019,0,4e-5,0,0.190787,0.0221,0.016,0.302,0.002,0.085,0.38,0.4693,156.4893,4.348,15.232,1.601,0.599214,0.142,0.703567,0.1011,0.06,3.017901,0.24704,0.0146,0,0,1.000015,71.8,4.29,0,1.0384,0,0,29.4,4.583,139.9,7.656,69.91,255.7509,3.92,1.86,101,167.98,0,58,160,71.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
754,70,70,0,2,50.93,164.94,18.96286,1.54,6,0.084067645,1.00868997,1,2,5,6,5389.853,2,2,145.7,40.83,0,7.19,13.97,0,0,0.0199667,8e-5,24.67,0.112,3.96024,2.3906,0.052,0.165,0,0.02,0,0,105,46.04,91.9965,0,4e-5,0,0.099874,7e-4,0,0,0,0.06,0,0.43201,151.5535,2.931,11.9954,0.59,0.897284,0.0018,1.349617,0.0564,17.03,6.71119,0.487593,0,4.5e-4,0,1.223357,256.02,3.88,0,1.0768,11.782,0,39.69,5.132,139.3,5.125,66.92,422.0585,8.09,1.58,75,163.86,0,116,120,48.47,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
755,72,72,1,1,65.51,169.98,22.65475,1.75,7,0.181743438,2.18240809,1,1,1,7,402.761,1,1,117.63,39,72.78,7.14,2.65,0,0,4.47e-5,4e-5,2.63,0.087,12.2535,2.3535,0.102,0.007,0.084,0.075,1.121,0.79,103.4,58.38,81.3816,0.02,3e-5,0,0.054968,0,0.862,0.562,0.331,0.201,0,0.33135,108.4468,1.547,7.9905,0.1592,2.160273,0.0124,0.337403,0.0054,0.33,5.602574,7.139856,0.5939,0.00255,0,1.069546,195.61,4.8,0,1.0276,10.29,0.0383,0.42,3.725,135.9,11.902,71.05,274.3955,8.4,1.75,72,169.96,0,61,120,67.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
756,66,66,0,2,96.58,189.39,27.04224,2.29,6,0.059073109,0.70928296,1,2,4,6,7512.336,2,2,136.42,26.09,69.22,32.17,21.92,0,0,0.0200116,5e-5,29.67,0.15,1.78838,2.2567,0.002,0.004,0.038,0.041,0.932,0.848,101,63.98,118.8259,0.35,1.7e-4,0.0208,0.03,0,0.178,0.008,0.63,0.518,0,0.36988,134.5739,2.659,10.9815,0.0055,0.998676,3e-4,1.000161,0.0017,7.92,4.678014,0,0,0.00232,0,1.243215,186.43,3.71,0,2.2525,11.414,0.0148,24.8,4.003,135,99.481,47.48,275.1849,8.89,2.21,59,186.15,0.1,77,106,93.91,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
757,65,65,0,2,65.17,160.05,25.51885,1.66,6,0.191848878,2.30115747,2,2,5,6,983.402,2,2,213.61,42.91,79.91,10.45,16.18,0.095032,0.0025,0.0498941,0.00957,31.1,0.16,5.39293,2.2889,0.312,0.251,0.113,0.09,0.725,0.605,103,116.68,38.6896,0,2.4e-4,0.0058,0.190578,0.0671,0.463,0.399,0.219,0.224,0,0.45997,141.537,1.791,9.4361,0.9298,0.703851,0.2512,0.055735,0.1223,0.88,2.377877,7.765421,0.7881,0.00244,0.001,1.290795,281.28,4.2,0,0.9281,12.761,0.0121,27.98,4.504,143.1,6.879,64.95,348.4917,3.39,1.64,70,156.62,0,64,113,59.16,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
758,58,59,0,2,65.05,166.91,24.00491,1.73,7,0.018079592,0.21695293,1,2,4,7,5163.844,1,1,225.24,36.99,198.4,34.35,22.09,0.003071,0.0042,0,0,28.97,0.139,9.71234,2.0501,0.068,0.005,0.179,0.117,1.195,0.85,107,95.73,70.6793,0.41,3e-4,0.2547,0.044359,0,0.701,0.502,0.365,0.299,0,0.2949,104.6477,1.5163,9.8671,0.7717,1.189803,0.1247,0.478311,0.0392,0.14,4.504817,0,0.0336,0.00806,0.002,1.290811,141.36,3.91,0,1.0137,14.43,0,27.91,3.605,141.1,11.992,3.12,294.1657,6.67,1.78,76,167.06,0,102,130,68.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
759,28,28,0,1,84.68,182.08,25.62408,2.07,6,0.0186542,0.22386808,0,1,2,6,1941.823,2,2,209.82,42.89,60.12,22.89,16.08,0,0,0.0300229,1e-5,23.45,0.124,5.43336,2.3728,0.208,0.056,0.184,0.096,1.595,0.799,100.9,92.67,85.8234,0.15,2.4e-4,0.0191,0.194218,0,1.161,0.529,0.473,0.245,0.063,0.44557,153.0297,0,8.717,0.691,1.56594,0,0.709317,0,26.68,4.65018,0,0,0.00162,0,1.19666,195.38,3.7,0,0.9937,0,0.0249,0,4.964,139.3,10.951,76.02,226.0217,7.8,2.13,62,182.3,0,67,93,88.28,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
760,58,58,1,2,95.37,176.18,29.86837,2.11,7,0.065384888,0.78464853,1,2,5,7,7961.673,1,1,443.23,36.96,89.76,20.44,24.13,0,0,0.0589175,5e-5,27.05,0.001,4.81724,2.1298,0.245,0.134,0.246,0.16,1.94,0.868,99,92.02,86.5253,0.11,0,0.0095,0.199983,9e-4,1.583,0.698,0.553,0.29,0.224,0.31931,108.7338,6.073,12.4451,2.3505,0.754586,0,0.657477,0.003,0,10.794332,2.426475,0.0328,0.00257,0,0.913041,276.74,3.79,0,1.0509,10.32,0.0263,0,3.78,133.9,5.154,58.89,196.0247,11.98,NA,NA,NA,NA,NA,NA,NA,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
761,79,79,0,4,103.21,164.94,38.61702,2.09,6,0.087250188,1.04695175,2,4,5,6,2758.048,2,2,185.49,32.1,66.29,12.95,15.47,0,0,0.0607104,0,3.16,0.191,0.08531,2.4273,0.122,0.105,0.049,0.034,0.939,0.835,93,64.23,92.8591,0.1,1.3e-4,0.012,0.223544,0,0.577,0.531,0.336,0.26,4.052,0.38122,123.899,1.9819,9.2768,0.9366,0.712632,0,1.386139,0.0017,0.53,5.49059,0.266833,0,0.00929,0,0.051072,108.43,4,0,1.2004,12.068,0,25.84,4.264,138.1,8.973,64.74,142.9334,7.97,2.3,81,166.95,0,94,129,106.55,0,0,0,0,1,0,0,0,0,0,3,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
762,67,67,0,1,74.86,174.9,24.46231,1.91,6,0.104004532,1.24844207,1,1,2,6,4222.23,1,1,140.69,37,37.54,22.93,18.06,4.9e-5,1e-4,1.072e-4,0,30,0.149,4.60289,1.904,0.06,0.147,0.001,0.033,0,0,107.2,57.2,84.3962,0.17,8e-5,0.0155,0,0,0,0,0.003,0.228,0,0.35828,119.8067,1.1993,9.8492,0.2024,0.600554,0.0135,0.009934,0,0.55,5.794353,0,0.0186,0,0,1.000348,230.43,3.4,0,0.8175,0,0.0202,29.79,4.429,137,7.001,59.77,180.4123,5.8,1.86,77,174.83,0,71,139,72.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
763,49,49,1,4,85.92,176.5,27.12299,2.06,6,0.061480632,0.73764239,1,4,2,6,2287.975,1,1,183.61,36.42,80.38,25.1,34.89,0,0,0.0298072,5e-5,28.04,0.201,8.90555,2.2313,0.209,0.142,0.198,0.171,0.776,0.634,102.2,115.42,72.1695,0.56,1.4e-4,0.0138,0.430157,0.021,0.509,0.396,0.303,0.24,3.162,0.37928,126.5403,1.8056,9.4397,0.0011,0.699613,0.0092,0.801587,0.0564,0.71,5.216621,0,0.0346,0.00533,0,0.849561,160.32,4.62,0,1.3038,12.35,0.0487,0.63,4.405,137.1,14.963,74.04,249.8165,8.2,1.95,80,176.43,0,85,107,84.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
764,48,49,1,4,64.83,170.08,22.65478,1.73,6,0.102950746,1.23506113,1,4,6,6,9678.125,1,1,877.13,31,504.95,23.98,26.27,1.88e-4,0.0014,0.0249574,7e-5,21.07,0.143,12.44713,2.3286,0.065,0.054,0.011,0.034,1.463,0.95,99.1,103.36,69.6828,0.09,0,0.0049,0.04011,0,0.586,0.541,0.812,0.617,0.774,0.38716,130.708,0.1209,10.8015,0.3379,1.637412,0.1883,0.700569,0.0044,17.36,6.305415,8.739501,0.7223,5.7e-4,0,1.047599,80.42,3.69,0,1.2266,0.819,0,27.09,5.166,137.9,18.821,71.04,155.3665,9.9,1.88,66,174.96,0,81,130,69.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
765,68,68,0,2,73.04,185.03,21.63318,1.99,7,0.021661213,0.26015612,2,2,1,7,588.427,2,2,238.15,42.2,57.44,22.1,21,0,0,0.039984,5e-5,23.03,0.041,4.41083,2.1717,0.11,0.105,0.062,0.071,0.579,0.75,101,60.07,97.5376,0.33,0,0.0263,0.109916,3e-4,0.274,0.325,0.212,0.318,0,0.4659,160.0545,0.0096,8.2743,0.4727,1.400425,0.0035,0.599116,0,0,6.342176,0,0,0.00394,0,0.221121,188.64,3.99,0,1.0053,0.099,0,22.46,4.707,138.1,15.393,67.18,249.649,8.7,2,63,185.41,0,57,125,76.96,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,0,131RR,158VF,N,Y,N,N,Low,High,Q2 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
766,44,44,1,2,54.46,156.97,21.79913,1.54,7,0.052670639,0.63211505,0,2,6,7,19034.946,1,1,812.88,25.82,51.19,4.71,13.87,0,2e-4,0.0110543,9e-5,23.99,0.053,12.90238,2.4764,0.173,0.154,0.011,0,0.417,0.589,104,120.06,49.4012,0.05,0,0,0.040249,4e-4,0.25,0.312,0.066,0.062,0,0.30421,92.3343,0.007,10.5738,0.3374,1.136337,0.0119,0.412868,0.0054,0,4.487534,0,0,0,0,1.415825,180.42,4.15,0,1.0956,12.205,0,30.17,3.91,137,8.013,68.92,184.5528,6.1,1.55,54,159.91,0,72,96,54.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,Y,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
767,69,69,1,3,63.01,168.99,22.5992,1.73,6,0.065112643,0.78119511,1,3,3,6,10629.428,1,1,358.51,25.89,74.97,6.41,8.66,0,0.0013,1.712e-4,0.00719,0,0.196,4.36325,2.3009,0.102,0.102,0.057,0.057,0.576,0.621,100,42.13,122.1784,0,1.3e-4,0.0086,0.079705,0.0042,0.323,0.417,0.161,0.12,0,0.36641,118.8581,4.3271,20.1977,1.0919,1.269728,0.2232,0.269308,0.0052,0.81,2.500964,3.427258,0.0387,0.00176,0.001,0.800477,198.86,4.11,0,1.0671,0.694,0,0,4.407,138,6.818,70.08,246.872,4.25,1.82,67,165.06,0,95,126,65.71,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
768,64,64,0,2,80.49,170.06,27.76656,1.94,6,0.093032271,1.1169374,1,2,4,6,2393.169,2,2,228.74,37.04,284.06,53.32,30.25,0.002081,0.004,0.0299594,0.00402,28.92,0.072,4.96098,2.0759,0.157,0.298,0.041,0.062,0.39,0.656,101,98.34,72.0505,0.03,9e-5,0.0183,0.021256,0.0147,0.258,0.428,0.172,0.243,0,0.32778,115.1294,2.9454,9.8882,1.0121,0.508746,0.1932,0.300088,0.0396,23.12,3.003711,0,0,6e-4,0,1.143693,126.66,3.26,0,0.881,0.282,0,22.98,3.929,141.9,11.936,3.55,231.9985,3.94,1.71,54,164.96,0,84,110,70.08,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
769,65,65,0,2,59.95,146.18,27.63647,1.52,8,0.056133389,0.67353287,1,2,2,8,2393.044,2,2,297.91,41.26,57.57,10.85,14.05,4.47e-4,0.0013,0.0503369,0.00603,25.9,0.206,5.24935,2.0649,0.181,0.066,0.549,0.161,2.717,0.854,108.1,109.71,50.2949,0,2e-4,0.0012,0.139907,0.0208,1.476,0.537,0.894,0.393,1.952,0.34008,128.0614,0.4358,8.992,0.5982,1.387703,0.2411,0.460025,0.0959,25.85,5.596978,3.753832,0.6794,0.00115,0,1.228025,337.73,4.31,1,0.904,12.997,0.0409,0.44,4.338,143.9,0.634,63.52,178.5159,8.92,1.55,61,145.64,0,63,115,59.91,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
770,54,54,2,3,86.7,160.05,32.87087,1.92,6,0.059851393,0.71812596,1,3,5,6,35842.869,2,2,1339.46,0,62.93,12.2,51.81,0.00167,0.0013,0.0766906,2e-5,25.6,0.002,5.90983,2.197,0.271,0.313,0.109,0.092,0.689,0.472,102.9,104.36,75.09,0.06,0,0,0.040824,0,0.29,0.254,0.273,0.285,0,0.27874,92.6356,0.0115,7.4612,1.5555,0.901375,0,1.766268,4e-4,0.16,9.143402,2.802951,0.0075,0.00731,0,0.968923,171.1,4,0,1.2599,12.364,0,38.54,3.486,142.1,5,56.93,258.4776,8.78,1.94,70,162.54,0,78,120,90.72,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,Y
771,60,60,0,2,63.81,153.02,27.174,1.61,6,0.043456973,0.52163618,1,2,2,6,1062.515,1,1,851.15,43.07,91.73,16.13,22.98,9.49e-4,0,0.0299608,9e-5,28.99,0.22,5.89809,2.3495,0.277,0.13,0.45,0.256,1.67,0.838,100,87.56,66.2721,0.19,1.5e-4,0.03,0.089189,6e-4,1.097,0.59,0.524,0.309,0,0.33949,108.1705,1.7968,7.3576,1.4889,1.485898,0.0124,0.229204,0.0047,0.6,5.496725,0,0,7.2e-4,0,1.519023,200.34,3.61,0,0.8941,11.716,0,0,3.776,144.2,6.814,71.97,220.0542,7.05,1.76,80,154.37,0,81,120,68.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
773,72,72,1,3,93.97,173.91,30.63734,2.07,8,0.080047986,0.96053454,1,3,3,8,19675.418,1,1,431.67,38.94,314.33,29.72,25.18,0,0,0.0597766,0.00308,32.38,0.038,4.6558,2.3796,0.106,0.162,0.033,0.042,0,0,101.9,98.26,69.3304,0,1.6e-4,0.0109,0.017704,9e-4,0.012,0.005,0,0,0,0.39397,119.1073,3.1378,9.6736,0.6046,0.806814,0.0066,0.479095,0.0054,18.58,13.165828,0.470969,0.0047,0.00148,0,1.482157,450.62,4.3,0,1.1599,9.613,0,30.76,4.779,142.1,2.981,68.91,196.7231,11.26,2.21,90,175.63,0,101,174,96.39,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
774,63,63,1,4,78,165.03,28.12806,1.85,7,0.085804365,1.02972197,1,4,4,7,3370.404,1,1,443.64,42.06,225.51,31.28,25.93,2.38e-4,4e-4,0.0246874,1e-5,2.34,0.061,6.99007,2.3944,0.466,0.133,0.162,0.059,0.743,0.466,103,100.44,70.1782,0.06,0,0,0.210076,5e-4,0.36,0.009,0.355,0.226,0,0.3496,114.4256,1.5974,0.551,0.9939,1.495986,0.0121,0.849709,0.0055,0,6.119169,7.391587,0.6725,0,0,1.097956,225.72,5.61,0,0.9952,9.125,0.0093,26.99,3.935,139.9,6.888,70.31,236.7287,9.46,1.84,67,166.27,0,108,140,73.1,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
775,51,51,0,3,72.05,165.05,26.16088,1.77,6,0.03028134,0.3626502,1,3,6,6,3649.852,2,2,1945.05,40.95,118.7,70.94,94.09,0.003778,0.0032,0.0452154,8e-5,29.7,0.157,3.9214,2.4432,0.137,0.063,0.103,0.089,0.662,0.586,104.9,115.63,58.9998,0.26,0,0.0048,0.099974,0.0142,0.367,0.292,0.251,0.257,0,0.35935,107.4237,2.5723,14.4165,0.2467,0.99794,0.2335,0.891206,0.1163,0,2.606746,5.392851,0.7046,0.00276,0.001,2.972801,263.36,4.62,1,1.0379,12.907,0.0303,40.98,4.183,138.1,13.635,67.94,279.8636,5.48,1.8,70,167.14,0,82,97,75.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,131HH,158VF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
776,40,40,1,1,57.95,167.11,20.61756,1.63,6,0.042710641,0.5120412,1,1,2,6,5477.941,1,1,148.52,40.3,41.3,15.05,19.81,1.8e-5,0.0016,0,0,1.24,0.084,13.20563,2.2217,0.003,0.007,0.044,0.059,0.56,0.599,93.5,93.3,66.7452,0,1.8e-4,0.0241,0.033049,4e-4,0.6,0.483,0.001,0,0.846,0.29314,112.2865,0.8077,9.5969,0.6768,0.401068,0.013,0.368197,0.0416,0.1,5.115526,0,0,0.00851,0.001,0.64071,469.43,4.31,1,0.9024,0.587,0.0275,31.19,3.417,137.9,3.039,56.05,434.7393,5.38,1.61,85,165.03,0,71,130,54.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,Y,N,Low,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
777,76,76,0,2,45.11,147.9,20.70022,1.37,7,0.061274058,0.73568845,0,2,6,7,4992.937,2,2,856.98,40.06,77.28,14.05,31.08,0.004157,0.0038,0.0199111,0.00505,24.03,0.067,4.91829,2.4416,0.292,0.324,0.014,0.031,0.471,0.739,98.9,46.19,70.8992,0,0,0,0.099494,0.011,0.346,0.449,0.195,0.305,0.999,0.35871,110.942,2.603,17.5596,8.2829,0.865651,0.2363,0.399324,0.1083,0,2.310137,0,0.0324,0,0,0.151215,170.19,4.07,0,1.0929,13.606,0.0425,39.05,3.864,144,335.105,72.98,267.3548,3.13,0.6,65,145.7,0,69,121,41.96,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
778,68,68,1,4,78.07,174.81,25.51067,1.94,8,0.175483596,2.10757125,0,4,3,8,1622.981,2,2,226.66,41.53,81.16,48.5,40.94,0.00147,8e-4,0.090582,5e-5,1.31,0.001,8.92345,2.386,0.178,0.147,0.064,0.063,0.814,0.739,105,71.29,88.4307,0,0,0,0.070003,5e-4,0.521,0.497,0.201,0.231,0,0.40161,130.3403,4.686,10.7283,0.3914,0.982132,0.0022,0.580944,0.0018,0.06,6.275001,0.665381,0.0059,9.6e-4,0,1.196455,234.62,3.81,0,1.1035,0,0.0245,0.61,4.493,139.9,6.67,73.06,113.9569,9.19,2.05,58,178.05,0,82,121,85.51,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,>1,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,Y
779,19,19,1,1,107.67,185.19,30.94624,2.32,8,0.086189805,1.03494848,0,1,2,8,18578.496,2,2,569.75,43.4,411.38,28.98,29.03,0,0,0.1377873,0.00275,1.16,0.001,0,4.6639,0,0.001,0.011,0.018,0,0,95.9,157.96,75.3175,0,0,0.001,0.299645,9e-4,0.042,0.319,0,0,0,0.42397,135.1053,3.0444,7.4613,2.4894,1.094208,0,1.682285,0.0028,0.01,8.863593,7.081375,0.5473,0.00439,0.001,1.282661,403.52,4.99,0,1.1092,0.788,0,23.14,4.956,141.9,8.008,79.23,344.9945,12.33,2.37,87,187.16,0.1,71,110,120.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,Y,Y,M,Yes,NAM,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
781,56,56,1,3,75.03,167.48,26.258,1.84,6,0.088842529,1.06610278,0,3,2,6,1057.365,1,1,306.82,45.08,56.52,6.91,14.01,0.003377,0.0025,0.0299961,0.00502,28.95,0.249,1.87974,2.1447,0.351,0.175,0.039,0.02,1.153,0.799,106.8,141.71,49.8298,0.2,1e-4,0.0167,0.172759,0.0046,0.671,0.505,0.406,0.271,0,0.44385,145.642,4.5016,25.2655,2.03,1.599028,0.0123,0.601392,0.0992,0,4.444016,4.178298,0.5317,0,0,1.108472,260.49,3.9,0,0.9313,0.776,0.0332,34.22,4.996,150.5,8.012,71.99,321.5401,7.1,1.91,80,170.07,0,77,124,80.62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
783,72,72,0,3,63.87,175.06,21.14294,1.76,7,0.078521996,0.94293901,1,3,3,7,753.756,2,2,168.31,38.9,125.6,30.88,26.28,0.002944,0.0036,0.0996796,7e-5,28.03,0.105,4.49934,2.187,0.073,0.06,0.114,0.058,1.346,0.847,100.9,86.33,67.8255,0.39,5e-5,0.1971,0.209017,0.029,0.61,0.425,0.623,0.365,0,0.36976,126.6483,2.0806,12.1963,0.5584,2.398513,0.2312,0.469946,5e-4,0,2.501969,0,0.0091,0,0,0,17.49,3.81,0,0.9736,0.873,0.0243,28.88,4.27,141,8.036,71.35,362.271,5.2,1.79,69,175.8,0,91,120,65.18,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,2-3,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131RR,158VF,Y,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
784,42,42,0,2,70.85,168.82,24.95263,1.81,7,0.044922275,0.5385416,1,2,2,7,1243.863,1,1,1202.26,31.85,123.33,51.47,59.02,0.002874,0.0014,0,0,29.42,0.002,7.78641,2.0722,0.112,0.132,0.123,0.128,1.065,0.849,104.9,103.3,65.76,0.41,0,0,0.012376,7e-4,0.622,0.587,0.303,0.278,0,0.40058,131.729,0,0,0,0.995911,0.1391,0.61836,0.066,0.02,4.096243,4.300957,0.5485,0,0,1.453757,195.44,4.1,0,1.0238,10.073,0,26.81,3.99,137,7.232,62.82,513.921,7,1.69,75,164.9,0,75,110,64.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,AUS,Australia,>= 50 ml/min,N,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
785,51,50,2,1,80.09,157.26,31.62788,1.8,7,0.044341138,0.53177171,1,1,1,7,19211.907,1,1,141.82,35.03,58.16,25.8,27.88,0.001294,0,1.626e-4,0,24.05,0.101,0,2.2715,0.112,0.005,0.082,0.08,0.413,0.001,101.9,77.69,104.7125,0.05,0,0.0064,0.040863,7e-4,0.24,0.274,0.096,0,4.858,0.39882,141.585,2.6548,15.026,1.218,1.020419,0.1274,0.544858,0.0404,0.27,2.747472,0.276078,0.0409,0.00117,0.001,0.290237,102.54,4.21,0,1.0516,12.479,0.0195,28.58,4.736,141.9,31.061,54.91,381.4404,4.07,1.84,67,157.05,0,86,93,80,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
786,52,53,1,3,82.52,174.04,27.40931,1.99,6,0.03403107,0.40801309,1,3,2,6,11094.471,1,1,540.27,37.15,244.91,15.71,38.19,8.47e-4,0.002,1.39e-5,0,0,0.018,4.92361,2.3002,0.018,0,0.153,0.116,1.659,0.904,105,104.87,71.8966,0.5,2.1e-4,0.1743,0.100074,0,0.714,0.478,0.753,0.464,2.33,0.33603,107.9484,2.1954,7.4076,3.0015,1.2298230000000001,0,0.576108,0,0.63,9.059122,4.675544,0.0202,0.00479,0,1.278244,345,5.03,0,1.035,9.994,0,23.57,3.607,141.1,8.488,55.68,254.7399,11.64,1.93,65,173.96,0,1,96,79.09,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
787,51,51,1,1,57.9,163.97,21.74274,1.61,6,0.051940538,0.62318688,1,1,3,6,6332.779,2,2,194.41,38.98,60,28.17,19.03,1.638572,0.0049,0,5e-5,23.07,0,5.19307,2.5008,0.172,0.296,0.001,0,0.399,0.593,105,97.88,68.9766,0,9e-5,0.0107,0,8e-4,0.357,0.407,0.151,0.241,0,0.4,131.4291,1.9393,9.9996,0.5651,0.617432,0.1796,0.477342,0.0931,3.35,5.32115,6.448898,0.7329,0.00145,0,1.491417,413.6,4.33,0,1.0746,14.906,0,33.15,4.42,137.9,11.98,66.58,269.2867,6.23,1.62,85,163.06,0,95,120,56.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
788,80,80,0,5,51.6,147.92,23.3706,1.45,6,0.101266602,1.21604772,1,5,2,6,5479.32,1,1,650.73,37.96,140.1,19.26,19.01,0.001337,0.0024,0.0282143,9e-5,0,0.049,24.51189,2.5217,0.11,0.077,0.046,0.042,0.793,0.647,102,38.81,91.0622,0,0,0,0.405905,0.0301,0.421,0.299,0.31,0.269,0,0.36921,114.6259,0,0,0,1.789989,0.1487,1.108836,0.1272,0,3.692035,6.233082,0.7595,0.0073,0.001,1.067975,283.91,4.6,0,0.9893,11.165,0.0031,0.59,4.09,138,10.24,69.97,486.3007,7.79,1.45,80,145.61,0,81,139,47.1,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
789,62,62,2,4,60.15,162.71,23.37258,1.64,6,0.060350983,0.7240575,2,4,5,6,11939.225,2,2,592.25,37.92,52.72,5.63,13.05,0,0,0.040135,0,2.07,0.259,3.50644,2.1961,0.173,0.122,0.029,0.015,0.613,0.682,103.9,77.8,83.0061,0,0,0,0.038195,0,0.281,0.186,0.222,0.216,3.94,0.41594,127.7483,2.0593,4.015,6e-4,1.04678,0,0.245831,0,12.79,3.204591,0,0,0.00389,0,1.321666,205.59,4.4,0,0.9753,0.629,0.0121,26.36,4.794,141,7.192,57.93,463.5155,5.01,1.78,65,161.08,0,98,118,63.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VV,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
790,71,71,1,3,57.02,155.01,23.76485,1.55,7,0.050704443,0.60750087,0,3,4,7,5391.431,1,1,330.03,33.81,72.16,15.03,11.56,0.002118,0.0033,0.0797838,0.00495,26.71,0.156,12.94829,2.2501,0.267,0.163,0.225,0.115,0.93,0.538,104.3,79.49,66.8012,0,5e-5,0.0111,0.090117,0.0125,0.633,0.338,0.295,0.185,1.362,0.39641,123.4472,4.3293,31.8952,5.1755,1.546964,0.1445,0.400255,0.0902,0.3,5.127693,0,0.0149,3.6e-4,0,1.19328,248.71,4.09,0,1.0443,18.748,0,30.6,4.316,140.9,5.293,68.91,368.9895,7.63,1.53,69,155.02,0,65,150,55.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
791,61,61,1,2,43.08,151.9,18.54677,1.36,7,0.053731352,0.64501373,1,2,4,7,11208.755,1,1,350.63,40.77,108.43,9.02,16.09,0,0,0.019073,0.00199,23.92,0.091,6.07069,2.408,0,0.002,0,0,0.038,0.537,99.2,51.56,76.9363,0,4e-5,0.0254,0.040865,0.0117,0.093,0.34,0.002,0.099,5.993,0.30201,104.2515,0.8184,11.9945,1.5618,0.999524,0.35,0.229025,0.1077,0.77,2.695851,3.905248,0.648,0,0,1.424493,224.84,0.84,0,1.0738,11.68,0,0,3.303,139.9,7.005,62.13,196.5542,4.09,1.3,80,149.94,0,95,133,41.31,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
792,75,75,1,3,83.18,171.2,28.22704,1.96,7,0.040279808,0.48280055,2,3,3,7,6032.498,1,1,333.82,45.02,90.37,20.03,39.45,0,1e-4,1.774e-4,0,27.06,0,4.2735900000000004,2.1722,0.154,0.196,0.187,0.19,0.732,0.703,104,50.83,107.9418,0.12,0,0,0.100038,0,0.381,0.369,0.274,0.295,4.301,0.42075,148.0263,2.5377,15.0208,3.784,1.407919,0,0.430122,0,19.66,8.232252,3.410911,0.0254,0.00118,0.001,1.524488,207.39,4.65,0,1.196,14.855,0.0263,35.99,5.095,136.1,8.562,70.35,363.2153,9.21,1.96,43,167.75,0,67,119,80.41,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
793,71,71,1,3,70.83,176.36,23.14386,1.88,7,0.038375156,0.46060828,0,3,6,7,20443.583,2,2,1075.3,34.38,77.62,14.02,19.18,0.498988,0.0075,0.0200225,4e-5,29.38,0.126,8.90984,2.3519,0.146,0.095,0.001,0,0.625,0.686,98,66.36,93.1721,0.33,0,0.0146,0.039829,9e-4,0.46,0.406,0.047,0.001,1.314,0.31951,104.2653,3.2146,13.5942,0,1.143805,0.0608,0.449936,0.0106,0.77,2.61961,5.740888,0.0337,0.00269,0,1.03476,152.5,4.17,1,1.1065,11.481,0,23.44,3.891,135.2,11.022,66.75,240.1734,5.09,1.91,73,175.8,0,91,111,71.01,0,0,0,0,1,0,0,0,0,0,3,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
794,45,46,0,3,58,169.88,20.30508,1.65,6,0.051322087,0.61643136,0,3,5,6,3946.002,2,2,509.21,33.26,76.07,28.03,30.16,0,0,2.87e-4,0,1.72,0.002,0,2.3178,0.249,0.125,0.179,0.09,1.316,0.825,100,128.01,53.0294,0.07,5e-5,0,0.009994,0,0.678,0.438,0.684,0.425,5.193,0.39734,126.0347,2.3246000000000002,14.0381,1.6993,2.406185,0,0.982295,0,0.28,4.001385,0,0,0,0,0.786131,177.13,4.2,0,1.0466,0.437,0.0361,38.09,4.294,139,13.32,72,408.1889,6.2,1.62,65,165.09,0,83,108,52.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Other,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
795,59,59,2,3,105.24,184.12,30.39442,2.29,6,0.038058136,0.45663951,2,3,1,6,7553.77,2,2,836.85,33.19,165,270.4,404.34,0.001998,0.0031,3.668e-4,9e-5,0.7,0.041,1.94226,2.4743,0.088,0.11,0.018,0.052,0.41,0.804,97.8,100.44,83.8088,0.42,0,0,0.090064,1e-4,0.31,0.538,0.149,0.254,3.39,0.42223,141.8408,0,0,0.0111,0.862218,0.084,0.898284,0.0835,27.94,6.000779,4.011723,0.6389,0.00151,0,0,170.06,3.8,0,1.6866,11.413,0.0621,22.19,4.485,136,12.054,61.98,246.9934,7.41,2.23,80,184.55,0,105,144,100.65,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
797,51,51,1,2,86.92,178.09,27.15918,2.07,6,0.069163687,0.83006887,1,2,3,6,10995.035,2,2,194.42,31.09,98.55,7.29,20.03,0.001127,4e-4,3.013e-4,0,23.23,0.156,5.39434,2.3115,0.221,0.22,0.025,0.044,0.421,0.566,103,94.73,86.1879,0.03,6e-5,0.0114,0.728227,4e-4,0.079,0,0.259,0.282,0.813,0.29338,92.6472,0.0313,7.3765,0.4919,0.855144,0,0.700947,0,16.36,3.403202,0,0,0.00221,0,1.063329,148.73,4.19,1,1.0375,11.047,0,26.72,2.841,140.8,7.008,57.97,131.2142,6.46,2.03,90,175.65,0,89,140,82.81,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
798,55,56,1,4,75.55,165.09,27.39783,1.81,7,0.039850323,0.478003,0,4,4,7,11384.973,1,1,650.08,46.84,232.41,30.67,36.88,0,0,2.99e-4,0,32.05,0.158,13.5655,2.5675,0.385,0.301,0.042,0.035,0.755,0.601,102,108.93,71.1192,0,2e-5,0,0.021304,0,0.414,0.394,0.282,0.182,0,0.43614000000000003,150.3162,2.7623,8.056,0.7215,1.204373,0,0.701322,0,0,8.998787,0.590507,0,0.0044,0,1.354433,176.79,4.18,0,0.8776,0.46,0.0667,32.19,4.783,137.1,14.718,83.12,395.0127,11.76,1.72,79,167.97,0.1,91,121,76.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,NA,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,N,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
799,61,61,1,3,77,171.92,26.07831,1.92,7,0.067959032,0.81710489,0,3,3,7,6834.077,2,2,1156.99,39.04,127.64,24.28,57.55,0.001578,0.0017,0,0,25.59,0.18,169.77216,2.5409,0.722,0.545,0.111,0.079,1.106,0.725,108,78.96,90.1955,0.03,2.1e-4,0.0067,0.124289,3e-4,0.786,0.495,0.379,0.301,0,0.3356,116.0222,0.016,0,0.4063,0.764402,0.0055,0.150184,0.0039,0,3.959417,3.506205,0.0265,0.00927,0,1.130041,259.09,4.7,0,1.005,12.923,0.023,31.55,4.178,139.9,2.944,69.03,491.868,5.61,1.93,71,172.02,0,73,109,74.58,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Western Europe,NA,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
800,36,36,0,0,59.98,158.15,23.95538,1.61,8,0.050531621,0.60701503,1,0,1,8,290.145,1,1,168.9,43.02,92.06,4.58,9.88,0,4e-4,0,7e-5,28.13,0.104,0,2.3225,0.472,0.249,0.204,0.072,1.879,0.78,105.1,103.35,69.8631,0,0,0,0.299732,0.0121,0.7,0.269,1.095,0.427,0,0.38822,132.0733,2.3695,17.0894,1.6145,1.331579,0.1096,0.372762,4e-4,0.7,3.219713,0,0,0,0,1.229478,430.39,4.3,0,0.9745,0,0.0428,24.79,4.622,140,20.654,73.98,270.5522,6.24,1.68,77,159.82,0,86,119,61.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
801,50,50,0,2,52.95,169.88,18.83148,1.6,8,0.044721034,0.5363351,0,2,2,8,301.503,1,1,196.04,42.66,53.45,34.41,21.97,0,5e-4,0.1024648,0.00682,32.03,0.121,0,2.1975,0.052,0.067,0.084,0.071,0.599,0.743,98.8,92.05,65.1602,0.13,0,0,0.10017,0.0356,0.47,0.474,0.14,0.129,4.947,0.38992,132.5566,2.0567,9.9392,1.2758,1.739977,0.2868,1.000225,0.1073,0.03,4.903097,3.381441,0.5899,0,0,0.937185,277.01,3.61,0,1.0141,0,0.0365,26.22,4.224,138,10.297,70.43,24.3873,8.02,1.62,70,172.98,0,80,124,56.67,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
802,57,57,0,4,55.07,175.06,18.20831,1.64,7,0.118529006,1.42277828,1,4,2,7,2805.168,2,2,358.16,30.64,85.93,13.06,19.96,0,0,0,0,30.96,0.001,12.823,2.4948,0.359,0.295,0.581,0.449,0.754,0.515,104,98.62,53.0103,0,1.3e-4,0.0215,0.043145,0.001,0.48,0.44,0.31,0.217,0,0.40664,135.1842,2.393,9.1982,1.3981,1.50031,0.084,0.477699,0,0.11,9.419251,3.131437,0.0288,0.00459,0,1.258618,266.8,4.56,0,0.9022,3.763,0,28.14,4.524,140.8,8.958,67.05,480.9518,10.88,1.64,88,171.98,0,88,158,49.59,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
803,56,55,0,1,71.07,173.58,24.05708,1.84,6,0.060166706,0.72173248,0,1,3,6,800.661,2,2,173.13,40.96,0,26.6,30.25,0,0,0,0,26.58,0,5.00274,2.5283,0.001,0.003,0.169,0.134,1.226,0.867,104,79.33,83.175,0.41,0,0,0.102615,1e-4,0.447,0.284,0.725,0.513,3.646,0.46173,166.9961,1.7455,13.5117,1.2836,1.393883,0.0993,0.610147,0.0421,16.89,3.803932,0.527628,0,0,0,0.961068,190.89,4.4,0,1.1887,10.6,0.0056,27.22,5.467,139.1,15.391,68.93,333.0384,6.1,1.81,81,174.72,0,70,117,68.74,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
804,65,65,1,1,75.04,161.04,27.64836,1.81,6,0.11064964100000001,1.32958276,1,1,1,6,4938.262,2,2,311.62,28.24,89.71,46.49,27.71,0.265418,0.0039,5.72e-5,3e-5,25.99,0.165,5.90305,2.3021,0.089,0.121,0,0,0,0,102.9,89.26,74.2006,0,2e-5,0.0033,0.100293,6e-4,0,0,0.001,0,4.331,0.4003,117.8844,0.0151,7.3972,0,1.202071,0.0648,0.299961,0,10.85,3.417871,0.040655,0.0406,0.00398,0,1.247326,425.94,3.79,1,0.9646,14.43,0.0157,29.15,4.42,139.3,5.1,3.9,268.3434,5.29,1.71,112,160.17,0,66,161,77.53,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
805,65,65,1,1,73.9,159.73,28.22977,1.75,8,0.132225534,1.58735864,0,1,5,8,3182.586,1,1,121.42,37.09,52.35,13.1,10.03,0,0,0.0212133,0.00607,22.95,0.05,16.44528,2.3586,0.161,0.181,0.132,0.137,0.457,0.055,101,82.47,80.0588,0,1.3e-4,0,0.050997,0.0416,0.182,0.241,0.224,0.226,0.048,0.41358,136.3444,5.4366,16.4687,2.6244,0.998415,0.3122,0.148992,0.082,0,3.203182,0,3e-4,0.00255,0,1.12012,174.38,5.57,0,1.0556,11.076,0.0407,1.03,4.785,139.7,4.291,73.92,399.6749,4.6,1.8,71,162.16,0,89,114,75.06,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
807,49,49,1,2,70.14,187.55,20.32633,2,7,0.062340252,0.74806583,1,2,5,7,9580.834,2,2,540.77,42.96,80.12,5.87,13.93,0,4e-4,0.0166589,8e-5,28.32,0.12,4.33577,2.5013,0.393,0.532,0.098,0.125,0.423,0.745,97.8,92.3,77.8321,0,9e-5,0,0.086605,0.0149,0.267,0.432,0.126,0.275,0,0.409,133.1709,0,0,0.0054,0.757203,0,0.816267,0.0418,27.04,4.818842,0.347747,0.0369,9.5e-4,0,1.254471,210.8,4.6,0,0.9853,11.981,0,29.11,5.195,137.1,8.656,64.65,333.2431,6.09,2.11,85,186.47,0,78,131,74.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
808,40,40,1,0,89.95,185.33,25.7623,2.12,8,0.075028563,0.8989065,0,0,5,8,5481.489,2,2,155.87,42.9,90.99,47.13,51.63,0.002469,0.0017,0.1002338,0.01961,25.22,0,0,2.3508,0.005,0.057,0.001,0,0.67,0.767,106.8,67.82,147.0012,0.15,4e-5,0.0122,0.199948,0.0396,0.366,0.386,0.261,0.288,0,0.38092,139.9974,3.8992,13.6026,1.4807,1.388115,0.2799,0.400002,0.108,0.82,2.907706,0.701787,0.6489,0,0,1.417437,214.16,4.39,0,0.852,12.058,0,0,4.336,136,10.296,64.91,557.7913,3.97,2.21,79,187.01,0,85,136,100.26,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
809,77,77,0,2,58.56,154.98,24.09532,1.56,6,0.017696307,0.21199426,0,2,4,6,4898.862,2,2,201.19,40.43,197.27,17.86,31.92,0.002325,0.0026,0.0399786,0.00947,26.61,0.119,0.04907,2.2016,0.345,0.136,0.053,0.004,1.631,0.836,102.2,102.17,46.9319,0.39,3e-5,0.0155,2.503606,0.0503,0.652,0.374,0.911,0.48,3.074,0.37849,127.7418,1.5572,8.5414,0.8551,3.495718,0.2409,0.461383,0.0801,0,2.617976,0.646168,0.4985,8.9e-4,0,1.018754,217.23,4.39,1,1.0454,11.912,0.0531,29.08,4.112,137.9,17.468,51.07,104.2839,6.53,1.61,71,156.05,0,72,140,61.85,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
810,73,73,1,2,63.88,149.83,28.24169,1.6,7,0.13305424,1.59618667,3,2,1,7,3612.955,2,2,155.79,39.94,82.1,23.3,16.81,7e-5,0,0,2e-5,29.07,0.002,5.52198,2.0809,0.065,0.1,0.073,0.041,0.769,0.699,105,80.73,56.0442,0,1.7e-4,0.0168,0.0508,0,0.478,0.379,0.236,0.218,0,0.34219,114.467,0.0585,5.7306,0.5142,1.658296,0,0.352716,0,0.78,8.60415,2.592723,0,3.3e-4,0,1.221331,340.9,4.11,1,0.9936,11.396,0.0415,28.82,3.998,141.9,5.099,0,303.8166,10.6,1.56,84,149.89,0,69,140,61.79,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
811,62,61,NA,3,49.19,175.84,16.49588,1.6,6,0.086274403,1.03608121,0,3,NA,6,NA,2,2,378.64,47.06,374.57,101.98,32.12,0.003027,0.0049,0.0821393,7e-5,24.88,0.091,6.09461,2.4264,0.927,0.53,1.772,0.665,3.219,0.902,102.4,70.53,81.1212,0.06,0,0.009,0.108047,0.0099,2.403,0.687,1.038,0.456,0,0.41229,139.0483,1.7953,10.6802,0.27,2.453229,0.2133,0.800795,0.0844,0,9.580756,3.100308,0.5701,0,0.001,0.870371,247.84,4.8,1,0.9931,11.872,0.0779,37.96,4.781,141,5.114,68.96,294.2975,15.07,1.62,62,180.17,0,51,110,50.15,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,NA,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
812,55,54,0,1,62.03,165.05,22.59047,1.69,8,0.114915038,1.37753893,1,1,2,8,301.446,1,1,121.46,47.45,63.62,18.76,26.25,0,0,0.0499611,0.00409,28.92,0.14,3.61936,2.348,0.402,0.266,0.137,0.151,0.859,0.711,108,115.43,56.0331,0.07,1.4e-4,0.013,0.201535,0.031,0.557,0.421,0.377,0.351,4.08,0.5076,175.4396,2.5016,13.7076,0.7558,1.17395,0.26,1.078256,0.1068,22.09,1.656532,0.433347,0.022,3.9e-4,0,1.032953,63.73,3.28,1,0.8855,0.751,0.052,0,5.085,143.1,19.525,74.98,372.6857,3.52,1.73,84,167.02,0.1,64,125,63.87,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
813,47,47,0,3,48.91,158.02,19.65561,1.49,6,0.00853629,0.10228835,0,3,1,6,571.121,2,2,215.41,37.93,142.28,19.7,22.9,0.086513,0.0088,0,2e-5,2.45,0.026,4.51023,2.174,0.261,0.244,0.082,0.068,0.946,0.726,107,114.41,49.0672,0.13,5e-5,0.0153,0.022592,6e-4,0.748,0.565,0.242,0.002,0.382,0.29699,96.9144,3.5731,9.9994,1.0734,1.300413,0.0541,0.269914,0.0023,0.37,5.105843,0.491697,0.0338,0,0,1.199529,199.89,4.69,0,1.0039,11.19,0.0032,0,3.816,144,12.28,61.01,327.6327,7.83,1.4,79,157.01,0,101,102,44.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
814,69,70,0,1,63.86,171.15,22.03562,1.73,6,0.071037528,0.85229236,0,1,4,6,673.56,2,2,186.08,41.87,75.25,21.09,25.19,0.002472,0.0027,0.0099519,0,0,0.002,8.99382,2.2931,0.292,0.401,0.124,0.121,0.415,0.543,0.4,67.66,70.8074,0.02,1.2e-4,0.0033,0.163581,0,0.416,0.467,0.069,0.156,3.321,0.34699,102.0548,0.9703,0.1342,0.1961,0.731008,0,0.651965,0,18.89,3.942279,0,0,0.00543,0.001,1.223527,236.79,4.82,0,0.9422,10.199,0.0057,23.01,2.891,137.3,5.111,69.05,237.9935,5.7,1.62,80,169.89,0.1,67,123,59.12,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
815,56,56,0,2,86.8,185.68,24.76651,2.12,6,0.096457206,1.15830631,0,2,5,6,3141.04,1,1,558.69,44.02,81.09,32.91,18.87,0.003519,0.0032,0.0766722,0.00914,24.34,0.141,0.0355,2.3177,0.141,0.036,0.266,0.176,0.918,0.476,100.9,131.84,64.9285,0.14,0,0.0152,0.340615,0.0331,0.491,0.289,0.418,0.252,0,0.36977,120.3781,1.454,10.9324,0.7802,1.898148,0.1765,0.450378,0.0931,0.55,5.677144,3.993903,0.4276,0,0,0.013089,90.26,3.81,1,0.8932,11.004,0.0312,23.03,4.02,142.9,8.459,67.96,321.0464,8.76,2.07,72,187.1,0,104,130,91.63,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
816,62,62,0,1,59.9,171.83,20.97032,1.7,7,0.086975657,1.04341192,0,1,3,7,1250.947,1,1,192.84,39.67,71.43,25.11,25.1,0,0,0.0105357,0,1.48,0.121,14.9103,2.186,0.173,0.133,0.122,0.112,0.756,0.701,105.1,79.91,72.1755,0,1.5e-4,0.0061,0,0,0.271,0.322,0.354,0.302,0.709,0.42958,147.7491,0,5.6835,0.0056,0.833616,0,0.266741,4e-4,0.28,6.191254,0,0.4892,0.00305,0.001,1.259413,175.32,4.7,0,0.9754,11.736,0.0704,32.6,4.461,140,9.99,59.32,231.978,7.61,1.7,70,169.87,0,76,123,58.14,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
817,62,62,0,3,67.26,171.17,22.61956,1.8,6,0.08870505,1.06502537,1,3,4,6,1420.331,2,2,416.9,34.37,99.69,28.99,46.51,0.282317,0.0082,0.0299415,0.01002,29,0.096,4.39455,2.5759,0.136,0.039,0.064,0.009,1.041,0.689,98,79.64,80.3215,0.17,0,0.0169,0.10019,0.0396,0.357,0.01,0.5,0.274,0,0.39327,128.9213,1.0906,9.8921,0.147,2.740273,0.455,0.640943,0.1693,0.41,2.574552,5.522246,0.0357,0.00287,0.001,0.969982,273.98,5.7,0,1.2867,16.737,0.0533,45.98,4.129,139.9,11.84,71.02,237.2574,5.92,1.79,71,171.91,0,96,110,70.14,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
818,56,56,1,1,52.48,165.07,19.21731,1.56,7,0.102992247,1.2364056,0,1,6,7,6940.176,2,2,377.38,42.37,55.08,29.23,42.43,0,0,0.0366115,0,33.97,0.07,17.43532,2.3005,0.745,0.533,0.001,0,1.346,0.86,93,106.04,53.0422,0,0,0,0.125983,3e-4,0.443,0.356,0.949,0.592,0.027,0.34343,114.7083,1.8522,16.454,0.7644,1.605486,0.0062,1.24461,0.0054,0.13,5.551792,0.481005,0.0159,0,0,1.99997,108.81,4.8,0,1.1707,11.2,0,27.41,4.797,134.9,6.019,83.16,232.6532,8.89,1.58,80,169,0,101,128,55.8,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
819,61,61,0,2,64.48,160.11,24.79864,1.68,6,0.035174759,0.42301726,0,2,1,6,674.764,1,1,211.76,46.94,63.38,21.67,23.87,0.001842,0.0012,0.0703549,9e-5,29.09,0.12,7.49639,2.5758,0,0.003,0,0.007,0.141,0.646,104.9,64.28,83.0115,0.15,0,0,0.100133,2e-4,0.145,0.386,0.098,0.176,0,0.40951,142.7885,0.0012,7.4091,1.1503,0.801184,0.0051,0.454503,0,10.75,5.507734,3.679902,0,2.3e-4,0,1.130028,273.26,4.67,0,1.0058,0.613,0.0778,22.5,5.065,141.9,5.989,72.1,243.2629,6.76,1.6,81,160,0,82,131,65,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
820,59,59,0,3,67.04,159.85,25.70856,1.69,6,0.040646565,0.48712271,1,3,2,6,1697.529,1,1,624.79,43.94,78.4,13.01,20.84,5.85e-4,0.0012,0.0297236,7e-5,0.78,0.171,0.00908,2.3754,0.08,0.102,0,0,0.046,0,97.1,90.39,73.4518,0,0,0,0.40161,0.0241,0.002,0,0.102,0.001,1.541,0.41837,132.2923,1.4838,0.1105,0.0041,0.777179,0,0.881881,0.0049,0,4.096809,0,0,1.5e-4,0,0.719462,356.01,4.68,0,1.0043,10.612,0.0027,31.99,5.136,139.9,22.967,68,265.8562,6.3,1.62,80,158.82,0,70,129,68.05,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
822,35,35,0,1,78.18,172.18,27.11091,1.91,6,0.075447213,0.90710941,1,1,2,6,1486.425,1,1,253.19,28.28,74.51,20.61,21.07,0,0,1.273e-4,0.00593,3.82,0.001,2.21068,2.3043,0.144,0.094,0,0,0.427,0.833,115.7,112.29,76.0094,0,0,0,0.053685,0.0132,0.001,0.004,0.383,0.517,0,0.36938,115.3407,2.6772,14.1597,0.3121,0.99486,0.1942,0.05356,0.0038,0.45,2.800612,0.387889,0.6479,0.00141,0,1.061813,195.28,4.47,0,1.1032,12.464,0,35.96,4.117,144.1,25.643,59.29,368.8614,3.77,1.93,64,174.02,0,79,111,77.73,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
823,69,69,0,3,68.06,163.06,25.15195,1.74,6,0.052775899,0.63318628,0,3,4,6,3189.348,2,2,249.16,28.99,76.89,18.93,20.84,0,0,0.0997077,0.00682,27.95,0,6.99984,2.3783,0.162,0.121,0.035,0.024,0.896,0.818,100,71.05,75.0079,0,0,0,0.30021,6e-4,0.44,0.489,0.355,0.281,0.656,0.37776,125.2852,2.5756,9.7947,1.2285,0.981506,0,0.875525,0,0.07,14.472032,0.342444,0,0.00536,0.001,1.021323,700.61,4.93,1,1.2318,12.07,0,36.27,4.166,134.4,3.816,64.92,273.7472,13.69,1.74,74,162.11,0,78,116,66.91,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
824,82,82,1,2,106.28,160.63,44.7492,2.08,6,0.088556868,1.06316627,0,2,2,6,1393.779,1,1,109.55,59.72,69.02,12.91,13.14,0.00131,0.0022,0.0633568,5e-5,26.08,0.179,6.68892,2.3306,0,0,0.014,0.026,0,0,105.1,79.5,67.1166,0.14,0,0,0.499857,0.0403,0,0.002,0,0,2.607,0.43342,152.5849,3.0996,11.8737,1.5092,1.429436,0.1572,0.220322,1e-4,0.29,2.690827,0.194396,0.0083,0,0,0,178.8,4.43,0,0.9715,10.726,0.0387,40.87,4.186,148.8,5.033,76.98,437.9301,4.97,2.15,75,160.18,0,26,145,105.37,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
825,76,76,1,5,50.02,171.85,17.6346,1.58,6,0.032482601,0.39016639,2,5,6,6,1942.326,1,1,428.81,0,71.93,8.41,19.96,0,0,3.498e-4,0,24.48,0,16.69431,2.3782,0.336,0.273,0.071,0.075,0.841,0.707,93.1,61.57,70.8735,0.27,0,0.0023,0.124249,0,0.53,0.509,0.355,0.238,0.787,0.29396,99.6084,5.4982,14.3983,0.5986,0.710548,0,0.599524,0,0.21,7.613611,0.642058,0.0146,0.0013,0,1.462034,190.78,4.31,0,1.2861,13.722,0.0106,31.76,3.391,132.3,5.112,64.93,321.2166,9.98,1.51,80,169.47,0,89,121,47.93,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,2-3,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
826,64,64,1,1,78.08,171.49,26.21812,1.92,7,0.117388223,1.40942631,2,1,1,7,6025.331,2,2,128.78,44.03,84.28,31.03,15.09,0.00215,0.0037,0.010393,0,30.94,0,4.7048,2.1141,0.039,0.128,0.129,0.179,0.053,0.448,102.2,78.5,86.8994,0.19,8e-5,0.0128,0.032375,0,0.238,0.375,0,0,1.144,0.41929,153.9393,0.0192,7.3962,0.6159,1.142406,0.0065,0.201673,0,20.06,5.257622,0.64498,0.0288,0.0037200000000000002,0,1.480931,200.13,4.1,1,1.0054,13.548,0.0036,24.91,5.049,138,15.463,71.08,222.4654,6.39,1.91,81,171.16,0,81,121,77.77,1,0,1,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,>= 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
827,46,46,0,1,64.28,173.18,21.48461,1.75,6,0.101513565,1.21728375,0,1,1,6,277.192,2,2,225.87,41.93,80.58,16.12,15.95,0,0,0.0126014,0,0,0.139,3.21047,2.2418,0.017,0.044,0.035,0.04,0.02,0,109,82.97,87.2029,0,1.4e-4,9e-4,0.080077,0,0,0,0.141,0.001,0,0.43957,145.9541,1.9089,7.7045,1.1536,3.12439,0,0.359316,0,17.93,4.825909,0.157947,0,0.00925,0.001,0.977815,254.6,4.6,0,0.9901,18.783,0,28.93,5.152,139,14.516,71.02,397.1383,9.63,1.71,85,173.47,0,90,140,67.02,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,NA,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
828,49,48,1,4,80.85,187.2,22.83542,2.06,7,0.125072854,1.50097018,1,4,3,7,1877.703,1,1,1522.54,29.84,107.84,40.16,26.14,3.6e-4,0.0021,0.0194356,5e-5,23.08,0.12,18.74572,2.2031,0.065,0.076,0.093,0.124,1.281,0.959,97.7,158.68,47.8357,0.18,3e-5,0.0155,0.09871,0.0013,0.997,0.728,0.373,0.361,0,0.41133,128.9903,1.5503,9.6707,0.2501,1.398668,0.111,0.641063,0.0027,0.29,12.136698,0.239041,0.0068,0.00595,0.001,1.114596,352.3,3.89,1,1.21,0.943,0.0363,30.76,5.54,141,5.3,51.18,161.3402,11.55,2.04,71,183.11,0,96,118,79.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
829,46,46,0,2,75.05,173.85,25.310669999999998,1.91,6,0.100025594,1.19898154,2,2,2,6,384.064,1,1,776.73,35.02,50.82,64.31,35.91,0,0,2.764e-4,9e-5,25.54,0.07,4.55086,2.1071,0.086,0.066,0.22,0.237,0.791,0.8,102,115.44,65.2946,0,1.1e-4,0,0.001048,7e-4,0.405,0.423,0.294,0.318,2.843,0.34993,129.2449,3.9011,10.8668,0.78,0.699672,0.0087,0.58173,0.091,0.82,5.015225,0.083053,0.0396,0.00117,0,1.211897,101.82,4.81,0,1.2022,11.353,0,0,3.993,142.9,15.574,68.4,194.7838,6.52,1.75,84,170.14,0,77,119,71.37,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,NA,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
831,66,66,0,1,80.66,173.39,27.41293,1.97,6,0.076764681,0.92117768,1,1,3,6,2137.964,1,1,182.15,44.93,59.3,12.29,14.95,0.001004,7e-4,0.0178498,7e-5,24.27,0,5.05876,2.3453,0.195,0.181,0.02,0.001,0.857,0.692,97.8,94.14,67.1409,0,1e-5,0.0087,0.108537,7e-4,0.55,0.445,0.283,0.243,0.594,0.37864,127.9325,0,10.3998,0.4806,0.91381,0.1386,0.482868,0.0975,0.65,4.262313,0.127576,0.0176,0,0,1.278404,329.28,4.51,0,0.9381,0,0.0437,0.9,3.976,139.1,8.532,71.07,222.3367,6.42,2.01,90,170.16,0,74,136,80.61,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Other,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
832,63,63,0,1,72.07,168.09,25.2718,1.81,6,0.114104302,1.36750559,0,1,2,6,481.306,1,1,237.03,32.47,70.93,15.73,14.03,0.091094,0.005,1.212e-4,5e-5,18.23,0.149,5.3667,2.3383,0.11,0.111,0.031,0.063,0.505,0.709,104,96.03,64.9631,0.12,1.9e-4,0.0212,0.199969,7e-4,0.313,0.359,0.227,0.258,1.607,0.36835,129.7159,0.699,8.5973,0.805,1.304011,0.0112,0.220785,0.003,0.37,5.428093,6.048139,0.02,0.00421,0,0.169063,224.97,3.76,0,1.0932,10.834,0.0392,30.39,3.934,141.9,5.142,62,237.9506,6.44,1.93,79,171.08,0,90,140,78.49,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
833,38,37,1,3,66.6,162.99,24.36046,1.72,7,0.008598761,0.10301163,0,3,5,7,8046.139,1,1,165.61,41.63,225.39,21.54,20.08,0.002926,0.0026,2.714e-4,3e-5,28.7,0.176,3.7605,2.4773,0.36,0.35,0.001,0.001,1.195,0.867,93.2,124.62,61.4356,0,0,0,0.251274,0.0104,0.775,0.638,0.362,0.291,0,0.35346,119.1759,1.2017,6.6402,0.4706,1.091424,0.0015,0.500552,0.0037,0.16,3.206894,0.401367,0.0096,0,0,0.969089,152.33,3.91,0,0.9899,14.953,0.0095,29.4,4.052,139.9,11.297,65.69,267.569,6.23,1.64,71,163.04,0.1,76,119,69.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
834,72,73,1,3,128.84,164.06,52.73477,2.29,8,0.096916688,1.1635201,1,3,3,8,11017.489,1,1,1186.24,38.01,96.81,15.9,21.07,0,0,0.0500575,8e-5,20.98,0.08,0.08554,2.4316,0.134,0.153,0.102,0.089,0.43,0.554,97.3,95.9,76.6899,0.11,1.9e-4,0.026,0.009968,0,0.331,0.378,0.153,0.193,3.22,0.3527,111.5328,1.2123,0.0562,0.0112,1.310895,0,0.599166,0,27.92,4.143307,0.057474,0,0.00534,0,0,215.95,3.35,0,1.0439,0,0.0137,27.74,4.747,143,8.373,60.1,231.9803,5.45,2.26,62,161.32,0.1,65,122,122.74,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
835,76,76,0,3,79.02,166.94,28.0534,1.89,6,0.054192565,0.65108034,1,3,5,6,11466.736,2,2,229.57,27.1,106.98,14.94,27.79,0.002412,0.0038,0.1296968,8e-5,0,0.136,5.71558,2.4588,0.138,0.269,0.031,0.054,0.856,0.624,97.8,54.22,107.2562,0.05,5e-5,0.0027,0.267474,3e-4,0.403,0.382,0.221,0.189,0,0.38068,125.545,0.941,8.1126,1.1163,1.078072,0.0058,0.539655,0.0017,13.4,5.919,0,0,0,0,1.032524,193.65,4.21,0,1.2936,10.954,0,35.93,4.173,142.9,14.95,69.08,196.0775,10.13,1.99,69,162.11,0,86,119,77,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,NA,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
836,51,51,1,1,51.45,156.1,20.77441,1.51,7,0.062902542,0.75515382,0,1,3,7,1120.114,2,2,302.61,39.98,108.34,36.69,30.2,0,0,9.61e-5,0.00232,27.43,0.001,6.08383,2.4085,0.343,0.289,0.052,0.061,0.437,0.574,101.9,104.63,53.0483,0,6e-5,0,0.050264,0.0064,0.18,0.264,0.287,0.339,0,0.38297,124.1778,2.4099,5.9355,0.6669,0.599611,0.1941,0.407854,0.0851,0,7.969631,3.646123,0.6004,0.00235,0.001,1.351228,378.43,4.3,0,0.9043,0.741,0.0295,25.04,4.089,136,19.051,72.54,323.6998,8.9,1.62,69,158.78,0,85,123,57.02,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,AUS,Australia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
837,70,70,1,2,58.05,166.9,21.26409,1.65,6,0.071860108,0.8619601,1,2,3,6,3237.597,2,2,209.57,44.09,75.94,14.06,10.77,0,0,0.0198396,1e-5,0,0,7.48001,2.2216,0.285,0.352,0.064,0.041,0.941,0.772,101.9,64.26,72.2132,0.17,2e-5,0,0.432302,0,0.645,0.485,0.318,0.295,8.971,0.42276,137.371,1.0595,4.9021,0,1.623017,0,0.576169,0,0.15,6.659773,6.149658,0.0185,0.0083,0,0.929725,496.29,4.83,0,0.9922,11.542,0,28.19,4.728,137,3.95,74.1,196.3646,9.1,1.61,77,165.8,0,80,141,56.98,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
838,77,77,1,2,85.76,163.52,32.0466,1.94,6,0.1240986,1.49065588,0,2,3,6,9503.771,1,2,117.81,39.04,85.04,28.02,17.86,0.002061,0.0025,0,0,2.81,0.002,5.89047,2.2049,0,0.079,0.001,0.033,0.058,0.609,104.8,45.41,140.6455,0,5e-5,0,0.099862,0,0.015,0.24,0.1,0.214,2.213,0.41668,140.839,1.9032,9.4987,1.5629,1.000006,0,0.687758,0,0.2,6.121401,0,0,0,0,1.089148,321.3,4.29,0,1.0105,11.596,0,28.86,4.572,139,6.028,65.49,237.1561,8.39,1.88,74,165.97,0,74,140,90.93,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
839,65,65,1,4,67.43,163.04,25.37684,1.72,8,0.064241085,0.77122857,1,4,5,8,3610.314,2,2,676.12,25.35,85.12,25.18,49.95,0,0,0.0375248,8e-5,26.97,0.056,5.89345,2.3764,0.137,0.145,0.039,0.043,0.737,0.654,99.9,66.47,91.0299,0.25,2.2e-4,0.0187,0.279036,4e-4,0.301,0.105,0.279,0.221,0.864,0.35464,127.0475,0,5.2294,0.4705,1.719576,0.18,1.297369,0.0605,0,10.827812,2.776707,0.0077,3.4e-4,0,1.215672,198.3,4.1,0,1.1994,0.592,0.0333,27.66,4.001,136.3,20.694,57.07,297.3808,16.93,1.85,80,169.86,0.1,101,150,75.99,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
840,72,72,0,4,80.24,158.72,31.22612,1.83,7,0.062627058,0.75126188,2,4,6,7,12317.248,2,2,344.69,25.43,140.65,15.92,20.93,0.002767,0.0019,0.0196664,1e-5,28.05,0.12,6.2031,2.3964,0,0,0.073,0.052,0.243,0,105,78.22,69.9731,0,1.1e-4,0.0037,0.079157,0,0.069,0.005,0.06,0,6.565,0.33987,104.1645,2.0556,3.8622,0.6405,1.893081,0.0036,0.969793,0.0041,28.09,18.076726,5.158511,0.0033,0,0,1.420545,257.67,4.19,1,1.1549,12.328,0.043,40.54,3.698,142.3,3.407,61.95,285.4387,20.05,1.75,70,157.11,0,78,122,78.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
841,77,77,1,3,53.67,160.15,20.97881,1.54,7,0.007032418,0.08460766,2,3,3,7,4125.417,1,1,520,26.92,94.63,25.9,20.96,0,0,0.019364,0.005,24.16,0.263,9.52702,2.1796,0.183,0.021,0.193,0.095,1.419,0.827,101,89.1,45.3978,0,1e-5,0,0.1902,0.0393,0.924,0.529,0.426,0.25,1.611,0.33028,101.7507,2.3379,10.1966,0.6768,2.717181,0.1879,0.859083,0.0711,0.14,4.985016,0,0,0,0,0.727506,267.01,3.6,0,1.11,0,0.021,28.61,3.957,144,11.007,62.04,4.1076,9.1,1.6,78,160.16,0,69,111,54.26,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
843,55,55,0,3,51.52,162,19.37828,1.54,8,0.059598971,0.7148626,3,3,2,8,1156.692,2,2,282.07,25.74,98.71,15.07,31.57,0,0,0.0101447,1e-5,26.94,0.001,5.99868,2.2292,0.044,0.008,0.086,0.118,0.529,0.735,102.2,111.79,39.5547,0.56,3e-4,0.028,0,0,0.291,0.392,0.252,0.27,0,0.2235,82.3313,1.5591,5.3747,0.0047,1.249565,0.0114,0.305814,2e-4,0,4.299195,0.295413,0,0.00145,0,1.329083,313.99,4.81,1,0.9034,0,0,0,3.38,138,6.872,53.01,233.7689,6.82,1.5,68,159.07,0,70,107,47.66,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,N,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
844,60,60,0,1,58.21,167.48,21.0974,1.65,8,0.073292988,0.87978029,0,1,4,8,713.869,1,1,67.32,41.92,226.89,18.98,17.74,0.002949,0.003,0.0499585,0.00597,28.93,0,5.33798,1.9118,0.144,0.117,0.014,0.009,0.427,0.643,105,119.74,58.383,0.27,1.2e-4,0.0099,0.256041,0.0107,0.228,0.375,0.128,0.185,2.609,0.44384,146.3507,4.0429,18.7065,1.1713,1.009798,0.2047,0.392208,0.0714,27.09,5.093642,0.338054,0.0199,0.00357,0,1.310867,240.37,4.59,0,1.0503,11.333,0.0403,24.04,5.198,136,5.1,73.82,213.0458,6.78,1.69,61,167.87,0,0,113,59.29,1,0,0,0,0,0,0,1,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
845,74,74,1,3,74.83,169.97,25.63427,1.84,7,0.159959175,1.92510964,0,3,2,7,2150.286,2,2,201.3,38.05,70.99,99.49,25.08,0.002589,0.0023,0.0996212,8.7e-4,28.01,0.1,24.31757,2.4003,0.321,0.208,0.097,0.059,1.239,0.828,102.1,72.7,79.5889,0,3e-5,0.011,0.700201,0.0102,0.816,0.559,0.455,0.31,0,0.41518,137.6233,2.5691,20.2044,1.2275,2.140836,0.0134,0.578389,0.0021,0.68,7.202448,2.060278,1e-4,0.00317,0.001,1.5193160000000001,271.08,5.18,0,0.9533,11.698,0.0293,0,4.795,130.6,10.103,79.95,327.0467,11.27,1.82,67,169.46,0,64,119,68.03,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
846,70,70,0,1,63.91,170.13,21.78684,1.74,6,0.034227669,0.40999179,0,1,1,6,1101.897,1,1,151.53,33.57,59.19,16.24,24.15,1.89e-4,0.0013,0.1019716,0.00686,24.98,0.144,4.3008,0.0357,0.429,0.293,1.518,0.431,1.672,0.751,101,65.46,86.6676,0.35,2e-5,0.006,0.188549,0.0074,1.198,0.554,0.545,0.304,1.903,0.39991,145.6528,2.8571,12.1532,0.223,2.130127,0.0616,0.449559,0.0545,16.66,3.90046,0,0,0,0,1.293641,114.25,3.6,0,1.0892,0,0.0145,29.19,4.299,135.9,8.735,65.07,129.3172,5.58,1.93,65,171,0,66,126,67.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
847,61,61,0,3,60.95,145.88,29.72977,1.53,6,0.059415502,0.71320568,1,3,2,6,1561.282,2,2,232.15,33.64,92.05,12.29,19.05,0.001791,0.0019,0.020354,0,30.95,0.151,6.06679,1.8783,0,0.084,0.026,0.089,0.046,0.669,103.9,99.82,51.2526,0.21,1e-4,0.0193,0,0,0.198,0.429,0,0.15,2.593,0.26916,90.2791,1.0742,5.5437,1.6705,0.541357,0,0.589689,0,0.45,5.931295,0.534368,0.0365,0.00249,0,1.180153,331.61,4.39,0,1.0045,11.731,0.0263,32.5,3.477,136.9,7.008,55.77,118.9795,6.6,1.53,92,145.62,0,62,148,65.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,POSITIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
848,51,51,0,3,83.97,164.04,30.84819,1.91,7,0.010957989,0.13145963,2,3,6,7,4170.764,1,1,1082.26,43.92,52.93,3.69,11.16,0,0,0.0200012,0.00274,30.35,0.071,7.57142,2.441,0.348,0.288,0.142,0.113,0.622,0.481,92.9,90.48,89.817,0,0,6e-4,0.171629,0.0215,0.231,0,0.35,0.244,2.759,0.43806,144.4012,2.6576,7.4642,0.8208,1.002413,0.0121,0.376066,0.0035,0.33,3.392398,0.095562,0.0357,7.5e-4,0,1.120409,187.38,3.62,1,1.1047,11.396,0.0113,26.16,4.92,142,17.888,76.07,424.5443,5.81,1.89,80,162.71,0.1,108,122,77.3,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,POSITIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
849,61,61,0,1,59.02,156.09,25.36869,1.58,7,0.025844787,0.30980727,0,1,1,7,287.954,1,1,230.67,38.99,94.5,28.01,116.45,0.004094,0.002,0.0200001,0.00344,23.69,0.04,7.84685,2.3529,0.227,0.19,0.161,0.112,1.311,0.85,105,83.44,72.5709,0,0,0.0014,0.020747,7e-4,0.595,0.402,0.746,0.593,0,0.34662,129.5414,2.3076,12.0536,0.725,1.514037,0.2009,0.300228,0.0044,17.32,1.610541,0.324573,0.0105,0.00162,0,1.340026,126.91,3.4,0,1.1085,14.612,0.006,35.32,4.059,135.9,11.937,70.95,214.0545,3.39,1.54,75,153.34,0.1,75,113,54.84,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
850,57,57,0,3,79.56,169.85,26.94579,1.9,7,0.115605309,1.38759466,1,3,5,7,4184.412,1,1,314.65,44.06,301.99,17.94,17.73,0.004221,0.0029,0,0,30.96,0.156,3.67887,2.482,0.06,0.196,0.067,0.098,0.528,0.777,101.1,87.55,88.5858,0,0,0,0.002387,0,0.302,0.46,0.201,0.269,0,0.35906,124.3367,2.6651,13.2533,1.4759,0.375454,0,0.229362,0,29.66,6.8563,0.152373,0,0.00281,0.001,1.616288,310.49,4,0,1.0389,11.605,0.0228,33.37,4.295,141.2,9.018,76.6,371.3287,6.8,1.92,62,170.16,0.1,82,111,85.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
852,72,72,2,2,59.91,163.94,22.23323,1.64,6,0.061487658,0.73753681,1,2,2,6,11042.666,2,2,545.25,31.07,75.17,44.31,24.04,0.003342,0.0036,0,9e-5,30.62,0.277,8.20625,2.2026,0.453,0.212,0.28,0.163,1.315,0.629,105,58.22,75.1461,0.47,2e-5,0.0146,0.015091,6e-4,0.662,0.285,0.479,0.205,1.862,0.34957,128.6816,0.0086,0.1096,1.0034,1.82055,0.2615,0.711057,0.0792,0.15,3.949135,0.315783,0.0335,2.5e-4,0.001,1.2651,173.6,4.38,0,0.9624,10.294,0.0164,25.25,4.137,136,12.708,51.9,274.0954,7.82,1.6,67,164.08,0,80,104,60.56,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,NA,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
853,41,42,0,2,87.24,171.98,29.62767,2,7,0.047449538,0.56846031,1,2,2,7,6836.094,1,1,296.43,44.1,198.95,18.77,26.27,0.003352,0.0024,0.0416744,5e-5,0.28,0.078,8.5879,2.6595,0.262,0.249,0.093,0.073,0.562,0.513,100.9,131.21,66.073,0.23,9e-5,0.0214,0.21987400000000001,8e-4,0.483,0.409,0.152,0.136,0,0.42969,138.0861,2.6669,12.5351,2.1792,1.010115,0.0133,1.517217,0.0045,0,6.887061,5.223722,0,5.4e-4,0,1.291036,530.72,4.2,1,1.1552,15.086,0,33.24,4.754,137.8,15.394,73,303.2959,10.38,1.84,65,168.09,0,79,125,79.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,>1,131RR,158VF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
854,43,44,1,2,58.06,157.7,23.36048,1.59,7,0.054681072,0.65682818,1,2,1,7,1072.377,2,2,620.04,44.04,194.28,49.07,30.23,0,0,0.065336,7e-5,28.01,0.145,0,2.5202,0.274,0.27,0.031,0.032,0.593,0.533,98.9,93.2,74.2711,0.16,0,4e-4,0.223277,0.0042,0.392,0.358,0.094,0.104,0,0.35178,120.7043,2.5038,14.6061,1.6877,1.870116,0.1496,0.237262,0.0055,0.7,2.898216,0.458783,0.0246,0.00272,0.001,1.415937,248.46,4.96,0,0.9619,11.47,0.0077,28.08,3.973,140,9.972,68.51,231.9821,4.13,1.67,73,157.84,0,91,125,63.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
855,58,58,1,1,69.89,170.82,23.73539,1.82,6,0.057530146,0.69009919,0,1,3,6,10263.635,2,2,306.39,42.05,98.82,28.9,36.82,0.001294,0.0011,0.0126333,0.01007,26.67,0.049,0,2.4223,0,0.004,0,0,0,0.637,99.9,123,54.486,0,6e-5,0.0112,0.370213,0.0975,0,0,0.004,0.292,0,0.39352,124.2114,0.4011,5.2545,0,0.995809,0.3857,0.343037,0.1305,0.19,1.681963,3.677918,0.7208,0,0,0.99127,113.91,5.11,0,1.0401,10.874,0,33.6,4.73,139.9,6.303,68.92,462.3771,3.21,1.97,66,175.56,0,72,110,77.56,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,2,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
856,59,59,1,2,61.93,163.64,23.14664,1.67,7,0.060712283,0.72827774,0,2,4,7,8556.016,2,2,680.33,41.08,198.68,16.16,20.02,7.67e-4,2e-4,0.0997929,0.00604,27.97,0.099,5.80863,2.5488,0.213,0.144,0.151,0.148,0.703,0.489,96.8,58.7,92.9794,0.14,0,0.0087,0.256509,0.0245,0.421,0.315,0.206,0.123,0,0.41649,134.2093,2.6044,10.46,1.8461,1.241442,0.1051,0.449138,0.0299,0.08,10.780153,0.117737,0.0376,0,0,1.081089,665.34,4.5,0,1.0175,13.009,0,28.76,4.732,139,12.999,79.6,309.5714,13.06,1.69,51,164.9,0,72,110,64.26,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
857,53,53,1,4,92.19,189.23,25.34737,2.22,6,0.064431578,0.77314634,1,4,5,6,12502.568,1,1,667.44,37.95,78.42,36.7,44.28,0,0,0.0095818,8e-5,29.1,0.096,6.06815,2.1162,0.061,0.089,0.009,0.001,0.593,0.829,103.1,78.87,97.5742,0.13,0,0.0129,0.200726,0.014,0.262,0.423,0.257,0.313,3.72,0.36099,108.0235,1.7195,4.9116,0.6058,1.190178,0.18,0.55071,0.0706,0,3.901517,0.506816,0,0,0,1.130114,235.99,4.1,0,1.0021,0,0.0202,29.61,3.712,139.9,6.835,61.29,303.9804,6.21,2.23,78,191.81,0,76,100,90.81,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,Y,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,NA,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
858,48,48,0,3,120.53,174.85,40.64042,2.31,6,0.242627192,2.91200497,1,3,5,6,4929.919,2,2,306.3,42.26,83.24,71.45,21.06,0,0,1.383e-4,0,3.37,0.001,6.9056,2.1985,0.395,0.241,0.093,0.041,1.649,0.764,94.9,98.99,105.6575,0,0,0.0019,0.090177,0,0.776,0.322,0.861,0.433,0,0.4786,154.2466,1.7341,10.7922,0.397,2.433621,0,0.866585,0,0.11,5.166932,0,0,0.00564,0,0.858507,327.53,4.93,0,1.0787,10.483,0.0403,26.67,5.549,135.2,15.03,81.85,320.8909,8.71,2.1,76,171.95,0,98,118,104.21,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
859,49,49,1,2,74.83,165.04,26.75919,1.82,6,0.019513934,0.23452843,0,2,2,6,10697.331,1,1,441.52,37.93,154.39,14.74,15.22,0.003023,0.0025,0.039967,0,25.32,0.001,3.47495,2.2374,0.039,0.067,0.027,0.075,0.101,0.603,104,139.03,55.6815,0.3,0,0,0.099816,0.001,0.024,0.005,0.181,0.36,0,0.27253,87.397,2.6684,16.1489,2.2604,0.71971,0.0034,0.350586,0.0026,0,4.488727,0,0,0,0,1.340035,179.98,4.77,0,0.9299,13.271,0.0338,26.49,3.256,138,9.961,60.02,315.9182,5.69,1.89,64,169.96,0,89,97,80.63,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
860,39,39,0,1,51.16,160.07,20.31529,1.52,7,0.045743894,0.54866689,0,2,1,7,4163.121,1,1,815.65,38.55,184.62,33.69,46.66,0.002291,0.0035,0,4e-5,30.77,0.194,4.60457,2.4203,0.29,0.128,0.21,0.103,1.569,0.718,106,114.26,53.8901,0.14,0,0.0123,0.202485,0.0099,0.799,0.435,0.593,0.276,0,0.4034,136.4916,0.8296,16.3577,1.7758,1.458853,0.2837,0.541748,0.0044,0.49,2.308508,7.129362,0.5654,0,0.001,1.230006,98.53,3.81,0,0.8822,7.628,0.0138,0.25,4.555,145,13.069,51.05,333.7393,5.3,1.49,61,162.09,0,57,102,50.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
861,66,67,1,1,49.44,145.17,24.15163,1.41,6,0.046096658,0.55325186,1,1,1,6,7119.25,1,1,241.6,43.96,62.88,55.31,23.23,0,0,0.0300018,0,0,0.21,4.68498,2.3745,0.276,0.146,0.366,0.168,1.792,0.867,104.9,109.72,46.2521,0,0,0,0.139821,0,0.866,0.526,0.722,0.396,0.163,0.39131,131.379,5.2852,11.1693,0.9939,2.945806,0,1.000278,0,0,4.093432,0.046716,0,0,0,0.208875,196.14,3.67,1,1.0152,10.757,0,36.27,4.52,138,15.421,60.43,345.4358,7.87,1.37,64,144.07,0,75,110,51.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
862,66,66,0,3,86.21,177.89,26.9698,2.02,7,0.100132774,1.20151239,1,3,6,7,6997.216,2,2,469.38,40.71,54.03,12,19.15,0,0,0.0200212,1e-5,31.05,0.001,6.0993,2.3008,0.146,0.066,0.055,0.026,0.733,0.62,105.3,78.99,91.9563,0.01,5e-5,0.0172,0.085462,0.0075,0.386,0.217,0.318,0.243,1.251,0.42546,141.0182,2.3953,12.0179,0.4009,1.303305,9e-4,0.480166,0,0.66,3.128676,0,0,0,0,1.284021,160.4,4.11,0,0.9837,12.216,0,28.29,5.163,141,8.569,70.05,243.5874,4.81,2.04,73,179.54,0,77,135,90.9,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Other,Y,Y,M,No,OTH,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
863,64,64,0,1,55.77,165.42,19.72307,1.63,7,0.014878334,0.17845652,1,1,5,7,3945.321,2,2,300.04,37.21,45.76,52.33,42.9,0,0,0.0300005,0.00216,26.82,0,6.69541,2.2332,0.291,0.241,0.092,0.092,1.229,0.757,102,61.96,95.308,0,0,0,0.100339,7e-4,0.651,0.442,0.582,0.345,0,0.40091,136.2581,2.8332,15.0122,0.9484,0.985642,0.0824,0.700554,0.0026,28.9,12.948717,5.482335,0.7247,0.00616,0.001,1.076922,202.44,3.9,1,1.025,0.338,0.0712,0,4.523,138.1,3.506,64.92,231.9911,13.63,1.61,60,167.99,0,82,130,60.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
864,33,32,1,1,74.97,157.29,30.80581,1.77,6,0.06260714,0.75149632,1,1,6,6,9122.963,1,2,377.67,44.04,204.39,133.54,93.69,0.002969,5e-4,0.0104612,0,3.11,0.149,4.499,4.1204,0.041,0.125,0,0,0.462,0.821,95.5,133.33,57.8981,0,0,0,0.099808,0,0.275,0.497,0.2,0.389,4.396,0.26693,91.5877,2.9248,9.9147,0.878,0.599724,0,0.87003,0.0015,0.37,2.995287,0.555253,0,2.5e-4,0,1.000753,136.72,3.69,1,1.2712,9.393,0.0302,29.05,3.659,138.1,32.307,69.92,277.1077,4.1,1.8,85,158.87,0,79,114,77.82,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
865,74,74,1,2,64.89,171.17,23.04399,1.75,8,0.119554167,1.43494735,1,2,2,8,8678.17,1,1,647.42,42.99,145.47,16.83,26.37,0.001599,0.0014,3.13e-4,1e-5,23.91,0.058,14.80203,2.4259,0.345,0.423,0.013,0.046,0.643,0.657,107,68.49,70.8816,0.34,3e-4,0.0324,0.050283,0,0.467,0.441,0.209,0.229,2.809,0.38878,135.0205,1.6244,8.6957,0.4879,0.599476,0,0.44112,0,33.88,7.347219,0.588654,0.5196,0,0,1.018696,546.8,3.32,0,0.8018,13.54,0.055,25.82,4.491,142.1,11.996,72.94,232.8796,8.39,1.67,80,171.94,0,61,129,64,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,GBR,United Kingdom,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
866,43,43,0,1,44.49,161.94,16.88614,1.43,7,0.107278251,1.28878276,0,1,5,7,1253.868,2,2,189.83,41.98,63.6,16.85,15.11,0,0,0.02001,7.4e-4,28.73,0.159,0.0704,2.3419,0.695,0.273,0.409,0.16,1.645,0,101,83.16,69.197,0,2e-4,0.0159,1.42934,0.0268,1.163,0.391,0.583,0.002,0,0.38331,119.2095,2.9081,14.3897,0.7494,3.034047,0.1207,1.078295,0.0796,0,1.816323,0,0.0311,0,0,1.153673,257.15,4.41,1,0.9852,12.747,0.0326,27.05,4.304,139.8,10.98,79.05,634.088,4.38,1.46,55,163.84,0.1,70,98,44.66,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
867,68,69,0,1,55.64,147.01,25.50209,1.47,8,0.068949177,0.82853399,1,1,2,8,4210.392,1,1,280.06,39.03,56.96,12.23,35.92,0,0,0.0198909,7.2e-4,29.08,0.152,7.00872,2.2244,0.086,0.167,0.024,0.045,0.021,0.02,107,92.71,50.0229,0.02,5e-5,0.0142,0.111651,8e-4,0,0,0.111,0.231,0.737,0.35454,117.9722,2.0848,11.3224,1.3196,0.735726,0.0083,0.315696,0.0031,17.27,2.814643,3.831284,0.0323,0,0,1.259992,215.95,3.61,0,1.0207,11.236,0.0475,24.31,4.192,139,6.67,69.94,278.9824,4.15,1.35,77,145.86,0,81,150,50.78,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
868,67,67,1,2,57.09,160.04,22.74585,1.6,6,0.055551627,0.66703953,0,2,4,6,18308.68,1,2,135.95,38.71,35.66,16.82,23.32,0.001112,0.0013,0.0440723,0.00608,21.8,0.129,2.49972,2.4094,0.101,0.129,0.054,0.038,0.916,0.841,103,70.07,74.1842,0.29,1e-5,0.0146,0.189999,0.0099,0.58,0.474,0.38,0.377,2.954,0.40289,133.0709,1.1997,12.0158,0.4199,2.336578,0.1887,0.676572,0.0053,32.41,3.705055,2.421856,0,0.00321,0.001,1.035733,340.78,4,1,1.1101,10.742,0.0281,22.96,4.315,138,17.557,62.84,273.9122,6.21,1.67,86,161.61,0,85,121,59.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
869,56,56,1,3,69,159.08,27.69963,1.71,7,0.082284376,0.98587627,2,3,6,7,20152.987,1,1,1146.68,36.05,69,17.82,44.37,0.0019,6e-4,0,4e-5,24.99,0,7.61373,2.1034,0,0.072,0.11,0.163,0,0.532,105,102.8,65.0292,0,6e-5,0.0149,0.071123,0.004,0.118,0.385,0,0.141,0,0.32263,108.0674,1.865,12.3235,0.0029,0.386403,0.0106,0.411712,0.0604,15.34,1.629322,0.051282,0.0106,7.1e-4,0,1.228959,121.07,3.8,0,1.0925,0,0.076,26.1,3.894,142.9,4.475,61.3,357.7739,2.57,1.71,66,159.85,0,85,108,67.22,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
870,47,48,0,2,82.21,170.19,28.54102,1.94,7,0.043505354,0.52161356,1,2,3,7,1010.992,2,2,186.94,41.03,58.81,63.97,26.92,0.001355,6e-4,0.0399015,3e-5,29.18,0,12.90071,2.4299,0.247,0.133,0.047,0.005,0.764,0.588,103,72.14,107.7592,0.05,0,0,0.463167,0.0079,0.438,0.313,0.264,0.172,0,0.35012,124.266,2.5937,7.8381,1.1811,1.300338,0.1709,0.440308,0.0291,31.77,5.109051,2.894196,0.5015,0,0,1.500117,285.12,4.81,0,1.0296,11.577,0.0477,28.51,4.175,140.1,3.413,79.74,433.8926,8.31,2,79,173.07,0.1,81,146,82.42,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
871,71,71,1,1,59.72,155.93,24.33657,1.61,7,0.073847139,0.88394646,0,1,2,7,4664.345,2,2,286.22,43.03,71.01,10.81,16.84,0,0,0.1033803,0.00503,24.71,0.11,8.8541,2.4365,0.558,0.33,0.129,0.059,0.889,0.589,105,48.47,123.5152,0,1e-5,0,0.400613,0.0284,0.611,0.404,0.224,0.142,4.667,0.3924,127.4726,1.2222,10.9147,0,2.212823,0.2814,1.098555,0.1175,0,3.59617,0.609185,0.0414,0.00469,0.001,1.452883,214.72,4.33,1,0.9902,10.501,0.018,23.25,4.508,143.8,5.044,72.92,388.9992,7.2,1.59,69,156.19,0,82,123,58.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,< 65,>= 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,NA,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,Y
872,70,70,0,4,69.98,151.54,30.0089,1.66,6,0.051394809,0.61770763,1,4,5,6,5515.48,1,1,332.65,38.45,60.86,16.12,14.99,0.073365,0.0035,0,0,0,0.119,3.89272,2.2992,0,0,0,0,0,0.001,105.1,60.42,86.8201,0.09,5e-5,4e-4,0,0,0,0,0,0.002,1.109,0.34813,127.9503,1.9937,8.5444,2.2266,1.002063,0,0.262776,0,0.15,2.631349,0.513097,0.001,0.00245,0,1.030002,261.49,3.29,0,1.0705,11.096,0.0174,0.54,4.293,141.1,3.347,66.45,273.8478,3.71,1.75,56,152.86,0,53,112,70.2,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
873,69,69,2,2,71.48,160.5,27.05427,1.76,7,0.018312994,0.22003004,NA,2,3,7,9040.899,2,2,943.06,44.2,97.14,7.97,27.28,0,0,0.0515688,0.00965,25.16,0.015,2.82063,2.7523,0.749,0.645,0.042,0.063,0.72,0.712,93.5,67.92,81.818,0.25,0,0.0069,0.201218,0.0245,0.392,0.45,0.291,0.366,0,0.36662,108.8,0.5617,6.0006,0,1.038064,0.2346,0.859667,0.0768,0,6.192731,0,0.0149,0,0,1.174659,308.99,3.99,0,1.1031,0,0,22.37,4.429,139,11.062,83.3,460.1467,8.87,1.68,77,163.8,0,73,140,72.53,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,NA,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
874,72,72,1,1,80.22,156.89,32.63104,1.8,7,0.05930616,0.71194386,1,1,1,7,1255.393,1,1,186.84,35.93,455.56,7.94,18.91,0.001428,0.0022,0.0399501,0.004,24.09,0.262,3.3713,2.2937,0.216,0.213,0.007,0,0.758,0.628,105.9,83.89,66.0212,0,1.1e-4,0.0034,0.140044,0.0431,0.469,0.293,0.236,0.182,0,0.33346,113.8828,3.3864,14.1464,0.304,1.068376,0.2002,0.168046,0.01,27.35,2.820835,0,0,0,0,1.168741,157.98,5.11,0,0.9933,13.105,0.0401,29.39,3.443,136,16.1,78.93,158.9746,4.4,1.87,57,155.21,0,69,104,79.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
875,60,61,1,4,57.1,160.08,22.50817,1.59,6,0.070021726,0.8408199,2,4,6,6,11166.43,1,1,254.01,35.97,63,52.28,36.88,0,0,0.0499631,3e-5,29.17,0.158,4.78562,2.1901,0.004,0.106,0.077,0.122,0.003,0,103,103.65,54.3166,0.54,5e-5,0.0214,0.090152,0,0,0,0.135,0.237,0,0.32832,113.784,0.0018,7.914,3.5945,0.5571,0,0.166772,0,17.98,2.025544,3.131056,0.0229,0,0,1.444676,146.12,3.79,0,0.9812,13.636,0.0215,27.22,3.963,136,7.24,63.59,376.1046,3.57,1.53,70,162.02,0,97,96,60.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
876,73,73,1,2,114.41,180.64,35.40182,2.33,6,0.154954082,1.86399268,0,2,1,6,23574.718,1,1,229.77,44.58,71.54,28.93,30.69,1.98e-4,0,0,0.01008,22.66,0.09,0.11754,3.0383,0.468,0.367,0.093,0.068,0.641,0.683,104,101.78,71.8114,0,0,0.0108,0.300883,0.0468,0.622,0.584,0.094,0.003,0,0.5056,172.4861,1.9446,7.1365,0.5754,0.905495,0.2249,0.115771,0.005,0,1.988382,2.422431,0.0132,0,0,0.350719,80.52,4.6,0,0.95,9.844,0,33.51,6,141,5.471,65.54,755.879,2.95,2.21,92,182.4,0,71,140,113.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
877,75,75,1,3,93.02,182.91,28.07247,2.11,6,0.068420947,0.82164402,0,3,5,6,6336.313,2,2,285.78,36.9,45.92,96.49,196.1,0.001874,0.0034,0.0482959,0.00279,2.79,0.044,14.64942,2.2364,0.177,0.026,0.661,0.505,1.958,0.847,98.9,111.25,50.6733,0.48,8e-5,0.0286,0.139905,8e-4,2.077,0.7,0.467,0.187,0,0.46325,153.261,1.9151,15.3252,1.2019,1.210876,0.0487,0.192538,0.0047,0,6.822011,0.301987,0.0269,9e-5,0,0.931038,120.88,2.83,0,0.9992,12.449,0.085,26.51,4.809,137.1,6.031,74.07,205.786,7.74,2.05,79,182.97,0.1,69,139,88.54,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
879,61,61,0,2,104.97,188.75,28.60803,2.33,6,0.08685627,1.04189167,1,2,5,6,685.752,2,2,207.51,35.93,207.07,17,19.03,0.002601,0.0019,0.0116702,0,30.09,0.159,6.50089,2.3533,0.207,0.152,0.077,0.071,1.518,0.808,98.9,71.98,106.3716,0.29,2.1e-4,0.0329,0.037625,0,0.67,0.447,0.648,0.354,0,0.37033,127.9537,2.3127,9.199,2.8883,1.803852,0.0053,0.956474,0.0771,0.42,8.150527,4.312272,0.0064,0,0,1.274262,318.58,4.19,0,1.0055,14.525,0,23,4.054,138,5.774,64.06,184.9942,9.37,2.3,80,185.09,0.1,73,117,99.04,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
880,63,63,0,3,89.95,163.11,33.30455,1.96,6,0.125821221,1.50801266,1,3,5,6,8413.142,2,2,300.15,46.07,61.88,16.15,16.11,8.07e-4,0.0014,0.0418941,0.00402,27.06,0.2,7.79267,2.4909,0.078,0.12,0.118,0.133,0.561,0.665,105.9,102.14,64.9915,0,4e-5,0,0.010265,0,0.425,0.413,0.13,0.189,4.664,0.46285,154.906,2.2914,9.5557,0.9131,1.408148,0.011,0.950012,0.0469,28.84,5.107824,2.457718,0.0143,0,0,1.160971,214.57,4.09,0,0.9931,0,0.7414,0,5.834,141.9,8.428,76.02,243.296,6.08,1.93,74,166.96,0,72,110,100.59,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
882,54,54,1,3,81.96,155.95,33.0294,1.82,6,0.028198828,0.33877155,1,3,5,6,16738.755,2,2,1476.3,37.88,51.6,39.31,59.03,8.36e-4,5e-4,0.0400606,8e-5,21.32,0,5.91738,2.2816,0.133,0.074,0.122,0.1,0.729,0.652,99.9,116.89,57.5109,0.46,0,0.0065,0.099994,6e-4,0.368,0.181,0.216,0.147,0,0.50232,163.0485,0,6.3013,2.0802,1.299883,0.0034,0.400262,0.0023,0,8.563498,0,0.012,9.9e-4,0,1.193274,398.29,3.79,0,1.0901,13.455,0.0186,25.91,5.874,138,7.004,60.94,258.9007,8.75,1.78,79,154.98,0,85,140,78.26,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,Low-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
883,61,61,0,1,68.97,157.27,27.12304,1.69,6,0.124949077,1.49860857,1,1,2,6,1005.365,1,1,172.69,40.08,165.88,22.82,25.19,0,0,0,0.00119,28.06,0,11.64478,2.3757,0.195,0.155,0.066,0.049,0.641,0.673,107.8,109.62,59.0818,0,6e-5,0.0154,0.015908,0.0104,0.34,0.282,0.242,0.201,0.774,0.36942,118.8162,2.3189,10.8909,1.4009,1.195687,0.1865,0.499455,0.0752,0,7.457347,11.792842,0.5796,0,0,1.192536,196.53,3.99,1,1.0376,0.909,0.0086,0.94,4.263,140.9,9.35,70.07,333.4964,9.87,1.7,71,159.76,0,81,1,70.11,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
884,46,46,1,1,79.99,158.19,31.33963,1.82,7,0.050737134,0.60821603,1,1,3,7,2557.899,1,1,269.47,33.25,153.87,29.08,10.25,9.6e-4,0,0.0189752,2e-5,23.09,0.016,6.78647,2.4511,0,0,0.128,0.112,0.529,0.006,101,155.24,55.8523,0,0,0,0.439823,4e-4,0.256,0.005,0.197,0.001,2.811,0.45404,144.3638,0.0166,0.1188,0.524,1.846207,0.0025,0.500107,0.0029,0.37,19.206731,4.312363,0.0275,0.00373,0,1.25716,323.04,4.97,0,1.0719,0.914,0.0015,0.53,5.54,137,6.927,69.89,276.1024,22.42,1.81,81,159.75,0,82,133,81.99,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,GBR,United Kingdom,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
885,65,64,2,3,105.3,167.02,40.1233,2.11,7,0.106383232,1.27683524,1,3,4,7,14394.802,1,1,306.11,37.74,57.23,8.69,14.02,0,5e-4,0.0893115,0.01004,0,0.199,5.00857,2.1407,0.448,0.199,0.308,0.139,2.693,0.858,102.1,81.8,97.0478,0,5e-5,0.0146,0.229928,0.0323,1.371,0.487,1.261,0.581,0,0.3505,123.8967,3.3516,11.3286,1.4117,2.397396,0.2699,0.748268,0.1382,0.06,3.068824,0.355279,0.6739,0.00163,0,1.196717,149.17,4.37,0,1.0224,12.27,0.0042,28.91,4.05,139,6.852,66.46,502.2182,5.6,2.06,77,164.21,0,73,136,103.02,0,1,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
886,53,53,1,2,77.09,175,25.15766,1.95,7,0.05785761,0.69459711,1,2,6,7,25901.761,1,1,876.52,45.03,140.81,19.12,31.29,0.001855,0.0016,0.0300189,7.4e-4,26.45,0.041,5.46233,2.471,0.145,0.184,0.001,0.001,0,0.513,97.7,101.36,75.6645,0,2e-5,0,0.208905,0.0048,0.021,0.304,0,0.156,0,0.41296,126.6338,3.1717,22.615,2.1823,0.881731,8e-4,0.799541,0.0033,0.34,5.699244,0,0.0082,0.00645,0,1.138758,215.77,4.88,0,1.2045,14.947,0,23.26,4.588,138,11.955,78.97,190.5099,7.01,2,81,173.27,0.1,90,120,79.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
887,69,69,0,2,70.14,164.9,26.08684,1.76,7,0.407573463,4.89293846,2,2,2,7,2044.419,2,2,240.48,39.39,43.95,10.92,13.75,0,0,0.214262,0.00382,26.97,0.002,6.79273,0,0.639,0.222,0.151,0.064,1.614,0.675,102,91.21,62.5776,0,2.1e-4,0.0271,0.100361,5e-4,0.861,0.362,0.581,0.23,1.7,0.35241,109.2433,1.1905,0.1187,0,1.62324,0.0094,0.655311,0.0056,0.01,3.104632,0.296922,0.5626,0.00275,0,1.423125,432.76,4.21,0,1.0786,14.084,0,32.13,4.221,142,2.988,58.98,184.8986,5.41,1.87,73,167.4,0,66,122,72.22,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
888,47,47,0,4,63.03,168.05,22.03387,1.72,6,0.031016791,0.37204697,3,4,4,6,1417.719,2,2,1638.98,28.1,231.47,20.5,36.79,0,0,0.0182864,1e-5,29.07,0.098,5.43547,2.2928,0.288,0.266,0.03,0.029,0.679,0.659,100,79.2,86.9463,0.11,0,0.0162,0.060901,0.0202,0.351,0.329,0.245,0.211,0,0.35306,112.2912,1.3587,8.0277,1.4241,1.501233,0.1205,0.713212,0.0596,0.08,6.903017,2.703034,0.6401,0.00511,0.001,0.993525,245.16,4.06,1,1.0812,13.643,0.0319,31.01,3.984,142,18.084,57.04,270.3972,10.64,1.67,85,167.91,0,96,125,60.72,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
889,70,71,1,2,76.08,180.09,23.44948,1.97,6,0.094842595,1.13776125,0,2,6,6,11944.613,1,1,306.93,27.05,75.08,19.78,24.11,0.062181,0.0034,2.209e-4,0,25.26,0,4.72621,2.2921,0.156,0.17,0.03,0.054,0.401,0.643,101.7,113.57,53.5884,0.14,7e-5,0.0148,0.209354,0,0.261,0.377,0.12,0.143,0.758,0.37065,127.9111,2.5655,11.4264,0.0117,0.79969,0,0.700855,0,0,3.058247,0,0,0.00473,0,0,110.57,3.14,0,0.9816,0,0.0698,27.08,3.89,137.1,3.447,45.07,246.9955,5.15,1.82,74,177.93,0,78,110,70.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
890,46,45,1,2,72.99,162.07,27.77725,1.78,8,0.05943226,0.71268519,1,2,1,8,3030.746,2,2,520.28,44.91,101.61,23.18,20.64,0,0,3.25e-5,2e-5,27.07,0.104,3.21074,2.2903,0.196,0.123,0.278,0.159,1.195,0.018,97.4,138,53.6385,0,0,0,0.040074,4e-4,0.672,0.345,0.305,0.002,3.033,0.35674,125.3267,1.8165,0.0081,0.002,1.42928,0.0019,0.799679,0.0641,0.29,6.910999,4.902181,0.6701,0,0,1.205573,250.1,3.73,0,0.9732,11.96,0.0092,0,4.01,140.1,5.12,72.06,203.6027,9,1.87,91,164.2,0.1,80,142,75.37,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
891,46,46,0,2,63.08,156.04,26.22947,1.63,7,0.059733817,0.7164733,1,2,5,7,3923.144,1,1,310.82,38.06,78,22.96,19.11,0.002534,0.0024,0.0189208,9e-5,24.03,0.119,5.69616,2.4092,0.11,0.146,0.013,0.02,0.16,0.457,96.6,57.51,140.0338,0.22,0,0.0169,0.111913,5e-4,0.106,0.009,0.086,0.181,0,0.33697,112.9665,1.9079,7.152,0.7785,0.634047,0.0072,0.348752,0,0.27,4.71962,8.911081,0.7197,0.00397,0,1.060728,353.4,4.81,0,1.0528,0.205,0.0084,23.63,4.417,137,6.808,73,475.8684,7,1.68,66,158.1,0,65,116,67.74,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
892,70,70,0,2,56.79,159.71,22.30296,1.57,7,0.059692787,0.71639816,0,2,4,7,1157.248,2,2,574.89,40.03,0,7.14,16.64,8.04e-4,7e-4,0.030018800000000002,9e-5,27.66,0.049,5.3337,2.4666,0.227,0.11,0.035,0.01,0.819,0.471,93.8,88.48,52.0841,0,7e-5,0.0015,0.10038,0.0198,0.41,0.326,0.267,0.132,2.893,0.41837,134.911,0.8965,5.2803,0.5391,3.061033,0.2251,1.100071,0.0659,0.68,3.31494,0.458664,0.0183,0.00673,0,1.229818,307.29,3.13,1,1.0077,11.437,0.012,27.28,4.466,144.3,6.006,67.08,350.9772,7,1.72,61,163.06,0,72,135,63.46,1,0,0,1,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
893,70,70,0,2,78.82,180.09,24.46511,2,6,0.188673357,2.26687983,0,2,2,6,2224.602,1,1,292.85,40.03,113.42,15.04,18.1,0.003171,0.0046,0.0401096,7e-5,2.02,0.13,11.62925,2.3015,0.392,0.417,0.145,0.151,0.505,0.006,106.9,83.07,81.5968,0,3e-5,0.0055,0.100532,0,0.509,0.475,0,0,0,0.43714,146.9745,1.5561,8.121,0.3959,0.90289,0,0.28886,8e-4,23.11,4.987684,0,0.0048,0.00597,0,0.96185,207.71,3.9,0,1.0628,16.817,0.0406,27.65,4.705,143.1,18.002,69.09,392.8942,7.12,2,88,178.64,0,77,124,82.37,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
894,67,67,0,2,49.42,162.13,18.74276,1.51,6,0.027530347,0.33028017,1,2,2,6,4146.917,1,1,281.89,38.93,61.96,15.06,12.32,0,0,0.0083919,5e-5,0,0.129,3.48289,2.2275,0.088,0.157,0.046,0.086,0.19,0.021,104.1,86.93,50.9851,0.29,1.2e-4,0.0148,0.22011,7e-4,0.012,0.003,0.207,0.312,1.189,0.41261,135.89940000000001,1.5593,11.1025,1.8165,0.509993,0.0083,0.469282,0.0039,0.45,5.685303,2.818542,0.0384,0,0,1.356148,341.42,3.3,0,1.2578,10.553,0.0086,29.02,4.889,140.1,10.282,67.07,186.1934,7,1.59,87,163.02,0,93,148,52.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
895,42,43,0,2,73.98,174.94,24.24342,1.9,6,0.180904512,2.17051068,1,2,2,6,2023.333,1,1,244.06,47.25,95.47,13.48,26.93,0,0,6.27e-5,0,26.38,0.081,3.93201,2.3497,0.049,0.084,0.194,0.152,0.771,0.76,103,87.8,87.7165,0.2,9e-5,0,0.070008,0,0.401,0.384,0.293,0.313,0,0.38862,130.9605,0,0.0743,1.044,0.996652,0,0.199578,0,26.44,3.9063,0.242495,5e-4,0.00853,0.001,1.09837,260.9,4.2,0,1.2038,10.118,0,0.15,4.69,140,6.922,64.96,311.4001,4.4,1.83,87,175.22,0.1,66,161,75.28,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
896,37,37,0,2,34.82,159.82,13.87652,1.31,7,0.048229984,0.57813396,0,2,3,7,142.107,1,1,210.37,40.35,54.09,7.8,11.1,0.004168,0.0039,4.89e-5,6e-5,27.05,0.111,0.09218,1.1646,0.016,0.183,0.015,0.071,0,0,104.9,141.59,34.3691,0.43,0,0.0194,0.162293,0.0208,0,0.231,0,0.002,0.07,0.35973,128.9471,1.9767,17.8602,0.6105,0.301597,0.2056,0.198978,0.0641,0,2.862846,2.549794,0.6786,0,0,1.007085,143.83,3.61,0,1.0328,12.517,0.0292,31.2,4.244,137.1,11.288,65.99,10.4144,3.58,1.35,90,161.5,0.1,81,146,40.47,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,Y,N,Low,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
897,66,66,0,2,64.09,183.81,19.37658,1.86,6,0.061531461,0.73883872,0,2,5,6,4938.908,1,1,159.87,39.13,122.95,39.27,38.14,3.38e-4,6e-4,0,1e-5,33.05,0.088,5.2023,2.1854,0.83,0.411,0.257,0.154,2.463,0.866,104.9,78.2,74.9402,0.23,1.6e-4,0.0081,0.05108,7e-4,1.331,0.568,1.008,0.386,0,0.38512,134.3697,2.4988,11.8757,0.5583,1.039597,0.0721,0.340426,0.0141,31.98,2.760275,0.077694,0.0241,4.9e-4,0.001,1.198557,216.54,4.81,0,1.1006,10.971,0,0.19,4.798,141,5.996,68.1,327.0551,4.4,1.79,67,181.97,0,113,109,59.94,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
898,66,66,3,2,95.55,180.79,28.65843,2.15,7,0.097727559,1.17235095,2,2,3,7,23482.736,2,2,183.7,36.99,140.56,19.07,25.07,0.00232,0,1.008e-4,0,25.6,0,11.25649,2.5631,0.128,0.128,0.001,0,1,0.902,97,94.43,76.9059,0.06,0,0.0071,0.779917,5e-4,0.437,0.393,0.613,0.623,0,0.37472,134.747,1.2136,0.1177,0.6344,0.922805,0,0.519796,0.0022,0.21,4.407198,4.602629,0.0011,0.00193,0.001,1.029434,322.18,4.2,0,0.9926,11.058,0.0268,27.23,4.236,137.9,8.026,66,237.4375,5.98,2.12,71,180.15,0,89,124,90.32,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
899,48,47,1,2,53.97,159.9,20.80795,1.55,7,0.039907474,0.47918623,1,2,4,7,15675.767,2,2,211.79,39.67,67.92,5.15,14.05,0.001522,0.0019,0,0,0,0.169,4.59063,2.3117,0,0.001,0.001,0.041,0,0.007,98.9,148.09,39.5522,0.17,0,0,0.070011,0,0,0,0,0.001,0,0.22774,86.3545,3.0505,11.0221,1.3352,0.297806,0,0.797824,7e-4,0.36,5.190031,0.391653,0.0062,0,0,0,200.65,3.4,0,1.1054,0,0.0888,32.07,3.656,143.8,7.58,55.96,249.6461,5.6,1.63,86,159.96,0.1,82,135,55.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
900,44,44,1,2,72.74,157.96,28.65143,1.74,8,0.139329467,1.67109236,1,2,2,8,7313.087,1,1,205.11,33.84,72.98,30.81,16.89,0.003951,0.0034,1.099e-4,8e-5,0.18,0.06,3.95768,2.2022,0.102,0.002,0.29,0.169,1.207,0.716,95.6,212.39,31.3801,0,0,0,0.016177,0.0496,0.708,0.456,0.364,0.229,2.891,0.28907,107.9934,2.1913,5.7599,2.3911,2.050623,0.3208,0.450813,0.1216,0.63,5.116255,5.562034,0.6311,0,0,1.049115,204.16,3.3,0,0.9447,0,0,0,3.533,141,8.526,62.95,148.7429,9.17,1.68,64,156.07,0,75,118,66.85,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
901,58,57,2,1,69.87,160.01,26.9187,1.72,6,0.033124081,0.39765044,0,1,1,6,11917.869,2,2,234.1,41.96,70.9,22.82,25.8,0.001558,0.0025,8.63e-5,0.00187,24.32,0.183,17.40411,2.2116,0.272,0.353,0.044,0.077,0.594,0.739,101.9,152.22,45.9979,0.26,1.2e-4,0.0127,0.260078,0.001,0.269,0.38,0.381,0.429,0,0.35965,115.1283,2.3346,9.807,0.4664,0.493331,0.2375,0.400148,0.1004,24.64,2.385345,4.321116,0.5753,0,0,0.807357,233.07,3.13,1,1.3024,12.957,0.073,0.6,4.158,142.9,6.161,67.03,226.0113,3.89,1.68,67,159.76,0,100,112,70.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VV,N,Y,Y,N,Low,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
902,49,49,0,1,60.34,160.06,23.92307,1.62,6,0.093668211,1.12329104,0,1,3,6,118.865,1,1,149.17,36.11,89.72,22.94,21.9,0.002684,0.0014,0.0300112,0.00185,0,0.329,5.00666,2.4072,0.373,0.119,0.092,0.001,2.173,0.82,102.2,109.91,58.7228,0,0,0.0124,0.644673,0.0098,1.073,0.404,1.02,0.316,0,0.40626,134.2206,0.279,7.3628,1.2922,4.242887,0.0854,0.290059,0,0.43,2.819584,0,0,0,0,0.806813,227.03,4.12,0,0.9744,0,0.0597,29.02,4.908,142.1,8.58,68.09,249.8708,7.92,1.6,66,160,0,57,111,59.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
903,60,60,0,2,68,163.01,25.14358,1.72,7,0.094613373,1.13488681,0,2,4,7,4488.365,1,1,235.2,38.99,87.29,39.62,71.06,0,2e-4,0,0.00346,27.21,0.125,0.09512,1.9224,0.064,0.089,0.03,0.058,0.641,0.739,104.6,133.9,44.9623,0,0,0,0.189975,0.0167,0.263,0.351,0.273,0.274,2.338,0.32155,117.8095,0,10.8929,0.3079,1.160663,0.2554,0.073776,0.0597,0,1.317829,0.243213,0.0371,0.00156,0.001,1.06242,104.44,4.19,0,0.971,11.314,0.0515,23.74,3.791,140.3,10.257,74,273.4807,2.67,1.69,71,164.26,0,67,112,68,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
904,50,51,0,2,90.17,174.05,29.73598,2.04,7,0.137776857,1.65168736,2,2,3,7,3738.218,1,1,297.9,42.18,78.06,15.71,18.03,0,0,0.020035,0,29.05,0.043,6.50342,2.3766,0.319,0.125,0.631,0.277,1.616,0.803,95.9,117.83,64.8995,0.43,1e-4,0.0068,0.095284,0,1.448,0.636,0.359,0.124,0,0.42029,142.2118,2.6412,5.7672,0.3468,1.356465,0,0.414968,0,0,5.627868,0,0,0,0,1.133709,240.6,4.5,0,1.02,0,0,36.06,4.536,139,11.953,73.03,209.3392,7.39,1.94,74,172.08,0,112,141,85.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
905,35,36,0,2,79.02,173.8,25.45945,1.93,6,0.050831445,0.61008959,2,2,6,6,1792.002,2,2,417.83,35.9,33.06,6.04,20.82,0,0,3.149e-4,0.00287,31,0.141,0.05295,2.1598,0.174,0.127,0.025,0.051,0.452,0.738,91.7,177.7,47.9335,0,0,0,0.921195,0.0345,0.008,0.255,0.348,0.365,0,0.30935,121.0654,1.0595,10.5115,2.4765,0.623276,0.2377,0.701292,0.0523,0,3.395353,0,0,0,0.001,1.091554,121.17,3.49,0,1.1099,0.591,0.017,33.34,4.107,132.1,59.51,55.09,427.1246,5.06,1.91,45,175.79,0.1,76,0,82.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,NA,NA,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,3,>1,NA,NA,Y,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,NA,Y,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
906,52,51,1,2,57.5,180.22,17.82515,1.72,6,0.131723472,1.58055857,0,2,6,6,16590.223,2,2,197.55,38.99,152.44,18.44,22.04,0.001204,0.002,2.74e-5,8e-5,25.93,0.13,4.6448,2.7031,0,0,0.065,0.065,0.604,0.625,104.9,90.56,75.1566,0.14,1.2e-4,0.012,1.430352,0.0492,0.391,0.347,0.152,0.002,0,0.37508,127.907,2.116,14.2029,1.2361,1.970129,0.2531,0.549908,0.0475,24.42,4.467303,7.094247,0.5708,0.00599,0.001,1.225617,235.1,4,0,1.2114,0,0,27.51,4.498,139.1,8.52,78.13,412.0096,8.1,1.9,73,181.21,0,99,121,58.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,NA,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,NA,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
907,48,49,1,3,106.14,185.87,30.69189,2.32,6,0.017614773,0.21157394,1,3,6,6,20082.002,1,1,342.44,38.04,87.92,15.03,31.79,0,0,0.0199402,2e-5,29.96,0.001,4.49857,2.5322,0.176,0.175,0.068,0.033,0.662,0.764,0.2,79.79,116.166,0,0,0,0.290395,7e-4,0.413,0.454,0.298,0.339,5.557,0.29862,98.6361,5.0713,14.3703,1.0861,0.802061,0.0133,0.64745,0.0037,0.93,4.303912,5.201532,0.5211,0.00649,0.001,0,218.67,4.65,2,1.105,11.708,0.0391,29.06,3.059,134.9,6.868,79.9,303.9666,5,2.39,60,188.25,0,77,126,111.42,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,2,>1,131RR,158FF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
908,49,48,1,1,80.23,191.6,21.7907,2.13,7,0.124873876,1.49802647,1,1,2,7,6027.606,2,2,1900.78,40.03,82.88,79.04,97.7,0.002971,0.0035,0.0995542,7e-5,29.09,0,10.04267,2.4194,0.111,0.125,0.084,0.06,0.505,0.012,98.9,126.49,54.9082,0,0,0.0053,0.071533,0,0.146,0.002,0.18,0.001,0,0.3796,132.6742,0.6982,10.9858,1.3011,2.592948,0.1506,1.217692,0.09,0.7,4.866615,3.904308,0.7207,0.00205,0,1.259587,335.86,4.29,0,1.0745,0.274,0,29.83,4.495,132,9.736,80.58,243.0273,10,1.97,95,190.21,0,86,147,79.93,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
909,61,60,1,1,97.1,180.21,29.75012,2.16,6,0.015174154,0.18242035,1,1,2,6,5157.685,2,2,383.51,38.05,108.42,29.17,23.74,0,0,0.0400895,8e-5,23.9,0.026,0,2.4992,0.685,0.548,0.113,0.094,1.198,0.868,99.1,64.51,114.9488,0.01,1.6e-4,0.0087,0.199987,7e-4,0.781,0.606,0.595,0.574,1.847,0.38179,132.0757,0.8194,0.0985,0.4584,0.599763,0,0.478547,0,27.02,3.244248,0.060503,0,0.0045,0.001,1.09869,198.62,4.4,0,0.9904,0,0,0.75,4.265,139.1,10.282,72.98,303.3573,4.49,2.17,84,180.9,0,84,162,99.58,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,< 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
910,64,63,0,3,59,164.29,21.55646,1.63,6,0.055936388,0.67094199,1,3,5,6,2580.228,1,1,590.7,24.35,435.46,28.86,31.35,0.086449,0.004,0.030026,0.00179,0.66,0.226,8.52977,2.0787,0.065,0.102,0,0.015,0.022,0.576,105,58.63,80.284,0,1e-5,0,0.12378,0.0058,0,0.286,0.128,0.236,0,0.34101,104.3424,1.7797,6.1012,1.8522,0.503873,0.0064,1.152466,0.0852,31.36,7.117787,8.900515,0.6337,0,0,1.249563,342.68,4.01,0,1.0982,14.352,0,21.82,4.483,138.8,9.466,48.1,191.8941,10.61,1.62,75,165.48,0.1,81,124,59.85,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
911,60,60,1,3,72.04,175.1,23.87359,1.89,6,0.03822366,0.45852297,1,3,6,6,16074.958,1,1,561.4,37.96,48.88,15.07,21.08,0.003432,0.0019,0.0679479,0.00101,21.84,0.09,0,2.124,0.235,0.191,0.258,0.174,0.886,0.755,98.1,92.63,73.6574,0.29,0,0.0019,0.029543,0.002,0.498,0.396,0.358,0.334,0.66,0.37173,119.4662,6.6668,15.2966,0.9057,0.998352,0.0055,1.519786,0.0989,0.13,6.631505,2.891968,0.7004,0.00118,0,0.057411,398.81,4.66,1,1.1086,10.216,0,27.33,4.521,131.6,11.928,71.93,273.0103,9.33,1.95,69,176.14,0,79,129,72.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
912,71,71,0,3,69.84,157.99,27.62525,1.69,6,0.061706512,0.74026001,1,3,5,6,2421.524,2,2,307.05,35.97,78.23,13.84,12.93,0.046102,0.0025,1.382e-4,0,30.92,0.188,6.48147,2.4352,0.23,0.165,0.023,0.043,0.577,0.441,105,61.34,89.5011,0.17,4e-5,0.0071,0.099714,0,0.404,0.379,0.126,0,0,0.43807,141.8412,2.6713,18.4445,1.2551,1.900371,0.0018,0.749924,0.0049,0.3,5.991268,11.14718,0.6999,0,0,1.403,355.14,4.8,1,0.9929,13.577,0.0659,27.25,4.857,138.1,15.315,72.06,481.9664,11.2,1.76,64,159.94,0.1,92,98,70.47,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
913,66,66,0,4,54.08,156.18,22.20171,1.52,6,0.085832644,1.03036183,1,4,6,6,5373.963,2,2,1892.63,34.88,76.91,9.79,32.21,6.83e-4,3e-4,0.0425149,1e-5,0.64,0.025,4.59763,2.2595,0.199,0.125,0.087,0.062,0.729,0.691,107,98.07,51.0462,0.04,0,0.0021,9.41e-4,0,0.501,0.386,0.2,0.144,2.028,0.37203,105.8661,2.0833,13.3203,1.38,1.500416,0,0.343024,0,0.2,3.910354,0,0,0,0,1.440774,178.31,4.67,0,1.1074,11.4,7e-4,32.82,4.698,138,15.386,70.88,302.3678,7.69,1.63,75,157.97,0,102,137,58.2,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
914,51,51,0,3,105.32,179.05,32.46889,2.22,7,0.050423148,0.60586998,2,3,6,7,10587.423,2,2,780.16,40.33,52.38,31.29,25.14,0,3e-4,2.267e-4,0,3.22,0.002,5.34939,0.967,0.173,0.145,0.162,0.159,0.755,0.708,0.2,157.74,53.0498,0,0,0,0.078913,5e-4,0.448,0.403,0.329,0.367,3.213,0.37925,129.9854,2.7735,13.3203,1.1339,0.882277,0,0.875436,0.0308,28.86,6.511398,4.445617,0.6465,0.00691,0,0.968981,207.95,3.73,1,1.1049,16.605,0,33.27,4.945,140.9,5.125,58.89,0,8.2,2.17,73,177.99,0.1,76,126,104.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
915,62,62,0,4,76.07,177.6,23.85292,1.93,6,0.098153143,1.1773235,1,4,5,6,657.095,2,2,445.75,34.78,107.31,31.63,26.97,0.002319,8e-4,0.030316,0,26.01,0,11.57016,2.3224,0.004,0.006,0.007,0.04,0,0.532,99,82.64,81.1068,0,0,0.0181,0.092773,0,0,0,0.006,0.255,4.028,0.37718,111.9888,0.0046,0.0727,0,0.729629,0,0.300407,0,18.21,2.919608,4.629104,0,4e-4,0.001,1.021535,380.86,4,0,1.0201,0,0.0385,25.55,3.798,137.1,11.019,56.98,397.1643,4.15,1.79,64,175.07,0,86,121,71.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
916,61,61,1,4,47.95,164.9,18.02122,1.51,6,0.060751641,0.72830267,1,4,3,6,3989.425,2,2,197.09,34.9,101.46,10.89,17,0,0,1.355e-4,1e-4,28.99,0.141,5.67949,2.0972,0.227,0.255,0.063,0.051,0.493,0.496,104.1,89.28,63.7193,0,9e-5,0.0055,0.399403,0.0434,0.07,0.001,0.299,0.347,0,0.41396,140.8258,2.2078,4.9078,0.0018,1.302244,0.1618,0.348708,0.0025,0,3.083373,0,0.002,0.0056,0.001,1.185697,256.56,4.87,0,0.979,13.652,0.0041,36.13,4.106,142.9,22.2,60.07,381.7266,5.4,1.55,71,165.03,0,72,135,49.34,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
917,70,71,0,1,95,174.04,31.21609,2.06,6,0.116290322,1.39406888,0,1,5,6,360.202,1,1,401.33,45.05,108.58,12.03,16.14,0.001142,0.0023,8.32e-5,0,23.54,0.089,9.6772,2.3201,0.064,0.146,0,0.002,0,0.399,98.9,81.45,79.5952,0.18,0,0.0175,0.156569,2e-4,0,0.284,0.003,0.169,1.685,0.37754,127.9793,2.4499,0.1005,0.0049,0.983958,0.0743,0.042377,0,0,4.017671,0,0.0115,0.0016,0,1.245061,161.32,4.9,0,0.9107,10.609,0,40.59,4.121,141.9,4.803,61.96,291.5587,5.61,1.98,75,172.96,0,67,129,91.66,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
918,49,49,1,2,83.72,178.04,26.70995,2.03,6,0.051351477,0.61659798,0,2,2,6,5842.771,1,1,403.91,41.94,83.85,68.73,25.93,3.49e-4,0,0.0318825,9e-5,0,0.079,10.610900000000001,2.4967,0.344,0.359,0.142,0.124,0.944,0.79,103,92.08,90.1926,0.45,0,0,0.079139,0.0183,0.49,0.376,0.497,0.44,0,0.43942,142.3997,1.0424,0.0561,0,1.260178,0.0079,1.199349,0.064,0,5.693449,0.277875,0.0345,0,0,1.039001,201.02,3.92,0,1.0515,11.222,0.0686,31.24,4.955,140.1,11.947,72.09,337.3902,8.7,1.92,45,179.8,0.1,56,96,81.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
919,38,38,1,3,107.94,179.35,33.59559,2.29,6,0.184689217,2.21801525,0,3,5,6,5696.613,1,1,833.41,44.05,96.85,113.19,101.82,0.001004,0.0018,1.524e-4,0,0.4,0.177,12.01912,2.2755,0.123,0.212,0.04,0.045,1.121,0.879,104,113.35,86.3892,0,3e-5,0.0013,0.005069,0,0.525,0.524,0.585,0.511,0,0.36288,124.518,0,0,0,0.629081,0,1.232793,0,0.74,12.093836,5.269046,0.016,0.00149,0,1.041819,231.37,4.43,1,1.058,10.735,0,33.29,4.785,138.9,6.08,52.26,291.4299,13.7,2.35,84,177.9,0,90,124,104.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
920,56,56,1,2,65.81,171.1,22.91447,1.78,6,0.045997967,0.55259877,0,2,2,6,4039.844,2,2,513.23,31.9,159.25,19.05,32.6,0.236619,0.0163,0.0399367,0.00287,25.1,0.076,0.02284,2.4574,0,0.049,0,0.001,0.018,0.512,102,108.32,68.9709,0.08,1e-5,0,0.300147,0.0307,0.006,0.148,0,0.002,1.748,0.39021,127.5394,2.9526,6.9448,1.3874,1.179049,0.0107,0.408081,0.0448,33.26,4.887904,1.786813,0.0297,0.00846,0.001,0.648116,282.22,4.38,2,1.2005,11.641,0.0378,27.64,4.434,138.9,8.479,55.08,293.3761,6.74,1.6,70,168.21,0,77,121,64.09,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
922,27,27,0,3,66.76,162.12,25.3066,1.71,7,0.126958042,1.52448381,1,3,2,7,6479.889,2,2,89.51,47.1,99.67,26.05,11.65,0,0,0.03999,1e-4,29.31,0.108,5.81151,2.1094,0.121,0.08,0.08,0.055,0.835,0.627,109.4,130.09,59.1161,0.22,0,0,0.091046,3e-4,0.402,0.254,0.413,0.213,2.065,0.42126,137.9898,2.1451,12.7979,0.33,2.397233,0,0.581755,0,0,4.68837,3.136867,0,0,0,1.557227,258.42,4.31,0,0.946,11.253,0,32.32,5.002,136.9,3.919,65.04,378.1408,7.92,1.79,66,162.4,0,112,108,67.39,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
923,25,25,1,0,57.83,168.05,20.68964,1.63,7,0.14743593,1.77017664,0,0,1,7,11170.811,1,1,366.91,38.03,118,78.33,102.93,2.57e-4,7e-4,0.1030336,0.00408,2.36,0.139,1.91753,2.3849,0.002,0,0.124,0.039,1.356,0.804,105.1,145.53,48.8778,0.18,1e-5,5e-4,0.040699,5e-4,0.668,0.382,0.564,0.276,0,0.36392,128.1836,1.3545,11.8758,0.4553,1.095213,0.1578,0.448464,0.005,0.62,3.997543,2.460741,0,0.00489,0.001,0.177122,428.99,3.69,0,0.9771,0.748,0,36.04,4.296,140.7,10.094,64.29,237.9297,6.3,1.67,72,169.85,0,92,121,60.47,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
924,54,54,2,3,62.11,160.07,24.09663,1.64,6,0.00981764,0.11791338,2,3,4,6,15454.832,2,2,972.46,35.93,41.9,8.04,18.18,0,0,0.0099268,1e-5,30.68,0,0.02481,2.0997,0,0.007,0.001,0.045,0,0.49,0,127.01,48.2381,0.38,2e-5,0.0185,0.040783,3e-4,0,0.197,0,0.098,6.15,0.2895,100.5305,1.2199,7.7413,0.7616,1.10012,0.0104,2.002774,0.06,0,4.600631,0,0.0081,0.00374,0,1.037889,155.45,3.66,1,1.0919,10.557,0.0546,30.8,3.549,137.3,13.629,51.47,178.8587,5.79,1.72,78,162.04,0,82,120,66.87,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,Low,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
925,79,79,0,4,108.31,182.84,32.73244,2.31,7,0.061292824,0.73663701,2,4,3,7,1997.141,1,1,268.49,36.97,152.63,63.01,39.7,0,0,0.0101102,0,25.91,0.096,10.65006,2.1539,0.075,0.165,0,0.018,0.038,0.687,96,56.84,107.963,0.64,0,0,0.102632,0,0.157,0.443,0,0,0,0.40842,128.1164,1.5731,0.0169,0,1.194561,0,0.501287,0,0.01,2.843421,0,0,0.00579,0,1.256514,105.58,4.7,0,1.0915,0.251,0.0043,29.82,4.293,133.6,10.261,67.06,345.0084,5.69,2.3,83,181.43,0,81,159,103.54,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
926,65,65,1,3,49.82,166.93,18.16172,1.55,7,0.051526571,0.61803229,2,3,4,7,6765.872,2,2,877.32,19.37,62.97,18.18,30.28,0,9e-4,0.011969,0.00826,22.5,0.175,19.44447,2.108,0.151,0.143,0.142,0.108,0.704,0.566,103,66.78,78.3949,0,1.1e-4,0.0082,0.001737,0.0293,0.46,0.336,0.119,0,0.705,0.24386,90.4702,0.5373,5.542,0.185,1.300865,0.3252,0.50157,0.0998,16.85,3.094726,0.475493,0.0391,0.004,0.001,1.275429,139.72,3.64,1,1.0433,12.343,3e-4,24.92,3.38,139,3.412,0,276.042,5.39,1.58,71,168.74,0,69,122,56.54,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),<18.5,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HR,158FF,Y,Y,N,N,Low,High-Intermediate,Q2 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
927,80,80,1,4,105.12,164.23,38.77362,2.08,7,0.115622583,1.38809103,0,4,4,7,10675.316,2,2,205.82,38,98.96,12.26,11.21,0,0,0.0769978,6e-5,26.96,0,3.67755,2.369,0.3,0.042,0.072,0.048,1.065,0.645,103.1,65.83,79.9128,0,0,0.01,0.352048,0.0039,0.804,0.442,0.351,0.085,0.786,0.39914,127.9865,4.9498,12.4027,1.0576,1.489335,0.0118,1.041937,0.043,0.02,4.110048,0,0,0,0,1.094029,225.13,4.3,0,0.8809,0.168,0.025,0,4.858,139,17.012,75.83,611.8548,7.75,2.08,78,164.27,0,99,124,107.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
928,67,68,0,3,76.81,175.09,24.97228,1.91,6,0.01462,0.17518375,1,3,2,6,2043.767,1,1,367.58,38.07,76.81,23.86,32.39,0,0.0032,0.0198716,0,0,0.071,5.2111,2.3114,0.174,0.162,0.018,0.002,0.94,0.809,105.8,73.14,83.9994,0,0,0.008,0.089236,0,0.473,0.369,0.455,0.399,3.603,0.31933,92.7291,1.2383,8.7684,1.0095,1.197151,0.0123,2.477311,0.0493,0,8.561476,0.229352,0.012,0,0,1.230025,219.25,3.03,0,1.1018,10.865,0.0652,36.49,3.404,140.8,10.265,61.83,409.5472,12.4,1.7,89,174.74,0,77,121,70.39,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
929,58,58,1,5,63.11,161.95,23.14698,1.68,7,0.050889557,0.61195551,2,5,5,7,7159.767,1,1,542.48,29.02,360.33,22.8,37.19,0.001483,0.0023,0.0260305,0.0022,25.06,0,6.14365,2.3756,0.625,0.254,0.558,0.155,2.182,0.758,97.7,72.29,86.6795,0.26,9e-5,0.0153,0.160904,0.0047,0.952,0.24,1.247,0.511,0,0.38808,119.2923,2.5415,12.106,0.6198,2.033348,0.1289,0.938814,0.068,0.19,7.111017,4.42122,0.5684,0,0.001,0.839557,322.33,4.69,0,1.0094,11.906,0.0092,25.68,4.575,140.8,15.021,66.15,422.6947,14.05,1.7,70,162.03,0.1,82,97,65.65,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,Y
930,60,60,1,4,48.17,154.27,20.23211,1.45,8,0.024462304,0.29331017,2,4,4,8,13571.058,2,2,877.61,38.86,223.42,17.08,30.67,0.001458,0.0018,0.058553,0.00319,0,0.042,5.12431,2.3786,0.322,0.341,0.21,0.151,1.284,0.703,0.3,76.09,61.8395,0.15,7e-5,0,0,2e-4,1.175,0.581,0.289,0.194,2.821,0.30427,91.2975,0.4819,9.9576,11.8702,0.719062,0.0056,0.572173,0.0686,0.47,4.085754,3.744409,0.0288,0,0,1.321047,246.73,4.29,0,1.2209,13.166,0.0178,38.18,3.895,142,9.799,58.11,160.2314,5.05,1.51,85,154.7,0,97,132,48.17,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
931,60,61,0,1,80.14,NA,25.51754,2,6,0.039818649,0.47827537,0,1,5,6,10626.705,2,2,288.79,41.57,48.04,10.92,15.95,0,0,0,0,27.89,0,20.66266,2.1989,0.739,0.52,0.14,0.094,1.353,0.753,105.1,71.98,89.6087,0,2e-5,0,0.020002,0,0.757,0.417,0.622,0.439,1.972,0.37351,117.4234,2.0045,9.3941,1.986,0.301077,0,0.310456,0,0.25,5.978985,0,0,9.5e-4,0.001,1.30451,345.05,4.2,0,0.957,0,0.0781,24.71,4.72,137,4.101,71.95,303.9058,6.26,1.75,66,170.9,0,64,118,71,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
932,63,63,0,1,74.1,158.75,29.06554,1.76,7,0.077291642,0.92748024,1,1,3,7,1941.363,1,1,198.19,37.06,77.57,15.02,13,0,0,0.0200198,3e-5,27.07,0,5.43425,2.2195,0.168,0.087,0.135,0.099,1.717,0.825,103,71.27,83.9997,0.25,8e-5,0.0016,0.100606,0,1.017,0.555,0.617,0.362,0,0.38975,139.0043,0.9594,0.1035,0.6598,1.458677,0,0.072056,0,0.23,3.603331,0,0.0026,2.9e-4,0,1.13387,419.29,4.21,0,1.0007,0.533,0,0,4.278,142,5.584,54.01,208.5889,6.39,1.86,78,159.76,0.1,70,149,81.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,GBR,United Kingdom,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
933,59,59,0,4,58.31,174.06,19.2942,1.68,8,0.137005152,1.64421728,1,4,6,8,12332.658,2,2,977.99,39.03,108.14,26.6,28.81,0.00157,0.0012,0.1009315,0.00404,30.04,0.061,7.63934,2.4448,0.328,0.276,0.002,0.013,0.586,0.656,96,68.5,79.2854,0.69,0,0.0303,0.099384,7e-4,0.471,0.486,0.164,0.149,0,0.43338,137.8435,0.8105,9.4385,0.4906,1.142179,0.0122,0.792243,0.0022,0,6.309911,3.011241,0,0,0.001,1.450723,163.74,4.1,0,1.0169,0,0.0839,30.56,4.829,132.7,8.303,69,248.0057,9.19,1.7,88,175.68,0,93,109,58.21,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VV,Y,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
934,76,76,0,3,76,171.58,25.82111,1.89,7,0.095952785,1.15085652,2,3,4,7,1990.055,1,1,178.55,42.59,106.69,29.62,20.93,8.04e-4,0,0.029915,0.00192,34.84,0,5.39199,2.4819,0.326,0.288,0.094,0.061,1.003,0.81,0.1,46.18,107.9883,0,0,0.0146,0.099959,9e-4,0.56,0.495,0.281,0.329,2.33,0.33402,100.8232,6.5977,17.4937,0.916,0.806836,0.0051,0.199595,0.0051,0.25,6.583981,5.204177,0.6799,0.00211,0.001,2.097015,388.36,4.21,0,1.0523,0,0.0127,26.7,3.988,140,8.517,76.95,450.6615,7.89,1.77,57,170.93,0,67,109,69.83,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,NA,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,NA,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
935,55,55,0,1,78.61,164.06,30.07165,1.87,6,0.057934038,0.6955381,0,1,4,6,1218.233,2,2,324.24,40.04,86.2,69.24,32.1,0,0,0.0700881,0.00377,29.66,0.112,7.13234,2.335,0.221,0.059,0.284,0.099,2.207,0.95,103,112.86,64.6967,0,0,0,0.200262,4e-4,1.19,0.624,1.089,0.495,0,0.43705,159.7391,2.0409,8.2541,0.6406,2.144556,7e-4,0.220811,1e-4,16.86,2.370816,3.5298060000000002,0.0137,3e-4,0.001,1.258361,217.64,4.68,0,1.0421,0,0.0308,29.06,4.997,141.1,8.343,68.95,291.7548,4.39,1.89,73,167.06,0,81,137,82.6,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
936,63,63,0,2,61.84,160.61,23.6623,1.64,7,0.047422222,0.56925061,2,2,1,7,832.952,1,1,159.12,38.99,173.42,7.99,14.92,0.001617,0.0014,0.0120122,0.0038,27.71,0.21,5.18503,2.2489,0.068,0.003,0.113,0.058,0.896,0.574,103.1,124.53,45.7303,0.13,0,0.0151,0.200243,0.0109,0.534,0.449,0.226,0,1.569,0.40119,140.955,2.3502,5.3234,0.9905,1.440501,0.228,0,0.041,0.1,4.589372,0.480672,0.0241,0.0347,0.001,0.901094,279.79,4.4,0,0.9265,11.566,0.0319,30,4.27,139,5.68,57.05,255.0449,6.88,NA,NA,NA,NA,NA,NA,NA,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,NA,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Western Europe,Y,Y,M,NA,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
937,81,81,0,4,128.63,182.85,38.73281,2.36,7,0.103144048,1.23661884,1,4,5,7,2517.331,2,2,300.9,33.99,87.69,49.41,59.03,0,7e-4,2.464e-4,2e-5,0,0.098,2.49923,0,0.795,0.3,0.105,0.053,1.485,0.673,96,138.88,45.9985,0,0,0,0.059908,2e-4,0.561,0.135,0.989,0.413,5.363,0.3561,105.98,2.8166,11.504,0.0016,1.798049,0.0097,0.407918,0.0057,0.38,6.885815,0.458093,0.0256,0.00257,0,1.226496,162.9,4.71,0,1.1556,13.482,0.0038,34.93,4.371,137.9,6.813,65.07,243.6761,11.6,2.28,70,181.01,0,85,120,111.78,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,NA,3-6,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,NA,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
938,30,30,0,0,78.85,175.67,25.32681,1.96,6,0.044870883,0.53785603,1,0,3,6,1081.874,2,2,194.13,45.99,89.7,70.66,59.04,0.001536,0.0016,0.0597033,0.00107,30.05,0.198,0.10977,2.276,0.162,0.007,0.17,0.099,1.077,0.656,97.2,152.21,59.2745,0.04,3.6e-4,0.0137,0.201558,0.0139,1.036,0.595,0.156,0,0.461,0.36103,136.1851,0,2.1495,0.0096,2.376234,0.0125,0.578631,0.0036,0.48,4.652443,2.070475,0.0221,0.0061,0.001,1.235642,175.88,4.4,0,0.9518,10.353,0,0.04,3.714,140,5.198,73.96,249.8335,8.3,1.98,91,175.29,0,85,130,79.91,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
939,26,25,1,2,75,180.08,23.71531,1.93,8,0.03711287,0.44453792,1,2,4,8,9723.941,2,2,407.69,30.09,64.76,47.29,37.91,0.003721,0.0041,2.198e-4,0.00403,31.12,0.103,1.83647,2.1677,0.018,0.154,0.019,0.049,0.47,0.675,103.9,101.24,90.0297,0.32,1.2e-4,0.032,0,7e-4,0.23,0.328,0.226,0.306,3.419,0.28654,104.0592,1.4067,0.0958,0.6591,1.002068,0.1139,0.310539,0.0818,0.78,6.290287,0.578943,0.6549,0.00492,0.001,0.961619,323.41,3.92,1,1.0152,13.381,0,25.59,3.996,150,4.636,49.19,321.8492,8.1,1.99,73,176.33,0,100,118,72.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
940,65,66,0,3,69.47,174.96,23.04425,1.83,6,0.174296063,2.09451709,0,3,2,6,1787.252,2,2,285.76,39.96,79.15,17.02,18.04,0.001242,0.0021,0.0999557,0,28.6,0.002,11.5391,2.1212,0.168,0.137,0.037,0.052,0.554,0.645,107.1,74.7,73.3708,0,5e-5,0.0069,0.399333,7e-4,0.394,0.401,0.181,0.196,0,0.28976,99.1325,1.7944,9.2276,0.3781,1.402318,0.0024,0.639096,9e-4,0,1.602357,0,0,0.00154,0,1.344826,81.52,3.81,0,0.9963,12.104,0.015,30.79,4.01,138,20.7,69.04,287.9327,3.58,1.79,61,175.04,0,85,110,65.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
941,66,66,0,3,71.42,157.49,29.36185,1.72,6,0.163625501,1.9603927,1,3,5,6,8024.342,2,2,2419.27,43.94,144.34,29.99,22.84,0,0,3.343e-4,4e-5,1.68,0.208,7.83633,2.4448,0.562,0.529,0.106,0.106,0.617,0.69,102.9,73.87,89.1353,0,5e-5,0.0026,0.148551,2e-4,0.427,0.508,0.26,0.313,1.898,0.421,146.3286,1.2759,5.3484,0,1.020098,0,0.281324,0,0.61,3.836409,1.961451,0.0138,0.00404,0,0.854182,71.53,3.5,0,1.0082,0.56,0.0317,29.14,4.031,138.9,22.924,73.05,435.1807,5.89,1.65,66,156.75,0,77,110,68.96,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
942,58,59,0,1,70,154.93,28.43912,1.69,7,0.03763255,0.45129745,1,1,1,7,1997.946,2,2,284.51,45.17,96.7,13.11,17.13,0.002121,0.0016,0.0087381,1e-4,19.95,0.172,5.00508,2.4623,0.073,0,0.05,0.001,1.204,0.704,90.1,128.95,44.2535,0.03,6e-5,0,0.069708,3e-4,0.663,0.375,0.415,0.216,0,0.36988,119.0432,1.4102,8.4119,0.4465,1.848212,0.1892,0.6201,0.0411,0.23,3.60097,0.488595,0.0253,0.00878,0.001,0,236.02,3.6,0,0.9997,10.914,0,30.88,4.103,143.2,13.972,69.95,350.9481,6.13,1.78,83,156.54,0,62,145,78.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
943,45,44,1,3,53.91,163.05,20.06367,1.56,6,0.048567764,0.58267273,1,3,5,6,8331.686,1,1,218.49,33.97,80.78,20.1,97.59,0.001767,0.003,0.0348776,0.01006,29.94,0.104,5.00459,2.1957,0.318,0.223,0.313,0.343,0.857,0.479,97.2,88.19,61.8683,0.29,0,0.0027,0,0.0292,0.536,0.385,0.274,0.162,0,0.16343,80.2979,2.3596,14.705,0.7186,1.54985,0.3202,0.800286,0.1231,10.64,4.386322,0.487117,0.5705,0.00768,0.002,1.191019,359.41,3.9,2,1.0926,13.216,0.0263,28.01,2.806,136.9,6.663,60.03,246.9564,9.09,1.52,68,163.05,0,96,113,52.18,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,JPN,Japan,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,High,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
944,30,30,0,4,70.11,179.25,22.20176,1.9,7,0.038242237,0.45944482,1,4,6,7,7000.775,2,2,2809.03,33.96,127.99,46.68,45.3,0,0,0.0487003,0.00295,24.95,0,4.59064,2.3185,0.328,0.241,0.459,0.273,2.187,0.867,104.9,100.7,85.7347,0.21,0,0,0.100353,0.0029,1.149,0.452,0.975,0.512,0,0.39599,129.3168,1.792,13.5824,1.2781,1.448569,0.0052,1.042548,0.0738,0.15,6.85601,5.502943,0.7717,0,0,1.505754,253.94,5.24,0,1.0409,11.125,0.0017,24.6,4.766,137.9,9.922,72.95,350.9566,8.85,2.02,96,182.93,0,103,130,76.08,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,N,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
945,62,63,1,2,55.78,163.98,20.45948,1.61,6,0.062105874,0.74604264,0,2,5,6,4627.014,1,1,441.82,36.35,100.43,11.99,16.04,0.002935,0.0016,0.0099537,0.00504,0.83,0.202,4.39512,2.192,0,0.092,0,0,0,0.009,106.9,86.08,55.6379,0.19,0,0.0112,0.050318,0.0196,0,0,0,0.18,0,0.31861,105.1572,1.656,3.8131,0.3998,0.621038,0.1995,0.236153,0.059,0,2.125368,0.328914,0.0256,0.00151,0.001,1.098308,140.61,4.1,0,1.0603,12.843,0.0357,35.74,3.552,143.1,7.005,48.89,329.4528,3.96,1.64,68,163.89,0.1,70,119,59.73,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
946,65,66,0,4,64.3,160.03,25.15519,1.66,6,0.042175461,0.50578378,0,4,2,6,1532.549,1,1,497.9,44.95,146.38,41.19,86.82,0.001824,0.0018,0.0200008,8e-5,26.06,0.128,12.71569,2.2596,0.13,0.23,0.004,0.064,0.35,0.682,98.1,71.04,85.8967,0.87,1.6e-4,0.0329,0,5e-4,0.042,0.322,0.159,0.312,0,0.35914,114.8222,0.9192,7.946,0.5075,0.676619,0.0909,0.358525,0.0594,13.35,3.990243,0,0,0.00273,0,1.450352,190.57,4.11,0,1.0077,12.753,0.0112,35.83,3.367,140.7,10.266,69.02,329.3634,5.25,1.65,66,159.37,0,71,124,61.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,NA,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,NA,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
947,83,83,1,5,114.23,158.89,52.36179,2.13,7,0.03701654,0.44415471,1,5,1,7,10247.975,1,1,297.57,42,55.91,15.05,16.99,0,0,0.0300192,1e-4,30.12,0.001,4.56424,2.4084,0.171,0.104,0.078,0.043,1.18,0.761,103,33.71,185.2236,0.11,1.1e-4,0.0054,0.196181,9e-4,0.73,0.482,0.338,0.214,0.324,0.48657,154.3076,0.0184,6.3262,0.3504,1.817769,0.1445,0.400295,0.0028,33.89,6.227128,4.342404,0.0279,6.9e-4,0,1.223686,328.68,4.3,0,1.0396,11.136,0,22.27,6.01,142.9,22.225,69.03,315.4221,8.72,2.08,81,159.08,0,104,149,106.56,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
948,66,66,0,2,59.15,167.31,21.48464,1.65,6,0.045680457,0.54830561,0,2,2,6,4862.633,2,2,229.66,32.28,59.12,36.49,20.8,2.85e-4,8e-4,0.0300138,0.00269,24.04,0.126,3.89676,2.5016,0.177,0.198,0.065,0.066,0.45,0.63,99.1,68.66,83.9312,0,0,0,0.069394,0.0049,0.021,0.001,0.275,0.341,0.679,0.345,111.6248,3.0932,10.9804,1.9873,1.321545,0.1502,0.311008,0.0041,0.59,2.453571,0,0,0.00259,0,0,142.1,3.8,0,0.9227,10.084,0,26.8,3.609,142,8.467,52.95,202.7752,4.49,1.75,71,169.81,0,80,139,63.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
949,70,70,0,1,82.08,170.06,28.79592,1.94,7,0.089648584,1.07665348,1,1,2,7,2274.136,1,1,315.37,50.64,66.72,40.64,24.7,0,0,0.099595,0.01013,24.38,0.002,3.92616,2.2173,0.819,0.24,3.857,0.821,2.01,0.776,105.9,91.99,69.9622,0.1,1.7e-4,0.0175,0.215506,0.044,1.368,0.606,0.571,0.229,0,0.41617,155.4448,2.6421,14.6903,0.0078,2.701,0.3143,0.501465,0.099,16.95,2.798883,4.408886,0.6448,0.00151,0,1.327029,103.43,4.18,0,1.0075,10.255,0,28.97,4.36,139.9,10.213,75.04,389.5354,6.1,1.91,89,170.04,0,87,139,76.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Western Europe,NA,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
950,71,71,0,3,65.1,170.9,23.05196,1.74,6,0.202275786,2.42538427,1,3,5,6,3608.593,1,1,161.14,33,319.52,18.14,24.14,0.001817,0.0032,1.03e-4,3e-5,24.61,0.075,6.86459,2.429,0.319,0.124,0.071,0,1.151,0.005,104.1,75.32,70.6926,0,0,0,0.811233,0.066,0.588,0.01,0.415,0.116,0,0.40809,131.2378,2.9474,11.1542,0.4995,3.643846,0.2524,1.07963,0.1206,0.56,3.450159,6.911264,0.6786,0,0,0,245.39,4.19,0,1.0225,11.662,0,0.24,4.387,141.6,18.806,75.02,94.1648,8.3,1.66,70,167.84,0,79,106,59.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
951,48,48,0,2,67.44,163.75,25.08932,1.73,7,0.150359347,1.8033816,0,2,5,7,3715.191,1,1,966.35,54.22,336.17,17.05,27.9,0.001567,0.0012,2.028e-4,9e-5,29.01,0.143,4.60026,2.5717,0.094,0.078,0.134,0.112,0.88,0.808,108.2,118.14,61.842,0,1.5e-4,0.0148,0.099363,0.03,0.417,0.421,0.451,0.413,1.198,0.47587,160.7046,3.4822,13.4689,5.3486,1.792743,0.2732,0.420747,0.0757,0,6.14152,7.088484,0.5785,0.00297,0.002,1.388754,433.09,4.2,0,0.9981,11.683,0,38.5,5.993,143.9,23.626,75.83,408.7162,9.38,1.84,79,164.96,0,66,125,68.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
952,71,71,0,3,81.18,172,27.75444,1.96,8,0.065482692,0.78430846,1,3,6,8,9879.497,2,2,200.58,43.13,76.96,12.11,17.13,2.59e-4,2e-4,0.0183775,8e-5,30.34,0.21,2.5385,2.244,0.129,0.145,0.11,0.06,1.066,0.762,100.8,77.5,81.1563,0.29,2.1e-4,0.0187,0.039749,0.001,0.355,0.232,0.66,0.364,0,0.37653,131.8949,4.9224,11.593,1.2836,1.306492,0.2021,0.387758,0.005,0.29,3.640521,1.671087,0.5304,0,0,1.221205,256.5,4.59,1,0.9785,0,0,0.96,3.853,139,5.114,68.42,356.8885,5.97,2.1,80,170.95,0,100,141,76.57,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
953,75,75,0,5,NA,NA,NA,NA,7,0.087949706,1.05467602,0,5,5,7,578.958,1,1,806.73,0,47.35,16.94,23.41,0.003551,0.0039,0.0100979,0,26.07,0.052,4.81852,2.0717,0.441,0.302,0.081,0.068,1.591,0.819,0,57.55,73.4503,0,1e-4,0.0058,0.090017,0,0.783,0.387,0.833,0.553,2.21,0.00414,86.6719,1.7455,9.9033,1.5999,0.877678,0,1.347523,0.0022,0.4,4.804611,0,0.0191,0.00121,0,1.197072,205.08,4.31,0,1.173,13.116,0,29.39,2.854,137,3.404,51.1,316.1087,7.34,1.46,7,157.81,0,57,125,43.44,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,NA,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),NA,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,NA,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
954,56,56,0,1,66.59,162.42,24.90652,1.71,7,0.099213259,1.19084695,0,1,4,7,9128.276,1,1,281.02,30.04,101.77,12.22,13.71,0,0,0.0584856,6e-5,24.98,0.129,3.90519,2.5024,0.098,0.136,0.123,0.067,0.815,0.588,101,82.53,83.9991,0,0,0,0.292271,0.0181,0.53,0.336,0.328,0.248,0,0.2991,94.129,2.2241,0.0587,0.4998,1.448358,0.0037,0.399861,0,0.6,7.203822,3.36006,0.0334,0,0,1.019234,413.61,4.5,0,1.1291,0,0.075,27.28,3.915,139.9,4.821,64.06,337.5108,9.48,1.82,75,167.1,0,69,106,74.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
955,59,59,0,1,48.23,147.91,22.32291,1.41,8,0.136868144,1.64261169,0,1,5,8,2130.607,1,1,332.69,32.05,82.75,18.2,34.45,0.004202,0.009,0.0102653,0.00183,0,0.06,5.50094,2.6216,0.313,0.245,0.272,0.151,1.438,0.564,104.8,60.51,88.2693,0,0,2e-4,0.278471,0.0414,0.707,0.279,0.622,0.278,0,0.40657,139.076,3.3913,12.1981,2.795,3.027803,0.2503,0.677694,0.0593,32.94,4.019437,6.617732,0.0395,0.00104,0.001,1.393546,456.87,3.55,0,1.017,11.125,0.0059,22.57,4.806,140.1,6.848,83.09,356.8834,7.69,1.52,102,150.21,0,81,136,54.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
956,60,60,0,3,99.56,169.27,33.92639,2.07,6,0.060539325,0.72640932,2,3,5,6,3904.391,2,2,290.73,42.91,140.88,27.88,34.96,0.001953,9e-4,0.045831,3e-5,29.73,0.139,3.92903,2.4415,0.196,0.126,0.123,0.134,1.016,0.716,95.2,113.46,61.9204,0.07,0,0,0.100742,1e-4,0.744,0.503,0.298,0.156,1.324,0.41655,140.4272,2.3557,11.0976,1.9857,1.692013,0.0782,0.498581,0.0041,0.75,4.365485,3.019998,0,0,0,1.228085,174.01,4.38,0,1.0169,0.345,0.0184,0.75,5.272,139.4,7.499,70.99,299.9681,6.62,2.15,64,169.8,0,63,120,105.42,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,F,Yes,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
957,75,75,1,1,61.05,162.78,23.20591,1.65,6,0.088750087,1.06530019,1,1,6,6,39505.788,1,1,184.73,35.02,58.08,11.08,16.12,0,0,0.0416814,7e-5,3.84,0.234,2.88206,2.4754,0.086,0.135,0,0,0.017,0.736,100.1,89.23,58.1692,0,0,0,0.131021,6e-4,0.003,0.172,0.09,0.357,0,0.35614,124.0099,2.1247,9.8969,0.4381,1.039893,0,0.559061,0,0.76,3.1681,0,0.0126,0.00221,0,1.145311,234.74,4.19,0,1.0122,12.363,0,29.84,3.926,135.9,8,66.55,368.1386,5.3,1.66,77,166.49,0,76,126,62.92,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,Y,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
958,76,76,2,3,54.98,156.99,22.28907,1.54,8,0.124193846,1.49074033,0,3,2,8,16967.57,1,1,383.81,35.09,190.52,13.88,11.11,0.002546,0.0033,0,0,0,0,5.59384,2.2294,0.274,0.18,0.069,0.032,0.817,0.682,101.6,84.15,47.424,0.11,9e-5,0.0022,0,0,0.517,0.35,0.344,0.298,0,0.35529,109.8267,2.3571,7.6297,0.4493,1.352343,0.0021,0.604019,0.0017,0,5.203953,0.587189,0.0268,0.00217,0,1.292712,175.48,4.19,0,1.1638,13.712,0,24.5,4.311,139,10.262,69.41,204.0653,5.79,1.55,80,157.43,0,69,147,55.69,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
959,52,52,0,2,96.79,183.13,28.23977,2.17,6,0.021804359,0.2615119,0,2,3,6,6965.145,2,2,213.92,33.94,71.74,91.61,26.23,0.002321,0.0025,0,0,24.62,0.001,4.53022,2.1025,0.28,0.16,0.179,0.115,1.793,0.84,105.9,155.25,55.623,0,0,0,0,0,1.165,0.512,0.559,0.338,2.684,0.37307,133.0302,1.6589,10.3809,0.5008,1.050469,0,2.440972,0.0049,10.71,14.410472,0.063776,0.02,0.0038,0.001,1.357818,329.6,3.81,0,1.1003,16.651,0,36.36,3.803,139.5,5.907,55.88,170.054,14.89,1.93,69,180.11,0.1,81,119,86.47,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
960,77,77,0,2,93.96,175.17,30.72963,2.09,6,0.153822794,1.84712059,0,2,1,6,787.803,1,1,230.82,41.94,66.14,50.67,75.4,0.0033,0.0026,0.0450958,0.00302,27.87,0.049,5.11543,2.3631,0.189,0.231,0.091,0.073,0.815,0.664,105,51.68,91.0051,0,1e-5,0,0.099493,7e-4,0.613,0.501,0.158,0.181,0,0.42021,143.908,0.0115,0,0,1.11289,0.1977,1.130623,0.0894,19.29,4.842043,6.304048,0.7394,0,0,1.196669,274.45,4.82,0,1.021,0,0.0511,0,4.6,137.9,8.441,70.06,303.698,5.87,2.06,98,175.21,0,69,149,94.46,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
961,55,56,1,4,41.27,147.96,17.96057,1.28,6,0.01838357,0.22089275,1,4,4,6,12678.95,2,2,593.19,34.01,78.29,21.88,66.8,0.001648,0,0,5e-5,28.06,0.149,4.60344,2.3837,0.16,0.204,0.017,0.048,0.146,0,0,65.41,67.5853,0.22,0,0.0147,0.073209,0.0063,0.018,0,0.18,0.208,0,0.2976,90.0261,1.7428,12.3315,2.9988,0.429809,0.0798,0.00534,0.0048,0,2.49087,0,0,0.00508,0,1.217619,290.57,4.06,0,0.9657,12.714,0.0507,40.38,3.189,139,25.666,52.92,451.8801,3.14,0,61,145.99,0.1,78,90,35.29,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
962,68,68,2,3,57.65,162.86,21.6331,1.61,6,0.025307346,0.30355665,0,3,2,6,16852.651,1,1,218.77,39.13,64.61,15.74,14.06,0.002165,0.0027,0.0300167,0,0,0.074,8.64168,2.15,0.004,0.022,0.11,0.102,1.413,0.883,106.1,55.71,98.0456,0.38,0,1e-4,0.047793,0,0.73,0.49,0.581,0.471,0,0.42966,135.1257,1.6003,10.9447,1.1194,1.900397,0.0049,0.831708,0.004,0,5.490743,0.474472,0.0331,0,0,1.381984,86.36,3.6,0,1.1138,13.082,0.0448,37.48,4.939,140.9,21.42,63.72,297.1936,8.96,1.51,80,161.89,0.1,70,150,56.88,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
963,73,73,1,3,58.49,152.72,24.26908,1.56,7,0.135298184,1.62466525,2,3,2,7,10553.057,1,1,135.81,30.16,58.16,11,13.96,0.001448,5e-4,0.0401204,0.00494,24,0.001,0.02497,2.2529,0.248,0.248,0.132,0.08,0.704,0,105.8,99.23,44.2496,0.29,1.4e-4,0.0142,0.339941,0.0159,0.402,0.004,0.258,0.203,0,0.42299,134.0946,2.3108,5.6867,0.9295,1.979632,0.0139,1.732961,0.086,0.51,5.107905,0,0.0306,0,0,0,304.04,4.38,0,0.9947,0.737,0,30,4.361,140.8,14.57,70.93,224.1442,8,1.46,59,153.04,0,0,119,55.19,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
964,62,62,0,3,59.54,166.91,21.62369,1.66,6,0.158555995,1.90042074,0,3,6,6,247.572,1,1,268.39,36.87,59.98,8.08,22.01,0.002442,0.003,0.0099276,0,25.97,0.06,6.44541,2.5444,0.029,0.137,0.006,0.072,0.036,0.726,103.1,59.8,85.9057,0.25,0,0.0159,0.200589,4e-4,0,0.263,0.095,0.315,1.954,0.30144,91.4989,0.0122,7.177,0,1.286973,0.0111,0.489389,0.0047,0.68,4.858015,3.019454,0.0191,0.00401,0,1.223991,337.74,4.11,1,0.9348,11.261,0.04,29.26,3.236,139,10.242,67.91,303.2201,7.69,1.58,63,164.99,0.1,83,119,57.91,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,>4,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
965,43,42,2,1,72.2,170.17,24.21403,1.86,6,0.065501732,0.78442106,1,1,4,6,17046.731,2,2,280.17,32.03,227.63,26.94,22.18,0.001313,8e-4,0.0099213,3e-5,27.29,0,4.28589,2.2484,0.197,0.158,0.089,0.088,0.542,0,101.2,170.49,45.055,0.19,0,0.009,0.109999,0.0105,0.328,0.242,0.14,0.001,0,0.35948,119.5601,4.0767,17.3654,1.3097,1.144331,0.0339,0.448025,0.0045,0,10.076181,5.490462,0.5909,0.00622,0,1.287018,461.91,3.79,1,1.0991,14.359,0.0128,31.97,4.14,137.1,6.022,73.34,146.7786,9.15,1.89,83,171.59,0,76,137,79.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
966,67,67,0,2,67.32,171.95,23.52514,1.77,7,0.080462939,0.96463988,1,2,1,7,1278.439,1,1,279.37,9.61,56.59,19,20.08,0.002164,5e-4,0.02994,0.00794,0,0.131,6.40619,2.1601,0.215,0.08,0.323,0.113,1.74,0.817,98.8,102.05,48.9654,0,1e-4,0.0038,0.101959,0.04,0.72,0.389,0.807,0.341,0,0.38079,133.8477,0.0155,0,0.0207,2.658549,0.2546,0.700659,0.1264,0.59,4.534785,6.017817,0.6701,0,0,0.969248,165.32,3.43,1,0.964,0.01,0.0428,34.48,4.552,141.9,3.433,51.92,314.3233,8.95,1.93,77,174.07,0,81,130,71.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,>= 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
967,78,78,0,3,71.82,169.99,24.97836,1.84,6,0.038688182,0.46413582,1,3,1,6,2022.228,2,2,647.54,34.03,89.22,22,21.99,0.002571,0.0021,0,0,0,0.118,6.46895,2.4156,0.101,0.096,0.017,0.019,0.135,0.58,98,44.35,106.3027,0,1.2e-4,0.0068,0.045906,0,0.008,0.131,0.142,0.216,0,0.429,150.3278,2.2167,9.3102,1.101,0.600257,0,0.069211,0,39.04,1.982304,0,0,0.00424,0.001,0.936446,167.08,4,0,1.0247,0,0.0222,26.06,4.479,137,8.427,61.01,243.517,3.29,1.67,60,168.03,0,69,104,66.96,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
968,64,64,1,3,83.99,180.47,25.30636,2.05,6,0.018954558,0.22737969,1,3,1,6,5752.749,2,2,515.28,42.8,213.84,24.95,27.91,0,0,0.0220162,0.00501,26.91,0.155,3.92178,2.3736,0.384,0.215,0.06,0.038,0.995,0.701,103,71.73,93.7549,0.22,0,0.0053,0.248752,0.0072,0.396,0.328,0.548,0.389,4.372,0.40149,137.5817,2.8357,12.5292,2.5032,1.842307,0.174,0.79551,0.0476,25.42,7.278899,0.135934,0.0041,0.0031,0.001,1.38903,405.4,4.41,1,1.0324,10.444,0,25.98,4.767,140,11.049,62.9,413.9137,12.31,2.14,81,180.18,0,78,150,83.95,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
969,65,65,1,3,134.82,186.84,40.87605,2.55,6,0.03756387,0.45129746,1,3,1,6,7903.221,2,2,232.25,39.94,85.09,40.18,28.92,0.001852,0.002,0.1139034,9e-5,24.05,0.134,5.17935,2.3906,0.789,0.247,0.02,0,2.234,0.749,103,67.19,150.9996,0.04,0,0.0046,0.475887,7e-4,0.904,0.008,1.308,0.374,0,0.45504,146.3442,1.0128,8.5868,1.2064,6.336223,0.0131,1.606747,0.0012,0.65,7.285269,0,0,0.00452,0.001,1.195269,295.45,4.39,0,0.98740000000000006,10.65,0,22.9,4.844,142,11.993,74.02,279.293,17.07,2.85,89,188.39,0,84,126,150.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
970,58,57,0,2,49.95,156.25,20.44951,1.48,6,0.037113382,0.44478567,1,2,5,6,9670.555,1,1,173.16,35.63,0,6.46,21.95,0.001835,0.0025,0.0074178,0.00503,30.05,0.234,4.78018,0,0.137,0.119,0.11,0.12,0.216,0.483,103.9,99.03,56.9281,0.29,0,0,0.147281,0.0419,0.062,0.213,0.089,0.155,4.22,0.3312,110.3532,2.5347,13.4402,1.0738,1.697425,0.2905,0.636493,0.1001,0,3.855047,0,0.04,0,0,1.335397,140.83,4.21,0,1.1199,15.212,0,39.06,3.551,146.5,2.585,49.95,309.425,7.6,1.45,0,156.6,0,57,104,49.44,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
971,69,69,1,2,49.96,161.96,19.28778,1.51,6,0.058637321,0.70402607,1,2,2,6,3499.987,2,1,177.2,38.31,99.48,10.94,24.14,0.002352,0.0017,0.06978,0.0029,22.8,0.149,10.77821,2.322,0.321,0.196,0.189,0.101,1.559,0.736,102.5,73.78,55.7964,0,1.2e-4,0,0.29973,0.0201,1.056,0.57,0.366,0.204,0,0.36366,116.009,0.4211,0,0.0018,1.484669,0.0138,0.601366,0.0892,0.51,2.819469,6.14809,0.8258,0.00267,0,1.218218,275,3.79,0,0.9012,0.436,0,25.08,4.707,137,5.136,62.51,333.0254,5.41,1.53,68,159.93,0,66,110,45.18,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
972,73,73,0,5,67.06,162.06,25.5063,1.71,6,0.082969411,0.99508107,0,5,5,6,1410.581,1,1,213.02,26.74,109.26,29.27,19.93,3.92e-4,5e-4,0.0300079,4e-5,25.01,0.071,6.68647,2.5018,0.043,0,0.035,0.027,0.471,0.455,92.2,68.73,75.1439,0.08,1e-5,0.0155,0.169993,4e-4,0.392,0.319,0.045,0.002,0,0.43606,144.9621,1.9411,6.8174,2.054,1.703641,0.0087,0.907547,0.0719,0.13,6.83113,2.614729,0,4.5e-4,0,1.00014,345.83,4.88,0,0.973,10.529,0,0,4.679,139,5.472,64,155.5417,9.59,1.7,80,161.64,0,64,117,65.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
973,71,72,1,3,70.09,173.92,23.95596,1.82,6,0.01976011,0.23743957,0,3,4,6,7376.023,2,2,348.28,35.09,287.88,17.61,21.08,0,0,0.0300289,5e-5,0.38,0.14,7.60275,2.3866,0.472,0.41,0.218,0.15,1.413,0.819,98.9,61.36,94.6685,0.51,0,0.0199,0.300609,0,1.125,0.639,0.374,0.31,0.42,0.34619,107.715,0.9764,7.0933,2.3428,1.407947,0,0.440133,0.0028,0.79,7.829701,0.363325,0,0.00244,0,1.063685,274.66,4.7,0,0.963,0.603,0.0302,33.02,3.633,132.2,17.193,58.96,209.3272,10.04,1.84,69,173.99,0,91,117,67.82,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
974,50,50,0,1,48.2,161.06,18.79152,1.5,6,0.062300685,0.74751685,0,1,3,6,1026.51,1,1,472,37.92,51.61,10.2,20.01,0,0,0,0,23.91,0.079,4.11129,2.2813,0.266,0.308,0,0.027,0.494,0.776,101,94.91,61.8731,0.17,0,0.004,0.130475,8e-4,0.105,0.271,0.3,0.423,0,0.41502,140.4118,2.8932,13.5422,0.3997,0.602924,0,0.209846,0,16.96,4.88049,3.179003,0.0079,0,0,0,303.54,4.39,1,0.9747,11.54,0.027,26.1,4.567,140.1,7.005,66.07,279.1362,6.1,1.52,81,158.01,0,84,130,47.88,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
975,73,73,1,3,70.96,170.97,24.59139,1.82,6,0.026431946,0.31711019,1,3,6,6,6488.517,2,2,267.1,18.32,165.06,10.99,25.82,0.003302,0.0037,0.025752,5e-5,24.17,0.069,4.27826,2.2311,0.117,0.199,0.005,0.03,0.473,0.846,102.6,71.13,79.2663,0.16,0,0.0024,0.007342,7e-4,0.341,0.461,0.147,0.328,0,0.33845,109.3002,2.3417,8.3752,0.8026,0.860878,0.0072,0.398934,0.0037,0,12.421713,3.859429,0.0293,6.4e-4,0,1.092549,220.05,3.15,0,1.1047,11.966,0.0336,34.35,3.854,139.9,9.505,57.9,183.943,10.67,1.73,60,170.03,0,68,111,68.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
976,33,32,0,1,80.94,169.86,27.65321,1.92,6,0.055036985,0.65998953,1,1,4,6,1909.768,1,1,210.32,40.73,56.24,16.09,4.23,0,0,0.0296579,6e-5,28.91,0.101,0.06606,2.1523,0.1,0,0.307,0.176,1.08,0.75,101.9,114.34,78.5658,0.35,0,0.001,0.500078,5e-4,0.525,0.319,0.454,0.275,0.157,0.41927,135.6646,2.0971,9.8056,1.5419,2.062376,5e-4,0.757363,0,0.57,5.483031,0,0,0.00291,0,0.931245,468.53,3.15,0,0.8789,0,0.0658,35.78,5.141,143.9,6.551,66.86,156.7347,8.17,2.04,112,174.09,0,98,151,86.77,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
977,56,56,1,2,69.92,164,25.83081,1.77,6,0.042798674,0.51334154,0,2,6,6,4015.519,1,1,359.33,42.97,45.13,15.07,17.14,6.28e-4,0,3.546e-4,8e-5,21.91,0.037,4.49957,2.1957,0.077,0.06,0,0,0.528,0.849,103,72.14,82.2096,0.25,1.2e-4,0.0284,0.269087,0.0318,0.246,0.442,0.29,0.443,0,0.41035,129.3414,2.2053,11.9971,0.5168,0.800753,0.168,1.033859,0.0689,0,2.313041,0.278977,0.0122,0,0,0,194.26,4.11,0,1.0826,15.87,0,32.93,4.52,139.9,8.93,71.9,297.2332,3.53,1.81,85,165.03,0,97,120,67.09,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
979,38,38,0,1,69.96,161.05,26.58194,1.75,6,0.06095972,0.73103786,0,1,2,6,2412.918,2,2,179.21,48.01,85.09,29.37,15.61,0,0,0.1299503,6e-5,24.63,0.089,0.07403,2.4023,0.203,0.006,0.001,0,0.814,0.435,96,106.85,70.8775,0,0,0,0.903371,0.0184,0.666,0.418,0.178,0,0,0.46007,162.8361,1.2975,9.4439,5.7793,2.938064,0.009,0.700623,6e-4,0.78,3.41098,5.298885,0,0.00246,0,1.109349,433.88,5,0,1.0594,12.495,0,26.09,4.899,139.1,8.558,73.65,317.2478,8,1.76,74,158.99,0,57,114,63.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,N,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
980,68,68,0,4,66.47,161.66,25.00478,1.73,7,0.042707795,0.51211206,1,4,5,7,2341.204,2,2,194.18,41.01,67.17,18.26,23.9,8.75e-4,0,0.0199376,0.00115,30.99,0.15,5.36242,2.0792,0.451,0.419,0.04,0.059,0.347,0.739,103,112.34,47.9526,0.26,0,0,0.510152,0.0092,0.068,0.334,0.237,0.29,0,0.41575,130.7367,1.7712,10.7412,2.1743,0.807021,0,0.700202,0.0034,17.16,3.205948,0,0,0.00375,0,1.031676,296.29,4.68,0,0.9747,14.77,0.0596,29.94,4.403,139.1,17.964,65.05,287.9144,5.4,1.71,65,162.14,0,64,112,68.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
982,73,73,1,3,73.93,169.91,24.98377,1.84,6,0.07223956,0.86883629,2,3,4,6,8492.038,1,1,218.74,41.03,330.86,35.14,16.91,0,3e-4,0,0,27.05,0.111,4.56608,2.0731,0.032,0.055,0.083,0.086,0.625,0.845,104,96.66,55.6539,0.18,0,0.0159,0.100111,0,0.379,0.505,0.188,0.23,2.143,0.35144,118.3739,0.9436,0.0665,0.0092,1.002045,0,1.413738,0,0,14.156502,3.390131,0.0148,0.00518,0,1.130018,235.53,3.59,1,0.9499,0,0.0808,0.74,4.1,139.1,4.01,61.96,90.3849,15.59,1.78,3,173.29,0,77,117,72.93,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
983,24,24,0,2,60.08,169.95,20.95155,1.69,6,0.042381192,0.5086141,0,2,1,6,12450.262,1,1,307.37,46.67,145.95,43.11,41.44,0.002137,0.0022,0,0,2.09,0.285,1.80823,2.2279,0.164,0.1,0.112,0.068,0.815,0.651,101,207.18,40.5059,0,1.3e-4,0.0225,0,2e-4,0.4,0.327,0.381,0.303,1.383,0.31488,107.7808,2.5142,13.4335,1.2218,2.740281,0.1168,0.512973,0.0444,0.44,3.601928,0,0.0183,0,0,1.147389,175.35,4.41,0,0.9303,13.48,0,26,3.894,142,5.113,80.88,180.7188,6.99,1.88,110,172.04,0,80,127,65.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,N,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
984,54,55,0,2,45.42,145.89,21.79899,1.36,6,0.046466116,0.55727396,1,2,3,6,1492.522,2,2,184.12,30.05,66.89,10.48,17.02,0,0,2.811e-4,0,27.04,0.155,9.61731,2.5059,0.004,0.004,0.023,0.042,0.163,0.515,97.2,93.82,53.3309,0.06,0,0.0061,0.09995,0,0.136,0.256,0.009,0.141,0,0.00267,64.0689,3.4407,19.9707,1.2366,1.803018,0.0084,1.321785,0.0017,0.15,8.008632,0,0,0,0,1.200988,462.64,3.91,0,0.9058,0.779,0.0603,31.21,2.708,139,4.089,70.94,267.6676,11.9,1.02,59,145.51,0,94,101,44.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
985,82,82,1,4,58.99,154.98,24.24542,1.57,6,0.075400965,0.90423703,2,4,3,6,12336.4,1,1,196.45,38.97,93.8,14.04,25.89,0.001546,0.0036,0,7e-5,0,0,5.42693,2.3501,0.222,0.318,0.001,0.014,0.51,0.742,101,47.55,78.0271,0,0,0,0.029637,3e-4,0.247,0.417,0.241,0.274,0.159,0.38937,135.3095,2.5067,11.5762,0.9556,1.093627,0.1866,0.689061,0.0774,0.66,7.173215,4.823626,0.6279,0,0,1.288616,105.37,3.12,0,1.1682,11.57,0.0139,25.7,4.442,139,10.642,64.09,398.1218,9.21,1.62,86,156.02,0,71,146,59.91,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
986,65,65,1,2,59.63,163.01,22.73172,1.63,6,0.021399645,0.25692974,0,2,5,6,8308.058,1,1,273.51,41.52,72.39,10.89,16.85,0.003847,0.0025,0.0200277,0,26.1,0.124,2.60156,2.3726,0.398,0.345,0.055,0.044,0.721,0.645,99.7,73.63,75.1096,0,1.3e-4,0.0177,0.129909,8e-4,0.422,0.292,0.294,0.352,3.941,0.41664,138.5891,2.0931,0.0862,0.8801,1.405756,0.1327,0.269662,0.0016,0.31,15.128668,3.528296,0.625,0.00164,0,1.093095,405.66,4.29,0,1.0017,0.451,0,31.94,4.656,139.1,8.597,70.04,242.9458,14.19,1.58,95,160.03,0,76,149,54.66,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
987,61,61,1,3,75.95,174.09,24.14759,1.89,6,0.062217505,0.74637145,1,3,6,6,19563.329,1,1,535.57,30.99,64.03,10.89,12.53,0.002902,0.0024,0.0099434,0,0,0.149,12.06401,2.1449,0.397,0.266,0.392,0.231,1.596,0.755,101.1,77.6,79.1678,0,9e-5,0.0143,0.124592,0,1.051,0.593,0.532,0.256,7.053,0.29719,100.7734,1.2264,6.8255,0.6206,1.301102,0.0037,1.259212,0.0822,27.01,4.970101,0.684979,0,0,0,1.320736,162.55,4.8,0,1.1765,11.56,0,23.77,3.665,135.9,8.426,58.88,291.2126,6.6,1.92,50,175.07,0,95,109,75.04,1,0,0,1,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
988,79,79,0,3,47.86,154.47,20.06557,1.44,6,0.058980188,0.7078504,1,3,4,6,674.972,1,1,177.88,30.05,354.48,15.66,26.72,0.003683,0.003,0.0737708,0.00407,21.11,0.149,6.06627,2.3535,0.11,0,0.117,0.078,0.913,0.017,101.1,73.87,49.9736,0,0,0,0.100695,0.001,0.599,0.325,0.271,0,3.272,0.31822,89.7408,2.9155,12.9558,0.4913,2.036369,0.2579,0.839562,0.0897,0,4.608551,0.427681,0,0.00277,0.001,1.098532,552.35,4.5,0,1.1088,12.032,0.0472,39.69,3.864,138.1,5.118,73.09,226.017,9.3,1.42,80,151.07,0,88,120,44.45,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
989,47,47,1,1,114.52,182.56,35.28691,2.35,7,0.06048771,0.72671272,1,1,6,7,12316.202,1,1,466.49,41.18,182.23,19.98,14.08,0,0,0.0300049,7e-5,29.48,0,8.24033,2.203,0.157,0.168,0.11,0.089,0.772,0.73,99.9,121.65,81.367,0.2,2.1e-4,0.0183,0.0474,1e-4,0.306,0.341,0.356,0.384,0,0.37933,134.2347,1.5228,8.9918,1.1765,1.096281,0.007,0.585156,0.0025,27.77,12.874459,4.468837,0.015,0,0,0.870732,255.37,3.31,1,1.103,0,0.0629,0.43,4.819,136.1,13.686,73.91,309.6548,10.61,2.39,83,180.22,0,113,120,111.4,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,Y
990,72,72,2,4,57.08,153.19,24.6795,1.55,6,0.074364284,0.89248153,1,4,2,6,25696.1,1,1,339.65,32.92,77.69,15.01,17.12,7.68e-4,0,0,0,21.06,0.149,10.96913,1.8976,0.003,0.048,0.019,0.049,0.046,0.017,103,91.66,53.2536,0.06,1e-5,0.0062,0,0,0.02,0.28,0.006,0.002,1.224,0.29843,91.1113,2.2334,12.2908,1.0207,0.59981,0.0094,0.39979,0.0227,0.01,5.920966,0.428743,0,0,0,0.851175,340.27,4.1,0,1.0411,11.732,0.0609,34.18,4.081,140,8.497,63.9,267.5064,6.49,1.44,70,150.68,0,89,111,49.47,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VV,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
991,76,76,0,3,103.59,175.05,33.51473,2.18,6,0.044323638,0.53230714,1,3,5,6,1124.012,1,1,341.2,41.06,125.16,69.21,27.94,0,0,0.099839,0.0072,20.94,0.116,1.88523,2.3727,0.154,0.087,0.147,0.096,0.89,0.647,98.8,97.22,62.9179,0,2.5e-4,0.0062,0.499981,0.0509,0.445,0.34,0.345,0.236,0,0.48298,152.4689,1.2086,8.1867,0.001,2.038276,0.2904,0.792807,0.0906,0.19,3.684856,4.288858,0.0381,0,0,1.110041,350.81,4.3,0,0.9708,0,0.0458,29.76,5.418,140,15.394,74.13,285.3707,6.5,2.09,79,175.49,0,70,138,103.08,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
992,71,70,1,4,59.99,156.51,24.56295,1.6,7,0.04323244,0.51894922,2,4,2,7,1218.363,1,1,743.69,39.97,302.27,13.87,15.56,0,3e-4,0.0199224,4e-5,23.05,0.24,0.09777,2.3018,0.246,0.231,0.048,0.058,0.528,0.499,100,78.88,61.0072,0.1,0,0.0112,0.017649,0,0.133,0,0.273,0.293,0.558,0.2957,91.9797,2.4975,16.3396,0.308,2.182679,0.1261,0.601515,0.0702,0.79,3.19223,0.058795,0.0272,2.9e-4,0,1.519567,176.11,4.2,0,1.0219,11.96,0,28.44,3.352,136,17.44,65.07,287.8938,6.2,1.64,68,157.59,0,78,121,60.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
993,69,70,1,2,55.93,179.01,17.97221,1.68,6,0.040182734,0.48221142,0,2,1,6,3240.807,2,2,565.45,48,95.66,13.99,16.96,0.004003,0.0044,0.0877142,0.00292,3.4,0.002,4.50789,2.3223,0.453,0.363,0.011,0,1.109,0.82,104,63.97,81.0778,0.15,4e-5,0.0217,0.052492,0.0102,0.566,0.401,0.596,0.516,8.435,0.44824,154.6071,0.5376,0,0.4289,1.178926,0.0114,0.408805,0.0557,0,3.617018,2.220026,0.6,8.3e-4,0,1.035838,245.26,4.6,0,0.8839,9.558,0,34.48,4.661,142.1,7.991,64.44,183.9961,4.52,1.69,74,176.49,0,68,126,54.34,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
994,48,48,0,1,81.07,176.31,26.67161,2,6,0.123452184,1.4812583,0,1,1,6,1817.669,1,1,253.47,42.94,97.66,17.83,21.91,0,0,0.0411342,2e-5,27.32,0.15,5.3626,2.5569,0.037,0.121,0,0.023,0.031,0.524,108.9,83.26,101.8376,0.21,0,0.0129,0.010604,0,0.013,0.008,0.007,0.186,2.169,0.48808,155.13,2.0336,10.3098,1.0391,1.001095,0.0024,0.138107,0,11.32,9.072218,0,0,0.00172,0,1.488258,286.64,4.31,0,0.8002,0.78,0.0606,0.57,5.038,143.1,8.611,70.93,333.0621,9.83,1.98,70,176.37,0,71,120,82.24,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
995,75,75,0,3,67.38,157.02,28.02687,1.67,6,0.174334737,2.09083889,0,3,4,6,2854.43,2,2,330.46,46.03,85.5,17.96,31.94,0.001153,0.0013,0.1002424,4e-5,27.82,0.121,10.45889,2.3473,0.239,0.227,0.001,0,0.751,0.396,101,71.29,77.0014,0.02,9e-5,0.0234,0.098013,6e-4,0.331,0.002,0.282,0.171,0,0.40828,130.1914,0.0153,8.0966,0.4994,1.439588,0.0461,0.699049,0.0053,0,6.280499,0,0.5121,0.00694,0.001,0.243511,236.76,4.09,1,1.0727,0.413,0.7549,29.82,4.636,138,18.099,64.08,494.8895,8.53,1.68,82,156.92,0,80,129,67.9,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
996,69,69,0,2,61.01,152.06,25.88461,1.57,6,0.133264178,1.59950261,1,2,3,6,3898.803,1,1,318.85,42.01,54.14,7.11,14.9,0,0,0.0133913,0,32.36,0.06,31.90698,2.4256,0.196,0.087,0.249,0.143,1.363,0.75,103.9,70.09,74.198,0.35,1.1e-4,0.0161,0.138408,0,0.687,0.446,0.52,0.228,0,0.39135,135.1249,1.4398,11.6067,0.6528,1.728122,0,1.043993,6e-4,0,10.298416,5.90416,0.5705,0.00241,0,1.089131,255.04,4.46,1,0.8864,0.12,0.0548,34.82,4.475,136.1,7.864,69.02,3.9683,19.12,1.61,65,151.77,0,65,141,62.55,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,OTHER,Other,Y,Y,F,No,CASA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
997,72,72,0,1,86.43,178.71,26.67926,2.05,6,0.151756905,1.81920643,1,1,2,6,1531.876,2,2,154.6,43.91,129.99,40.19,11.08,0,0,0.0451305,5e-5,27.09,0,7.60342,2.3445,0.218,0.14,0.025,0.007,0.639,0.566,96.8,69.36,83.9993,0,0,0.0118,0.508253,9e-4,0.447,0.502,0.15,0.001,2.594,0.39236,137.4195,3.1374,7.9337,0.6418,1.90015,0.0042,0.679959,0.0012,26.89,3.294343,3.899519,0,4.9e-4,0,0.129786,230.78,3.69,0,0.9945,9.715,0.0659,22,4.505,139,8.002,71.03,288.5502,5.61,2.1,71,178.03,0,63,115,88.98,1,1,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
998,66,67,0,3,62.98,161.6,24.76493,1.67,7,0.072218308,0.86691376,1,3,3,7,584.549,1,1,409.23,42.66,205.4,38.98,20.04,0.002182,0.0016,0.0198746,0,26.08,0.14,4.99808,2.2246,0.004,0,0.54,0.165,1.929,0.848,103,92.41,62.202,0.07,1e-4,0.0243,0,0,0.84,0.348,0.908,0.447,0,0.37136,115.5276,2.1003,8.7718,0.7809,3.061758,0.0753,0.371705,6e-4,0.82,2.898357,3.994324,0.0086,0.00221,0,1.187972,283.54,4.86,0,1.0575,7.881,0.0381,0.41,4.395,140.1,5.498,71.07,189.8094,5.31,1.68,81,160.14,0,87,127,65.01,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,N,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
999,75,75,0,2,98.97,167.03,35.42289,2.07,8,0.060581436,0.72749854,0,2,3,8,175.825,1,1,352.35,44.95,57.53,51.59,51.59,0.001772,3e-4,9.97e-5,0,28.87,0,80.96356,2.6585,0.085,0.077,0.017,0.033,0.019,0,105.5,108.05,53.0081,0.55,1.2e-4,0.0269,0.12798,0.0017,0.022,0.292,0,0,0,0.38966,137.2368,0,0.0706,0.2009,0.995341,0.0091,0.172264,8e-4,0.59,2.568952,4.300593,0.0215,0,0,1.442254,91.44,4.21,1,1.0694,13.325,0.0529,21.93,3.06,138,66.541,74.23,319.43,4.16,2.03,76,161.01,0,78,136,90.19,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Asia,N,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1000,43,43,1,3,91.11,172.9,29.94124,2.03,7,0.420308512,5.05489946,2,3,3,7,9002.078,2,2,448.3,41.91,96.9,11.97,23.94,0,8e-4,0.0400825,0.00599,27.26,0.112,6.20849,2.4013,0.197,0.15,0.029,0.014,0.846,0.72,105.1,101.63,69.873,0.35,1e-5,0.0198,0.300936,0.026,0.58,0.394,0.248,0.181,1.612,0.40558,125.859,2.8306,12.2584,1.2932,4.241389,0.1979,1.720648,0.1054,17.91,5.60424,0,0.0183,0.00158,0.001,1.000313,591.86,3.99,0,0.4579,0.954,0,24.94,5.148,137.9,5.175,70.98,274.4152,9.1,2.04,73,172.91,0,77,146,93.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1001,62,62,0,5,59.04,150.59,25.61958,1.53,8,0.089780986,1.07803549,2,5,6,8,11378.227,2,2,265.43,36.98,88.94,10.95,19.19,6.11e-4,0,0.099888,0.00375,26.92,0.187,0,2.1955,0.172,0.113,0.225,0.126,1.591,0.75,99.1,124.46,44.2014,0.12,5e-5,0.0191,0.16772,0.018,0.78,0.431,0.612,0.349,2.871,0.3734,122.0225,1.733,10.202,0.6005,2.627394,0.2428,0.719737,0.0042,0.17,4.409548,3.199802,0,1.7e-4,0,1.405011,567.02,3.88,0,0.9512,0,0.0288,22.57,4.392,141,6.913,67.04,249.5509,9.01,1.49,73,152.01,0,71,122,58.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1002,54,54,0,1,54.62,147.83,24.62441,1.46,7,0.09939524,1.19330908,0,1,5,7,3901.734,1,1,167.63,38.3,99.64,21.83,23.83,0.002006,7e-4,0,0,25.73,0.15,0.05682,2.2183,0.05,0.005,0.092,0.102,0.293,0.028,105,125.98,42.1908,0,3e-5,0,0.095669,5e-4,0.205,0.292,0.072,0.001,0.419,0.33631,108.063,1.8031,11.7875,2.7956,1.075055,0.156,0.351084,0.0313,0,2.468251,4.827192,0.6628,0.00796,0.001,1.165288,148.4,3.5,0,1.0088,11.871,0,29.51,3.801,142,8.533,68.03,287.9553,4.01,1.51,81,146.38,0,95,139,55.24,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1003,73,73,1,3,57.02,152.08,24.45257,1.54,8,0.158755564,1.90375378,1,3,3,8,10090.055,1,1,363.62,37.1,125.84,9.06,17,4.4e-5,0.0016,0.0314576,0.01003,22.9,0.139,0.02218,2.4085,0.108,0.11,0.013,0.041,0.58,0.748,98.8,71.49,60.8564,0.06,2e-5,0,0.148889,0.0415,0.243,0.318,0.2,0.249,0,0.40827,131.0632,1.0894,12.0902,0.7082,1.136424,0.2709,0.260076,0.0706,0.72,4.190199,6.097251,0.8005,0.00171,0,0.840323,715.43,3.8,1,0.9342,11.798,0.0079,31.56,4.986,141.9,4.69,69.4,130.5574,6,1.55,60,152.77,0,70,118,58.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1004,65,65,0,2,83.55,157.89,33.94483,1.84,6,0.081574979,0.97850045,1,2,2,6,417.414,2,2,70.9,42.15,84.34,21.09,9.92,0,0,0.0080305,0,23.97,0.073,5.50617,2.3009,0.247,0.037,0.615,0.189,2.761,0.851,102.9,69.76,88.6233,0,3e-5,0,1.159656,0,1.198,0.426,1.381,0.474,2.377,0.41927,139.8388,1.8812,9.2047,0.7805,12.346396,0,0.700999,0,13.39,7.372694,0.028176,0,9.9e-4,0,1.249887,800.44,4.8,0,0.9447,0.38,0.0027,32.56,4.715,139.9,9.911,76.97,161.9904,12.47,1.92,64,155.91,0,66,121,76,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,4,>1,131HR,158VV,N,Y,N,N,High,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1006,43,42,1,3,81.97,178.86,25.34517,1.99,8,0.037067755,0.44480592,2,3,4,8,10839.107,1,1,200.99,31.03,76.87,20.86,17.15,0.001424,0.0019,1.751e-4,1e-5,27.98,0.059,9.95451,2.3579,0.128,0.154,0.001,0,0.739,0.777,99.1,89.2,92.9684,0.08,0,0,0.399429,0.0196,0.145,0,0.414,0.457,4.71,0.4104,131.3272,2.2817,12.2284,0,0.692134,0,0.598388,0.0465,0.41,3.899821,0.107397,0.0297,4.3e-4,0,1.259716,223.48,4.01,0,0.9318,11.338,0,32.21,4.92,137.1,6.875,64.11,416.0964,6.05,1.91,66,179.03,0,77,101,74.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1007,62,62,0,2,70.13,168.06,25.15185,1.79,6,0.102795536,1.23405643,1,2,1,6,6349.951,1,1,453.83,38.06,91.27,19.07,32.41,0.001632,0.0025,0.0625675,0.00402,23.17,0.176,9.40636,2.4336,0.087,0.034,0.119,0.064,1.204,0.75,104.9,105.48,65.2054,0.37,1.6e-4,0.0055,0.070008,0.0182,0.586,0.308,0.503,0.273,0,0.41788,146.6352,0.0037,0,0.3247,1.580337,0.2389,0.4203,0.0878,16.22,3.209346,4.120575,0.7192,0,0,0.108995,106.06,4.51,0,0.9401,0.407,0.071,25.66,4.177,145,6.848,55.86,341.0434,5.2,1.8,73,166.23,0,66,116,68.08,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1008,50,50,1,4,64.59,166.93,23.04411,1.73,7,0.056267805,0.67516559,1,4,5,7,11974.635,1,1,1289.28,35.07,91.18,14.13,18.31,0.003062,0.0017,0.0504975,0.01088,29.19,0.125,4.41914,2.4994,0.203,0.332,0.02,0.043,0.726,0.786,99.9,68.74,97.0038,0,0,0,0.698831,0.0602,0.319,0.385,0.351,0.512,0,0.32997,108.4681,0,0.0954,0.5766,0.897508,0.3201,0.400128,0.1271,0.52,5.346777,8.362518,0.7405,5.7e-4,0,1.135421,293.9,4.46,0,1.0227,10.323,0.0237,28.42,4.155,135.8,6.499,68.96,884.2439,6.55,1.7,56,165.03,0,103,120,64.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1009,73,73,1,3,69.04,162.81,25.73819,1.73,6,0.135263377,1.62335649,0,3,6,6,7904.795,2,2,216.5,28.4,97.86,39.88,33.61,0.002668,0.0028,0.0298931,0.00172,30.5,0.031,12.45477,2.0631,0.245,0.096,0.17,0.076,1.283,0.634,96.2,62.26,82.9582,0.01,7e-5,0.0241,0,4e-4,0.845,0.406,0.405,0.185,0,0.43683,131.6479,3.7638,12.1908,1.6724,2.501564,0.2197,1.000311,0.0895,0.8,7.475304,4.885419,0.0413,0.00584,0.001,1.392984,170.71,4.14,0,1.0679,10.504,6e-4,25.38,4.706,139.9,12.869,66.12,267.9462,11.97,1.72,80,161.82,0.1,107,165,66.95,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,2,0,131HR,158VF,N,Y,N,N,Low-Intermediate,High,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1010,64,65,0,2,70.08,185.06,20.9644,1.94,6,0.19338224,2.31798464,1,2,2,6,2793.46,1,1,144.61,35.54,39.42,31.19,19.02,0.001574,0,6.88e-5,0,31.08,0,6.40162,2.1281,0.014,0.049,0.009,0.037,0.424,0.642,105,90.34,67.8633,0.42,0,0.004,0.09927,0,0.057,0,0.244,0.264,0,0.3614,127.9073,2.4035,7.7025,1.551,0.340883,0.005,0.001851,0,0,3.6195,5.637673,0,0.00236,0.001,1.109669,99.53,3.7,0,1.2008,0.573,0,40.08,3.667,139.9,8.493,66.83,367.6508,3.9,1.85,79,184.13,0,66,127,66.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1011,36,36,1,0,94.16,164.93,34.59074,2.01,7,0.1462854,1.75546923,1,0,2,7,4434.189,1,1,593.17,38.46,68.45,20.81,19.8,6.66e-4,8e-4,0.0535611,8e-5,20.86,0.105,7.49332,2.255,0,0,0.012,0.023,0.302,0.495,104,115.51,75.6248,0.07,0,0,0.059916,4e-4,0.216,0.355,0.006,0,0,0.37516,124.3466,1.3444,9.7715,0.48,1.242576,0,0.299571,0.0034,0,7.913371,0.655966,0.4983,0.00691,0,0.15452,469.7,4.7,0,0.8979,10.849,0,24.43,4.69,139.9,3.405,73.01,214.1389,9.81,2.01,89,164.29,0,72,133,91.39,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1012,55,55,1,1,NA,146.74,NA,NA,7,0.036807909,0.44132494,2,1,5,7,6506.153,1,1,219.4,38.95,126.52,18,25.85,0.001777,0.0015,3.451e-4,5e-5,27.65,0,0,2.1736,0,0.077,0.003,0.052,0,0,104,121.97,42.2908,0.13,0,0.0201,0.004988,3e-4,0,0.01,0,0,3.826,0.35169,124.8806,2.3127,0.1079,1.022,0.480214,0,0.237194,0.0026,0.04,5.629663,3.210601,0.025,0.00222,0,1.255302,210.7,3.83,0,0.9948,14.551,0,22.24,3.954,139.9,8.232,55.57,196.078,6.14,1.41,77,145.69,0,80,107,52.45,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,NA,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1013,45,45,0,2,56.5,160.12,22.05388,1.58,6,0.041022661,0.49230952,0,2,6,6,1856.58,2,2,770.09,39.95,77.56,11,16.14,0.001031,0.0013,0.0200338,0.00701,30.53,0.13,6.76312,2.5792,0.005,0.052,0.165,0.175,0.99,0.846,99.9,88.75,73.1738,0,1e-5,0.0036,0.009907,0.01,0.575,0.513,0.364,0.46,2.314,0.31937,112.8758,1.8435,11.9931,1.4317,0.802276,0.2515,1.020006,0.1,17.19,14.151826,3.110353,0.6873,0.00236,0,1.29431,581.66,4.4,1,1.1008,12.19,0,30.37,4.097,137.1,6.863,75.82,206.663,13.65,1.62,60,162.8,0,92,110,59.99,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1014,60,60,1,4,49.93,156.1,20.27357,1.48,7,0.073601626,0.88335156,2,4,6,7,5148.97,1,1,1613.13,29.91,119.05,21.68,35.91,0.002012,0.0029,0.0399528,0.01397,21.99,0,0.04892,2.4068,0,0,0.001,0.029,0,0.023,101,71.95,84.9257,0.21,1.3e-4,0.0151,0.199984,0.0442,0,0,0.143,0.308,3.451,0.2986,100.2003,1.8351,12.0605,1.5133,0.843372,0.3129,0.358822,0.1191,25.12,3.366223,3.080478,0.7121,0,0,0.940009,477.21,3.41,0,0.9134,0.957,0,28.91,3.915,136.9,11.291,58.63,288.4899,5.2,1.46,56,155.85,0,78,91,53.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,NA,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
1015,53,53,1,4,75.03,179.02,23.62172,1.94,7,0.029222371,0.35068312,1,4,6,7,19568.318,1,1,383.87,25.98,37.43,36.27,18.05,0,0,0,2e-5,27.21,0.138,3.90579,1.2012,0.174,0.147,0.039,0.014,1.15,0.856,98,141.68,52.155,0.12,8e-5,0,0.25651,0.0019,0.619,0.504,0.475,0.422,2.754,0.38794,132.9589,3.321,7.1656,0.768,1.460914,0.0803,0.849668,0.1171,0.67,6.098131,4.558206,0.0237,2.7e-4,0,0.91954,200.47,3.09,0,1.096,12.324,0,28.66,4.591,134.6,9.993,52.92,202.7431,9.04,1.93,80,178.01,0,77,111,70.12,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1017,23,23,0,1,86.33,177.03,27.55172,2.04,8,0.099834953,1.19756265,0,1,2,8,2809.598,1,1,161.04,43.56,53.69,21.7,15.09,0.06037,0.0024,0.0698145,9e-5,26.57,0.057,0,2.5437,0.104,0.175,0,0.001,0.301,0.537,96.7,157.43,67.1204,0,6e-5,0.0142,0.499852,0.0022,0.18,0.357,0.006,0,4.131,0.41298,132.361,2.1198,11.2214,0.7633,0.798576,0,1.352664,0.0502,34.79,6.172584,2.067787,0.0021,0,0,1.19546,248.29,4.48,0,0.8694,11.857,0.0445,0,4.608,141,5.311,69.07,279.5602,8.59,1.98,71,180.06,0,75,88,86.86,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1018,53,53,1,2,66.98,166.43,23.11638,1.75,8,0.108893693,1.30627713,0,2,4,8,4459.663,1,1,220.21,37.94,98.4,16.95,13,0,0,0.0198722,0.00795,25.11,0,3.49894,2.3247,0.159,0.161,0.126,0.112,0.818,0.743,101,119.98,52.5853,0.17,2.8e-4,0.0107,0.099253,0.0628,0.548,0.452,0.242,0.252,3.265,0.34002,108.7338,4.1572,10.9319,1.2998,1.248137,0.2136,0.698537,0.1182,0.81,8.135168,4.324217,0.6949,0.00128,0,1.081426,294.06,4.33,0,1.2897,13.809,0.0318,30.15,4.308,139.9,7.01,67.08,196.9816,9.15,1.9,70,169.83,0,84,121,74.39,0,1,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,Y
1019,38,38,1,2,69.44,185.05,20.44757,1.94,7,0.058811613,0.70584386,0,2,6,7,14642.095,2,2,1287.65,42.72,223.68,40.11,44.8,0.001447,2e-4,0.0292974,0.00173,28.49,0.083,6.48422,2.4474,0.227,0.144,0.027,0.01,0.723,0.638,102,103.59,94.1118,0.06,7e-5,0,0.039797,2e-4,0.212,0.006,0.366,0.306,0,0.43187,142.1895,1.5191,16.2605,1.0339,1.536743,0.0081,0.599464,0.0463,0.72,7.67698,4.479662,0.0199,0.00551,0,0.968949,389.54,4.2,0,1.1076,0.882,0.0085,32.92,5.371,127.3,9.917,80.48,410.2822,11.2,1.98,80,187.77,0,95,117,71.83,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1021,70,70,1,4,71.92,165.06,26.09497,1.78,8,0.081333379,0.97607661,1,4,3,8,4417.683,2,2,563.36,45.96,314.62,19.91,16.91,0.002349,0.0015,2.762e-4,0,26.33,0.001,6.71572,2.3758,0.001,0.124,0,0,0,0.01,100.9,88.37,58.1392,0,0,0,0.070013,0,0,0,0,0.129,0,0.42974,143.1136,0.0017,6.3089,0.008,0.29834,0,0.369757,0.0053,0.52,2.285129,3.678806,0.6,0.00536,0,1.230083,220.47,4.54,0,1.095,10.729,0.0368,27.3,5.106,143,15.379,72.13,380.601,3.65,1.89,85,165.02,0.1,95,166,71.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),<18.5,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,Yes,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1022,68,68,0,2,71.93,174,24.22025,1.87,7,0.142151156,1.70824135,2,2,3,7,6851.869,1,1,241.75,43.08,110.74,45.78,32.06,0.034404,0.0048,0.015709,0,26.62,0.134,6.4669,2.3499,0.092,0.068,0.109,0.112,0.091,0,93.1,64.3,91.9925,0,3e-5,0,0.090088,9e-4,0.319,0.385,0.005,0,2.555,0.41578,137.5093,1.3938,9.9076,0.0102,0.761819,0.0856,0.407441,0.0014,0.38,2.571769,0,0,0.00339,0,0.785057,163.04,3.59,0,0,0.87,0.0631,22.57,4.903,139,5.148,59.38,184.6793,4.49,1.83,80,174.04,0,71,120,73.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,NA,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Asia,NA,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1023,76,76,0,4,99.02,175.51,32.66005,2.14,8,0.129821444,1.55576038,0,4,5,8,1410.942,2,2,254.38,38.04,112.21,10.2,19.04,0,0,0.0099707,1e-5,25.59,0.128,6.98102,2.3492,0.32,0.168,0.133,0.095,1.159,0.757,105.9,64.08,86.2463,0,0,0.0217,0.149539,7e-4,0.754,0.494,0.361,0.203,1.112,0.45406,148.1961,3.4516,15.1938,2.3807,1.30377,0.0135,0.199772,0,0,3.048668,0,0.6222,0.00304,0,0.865833,167.22,4.7,0,0.9365,0.118,0,22.72,5.079,142.1,21.383,74.17,231.9969,5.39,2.24,75,177.38,0,67,131,102.17,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1024,63,63,2,3,80.57,168.08,27.69947,1.92,6,0.052971554,0.63578829,1,3,4,6,8071.746,2,2,544.67,31.51,83.23,36.4,21.95,0.002846,0.003,0.0200173,9e-5,23.5,0.001,3.36949,2.208,0,0,0.042,0.086,0,0.454,98.8,99.87,69.5964,0.07,2.9e-4,0.013,0.006187,3e-4,0,0.369,0,0.001,2.107,0.40375,133.144,0,7.4241,1.3078,1.260057,0.0118,0.598476,0.0746,0.29,8.561662,0.294378,0,0.00966,0.001,0.748435,263.5,4.92,0,1.1104,12.296,0.0649,31.04,4.916,139.4,13.34,53,280.3484,9.11,1.93,76,171.1,0,90,120,90.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1025,25,25,0,1,66.7,158.88,26.50538,1.69,6,0.056492632,0.67833634,0,1,1,6,1000.652,1,1,497.12,40.98,116.14,45.96,28.9,0.003603,0.0022,0.0237829,5e-5,33.29,0.001,6.28435,2.4345,0.061,0.019,0.066,0.056,0.506,0.614,102.3,133.96,63.7211,0.03,0,0,0.321584,0.0095,0.301,0.321,0.133,0.114,0,0.34987,121.7013,0.0084,8.4769,0.9285,1.867149,0.0047,0.647691,0,0,2.197806,3.596296,0.5691,0.0029,0,1.489187,121.21,4.21,0,1.1335,11.585,0.0241,22.61,4.507,138,20.624,72.33,389.7171,4.61,1.67,78,158.88,0,63,146,64.69,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,N,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1026,76,76,1,4,52.1,148.59,24.0054,1.45,6,0.117155821,1.40659323,2,4,6,6,8352.36,1,1,161.22,42.57,47.49,8.21,0,0,0,0.0300073,0,28.37,0.149,8.93443,2.1665,0.064,0.024,0.118,0.065,1.017,0.689,107,59.25,62.6285,0,4e-5,0.0139,0.201362,0,0.839,0.514,0.207,0,0,0.35652,124.042,2.3492,0.114,0.0042,1.698572,0,0.902802,0.003,0,6.052485,0.198406,0,0.0036,0,1.060227,238.26,3.5,0,1.0712,8.556,0,27.7,3.985,142.5,7.575,59.35,359.5765,9.9,1.49,88,147.92,0,91,127,53.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,OTHER,Other,Y,Y,F,No,OTH,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1027,68,68,1,5,55.82,152.13,24.21756,1.51,8,0.050010882,0.60003628,2,5,6,8,30663.748,2,2,601.86,24.91,181.2,9.04,12.08,3.39e-4,8e-4,0.0136295,0.00991,0,0,6.75678,2.2263,0.051,0.058,0.001,0,0.623,0.84,94.4,71.04,69.9479,0.24,1e-4,0.0122,0.119985,0.0499,0.371,0.438,0.233,0.291,4.082,0.27513,81.3803,0,0.0477,0.6997,1.002646,0.3304,1.000189,0.1601,16.4,6.800157,6.785064,0.7391,7e-4,0.001,1.01635,474.68,4.81,0,1.2347,10.724,0,29.96,3.534,132,15.393,60.05,166.2851,9.8,1.49,60,153.04,0,96,81,53.29,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,Y,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1028,58,58,1,2,89.93,168.57,32.2915,2.01,8,0.094939193,1.1396866,0,2,6,8,1921.891,1,1,223.87,49.12,55.91,53.99,23.63,0.002235,8e-4,0.1198454,0.00116,28.74,0.211,0.03931,2.2475,0.109,0.096,0.115,0.064,1.106,0.851,103,83.3,83.7199,0,6e-5,0.0061,0.041956,9e-4,0.67,0.547,0.361,0.293,0,0.37376,116.033,3.3954,8.712,2.3306,1.536735,0.156,0.366873,0.0886,17.17,3.69346,4.998856,0.6725,0.00212,0,1.291502,244.87,4.81,0,1.002,8.974,0,0.19,3.887,140.1,6.669,73.1,76.2773,5.67,2.14,75,170.15,0,69,116,92.38,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1029,62,62,1,2,96.08,175.02,30.61355,2.09,7,0.109179874,1.31179631,2,2,3,7,3368.169,1,1,744.97,34.39,79.11,19.95,16.97,0.00299,6e-4,0.0597865,0.00492,0,0.101,6.06482,1.9892,0.003,0,0.001,0,0.579,0.78,103.1,129.29,58.0954,0.08,2.5e-4,0.0085,0.071884,0.0065,0.335,0.388,0.218,0.26,0,0.39327,133.0889,1.6775,0.0514,0.6002,0.569424,0.0092,0.229286,0.0405,0,3.403099,4.329951,0.0301,0.00553,0,0.616155,221.86,3.9,1,1.0281,11.762,0.0281,36.7,4.397,134.9,10.212,59.01,235.7078,4.86,2.19,79,178.01,0,77,131,104.31,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1030,51,51,1,2,NA,NA,NA,NA,7,0.051492889,0.61759763,2,2,5,7,6063.332,2,1,306.73,34.09,76.88,17.88,16.81,0.002575,0.0023,0,0,28.02,0,8.2503,2.5207,0.147,0.145,0.032,0.049,0.771,0.498,104,53.12,144.3231,0.14,0,0,0.129835,0,0.427,0.284,0.257,0.184,5.677,0.41438,145.7062,2.8528,10.9069,1.1731,0.877973,0,0.843901,7e-4,26.52,6.056481,0.427248,0.0378,0.00548,0,0.90965,237.52,4.25,0,0.9995,10.048,0,23.38,4.917,140.8,8.208,69.93,340.0754,8.86,1.89,76,178.63,0,93,109,67.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,131HH,158VF,Y,Y,Y,N,Low-Intermediate,Low-Intermediate,NA,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1031,19,19,1,0,62.94,171.95,21.82814,1.73,7,0.029679907,0.35591092,0,0,2,7,4604.5,1,1,877.09,40,47.47,13.9,16.94,0,0,0.0996662,0.00402,24.92,0.05,0.102,2.5001,0.187,0.194,0.141,0.11,1.661,0.957,90.6,128.91,65.949700000000007,0,0,0.0094,0.160672,5e-4,0.856,0.568,0.84,0.58,0,0.41092,137.3665,2.4149,20.9642,4.251,1.451497,0.0124,0.500413,0.0044,0,3.071245,0.673755,0,0,0,1.193193,355.88,3.4,0,0.9224,0,0,40.56,4.618,137.1,9.079,77.65,352.3544,4.3,1.7,83,170.12,0.1,86,111,63.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1033,34,34,1,2,75.04,179.24,23.53004,1.95,6,0.240295516,2.88354265,0,2,6,6,9752.836,1,1,216.34,32.95,269.74,22.89,16.04,8.6e-5,0,0.0078077,3e-5,1.65,0,4.91132,2.3487,0.189,0.266,0,0,0.034,0.68,105,95.19,86.4741,0.28,3e-5,0,0.622796,7e-4,0,0.188,0.16,0.319,3.234,0.41224,131.8247,2.1158,0.9323,0.9007,0.703105,0.1892,0.580941,0.0787,12.77,4.209443,3.130866,0.5182,6e-5,0,1.019771,383.26,4.5,1,0.9703,0.592,0,40.52,4.59,136.9,15.41,65.68,474.1362,5.21,2.03,70,178.09,0,99,113,77.46,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1034,38,38,1,3,47.02,171.07,16.54862,1.55,7,0.054379167,0.65248981,1,3,6,7,5994.731,1,1,Inf,43.93,129.18,16.98,61.81,0.001227,0,0.0093409,6e-5,30.42,0.204,4.92131,2.4178,0.092,0.098,0.066,0.067,0.599,0.627,0,109.24,55.6332,0,6e-5,0.009,0.117381,9e-4,0.116,0.007,0.329,0.271,0,0.392,127.9924,3.3171,18.8122,1.1483,2.216663,0.2596,0.511217,0.0654,0.7,3.502499,0,0.0062,0,0,0.963721,579.74,3.99,0,0.9815,13.54,0.0077,32.99,4.561,139.1,15.389,70.9,297.8045,5.6,1.53,94,170.07,0,87,117,45.46,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1035,62,62,0,1,54.64,160.06,21.25047,1.56,8,0.13407334,1.60872139,1,1,6,8,742.242,NA,1,197.96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,China,CHN,China,NA,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,NA,Rituximab plus 8 CHOP cycles,NA,NA,Y
1036,58,58,1,2,80.99,180.04,25.43456,2.01,6,0.096123665,1.15379089,0,2,2,6,3870.825,1,1,209.2,44.07,61.95,17.09,31.64,0,3e-4,0.010232,4e-5,25.03,0,10.35824,2.6852,0.153,0.222,0,0,0.289,0.646,105,99.06,79.2109,0,0,0.0088,0.492404,0.0069,0.095,0.36,0.14,0.221,3.811,0.45968,155.9199,0.7055,0.0479,0.6165,1.000641,0.0085,0.512316,0.0013,0.72,4.239662,0.433091,0.0162,0,0,1.141355,375.52,5.07,0,0.9688,10.004,0,0.37,4.632,140,7.026,66,436.7035,6.37,2.1,90,181.57,0,75,140,90.06,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1037,69,69,0,1,55.36,158.88,22.05856,1.57,6,0.118711683,1.42528615,0,1,5,6,1346.204,2,2,216.42,48.94,82.81,9.17,14.82,9.2e-5,0,0.0400127,0,24.09,0.191,7.29894,2.4732,0.359,0.404,0.072,0.055,1.152,0.858,104,82.58,56.6992,0.4,1e-4,0,0.773181,2e-4,0.755,0.564,0.43,0.425,0,0.41469,133.0648,3.767,12.2952,2.8881,0.818627,0,0.294876,0,0,3.182136,0.613756,0.0021,0.00737,0,1.227783,151.82,4.2,0,0.986,0.647,0.0332,30.59,3.982,173.1,6.849,70.93,217.3782,4.3,1.57,68,157.53,0,64,130,53.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1038,70,70,0,2,82.27,173.02,26.968,1.97,6,0.0382955,0.46002304,0,2,4,6,1279.71,2,2,187.99,36.9,58.81,10.47,11.98,2.87e-4,0.001,0.0130743,9e-5,25.91,0.045,3.90411,2.3799,0.093,0.178,0.097,0.155,0.372,0.735,100.9,58.32,115.5106,0,0,0,0.262164,9e-4,0.118,0.298,0.184,0.359,0,0.4111,127.945,1.9337,5.0646,0.0077,0.855494,8e-4,0.441127,0.0056,0.12,4.686256,0,0.0228,0.00115,0,1.000414,439.89,3.89,0,0.9781,12.829,0.0275,28.85,4.798,139,7.215,71.45,184.9558,5.79,1.93,71,169.91,0,72,136,78.11,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1039,59,59,2,2,72.05,157.91,28.67954,1.73,7,0.102109809,1.22663778,0,2,5,7,21296.134,1,1,315.26,41.99,89.91,15.04,22.19,0.001544,8e-4,0.0277898,4e-5,26.91,0.13,8.91819,2.3525,0.114,0.007,0.018,0.027,0.551,0.496,105,71.68,102.4766,0.17,0,0.0121,0.039996,0,0.265,0.329,0.106,0.002,2.573,0.46003,141.5024,0.9024,8.0428,0,1.878357,0.0557,1.098393,6e-4,0,7.89651,4.592314,0.0236,0.0021,0,1.031783,303.55,5.11,1,1.0078,11.696,0,32.09,5.155,140.7,10.206,72.55,595.4546,11.46,1.96,80,160.87,0,79,111,75.04,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1040,74,74,2,3,67.01,150.22,29.65919,1.64,6,0.105868209,1.27198097,1,3,4,6,6455.473,1,1,787.1,22.06,980.55,11.78,10.1,0,0,0.0501643,7e-5,31.99,0,4.75919,2.4234,0.49,0.29,0.151,0.061,1.459,0.759,97.8,72.81,77.1549,0.39,3e-5,0.015,1.037716,0.001,0.94,0.5,0.391,0.208,0,0.31947,95.0787,0.3284,0,0.0103,2.398334,0.1108,2.635587,0.0474,0,4.100175,5.062594,0.0193,0.00151,0,1.081672,461.62,4.89,1,0.9002,11.09,0,0,3.738,138,13.676,60.27,279.1112,7.66,1.71,71,152.04,0.1,93,135,75.94,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",< 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1041,74,74,0,4,59.9,160.06,22.91875,1.62,6,0.158622419,1.90243167,1,4,4,6,4435.511,2,2,1076.5,26.01,113.85,6.51,18.06,5.72e-4,0.0011,6.78e-5,8.6e-4,2.86,0.141,6.81864,2.0576,0.444,0.36,0.251,0.154,1.57,0.713,106.9,43.3,111.4648,0.12,1.3e-4,0.0201,0.127676,0.0162,0.77,0.387,0.629,0.343,0,0.344,118.3672,2.1951,10.0486,0.6152,1.002798,0.157,0.399672,0.0789,0.06,3.999106,0.641222,0.0335,0.00414,0,1.03233,206.41,4.68,1,0.9395,13.58,0,28.99,4.235,141.9,5.136,65.01,362.989,6.48,1.62,67,160.13,0,72,109,61.6,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,< 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1042,58,58,0,2,50.24,149.66,22.6553,1.44,7,0.132019857,1.58413887,1,2,3,7,4997.842,1,1,241.81,25.92,113.03,19.89,33.73,6.66e-4,0.0027,0.0115086,0,2.52,0.002,7.49775,2.2942,0,0.07,0,0,0,0.555,100.1,83.84,61.908,0.33,4e-5,0.0174,0.020412,0,0,0.004,0,0.122,2.352,0.30007,101.7911,1.7372,7.0582,0,1.10023,0.0118,0.349727,0,0,2.996832,0,0,0,0,0.959636,460.04,4.1,1,0.9692,10.744,0.0385,27.28,3.384,141.1,9.984,60.43,261.9968,4.41,1.43,79,149.72,0,79,120,48.31,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,3,0,131HH,158VF,Y,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1043,64,64,0,2,66.95,168.59,23.93533,1.76,7,0.058811482,0.70559634,1,2,1,7,1371.979,1,1,269.41,41.35,90.52,14.84,14.99,0,0,0.1049634,4e-5,20.71,0.121,5.33678,2.2982,0.219,0.296,0.144,0.157,0.888,0.742,106.8,93.81,61.9993,0,1e-4,0.0055,0.699897,6e-4,0.515,0.481,0.355,0.376,0,0.2568,86.9765,2.438,11.8851,0.3758,1.361337,0.0058,0.846744,0.0035,0.28,2.862659,0.547599,0,0.00154,0,1.22934,313.25,3.6,0,1.0069,0,0,30.28,3.39,138,7.522,66.97,214.1099,5.67,1.64,78,166.91,0.1,89,128,63.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1044,57,57,0,3,72.95,160.91,27.746,1.75,7,0.18080878,2.1697795,0,3,3,7,7846.317,2,2,348.05,32.93,37.36,12.91,17.11,0.001029,0.0022,0.0201112,0.00313,32.07,0.067,3.18381,2.0694,0.221,0.16,0.111,0.083,0.511,0.015,98.1,89.53,72.7051,0.43,8e-5,0.009,0.249793,0.0049,0.524,0.421,0.007,0,0,0.37611,124.1887,1.545,14.2829,0.0117,0.798488,0.0049,0.469792,0.0392,0.46,4.219309,0.268377,0.0088,0.00375,0,1.435218,192.93,3.19,0,1.1359,16.119,0.0034,32.5,4.028,142.9,13.105,70.97,344.9995,5.76,1.76,67,160.11,0,78,111,73.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1045,41,41,0,2,59.54,161.07,22.90864,1.62,7,0.06312932,0.75646783,2,2,5,7,3817.6,2,2,1343.01,38.31,84.05,16.15,26.32,0.002238,6e-4,0.0501725,6e-5,29.07,0.096,0,2.4486,0.085,0.126,0.029,0.051,0.005,0,106,115.98,63.4611,0.41,0,0.0168,0.299557,1e-4,0.012,0.006,0,0,0,0.32381,100.0237,3.2239,12.0953,8.9483,1.233116,0,1.495477,0.0033,0,5.1014,6.245474,0.0163,0,0,1.541487,264.21,4.37,1,1.2976,10.423,0,28.69,3.459,142.9,5.16,69.97,339.8481,7.8,1.59,82,159.99,0,93,121,60.21,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1046,86,86,1,3,43.37,146.52,19.37674,1.33,6,0.033257936,0.39860737,1,3,2,6,5047.021,2,2,1186.28,27.07,92.05,12.91,21,0.002943,0.0036,0,0.00388,24.1,0.125,0.07724,2.1715,0.034,0.176,0,0,0,0.426,0,33.38,72.8206,0.46,0,0.0114,0.040351,0.0148,0,0.002,0,0.001,2.22,0.30306,103.2314,2.7984,17.0472,0.6438,1.148288,0.2266,0.350801,0.0896,0.44,6.303059,2.769669,0.0286,0,0,0.840466,475.12,4.71,0,1.1333,11.959,0,31.82,3.676,121.5,8.597,61.2,244.1814,7.75,1.24,59,146.63,0,44,110,44.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1048,60,61,0,2,57.98,164.97,21.24446,1.64,7,0.634526042,7.61314813,0,2,5,7,1763.568,1,1,188.06,36.06,70.97,12.21,11.78,0.002317,0.0017,9.27e-5,0,30.64,0.099,3.94611,2.2296,0.242,0.313,0.083,0.065,1.263,0.765,104.1,68.83,93.7566,0,3e-5,0.0026,0.299981,0,0.532,0.356,0.863,0.52,0,0.40092,135.1915,2.4081,12.8562,0.7453,0.950725,0,0.795948,0,0.56,2.8305,6.776212,0.5198,0.00435,0.001,1.385465,336.96,4.05,0,0.9561,0.663,0.0079,30.87,4.396,141.9,6.796,70.17,398.6759,4.81,1.59,80,162.1,0,67,120,56.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1051,51,51,1,2,47.47,158.85,19.26878,1.48,6,0.070453389,0.84434971,0,2,5,6,15333.712,1,1,1596.22,39.09,130.12,12.7,26.19,0.445411,0.0043,0.0914407,1e-4,22.43,0.001,3.96621,2.4972,0.051,0.132,0.022,0.066,0.012,0.425,104,91.19,53.9631,0,1.1e-4,0,0.03996,0.0109,0,0.183,0.005,0.211,0,0.31474,113.8368,2.1008,8.6598,0.9393,1.195448,0.0581,0.470637,0.0905,0.19,4.827255,0.420393,0.6803,0,0.001,1.401542,276.94,4.42,0,1.1055,10.418,0.0625,29.89,3.778,138.1,15.907,71.06,398.8649,6.37,1.51,72,158.19,0,71,120,49.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1052,46,47,2,3,100.64,171.99,33.67963,2.13,7,0.044891089,0.53937978,0,3,3,7,14220.155,1,1,379.98,37.91,48.07,126.08,54.69,0,5e-4,0.0439703,9e-5,20.91,0.075,6.59218,2.425,0.042,0.157,0.073,0.089,0.359,0.659,102,108,74.8091,0,1e-4,0.0154,0,0,0.479,0.567,0,0.001,1.686,0.28304,93.4069,0.5109,0,0,0.209504,0.005,0.827698,0.0605,0.53,5.318678,5.620497,0.7204,3e-5,0,0.965604,139.82,3.4,0,1.0696,0.599,0,0,3.04,141.9,8.56,43.63,241.8798,7.81,2.18,60,168.93,0,86,131,100.19,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1053,78,78,0,3,87.8,176.01,28.03367,2.07,7,0.056496967,0.67858692,1,3,5,7,10613.68,2,1,773.6,43.06,96.65,12.2,24.07,0.001922,0.0015,0.0999099,0,26.93,0,6.06617,2.7328,0.289,0.344,0.021,0.024,0.344,0,99,64.18,81.1579,0,0,0,0.701669,7e-4,0.102,0.008,0.197,0.198,0.146,0.41852,135.6336,2.6522,10.761,0.4541,0.496686,0,0.800738,0.0145,0.63,3.165424,3.019218,0.0082,0.0076,0.001,1.13012,405.64,4.76,0,1.1303,12.99,0,28.01,5.05,128.1,8.575,80.07,327.1754,5.35,2.1,62,176.19,0,76,119,87.2,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1054,40,39,1,2,73.42,181.49,22.57721,1.93,6,0.095985117,1.1518603,0,2,5,6,13166.959,1,1,463.15,38.98,103.73,16.86,26.79,0,0,0.0235562,0,0,0.228,13.11398,2.24,0.444,0.128,0.292,0.112,2.234,0.825,97.8,132.61,52.5675,0,2e-5,0,0.135615,0,1.453,0.538,0.903,0.392,1.633,0.35988,126.8411,2.4881,11.0314,3.6045,1.971217,0,1.700758,9e-4,0.54,3.602169,0,0,0,0,1.202581,260.69,4.19,0,1.0903,0.606,0.0452,29.06,4.026,137,9.986,76.04,205.9261,5.71,2.02,90,183.83,0,80,146,75.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1055,58,58,1,2,63.9,165.08,23.32688,1.69,8,0.054728578,0.6564343,2,2,4,8,9745.496,1,1,276.63,37.97,88.25,24.57,24.01,0.12870500000000001,0.0048,0.0297356,3e-5,0,0.119,4.12817,2.5792,0.07,0.163,0,0.001,0.434,0.731,98,105.03,55.9398,0.23,8e-5,0.0278,0.00697,0,0.33,0.422,0.039,0.21,0,0.26498,96.2389,2.2526,15.1958,1.1261,0.715584,0.1505,0.267964,0.0761,13.29,3.234781,0.288291,0,0,0,1.350764,225.64,3.9,0,1.0913,12.184,0,0,3.28,139,7.066,73.99,435.0983,4.47,1.69,70,168.87,0,79,108,66.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,Y,Y,N,N,Low,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1056,34,34,0,3,80.91,160.02,32.20099,1.83,7,0.02948122,0.35353167,0,3,4,7,10108.291,1,1,1834.12,39.48,53.84,48.13,186.67,0,0,0.0297479,6e-5,22.97,0.179,5.0374,2.3556,0.322,0.292,0.106,0.084,0.775,0.775,103,127.71,64.9439,0,0,0,0.193782,8e-4,0.307,0.13,0.552,0.511,0,0.33066,105.3015,2.827,13.1442,1.2573,1.097995,0,0.571064,0.0486,29.04,2.697811,0,0.0033,0,0,1.13187,321.55,4.09,0,1.0464,11.038,0.0122,0.14,4.254,140.1,9.857,68.01,481.5231,4.1,1.8,55,160.14,0,91,107,78.21,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1057,58,58,0,2,59.03,166.28,21.62979,1.66,6,0.022466319,0.27036959,1,2,5,6,11463.51,1,1,191.92,45.95,72.3,26.9,36.1,8.46e-4,0.0015,0.0103841,8.9e-4,2.75,0.138,9.27477,2.6244,0.455,0.335,0.029,0.008,1.2,0.716,104,99.49,61.0077,0,0,0,0.139874,0.01,0.571,0.364,0.484,0.298,5.44,0.37061,118.0678,2.6885,15.7771,0.7895,0.700338,0.0129,0.280411,0.0478,0.62,2.316376,0,0.5694,0.00531,0.001,1.211326,209.21,4.28,0,1.1356,13.066,0.0549,28.11,4.604,144.1,11.287,82.25,245.7782,4.09,1.76,70,166.06,0,62,120,57.86,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1058,26,26,0,2,79.97,169.77,27.33669,1.92,6,0.056420577,0.67770657,0,2,3,6,1073.274,2,2,271.92,40.96,65.01,33.82,32.57,0.001054,0.0014,0.018612,0,25.63,0.245,5.25077,2.4747,0.167,0.023,0.02,0.001,1.073,0.779,106,127.92,65.0484,0.17,0,0.0037,0.109931,0,0.634,0.382,0.471,0.244,0.872,0.44303,148.4217,1.614,9.3129,0.5145,2.050002,0,0.599977,0,0,2.104864,0,0,0.00175,0,1.234559,237.53,4.08,1,1.046,11.828,0.0168,30.75,5.1,144.9,8.579,76.05,406.5407,4.45,1.88,63,169.98,0,64,120,80.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1059,72,72,0,4,65.27,167.41,23.35896,1.73,6,0.100228714,1.20232836,0,4,2,6,2985.888,1,1,304.73,38.18,201.31,34.01,35.27,0,0,0.0998537,6e-5,27.97,0.002,5.58337,2.2638,0.307,0.097,0.452,0.168,1.913,0.773,102.7,51.91,104.8644,0.19,8e-5,0.0083,0.099439,0,1.045,0.414,0.72,0.382,0,0.36006,122.2047,2.7534,12.3772,1.6154,3.592484,0.0018,0.542228,6e-4,0,3.204024,0.491849,0.0189,0,0,0.152829,250.61,4.31,0,0.9741,13.173,0.0075,34.17,3.794,137.9,14.772,64.94,359.6817,6.03,1.82,70,169.93,0,79,142,69.95,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,High,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1060,39,40,1,3,79.99,161.09,31.22527,1.83,7,0.077783142,0.93232219,1,3,5,7,10116.659,1,1,2662.9,39.96,103.47,23.91,21.71,8.59e-4,8e-4,0.0246371,0.00377,23.95,0.121,12.26271,2.506,0.104,0.114,0.098,0.095,0.438,0.401,96,72.68,110.1296,0.05,1.1e-4,0,0.118955,6e-4,0.321,0.439,0.008,0.001,0.834,0.31278,104.5092,2.0555,14.1778,0.4003,0.788448,0.2113,0.598657,0.0819,0.66,3.46854,4.04426,0.6583,0.00856,0.001,1.326437,89.02,4,0,1.1075,8.561,0,0,3.995,134.4,7.878,64.97,311.4454,6.77,1.91,69,162.73,0,93,109,77.96,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1062,43,43,1,4,52.35,164.94,19.03769,1.56,7,0.049319585,0.59060594,0,4,5,7,14203.931,1,1,1037.2,43.88,75.89,7.81,20.84,0,0,0.0296292,0.00335,29.87,0.165,4.9991,2.3843,0.526,0.423,0.094,0.105,0.703,0.559,101.1,122.39,51.2515,0.05,7e-5,0.0109,0.299393,0.0552,0.607,0.451,0.119,0.002,0,0.3794,135.428,2.7022,15.6188,1.4661,0.997428,0.2034,0.289025,0.0414,17.24,4.123393,0.137998,0.0249,0,0,1.181445,359.99,3.69,0,0.997,13.072,0.0246,29.03,4.409,136,15.903,69.03,226.0215,6,1.41,77,163.88,0,95,113,49.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,< 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1063,60,60,1,2,105.27,170.01,36.75779,2.15,6,0.156465068,1.87623426,0,2,2,6,6719.905,2,2,275.96,41.03,173.22,21.04,19.12,1.84e-4,3e-4,0,0,27.07,0.001,12.92292,2.6248,0.323,0.125,0.142,0.087,0.882,0.414,105,73.83,102.4567,0,0,0.0047,0.209609,2e-4,0.562,0.399,0.256,0,0,0.43666,138.7748,3.7346,11.1889,0.6723,1.728179,0.0076,0.423403,0.0019,0.68,5.642132,3.390283,0.5001,0.00742,0,1.420204,244.88,5,1,0.9998,0.239,0,0,5.083,136.9,5.111,80.84,333.0066,9.41,2.28,81,169.48,0,90,138,110.4,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,GBR,United Kingdom,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1064,48,48,0,2,58.06,165,21.13227,1.61,6,0.119389306,1.43214831,1,2,2,6,1248.345,2,2,1150.48,44.02,123.95,27.21,22.02,0.002159,0.0021,0,0,29.48,0.21,5.41277,2.1594,0.192,0.224,0.083,0.075,0.494,0.698,105,124.63,53.4844,0.08,0,2e-4,0.10039,0,0.33,0.434,0.202,0.231,3.013,0.41395,135.3506,2.8952,17.5071,1.1905,1.009581,0.0051,0.199472,0,0,3.266552,0,0,0.00136,0,1.373556,162.02,4.79,0,0.9396,10.059,0.022,30.96,4.51,141.1,11.248,75.9,297.3358,4.5,1.59,80,165.03,0,80,110,58.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1065,78,78,0,3,69.03,152.69,28.98199,1.65,6,0.14827973,1.77918912,1,3,2,6,886.516,2,2,225.23,39.4,405.98,69.68,23.17,0,0,0.0399336,0.00605,20.84,0.04,5.30489,2.1469,0.086,0.142,0.036,0.03,0.881,0.891,108.2,58.7,81.3566,0.22,1.3e-4,0.0261,0.130097,0.0072,0.422,0.44,0.426,0.511,0,0.27628,84.7006,0.0091,0,0.7215,0.809102,0.2376,0.530984,0.0705,0.18,4.195173,3.569411,0.028,0,0.001,1.031733,379,4.39,1,0.8516,11.295,0,0.63,3.791,180.1,10.099,47.46,255.8106,7.24,1.7,79,155.28,0,68,138,69.04,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1066,77,77,2,3,51.22,168.04,18.22444,1.58,7,0.038178929,0.45855319,1,3,6,7,26049.281,1,1,186.69,14.87,272.24,17.88,17.26,8.8e-5,0,0,0.00172,26.04,0.152,7.37123,2.1065,0.107,0.163,0.066,0.093,0.365,0.734,104,81.45,52.0675,0,0,0,0.10078,0.0237,0.342,0.506,0.079,0.232,0.222,0.28367,91.1772,2.7741,7.464,0.0083,0.701604,0.3318,0.227982,0.1193,0,2.021724,0.34587,0.4232,0,0,0.930375,77.52,3.7,0,1.1809,14.394,0.0345,37.83,2.973,141.1,6.67,47.96,3.4311,3.68,1.6,62,169.82,0.1,82,107,51.64,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,Yes,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1067,66,66,0,3,60.46,155.17,24.4672,1.6,6,0.157622478,1.89408517,0,3,2,6,3183.422,2,2,647.47,43.91,49.97,12.94,32.1,3.71e-4,0,0.0997533,1e-4,27.07,0.139,0.10102,2.548,0.293,0.286,0.081,0.087,0.523,0.555,97.1,75.8,63.0041,0.32,1e-4,0.0077,0.159578,1e-4,0.407,0.412,0.096,0.145,0,0.31713,112.9418,1.1938,11.6321,0.3025,2.181933,0.01,1.345941,0.0442,20.94,2.199647,0.353414,0,0,0,1.353422,293.65,4.19,0,0.9401,16.617,0,24.49,3.351,139.3,5.04,73.08,362.3984,5.45,1.64,80,155.23,0,78,124,64.92,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1068,41,42,0,0,75.02,164.25,27.43388,1.83,6,0.259369281,3.11521317,0,0,1,6,478.871,2,2,138.64,41.01,56.79,15.96,16.87,0,0,0.0199384,0,21,0.207,5.89951,2.1966,0,0,0.013,0.043,0.642,0.782,103,135.79,53.0513,0,9e-5,0,0.118702,5e-4,0.256,0.386,0.257,0.255,2.11,0.46155,147.0181,1.0387,0,0.7536,1.401497,0,0.699412,0.0012,0,2.703965,0,0.0125,0.00306,0,1.031829,303.3,4.46,0,0.8364,10.584,0,27.38,5.163,143.8,10.237,64.97,389,4.28,1.82,81,165.08,0,66,159,75.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1069,34,34,0,3,63.15,150.31,27.93798,1.59,7,0.155448649,1.86462555,1,3,3,7,4491.376,2,2,409.19,42.86,1038.97,13.89,21.08,8.7e-5,0,0.0200135,0.00493,32.96,0.125,4.9948,2.7502,0.205,0.195,0,0.031,0.054,0.589,101.1,139.52,52.2312,0,1.5e-4,0.0031,0.004632,7e-4,0.077,0.274,0.155,0.245,0.821,0.49038,152.4351,1.4232,18.3527,2.1993,0.801544,0.0064,0.390119,0.0043,11.81,5.291402,0.139313,0.0378,0.00394,0.001,1.551122,184.8,4.62,0,1.0397,8.99,0,0,5.456,134.6,26.29,79.31,376.3061,6.29,1.75,55,149.79,0.1,79,107,66.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1070,60,61,0,2,78.91,172.03,26.08641,1.92,6,NA,NA,0,2,3,6,6453.066,2,2,205.88,31,53.94,18.31,23.91,0,0,0.0996449,9e-5,26.06,0.031,1.79237,2.1253,0.284,0.529,0.078,0.117,0.64,0.764,0,90.32,71.529,0,0,0.008,0.40127,9e-4,0.431,0.528,0.336,0.406,0.584,0.30857,101.785,1.8714,12.7924,1.0377,0.095182,0,0.445443,0,0.42,2.820329,0.194361,0.0041,0,0,0.87147,296.2,4.2,1,1.207,11.899,0,33.84,3.881,132.2,6.848,69,245.0119,3.88,1.91,70,171.2,0.1,86,120,74.97,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,NA,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1071,61,61,0,2,67.92,182.16,20.64555,1.87,6,0.062873582,0.75359323,1,2,2,6,324.677,1,1,1142.47,40.78,286.61,16.07,19.05,0.001767,0.002,1.233e-4,2e-5,22.34,0.105,5.89698,2.3239,0.234,0.192,0.106,0.07,0.707,0.43,107,137.35,56.8314,0,0,0.0041,0.032766000000000003,4e-4,0.256,0,0.335,0.263,5.234,0.41459,132.8584,2.9157,12.4086,0.7789,1.389148,0.0061,1.023281,0.0661,0.33,6.68503,0.472412,0.0345,0.00864,0,0.135531,255.33,4.2,0,1.0068,15.922,0,39.27,4.497,145,19.089,72.9,362.9923,9.48,1.72,69,180.19,0,73,109,68.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1072,81,81,0,2,76.51,166.96,27.62287,1.85,7,0.052506984,0.63061232,0,2,1,7,411.56,1,1,204.57,40.97,76.91,15.05,14.05,0.001966,0.002,0.0501459,0.00837,26.99,0.171,2.57741,2.3015,0.272,0.063,0.19,0.037,2.094,0.704,104,83.47,49.5164,0.27,1.4e-4,0.0307,0.189958,0.0281,1.558,0.516,0.418,0.113,0,0.42305,134.4506,2.2392,12.551,1.821,2.2088,0.3144,0.198847,0.0905,17.27,2.602044,2.801897,0.6591,0.0016,0.001,1.238751,308.54,4.21,0,0.9812,11.658,0,27.23,4.464,139,15.396,72.01,240.83,4.49,1.81,80,165.08,0,77,129,75.99,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1074,73,73,0,3,72.94,164.18,26.22444,1.8,6,0.057928018,0.69442686,0,3,3,6,3785.313,2,2,210.73,40.03,54.09,5.1,10.15,0.003849,0.0035,0.0427755,0.00315,27.9,0.155,4.89575,2.3231,0.153,0.232,0.053,0.034,0.347,0,104.9,50.36,121.8139,0,0,0,0.341181,0.0104,0.086,0,0.099,0.141,2.054,0.411,134.4936,1.1635,9.9272,1.4949,1.311019,0.021,0.544637,0.0841,0,6.436856,3.198916,0.6556,0,0,1.259894,148.72,5.05,0,0.9246,13.025,0,29.51,4.696,140,3.952,57,398.8346,8.2,1.94,74,169.89,0,96,126,78.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1075,25,25,1,3,112.94,172.02,39.69799,2.26,6,0.06769075,0.81326939,0,3,6,6,11044.564,1,1,821.82,44.05,100.18,9.77,18.81,0.001418,0.0017,0,6e-5,24.91,0.213,0,2.1273,0.192,0.244,0.008,0.022,0.247,0.415,104.1,223.83,61.0029,0,0,4e-4,0.239874,9e-4,0.013,0.007,0.217,0.217,0.469,0.34243,121.6277,2.3605,10.5198,0.0045,0.830842,0.1403,0.698103,0.0133,0.2,5.040063,8.324596,0.5592,0.0059,0.001,0.980706,220.19,4.1,0,1.1128,10.514,0,30.12,4.403,143,25.146,74.27,449.0741,6.05,2.33,75,173.94,0,75,129,119.87,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1076,56,56,0,2,105.48,194.2,27.21092,2.35,8,0.092184577,1.10698598,2,2,3,8,3084.13,2,2,533.53,36.4,74.48,32.12,16.97,9e-6,0,0.0305165,0.00594,24.95,0.002,4.99192,2.1757,0.321,0.253,0.129,0.1,0.473,0,89.2,83.75,97.1104,0,0,0,0.339946,0.0081,0.427,0.226,0.018,0.001,0,0.34926,130.2339,2.792,5.5445,1.1696,1.603998,9e-4,0.600702,0.0815,29,6.80828,3.349209,0.5755,0,0,0,322.1,3.91,0,0.9338,11.412,0,24.1,4.275,135.2,4.1,57.09,312.0694,8.54,2.28,71,193.73,0,80,131,102.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,High,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1077,58,58,1,3,84.75,186.41,24.21937,2.11,6,0.004087222,0.04894621,1,3,4,6,14295.921,2,2,3506.01,39.07,62.68,15.65,26.95,9.63e-4,5e-4,0.0497359,0.00726,1.25,0,3.02263,2.0984,0.087,0.112,0.063,0.058,0.638,0.698,0.5,110.81,65.8985,0,0,0,0.078941,3e-4,0.188,0.318,0.351,0.319,2.55,0.37417,121.5106,4.2087,10.5099,1.3878,1.094273,0.1792,0.300263,0.0047,16.49,6.704628,2.802229,0.0166,0,0,0.929864,221.76,3.89,1,1.2146,11.786,0.0284,33.73,3.658,138,10.282,60.07,246.2571,8.92,2.07,71,189.11,0,73,123,98.63,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1078,45,46,1,2,63.14,165.1,23.22553,1.68,8,0.05826803,0.70019057,1,2,2,8,5965.571,2,2,254.03,32.71,66.73,26.68,27.71,6.48e-4,8e-4,0.0203289,0.0029,26.35,0.001,0.08648,2.1439,0.12,0.068,0.307,0.215,1.574,0.847,99,108.41,61.8826,0.14,3e-5,0.0129,0.006359,0.0044,0.857,0.495,0.669,0.416,0.499,0.38004,120.7109,2.7588,16.4426,1.454,0.902162,0.2091,0.269779,0.0827,0,3.891404,3.603305,0.7709,0,0,1.067039,229.54,3.59,0,1.056,11.012,0.0638,31.04,4.5,141.1,8.503,66.82,219.3548,4.65,1.62,80,168.01,0.1,87,130,58.25,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,Y
1079,72,72,0,3,57.83,161.99,22.53801,1.59,8,0.040959166,0.49140937,0,3,5,8,1072.378,1,1,268.11,36.93,58.17,20.23,24.08,5.33e-4,0,2.153e-4,0,23.49,0,11.76164,2.4254,0.267,0.232,0.138,0.104,1.017,0.758,100,56.84,74.0554,0.03,0,0.0209,0.001957,0,0.862,0.557,0.263,0.218,0,0.38528,130.6166,2.0463,12.522,2.2182,1.50695,0,1.322222,0.002,0,18.458327,3.991511,0.0385,0.0028,0,1.158105,200.87,3.61,0,0.9124,10.823,0,24.4,4.183,137,10.278,65.99,202.7444,19.74,1.51,75,159.81,0,69,122,54.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High,Low-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,Yes,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1080,74,74,0,3,91.19,182.11,27.11638,2.13,6,0.078558537,0.9420639,1,3,4,6,4295.049,1,1,322.32,30.7,89.29,77.59,30.64,6.51e-4,1e-4,0.0099694,0,3.4,0,11.11897,2.231,0.502,0.461,0.118,0.094,1.086,0.764,101,72.8,93.8135,0.05,1e-4,0.0137,0.139862,0,0.882,0.596,0.328,0.291,0,0.37619,129.5539,3.4662,5.354,1.1569,0.75808,0,0.601054,0.0011,0.42,2.959251,0,2e-4,0,0,1.092228,216.64,4.3,0,1.1916,13.083,0.0619,33.9,4.206,137.1,357.669,3.29,351.2296,5.51,2.1,76,183.64,0,72,109,92.23,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,Y,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1081,79,79,1,4,62.91,177.95,19.86913,1.77,6,0.021921341,0.2630459,0,4,6,6,10738.183,2,2,315.31,43,67.31,14,27.66,0.002473,0.0027,0.0582851,7e-5,27.97,0.162,13.53505,2.3725,0.306,0.3,0.353,0.278,1.033,0.743,100.1,47.41,87.799,0.43,1.2e-4,0.0217,0.301404,6e-4,0.84,0.57,0.278,0.247,2.561,0.41055,131.0815,1.1946,10.779,0.8831,1.195338,0.01,0.761407,0.0055,0,3.997594,0,0,0.00698,0.001,1.054968,289.46,4.61,0,0.9402,13.108,0.0628,22.59,4.491,140.1,11.992,67.03,567.9257,5.91,1.64,54,175.01,0,68,100,57.62,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1082,47,47,1,1,80.32,180.21,24.61009,2.02,6,0.124105886,1.48972502,1,1,2,6,8215.405,1,1,231.41,37.22,51.85,11.91,16.04,0.001766,0,0.0300124,4e-5,0,0.058,7.49831,2.3588,0.182,0.19,0.046,0.061,0.43,0.515,100,99.66,72.3558,0,0,0.0051,0.12739,4e-4,0.304,0.356,0.118,0.186,5.289,0.32983,106.9674,3.0783,9.4948,1.0439,1.550327,0.0059,0.957963,0.0038,0.16,4.941081,0,0,0.00336,0,0.148304,267.57,3.59,1,1.0692,0.722,0.02,25.01,4.338,137,3.51,61.01,243.5039,7.1,1.93,91,178.98,0,81,121,78.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1084,42,42,1,2,59.55,158.02,23.94297,1.62,8,0.044897533,0.53823497,1,2,6,8,18338.562,1,1,497.76,40.04,83.28,15.09,18.92,3.74e-4,5e-4,0.0596978,0.01974,31.12,0,4.99847,2.138,0.067,0.145,0.024,0.071,0.322,0.628,105.9,105.07,66.2658,0.3,7e-5,0.0153,0.051095,0.0738,0.004,0.006,0.25,0.351,0,0.38561,127.4217,2.2072,10.9998,0.6672,0.366005,0.3307,0.26969,0.1906,0,3.313654,5.615066,0.7793,0,0,0.961611,327.04,3.49,0,0.8901,0.379,0.0147,30.45,4.35,139.9,5.111,65.99,0,5.09,1.62,80,158.54,0,81,132,58.49,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1085,64,64,1,2,69.85,165.05,25.21683,1.75,6,0.029481292,0.35381732,1,2,1,6,5031.114,1,1,1203.74,31.06,128.59,49.24,51.94,3.77e-4,0,0.0293542,8e-5,29.05,0.13,3.06415,2.4169,0.149,0.125,0.119,0.113,0.792,0.695,95.5,80.38,73.9475,0,5e-5,0,0.05003,1e-4,0.483,0.399,0.339,0.271,0.363,0.34955,110.4205,1.8803,0.0557,0.2918,1.091153,0.0055,0.53922,0.0027,0.27,3.741365,0.591033,0.0395,0,0,1.098798,273.93,4.67,1,0.99,0.311,0,28.45,4.117,140.1,22.255,1.94,321.773,5.27,1.69,62,164.91,0,72,99,66.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,AUS,Australia,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Other,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1086,57,58,0,3,69.03,163.9,26.09044,1.75,6,0.045366502,0.54435663,0,3,5,6,679.909,1,1,286.26,39.01,0,10.87,23.83,0.001554,8e-4,0,0,25.91,0.08,7.01496,2.2342,0.072,0.156,0.111,0.135,0.185,0.597,97.7,74.12,85.8371,0.04,0,0,0.090096,1e-4,0.105,0.306,0.156,0.274,1.066,0.39095,134.5994,0.0025,0,0,0.87018,0,0.095911,0,0,1.526255,0,0,0.0037200000000000002,0,0.84372,175.44,4.19,0,1.0056,11.563,0.0214,30.09,4.515,132.1,12.674,55.79,392.4789,2.3,1.62,69,163.08,0,99,108,62.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1087,59,59,0,3,85.59,175.36,27.05578,2.02,6,0.023714997,0.28461904,1,3,4,6,7701.822,2,2,300.8,33.01,52.62,41.71,24.09,0.148001,0.0022,0,0,29.67,0.1,3.67321,2.2612,0.241,0.28,0.031,0.067,0.415,0.56,101,101.16,75.863,0.14,1.2e-4,0.0152,0.092369,0,0.37,0.444,0.1,0.176,5.499,0.36487000000000003,125.2126,1.5564,10.174,0.3743,1.390928,0.0097,0.398735,0.0018,0,3.206214,0,0,0.00318,0,1.424734,272.55,4.18,0,0.8849,0,0.0088,26.97,3.664,139.4,12.108,64.74,455.7349,5.77,2.22,79,175.96,0,80,122,87.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1088,67,67,1,2,49.1,162.04,18.82318,1.52,6,0.04158422,0.49927222,0,2,1,6,4488.76,1,1,256.37,48.04,56.07,12.33,16.18,0.002455,0.0021,0.0999799,7e-5,20.62,0.21,3.21065,2.3894,0.279,0.121,0.201,0.128,1.597,0.742,105.1,86.41,49.6224,0,1e-5,0,0.25183,0.0023,1.062,0.504,0.561,0.303,0,0.40911,140.9469,1.9736,13.9168,1.1562,2.341495,0.0049,0.296372,0.0026,0.3,1.788164,0,5e-4,0.0056,0.001,0.996995,139.53,4.01,0,0.8492,8.74,0.0201,28.98,4.053,140,11.866,82.28,249.2349,3.82,1.47,69,160.17,0,0,130,47.87,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1089,61,61,0,2,102.28,190.24,27.34232,2.31,6,0.027408709,0.32919418,1,2,1,6,1479.382,1,1,277.8,42.89,101.07,22.96,17.95,5.09e-4,0.0015,0.0430269,0.00492,21.9,0.183,6.06562,2.4033,0.142,0.008,0.044,0,1.181,0,100,72.23,145.2549,0,0,0,0.099753,0.0396,0.413,0,0.519,0.124,0,0.4571,147.6149,4.0018,13.5918,0.6072,1.91057,0.2531,0.801669,0.1023,31.99,4.821167,3.899794,0.6404,6.6e-4,0.001,0,344.71,3.8,0,1.1038,10.116,0.028,28.19,4.738,139,10.229,71.08,373.1253,9.59,2.35,93,192.28,0,79,136,106.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1090,67,67,0,2,124.15,179.69,40.12326,2.35,7,0.057706521,0.69259317,1,2,4,7,2623.259,2,2,241.8,35.44,76.9,26.7,23.9,7.07e-4,2e-4,0.0099676,0,0,0.051,4.69324,2.1895,0.081,0,0.094,0.067,2.155,0.815,101,72.22,102.2637,0.11,1.2e-4,0,0.099354,0,1.005,0.515,0.918,0.321,0.442,0.40181,131.7474,0,0,0.332,2.693729,0,0.40975,0,0.6,9.193284,6.946032,0.0266,0.00431,0.001,1.273979,569.18,4.29,0,1.0052,0,0.0648,0.54,4.695,144.2,6.814,56.02,273.7541,13.66,2.24,80,178.87,0,64,134,120.89,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1091,35,35,1,2,94.98,171.14,32.62656,2.04,8,0.020933465,0.25088971,1,2,3,8,6479.666,2,2,602.33,33.99,72.9,34.3,22.98,7.5e-4,0,0.0279838,1e-5,31.17,0.114,0,2.346,0.086,0,0.171,0.076,1.598,0.726,97.2,112.34,88.7094,0,0,0.0093,0.299668,9e-4,0.725,0.376,0.63,0.246,3.031,0.43017,146.8391,1.3411,7.1588,1.5007,1.703806,0.0014,0.420742,0,24.46,8.211792,5.793821,0.3844,0.00251,0,0.937862,559.33,4,0,0.9969,9.95,0,0.33,4.571,140.8,9.013,0,369.0341,13.25,2.03,70,171.03,0,83,125,89.08,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1092,66,66,1,3,72.88,162.41,27.73442,1.78,6,0.022693683,0.27233675,1,3,3,6,2509.341,1,1,218.18,38.06,49.97,8.86,0,0.002665,0.0028,0.0230123,6e-5,0,0.08,5.47224,2.4554,0,0.003,0.026,0.064,0.471,0.709,0,75.81,78.3868,0.18,0,0,0,0,0.38,0.437,0.185,0.197,1.962,0.406,131.8689,9.6845,11.3126,0.6324,0.941591,0,0.14917,0,0.53,6.862896,0.46517,0.0279,2.3e-4,0,1.125077,245.97,3.24,0,0.8531,0,0.0691,34.13,4.222,135.2,7.507,49.28,3.6106,6.61,1.72,84,159.92,0,73,148,70.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1093,28,28,0,3,84.48,174.87,28.4437,2.01,6,0.111584527,1.33741079,0,3,2,6,1026.929,1,1,499.78,42.24,139.71,34.97,37.03,0.001146,0.0027,0.1036527,0.0039,3.8,0.8,10.8634,2.2202,0.306,0.198,0.095,0.063,0.886,0.538,105.1,152.8,66.2011,0,0,0,0.501015,0.012,0.403,0.309,0.351,0.224,0,0.41904,133.7725,1.2569,13.5661,0.581,2.002252,0.1801,0.428061,0.0049,0.79,3.362923,0,0.0197,4.3e-4,0,1.459934,247.26,3.8,0,0.9934,15.445,0,26.14,4.327,141.1,8.327,73.99,344.9044,8.56,1.98,63,173.67,0,69,97,86.09,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1094,30,30,1,1,48.52,166.02,17.85143,1.54,6,0.055280573,0.66349384,1,1,5,6,2919.283,2,2,172.62,37.13,44.85,28.5,18.08,0.002712,0.0019,0.0200331,9e-5,23.06,0.109,0.00805,2.3025,0.083,0.136,0.079,0.07,1.084,0.842,103,129.93,56.5544,0.19,1.6e-4,0.0121,0.159606,0.0061,0.648,0.49,0.467,0.428,1.281,0.46557,155.8768,2.2662,18.4212,1.7093,1.320195,0.0795,0.341615,3e-4,0.62,5.624178,0.473877,0,0,0,0.968931,192.63,4.6,0,0.9944,10.229,0,24.2,4.807,140,10.564,70.97,458.955,6.4,1.53,68,165.07,0,78,102,52.1,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1095,70,70,0,2,79.94,179.06,24.69115,2,7,0.04971106,0.59687941,1,2,3,7,149.441,1,1,462.67,31.93,81.74,7.05,20.03,0.311479,0.0398,0.0099827,0.00491,26.93,0.14,0.08392,2.2281,0.018,0.007,0,0,0.322,0.557,99,103.31,53.7886,0,0,0,0.349462,0.0511,0.144,0.207,0.086,0.001,0,0.36676,120.2951,4.5266,14.1819,0.8794,0.80192,0.2411,0.501414,0.0735,17.11,3.486056,0.417345,0.7283,0.00375,0.001,0.966187,273.96,3.08,0,1.1689,15.422,0.0103,24.04,4.345,137.1,7.819,65.02,231.9835,5.46,1.93,84,175.57,0,105,140,80.9,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
1096,25,25,1,1,81.64,180.77,24.17443,2.03,6,0.020257766,0.24295581,1,1,4,6,30155.86,1,1,279.45,42.93,59.4,15.03,16.87,1.75e-4,0,0.0099839,0,0.28,0.098,4.91013,2.3337,0.004,0,0.097,0.105,0.627,0.653,100.9,133.35,70.6707,0,0,0,0.048651,0,0.263,0.008,0.379,0.384,1.15,0.41711,139.0613,2.0177,7.523,0.0063,1.190539,0.0025,0.712624,5e-4,0.35,6.019289,0.2845,0.0026,0.0032,0,0.934411,228.09,3.39,0,1.0048,11.069,0.0494,40.08,4.784,141,7.101,78.99,254.8788,7.34,2.19,85,185.01,0,57,149,85.72,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,N,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1097,71,71,0,3,56.03,159.66,21.79904,1.58,7,0.097468932,1.16895807,1,3,6,7,3171.305,2,2,179.29,39.08,248.18,30.71,16.89,0.002903,0.0037,0.0119451,0.00405,26.96,0.308,3.92084,2.3114,0.118,0.104,0.059,0.078,0.055,0.02,102.3,95.33,51.4891,0.17,9e-5,0.0267,0.070045,0.0277,0.135,0.28,0.002,0,0.131,0.38869,134.6059,2.6833,14.0717,0.6003,0.799192,0.1856,0.887574,0.1041,0.7,9.617523,5.093697,0.72,0.00426,0.001,1.241555,180.93,3.8,0,1.0068,16.934,0,25.02,4.176,140.7,35.639,71.58,380.5876,11.92,1.59,71,159.98,0,89,121,54.95,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1098,30,30,1,2,65.66,166.95,24.37525,1.73,6,0.042767673,0.51255191,1,2,5,6,3741.63,1,1,249.8,31.03,46.39,18.2,16.89,0.001922,0.003,3.085e-4,4e-5,25.83,0.149,10.24055,2.3483,0.111,0.03,0.082,0.045,1.569,0.92,97.2,125.63,67.0708,0.06,0,0,0.123366,5e-4,0.919,0.639,0.572,0.337,0,0.3964,129.5893,0,0.0381,0,1.10025,0.0068,0.972051,0.052,0.41,11.759356,0,0.0417,0,0,1.290962,241.89,4.5,0,0.8987,10.869,0,22.27,4.467,138.8,8.941,50.86,303.0031,12.19,1.71,78,164.9,0.1,112,130,67.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,1,131HR,158FF,N,Y,N,N,Low,High-Intermediate,Q4 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1099,77,77,0,4,84.54,175.08,27.41295,2.02,8,0.02558256,0.30698462,1,4,6,8,8038.914,2,2,207.34,41.96,43.9,11.08,22.85,3.45e-4,0,0.008122,5e-5,30.36,0.149,2.2003,2.1739,0.188,0.172,0.009,0.001,0.547,0.779,0,56.44,89.3374,0.04,1e-4,0.0176,0.140141,0.0166,0.256,0.436,0.243,0.243,0,0.40857,137.4516,1.2281,10.6,1.0262,0.819668,0.1041,0.422263,0.0035,0,2.991941,0.356758,0.0024,0,0,1.229961,226.18,4.09,1,0.9187,11.867,0.0129,37,4.574,137.1,9.167,54.02,395.0503,4.59,2.03,70,174.17,0,73,139,83.35,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VV,N,Y,N,N,High,High,Q2 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1100,50,50,2,2,78.07,160.92,29.75268,1.81,7,0.041556701,0.4991624,0,2,3,7,29175.463,1,1,673.94,42.04,308.8,18.04,22.05,0,0,0.0698233,0,0,0.141,16.72322,2.3202,0.002,0,0.036,0.03,0.753,0.802,101.2,125.92,61.7256,0,9e-5,0.0282,0.077138,0,0.138,0.253,0.439,0.395,1.54,0.38548,124.3002,0.0187,7.6666,0.5602,1.018954,0,0.220369,0,27.78,3.770695,0.570738,0.0195,0.00127,0,0.90387,268.82,4.31,0,0.9251,0.806,0.0454,23.06,4.518,137.1,3.513,64.03,261.7134,5.6,1.93,63,163.56,0,78,121,90.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1102,52,53,0,3,55.81,172.01,19.27098,1.65,7,0.086161305999999993,1.03431255,1,3,5,7,5565.867,2,2,1117.81,42.53,80.79,47.39,32.18,0,0,0.0100276,0.00338,3.75,0.221,0.01203,2.5465,0.193,0.061,0.085,0.026,1.36,0.76,92.9,71.54,86.915,0.16,7e-5,0.0024,0.339961,0.0299,0.588,0.35,0.571,0.263,6.785,0.43025,151.0907,1.4921,13.6522,0.6449,2.477685,0.1587,0.709629,0.0629,12.85,5.592831,0.249292,0,0.00524,0,0,381.98,4.92,0,1.0627,0.419,0.0031,0.05,4.635,133.3,15.049,80.12,199.9308,9.77,1.67,67,170.2,0,57,114,59.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,N,N,High,High,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1103,37,38,0,3,97.82,170.16,33.46484,2.08,6,0.033952271,0.40735001,1,3,3,6,6102.142,2,2,263.09,48.98,71.06,28.91,15.63,0,0,0.019959,0,26.52,0.261,2.80413,2.2686,0.04,0.145,0.102,0.115,0.22,0.703,101,107.09,81.063,0.2,3e-5,0.0098,0.069314,0,0.183,0.414,0.007,0.214,3.217,0.38106,119.1649,1.0148,11.9893,1.5698,1.198802,0,0.321894,0,11.39,3.702964,0,0,0.00103,0,1.259409,192.47,4.07,0,1.0961,11.445,0.0261,30.5,4.395,141.1,5.301,71.93,333.0214,4.68,2.01,58,168.04,0,74,103,95.5,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1104,82,82,0,3,43.23,156.76,17.63403,1.39,8,NA,NA,2,3,3,8,4954.652,2,2,316.27,38.1,356.52,19.71,26.97,0.001157,0.002,0.1017939,0.00796,29.09,0.001,4.96089,2.2143,0.206,0.127,0.047,0.001,0.598,0,99,67.55,51.5455,0,1.9e-4,0,0.266549,0.0858,0.48,0.173,0.1,0,0,0.38639,125.4261,3.3622,11.4103,0.5133,1.164375,0.3236,0.611214,0.0829,0,6.417548,6.694779,0.6911,0.00828,0.002,1.354323,194.53,4.5,0,1.5231,14.641,0,36.25,4.624,137,14.023,52.54,104.7342,9.81,1.28,55,155.9,0,79,110,43.94,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,NA,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1106,73,74,1,4,74.88,159.75,28.88245,1.78,7,0.037165794,0.44579561,0,4,4,7,6105.732,1,1,501.12,41.42,151.52,17.01,18.92,0.014539,0.0036,0.0300292,1e-4,27.07,0.16,6.50283,2.5289,0.087,0.163,0.058,0.147,0.252,0.781,100.4,70.65,63.1231,0.12,1.2e-4,0.002,0,2e-4,0.253,0.474,0.179,0.352,1.047,0.37933,127.9858,1.9367,10.6961,1.0876,0.239982,0.0018,0.39941,0.0647,10.73,6.043458,3.523753,0.011,0,0,0.852896,213.7,3.9,1,0.9287,0.345,0.015,28.84,4.176,136.9,6.823,75.03,226.0005,5.21,1.83,71,159.97,0,76,140,78.97,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Other,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1107,67,67,1,3,61.08,159.8,24.22142,1.64,6,0.038714166,0.46413308,0,3,1,6,3475.023,2,2,225.76,40.08,55.9,13.94,13.12,0.001772,0.0021,0.010262,7e-5,25.97,0.181,5.37045,2.0919,0.573,0.295,0.628,0.396,2.482,0.854,103,97.21,59.0835,0.19,0,0,0.338265,7e-4,1.44,0.565,1.045,0.419,0,0.44913,149.5683,0.018,5.1789,0.6294,1.531249,0.0054,0.400075,0.0018,0.21,7.960703,3.620274,0.027,0,0.001,1.10931,327.98,4.31,0,1.1008,0,0.0657,33.22,5.992,139.9,8.523,72.33,161.9962,10.65,1.65,72,161.03,0,69,110,60.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,Yes,0,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1108,81,81,1,3,56.41,147.97,26.12135,1.48,7,0.167945837,2.01572727,1,3,5,7,8492.911,2,2,208.67,43.72,77.57,11,17.03,0,0,0.0298332,0,26.1,0.001,7.49423,2.4471,0.06,0.093,0.001,0.041,0,0,104,56.38,61.8878,0.21,1.8e-4,0.0185,0.003299,0,0.018,0.279,0,0,1.916,0.37222,117.6694,0.8648,7.0531,0.0052,0.819687,0,0.460681,0,0.43,6.506278,3.199216,0.0303,0.00452,0,1.222258,243.12,3.88,0,1.193,0.383,0,0.21,4.319,144.2,8.566,69,242.4568,7.04,1.49,56,147.06,0,80,122,53.32,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1109,18,19,0,2,62.08,156.19,25.10637,1.63,7,0.028450353,0.34142909,1,2,4,7,9733.603,1,1,697.12,34.16,88.69,10.81,29,0.001117,0.002,0.0300009,0.00706,27.96,0.051,5.71575,2.1078,0.456,0.408,0.282,0.119,1.77,0.705,102,129.46,75.4038,0.02,1e-4,2e-4,0.029957,0.0103,0.929,0.425,0.689,0.327,0.478,0.30399,112.4979,2.8017,14.3401,3.9762,1.075115,0.1823,0.30854,0.0397,0.57,6.56062,0.190716,0.6657,0,0,1.39239,359.87,4.62,0,1.2958,16.997,0,29.46,3.828,140,6.819,71,272.6921,7.8,1.7,79,157.88,0,81,106,66.86,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1110,53,54,0,2,64.08,157.9,25.39347,1.65,6,0.181436783,2.17617385,0,2,2,6,513.249,1,1,185.39,47.07,255.92,17.82,26.23,0.00195,0,0.0191126,5e-5,0,0.104,3.09416,2.4584,0.057,0,0.067,0.011,0.901,0.771,102.1,88.03,74.9915,0.09,0,0,0.140102,4e-4,0.403,0.381,0.352,0.314,3.931,0.36987,135.0131,1.8446,9.4366,1.3886,1.118936,0.0106,0.109385,0,0,4.2914,1.644013,0,0,0,1.350278,456.24,4.95,0,1.0977,0,0.0396,27.62,4,144.3,2.999,77.93,303.8916,5.9,1.72,81,159.81,0,61,119,67.08,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,< 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1111,66,66,0,4,69.78,161.09,26.70832,1.71,7,0.033308096,0.39945116,0,4,6,7,6029.744,2,2,702.44,36.31,48.88,22.94,19.02,0,0,0.1200971,7e-5,25.35,0.001,0.03549,2.2095,0.368,0.241,0.117,0.087,1.41,0.771,104,78.24,71.4024,0.28,1.4e-4,0.0054,0.271163,0,0.806,0.468,0.524,0.34,0,0.42313,139.0809,1.4119,8.216,0.0348,0.852416,0,0.939079,0,31.98,3.007391,0,0,0.00489,0,1.130094,317.09,4.89,1,0.9559,0.248,0,22.09,4.528,138.1,3.519,67.04,66.2858,4.65,1.76,88,165.07,0,78,140,71.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1112,52,52,0,1,61.03,160.07,23.44756,1.63,6,0.05012683,0.60179566,1,1,5,6,1944.578,2,2,365.74,39.95,87.65,16.9,13.88,0.003332,0.0036,1.828e-4,0.00304,24.6,0.085,0.0123,2.2484,0.625,0.369,0.418,0.171,2.462,0.887,98,92.8,72.9525,0.06,3e-5,0.0135,0.159986,0.043,1.686,0.63,0.895,0.375,1.852,0.36833,120.6136,8.6173,24.7447,2.4174,1.407452,0.2467,0.475834,0.1196,0.53,5.012416,0.035182,0.026,0,0,1.065183,342.16,4.3,1,0.9421,12.217,0,25.99,4.036,136.1,6.047,69.7,267.7053,7.76,1.64,81,159.93,0,72,130,61.05,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1113,69,69,0,2,60.96,158.87,24.15151,1.63,8,0.18667335,2.24008215,0,2,2,8,4660.797,1,1,183.7,41.1,254.38,21.04,16.08,0,1e-4,0.048731,0.006,29.03,0.201,12.10887,2.2144,0.19,0.149,0.044,0.059,0.245,0.659,99.1,79.36,66.4773,0,0,0,0.399766,0.0339,0.307,0.45,0.051,0.162,0,0.42041,139.0402,2.6501,16.2609,1.3251,1.020496,0.3205,0.601025,0.1312,0,3.004265,5.090914,0.5593,0,0,1.107791,166.26,5.25,0,0.9034,8.716,0.0383,35.8,4.796,140,6.891,80.76,339.3534,5.26,1.65,66,158.5,0,64,100,59.95,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,2-3,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,OTHER,Other,Y,Y,M,No,CASA,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
1114,77,76,0,3,83.35,179.09,26.03827,2.03,6,0.060373097,0.72425893,2,3,1,6,2504.473,2,2,178.41,38.81,106.02,77.33,24.06,0.004311,0.0042,0.0995591,0.00388,1.8,0.063,3.21021,2.3269,0.286,0.331,0.054,0.064,0.43,0.517,102,70.12,84.9858,0.06,2.4e-4,0.0244,0.402051,0.0253,0.336,0.373,0.148,0.214,3.929,0.39471,131.0586,2.6551,6.6943,0.8664,0.987537,0.0074,0.476125,0.0041,0,5.201715,0.061822,0.024,0.00607,0.001,0,218.33,3.89,1,1.1263,12.372,0,31.03,4.238,138,23.722,63.91,267.9717,7.36,2.02,80,180.03,0,76,139,83.5,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1115,72,72,0,5,59.97,155,25.18639,1.57,7,0.03520527,0.42379331,1,5,1,7,388.358,2,2,NA,38.02,55.96,14.92,16.01,3.87e-4,1e-4,0,0,27.6,0.03,4.41562,2.353,0.16,0.09,0.098,0.052,1.087,0.808,92.8,73.94,64.6733,0.1,2.1e-4,0.0246,0.099526,4e-4,0.588,0.468,0.504,0.364,0,0.38731,128.8051,2.8664,6.2593,1.2901,1.427976,5e-4,0.300982,0,0.05,7.329921,2.39261,0.0393,0.00202,0.001,1.184672,388.3,4.3,0,1.0936,12.094,0.0184,28.9,4.391,137.1,5.991,67.35,279.3323,9.13,1.57,80,156.32,0,83,150,58.99,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,DEU,Germany,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High,High,Q1 ITT,High,NA,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1116,45,44,0,0,58.25,160.11,22.99232,1.61,6,0.045241773,0.54338384,1,0,1,6,2458.818,2,2,77.66,38.93,41.65,7.25,10.9,0,0,0.0199869,2e-5,20.31,0.079,6.29036,2.5517,0.24,0.18,0.212,0.175,1.087,0.69,102,77.87,70.9669,0,0,0,0.529922,0.0042,0.75,0.478,0.476,0.308,2.944,0.37644,129.2171,0,0,0.6698,1.403617,0.0819,0.343166,5e-4,17.16,1.795342,0.104281,0.0214,0.00388,0,0,200.04,4.02,0,0.8098,0.793,0.0575,0.76,4.413,141,8.547,64.96,337.8282,3.63,1.65,82,159.73,0,80,128,57.5,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1118,73,73,2,3,70.4,159.07,27.52976,1.73,6,0.028399949,0.34081096,1,3,6,6,32797.486,1,1,461.25,28.43,66.75,33.87,74.85,0,0,0,0.00692,25.93,0.154,6.27279,1.9451,0.145,0.274,0.01,0.013,0.43,0.653,107,73.57,72.5297,0.07,4e-5,0,0.119622,0.0303,0.051,0.23,0.176,0.209,0.732,0.36097,126.3594,1.7989,8.4776,0.7146,0.984222,0.2225,0.697736,0.0792,0.29,4.190328,0,0.0089,0.00479,0,0.9691,227.28,3.91,0,0.8937,0,0.0463,26.15,4.149,137.9,5.988,62.11,142.371,6.81,1.74,80,160.98,0,82,140,76.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1119,71,71,0,2,96.09,174.04,31.6044,2.1,7,0.068391706,0.82281218,0,2,3,7,2758.077,1,1,250.77,40.02,261.15,18.82,32.06,6.71e-4,8e-4,0.1027805,0.00591,3.68,0.149,8.49372,2.4027,0.11,0.179,0.044,0.047,0.681,0.78,99.9,78.58,83.058,0,9e-5,0,0.201054,0.0183,0.295,0.398,0.339,0.372,0,0.36952,111.6366,1.8546,7.3194,0.0026,1.195735,0.1846,0.463559,0.0641,31.79,2.063483,0.242248,0.6338,0.00212,0,1.062236,219.05,6.23,0,1.0007,12.414,0.0132,0.08,3.988,137.9,10.273,62.09,190.2169,4.3,2.11,79,172.95,0,78,121,96.37,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1120,73,73,0,4,96.04,174.97,30.83821,2.06,6,0.057621692,0.69143881,0,4,2,6,3589.848,2,2,178.49,39.95,86.37,10.25,15.61,0.001781,0.0024,0.0996846,8e-5,0,0.131,5.90957,2.1896,0.722,0.294,3.419,0.751,2.471,0.799,104.9,93.63,71.8293,0,3e-5,0,0.189957,8e-4,1.542,0.448,1.168,0.427,0,0.42302,130.6805,1.9502,10.3291,0.5771,2.182254,0,1.899361,0.0054,0,4.195656,0.097688,0.0097,7.3e-4,0,1.064555,244.12,4.1,0,0.9742,12.115,0,29.33,4.697,138.9,9.275,63.96,433.0328,8.05,2,61,173.92,0,92,116,87.03,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,OTHER,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1121,61,61,0,2,48.31,157.9,19.47257,1.46,6,0.082768709,0.99343884,0,2,6,6,478.485,1,1,567.25,27.98,301.77,27.82,59.56,0.003377,0.0035,0.0470066,2e-5,3.59,0.185,12.84319,2.2489,0.055,0.208,0.041,0.067,1.018,0.89,99.1,86.4,58.3223,0.04,1.1e-4,0.0079,0.00495,0,0.446,0.501,0.587,0.665,0,0.21243,74.5733,0.0118,7.7026,0.8666,0.828253,0.0032,0.300224,0,0.47,1.521265,0.582923,0.0134,1.8e-4,0.001,1.253943,214.37,5,0,0.9951,0.738,0.0541,28.6,2.55,137.7,6.858,67,428.1521,2.37,1.38,65,157.38,0,72,114,46.05,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1122,61,61,0,1,76.53,165.06,27.98855,1.85,7,0.233430853,2.80196473,0,1,5,7,8257.711,1,1,168.65,45.01,112.14,19.15,18.69,0.001239,2e-4,3.136e-4,1e-4,25.7,0,5.70613,2.2041,0.189,0.137,0.181,0.095,1.793,0.878,105,101.92,67.9974,0,2e-5,0,0,0.0021,0.751,0.447,1.006,0.502,0,0.43862,133.0407,2.0348,11.4681,0.3552,1.372827,0.146,0.305836,0.0661,0,1.677447,4.449754,0.6711,0,0,1.14886,137.96,4.5,0,1.054,11.355,4e-4,32.92,4.837,144.8,22.13,83.71,236.6399,3.85,1.95,80,164.19,0,79,131,77.39,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1123,60,60,0,3,49.14,162.06,19.13772,1.51,7,0.055874695,0.67065667,1,3,2,7,288.371,1,1,438.65,28.19,120.99,24.47,25.04,0.003533,0.0038,0.0303782,0.00404,24.98,0.18,4.63159,2.1546,0.287,0.142,0.219,0.122,0.976,0.411,104.9,94.47,57.4329,0.02,1.2e-4,0.0196,0.150357,0.0198,0.423,0.121,0.447,0.278,4.196,0.37499,131.3554,1.5404,11.8828,0.5012,2.214475,0.2221,0.400042,0.0716,12.69,3.932788,0.410607,0.0362,0,0,1.000928,207.57,3.6,0,0.9988,12.166,0.0251,29.66,4.224,140,5.471,63.43,243.2529,5.81,1.65,77,163.06,0.1,59,127,54.86,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1124,42,43,1,3,105.22,172.91,35.1759,2.2,8,0.035242723,0.4235547,1,3,3,8,21018.812,1,1,911.22,48.81,62.93,27.13,34.87,0.004041,0.0028,0.099989,0.01949,19.65,0.196,8.02213,2.2918,0.162,0.08,0.116,0.091,0.899,0.75,97.6,108.01,84.3629,0.06,1e-5,0.0108,0.199972,0.0729,0.422,0.254,0.444,0.344,1.421,0.42313,138.9481,1.4723,9.7818,0.5008,1.401456,0.393,0.461971,0.2333,15.9,3.805988,8.206644,0.8105,0,0,0.14787,138.05,3.49,0,1.0984,14.653,0,32.26,4.816,136.9,13.476,84.96,303.4654,5.63,2.19,73,170.07,0,70,120,97.84,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1125,56,57,1,4,68.03,170.16,23.15796,1.79,7,0.020866991,0.2500955,1,4,6,7,18543.079,1,1,449.04,28.33,60.48,16.14,18.06,7.29e-4,7e-4,0.0219511,0,33.36,0.09,3.03923,2.1239,0.102,0.146,0.116,0.096,0.222,0.013,97.7,79.13,88.4121,0,0,0.0123,0.321742,7e-4,0.071,0.2,0.036,0.001,0,0.34527,101.1849,3.5434,13.3634,1.1628,1.381326,0.0017,0.697073,0.0019,17.59,6.498289,1.847003,0.0119,0.00684,0.001,1.256865,190.81,4.1,0,1.1815,0.656,0.0138,0.46,4.24,137.1,8.595,58.12,408.8631,9.22,1.93,85,171.68,0.1,77,149,69.85,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158FF,Y,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1126,71,71,0,3,68.06,169.86,23.88086,1.78,7,0.187571092,2.25673795,2,3,4,7,3474.802,2,2,234.42,39.04,80,9.03,15.22,0,0,0.0453532,1e-4,0,0.037,6.72444,2.4518,0.272,0.154,0.129,0.068,1.592,0.757,100.9,57.93,83.9998,0.02,1.5e-4,0.0031,0.100496,5e-4,1.181,0.572,0.363,0.191,0,0.3442,119.3272,4.3225,13.9055,8.9322,1.376144,0.0055,0.697882,0.0019,22.17,6.86355,2.890484,0.5775,8.5e-4,0,1.069656,309.89,3.69,1,1.093,8.847,0.0394,16.81,4.707,138.1,6.068,77.07,195.4752,9.8,1.7,94,167.48,0,89,140,68.03,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131RR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,Y
1127,77,77,0,3,65.57,157.13,26.33718,1.65,7,0.078863646,0.9449767,1,3,2,7,2546.693,1,1,355.44,40.95,112.61,10.95,19.2,0,0,0.0102599,1e-5,0,0,3.03709,2.4521,0.579,0.363,0.083,0.022,1.597,0.797,101.4,87.33,59.537,0,0,0.0013,0.178858,0,0.859,0.449,0.707,0.412,1.118,0.38999,133.0012,4.041,10.6852,0.4205,1.11857,0.0071,0.531807,0,0.65,2.092795,5.203902,0.0138,0,0,1.093309,227.76,3.79,1,0.9751,11.206,0.0078,27.32,4.681,139.4,8.588,68.6,231.9992,4.1,1.62,80,157.49,0,101,147,64.16,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,Y
1128,66,66,0,4,70.58,166.94,25.71094,1.79,8,0.032091167,0.38481821,1,4,1,8,3021.809,1,1,217.95,43.01,44.38,5.61,13.88,9.82e-4,0.0026,0.0216002,7.2e-4,25.57,0.01,0.00614,2.2772,0.321,0.338,0.139,0.108,0.808,0.737,102.1,103.36,53.9772,0.13,2e-4,0.0175,3.76e-4,0.0135,0.424,0.356,0.502,0.442,1.073,0.43035,144.9115,1.0999,7.1373,0,0.632862,0.0139,1.094749,0.0916,0.6,4.473018,3.773498,0.0313,0,0.001,1.19178,183.83,3.17,1,0.9341,10.203,0.0294,28.01,4.787,135.8,11.004,64.99,381.8362,6.9,1.77,87,168.93,0.1,91,160,69.96,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1129,56,57,1,2,54.19,158.09,21.45318,1.54,6,0.126738573,1.52115231,0,2,4,6,6117.135,2,2,159.84,40.05,44.27,6.14,10.34,0,0,1.81e-5,0,24.28,0.002,4.1089,2.4253,0.229,0.289,0,0,0.741,0.817,92.9,81.94,77.0063,0,0,0.0015,0.109712,0,0.358,0.455,0.302,0.338,0,0.38557,124.1801,2.5247,16.4239,0.6207,0.429641,0,0.39878,0,0.08,6.206509,0.296233,0.0049,0,0,0.758032,317.81,4.2,0,0.9053,0.475,0.0239,0.01,4.832,131.1,10.285,76.09,404.5698,5.69,1.58,67,157.8,0,89,131,53.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1131,55,55,0,2,69.04,176.01,22.31025,1.83,6,0.066848197,0.80240112,1,2,2,6,1483.302,1,1,157.05,33.96,58.12,16.19,17.06,6.69e-4,9e-4,0.1045715,3e-5,25,0.131,0,2.0295,0.312,0.317,0.151,0.123,1.204,0.665,106.3,69.63,94.9502,0.22,0,0.0127,0.124517,5e-4,0.608,0.339,0.476,0.34,1.455,0.34692,119.3521,1.1987,11.2945,0.622,0.699235,0,0.702268,0,17.11,2.408508,0,0,0,0,1.267944,177.41,3.6,0,0.9169,8.811,0,0.22,4.243,137.6,10.283,55,272.3431,5.01,1.76,75,177.86,0,105,113,64.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131RR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1132,56,56,1,1,NA,167.22,NA,NA,6,0.070673777,0.84660755,0,1,1,6,2385.755,1,1,296.08,45.4,74.14,51.75,51.76,0.00245,0.0022,0.0370286,3e-5,25.06,0.06,16.29147,2.1672,0.824,0.533,0.143,0.082,0.79,0.014,102.1,78.77,94.7221,0.6,1.7e-4,0.1042,0.052498,0,0.522,0.01,0.255,0.179,0,0.46028,151.4629,1.7991,11.0383,0.6119,0.980337,0.0103,0.850421,8e-4,0,12.533034,0.308876,0.0317,0,0,1.519249,269.89,4.37,1,1.0917,13.676,0.0098,26.58,5.141,138.1,6.415,76.12,271.7225,12.18,1.79,111,167.57,0,78,160,64.95,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,NA,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1133,59,59,0,0,60.92,173.53,20.5466,1.72,6,0.057642351,0.69217239,0,0,2,6,NA,2,2,1083.08,47.39,69.96,22.05,26.92,0.003763,0.0013,0.0400937,0.01124,28.2,0.095,5.00915,2.3701,0,0.06,0.018,0.067,0,0.632,104,108.04,54.8343,0.01,1e-4,0.0111,0.18999,0.0547,0.017,0.441,0,0.002,3.675,0.45691,150.9429,2.5108,9.8019,1.6048,0.507213,0.2778,0.235078,0.1004,0,3.696927,3.52905,0.7108,0.00168,0,0.063058,71.63,3.54,0,1.0186,12.063,0.0387,26,4.576,143.1,22.321,75.21,4.2834,4.36,1.69,20,176.03,0,70,111,64.22,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,1,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1134,41,41,1,2,71.7,183.49,21.441770000000002,1.95,7,0.039768111,0.47736901,0,2,2,7,6334.722,2,2,208.14,45.91,90.42,13.1,25.93,1.82e-4,0.0013,0.0296154,8e-5,29.07,0.144,10.93431,2.2996,0.318,0.165,0.185,0.111,1.214,0.718,103,105.5,77.0495,0.06,2e-5,0.0098,0.053608,0.0098,0.61,0.367,0.562,0.294,2.67,0.41016,132.1438,2.7468,9.4265,0.4241,1.774193,0.2266,0.700892,0.057,0.44,5.890813,0.293802,0.0259,0.00426,0,1.209692,491.47,4.19,0,0.9826,11.778,0.0295,31.01,4.605,143,3.595,68.69,291.3842,8.24,2,71,184.57,0,81,130,75.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1135,62,62,0,3,70.13,158.79,28.0685,1.72,7,0.059344433,0.71202423,0,3,4,7,1375.568,1,1,165.4,38.99,80.75,16.05,18.89,0.003565,0.0032,0.01988,3e-5,30.07,0.147,6.2068,2.3243,0.018,0.008,0.107,0.074,0.823,0.72,110.9,100.53,61.8128,0.17,2.5e-4,0.0018,0.099614,0,0.525,0.422,0.233,0.224,2.27,0.40091,138.8692,1.4936,11.2972,1.0646,1.39825,0.0067,0.559045,0,0,4.008022,2.612418,0.0036,0,0,1.228828,186.34,3.6,1,1.0425,10.346,0.034,35.92,4.06,138.9,6.018,68.07,135.3841,6.05,1.7,80,159,0,70,125,68.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NA,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,Y,Low-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1137,80,80,0,1,NA,164.9,NA,NA,7,0.113872073,1.3659686,1,1,4,7,3206.761,1,1,235.7,37.93,39.95,7.81,26.91,0.001824,0.0024,0.0399774,6e-5,28.43,0.151,17.19842,2.146,0.471,0.457,0.109,0.091,1.493,0.827,102.3,55.6,79.4114,0.27,9e-5,0.0095,0.100319,6e-4,1.038,0.664,0.493,0.321,0,0.36215,138.0871,2.1892,15.2143,1.1445,1.235668,0.1274,0.559604,0.0397,0.11,4.60462,1.8374220000000001,0.0388,0,0,0.934764,108.94,4,0,0.9987,10.643,0.0471,27.44,3.566,138.9,7.898,67.95,330.1395,6.79,1.76,81,163.07,0,65,141,64.53,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),NA,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,NA,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1138,55,55,0,3,73.93,180.16,22.98972,1.94,6,0.019086119,0.22923216,1,3,1,6,2606.573,1,1,300.93,39.08,195.77,75.26,49.28,0.001917,0.0018,0,4e-5,0.53,0.251,3.89302,2.1231,0,0.004,0.062,0.094,0.174,0.666,106.6,78.43,86.1362,0.26,0,0.0156,0.00651,3e-4,0.157,0.391,0.004,0.161,2,0.37417,123.6815,1.1011,7.0544,0.0099,0.652172,0.1294,0.004947,0,0.68,2.607371,2.457197,0.0386,0.00279,0.001,0,80.99,3.7,1,0.9936,0,0.0198,22.14,3.936,144.3,7.007,59.94,196.2768,3.54,1.87,68,180.3,0,59,108,72.52,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1139,38,38,1,2,56.94,164.84,20.74901,1.59,7,0.100338697,1.20312726,1,2,2,7,6573.629,2,2,555.64,38.68,128.38,26.5,36.3,0.001958,2e-4,0,0,27.93,0.091,4.70414,2.261,0.121,0.028,0.034,0,0.502,0,100.1,112.8,54.9475,0,5e-5,0,0.207801,0.0039,0.148,0,0.206,0.1,0,0.40322,137.7846,3.5791,12.7164,3.6602,1.700584,0.1491,0.590627,0.001,0,4.298317,0.213436,0.0095,0.00191,0,1.037849,279.15,4.04,0,0.996,10.601,1e-4,26.7,4.564,145,5.989,73.06,139.0138,8.15,1.55,66,166.96,0,68,115,56.44,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1140,58,58,0,3,81.16,170.12,28.31689,1.94,7,0.105867097,1.27035497,0,3,6,7,9790.046,2,2,2698.01,42.82,86.03,28.97,100.54,4.56e-4,9e-4,0.0104146,6e-5,24.26,0.219,2.2985,2.2773,0.09,0.008,0.085,0.049,1.482,0.843,106.6,78.41,85.4143,0,1.4e-4,0.0039,0.122663,0.0415,0.638,0.467,0.795,0.442,1.939,0.44165,159.6682,2.0184,11.0346,1.6286,0.633637,0.15310000000000001,0.227959,0.0034,38.04,2.027327,0,0,0.00121,0,1.114363,212.05,4.22,0,0.9711,0,0,0,5.12,144.1,6.015,79.91,249.0394,3.69,2,84,171.11,0,72,148,82.66,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1141,65,65,1,2,113.72,192.28,30.70082,2.45,6,0.118112884,1.41798982,0,2,1,6,7145.548,2,2,130.5,55.55,44.82,30.81,20.89,3.61e-4,9e-4,0.0328327,0,0,0.065,14.56008,2.3799,0.289,0.097,0.119,0.054,1.768,0.841,103.1,78.16,115.7085,0.17,0,0,0.215693,0,0.918,0.482,0.627,0.321,2.742,0.46793,160.2014,1.6847,4.8131,0.0033,1.640477,0,1.16851,0.0051,0.29,6.663331,6.027563,0.022,0.00171,0,1.030041,240.15,5.12,1,0.9844,0,0.0442,34.67,4.994,140,5.998,76.84,1314.5738,9.11,2.35,68,190.48,0.1,68,130,110.51,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1142,49,49,1,2,99.52,175.01,32.26849,2.13,8,0.098810723,1.18584194,2,2,6,8,12330.233,1,1,746.51,38.03,84.54,11.91,19.03,0,0,0.0602713,0.02125,28.23,0,3.89795,2.3759,0.326,0.185,0.472,0.267,1.198,0.679,0,90.64,88.3112,0,0,0.002,0.453775,0.2586,0.631,0.347,0.598,0.395,0,0.32315,109.8779,3.4108,17.5837,1.8501,1.12266,0.3692,1.390685,0.2677,0,10.929524,7.198248,0.7872,0,0,1.112521,254.97,4.24,0,1.2367,10.608,0,0.33,4.181,136.1,10.008,67.02,333.8038,11.73,2.28,67,174.68,0,89,102,99.26,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,High-Intermediate,Q4 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1143,46,46,1,2,54.11,179.19,17.25627,1.67,6,0.085453175,1.02394574,0,2,2,6,4014.792,1,1,247.67,38.41,133.52,28.75,15.96,0,3e-4,0.0200028,0,0,0.128,5.34536,2.4017,0,0.007,0.001,0.055,0.184,0.741,102.1,87.95,83.9995,0.02,0,0,0.200695,0,0.225,0.532,0.003,0.187,1.686,0.39923,127.8683,2.6161,13.4127,1.7464,0.506502,0,0.055826,0,26.57,2.50714,0,0,4.6e-4,0,1.021181,233.36,3.91,0,1.0495,9.015,0.0137,26,4.583,140,2.991,69,309.0533,4.13,1.65,66,180.19,0,66,104,56.8,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1144,74,74,0,3,68.38,158.1,27.18212,1.72,8,0.028270376,0.33833918,0,3,3,8,4167.143,2,2,403.4,43.41,62.95,15.05,21.97,0,0,0.0628658,0.00505,0.55,0.21,4.66922,2.3701,0.077,0,0.18,0.094,0.868,0.693,101,94.9,54.9726,0.03,4e-5,0,0.250728,0.01,0.49,0.279,0.314,0.214,2.908,0.42055,145.2644,1.9185,12.8296,1.0509,3.069553,0.186,0.701397,0.0583,0,2.777469,0.177047,0.0196,0,0,0.231985,187.84,3.93,0,0.991,11.247,0,36.15,4.296,137.9,7.395,70.01,251.0294,6.04,1.79,80,158.63,0,73,109,70.15,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
1146,44,44,0,4,62.93,165.02,22.60348,1.67,8,0.121217145,1.45605478,1,4,4,8,896.858,1,1,784.31,39.04,69.06,16.17,17,0.003071,0.0036,0.0102902,4e-5,29.08,0.068,0,2.4683,0.307,0.423,0.049,0.044,0.848,0.664,103,175.55,38.6948,0,0,0,0.033938,0,0.481,0.334,0.273,0.276,0,0.36642,111.1914,1.3701,8.9358,0.837,1.307737,0.0016,1.302421,0.075,14.93,6.908064,4.935734,0.0177,0.0043,0.001,1.261052,512.25,3.69,1,0.9945,13.513,0.0198,26.14,4.71,142.9,17.111,67.42,228.2693,11.32,1.65,86,163.09,0,86,113,60.41,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VV,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1147,74,74,0,1,54.83,149.81,24.54514,1.47,7,0.14199793,1.70436789,0,1,2,7,254.086,1,1,301.71,37.96,51.7,12.27,18.08,0,0,0.0501919,0.00597,26.07,0.056,13.14399,2.5064,0.61,0.216,0.329,0.085,2.194,0.602,108.4,56.49,71.6056,0,4e-4,0.0111,0.499929,0.043,1.611,0.433,0.865,0.276,3.486,0.41091,135.9272,1.6702,10.1435,1.198,2.386299,0.2087,0.32748,0.0869,0.48,2.601604,0.123908,0.0332,0.00578,0,0.930049,251.94,4.29,0,0.745,0.25,0,0.68,4.557,143,6.669,71.94,404.4032,4.49,1.57,65,146.41,0,0,110,54.13,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1148,44,43,1,1,67.99,176.44,21.89912,1.84,8,0,0,1,1,1,8,3389.544,2,2,219.64,42.65,26.34,14.84,16.92,0,0,0.0909928,0.00793,23.05,0,0,2.3205,0.842,0.539,0.133,0.082,1.113,0.679,94.1,101.14,76.0209,0.57,0,0.0138,0.666816,0.0601,0.802,0.487,0.262,0.188,0.698,0.30438,115.0045,3.8116,9.3853,2.3127,0.862334,0.0566,0.714647,0.0294,37.82,6.350174,4.55319,0.6262,7.1e-4,0,1.01213,284.16,4.96,0,0.8653,10.589,0,25.67,4.119,133,3.405,64.92,336.1422,7.1,1.86,79,176.43,0,92,117,68.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1149,37,38,0,0,63.13,169.88,22.3708,1.73,6,0.073837404,0.88627317,1,0,4,6,677.755,2,2,140.73,45.1,107.63,26.93,22.17,9.3e-5,0.0016,0.0498393,0,22.2,0.115,13.70069,2.4508,0.217,0.103,0.276,0.141,1.295,0.643,105.1,98.97,75.1055,0.12,0,0,0.200662,0.001,0.644,0.335,0.52,0.272,0,0.49103,171.7382,0,0,0.9152,2.728136,0.2082,0.430622,0.0607,11.03,3.680738,0.636188,0.012,0.00325,0,0.962252,204.92,4.11,0,0,0,0.0276,0,5.395,146.5,5.886,66.03,439.0706,6.51,1.63,91,168,0,64,123,59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1150,70,70,0,2,59.96,157.06,23.62602,1.59,8,0.034223801,0.41083561,1,2,4,8,4482.163,1,2,171.98,28.93,314.82,33.56,21.94,0.002529,0.0018,0.0071528,0,34.35,0.049,5.37009,2.1396,0.175,0.169,0.066,0.094,0.463,0.422,105.1,111.5,44.1568,0.45,0,0.0205,0.006202,0,0.391,0.333,0.117,0.145,1.534,0.25115,87.2323,2.1028,13.2868,0.9425,1.040181,4e-4,0.618264,0,0.74,5.632091,1.755836,0.0098,0.00682,0.001,1.300461,283.44,4.7,1,1.0134,10.54,0.0376,0,3.278,139.8,6.037,52.16,115.9858,6.58,1.62,50,155.93,0.1,80,103,59.93,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1151,52,51,0,1,84.24,172.7,28.41616,1.98,7,0.174187375,2.08885049,0,1,1,7,511.289,1,1,261.62,38.83,99.25,12.1,16.84,3.27e-4,3e-4,0.0300072,0,25.08,0.035,7.44846,2.523,0.254,0.059,0.077,0.043,1.103,0.561,109.2,112.29,62.813,0,0,0,0.24016,0,0.42,0,0.574,0.25,0,0.42066,144.4209,0,7.9036,0.286,2.259899,0,0.391396,0,0,3.1037689999999998,3.327783,0,0.00189,0.001,0.871077,267.63,4.11,1,0.9789,12.965,0,27.97,5.237,144.1,4.12,76.58,214.1192,5.9,1.82,79,165.01,0,76,134,74.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1152,56,56,0,3,61.63,162.13,23.14551,1.65,7,0.084436086,1.01396202,0,3,1,7,1848.859,2,2,218,42.1,174.47,11,18.63,0,8e-4,0.0597414,0.00291,24.29,0.104,3.99927,4.7609,0.275,0.155,0.033,0,0.912,0.712,105.9,82.71,73.5916,0.08,1.6e-4,0.0106,1.226838,0.0354,0.652,0.394,0.252,0.238,0,0.44616,143.9452,2.1584,9.4027,2.6912,1.870328,0.0127,0.513715,0,0,14.280331,0.499834,0.5679,0,0,1.161068,535.97,4.89,1,0.9803,10.176,0.0037,34.91,5.162,145.1,16.743,72.31,243.3206,17.32,1.66,61,162.42,0,70,119,60.46,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1153,64,63,0,3,66.87,168.96,23.69412,1.76,6,0.078329457,0.94023861,1,3,2,6,1929.61,2,2,221.51,40.07,104.21,32.32,32.17,0.002485,0.0025,0.0457837,0,25.69,0.07,6.08934,2.3766,0.031,0.063,0.001,0.001,0.051,0,93.4,115.48,48.4573,0.25,1e-5,0.017,0.042963,0,0.019,0,0.056,0.002,5.434,0.37481,116.9689,2.1486,8.8307,0.6297,1.860804,0.0065,0.601433,0,0,3.997678,2.052945,0.0326,2.2e-4,0,1.229613,325.05,3.99,0,1.1025,10.869,0.0133,30.41,4.27,139.1,8.49,73.92,246.9485,8.09,1.74,76,167.4,0,69,119,66.26,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1154,68,67,1,2,67.85,167.29,24.13883,1.73,6,0.060210927,0.72253536,0,2,2,6,9879.029,1,1,142.18,44.94,55.29,13.94,10.04,0.004198,0.0025,0.0198391,0.00337,27.95,0.239,2.37283,2.3966,0.399,0.37,0.091,0.073,0.778,0.707,102.1,80.99,68.9771,0,0,0.0097,1.459256,0.0318,0.427,0.382,0.339,0.34,0.982,0.40097,138.6811,2.5217,11.2024,0.665,1.99712,0.212,0.543046,0.0711,0.21,3.451618,0.525218,0.0342,0.00452,0.001,1.389078,376.8,4.09,0,0.9904,12.931,0.0194,31.41,4.261,138.9,17.042,80.17,237.4589,6.19,1.62,59,167.08,0,97,135,62.97,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1155,48,47,0,1,71.87,178.18,23.1893,1.9,6,0.1342889,1.61083195,0,1,1,6,1060.462,2,2,129.05,39.91,62.95,14.02,18.01,0,0,0.0200397,2e-5,0,0.07,4.87235,2.2065,0.312,0.207,0.157,0.086,2.139,0.912,101,114.35,62.7094,0,0,0,0.270438,3e-4,1.308,0.603,0.887,0.514,0,0.45204,146.1367,1.1859,4.9024,0.7195,2.388024,0.0048,0.627161,0.0027,0,3.61118,4.633597,0.6554,0,0,0.772266,234.91,4.81,0,1.115,0.687,0.053,34.97,4.896,137.1,15.325,68.93,356.5855,6.27,1.78,89,180.05,0,96,128,71.77,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1157,61,61,0,1,54.82,164.29,19.81308,1.58,7,0.104050725,1.24650159,0,1,2,7,412.051,1,1,143.91,30.11,84.29,14.86,28.09,0.157436,0.0326,3.329e-4,0,17.61,0.14,8.9154,0,0.113,0.191,0.167,0.202,0.049,0,109.5,79.88,70.6582,0.37,0,0.0299,0.05132,0,0.23,0.309,0,0,0.795,0.37849,122.0912,1.5017,5.3487,0.2173,0.801732,0.0104,0.22029,0.0015,0.13,5.930465,5.0635,0.6785,0.00206,0.001,0.870969,120.62,3.12,1,0.9753,0.85,0.0698,30.03,3.781,145.5,5.11,43.1,214.0206,7.62,1.54,81,162.78,0.1,63,144,53.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),<18.5,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,Yes,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1158,59,60,0,1,82.09,153.97,34.62758,1.8,7,0.094314266,1.13221765,0,1,4,7,2320.213,2,2,445.77,40.99,240.9,17.06,24.02,1.9e-4,3e-4,0.0508512,0.00207,28.06,0.205,4.32695,1.9647,0.001,0.001,0.001,0.004,0.018,0.483,0.4,132.95,52.0181,0.24,0,0,0.159834,5e-4,0.004,0.162,0.004,0.122,7.432,0.40989,129.8034,0.0038,7.0536,0.2867,1.487336,0.1194,0.518301,1e-4,0.77,2.281695,0.359867,0.0026,0.00586,0,1.09852,266.47,3.88,1,0.8371,12.075,0.0563,27.76,4.629,134.6,2.989,63.99,157.4974,3.9,1.71,71,153.8,0,69,131,83.41,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,>= 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1159,72,71,1,2,65.1,156.09,26.88341,1.66,7,0.123904764,1.48816431,1,2,3,7,7373.597,NA,2,480.83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.6,71,155.86,0,78,131,67.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,GBR,United Kingdom,NA,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,NA,NA,N,Y,Y,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,NA,GA101 plus 6 CHOP cycles,NA,NA,N
1160,76,76,0,3,62.94,151.26,27.46915,1.59,6,0.061685424,0.74098855,1,3,5,6,1127.548,1,1,193.2,39.24,50.97,13.85,16.15,0.001927,4e-4,0.0211788,0.00506,26.37,0.1,19.07263,2.3259,0.159,0.055,0.227,0.13,0.806,0.578,98.1,64.5,62.8165,0.05,1.2e-4,0.0083,0.193048,0.0232,0.559,0.394,0.256,0.155,1.299,0.39133,130.873,3.7734,14.2988,0.4803,1.306002,0.1126,0.377611,0.0491,16.82,6.521951,2.957811,0,0.00171,0.001,1.354558,211.73,4.36,0,1.0272,0,0.0261,27.4,4.262,137.8,9.018,79.95,179.4751,9.5,1.6,69,154.44,0,69,120,64.9,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,3,>1,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1161,56,56,1,4,57.03,152.92,24.45533,1.54,7,0.023310254,0.28005574,1,4,5,7,7203.943,2,2,138.8,37.75,62.91,20.72,20.04,7.36e-4,0.001,0.0099862,0,27.08,0.088,4.50763,2.2738,0.112,0.071,0.049,0.014,1.116,0.869,105,82.52,72.5172,0.52,1.1e-4,0.0327,0.161229,0,0.402,0.335,0.654,0.464,1.254,0.40969,128.6131,2.4102,13.7074,3.5581,1.123589,0.0019,0.282509,0,16.03,3.290412,0,0,0.00183,0,1.142835,275.12,4.98,0,1.0599,13.268,0,28.9,4.401,139.9,7.273,71.41,238.5084,6.21,1.57,63,154.99,0,79,110,57.05,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1162,60,60,1,2,86.53,175.29,28.50423,2.02,6,0.04794741,0.57567383,0,2,2,6,15481.319,2,2,129.67,39.91,93.19,12,16.11,0,0,0.0199215,0,0,0.058,4.30022,2.3512,0.003,0,0.11,0.09,0.994,0.798,102.1,104.91,65.6927,0.37,1e-5,0.0195,0.236191,0,0.323,0.004,0.674,0.417,0,0.46891,157.7218,1.0117,13.5088,1.772,1.267662,0,0.300052,0,0,3.331833,0,0,0,0,0,119.98,3.59,0,0.9404,0,0.0823,40.52,5.879,139.1,10.961,69.09,449.3285,5.89,1.92,58,172.97,0,84,120,78.16,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1165,74,74,0,3,69.96,165.07,25.26807,1.76,6,0.03711081,0.44502972,1,3,3,6,621.356,2,2,159.95,38.02,247.22,100.42,23.96,0.003224,0.0032,0.0368561,1e-5,24.91,0.24,5.32638,2.3485,0.062,0,0.097,0.081,1.196,0.819,102,58.04,88.3985,0,0,0,0.109934,0,0.641,0.466,0.411,0.338,2.362,0.38972,129.7356,2.5608,10.8899,0.8016,2.413271,0,0.697771,8e-4,11.01,5.935777,4.67831,0.0296,0,0,0.990963,308.5,4.8,1,1.0921,11.208,0.0567,0.41,4.4,137,6.864,64.41,202.6162,8.76,1.63,60,167.91,0,88,100,71.47,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1166,63,63,0,2,53.51,149.69,23.8814,1.48,7,0.07886229,0.94657211,0,2,2,7,361.582,2,2,264.38,44.91,97.58,18.83,18.16,5.38e-4,3e-4,0.1228652,0.006,32.54,0.13,0,2.2766,0.217,0.181,0.228,0.22,0.909,0.661,99,58.98,79.5599,0,0,8e-4,0.324804,0.0285,0.562,0.471,0.278,0.17,1.951,0.36448,121.0552,2.3609,7.7352,1.1598,1.41989,0.1935,0.413327,0.0524,17.16,4.150957,4.468998,0.7094,0.00416,0,0.910329,474.22,4.41,1,0.9954,9.242,0.0275,24.69,4.182,145,8.579,69.31,113.7854,6.31,1.52,80,150.23,0,61,135,56.44,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1167,64,64,0,2,80.18,162.12,29.85775,1.84,6,0.065399854,0.78427748,1,2,6,6,8044.023,1,1,270.76,36.71,269.34,25.93,19.16,0,0,0.0165026,0,22.93,0.181,6.03016,2.1169,0,0,0.013,0.05,0,0.629,100,152.45,36.1139,0.23,2e-5,0.0198,0,0,0.023,0.468,0,0,3.707,0.34861,125.093,0.0062,0,0.4771,0.299371,0,0.870692,0,0.78,6.755785,0,0,0.00415,0,0,108.26,3.6,1,1.0084,0.255,0.0415,29.53,3.107,140,26.601,50.87,181.7915,8.22,1.72,63,160.94,0,81,120,75.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1168,49,49,0,2,63.83,157.8,25.95883,1.65,7,0.03563077,0.42761481,1,2,4,7,1457.938,1,1,132.69,41.79,69.01,20.1,22.02,0.001114,0.0011,0.0083515,7e-5,23.59,0.089,12.36178,2.5013,0.112,0.098,0.017,0.018,0.83,0.774,106,71.38,97.4119,0,0,0,0.099411,0.0098,0.282,0.154,0.557,0.41,2.249,0.3691,124.9811,3.9095,14.3954,2.1475,1.293523,0.0798,0.598882,0.07,0.28,2.198627,0,0.0102,0.00157,0,1.383181,305.61,3.6,0,0.9032,0.944,0.0198,28.79,4.132,140.9,13.64,74.19,326.7332,4.55,1.63,83,155.9,0,95,148,64.42,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,1,1,131HH,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1169,66,66,1,1,48.8,159.55,19.48522,1.48,6,0.033382962,0.40053959,0,1,4,6,9378.646,2,2,630.13,39.91,102.03,20.32,41.44,7.92e-4,0.001,0.0200308,1e-5,26.5,0.002,6.06693,2.2861,0.319,0.25,0.026,0.039,0.62,0.718,101.9,98.92,51.5097,0.21,0,0.0012,0.020955,0,0.415,0.329,0.306,0.372,3.08,0.37573,124.7792,4.1981,9.3364,0.7676,0.6693,0,0.601086,0.0051,0,4.559125,4.042932,0.5496,0,0,1.350342,212.89,4.6,0,1.1215,12.975,0.0274,31.94,4.293,134.2,15.311,61,95.1089,6.38,1.33,80,159.88,0,89,117,45.37,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1171,55,55,0,1,103.21,175.1,33.93368,2.16,7,0.08822546,1.05881563,1,1,5,7,2883.593,1,1,352.22,34.97,197.1,16.77,20.88,0,0,0.029722,7.1e-4,2.19,0.285,4.63624,2.2433,0,0,0.087,0.089,0.031,0.513,106.6,137.72,53.0317,0.38,8e-5,0.0241,8.12e-4,0.0021,0.156,0.32,0.001,0,0,0.3603,129.0893,2.2866,5.7963,0.6991,1.490525,0.2598,1.000354,0.1203,0.55,5.474244,4.568007,0.7384,0.00659,0.001,1.000044,206.95,4.1,0,0.8874,11.948,0,0.9,3.821,145.2,8.004,62.85,329.5988,7.85,2.1,69,174.1,0,92,120,95.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1172,44,45,0,1,66.81,172.36,22.21893,1.77,7,0.205938253,2.46701037,1,1,1,7,1189.428,1,1,197.33,36.1,91.07,9.91,22,0.001956,9e-4,0.0087813,6e-5,0,0.075,8.90705,2.2213,0.004,0.06,0.029,0.04,0.5,0.603,99,99.17,67.6211,0,0,0,0.124446,6e-4,0.198,0.222,0.242,0.226,0.673,0.33074,125.1406,1.2648,14.1804,1.7303,0.98005,0.0112,0.598664,0.0615,0.38,2.594362,0.585804,0.0077,0.00457,0,1.031127,183.76,3.8,0,0.92,13.005,0.0116,33.44,4.265,135.8,9.026,69.04,199.3115,3.18,1.74,84,170.84,0.1,94,127,65.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,N,Y,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1173,32,33,0,2,58.09,166.93,21.34962,1.65,6,0.237749364,2.85387725,1,2,2,6,1365.968,2,2,243.42,41.64,89.67,9.05,15.82,0,0,3.668e-4,1e-5,28.74,0.001,4.66876,2.2569,0.297,0.245,0.035,0.051,1.033,0.841,101.1,130.37,57.562,0,0,0,0.201504,3e-4,0.416,0.35,0.63,0.575,0,0.40798,130.8002,2.4411,10.6923,0.4723,1.231734,0,0.589601,0,0.41,3.893584,0.172575,0,0.00495,0,1.336603,262.05,4.09,0,1.1013,0.288,0.0459,32.74,5.485,140,10.395,74.99,196.0641,5.39,1.62,81,167.65,0,84,112,64.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,DEU,Germany,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1174,61,61,0,0,80.9,177.9,25.33547,2,8,0.100963194,1.21198692,0,0,2,8,299.385,2,2,129.26,41.73,80.57,6.67,11.87,0,0,0.0998632,2e-5,28.92,0.21,6.67655,2.2346,0.04,0,0.239,0.137,0.842,0.559,106.1,92.03,83.0066,0.08,0,0,0.339909,0,0.656,0.384,0.127,0,0.188,0.34326,121.5402,1.7548,0.1337,0.6989,2.300016,0,0.56963,0,0.53,5.401804,0,0,0.00943,0.001,1.169717,308.93,3.93,0,1.0034,0,0,22.99,3.971,135.1,3.409,3.77,245.0463,8.86,2.02,63,176.12,0,82,96,82.67,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,Y,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1175,68,68,0,2,87.47,154.92,37.02149,1.86,7,0.028624667,0.34313024,1,2,5,7,3936.625,NA,1,1076.05,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.71,79,154.82,0,94,119,83.26,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,NA,N,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,NA,Rituximab plus 6 CHOP cycles,NA,NA,N
1176,60,60,0,3,69.84,170.78,23.52984,1.81,6,0.047232586,0.56703606,1,3,4,6,3684.799,2,2,1288.8,47.16,57.5,43.52,30.97,7.52e-4,0,0.1046834,9.5e-4,27.99,0.081,4.98173,2.4505,0.125,0.16,0.008,0.001,0.701,0.724,98.1,72,91.0053,0.21,5e-5,0.0051,0.241937,0.0038,0.21,0.291,0.394,0.371,0.393,0.41119,141.1702,1.8158,12.2193,0.7542,1.390699,0.0971,0.524918,0.0596,0,4.004429,3.328487,0.0402,0,0.001,0.997222,241.77,4.22,0,1.1002,0.413,0.0182,24.5,4.412,136.6,14.934,70.01,228.2536,6.49,1.79,81,168.5,0,129,130,68.02,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1177,66,66,0,2,102.11,174,33.33279,2.11,6,0.078340015,0.93949694,0,2,1,6,2269.526,2,2,224.07,41.98,73.08,19.75,18.02,0,0,0.0102637,0,27.14,0.125,4.9139,2.1623,0.311,0.298,0.231,0.154,1.564,0.788,106.7,88.59,79.2816,0.14,2e-5,0.019,0.210028,2e-4,0.782,0.487,0.575,0.363,0,0.43567,150.9441,0,0.0817,0.3534,1.60134,0.0055,1.113813,0.0046,0.45,2.083619,0,0,0.00298,0,1.080549,87.26,4.1,0,0.9176,11.879,0.0866,24.35,4.59,138,15.395,64.02,305.4377,4.51,2.08,87,174.95,0,67,148,99.53,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1178,46,46,1,2,81.12,175.03,26.09468,1.98,7,0.071116521,0.85351719,0,2,6,7,6287.409,2,2,220.16,43.01,122.44,11,10,0,0,0.0080602,0,23.74,0,0.01674,2.5174,0.07,0.044,0.083,0.049,1.068,0.74,102.1,111.05,67.9275,0,2e-5,0,0.040565,0,0.53,0.321,0.596,0.32,3.337,0.3615,129.8948,0.8009,0,1.2208,2.944488,6e-4,1.744434,5e-4,0,25.419101,4.33053,0,0,0,1.141182,393.83,4.31,0,0.9723,0,0,27.21,4.507,143.1,3.418,70.07,267.6693,35.54,1.94,70,174.08,0,75,116,77.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
1179,42,42,1,2,53.86,153.76,22.75063,1.51,7,0.145060081,1.73933822,1,2,6,7,12496.026,2,2,89.74,47.05,79.15,15.1,2.7,0,0,0.0099234,0.00395,28.02,0.059,7.85111,2.1354,0.088,0.146,0.001,0,0.582,0.88,100.1,104.53,62.5637,0,0,0,0.771802,0.2084,0.425,0.484,0.269,0.443,0,0.48132,162.8813,2.3181,10.6959,0.4015,1.369782,0.281,0.238145,0.1058,0,2.423579,0,0.0251,0,0,1.228143,268.62,3.48,0,0,0,0.0645,0,6.024,139,10.963,73.04,356.5966,3.87,1.48,79,156.17,0,70,134,55.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1180,31,31,1,2,91.08,180.02,27.51507,2.1,6,0.096005907,1.15354222,0,2,3,6,3681.09,1,1,487.66,31.45,46.23,23.81,17.7,0.002003,0.0019,1.87e-5,0,29.07,0,0,2.1461,0.177,0.217,0.02,0.026,0.537,0.692,97.8,133.34,72.1981,0.04,1.2e-4,0.0171,0.019858,0,0.409,0.373,0.149,0.221,0,0.34417,101.3734,0,0,0,1.727234,0.0093,1.493711,0.0012,0.46,7.210362,4.4396,0.0125,0.00234,0,0.220227,242.03,4.09,1,1.0683,10.422,0,27.32,4.35,139.9,6.856,65.34,95.7516,9.61,1.95,85,180.56,0,91,125,85.95,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1181,63,63,2,1,107.96,175.91,33.31018,2.29,7,0.059588946,0.71466025,0,1,5,7,21230.161,2,2,622.25,41.01,77.88,22.86,22.99,0,0,0.049961,2e-5,3.16,0.15,4.99897,2.4422,0.467,0.446,0.127,0.114,1.123,0.825,102,88.68,91.0296,0,0,0,1.616298,8e-4,0.772,0.557,0.376,0.359,0,0.35933,130.9692,5.1871,11.7885,0.6545,1.265418,0.0079,1.204015,0.0447,0.76,2.174382,0.217736,0,0.00404,0,1.057731,80.63,4.4,0,1.1196,13.537,0,31.04,3.911,139,19.793,73.96,397.6562,5.39,2.18,86,175.03,0.1,103,142,105.88,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,Yes,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1182,60,60,0,0,98.03,163.01,37.34295,2.03,6,0.097265743,1.16679994,0,0,3,6,4117.848,1,1,147.8,44.1,28.2,20.42,21.03,0.003341,0.0038,0.1194758,0.00951,23.2,0.068,4.55412,2.2883,0.047,0.003,0.055,0.04,0.415,0,102.9,78.55,97.5127,0,4e-5,0.0041,0.274003,0.0309,0.268,0.009,0.098,0,0.888,0.47888,166.4842,3.6446,14.512,1.8198,2.291562,0.2201,0.31664,0.0701,0,4.314867,0.501637,0.6045,8.1e-4,0,0,133.9,3.3,0,0.9853,0,0.004,32.07,4.897,139,15.692,78.08,440.6398,6.54,1.97,80,163.08,0,62,125,95.84,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1183,52,53,0,4,58.83,169.97,20.72471,1.65,6,0.083447082,1.00142273,1,4,6,6,3903.222,2,2,549.86,41.94,48.02,25.46,21.99,7.46e-4,0,0.1348612,9e-5,27.05,0.075,2.53794,2.4989,0.309,0.305,0.144,0.125,0.848,0.73,0.3,89.76,63.0344,0.21,0,0,0.089977,1e-4,0.464,0.393,0.327,0.304,0,0.36961,116.9349,0,11.0732,1.5939,1.448966,0.0095,0.617477,0.0014,0.72,5.539407,4.935127,0.0355,0.00202,0.001,1.069566,218.85,4.21,0,1.0583,0.476,2e-4,24.97,4.103,141,15.393,65.04,338.5331,9.79,1.68,70,170.1,0,80,104,58.66,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1185,68,68,1,2,80.07,178.77,24.97942,1.99,6,0.091698148,1.10072057,2,2,5,6,14969.303,1,1,277.19,30.79,73.13,13.83,21.07,0.002175,0.001,0.0224743,2e-5,22,0,5.49528,2.08,0.229,0.241,0.114,0.108,0.515,0.644,0,109.92,53.0323,0,8e-5,0.0038,9.7e-4,0,0.268,0.423,0.215,0.209,1.398,0.35496,109.0539,3.2725,12.2905,0.7174,1.389761,0.006,0.501169,0.0014,0.84,3.523071,3.208413,0.018,0,0,1.189612,257.28,4.09,0,1.0036,0,0,23.67,4.165,138,4.872,59.5,75.9064,5.68,1.93,80,178.03,0,58,134,76.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1186,54,54,1,2,51.53,150.97,23.05255,1.47,6,0.086927846,1.04297921,1,2,4,6,1453.423,1,2,600.96,24.98,66.95,29.63,21.98,0,7e-4,0,0,26.98,0.07,13.52121,2.3003,0.13,0.094,0.313,0.159,1.066,0.731,99,112.85,44.2477,0.32,1.3e-4,0.0283,0,0,0.649,0.452,0.289,0.174,0,0.28932,96.9625,2.5183,11.0246,0.6622,1.601441,0,0.700346,0,14.95,7.304785,0.2348,0,0.00963,0,1.207587,219.61,3.09,1,0.9925,7.573,0.032,0.12,3.614,131.1,3.709,66.03,21.2131,9.74,1.42,84,150.26,0,81,133,52.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low,High-Intermediate,Q2 ITT,High,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1188,44,44,0,4,60.1,173.01,20.6836,1.72,7,0.073999104,0.88893951,0,4,6,7,4757.302,1,1,559.94,44.03,74.82,85.72,61.23,0.089383,0.0047,0.0598318,0.00235,28.36,0.146,7.13375,2.322,0.02,0.078,0.086,0.109,0.049,0.014,107,100.62,69.5363,0.61,2e-5,0.0211,0.020155,0.0257,0.024,0.081,0.007,0,3.661,0.41086,140.9578,2.0426,13.4531,0.6779,1.325222,0.2752,0.43022,0.1224,0,3.226962,4.307401,0.5343,0.00228,0.001,1.278454,81.66,4.65,0,1.0512,0,0.0191,32.26,5.468,142,6.821,69.96,494.2773,5.8,1.72,80,174.07,0,84,119,58.18,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,NA,N,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1189,77,77,0,2,83.54,181.29,25.92246,2.03,8,0.039499681,0.47360155,1,2,6,8,618.017,1,1,226.66,37.02,78.02,48.35,29.09,0.001009,0.001,0.0999677,2e-5,21.81,0.076,8.27734,2.1431,0.08,0.115,0.001,0.031,0.505,0.683,104.1,60.1,87.5914,0.07,0,0.013,0.068627,0,0.261,0.392,0.205,0.252,3.165,0.39339,130.9748,1.5689,7.4653,0.0116,0.693218,0,0.671032,0.0031,0.83,2.801136,2.595045,0,0.00203,0,0.892816,153.92,3.87,0,1.0943,11.243,0.0056,26.1,4.565,138.9,9.975,70.01,398.6757,4.87,2.09,60,180.11,0.1,89,102,79.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,>1,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
1190,66,66,1,4,46.2,157.49,18.7757,1.44,6,0.051657944,0.61887747,0,4,6,6,4346.762,2,2,190.36,38.99,77.13,18.62,21.01,9.46e-4,0.0011,0.1049656,0.0051,33.01,0.034,5.20923,2.3408,0.236,0.124,0.019,0.001,0.85,0.684,96.4,58.71,82.0718,0.08,0,0,0.167764,8e-4,0.414,0.245,0.284,0.201,0,0.27236,84.7551,1.741,8.7181,0.7983,1.81932,0.0786,1.100965,0.0724,0,3.943016,0.699427,0,0,0,1.355485,198.67,4.54,1,1.008,10.105,0.0721,24.09,3.498,140,36.926,80.15,296.0719,7.45,1.55,61,160.09,0.1,83,116,47.83,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1191,45,45,1,2,80.45,164.97,28.96986,1.89,8,0.096347872,1.15768806,1,2,1,8,2503.867,2,2,487.96,45.07,63.04,19.91,30.16,0,0,0.039902,2e-5,27.91,0.2,24.43391,2.2904,0.111,0.145,0.034,0.031,0.439,0.749,108,88.47,90.038,0.32,7e-5,0.0234,0.119182,5e-4,0.202,0.31,0.144,0.269,1.068,0.43037,139.0295,1.2012,10.0711,0.0797,0.906407,0.0067,0.066099,0,0,2.337587,0,0,0,0,1.064948,167.08,4.61,0,0.9813,0.284,0.053,0,5.008,142.9,10.268,79.04,344.992,2.92,1.82,97,167.92,0,75,139,81.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,High-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1192,64,64,1,3,85.61,163.09,32.25202,1.92,7,0.064635398,0.77489165,2,3,6,7,15842.28,1,1,430.3,26.62,52.88,12.98,15.71,4.2e-5,9e-4,0,0,25.59,0,12.16937,2.28,0.05,0.117,0.038,0.033,0.598,0.68,100.9,89.21,75.5768,0,1.2e-4,0.0203,0.081718,0,0.394,0.359,0.249,0.263,2.003,0.33318,107.7137,1.8432,8.9061,0.6999,0.815896,0,0.295111,2e-4,25.51,6.2884,0.143878,0.0073,0,0,2.055813,295.46,5,0,0.9532,13.772,0,22.41,3.504,131.6,4.999,53.02,172.9311,6.73,1.82,74,162.54,0,71,109,85.99,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1193,71,71,0,3,104.04,164.91,39.70435,2.09,6,0.104443554,1.25394336,0,3,3,6,7098.627,1,1,743.46,40.92,124.52,17.85,18.82,8.84e-4,2e-4,0.0100102,0,0.93,0.119,5.03053,2.2927,0.004,0,0.031,0.016,0.88,0.681,104.1,120.88,50.4783,0.11,0,0,0.336202,0,0.545,0.377,0.226,0.001,0,0.42057,142.4758,2.5486,9.3374,1.7386,2.553412,0,0.498657,0,0.1,5.998713,2.152067,0.0095,0.00148,0,1.03183,417.67,3.59,0,1.0971,13.304,0.0112,27.12,4.258,141,8.463,71.49,237.9258,8.89,1.95,80,162.1,0,84,121,94.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1194,39,40,1,2,83.05,172.92,28.07178,1.98,6,0.062557844,0.75072512,0,2,4,6,12320.947,2,2,1060.88,35.93,83.81,27.37,25.41,0,0,0.0399089,1e-5,3.74,0.055,4.47979,2.4869,0.17,0.209,0.075,0.112,0.483,0.677,100.1,115.95,71.403,0.26,5e-5,0.0296,0.34011,0,0.06,0.252,0.41,0.471,1.751,0.35629,125.3444,1.0976,7.196,0.499,0.798378,0,0.598456,0,0,12.609192,3.127333,0.0249,0,0,0.970655,377.95,3.99,0,1.1675,0.387,0.083,27.51,4.57,134.8,11.978,74.03,130.9354,13.89,1.92,81,172.97,0,92,124,79.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131RR,158VF,N,Y,N,N,Low,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1195,69,69,0,3,74.96,188.94,21.32686,2.02,7,0.123302882,1.47872902,0,3,6,7,1151.036,1,1,159.81,46.01,76.93,19.83,18.06,0,0,0.0196392,0,26.99,0.198,10.82537,2.2009,0.637,0.19,1.078,0.186,2.881,0.773,105.1,75.3,88.1821,0,1.4e-4,0.0062,0.090919,7e-4,1.811,0.542,0.847,0.203,0.502,0.49289,165.2676,2.2606,20.107,0,3.185379,0.2278,0.407441,0,0.49,3.530031,0,0,0.00183,0,1.114939,192.29,4.61,0,0.9495,9.328,0,34.91,5.767,144.1,5.176,76.07,369.9727,7.2,2.16,72,190.41,0,0,121,81.08,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1196,66,67,1,3,96.07,169.06,32.99182,2.04,7,0.058552325,0.70233023000000006,2,3,2,7,8791.391,2,2,293.52,27.98,66.25,35.21,17.13,0,0,0.0177593,0.00229,24.22,0.06,0,2.2721,0.465,0.159,0.024,0,1.691,0.745,102.9,83.63,86.6462,0.26,0,0.0098,0.070019,0.001,0.898,0.417,0.557,0.161,1.421,0.4595,147.6773,4.069,12.6794,0.3019,1.499261,0.328,0.575245,0.0901,0.67,5.300305,5.706354,0.0363,4.8e-4,0,1.065312,293.14,5.72,0,0.9706,0,0.0297,17.17,5.131,136.3,5.094,68.95,286.6171,8.18,2.05,73,167.92,0,69,152,96.38,1,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,High,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1197,63,64,1,2,70.49,166.99,24.67057,1.8,6,0.08993314,1.07959985,1,2,3,6,4102.298,2,2,163.04,39.94,83.45,43.66,20.1,0.001214,6e-4,1.321e-4,0,27.03,0.1,5.69867,2.3276,0.118,0.123,0.001,0,0.653,0.744,0,73.12,97.2044,0,0,0,0.160387,2e-4,0.303,0.386,0.344,0.371,4.142,0.38071,129.7584,2.7508,8.5381,0.8457,1.59192,0.0066,0.353693,0,0,13.298085,0.480076,0,0.00508,0,0.963866,507.83,4.11,1,1.0891,0.597,0,30.98,4.484,139,6.614,79.05,178.9788,15.49,1.7,100,162.08,0,75,143,64.84,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1198,52,52,0,2,75.95,183.44,22.81434,2,6,0.061160372,0.73385292,0,2,3,6,4346.198,2,2,883.25,39.03,100.06,21.03,41.38,0.002541,0.0017,0.0189171,0.00174,25.04,0.159,4.10195,2.502,0.197,0.237,0.041,0.03,0.58,0.737,104,102.09,76.0164,0.31,1.7e-4,0.009,0.033028,7e-4,0.371,0.438,0.135,0.199,0,0.3599,127.9774,2.0604,8.933,0.5864,1.764542,0.1995,0.501232,0.0031,0.34,4.528914,7.855053,0.0246,0,0,1.096754,200.55,4.2,0,1.0007,0.965,0.0226,31.28,4.444,140.8,8.036,69.01,335.3795,6.68,2.03,55,186.48,0,91,90,81.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1199,66,66,1,4,41.31,145.86,19.19591,1.27,8,0.016822189,0.20171687,1,4,3,8,5438.162,1,1,402.08,44.01,126.21,16.12,25.83,0.001386,0.0033,0.0279999,0,25.09,0.119,0.11622,2.8199,0.087,0.149,0.021,0.051,0.007,0,98.9,83.62,45.9856,0,0,0,0.06925,0,0.008,0.002,0,0.001,0,0.35484,109.173,4.5702,25.3108,5.176,0.733486,0,0.248537,0,0.22,4.007351,3.614782,0.0229,0,0,1.198187,405.42,4.81,0,0.7414,12.178,0.0329,26.42,4.057,135.9,10.228,74.14,249.0345,5.6,1.27,67,145.93,0,88,139,41.48,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1200,56,56,1,1,70.8,168.1,25.03991,1.81,8,0.083214134,0.99813433,2,1,4,8,19593.977,1,2,314.55,42.95,72.92,25.98,23.22,0,2e-4,0.0363585,3e-5,2.31,0,3.49993,2.396,0.143,0.123,0.145,0.118,0.569,0.019,102.2,90.8,75.1112,0.13,2.4e-4,0.0279,0.121541,0,0.298,0.187,0.243,0.001,3.802,0.39875,138.967,1.9731,19.7612,1.1258,1.058471,0,1.189384,0,23.15,13.053439,3.458949,0.4969,0,0,1.161317,252.78,4.2,0,0.953,0,0,0,4.708,141,12.231,79.69,390.9258,15.64,1.87,70,167.18,0,65,130,70.82,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1201,75,75,1,3,69.04,157.78,27.7704,1.7,6,0.111636357,1.34275531,0,3,2,6,3784.098,1,1,448.24,32.94,374.71,57.95,41.04,0.001836,0.0013,0.0191934,0.00404,1.69,0.138,4.63894,2.2015,0.252,0.256,0.155,0.146,0.999,0.765,103.1,71.29,76.0129,0,0,0.0049,0.02078,5e-4,0.75,0.576,0.336,0.254,0.447,0.26604,91.6855,2.4984,10.204,1.0408,0.551396,0.1736,0.068884,0.028,63.69,3.626756,0.662648,0.017,0.00221,0,1.290368,111.33,4.49,0,1.2263,12.049,0.0702,0,3.151,141.1,12.982,66.49,291.1243,4.8,1.63,51,155.81,0,68,110,67.83,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1202,49,49,1,0,66.99,170.11,23.14377,1.77,8,0.154428271,1.85695127,0,0,1,8,2079.6,2,2,634.74,44.99,97.33,33.7,28.93,0.00157,0.0015,0.1033378,0.01788,31.02,0.1,3.20098,2.4747,0.197,0.151,0.091,0.078,0.453,0,98,83.98,79.1126,0.22,0,0.0137,0.006701,0.0222,0.34,0.292,0.009,0,1.468,0.32295,123.6645,13.5862,24.5404,4.2549,1.014447,0.3098,0.476984,0.1716,0.21,4.503555,7.989016,0.7597,0,0.001,1.220145,269.65,4.09,0,1.1015,11.272,0,30.38,3.449,138.1,6.081,79.14,362.6258,6.51,1.72,78,170.02,0,64,121,65.46,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1203,35,35,1,2,71.3,185.12,20.94961,1.96,7,0.051008732,0.61300601,1,2,5,7,12137.573,2,2,344.29,35,137.86,53.01,35.37,0,0.0015,0.0320787,2e-5,26.79,0.061,8.2077,2.3179,0.243,0.177,0.219,0.184,1.411,0.819,104.1,96.78,85.9783,0.23,4e-5,0.0085,0.004412,9e-4,0.863,0.537,0.511,0.328,1.234,0.36099,114.2105,1.5731,9.2762,0,1.075066,0.0088,0.701077,0.0488,0.53,4.82973,0,0,0,0,1.349437,230,4.13,0,0.9261,10.669,0.0458,29.91,3.875,142,5.08,66.97,302.8997,7.12,1.96,74,185.05,0,71,115,74.84,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
1205,70,70,1,1,52.79,155.93,21.6094,1.52,6,0.151114218,1.81261552,0,1,1,6,3479.935,1,1,289.46,45.33,65.49,17.88,17.1,0.003038,0.0012,0.0198853,0.00491,27.9,0.2,5.35032,2.3605,0.292,0.229,0.154,0.141,1.177,0.776,105.9,84.12,61.805,0.36,2.5e-4,0.0121,0.119985,0.0501,0.724,0.456,0.387,0.319,0,0.3886,129.0024,6.4265,16.1396,1.2986,1.691033,0.4174,0.559862,0.1599,0.73,5.593553,5.694159,0.7716,0,0,0,51.68,3.18,1,1.0057,11.712,0.0575,30.94,3.774,141,11.079,79.91,303.9043,6.99,1.59,70,156.66,0.1,57,132,56.05,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1208,56,56,2,3,55.29,160.04,21.54231,1.58,6,0.055073617,0.66162884,2,3,4,6,3638.386,1,1,1051.36,41.89,84.28,12.21,18.02,0,0,0.073728,0.02005,27.54,0.001,6.72414,2.6765,0.215,0.191,0,0,0.009,0,97.5,70.11,87.1162,0.08,0,0,0.357573,0.1384,0.002,0.002,0.005,0.09,0,0.39916,128.9866,3.2207,8.2373,0.7516,0.631782,0.3875,0.697156,0.2539,17.91,4.010186,7.646434,0.8606,0.0016,0,1.000149,326.59,4.36,0,1.1067,14.271,0,22.34,5.231,133.9,13.57,74.08,327.9398,6.28,1.63,80,160.95,0,109,109,55.03,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1209,60,61,1,4,46.1,160.9,18.59532,1.47,7,0.036856434,0.44238925,0,4,5,7,21719.895,1,1,203.3,43.97,50.51,11.07,16.01,0.003828,0.0032,0.0281655,0.00793,27.67,0.008,23.00318,2.4299,0.023,0.105,0.019,0.022,0.05,0.649,105.1,58.83,93.1167,0.59,1e-5,0.0129,0.18998,0.0228,0.169,0.322,0.008,0.149,1.78,0.31565,96.9313,1.5858,7.2424,0.9351,1.35603,0.2087,0.320241,0.0709,0,5.105888,5.086836,0.6309,0.00127,0,1.380864,290.92,5.43,0,1.0925,11.208,0.0104,27.74,3.455,140.7,13.665,62.96,472.7653,8.49,1.41,60,162.09,0,76,109,44.82,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,N,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1210,65,65,0,4,78.92,162.1,29.8078,1.86,7,0.055891425,0.6711084,1,4,5,7,7916.527,1,1,359.4,31.96,127.42,29.57,181.17,0,0,0.0200052,0.0051,26,0.21,9.92652,2.2946,0.061,0.02,0.076,0.084,0.577,0.628,106.6,51.71,115.9488,0.38,0,0.0131,0.073046,0.0062,0.403,0.365,0.051,0.001,0,0.32166,112.2972,0.9996,7.8001,0.7254,0.704668,0.238,0.069817,0.0583,0.72,1.967354,0.341537,0.0342,0,0,1.292814,83.65,4.2,0,1.0632,0.234,0.0555,31.46,3.808,142,7.006,61.09,342.228,3.17,1.93,85,162.7,0,70,159,79.97,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1211,69,69,0,3,88.04,165.09,31.60039,1.98,6,0.028282056,0.33955787,0,3,1,6,1819.413,2,2,1149.33,39.94,60.04,15.04,21.08,1.3e-4,0,0.0150595,3e-5,23.92,0,0.11958,2.3684,0,0.003,0.001,0.013,0.321,0.019,96.2,75.07,79.4148,0.23,1e-5,0.0014,0.009858,5e-4,0.006,0,0.204,0.224,0,0.38027,130.2452,2.1034,3.2166,0.1725,0.996984,0,0.621104,2e-4,0.77,10.791545,4.513296,0.4965,0.0082,0.001,0.809588,353.31,4.09,1,1.0467,11.904,0.002,24.7,4.27,137.8,10.219,67.02,79.5751,16.77,1.91,80,164.17,0,78,120,84.69,1,1,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Normal,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1212,73,73,0,5,76.96,172.04,25.98685,1.91,7,0.144148344,1.72832876,1,5,4,7,3556.045,1,1,357.08,38.97,136.88,34.6,20.09,0.002669,0.0019,0.102203,0.00734,27.45,0.105,3.50588,2.2494,0.433,0.199,0.155,0.063,1.157,0.523,102.2,72.8,73.7873,0.35,3e-5,0.0191,0.200735,0.0316,0.868,0.481,0.252,0,0,0.34665,116.0043,4.5769,15.9171,2.1037,2.709821,0.2702,1.113596,0.1312,23.7,6.406725,7.351282,0.6384,0.00587,0.002,0.99391,277.82,4.7,0,1.1974,12.115,0,30.96,3.963,141.1,12.997,64.36,321.3592,13.54,1.86,66,169.9,0,76,109,71.52,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,Y,Y,N,N,High,High,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,Y
1214,77,77,2,5,64.94,158.05,26.10395,1.66,8,0.043308074,0.52058762,1,5,6,8,20639.067,1,1,897.86,33.99,233.66,43.51,26.31,0.002088,5e-4,0.029254,3e-5,2.72,0,5.35985,2.2488,0,0,0,0,0,0.571,0.4,76.2,60.4363,0.36,9e-5,0.1782,0,0,0,0.411,0,0,2.466,0.37906,117.8618,1.69,0.0354,0,0.651379,0.0062,1.403378,0.0682,0,5.756616,3.604779,0.6714,0.00707,0.001,1.132456,239.63,4.11,0,0.9896,9.475,0,25.29,4.392,139,9.145,66.88,303.2726,7.62,1.71,73,157.8,0,63,124,64.25,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1215,81,81,1,4,70.2,161.96,26.23344,1.75,7,0.139357531,1.67366202,0,4,4,7,17484.769,2,2,882.53,43.96,245.04,37.61,23.95,0,0.0014,2.253e-4,0,27.25,0.104,13.06398,2.4755,0.032,0.169,0,0.012,0.011,0.531,104.4,57.96,78.8603,0,0,0,0.10997,0,0.013,0.336,0,0.001,4.074,0.35131,118.815,1.5074,8.0323,0.4079,0.799404,0,0.700065,0,0.44,10.781064,0.272997,0.019,0,0,1.253836,214.19,4.09,1,0.9985,10.609,0.0949,26.89,4.122,138.1,7.372,82.03,387.9507,12.1,1.71,80,159.87,0,101,161,71.46,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1216,66,66,1,4,87.08,154.59,37.43374,1.85,6,0.080023509,0.96083815,1,4,5,6,12992.064,2,2,348.05,42.54,280.36,10.8,24.69,0.002406,0.0016,2.592e-4,1e-5,25.05,0,5.24672,2.4138,0.15,0.141,0.075,0.049,0.708,0.821,98.9,107.24,56.5032,0,0,0,0.049388,0.0052,0.312,0.393,0.36,0.419,0,0.32116,103.7259,0.0036,0.0068,0.2006,0.729168,0.1526,0.599281,0.0665,0.27,2.403926,2.929617,0.6088,0.00182,0.001,1.031879,100.12,4.03,1,1.0067,12.89,0.0311,31.34,4.542,136,17.067,67.01,231.9839,4.12,1.91,101,156.56,0,106,175,92.15,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,POSITIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,Y,N,High,High,Q2 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1217,47,47,0,3,60.2,157.9,24.26841,1.6,7,NA,NA,0,3,3,7,361.99,1,1,768.89,35.99,47.5,16.91,26.07,0.002824,0.0016,0.0521498,0.00605,20.24,0.154,0.07828,2.2087,0.104,0.088,0.105,0.094,0.758,0.68,101.1,95.35,73.3578,0.14,0,0.0032,0.1999,4e-4,0.436,0.388,0.299,0.241,0,0.41932,143.3485,2.1045,10.672,1.8543,2.462322,0.0998,0.601957,0.0468,0,2.899891,4.840778,0.0235,0,0,1.223689,200.65,3.79,1,0.996,9.837,0,34.02,4.267,140.8,3.972,70.67,364.6353,5.6,1.66,70,160.17,0,77,107,62.19,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,NA,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1218,72,72,0,2,55.96,152.01,24.16159,1.52,6,0.071350647,0.8564341,1,2,2,6,155.144,1,1,209.1,44.05,54.12,9.05,15.91,0.001365,6e-4,2.413e-4,0,30.39,0.1,5.53076,2.2237,0.145,0.008,0.051,0.001,0.89,0.707,102,83.19,57.7571,0,0,0.007,0,0,0.447,0.216,0.369,0.244,0.561,0.36987,126.3188,1.9021,9.1298,0.7272,4.215803,0,1.259214,0,0,9.13503,3.905219,0,0,0,1.056621,491.22,4.44,0,0.9743,12.782,0.0023,35.93,4.143,145.7,7.994,83,184.4375,15.92,1.61,8,153.94,0.1,79,100,61.06,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1219,66,66,1,4,45.13,150.39,19.97312,1.39,8,0.058618375,0.70328496,0,4,4,8,30072.22,2,2,468.33,35.92,72.47,42.55,150.19,0,0.002,0.010234,1e-5,25.93,0.12,5.71933,2.0741,0.098,0.243,0.001,0.069,0,0.018,108.1,78.21,62.6576,0,6e-5,0.0196,0.078217,3e-4,0,0.383,0,0.001,4.1,0.38428,117.8057,0.5361,8.3857,1.1829,0,0.0043,0.36004,0.0475,0,4.209843,0,0.011,0.00114,0,0.995672,154.63,3,1,1.2011,13.644,0.0405,29.8,3.985,141.1,8.553,50.87,273.7072,4.5,1.48,62,150,0,106,120,48.13,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,>4,>1,131HR,158FF,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,NA,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1220,51,51,0,1,68.03,155.2,27.71942,1.68,8,0.132663789,1.59122981,1,1,6,8,791.337,1,1,170.34,44.07,46.72,18.2,11.13,1.51e-4,4e-4,0.0596066,0.00219,27.05,0.07,8.57695,2.2782,0.283,0.169,0.197,0.133,1.18,0.654,101.9,108.45,65.0475,0.17,1.8e-4,0.0063,0.454215,0.0458,0.741,0.37,0.471,0.26,0,0.38932,125.8808,1.4403,11.1896,0.2252,1.940087,0.3574,0.199835,0.089,0.51,1.491986,0,0.5912,0.00598,0,0.243513,227.26,3.7,0,0.882,11.866,0,30.88,4.552,134.6,5.98,71.41,330.7948,2.99,1.77,70,155.19,0,81,125,70.17,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1222,49,49,1,1,69.87,170.15,24.39394,1.82,7,0.047738171,0.57330315,0,1,3,7,4970.399,1,1,185.93,43.08,99.98,8.75,23.85,0.001224,0,0.0997697,0,26.03,0.174,5.04736,2.4074,0.182,0.211,0.059,0.094,0.133,0.679,103,74.11,90.3215,0,0,0.0184,0.134958,4e-4,0.342,0.494,0.001,0.124,3.288,0.33517,108.5296,0,0,0,0.98898,0.0028,0.899755,0.0622,0.39,4.262218,0,0,0,0,1.190255,268.85,4.19,0,0.9161,9.787,0.0074,28.69,3.344,143,2.115,67.01,180.8815,6.42,1.77,61,169.82,0,68,130,68.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1223,76,76,2,5,80.57,165.06,28.86951,1.91,6,0.104058194,1.24907797,2,5,6,6,56530.261,1,1,826.88,27,88.96,16.8,23.82,0.001287,0,0,0,24.85,0.023,7.10611,2.4229,0.056,0.14,0.036,0.039,0.58,0.729,103,78.1,64.7198,0.19,1.7e-4,0.0059,0.001465,0,0.37,0.398,0.099,0.198,0,0.29742,91.3191,4.3508,14.6238,5.3261,0.699351,0,0.3015,0,0.56,5.010558,0,0.0056,0.00183,0,0.969222,146.18,4.1,1,1.08,10.449,0.0365,28.69,3.162,141.1,10.067,67.01,243.2987,6.14,1.93,77,167,0,65,134,84.94,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low-Intermediate,High,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1224,56,56,0,1,50.85,157.95,20.312,1.5,6,0.118471578,1.41994382,2,1,5,6,5121.874,1,1,159.67,37,98.95,24.14,18.85,0.001751,0.0018,1.445e-4,0.00214,23.01,0.119,12.46771,2.6708,0.257,0.142,0.087,0.038,1.213,0.604,101.1,81.96,70.6485,0,6e-5,0,0.500339,0.05,0.65,0.353,0.367,0.156,0,0.36353,119.8316,3.6005,11.0065,0.7908,1.443814,0.1739,0.411415,0.0903,0.53,3.142344,4.882475,0.0395,0.00433,0.001,1.078591,572.94,4.2,1,0.8026,7.854,0.0196,24.91,3.77,140.7,7.479,61.98,307.2175,5.53,1.43,69,158.98,0,77,99,49.2,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1225,57,57,0,1,63.07,163.05,24.03825,1.69,7,0.082326967,0.98809016,0,1,1,7,1026.441,2,2,353.66,43.96,216.05,32.96,45.01,0.837312,0.027,0.0487243,0,24.95,0.091,6.0934,2.1379,0.074,0.167,0.06,0.103,0.017,0.321,92,115.1,46.1629,0,2.4e-4,0,0.100932,7e-4,0.002,0.007,0.007,0.223,0,0.30341,97.4513,0.01,12.1059,0.51,1.192897,0.0039,0.977175,7e-4,0.21,6.097713,0,0,0.00284,0,1.421303,359.58,3.61,0,1.1568,0,0.0564,29.16,3.989,138.2,9.973,79.98,184.7078,7.9,1.62,56,161.09,0,63,103,62.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NA,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1226,85,86,0,5,80.7,161.88,30.8048,1.89,7,0.082893886,0.995079,1,5,4,7,286.52,2,2,439.91,41.92,79.11,9.05,27.38,0,0,0.0786249,0.00114,30.45,0,6.68729,2.3796,0.521,0.458,0.076,0.068,0.888,0.769,106.1,65.3,66.4834,0,2e-5,0,1.138831,0.001,0.513,0.414,0.373,0.34,0,0.35115,111.0939,4.4309,15.1994,0.5013,0.611431,0,0.638852,0.0013,0.8,2.515522,0.606395,0,0.00206,0,1.452838,171.91,4.31,0,1.0225,12.739,0.0704,28.94,3.936,130.8,18.299,66.25,368.4578,4.8,1.84,70,160.71,0,80,120,86.32,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,Yes,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1227,67,67,2,3,104.08,174.97,34.53998,2.17,7,0.060731292,0.72840113,2,3,6,7,11585.471,1,1,879.3,7.85,77.87,6.85,11.42,0,0,0.0198386,0,0.45,0,16.79325,2.456,0.305,0.251,0.233,0.126,1.691,0.847,0,104.9,67.1292,0.11,3e-5,0,0.200594,0,1.043,0.624,0.544,0.304,0.811,0.29305,97.8342,2.0238,8.2442,0.5791,1.601805,0,0.698299,0,0,6.802142,6.546815,0.0251,0,0,0.870805,241.1,3.8,0,1.2002,12.917,0.023,0.45,3.997,131.1,8.01,69.98,305.2549,10.56,2.36,69,178.15,0,100,125,109.9,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1228,68,68,0,4,58.99,169.97,20.5742,1.67,7,0.04639849,0.55652964,1,4,3,7,5952.095,1,1,351.56,26.92,234.75,27.75,39.76,0.004293,0.0109,0.0099498,0.00234,24.99,0.198,6.06804,2.4744,0.127,0,0.154,0.045,1.078,0.651,98.1,68.26,77.0491,0.25,8e-5,0.0141,0.009939,9e-4,0.705,0.36,0.258,0,5.025,0.29411,98.3799,4.3513,12.7168,2.9302,1.58793,0.2012,0.929667,0.0908,12.15,7.434586,8.296531,0.5822,0.00423,0.002,1.065103,191.11,3.9,1,1.1054,12.04,0,29.64,3.297,139,10.974,2.72,613.3727,11.48,1.66,62,170.03,0.1,103,96,59.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VV,Y,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1230,72,72,0,3,70.12,174.86,23.41805,1.86,7,0.09373153,1.12391632,1,3,2,7,2206.255,2,2,342.01,36.08,355.26,26.09,28.91,4.43e-4,4e-4,1.642e-4,0,25.1,0.082,3.57321,2.5008,0,0,0,0,0.056,0.599,105,66.7,79.8019,0.23,4e-5,0,0.139969,0,0,0,0.154,0.28,0.921,0.3116,98.071,4.3444,11.2925,1.3678,1.519886,0,0.215979,0,0,2.09103,0.660912,0.0116,0.0072,0.001,1.101518,211.78,3.9,1,0.9432,0.256,0.0345,30.14,3.839,137.2,11.576,53.58,813.5668,3.95,1.83,63,176.03,0.1,69,97,70.05,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1231,63,63,0,3,80.55,157.95,32.28411,1.82,6,0.067002805,0.80397108,0,3,3,6,3264.201,2,2,220.76,37.01,69.02,33.37,28.45,0,4e-4,0.0500516,6e-5,27.07,0,3.22145,2.1021,0.246,0.155,0.068,0.047,0.778,0.62,97.9,87.47,71.8422,0.83,1.1e-4,0.4013,0.313287,0.0073,0.713,0.577,0.043,0,0,0.43089,143.0156,2.59,10.4965,0.8914,0.819422,0.0019,0.338323,0.001,0,11.814197,4.289553,0.6096,0.00247,0,1.326836,816.38,4.78,0,1.0755,13.563,0,29.52,4.45,136.1,9.086,71.07,279.601,14.24,1.9,79,160.01,0,98,119,85.52,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1232,70,70,0,3,79.04,172.97,26.24342,1.94,6,0.085417516,1.02414968,0,3,3,6,2682.11,1,1,223.81,26.66,48.64,37.01,16.99,0.001973,9e-4,2.251e-4,0,27.89,0.1,12.12569,2.5386,0.088,0.09,0.134,0.091,0.758,0.631,99.7,64.48,81.9604,0.42,8e-5,0.0131,0.099475,0,0.489,0.401,0.213,0.157,2.164,0.3587,128.9122,0,0.0871,0.4292,0.727428,3e-4,0.470364,0.0051,0.18,3.844817,3.524351,0.0151,0.00203,0,0.926964,192.88,4.4,0,0.9413,0.343,0.0365,27.01,4.039,138,4.049,79.65,113.3665,5.2,2.05,68,174.09,0,59,113,83.11,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1233,65,65,0,1,70.5,165,25.44194,1.78,7,0.660297797,7.91887484,1,1,5,7,3910.665,2,2,170.82,34,58.81,18.54,21.05,0.004188,0.0044,0.0822619,0.00211,2.27,0.2,3.02365,2.4934,0.108,0,0.059,0.043,0.786,0.565,100.1,73.84,75.1091,0,0,0.0046,0.139848,9e-4,0.19,0,0.382,0.234,4.584,0.42285,139.029,3.3294,12.9067,1.0711,2.540042,0.1301,0.866417,0.0921,18.08,4.123248,2.070913,0.6669,0.00261,0.001,0.066995,254.45,4.81,0,0.9413,11.692,0,31.37,4.598,140.1,5.196,66.07,273.805,9.15,1.79,79,163.93,0,72,135,73.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1234,52,52,0,2,82.13,169.92,28.30869,1.94,6,0.027387442,0.32931216,1,2,5,6,3870.954,1,1,362.83,41.25,52.46,39.99,21.05,0.001685,1e-4,0.0399678,3e-5,30.98,0.158,3.92275,2.0964,0.088,0,0.073,0.018,1.55,0.855,103.1,128.09,57.6793,0.17,7e-5,0,0.099614,7e-4,1.11,0.54,0.31,0.18,1.281,0.40704,133.9379,4.5304,26.1037,1.6068,2.291836,0.0056,1.242724,0.0607,27.96,5.159296,0.507906,0.0098,0.0063,0,1.417613,250.59,4,0,0.9826,13.161,0,26.98,4.385,142.9,6.959,70.91,261.7584,7.6,1.97,81,168.07,0,60,127,83.22,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1235,58,58,2,2,55.27,159.72,21.38917,1.57,8,0.116946391,1.40452775,2,2,6,8,16078.155,2,2,239.21,38.28,220.08,24.6,19.56,2.45e-4,0,1.25e-5,3e-5,30.93,0.206,8.56758,2.4156,0.096,0.088,0.002,0.018,0.298,0.514,101.6,120.06,47.2176,0,0,0.0017,0.20376,0.0442,0.027,0.195,0.183,0.179,0,0.3807,118.5498,3.0095,12.9396,1.0192,1.438436,0.154,0.360112,0.1253,26.4,3.63233,10.793659,0.7504,0.00556,0.001,1.269538,382.76,4.4,1,1.0949,14.452,0,31.63,4.108,139.9,11.871,69.03,231.0977,6.3,1.57,61,158.9,0,67,120,54.62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,< 55,>= 60,< 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1236,55,55,1,4,67.38,170.08,24.00135,1.77,6,0.021022662,0.25264156,1,4,2,6,14254.43,2,2,1034.93,32.38,255.37,41.95,233.63,0.003227,0.002,2.982e-4,0,29.07,0.001,0,2.3833,0.367,0.344,0.001,0.002,0.502,0.356,96.8,82.46,76.9748,0.12,0,0,0.135651,1e-4,0.464,0.454,0.063,0.068,0,0.30981,114.7228,0,5.3416,0.6157,1.12686,0,0.485716,0,0,6.41855,5.749398,0.0258,0,0,1.1932,345.38,3.62,1,1.0109,13.166,0.0493,36.58,4.092,138.5,4.155,66.1,305.7606,8.82,1.72,80,171.12,0.1,93,125,68.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,NA,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1237,65,65,1,4,60.97,162.94,22.97418,1.65,7,0.052540203,0.6306459,0,4,5,7,15677.452,1,1,285.1,46.04,158.44,19.86,38.32,0.001167,0.0011,0.0090575,0.00959,29.92,0.119,4.27818,2.2253,0.125,0.138,0,0,0.082,0.681,100.1,81.26,73.4894,0.37,8e-5,0.0089,0.099449,0.0498,0.009,0.268,0.076,0.215,0.401,0.37969,123.0922,3.9143,12.105,1.202,1.093628,0.3184,0.66023,0.165,0.09,4.697591,7.07928,0.8633,7.3e-4,0.001,1.459138,145.59,3.91,1,1.1457,13.907,0,22.96,4.508,137.9,14.684,66.81,320.9323,7.16,1.66,75,162.61,0,128,127,57.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1238,69,69,0,3,55.6,162.89,21.4035,1.6,6,0.085763658,1.02916735,1,3,5,6,4244.237,1,1,142.07,42.92,37.54,12.06,13.77,0,0,0.0399893,9e-5,24.94,0.166,5.57419,2.3238,0.429,0.362,0.297,0.198,1.988,0.89,106.9,49.03,90.0622,0.01,3e-5,0.0058,0.299773,0.0162,1.025,0.627,0.909,0.491,1.676,0.41876,139.0782,1.0984,10.0121,0.0056,2.211714,0.1315,0.232377,0.0046,0,1.501164,0,0.0342,0.00183,0,0,176.66,3.3,0,0.8395,0,0.0579,28.85,4.74,137.1,8.527,76.06,268.5924,2.78,1.65,90,160.95,0,68,157,55.21,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1239,59,59,1,2,63.9,155.05,26.50685,1.64,6,0.128560635,1.54219025,1,2,3,6,2322.893,2,2,517.59,41.13,74.23,21.82,25.98,0.003508,0.0016,0.1011657,0.00407,2.94,0.066,0,2.3519,0.86,0.555,0.19,0.129,1.614,0.787,101.1,81.68,76.6175,0.03,0,0.0093,0.249486,0.0087,0.773,0.496,0.72,0.427,0,0.39077,126.6585,3.8978,14.1975,1.0146,2.00055,0.2043,0.799333,0.0722,26.08,5.595015,5.011919,0.0409,0.00123,0,1.006248,307.64,4.22,0,0.9089,11.25,0,0.72,4.244,135.1,6.944,73.94,243.8781,9.96,1.85,64,155.91,0.1,90,104,71.48,0,0,0,0,0,0,0,1,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1240,30,29,2,1,79.92,170.02,27.1061,1.92,8,0.142628553,1.71041965,0,1,1,8,7940.29,1,1,298.38,43.65,96.42,52.01,23.45,0.003758,0.0033,0,0,17.57,0.001,6.20723,2.4406,0.001,0.095,0.001,0.014,0.015,0.419,107.1,112.95,83.0314,0,0,0,0,0,0,0,0.017,0.26,0.518,0.41061,137.9129,0.2556,0.0221,0,0.699509,0,0.850808,0.0326,16.54,8.199947,7.873894,0.7207,0.00355,0,1.415316,261.96,5.19,0,1.0938,15.359,0,29.07,5.037,140,5.158,71.94,214.0166,7.1,1.8,90,172,0.1,88,138,73.02,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1241,49,48,1,3,73.01,169.89,24.6095,1.85,8,0.212759274,2.55554103,2,3,1,8,3829.629,2,1,638.31,38.29,94.06,11.07,16.05,4.13e-4,0,0.0297973,0.0138,26.11,0.136,4.32854,2.1228,0,0,0,0,0.044,0.627,102,116.16,59.0263,0,1e-5,0,0.170939,0.0792,0,0.006,0.036,0.21,2.984,0.34514,107.9482,0.0072,0,0.2692,1.249819,0.3816,0.800757,0.136,0.7,3.778008,5.705029,0.7405,0.00983,0.001,1.16837,275.72,4.7,0,0.9809,11.601,0,29.03,4.043,139,4.999,0.16,269.8877,6.52,1.89,91,173.79,0,70,112,80.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1242,71,71,1,1,75.97,175.5,24.33588,1.92,6,0.051548636,0.6183711,0,1,6,6,19314.786,2,2,185.26,36.98,80.15,27.93,51.31,0,0,0.1097859,8e-5,33.79,0.061,6.28335,2.4918,0.093,0.115,0.023,0.05,0.219,0.011,98.9,52.27,104.1887,0,0,0,0.20148,5e-4,0.299,0.358,0.005,0.002,0,0.46642,164.6519,0.0057,0.0873,0.4879,0.515062,0,0.54997,0,29.32,4.099082,0.082692,0,0,0,1.2203870000000001,226.35,4.61,0,1.169,11.537,0.0512,29.53,4.877,140.1,7.349,75.08,403.231,5.99,2.05,61,176.47,0,74,116,79.24,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1243,49,50,0,4,54.9,159.03,21.45307,1.55,8,0.060295723,0.72379584,2,4,6,8,3078.988,2,2,429.77,37.97,88.27,51.64,59.17,0,0,0.0200253,0.00401,21.06,0.103,3.79613,2.2496,0.221,0.222,0.142,0.143,0.754,0.756,106,73.87,81.3743,0.45,5e-5,0.017,0.035216,9e-4,0.33,0.243,0.489,0.549,1.121,0.33281,108.5567,1.1176,9.4453,1.7085,0.397086,0.0083,0.600711,0.0042,0.19,4.88075,7.24747,0.7014,0,0,0,195.42,3.51,0,1.0227,0.127,0,25.14,4.102,141,5.127,1.78,156.1683,6.39,1.5,86,155.87,0,96,171,47.71,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),<18.5,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1244,59,59,1,3,74.53,176.28,23.52899,1.95,6,0.02512596,0.30162118,1,3,3,6,2632.871,1,1,302.86,27.74,91.14,46.64,42.17,0.002007,0.0045,1.585e-4,4e-5,0.13,0.156,1.79138,0,0.217,0.169,0.376,0.201,1.197,0.823,95.9,116.66,61.8637,0.06,0,0.0106,0.067996,4e-4,0.61,0.433,0.47,0.373,0.185,0.34141,113.6162,1.3868,9.28,1.2866,1.10048,0.0094,0.771657,0.0656,13.52,5.401395,0,0,0.00721,0,0,0,3.9,0,1.1345,12.654,0,30.87,3.97,139.1,10.298,56.91,147.5569,7.91,1.81,80,173.88,0,75,110,70.14,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1245,40,41,2,3,87.62,175.07,28.65811,2.02,7,0.062470842,0.7494855,1,3,4,7,32639.944,1,1,917.82,45.01,79.94,64.27,31.46,0,4e-4,0.008213,0.00134,28.24,0.001,5.35662,2.3495,0.225,0.168,0.663,0.322,1.413,0.748,104.1,124.48,69.9163,0.05,2.6e-4,0.1492,0.032476,0.0181,1.298,0.65,0.303,0.002,0,0.4079,139.0823,0.0118,9.4664,1.0698,1.402693,0.2106,1.721596,0.1602,0.14,5.8005,5.171615,0.457,0,0,1.329528,247.52,4.79,0,0.8807,9.105,0.022,26.88,4.276,144.9,8.616,75.07,400.1477,8.34,2.03,79,173.42,0,81,162,90.63,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1246,75,75,0,2,59.98,163.08,22.32479,1.64,6,0.089595478,1.0754666,0,2,4,6,193.772,2,2,154.29,30.05,0,10.52,12.05,0.001533,3e-4,0.0200327,3e-5,28.1,0.059,3.26378,2.2819,0.246,0.253,0.037,0.047,0.526,0.648,109,67.58,65.7019,0.26,1.7e-4,0.0223,0.458515,0.0084,0.38,0.339,0.098,0.148,3.078,0.41385,143.4517,2.95,13.9056,2.4447,1.235375,0,0.749757,0.0016,33.04,4.501804,0.672647,0,0,0,1.034425,415.05,4.11,0,0.8395,0.667,0.0519,0.9,4.788,146.1,6.915,65.09,321.0251,7.01,1.61,57,164.96,0.1,86,107,58.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1247,69,68,1,2,44.96,170.93,15.80845,1.48,7,0.059806627,0.71801908,2,2,1,7,2245.031,2,2,176.36,36.56,531.19,25.11,19.96,5.85e-4,0.0015,3.35e-5,4e-5,27.92,0.135,3.03512,2.2738,0.071,0.125,0.012,0.035,0.02,0.433,97.2,77.83,53.9921,0.31,0,0,0.089526,0.0129,0.176,0.37,0,0,0,0.34301,117.9763,3.3969,15.0429,0.3307,0.590148,0.1503,0.178254,0.0043,0.21,3.009526,5.346504,0.6529,0,0,1.120325,301.41,4.5,0,1.0288,11.036,0.017,29.08,3.958,142.1,3.998,76.07,148.8534,3.9,1.5,69,170.17,0,66,114,43.75,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,POL,Poland,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1248,48,48,1,2,76.06,178.67,24.00324,1.93,6,0.018344723,0.22003918,1,2,3,6,8172.425,2,2,209.44,30.22,51.18,24.45,32.13,0.001385,0.0019,2.801e-4,0.00401,22.96,0.126,0,2.3004,0.235,0.151,0.16,0.091,1.316,0.736,103,147.55,53.0506,0.01,7e-5,0,0.260032,0.0291,0.906,0.553,0.355,0.164,0.772,0.41252,142.5229,4.3204,10.872,1.0017,1.386722,0.2327,0.525557,0.0924,15.96,3.745994,3.051362,0,0.00418,0,0.955195,183.28,3.32,0,1.3049,11.489,0.003,33.83,5.144,139,9.025,59.32,148.8606,6.27,1.8,100,179.94,0,112,110,78.88,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1249,68,68,1,3,80.03,164.9,29.4055,1.89,7,0.117321189,1.40699358,2,3,6,7,7193.451,2,2,147.19,33.96,76.12,28.09,23.4,3.78e-4,0,0,0,32.54,0.08,9.2148,2.5126,0,0.002,0,0.001,0.485,0.848,101,99.81,63.0757,0.21,9e-5,0.016,0.136719,3e-4,0.33,0.511,0.085,0.278,2.091,0.33219,113.3945,2.1244,7.7936,0.9228,0.69931,0.0039,0.372505,0.0029,0.01,3.378954,0.326523,0.0043,4.5e-4,0,1.356744,211.83,4.5,0,1.0544,11.402,0,28.9,4.224,140,9.976,58.02,398.9351,4.8,1.96,85,163.05,0,73,139,78.19,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1252,58,58,0,3,65.04,153.25,27.62518,1.64,6,0.145302088,1.74339431,1,3,6,6,1457.13,1,1,248.86,38.08,88.06,12.93,13.44,0,0,0.132959,0.00501,28.5,0.098,7.89369,2.3932,0.178,0.045,0.166,0.071,2.473,0.91,99.1,116.71,52.0703,0.27,0,0.0106,0.320053,0.0261,1.399,0.628,1.019,0.389,2.248,0.41905,147.0959,6.2522,13.6535,1.0234,2.793043,0.0107,0.783674,0,0,5.696448,0.008159,0,0,0,1.099588,320.39,2.84,0,0.8775,0.161,0.0482,0.68,4.289,142,10.281,73,279.3942,11.18,1.69,77,152.58,0,76,116,67.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1253,62,62,1,3,49.86,156.06,20.48037,1.49,6,0.063963298,0.76741476,2,3,6,6,12688.7,1,1,213.05,31.46,113.36,15.07,22.03,0.001164,6e-4,0.029963,0.00798,22.92,0.121,6.41319,2.2755,0.181,0.162,0.186,0.127,1.206,0.656,100,76.86,65.0413,0.22,0,0.0196,0.452575,0.0423,0.616,0.358,0.546,0.303,0,0.35028,116.7105,1.5933,10.1464,1.0056,2.474778,0.2489,1.473922,0.1365,0.08,5.758947,1.652443,0.0077,0.00738,0.001,0.179505,300.68,3.89,1,1.0672,12.28,0.0756,29.61,3.843,143.9,5.164,69.02,333.0861,11.61,1.43,80,155.27,0,78,109,49.91,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,High,High,Q2 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1254,60,61,0,2,66.05,175.87,21.48454,1.81,6,0.070242324,0.84197256,1,2,3,6,1026.045,1,1,315.91,24.88,62.91,13.98,22.88,1.85e-4,0,0.0200305,0.00111,24.37,0.096,3.46623,2.3291,0.097,0.103,0.011,0.01,0.806,0.804,101,101.15,63.1081,0.1,6e-5,0,0.529624,0.0119,0.391,0.438,0.343,0.426,1.767,0.35497,125.4487,3.6506,10.1921,0.5303,2.393984,0.0058,0.450897,0,0,4.084513,0.615787,0,0,0,0.002936,216.78,3.2,0,0.9414,10.343,0.0541,42.09,3.888,139,3.495,59.3,358.4587,7.11,1.9,76,178.68,0,74,129,68.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1255,66,66,0,1,68.08,168.08,24.16045,1.77,6,0.09426103,1.13252795,1,1,1,6,245.555,1,1,498.77,42.3,77.56,102.21,81.08,8.87e-4,0.0017,0.029816,7e-5,28.02,0.094,5.57272,2.6431,0,0,0.067,0.074,0.476,0.718,99.4,80.8,69.9515,0,0,0,0.265188,0,0.45,0.537,0.004,0.018,0.013,0.33818,119.2032,1.9004,0,0,1.393609,0.0107,0.358688,0.001,0.47,2.409927,0,0,0.00442,0,0.980847,103.23,3.71,1,1.0737,0,0.0144,27.96,3.774,136.2,10.871,74.95,235.6148,4.91,1.81,68,167.92,0,66,119,67.95,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1256,69,69,0,2,58.7,162.05,22.83608,1.62,7,0.069219142,0.82876412,1,2,1,7,300.83,2,2,162.7,42.71,52.25,6.59,0,0.00189,0.0027,0.0289668,6e-5,3.14,0.195,5.35553,2.42,0.314,0.089,0.577,0.236,1.512,0.482,102.9,63.71,70.3756,0,1.6e-4,0.0212,0.002387,8e-4,1.177,0.503,0.474,0.043,0,0.3592,117.7417,0.9285,14.5278,9.4622,1.853373,0.1482,0.063426,0.0534,0.64,2.897882,0,0.008,0.00302,0.001,1.282291,236.98,4.11,0,0.864,9.007,0.0311,0,3.495,145,6.809,62.86,153.8607,4.58,1.64,88,165.03,0,68,145,64.42,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1257,47,47,0,2,64.91,156.16,26.18661,1.65,7,0.064955575,0.78021737,0,2,5,7,2022.751,1,1,612.89,43.21,163.26,24.92,19.93,4.54e-4,0,3.171e-4,8e-5,2.26,0.127,12.82345,2.4876,0.167,0.226,0.022,0.042,0.521,0.567,105,103.53,63.1342,0.37,9e-5,0.0247,0.022142,0.0053,0.34,0.374,0.145,0.144,0,0.3548,112.2914,3.2952,14.6353,0.6599,0.99909,0.0206,0.296582,0.0696,0.23,2.052971,0,0.6711,0.00479,0,1.000255,148.32,5.56,0,0.9146,9.603,0.0032,0.6,4.266,137.1,17.956,70.97,391.6299,3.7,1.71,71,157.33,0,80,96,65.13,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1258,46,46,0,4,57.07,156.14,23.58932,1.57,6,0.021063125,0.25298101,1,4,2,6,475.36,1,1,600.6,36.03,93.25,16.81,27.93,8.03e-4,3e-4,0.0515051,0.01001,1.67,0.346,5.35841,2.2064,0.156,0.029,0.067,0.022,1.368,0.798,102,86.14,73.1258,0.12,0,0.0107,0.099538,0.0171,0.642,0.378,0.584,0.328,0,0.40197,135.0975,2.1243,6.8428,0.9213,1.319898,0.2395,0.119607,0.0053,0.21,6.124019,4.329358,0.7005,0.005,0.001,1.368267,289.37,4.49,1,1.0601,11.995,0,25.98,4.288,137,15.313,63,255.9758,8.08,1.49,87,155.8,0,98,115,53.95,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HR,158FF,N,Y,Y,N,High,High,Q1 ITT,High,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1259,38,38,1,1,58.99,182.41,18.14882,1.76,7,0.084369505,1.01269274,0,1,1,7,5480.208,2,2,184.39,42.03,314.31,17.81,17.97,0.001469,2e-4,0.0810977,0.00333,26.33,0.1,3.73504,2.3252,0.109,0.166,0.052,0.04,0.776,0.536,101,80.21,79.6838,0.01,0,0,0.34434,0.0208,0.284,0.005,0.423,0.312,0,0.40911,135.0005,1.1262,11.8105,0.5027,1.310843,0.1912,0.599822,0.0502,27.95,5.173887,3.010656,0.0414,0,0.001,0.245508,567.56,4.77,0,0.9487,10.595,0,0.95,5.015,138,8.035,75.82,285.551,8.42,1.71,79,179.8,0,92,146,56.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131RR,158FF,Y,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,Y,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1260,52,53,2,4,51.49,179.03,16.21678,1.64,6,0.022511082,0.27012089,1,4,6,6,14260.088,2,2,375.63,38.99,76,49.88,40.18,0.001489,0.0012,0,0,1.19,0,5.70709,2.3968,0.003,0.005,0.054,0.045,0.742,0.833,98,96.66,61.833,0.33,1.5e-4,0.0161,0.010344,0,0.372,0.424,0.341,0.332,4.701,0.35734,103.6142,2.5152,9.8592,2.9853,1.100559,0,0.350836,0,0.11,7.000936,3.900344,0,0,0,0.970657,232.43,4.11,1,0.9469,0.969,0.0069,21.99,3.705,142.1,5.126,63.99,403.3828,8.9,1.66,54,178.1,0.1,71,108,52.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,NA,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1262,71,71,1,3,99.03,170.08,32.32127,2.07,8,0.834116128,10.01680584,0,3,2,8,11551.302,1,1,413.05,36.98,88.21,8.34,13.72,5.06e-4,6e-4,0,0,27.6,0.071,9.62259,2.4793,0.361,0.27,0.137,0.077,1.178,0.655,101.9,72.5,85.8054,0.03,0,0,0.060512,0,0.546,0.237,0.495,0.34,2.847,0.41288,138.6145,0.338,8.3067,0,1.099406,0,0.698915,0.0015,0,9.056798,6.586404,0.5796,0.00483,0,1.062835,346.09,4.31,0,1.0249,0,0.021,28.99,4.795,139,10.21,62.92,303.1373,9,2.05,94,167.51,0,66,137,98.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1263,63,63,1,1,87.15,168.43,30.850460000000002,1.98,6,0.125107528,1.50040642,0,1,5,6,10649.892,2,2,146.4,38.94,61.33,25.98,18.4,0,0,0.0622245,0.0061,25.59,0.187,24.29495,2.3235,0.068,0.03,0.028,0.034,0.034,0.516,109.1,96.37,65.0283,0.1,0,0.0039,0.19996,0.0278,0.022,0.003,0.062,0.182,0,0.42982,138.9961,0.0157,0.0903,0.5746,0.943827,0.1541,0.215681,0.0391,0.1,5.385025,3.772579,0.5786,0,0,1.340034,469.49,5.61,0,1.1991,11.118,0.024,26.55,4.759,137,3.05,64.09,315.1023,6.7,1.89,80,163.09,0,94,121,75.06,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1264,74,74,1,3,63.09,157.93,25.43753,1.65,7,0.072672751,0.87140892,1,3,6,7,4182.932,2,2,296.09,37.04,96.78,53.29,26.52,0.001537,7e-4,0.030029,3e-5,25.24,0.279,20.66995,2.2491,0,0,0.001,0,0,0.517,98,45.01,93.3023,0,1e-4,0,0.300211,0.0199,0.021,0.376,0,0,0.25,0.37556,126.0172,0.0056,0,0.5173,1.039923,0.0062,0.098055,0.0038,0.56,2.083119,0.601619,0.0019,0.00354,0.001,1.092973,241,3.8,0,0.9715,0,0.0902,0.62,4.309,138.9,12.055,52.81,350.6232,3.29,1.6,59,156.06,0,77,106,64.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1265,68,68,0,3,87.73,186.61,25.03185,2.11,6,0.106242051,1.27479105,1,3,4,6,2765.967,1,1,339.62,44,46.18,40.86,30.11,9.46e-4,0.0016,0.0376071,0,0,0.1,3.91846,2.2066,0.04,0.001,0.03,0.033,0.817,0.827,99.3,98.24,70.9195,0.07,2e-5,0,0.069706,0,0.381,0.387,0.391,0.321,0.294,0.37423,122.3821,0.0033,10.5948,0.6435,1.232045,0.0065,0.470052,0.0017,0,4.003791,0.558302,0.0044,0.00366,0,1.008487,386.22,5.22,0,1.016,12.968,0,43.51,3.782,139,4.461,65,167.5617,6.15,2.06,62,188.57,0,64,117,88.12,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,GBR,United Kingdom,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1266,67,67,0,1,82.49,162.93,31.20308,1.9,6,0.080847943,0.97028714,0,1,5,6,2341.223,2,2,174.68,44.08,67.73,14.03,18.08,0.00182,8e-4,0.0296521,1e-4,27.2,0.07,5.41097,2.1959,0.358,0.375,0.134,0.154,0.254,0,98.7,103.81,62.9016,0.11,0,0.0029,0.399693,0.005,0.264,0.394,0.005,0,1.934,0.33664,116.0075,2.7685,11.216,0.7996,0.865348,0.0579,0.509549,0.0769,32.96,3.574955,3.844321,0.5393,0,0,1.259618,333.52,3.69,0,0.9508,0,0.0421,19.21,3.998,135.2,4.171,76.59,462.9522,5.4,1.96,68,164.95,0,73,125,93.75,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1267,64,63,1,1,45.2,161.85,17.64268,1.46,7,0.061051677,0.73144227,0,1,2,7,4900.01,1,1,148.92,35.99,0,8.89,21.03,0,0,0.0198425,0.00401,1.93,0.179,5.79846,2.3498,0.067,0.13,0.031,0.04,0.705,0.652,99.1,78.16,58.3046,0,0,0,0.371203,0.0179,0.252,0.006,0.343,0.372,0.464,0.32065,123.8492,0,7.0867000000000004,1.5915,1.501334,0.1653,0.342676,0.0056,0,2.199638,0,0,0.00364,0,1.066822,85.46,3.99,0,0.9509,0,0,33.12,4.024,136,6.615,54.73,162.6907,3.45,1.55,74,163.99,0,90,119,49.93,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1268,64,63,0,2,82.83,177.15,26.90183,2.01,8,0.08613677,1.03448926,1,2,4,8,3477.83,2,2,328.11,42.02,68.77,27.63,18.12,9.66e-4,0.0018,0.0199683,6e-5,2.99,0.129,8.00769,2.1255,0.07,0.237,0.007,0.052,0,0,103,73.06,92.7103,0,0,0,0.201137,5e-4,0.002,0.306,0,0,3.681,0.34334,122.4709,0,11.397,0.1246,0.859409,0.0045,0.372261,0.0524,25.98,3.190763,3.849972,0.0083,0.00121,0,1.189339,252.52,4.28,0,1.2055,12.237,0.0581,30.01,3.887,142,6.859,74.57,161.3764,4.15,2.28,64,178,0,60,118,82.89,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NA,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1269,79,79,0,3,94.99,164.94,35.45128,2.01,6,0.035841883,0.42976327,0,3,2,6,1043.106,2,2,743.96,37.94,96.62,9.83,19.91,0.034356,0.0277,0.0073945,0,25.98,0.176,7.9784,2.3046,0.56,0.305,0.048,0.001,0.862,0.545,107.1,82.61,72.3998,0,1.3e-4,0.0078,0.199944,8e-4,0.511,0.316,0.308,0.134,0.197,0.4012,129.2859,2.2182,10.7801,1.1188,1.683193,0.0063,0.45166,6e-4,24.99,3.012603,0,0,0,0,1.181534,203.48,4.44,0,1.0056,12.386,0.045,29.02,4.415,143,14.679,69.99,98.3606,6.6,1.96,77,163.89,0,94,140,95.78,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT REPORTED,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1270,58,58,1,0,70.83,175.04,23.36386,1.86,7,0.08613869,1.03340747,0,0,4,7,2542.187,2,2,170.59,37.04,82.94,76.28,20.83,0,0,0.0999886,0.00215,25.92,0.168,8.82753,2.2055,0.462,0.287,0.214,0.183,1.004,0.661,0.4,84.81,79.0654,0,0,0.0039,0.068584,7e-4,0.693,0.459,0.407,0.297,5.028,0.30403,101.4545,5.4296,15.8921,0.8276,1.790721,0.1506,1.300314,0.0864,0.69,13.243957,0.543536,0.0175,0,0,0.165659,255.68,3.83,0,0.9551,0,0.0021,31,3.51,137,6.809,71.97,84.3091,15.89,1.89,60,176.91,0.1,87,112,76.98,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1271,65,65,0,3,112.6,190.31,30.89162,2.38,6,0.079717618,0.95617201,0,3,2,6,10488.295,2,2,292.96,43.93,76.82,11.92,12.98,0,0,0.0081624,0,0,0.173,13.63619,2.5937,0.145,0.005,0.316,0.116,2.333,0.872,99,78.91,108.0014,0.06,0,0,0.907859,0,1.454,0.547,0.949,0.362,3.882,0.48133,158.0415,2.3816,9.031,0.3691,2.510714,0,0.470442,0,0.81,3.821637,0,0,0.00259,0,0,191.06,4.95,0,0.9402,0.537,0.0496,25.81,5.232,139.5,13.89,72.96,315.1263,6.55,2.35,85,190.34,0,67,140,114.87,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1272,43,43,0,2,57.07,158.04,22.94282,1.58,7,0.081175616,0.9730586,1,2,1,7,1127.581,2,2,142.14,38.98,103.05,29.29,23.35,8e-4,6e-4,0.0298994,0.00104,28.08,0.277,0,2.4048,0,0,0,0,0.187,0.678,107.5,109.05,57.0556,0,8e-5,0,0.700242,0.0279,0.071,0.348,0.007,0.001,0,0.43038,140.4736,1.9136,10.1759,1.1547,1.602516,0.2088,0.328279,0.0053,18.08,2.561453,0.212473,0,0,0,1.063263,150.2,4.4,1,0.9675,8.44,0.0074,22.6,4.809,142,7.003,65.07,166.8484,4.86,1.5,74,156.07,0,105,117,50.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,OTHER,Other,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1273,73,73,0,3,91.86,175.34,29.82993,2.06,6,0.055486791,0.66587961,1,3,1,6,1910.221,2,2,718.53,40.96,95.41,24.01,64.83,6.4e-5,0.0015,0.0507934,0.00174,25.01,0.14,3.93902,2.3176,0.332,0.237,0.15,0.073,1.418,0.68,101.1,98.83,60.009,0,0,0,0.03997,0.0018,0.816,0.376,0.547,0.361,0,0.40823,138.1818,1.1004,10.5765,0.223,1.764402,0.1858,1.454548,0.1076,16.93,8.571022,3.141914,0.0102,0,0,0.269404,162.48,4.5,0,1.0902,0.102,0.031,27.23,4.89,137,8.556,78.94,171.2122,9.84,2.09,56,177.81,0,63,118,100.69,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1274,44,45,0,1,63.03,169.95,21.96706,1.73,6,0.043215381,0.51869439,1,1,3,6,598.26,1,1,200.64,15.62,86.13,7.25,17.97,0.001243,0.0021,0.0399731,0.002,25.89,0.178,11.50944,2.2226,0.376,0.305,0.052,0.056,0.621,0,104.5,120.22,58.6795,0.23,0,0.0019,0.483148,0.0218,0.276,0.004,0.289,0.227,0,0.38909,126.9907,1.6226,5.9438,0.5876,0.873537,0.0127,0.556903,0.0482,0.33,4.889151,0.117384,0.0319,4e-5,0,1.199596,256.84,3.79,0,1.0273,15.079,0.0384,27.55,4.187,141,9.342,64.93,1085.0211,6.55,1.66,70,169.88,0,101,116,62.16,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1275,71,71,0,4,91.75,177.85,29.41024,2.1,6,0.660846891,7.9344466,1,4,4,6,1373.734,2,2,529.09,39.35,110.54,12,36.93,0,0,0.1052667,8e-5,24.06,0.06,3.39946,2.2942,0.287,0.296,0.004,0.001,0.499,0.667,101,51.73,140.3666,0,0,0,0.11715,0,0.322,0.442,0.107,0.157,2.322,0.47277,157.2558,2.3626,9.4975,0.8955,0.705076,0,0.888584,8e-4,20.16,5.697067,4.81457,0.0184,0.00112,0,0.900901,244.98,4.78,0,1.0499,0,0,27.62,4.69,140.9,8.57,71.09,311.2211,6.32,2.06,96,176.12,0,87,166,86.37,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1276,69,68,1,4,70.25,174.73,23.8765,1.86,6,0.011919019,0.14265107,2,4,5,6,3841.049,1,1,338.87,30.05,84.77,19.15,33.31,1.05e-4,9e-4,0.0414109,0.00195,0.14,0.099,12.84062,2.2552,0.303,0.338,0.097,0.095,1.158,0.856,102,87.87,70.7515,0,7e-5,0.0063,0.029831,7e-4,0.651,0.524,0.52,0.46,0.343,0.28922,91.6379,2.6934,9.2841,1.1663,0.629922,0.0077,0.96122,0.0045,0.68,6.044275,0.564341,0,0,0,0.71525,341.62,4.39,1,1.099,13.184,0.0697,30.71,3.397,137,8.639,66.07,374.7806,7.9,1.81,69,178.12,0,93,119,72.04,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1277,30,30,0,1,44.98,165.13,16.42258,1.47,6,0.047195647,0.56725981,0,1,2,6,3042.626,2,2,247.57,42.46,75.1,76.09,31.17,0,0,0.0099259,0,24.21,0.1,4.68382,2.3088,0.21,0.081,0.138,0.092,1.3,0.696,103.9,117.82,50.1533,0,0,0,0,0,0.667,0.378,0.563,0.258,4.528,0.43293,135.7872,2.738,13.8509,1.1032,3.56708,0.0094,0.487029,0,25.86,5.015303,0.2499,0,0,0,1.000877,298.49,3.4,0,1.1903,11.813,0.025,27.91,5.059,138,26.334,74.19,243.9553,8.23,1.52,56,165,0,98,95,45.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1278,61,61,1,2,71.26,170,25.36776,1.85,8,0.131598393,1.5795575,2,2,3,8,9265.597,2,2,193.76,17.82,101.66,15.22,26.9,0.002289,0.0023,0.0092556,0,27.08,0.07,5.29692,2.2294,0.157,0.207,0.213,0.181,0.902,0.754,101.9,71.26,91.0655,0.15,1.2e-4,0.2248,0.059970999999999997,1e-4,0.435,0.3,0.545,0.457,1.757,0.30675,105.743,1.0603,8.8405,0.2997,0.897069,0.0023,0.38956,0,17.01,3.020771,2.532528,0.0268,0,0,1.217825,209.29,4.03,0,1.0202,9.982,0,27.19,4.003,136.1,9.376,59.45,245.4351,5.4,1.84,77,166.91,0,69,115,67.15,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1279,19,19,0,3,68.07,167.79,24.50798,1.77,6,0.009963948,0.11957025,0,3,5,6,2123.952,2,2,932.74,34.83,87.74,26.22,29.51,0,0,0.050351,0.00605,20.41,0.141,0,0.9215,0.309,0.272,0.496,0.58,1.224,0.844,102.1,155.98,58.4083,0.07,1e-5,7e-4,0,0,0.675,0.495,0.62,0.488,3.505,0.42338,157.0314,3.3676,9.8003,0.3273,0.879482,0,0.430208,0,0.58,5.356445,0,0,0.00303,0,1.442297,233.52,4.49,0,1.0276,13.708,0,30.12,4.902,140,11.967,70.92,279.0331,5.53,1.82,80,168.92,0,101,110,70.93,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1280,55,55,1,2,53.92,164.24,19.57781,1.57,7,0.115153391,1.38258932,1,2,4,7,5863.058,1,1,272.96,39.9,240.6,14.08,21.63,0.004176,0.0046,0.0129459,2e-5,26.03,0.186,3.59891,2.458,0.279,0.301,0,0.001,0.49,0.005,106.8,86.35,63.865,0.04,0,0.0014,0.061279,6e-4,0.262,0.182,0.128,0.001,4.989,0.36055,109.4461,3.9518,22.9767,1.5294,1.203636,0.0044,0.300276,0.0327,0.49,4.85699,0,0.0044,0,0,1.192793,374.06,4.65,0,0,10.702,0,0.97,4.133,142.5,20.885,82.87,321.7068,6.73,1.63,95,162.01,0,83,141,50.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
1281,73,73,0,3,84.15,167.38,30.09823,1.92,6,0.05890152,0.70750054,1,3,6,6,9348.379,1,1,178.15,33.05,73.97,56.65,32.08,0,0,0.0073991,6e-5,28.09,0.16,3.13003,2.0704,0.065,0,0.065,0.053,0.884,0.84,96,94.93,60.0443,0,1.9e-4,0,0,3e-4,0.61,0.569,0.275,0.288,0,0.29717,96.9365,0.2091,8.9399,0.54990000000000006,0.878327,0,0.599431,0,0.56,5.018791,3.505929,0,0,0,1.481495,250.84,4.61,0,1.2998,11.739,0.0203,28.26,3.207,134.2,4.072,63.05,362.8617,5.98,2.05,46,170,0,68,111,86.46,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1282,64,64,0,2,79.94,159.77,31.58043,1.82,6,0.039063184,0.46871569,0,2,6,6,1671.412,1,1,369.8,27.23,81.38,36.6,23.89,7.7e-4,4e-4,0.0160768,4e-5,2.35,0,5.62091,1.8615,0.228,0.042,0.02,0,0.618,0,102.4,120.16,60.1105,0.22,0,0.0083,0.249301,8e-4,0.441,0.213,0.149,0,3.777,0.32904,105.6021,2.087,9.9091,0.8366,1.797665,0.006,1.022319,0.0017,0.52,12.081269,0,0,0.00142,0,1.480015,327.28,3.42,0,1.0421,13.506,0.0171,25.93,4.252,134.1,5.726,59.3,226.0006,14.58,1.84,50,160.13,0.1,71,121,81,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1283,29,29,0,2,53.95,170.11,18.50736,1.62,8,0.033027211,0.39734442,2,2,6,8,8136.436,2,2,381.06,0,205.65,28.96,56.9,0.001734,0.0019,0.0099965,2e-5,27.95,0,5.68666,1.936,0.004,0.004,0.066,0.109,0.67,0.739,97.8,111.12,67.8459,0,1e-5,0.004,0.061338,5e-4,0.226,0.325,0.243,0.295,1.628,0.00271,64.2419,2.1533,17.6014,2.3677,0.498133,0.009,0.853528,0.0555,0,7.808351,3.772164,0.5742,3.1e-4,0,1.388679,411.05,3.9,0,1.2399,10.206,0.0332,36.02,3.308,139.1,3.408,59.37,190.2565,11.89,1.65,70,170.09,0.1,83,110,53.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,Y,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1285,82,82,0,2,58.08,167.7,20.98964,1.65,7,0.149334562,1.79193096,1,2,3,7,565.775,2,2,160.87,37.07,77.87,21.03,23.28,0.001567,0.0017,0.0680707,9e-5,29.77,0.126,6.38466,2.2781,0.273,0.155,0.13,0.087,0.91,0.569,105,64.19,61.9533,0.23,0,0.0093,0.170264,7e-4,0.643,0.382,0.29,0.183,0,0.38868,121.3422,3.4672,12.9393,0.2702,2.254421,0.0106,0.477562,0.0024,0,2.899961,0,0.0029,0,0,1.241685,211.06,3.89,1,0.9598,11.525,0.0603,33.4,4.187,138.1,32.466,73.94,273.5939,5.01,1.7,72,165.06,0,79,121,60.18,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1286,56,56,1,3,82.1,170.41,28.07804,1.94,6,0.01738989,0.20838951,1,3,1,6,2379.542,2,2,513.43,38.91,350.59,33.94,16.9,0.002628,0.002,0.0400509,0.00494,23.13,0.198,3.52639,2.2606,0.086,0.208,0.003,0.023,0,0,102.3,108.91,77.9627,0.16,3e-5,0.0149,0.069711,4e-4,0,0,0.006,0.001,0,0.45203,152.9155,3.0345,14.6202,0.6439,0.729187,0.1282,0.399323,0.0487,0.08,9.085666,5.850152,0.7697,7e-4,0.001,1.151024,177.01,3.83,1,1.1295,11.538,0,27.94,4.605,143.1,5.251,70.73,290.9833,9.81,1.82,81,170.07,0,85,132,82.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1287,61,61,1,3,65.09,159.73,25.90335,1.68,7,0.102499832,1.22996821,2,3,6,7,15398.467,2,2,377.31,30.97,243.58,19.15,35.92,0,0,0.0310307,7e-5,28.08,0.211,15.88162,1.8796,0.305,0.076,0.368,0.153,1.887,0.769,106.2,104.85,56.8082,0.13,1.7e-4,0.0156,0.182289,7e-4,1.017,0.47,0.629,0.223,0.127,0.33217,115.0392,1.3734,11.6639,1.1628,3.122506,0.0754,0.69811,0.0749,13.56,3.842232,2.115937,0.0209,0.00569,0.001,1.442905,161.93,3.71,0,1.0311,11.537,0.048,0.02,4.258,137.1,8.92,66.05,309.9826,8.27,1.59,52,157.88,0,69,108,64,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,Y,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1288,60,61,0,1,68.81,164.98,24.76776,1.75,8,0.07187625,0.86187958,0,1,1,8,1712.706,2,2,699.21,46.28,83.07,11.97,9.91,0.002318,0.0011,0.009998,0,25.6,0.058,0.01271,2.5512,0.003,0.006,0.009,0,0.398,0.591,102,122.32,50.437,0,0,5e-4,0.119719,0.001,0.02,0,0.204,0.291,0,0.35128,117.064,3.0066,11.8704,0.4226,1.469035,0.0113,0.410378,0.0295,0,4.291508,5.004136,0.0397,0,0,1.010704,220.71,4.51,0,1.0072,13.089,0,46.06,4.091,142,10.297,71.95,398.3972,6.38,1.79,93,164.92,0.1,74,170,68.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,Y,Y,WHITE,Other,N,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1289,77,76,0,3,77.04,167.95,27.59391,1.87,6,0.062963629,0.75489391,0,3,5,6,3956.37,2,2,115.52,41.94,44.17,29.5,13.86,9.46e-4,0,0.0199606,3e-5,24.06,0.002,7.10346,2.2723,0.316,0.17,0.373,0.277,1.223,0.015,100,72.26,69.3461,0.09,0,0,0.118719,5e-4,0.976,0.422,0.341,0.118,0,0.47749,158.2079,2.8636,14.1919,1.021,2.326557,0.0086,0.721197,0.0039,0.29,5.640906,0.650893,0.0159,0,0,0.96992,430.52,4.2,0,0.9925,11.636,0.0543,28.27,6.009,137,11.023,83.13,333.0637,8.69,1.81,76,168.92,0,91,116,74.07,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1290,77,77,1,3,63.09,159.84,24.65912,1.65,6,0.049838291,0.59834539,2,3,3,6,3953.227,1,1,494.93,38.08,61.88,23.96,65.19,0,0,3.091e-4,0,26.09,0.096,4.10602,2.3282,0,0,0.001,0,0.289,0.481,104,43.72,105.1157,0,8e-5,0.0088,0.199897,1e-4,0,0,0.153,0.22,2.482,0.41959,140.7172,1.2944,9.207,0,1.085983,0,0.50994,0,0.59,7.501401,0.647385,0,0,0,0.87330700000000006,187.1,3.61,1,0.9808,11.722,0.0047,30.29,4.332,144,19.032,57.61,316.3349,10.02,1.65,60,157.72,0,82,109,62.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,< 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1291,70,70,0,3,64.02,157.97,24.6864,1.64,8,0.205525261,2.46615758,1,3,2,8,1719.262,2,2,248.63,44.58,97.71,21,27.83,5.15e-4,6e-4,0.04199,0,28.02,0.2,3.92946,2.5295,0.456,0.411,0.071,0.056,0.839,0.604,98.9,63.93,88.2601,0,8e-5,0.0054,0.190597,0,0.461,0.326,0.311,0.281,0,0.37019,117.737,0.0113,3.656,1.3293,1.472977,0,0.655008,0,0.75,5.919607,0.281426,0.0204,0.00921,0.001,1.526927,352.31,3.97,0,1.0046,14.734,0,29.61,4.392,140.8,32.301,70.94,440.8256,8.91,1.66,57,159.77,0.1,65,103,66.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1292,67,67,0,5,53.83,153.31,22.5592,1.5,7,0.031186995,0.37351721,0,5,3,7,3984.003,2,2,477.16,26.82,90.46,15.1,17.9,6.7e-4,5e-4,0.0104038,0,29.94,0.181,7.87113,2.0943,0.225,0.209,0.061,0.057,1.062,0.813,98,65.94,70.8921,0.16,2.1e-4,0.0144,0.096535,0,0.535,0.446,0.434,0.359,3.36,0.32014,94.003,0,0,0.4166,1.200512,0,0.198103,0,0.3,4.197692,0,0,0,0,1.092018,397.91,4.81,0,0.9989,11.391,0.0461,26.74,4.191,137,10.281,64.95,261.7702,6.78,1.55,51,152.07,0,63,110,54.6,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1293,58,58,0,4,70.09,164.18,25.50382,1.77,7,0.037018064,0.44388355,1,4,6,7,16553.374,2,2,1148.57,27.03,62.96,28.48,21.82,0.004259,0.0029,0.0200317,0.00909,0,0,6.4044,2.1036,0,0,0,0,0.513,0.739,98,77.62,84.2971,0.36,0,0,0.041187,0.001,0.143,0.009,0.255,0.294,3.661,0.30927,98.7109,1.9034,9.285,0.6512,1.030858,0.2544,0.499092,0.0738,0.01,6.201727,4.969599,0.6402,0.00592,0.001,1.135919,269.49,4.08,1,1.0204,0.838,0.0466,23.01,3.94,139.1,14.662,61.11,178.9647,8.39,1.75,76,164.94,0,83,114,66.87,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,High,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1294,79,79,1,1,95.18,191.02,25.50926,2.29,7,0.053836285,0.64569018,0,1,1,7,5049.689,2,2,289.04,38,48.75,20.43,19.89,2.2e-4,0.0019,0.0300135,2e-5,1.77,0,5.17948,2.4257,0.302,0.379,0.068,0.07,0.528,0.001,98,60.3,88.947,0,0,0,0.622767,0.0133,0.45,0.455,0.047,0,0,0.34614,122.4883,0.0171,9.614,0.0107,1.471686,0,2.628646,0.0018,27.1,4.005729,0,0,4.7e-4,0,0.969468,457.11,4.62,1,0.937,0,0.0057,28.93,4.08,134.7,6.005,69.96,440.67380000000003,8.51,2.3,83,189.58,0,80,129,90.75,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1295,45,45,0,1,82.25,176.09,26.09775,2.01,6,0.036531933,0.43870873,0,1,2,6,476.915,2,2,489.35,39.2,88.85,14.98,13.83,0,1e-4,1.475e-4,0.0023,3.87,0,8.20516,2.277,0,0,0.001,0.042,0,0,104,43.68,195.2184,0.29,0,0.0247,0.029043,3e-4,0,0.249,0,0,1.586,0.37481,125.5938,1.6892,6.495,0.0112,0.918973,0.2301,0.319733,0.0042,0,4.320908,0,0.0184,8.4e-4,0.001,0.182498,267.67,4.2,0,0.6426,0,0.0445,32.17,4.804,141.9,8.568,51.06,299.8327,6.09,1.97,85,177.87,0,74,129,85.72,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,JPN,Japan,< 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1296,65,65,1,3,54.48,157.32,21.76651,1.54,7,0.121778205,1.45994096,1,3,3,7,11516.542,1,1,575.76,37.94,109.56,21.04,20.88,0.001095,0.001,0.1043453,0.00407,1.14,0,6.69469,2.2253,0.147,0.243,0,0.001,0.035,0.022,0.4,63.31,85.8214,0,9e-5,0.0094,0.176043,0.0212,0.096,0.36,0,0.001,0.799,0.25286,72.4015,0.906,7.2925,0.0015,0.987385,0.0139,0.54639,0.0764,0,6.401878,0.042396,0.7012,2.8e-4,0,1.197372,337.04,5.3,1,1.0096,13.159,0.0105,28.53,3.187,136.1,9.985,69.05,312.2439,8.09,1.43,69,157.96,0,70,107,52.2,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1297,19,19,0,2,66.9,168.08,23.93684,1.75,8,0.103914637,1.24571394,1,2,2,8,3049.837,1,1,515.03,26.02,242.14,162.84,82.14,0.879378,0.0868,1.788e-4,1e-5,32.36,0.109,6.79356,1.9982,0.05,0.107,0.075,0.087,0.518,0.574,106.1,156.74,61.8459,0,1e-4,0.0057,0.209076,8e-4,0.245,0.321,0.206,0.186,0,0.3377,122.6696,2.4761,12.0593,1.617,1.19895,0.2108,0.624817,0.0944,0.84,3.600061,3.471943,0.0163,0.0037200000000000002,0,1.269693,223.04,3.89,1,1.0345,14.599,0,33.08,4.238,143,5.027,64.91,411.4541,5.45,1.83,88,166.91,0,72,136,68.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1298,60,60,3,4,78.05,175.21,25.18963,1.95,6,0.043689389,0.524672,1,4,5,6,18232.492,1,1,2379.84,32.04,92.13,11.91,21.24,0.002624,0.0015,0,0,22.9,0,5.71158,2.3243,0.255,0.17,0.042,0.018,0.945,0.643,92.8,73.08,97.5256,0,6e-5,0,0.099615,9e-4,0.29,0.002,0.579,0.334,0,0.42057,140.2997,0,0,0.011,2.093312,0.0071,0.500942,0,0.29,4.120061,5.222668,0.03,0,0,0.889702,252.25,4.31,0,1.0099,12.929,0,31.48,4.109,133.5,12.193,64.96,172.3468,7.15,1.92,56,175.07,0,95,115,77.97,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1299,80,80,0,3,62.48,149.07,28.02552,1.56,6,0.112424951,1.34952296,0,3,3,6,2808.476,1,1,213.6,24.49,62.57,6.7,10.06,6.3e-4,2e-4,0,0,25.09,0.001,3.89426,2.3036,0.153,0.179,0.026,0.026,0.082,0.638,99.4,49.77,79.5921,0.17,0,0.014,0.090088,6e-4,0.268,0.409,0,0.008,0,0.36387,114.2827,3.4226,12.7286,0.5597,0.538015,0.0125,0.281323,0.0012,0.45,6.204733,3.129964,0.0258,0.00133,0,0.944611,459.15,3.8,1,0.998,0.768,0.0089,30.26,4.033,140,0.391,55.91,130.8657,6.34,1.51,61,149.98,0.1,63,55,59.15,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,Yes,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1300,56,56,0,3,63.1,156.14,25.92124,1.65,7,0.130610416,1.56710137,0,3,4,7,4665.817,1,1,234.47,45.09,120.82,12.93,23.86,2.1e-5,0.0012,8.55e-4,5e-5,26.28,0.118,7.78656,2.6725,0.007,0.195,0,0.013,0,0.579,106,70.44,90.9924,0.21,5e-5,0.0144,0.004005,4e-4,0,0.001,0.008,0.27,0,0.40081,130.0551,1.0891,11.007,1.1349,0.650378,0.0075,0.149055,0.003,0,2.698133,0,0,0.0013,0.001,1.490859,149.19,4,0,1.1514,13.158,0,32.91,4.532,136.9,37.606,71.89,420.4959,4.4,1.7,52,153.93,0,87,100,60.91,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131RR,NA,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1301,65,65,0,2,69.88,152.09,29.05397,1.65,6,0.040507517,0.48611699,0,2,1,6,246.047,1,1,134.24,38.38,78.66,7.82,0,0,0,0.0698533,3e-5,29.1,0.088,4.99932,2.3942,0.59,0.112,0.672,0.176,3.913,0.856,103.9,79.88,65.8082,0.3,2.3e-4,0.0225,0.049964,0,2.374,0.513,2.553,0.429,0,0.41484,120.4193,1.8043,0.1357,0.5846,2.850551,0,0.413829,0,0.74,5.261453,2.724478,0.0173,8e-4,0,1.223807,452.87,4.29,0,0.9582,0.727,0.0411,26.58,5.144,143.1,7.001,52.46,398.7138,7.3,1.61,81,152.03,0,92,131,62.53,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,OTH,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1302,69,69,0,4,76.22,163.08,27.90859,1.82,6,0.099270577,1.19076591,0,4,6,6,2511.22,2,2,878.71,12.22,58.84,21.53,33.75,0,0,0.0115207,0.00408,21.98,0.002,3.89634,2.1811,0.334,0.225,0.051,0.037,1.221,0.817,98.6,145.06,35.6533,0.14,6e-5,0.0108,0.499892,0.026,0.668,0.469,0.502,0.306,4.451,0.25561,79.0189,2.6955,9.8089,1.0694,0.999685,0.1054,0.621316,0.0648,0,2.019589,0.334561,0,0,0,1.099131,196.54,3.61,0,1.1958,11.251,0.0267,38.96,3.231,137,6.083,70.04,439.1434,4,1.84,68,165.03,0.1,88,129,79.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,High,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1303,38,38,0,3,78.95,176.05,25.03331,1.98,7,0.101416101,1.21564323,0,3,5,7,4989.942,2,2,237.83,37.02,66.39,15.08,0,0,5e-4,0,2e-5,26.99,0.036,0.08256,2.3107,0,0.002,0.034,0.024,0.64,0.788,103,98.76,87.8124,0.11,3e-4,0.024,0.179759,0.0169,0.426,0.383,0.163,0.124,0,0.39592,129.4366,1.8945,14.333,0.2237,0.80039,0.0078,0.220011,0.0308,0,3.399591,5.494443,0.7601,0.00276,0,0.800269,144.94,4.2,0,1.104,12.976,0.0046,29.57,4.705,136.1,12.105,67.09,338.5622,5.28,1.96,80,177.83,0,104,116,81.96,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1304,58,58,0,2,45.2,144.04,22.82329,1.34,7,0.075866839,0.9115368,1,2,3,7,1836.891,2,2,248.31,41.92,55.15,8.84,12.92,0,0,0.0104937,4e-5,29.04,0.063,0.08213,2.3973,0.224,0.184,0.077,0.066,1.07,0.828,101,121.56,44.2531,0,0,0,0.201315,0.0183,0.601,0.468,0.564,0.438,0,0.36019,118.6119,2.7593,14.5183,1.0793,0.699469,0.001,0.230126,0.0012,0,3.241607,1.23e-4,0.0155,0,0,2.01329,239.42,4.2,0,0.9941,14.263,0,46.01,4.363,137.9,9.99,67.03,152.9018,4.49,1.33,70,133.92,0,82,113,44.84,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1305,59,59,0,1,57.86,159.97,22.53542,1.6,8,0.055673967,0.6679199,0,1,5,8,1636.118,1,1,317.82,37.08,54.73,18.55,21.06,0.004282,0.0021,0.0633511,0.02109,25.93,0.121,2.53982,2.3632,0.317,0.294,0.137,0.091,0.754,0.575,99,73.85,72.5535,0.03,1.7e-4,0.016,0.00811,0.0505,0.331,0.262,0.274,0.227,3.271,0.39606,132.6443,2.7693,11.1558,1.9838,1.398009,0.3149,0.259123,0.0953,0.36,4.946347,6.209923,0.8217,0.0025,0,1.173722,346.94,3.8,0,0.9056,0.844,0.0033,29.87,4.568,143.2,13.748,58.92,422.2367,6.31,1.57,81,161.06,0,85,121,58.12,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1306,50,50,0,4,55.13,155,23.14703,1.53,6,0.070744614,0.8501741,1,4,5,6,11818.336,2,2,1520.44,37.94,62.72,3.03,18.87,0,0,0.0145669,0.00299,23.15,0.049,5.70973,2.463,0.199,0.219,0.047,0.051,0.842,0.746,102,94.59,75.0719,0,0,0,0.300508,0.0241,0.496,0.375,0.282,0.304,0,0.3617,117.5113,1.2002,14.2749,0.915,0.555537,0.0752,0.421118,0.0334,26.02,5.766985,0,0.0133,0.00723,0,1.259955,232.21,4.3,1,0.9895,11.961,0.0319,30.21,4.92,139,8.382,68.34,391.8611,6.59,1.5,81,155.94,0,90,126,53.54,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1307,75,75,0,2,47.78,153.05,20.71454,1.43,6,0.026300036,0.31583647,0,2,2,6,4121.292,1,1,124.03,35.95,40.56,43.67,40.93,1.18e-4,3e-4,0.0278492,9e-5,23.91,0,4.01191,2.0223,0.273,0.156,0.181,0.096,1.608,0.854,92.3,82.55,56.4404,0.25,0,0.0024,0.039281,0,0.749,0.466,0.79,0.405,2.599,0.44337,153.1417,3.3999,13.6977,0.7602,3.060568,0.0103,0.602989,0.0022,0,7.545282,0.134711,0,0.00591,0,0.048756,226.71,4,1,1.6243,11.81,0,36.05,4.673,137,10.283,70.04,183.1419,11.89,1.42,59,154.99,0,69,97,45.81,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1308,41,41,1,4,62.11,175.91,20.20372,1.77,6,0.042875105,0.51532935,1,4,2,6,7215.096,2,1,1148.76,41.03,276.11,31.59,48.7,0,0.0014,0.0502247,0,22.27,0.126,22.32494,2.5315,0.081,0.119,0.087,0.163,0.393,0.749,100.9,83.43,90.8422,0,0,0,0.200101,0,0.245,0.505,0.111,0.25,0,0.38707,120.6892,1.2056,6.6163,0.6048,1.200196,0,0.33662,0,0.34,5.480561,0,0.0183,0.00247,0.001,1.098064,275.23,3.84,1,1.0664,13.944,0.0466,30.1,4.492,135,11.73,69.92,371.3366,7.53,1.75,58,176.67,0,84,100,62.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,1,131HH,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1309,52,52,0,4,79.28,162.86,29.60606,1.86,6,0.095200964,1.14247955,1,4,1,6,756.295,1,1,532.1,45.05,78.63,80.28,71.11,0.002195,0.0032,0.0128673,1e-4,25.09,0.1,5.7932,2.2523,0.208,0.234,0.078,0.052,0.576,0.471,107.9,109.83,73.649,0.13,0,0.0064,0.037881,8e-4,0.178,0.003,0.249,0.191,0.521,0.46793,152.3238,3.2212,13.7682,0.2002,1.399018,0.1938,0.34133,0.0661,0.16,1.582768,0.14312,0.0418,0.00134,0,0.871576,100.95,3.99,0,1.3715,13.231,0.0125,30.83,5.019,143.9,11.05,80.03,389.7832,3.11,1.9,72,166.93,0,81,100,87.79,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1310,59,59,1,2,58.09,144.31,29.66847,1.48,6,0.035628288,0.4280624,1,2,4,6,9753.899,2,2,566.39,42.92,14.56,7.22,17.02,0.001784,0.0017,1.7e-6,3e-5,0,0.065,4.63285,2.3935,0.023,0.215,0.038,0.11,0.039,0.751,102.9,73.8,75.1315,0,0,0,0.099978,0.0097,0.001,0.345,0.117,0.314,2.448,0.32335,97.4378,0.0103,5.3654,0.6695,0.535928,0.2121,0.321176,0.089,0.16,2.576258,0.345868,0,0.00496,0,1.298805,289.81,4.31,1,1.0903,13.62,0,29.42,4.087,140.8,4.29,69.05,528.1928,4.28,1.57,69,144.68,0,90,111,58.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,< 65,>= 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1311,64,64,1,4,84.02,169.25,28.68909,1.95,7,0.057164279,0.68603252,2,4,5,7,6716.41,2,2,727,29.88,97.07,14.04,23.02,0.001715,2e-4,0.0621662,0.00225,28.2,0.129,5.62503,2.354,0.156,0.309,0.046,0.081,0.05,0.458,102.1,83.2,82.2084,0,0,0.0015,0.270069,0.0201,0.03,0.391,0.096,0.232,4.222,0.35155,113.4665,0.0021,7.0006,0,0.00909,0.0087,0.619322,0.0892,31.01,3.586516,4.97885,0.4976,0.00282,0,1.658792,134.58,3.12,0,1.2711,12.169,0.0334,26.18,4.401,136,7.998,44.91,368.8936,4.8,2.11,68,171.51,0,75,109,92.91,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1312,71,71,1,1,45.82,152.04,20.26639,1.41,7,0.036753472,0.4415358,0,1,1,7,1743.722,2,2,282.57,34.04,164.08,33.07,42.11,0.003257,0.0105,0.044922,0,23.29,0,6.62969,2.3012,0.174,0.017,0.143,0.066,0.854,0.447,103.1,69.03,63.5908,0.03,0,0,0.056323,0,0.609,0.339,0.188,0.001,0.83,0.35551,127.9306,1.0624,5.9202,0.7184,1.059157,0.0165,0.300207,0.0016,22.14,7.153763,8.482384,0.7001,0.00824,0.001,1.336859,209.77,4.69,1,1.0938,13.114,0,27.41,4.146,140,5.129,55.63,159.4949,7.81,1.48,85,152.07,0,83,121,47.74,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1313,68,67,1,2,106.14,172.99,36.90365,2.2,6,0.139385049,1.6740954,0,2,1,6,15023.564,2,2,291.19,44.09,54.61,19.88,35.96,0.002896,0.004,0.0399123,0.00368,0,0,7.60054,2.4748,0.11,0.185,0.031,0.065,0.019,0.015,106.1,73.91,88.1322,0,1.2e-4,0,0.005334,5e-4,0.107,0.383,0,0.001,0,0.46956,162.5915,4.3538,19.3058,1.7869,0.919654,0.1152,0.799993,0.0961,0.72,6.098769,0.470736,0.0363,0.00721,0.001,0.653972,225.16,5.06,1,1.0259,10.563,0.0129,34.08,5.237,136,6.007,89.58,230.103,8,2.28,96,173.83,0,63,157,110.73,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1315,66,67,1,3,74.95,167.2,26.91325,1.85,6,0.023872942,0.2861846,1,3,6,6,16566.144,1,1,1534.89,30.98,92.99,16.01,30.77,0,0,3.102e-4,0,0,0,5.42682,2.4237,0.101,0.219,0.004,0.062,0.013,0.569,0,61.49,94.8357,0.05,0,0.0053,2.08e-4,0,0.158,0.425,0,0.193,0,0.33672,113.036,0.005,0.0116,0.7928,0.869042,0,1.321223,0.0018,0,4.631348,0.074454,0,0.00171,0.001,0.963163,197.74,3.13,0,1.1138,0.817,0.0082,24.79,4.082,135.8,11.983,58.82,269.175,6.88,1.91,94,168.92,0,91,148,79.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1316,66,65,0,3,73.29,161.82,27.34951,1.78,6,0.10024332,1.20325424,0,3,5,6,217.844,1,1,344.89,41.36,175.67,15.88,18.06,0.002127,0.0032,0.0224261,5e-5,33.98,0.135,4.68787,2.2924,0.172,0.107,0.146,0.116,0.689,0.021,109.2,72.26,74.1298,0.06,1.6e-4,0.006,0.111318,0.0106,0.241,0,0.308,0.297,3.512,0.32715,104.5896,2.6562,11.1728,0.6715,1.43728,0.0122,0.699915,0.0597,19.21,4.292679,3.126868,0.5839,0,0.001,1.511411,218.12,4.7,0,0.9033,12.005,0.0227,27.79,3.7,145,5.517,63.01,446.0516,7.04,1.77,81,162.44,0,68,145,73.97,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1319,65,65,2,5,69.04,165.08,24.45894,1.76,6,0.048999564,0.5885105,1,5,6,6,39504.881,1,1,525.08,35.91,54.83,20.6,26.01,0.002897,0.0022,2.326e-4,8e-5,25.01,0.1,4.39036,2.2404,0.091,0.215,0.137,0.136,0.858,0.878,97.1,112.74,53.0479,0.05,1e-5,0.0089,0.100792,0.003,0.357,0.384,0.471,0.526,4.809,0.37405,114.0062,1.9381,12.1987,0.5202,0.919068,0.0787,0.580771,0.0748,0,3.552052,0,0.0075,0,0.001,1.061331,274.73,3.72,0,1.0946,10.787,0,37.95,4.36,135.9,8.582,51.77,231.1558,5,1.78,74,167.94,0,89,119,68.06,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1320,59,59,2,3,106.99,170.32,39.62679,2.16,6,0.055182201,0.6616592,1,3,4,6,39505.572,1,1,296.44,29.03,224.32,48.5,41.06,0,0,1.78e-5,0,24.65,0.058,3.91013,2.2749,0.247,0.253,0.233,0.165,0.757,0.586,99,82.46,88.2008,0,0,0.008,0,0,0.522,0.442,0.178,0.15,1.758,0.22343,68.9676,2.0039,0.1216,1.5668,0.630552,0,0.994235,0,0.25,12.902329,0.019921,0,0,0,1.230074,229.01,3.6,0,1.2007,9.323,0,27.32,2.544,135.9,10.255,54.04,439.8072,16.05,2.09,64,172.03,0.1,88,119,104.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,NA,Y,F,Yes,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1321,73,73,1,3,44.96,165.01,16.72589,1.46,6,0.035260922,0.42219783,1,3,4,6,3611.822,2,2,281.65,1.46,109.44,22.04,35.14,0,0,0.0999143,0,28.18,0.069,7.70894,2.0927,0.108,0.162,0.044,0.065,0.642,0.709,110,56.52,72.5649,0,0,0.0145,0.119926,0,0.338,0.412,0.135,0.184,3.359,0.35863,107.2383,0,0,0.6944,1.001821,0,0.903073,0,0,12.756907,2.335715,0,0.00511,0,1.230234,252.54,4.31,0,0.9914,10.607,0.0262,22.52,3.585,138.9,10.263,0,298.0777,14.28,1.44,33,166,0.1,74,0,43.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1322,82,82,1,4,105.01,177.88,33.53146,2.2,7,0.08762695,1.05075566,2,4,6,7,13594.048,1,1,1166,30.5,47.36,24.34,34.12,0,0,0.0411042,4e-5,25.16,0.001,0.01607,2.4206,0.112,0.064,0.055,0.045,0.789,0.739,98.9,31.48,187.0347,0.06,0,0.0063,0.289941,0,0.525,0.42,0.3,0.244,0,0.32013,109.8336,0.4434,9.2986,0.4203,0.880659,0,1.061143,0,19.93,2.499137,0,0,0.00703,0,0.099307,129.14,4.76,0,1.2538,9.264,0,31.77,3.987,136.9,9.552,61.91,362.6645,4.58,2.34,80,178.15,0,71,146,104.23,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1323,69,69,1,3,54.98,154.13,23.06973,1.51,6,0.046916348,0.56381808,1,3,5,6,6334.221,2,2,495.1,0,66.75,11.02,20.02,0.002802,0.0048,0,6e-5,0,0.079,12.32063,2.0956,0.224,0.338,0.133,0.16,0.536,0.556,101,83.09,45.9966,0.21,9e-5,0.0129,0,2e-4,0.243,0.041,0.218,0.287,1.826,0.27872,91.4666,0.258,7.119,0.0106,0.400122,0.1492,0.498922,0.0708,0.62,5.200101,0,0.0251,0.00593,0.001,1.200053,212.18,3.8,0,0.9544,0.752,0.0392,27.38,3.703,141.5,6.041,57.1,160.3137,6.31,1.45,65,152.06,0,98,120,51.65,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,>1,131HH,158VF,Y,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1325,59,59,0,2,71.98,159.93,28.02161,1.76,7,0.120068342,1.44056478,0,2,1,7,8261.167,2,2,225.36,40.01,70.86,25.84,18.83,8.08e-4,0.0018,3.215e-4,3e-5,25.91,0.001,5.58557,2.3485,0.073,0.061,0.103,0.067,0.811,0.71,108.1,96.77,70.9491,0.11,0,0.0023,0.179991,3e-4,0.431,0.366,0.247,0.201,0,0.38767,134.563,0.9474,7.8609,0.8778,2.312654,0,0.929744,0,0,5.900619,4.234299,0,0.0037200000000000002,0,0.939796,138.45,3.93,1,1.0068,12.669,0,30.97,4.063,139,5.164,69.07,230.6956,8.78,1.76,80,160,0,102,129,69.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1326,69,69,0,2,51.75,156.01,21.50162,1.49,6,0.031452728,0.3766491,0,2,4,6,2096.617,1,1,134.13,43.05,80.96,7.83,9.87,2.98e-4,0.0013,0,4e-5,19.81,0.07,3.88279,2.3407,0.067,0.185,0,0.024,0,0.61,110.2,91.69,49.7956,0.01,2e-5,0.0018,0.099608,0.0065,0.009,0.406,0,0.161,0,0.32811,102.8805,2.77,13.0087,0.7511,0.539899,0.0083,0.360028,0.0052,0.04,3.996661,2.534982,0.5701,1.8e-4,0,0.408077,177.78,3.81,0,1.1087,12.089,0.0277,31.91,3.807,139.1,6.67,64.4,3.1027,4.56,1.57,66,156.18,0,81,99,50.63,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,UNKNOWN,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1327,46,46,0,5,54.98,175.29,18.16928,1.66,7,0.109094154,1.31168298,2,5,3,7,4316.399,1,1,1525.3,41.01,48.63,30.7,26.71,0,0,0.0601129,0,14.56,0.062,5.38431,2.3,0.491,0.459,0.578,0.329,0.907,0.629,99,107.24,60.9497,0.23,1.3e-4,0.0234,3.04e-4,0,0.647,0.42,0.28,0.216,0,0.39258,129.8396,2.1912,9.0309,0.7807,1.348039,0,0.45229,0,0.31,4.424804,0.252178,0,0,0,1.2918,398.32,3.89,0,1.0006,10.031,0,33.55,4.9,142,6.083,65.69,263.0159,6.06,1.61,59,173.73,0,87,121,50.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1328,59,59,0,3,64.04,165.06,23.14641,1.71,6,0.045698811,0.54864836,1,3,2,6,2506.84,1,1,673.68,38.62,94.41,28.48,24.13,0.003343,0.0036,0.0997475,0.00602,28.04,0.236,4.27942,2.2299,0.17,0.179,0.373,0.5,0.642,0.662,100.6,72.22,94.5074,0.33,0,0.0114,0.019852,0.0204,0.353,0.325,0.236,0.268,0,0.42354,147.4658,0,9.0664,1.6046,1.301768,0.2743,0.325314,0.0892,0.32,5.06742,3.98772,0.7078,0,0.001,1.224788,216.96,3.9,0,1.08,0.535,0.0238,24.7,4.981,141.1,13.658,71.04,365.8055,6.75,1.91,77,166.27,0,90,123,67.86,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,NA,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,NA,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1329,50,50,1,2,46.02,157.12,18.6481,1.45,7,0.137205346,1.64559344,1,2,2,7,1368.509,1,1,126.29,45.98,239.35,29.71,21.92,0.001395,1e-4,2.27e-4,0,28.01,0.112,0,2.3485,0.149,0.152,0.047,0.053,0.565,0.739,99.1,133.15,44.2858,0.07,1.2e-4,0.0161,0.00696,9e-4,0.018,0.005,0.432,0.513,3.739,0.36494,112.814,4.2322,17.4894,0.2851,1.11309,0.1515,0.713382,0.1003,0,3.21308,6.187012,0.6172,0,0,1.218346,343.38,4.3,0,0.9736,12.643,0,36.77,4.358,140.8,13.235,69.28,249.8444,5.6,1.53,91,157.64,0,80,140,47.71,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1330,34,33,0,1,51.24,154.37,21.63032,1.48,8,0.111726571,1.33766345,1,1,4,8,2582.719,1,1,866.72,40.09,56.01,16.03,33.43,3.64e-4,2e-4,0.0104634,9e-5,26.95,0.121,3.21067,2.3244,0.02,0.041,0.15,0.148,0.848,0.817,104.9,147.4,46.9492,0.03,0,0,0.129518,3e-4,0.461,0.478,0.35,0.343,3.742,0.35124,131.689,2.4089,15.0561,1.5534,0.772084,0.0067,0.480045,0.0492,0,4.203464,6.419947,0.5707,0,0.001,1.363181,254.49,4.3,0,0.8467,10.267,0,27.06,4.234,142.9,4.029,59.31,183.5503,5.92,1.41,77,154.09,0,82,102,50.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1332,58,58,0,2,83.16,177.42,26.19491,2.01,7,0.077765509,0.93407829,0,2,6,7,5041.504,2,2,372.91,46.05,51.25,7.68,13.04,0,0,0.1538247,0.00702,22.82,0.15,6.20381,2.5473,0.476,0.224,0.029,0.001,1.168,0.761,102.2,76.4,86.9769,0,9e-5,0,0.401767,0.0283,0.65,0.45,0.459,0.295,6.506,0.44956,143.9973,3.3848,10.9913,0.7251,1.209193,0.1417,0.450809,0.0044,29.95,3.598461,0,0,0.00132,0,0,283.88,3.29,0,0.3758,0,0,0,5.274,141,3.455,73.91,286.0015,5.61,2.09,80,177.19,0,77,139,91.45,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,>1,131HR,158VF,N,Y,N,N,Low,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1333,49,49,0,3,97.06,174.71,32.31331,2.1,7,0.058470778,0.70118219,0,3,1,7,1509.827,1,1,183.89,40.32,52.42,15.5,14.85,0,0,0.0198573,0.00853,26.96,0.144,1.71152,2.4475,0.118,0.107,0.038,0.033,0.968,0.814,101.2,122.57,68.138,0.03,5e-5,0.0041,0.453837,0.0497,0.575,0.43,0.354,0.267,3.388,0.42317,143.9899,1.7347,0.0161,0.7205,1.323715,0.2398,0.390545,0.0649,0.51,2.906992,0.488454,0.0216,0,0,0.077727,141.75,3.71,0,0.9934,0,0.0602,26.28,4.594,144.2,21.981,63.07,214.1417,4.4,2.06,84,174.06,0.1,50,111,90.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1334,57,58,1,2,100.74,175.59,32.95991,2.17,7,0.081619279,0.97952569,2,2,1,7,4924.746,2,2,156.34,40.96,76.12,36.81,25.93,0.001469,0.0026,0.0214411,6e-5,21.18,0.34,5.39801,2.5234,0.176,0.202,0.009,0.001,0.354,0.009,101.9,75.08,108.7567,0,5e-5,0,0.099337,5e-4,0.242,0.264,0.012,0,0,0.42848,146.8608,1.9887,7.8902,0.6122,0.828827,0.0114,1.241859,0.0029,23.19,15.982864,7.418929,0.0318,8.9e-4,0,0.962375,381.07,4.41,0,1.0468,0.804,0,28.01,4.62,136.9,10.569,70.63,454.331,17.21,2.19,55,176.04,0,69,98,94.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HH,158FF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1335,72,72,1,2,77.06,153.57,32.44202,1.74,7,0.069503856,0.83401283,1,2,3,7,9579.19,1,1,539.84,40.09,55.52,11.32,18.06,5.82e-4,7e-4,0,0,0.73,0.05,8.91033,2.2956,0.073,0.142,0.09,0.136,0.621,0.817,101.8,94.68,59.1348,0,0,0,0.019505,4e-4,0.203,0.503,0.334,0.37,1.284,0.37856,122.5829,2.7029,11.6349,1.0597,0.429722,0.0121,0.488988,0.0055,0,6.498509,0.121654,0.0026,0.0017,0,1.388505,274.78,4.09,0,1.0211,14.379,0,29.34,4.395,138.9,8.411,68,246.9778,7.1,1.76,70,151.38,0,85,118,72.97,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1336,78,77,0,3,82.32,150.5,37.19723,1.77,7,0.123666745,1.48611963,1,3,4,7,4887.972,1,1,757.59,49.4,64.93,17.01,21.93,0.003521,0.0041,0.044316,0.00187,0.76,0.029,4.13763,2.2073,0.622,0.529,0.035,0.008,0.472,0,103.1,87.8,55.7961,0,0,0,0.706779,0.0212,0.181,0,0.212,0.202,0,0.48589,154.6497,3.0901,7.4414,1.239,0.984989,0.0577,0.749995,0.0826,0.11,5.058376,3.593842,0.0193,1e-5,0,1.359668,305.13,4.89,1,0.8354,13.019,0.0324,29.89,5.004,140.9,5.275,75.36,526.8463,6.51,1.82,81,150.03,0,76,129,80.71,1,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1337,59,58,0,2,72.1,177.87,22.7783,1.91,6,0.155150677,1.86107638,1,2,1,6,1429.549,2,2,169.9,41.55,70.76,46.81,19.18,0,0,0.0347289,0,27.98,0.333,4.63313,2.502,0.219,0.133,0.063,0.015,0.828,0.632,103,76.25,79.3084,0,2.4e-4,0.0064,0.033942,0,0.282,0.231,0.472,0.281,2.789,0.43193,145.2645,1.7541,7.0999,0.0028,1.309411,0.0049,0.800681,0,0.83,4.630543,0.472764,0,8.8e-4,0,0.916015,188.31,4,0,0.889,0.118,0,22.78,5.18,140.7,8.598,59.94,148.894,7.82,1.89,86,175.06,0,70,130,69.03,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1338,43,43,0,2,50.95,166.07,18.64896,1.57,6,0.021129919,0.25377445,1,2,5,6,2966.25,1,1,367.46,50.37,89.29,18.99,20,0,0,0.0997615,0.00214,23.25,0.116,4.60449,2.3878,0.153,0.217,0.058,0.128,0.032,0.559,100.7,93.76,70.824700000000007,0.04,0,0,0.33993,0.0109,0.008,0.281,0.064,0.257,7.285,0.41646,145.0062,2.0625,9.4,4.3273,1.039734,0.0127,0.279566,0,0,2.673637,1.780823,0.0153,0,0,0,236.21,4.31,0,1.0278,11.694,0.0537,35.9,4.993,137.9,42.68,77.03,310.5525,4.4,1.58,62,169.21,0.1,63,124,54.1,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1339,66,66,1,3,48.99,NA,18.07104,1.53,7,0.049962664,0.59927834,1,3,5,7,5000.981,1,1,303.31,40.96,83.87,17.85,37,0.001273,9e-4,0.0251602,0.00103,27.04,0.177,0,2.1397,0.199,0.156,0.076,0.045,0.772,0.597,98.9,108.93,42.7792,0.11,3e-5,0.0221,0.040702,0,0.386,0.307,0.208,0.001,0,0.36266,122.1559,0.5073,1.5759,0.6676,1.001688,0.0083,0.699207,0.0482,0.44,3.998596,0.091753,0,0,0,0.968366,179.11,3.81,0,1.0189,11.608,0.0222,32.06,4.256,142.1,10.292,53.06,317.5945,5.62,1.47,80,161.05,0,103,140,45.19,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1340,67,67,0,2,67.24,167.86,24.91674,1.76,6,0.058984466,0.70900926,0,2,1,6,472.174,1,1,269.95,43.92,77.32,30.62,16.99,0.0015790000000000001,0.0016,0.0501197,4e-5,29.95,0.209,4.0649,2.1774,0.237,0.2,0.269,0.155,1.817,0.911,107.8,85.01,65.0055,0,0,0.0034,0.184752,0.0013,1.553,0.727,0.458,0.365,0,0.39063,131.1523,0.0163,9.6004,1.3383,1.557079,0.1961,0.229353,0,0.43,1.386406,0,0,0,0,0.96009,191.42,4.19,0,0.9541,10.301,0,25.99,4.238,144,8.549,72.04,267.7962,3.17,1.72,70,166.9,0,81,106,65.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1341,70,70,0,4,47.98,150.93,20.78152,1.41,7,0.08840724,1.06005542,1,4,2,7,1095.052,2,2,248.17,38.02,85.17,10.42,12.55,0.00105,8e-4,0,4e-5,28.05,0.098,6.42325,2.2139,0.279,0.254,0,0,0.212,0.022,105.9,102.81,41.697,0,3e-5,0,0.150179,0.0277,0.17,0,0.087,0.115,0,0.30956,92.1366,2.3736,0,0,0.650109,0.0891,0.700313,0.1249,0.52,3.590036,12.969275,0.759,0.00544,0,1.062482,172.7,3.8,0,1.0993,12.612,0.0078,0.34,3.985,144.1,8.824,55.95,238.2423,5.5,1.26,71,148.94,0,78,119,42.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
1342,68,68,0,4,97.92,171.16,33.0351,2.06,6,0.130401543,1.56445674,2,4,6,6,1927.079,1,1,742.64,25.14,96.44,113.94,34.36,7.34e-4,3e-4,0.0565546,8e-5,0,0.126,6.96082,2.3853,0.27,0.186,0.239,0.147,0.801,0.571,101.9,91.69,70.7974,0.07,1e-5,0,0.100351,9e-4,0.503,0.353,0.254,0.165,0,0.37882,116.0111,1.0827,0,0.01,1.102735,0.002,1.189694,0.0532,16.16,4.096584,0,0,0.00381,0,1.130089,103.28,4.11,0,1.0958,10.96,0.026,39.88,4.1,138.9,7.875,57.91,309.1052,7.65,2.14,71,172.94,0.1,77,139,97.85,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,Y,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1343,54,55,0,1,59.17,169.24,21.11991,1.68,7,0.05406004,0.64895321,0,1,1,7,7353.976,1,1,212.21,34.06,164.81,36.6,24.08,0.00183,0.0014,0.0469007,0.00714,22.34,0.172,4.53662,2.2495,0.24,0.088,0.091,0.038,1.554,0.798,103,97.67,70.4077,0.26,2.2e-4,0.022,0.032816,0.0248,0.824,0.416,0.653,0.359,0,0.37748,131.9585,3.0981,16.2011,1.2207,2.454218,0.3124,0.407767,0.0052,0,5.57562,4.043972,0.0187,0.00871,0,0.935303,302.25,4.19,1,1.1014,11.669,0,42.34,4.134,141,39.393,71,90.1357,7.62,1.8,80,171.03,0.1,83,113,62.36,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1345,56,56,1,2,60.92,159.75,23.66125,1.63,6,0.092213297,1.10647392,0,2,3,6,2704.262,2,2,211.94,28.7,66.85,21,36.18,0.001389,0.0014,0.0300145,0,26.24,0.05,7.4996,2.2476,0.161,0.075,0.269,0.149,1.598,0.824,98,83.43,72.5181,0,0,0,0.099788,4e-4,0.813,0.464,0.585,0.376,0.893,0.40186,137.1242,2.6373,16.2518,1.7924,1.92966,0.0093,0.500487,0.0048,21.37,4.099681,5.098211,0.6313,8.3e-4,0.001,0.175977,239.62,3.09,0,1.1569,0.918,0,27.04,4.491,141,8.203,77.01,392.4866,7.44,1.63,79,160.17,0,82,116,60.13,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,Y,Y,Y,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1346,63,63,0,0,73.07,156.05,29.73603,1.74,7,0.150658887,1.80848496,1,0,2,7,170.074,2,2,168.61,43.92,51.8,59.66,23.9,0.00364,0.0017,0.1025802,4e-5,0,0.069,6.78413,2.254,0.04,0.059,0.233,0.218,0.515,0.561,95.8,87.95,66.3876,0,0,0,0.207723,7e-4,0.235,0.309,0.203,0.243,0,0.43159,146.0186,0,0,0.5647,2.500035,0.1276,1.296568,0.0606,0.7,6.181152,4.360092,0.0406,0.00727,0,0,170.51,4.6,0,0.9443,0,0.0527,0,4.602,138,13.675,68.08,214.0361,10.1,1.78,72,153.75,0,64,112,72.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,2,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1347,53,53,2,4,66.6,175,21.93089,1.82,7,0.014595394,0.17516776,1,4,3,7,7958.136,2,2,301.53,29.84,202.78,8.01,14.98,0.002301,0.0039,0.0756555,0.01233,2.18,0.085,4.29204,2.3493,0.341,0.365,0.186,0.133,1.732,0.899,97.4,91.62,72.2867,0.09,0,0.016,0.17739,0.059,0.909,0.59,0.752,0.573,3.034,0.41518,139.0228,1.2866,7.4043,0.4212,1.000414,0.3277,0.400454,0.0853,0.65,5.058973,7.141978,0.5799,0,0.001,1.19013,427.02,3.81,1,0.9756,11.571,0.0376,31.19,4.738,140.8,8.782,59.14,407.0071,7.58,1.78,63,172.97,0,75,116,66.02,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1348,69,70,0,4,119.44,184.49,35.27649,2.36,6,0.064657258,0.77656376,1,4,4,6,8043.979,1,1,346.51,38,76.89,15.71,22.16,3.16e-4,1e-4,2.609e-4,0,21.94,0.125,2.67649,2.1508,0.082,0.002,0.089,0.057,1.466,0.859,104.1,63.06,114.1032,0,1e-5,0.0097,0.149694,0,0.782,0.512,0.594,0.319,0.594,0.26995,90.8189,1.3488,8.7148,0.4802,1.900163,0.0068,0.680773,0,0.08,4.297255,0.697983,0.0065,0,0,0.906208,203.43,3.6,0,1.0724,10.886,0,24.01,3.023,138,4.058,51.9,303.7849,6.82,2.36,80,182.82,0,67,120,117.33,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1349,57,57,0,2,104.98,190.89,28.02423,2.33,7,0.221513375,2.65867356,1,2,5,7,332.487,2,2,223.09,32.05,62.48,58.2,76.6,3.82e-4,0,2e-4,0,25.94,0,5.6446,2.0207,0,0.004,0,0.001,0.037,0.737,103.1,112.81,64.6785,0.02,1.7e-4,0.0139,0.049869,0,0.015,0.297,0.046,0.22,1.788,0.388,133.9276,2.3269,0,0.5585,0.391425,0,0.700897,0.004,0.48,4.911316,0.186876,0.0184,0,0,0.92329,203.74,4.31,1,1.106,11.031,0.0496,32.04,4.221,142.9,9.99,54.21,208.0195,6.2,2.38,74,191.94,0,80,120,104.31,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1350,38,38,0,2,62.93,160.03,24.0382,1.64,7,0.066640743,0.79977711,1,2,5,7,1250.217,1,1,219.8,35.9,165.04,20.05,27.18,0.003892,0.0026,0.0103449,6e-5,27.06,0.244,0.11712,2.3972,0.173,0.124,0,0,0.691,0.789,106.3,167.78,42.3,0,0,0.0013,0,3e-4,0.233,0.276,0.318,0.37,2.399,0.43251,145.0063,2.5298,12.3749,1.1923,1.459418,0.1696,0.501498,0.1052,17.09,3.457367,4.258526,0.5032,0,0,1.388736,203.5,4.57,0,1.1079,12.371,0,26.17,4.798,142,54.897,63.97,221.5666,6.29,1.6,65,157.85,0.1,68,99,62.92,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VV,Y,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1351,68,68,0,3,68.99,158.62,27.11134,1.71,6,0.084844794,1.01851677,0,3,2,6,2229.195,1,1,163.38,40.09,76.08,28.15,28.86,0.002143,0.0027,4.58e-5,0,2.46,0.11,4.64598,2.2025,0.1,0.038,0.251,0.162,2.117,0.907,102,102.03,56.3703,0.11,1.9e-4,0.0076,0.060761,9e-4,1.116,0.613,1.008,0.592,0,0.35871,121.6799,2.0914,12.3212,0.7196,1.000063,0.0039,0.167616,0,29.99,3.298553,0,0,0.00136,0,0,129.27,3.08,0,1.0003,0,0.0051,27.98,4.43,140,12.08,58.85,380.3588,4.2,1.6,80,156.53,0,78,133,60.95,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1352,68,68,1,3,97.09,185.79,27.6844,2.23,7,0.023710433,0.2845567,0,3,5,7,4117.078,2,2,184.89,44.7,42.57,14.86,15.62,0,0,0.0300199,0,20.62,0.001,0,2.4166,0,0.092,0,0,0,0,101.9,79.68,71.6379,0.2,2.1e-4,0.0252,0.010422,0,0,0.004,0,0.111,0,0.44239,144.5766,3.0958,15.8849,0.5134,0.836915,0.0109,0.653467,0.0013,0.57,4.002722,0.412293,0,0.00605,0,0.930337,383.4,4.79,0,1.0101,12.595,0,25.02,5.097,138,5.084,70.32,209.5828,6.09,2.26,80,182.92,0,84,139,94.66,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1353,75,75,1,2,94.5,172.72,32.23036,2.06,6,0.030836669,0.3700676,1,2,6,6,26746.213,2,2,242.82,45.97,64.87,23.91,24.16,6.43e-4,0,0.0820125,5e-5,29.99,0.001,4.63022,2.377,0.066,0.066,0.007,0,0.659,0.811,101.1,72.1,81.199700000000007,0.15,1.5e-4,0.0144,1.530384,0.02,0.418,0.529,0.186,0.164,0.563,0.41494,141.0427,2.4112,0.0187,0,0.719391,0.0032,1.165952,0.0703,0.77,4.407848,3.353242,0,0,0,0.482274,259.49,4.2,1,1.0669,0.644,0.0175,22.5,4.332,137.9,7.993,74.55,132.32,6.54,2.01,68,173.98,0,65,119,94.85,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,< 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1355,73,73,0,2,77.67,164.97,27.76801,1.86,7,0.103558986,1.24235397,0,2,2,7,1851.079,1,1,462.53,40.99,164.64,32.2,42.86,0,0,0.0503231,0,28.45,0.13,5.7001,2.4969,0.172,0.119,0.11,0.096,0.616,0.591,0.5,70.49,73.3426,0.03,1.5e-4,0.0036,0.101958,7e-4,0.301,0.028,0.252,0.227,2.885,0.37152,115.7239,2.8299,9.9943,0.772,1.91175,0.0107,0.41978,0,34.95,7.800785,2.779154,0,0,0,1.164663,228.95,4.59,0,1.0219,10.766,0.0177,24.73,3.998,137,6.826,74.49,273.7216,11.64,1.83,90,162.77,0,73,152,73.01,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1356,47,47,0,3,62.45,164.23,23.06954,1.67,6,0.136163395,1.63559986,0,3,5,6,4160.957,2,2,312.74,40.99,275.42,33.24,24,0.002534,0.0035,0.0200395,9e-5,23.7,0.211,3.62532,2.4764,0,0,0,0,0.087,0.769,104,84.79,74.9213,0.04,3.7e-4,0.031,0.09944,0.0048,0.178,0.409,0.029,0.189,0,0.3389,108.8623,0.0052,0.014,0.5576,1.090758,0.1858,0.300283,0.0557,0,4.57534,4.19444,0.0271,0.00405,0.001,0.908973,212.46,4.31,1,0.9958,11.775,0.0224,36.69,3.942,144.1,8.913,62.21,288.4424,6.73,1.75,71,164.01,0,92,121,66.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1357,70,70,2,3,70.37,163.21,26.34369,1.76,6,0.061150071,0.73405996,3,3,3,6,19585.278,2,2,529.06,37.78,65.6,47.69,36.9,1.57e-4,0,0,0,17.4,0.061,5.00173,2.3791,0.462,0.302,0.091,0.047,0.94,0.62,0.3,85.66,68.9982,0,1e-4,0,0.04949,0,0.655,0.431,0.298,0.187,0,0.30927,103.1893,2.106,7.1192,1.3919,1.999122,5e-4,1.933351,0,22.12,6.968102,2.603079,0,0.00694,0,0.870102,318.91,3.48,1,0.9914,9.495,0,27.17,4.014,137.3,11.99,64.93,446.4528,9.2,1.73,87,164.95,0,80,122,69.93,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1358,61,61,0,4,79.06,182.14,23.51577,2,6,0.052476298,0.6295086,0,4,4,6,8102.822,1,1,644.67,36.96,53.2,15.07,18.07,0.001074,0.0013,3.34e-5,0,26.66,0.101,6.28666,2.0659,0.315,0.191,0.291,0.162,1.263,0.773,102.5,93.11,85.6879,0.59,0,0.0148,0.006548,0,0.738,0.479,0.492,0.316,0,0.46424,154.4849,2.0828,7.2365,0.7747,1.046824,0.0057,0.875277,0.0027,0,3.599959,1.953838,0,0,0.001,1.098169,25.01,4.64,0,1.1819,11.833,0.024,27.63,4.716,139.9,34.884,58.94,272.9026,5.94,2,67,182.83,0,88,94,80.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1360,63,63,0,3,75.93,165.92,27.63685,1.83,7,0.059747869,0.71686594,0,3,6,7,2500.221,2,2,210.99,39.07,35.29,29.71,42.85,0,0,2.123e-4,4e-5,27.93,0,4.52645,2.3481,0.268,0.209,0.151,0.098,1.402,0.772,96.8,115.34,49.2928,0,0,0,0.117174,5e-4,0.903,0.529,0.418,0.271,0.507,0.34937,122.7652,0.7892,0,0.2028,1.254984,0.0029,0.642158,0.0419,16.05,6.789203,9.631003,0.545,0,0,0.937819,210.94,3.69,1,1.0608,0.108,0,0,4.703,140.8,8.481,57.42,163.7257,8.7,1.88,69,167.19,0,74,129,79.75,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,Y
1361,54,54,0,2,59.96,155,25.50257,1.59,8,0.06190994,0.74317166,0,2,2,8,1115.715,1,1,165.61,36.93,53.81,13.12,14.05,0,0,0,1e-5,33.07,0.071,11.57605,2.71,0.242,0.186,0.068,0.056,1.102,0.753,104,84.86,69.3007,0.21,0,0.0133,0.129473,7e-4,0.838,0.576,0.173,0.051,0,0.35166,115.1711,0.3441,9.3884,0.7138,1.39897,0.0051,0.120245,0,30.59,4.96555,0,0.0077,0.0012,0,2.350749,221.89,4.59,0,0.7682,0.287,0,0.38,4.567,138,8.026,70.63,202.595,6.29,1.7,104,157.92,0,70,190,63.92,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,Y
1362,48,48,0,2,59.09,155.98,24.16101,1.58,7,0.010111827,0.12128101,0,2,2,7,1537.444,1,1,216.07,35.74,62.83,26.74,24.96,0.29398,0.0337,1.295e-4,6e-5,26.93,0.103,4.49885,2.0793,0.113,0.007,0.127,0.09,0.918,0.699,101.9,106.79,61.9571,0.04,2.8e-4,0.0078,0.090152,0.005,0.447,0.27,0.497,0.335,0.988,0.35034,121.3072,2.9216,14.4329,0.9993,1.030255,0.1007,0.240583,0.0476,0.31,3.900993,3.019445,0.7121,0,0,1.510369,217.64,4.7,0,0.9243,0.378,0.0416,24.33,4.337,141.1,10.981,64.67,358.2073,5.49,1.55,69,155.12,0,63,113,58.63,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHE,Switzerland,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1363,47,47,1,2,56.44,175.09,18.36441,1.67,6,0.064978095,0.77966537,0,2,5,6,10661.434,1,1,269.68,40.04,30.99,7.47,8.27,4.73e-4,6e-4,0.0199774,4e-5,25.43,0,3.7011,2.2517,0.18,0.253,0.037,0.066,0.665,0.82,103,94.04,68.8052,0,0,0,0.025612,6e-4,0.329,0.438,0.365,0.444,0,0.36347,108.4812,1.6113,4.9992,0,0.251159,0.0045,0.2996,0.0013,0,3.828698,0,0.0232,0,0.001,0.95959,377.66,4.11,0,1.0978,11.843,0,40.48,4.612,141.1,3.404,66.85,18.694,5.12,1.8,81,176.32,0,79,131,60.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1364,62,62,1,3,48.06,148.49,21.61006,1.41,6,0.040160507,0.48181126,1,3,5,6,10587.692,1,1,458.08,34.94,61.92,7.07,13,0.001715,0.0019,0.0099143,6e-5,27.08,0.001,3.99875,2.2706,0.004,0.041,0.003,0.011,0.01,0.005,93.1,76.24,59.9091,0,0,0.0029,0.140758,7e-4,0.02,0.239,0,0,5.172,0.29961,97.7279,1.7596,7.5211,0.7265,1.622636,0.0082,0.986762,0.0401,0.13,4.660493,5.380333,0.0161,0.00687,0.001,1.230859,356.61,4.15,0,0.8029,11.495,0,28.19,3.58,134.4,5,56.96,276.6669,8.49,1.4,68,145.99,0.1,83,120,48.07,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1365,34,33,0,2,55.97,160.1,21.44048,1.58,8,0.060037417,0.72112921,1,2,3,8,1784.97,2,2,1026.76,34.94,83.41,70.93,85.14,0,0.001,0.0500533,0.00404,31.2,0.001,3.93719,2.0659,0.159,0.134,0.14,0.111,0.747,0.745,102.2,138.41,44.2079,0.31,1e-5,0.0041,0.069801,4e-4,0.382,0.315,0.282,0.258,0.272,0.31986,105.7079,2.22,9.7974,0.6569,1.75961,0.0123,1.70212,0.0895,0.11,6.760463,3.420708,0.008,0.00141,0,1.162072,188.89,3.8,0,0.955,0.393,0.0243,26.1,3.427,136.2,6.871,50.77,196.6231,9.34,1.55,80,159.84,0,80,139,55.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,Yes,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1366,66,66,2,2,90.06,154.1,39.77328,1.87,7,0.188324374,2.25646517,1,2,5,7,17793.355,1,1,153.14,35.01,82.91,10.12,14.03,0,0,0.0269222,8e-5,23.1,0,4.76224,2.1294,0.239,0.214,0.054,0.064,1.046,0.846,103.1,104.31,61.0075,0.31,9e-5,0.0108,0.200368,5e-4,0.389,0.374,0.663,0.581,0,0.3188,114.6643,0.012,11.0069,1.4046,1.010314,0.0117,0.708754,0.0046,0.71,6.576072,3.202475,0.562,0,0,1.265701,504.28,4.39,0,0.8784,8.932,0,24.89,4.098,139,8.551,63.74,0,9.33,1.91,69,157.06,0,62,128,97.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1367,55,54,0,2,48.97,168.08,17.90766,1.56,6,0.018558386,0.22258031,0,2,3,6,3078.913,2,2,336.79,42.05,90.15,14.6,15.97,0.002522,9e-4,0.0100178,5e-5,3.09,0.164,4.74142,2.2423,0.128,0.142,0.129,0.089,1.033,0.816,97.8,137.49,37.2639,0.03,1.1e-4,0.0208,0.039871,4e-4,0.469,0.455,0.511,0.396,0,0.43902,142.4918,0,0,0,1.062206,0,0.460606,0,16.07,5.12601,0.626457,0.0246,0.00376,0.001,1.079764,251.52,3.5,0,1.0025,0.415,0.0662,0.16,4.516,138,5.301,64.14,5.4826,7.99,1.61,81,167.99,0,82,126,49.98,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1368,58,57,0,2,61.76,147.99,27.77046,1.55,7,0.048057854,0.57699626,0,2,3,7,600.484,2,2,171.95,39.91,187.57,17.91,12.9,0.00165,0.0016,1.468e-4,7e-5,30.05,0.28,8.85891,2.274,0.313,0.087,0.211,0.076,0.669,0,105.9,75.3,79.5942,0,1e-5,0.0169,0.129396,0.001,0.302,0,0.27,0,1.989,0.38103,126.6866,3.5212,15.8277,5.2398,3.074116,0.2747,0.249618,0.0029,0,4.491261,2.792889,0.0398,0,0,1.393681,446.77,4.39,1,1.0014,11.705,0.0157,31.1,4.187,140.9,7.008,68.82,226.1625,8.38,1.65,53,149.81,0,79,89,66.81,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NA,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,0,131HH,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1369,57,56,1,1,75.05,165,26.77372,1.85,8,0.403211673,4.83622028,0,1,4,8,8047.926,1,1,320.37,41.99,107.66,59.58,45.95,2.76e-4,0,0.0237454,0.0079,30.2,0.125,4.05347,2.3542,0,0,0.139,0.161,0.697,0.831,0,114.67,68.9868,0,1e-5,0,0.158236,0.0444,0.364,0.523,0.247,0.281,0.933,0.39999,127.9178,0.0127,7.4091,0,0.988202,0.3121,1.291101,0.1297,28.68,5.475645,0.313628,0.2777,0.00159,0,0.828394,99.91,3.79,0,0.9072,0.455,0.03,28.63,4.624,137,15.033,60.01,231.9863,7.46,1.97,63,165.01,0,72,131,78.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,>= 75,III,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1370,67,68,1,2,54.89,173.78,18.20889,1.65,7,0.052301708,0.62701467,0,2,1,7,1189.288,2,2,508.95,35.77,61.81,29.32,25.07,0.001968,0.0023,0.0696136,4e-5,2.86,0.064,5.71874,2.3307,0.044,0.126,0,0.043,0,0.598,95.2,85.66,56.7337,0.34,0,0.0033,0.30052,4e-4,0.011,0.405,0,0.002,4.098,0.31379,92.9458,1.4534,7.2655,0.7997,0.339228,0,0.69756,0.0303,0,12.223152,0.66538,0.0399,0,0,0,569.92,4.1,0,1.0672,13.506,0,25.92,4.067,138,3.905,67.99,95.7581,13.61,1.6,59,173.99,0,58,106,55.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1371,65,65,NA,3,92.26,160.93,36.77476,1.97,6,0.101468638,1.21841229,1,3,NA,6,3217.867,2,2,226.01,42.95,84.1,31.48,14.91,0,0,0.0100068,6e-5,0.51,0.129,4.78113,2.3247,0.164,0.007,0.118,0.067,1.404,0.777,107,132.6,51.7864,0,0,0,0.181304,2e-4,0.838,0.516,0.329,0.136,1.302,0.46756,149.9466,2.5876,9.7918,0.0071,10.641737,0.2206,0.619054,0.0566,25.44,4.707568,4.461283,0.0173,0.00254,0,1.036786,174.42,4.5,1,1.1382,12.447,0,23.83,5.473,144.9,14.624,70.06,85.0349,8.7,1.78,87,159.79,0,100,138,84.01,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,NA,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1372,71,71,0,2,57.01,142.77,28.64119,1.44,6,0.083292285,0.99938999,0,2,3,6,1157.307,1,1,189.95,39,82.96,23.8,16.15,0.274371,0.0044,1.838e-4,7e-5,29.98,0.195,5.89705,2.3103,0.353,0.346,0.003,0.01,0.51,0.706,99,83.52,55.7622,0.13,2.2e-4,0.0289,0.110686,0.0048,0.123,0.196,0.339,0.407,0.343,0.38344,132.0777,2.5705,10.8362,1.5769,1.147933,0.1572,0.300218,0.0674,24.44,2.712698,0.196863,0.0394,0.00141,0.001,1.194374,100.67,4.79,1,0.9664,12.035,0.0226,24.49,4.196,138.9,352.093,57.03,210.8204,4.6,1.46,70,87.48,0.1,79,122,54.91,1,1,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1373,36,36,0,1,96.96,172.99,31.40835,2.1,7,0.034817702,0.41745834,1,1,2,7,893.307,2,2,163.08,44.97,98.79,27,23.14,0,0,0,2e-5,30.31,0.128,4.70975,2.2262,0.179,0.007,0.115,0.034,1.342,0.737,106.1,178.32,54.7325,0.28,1e-4,0.0249,0.004923,9e-4,0.805,0.41,0.372,0.175,0.301,0.46446,149.9227,1.7394,11.3959,1.3491,2.954272,0.1696,0.491293,0.0029,0,5.955391,0.706446,0.0161,0.00703,0,1.030006,248.46,4.5,1,0.8849,11.043,0.7469,27.53,5.197,144.1,8.468,65.99,303.4736,9.87,2.17,75,176,0,81,117,102.13,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1374,68,68,0,3,48.98,149.89,22.74673,1.43,7,0.028375365,0.3402757,1,3,4,7,6291.55,1,1,346.29,34.07,59.61,16.07,28.84,0.001061,5e-4,0.0300144,0.00689,0.7,0.101,0.09843,2.1236,0.292,0.213,0.069,0.047,0.511,0.589,0,103.32,39.4063,0.06,0,0,0.07637,0.0071,0.228,0.124,0.212,0.195,0,0.32515,103.0672,2.007,11.3905,1.3927,1.658298,0.1047,1.127665,0.1303,0,3.396483,6.674389,0.7569,0.00305,0,1.000593,440.2,4.39,0,1.0367,23.313,0,38.66,3.416,136.9,6.858,70.01,181.1163,6.62,1.28,68,145.95,0,73,101,43.97,1,0,0,0,0,0,0,1,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1375,70,70,0,3,65.07,150.91,28.66001,1.62,6,0.076178508,0.91409383,0,3,3,6,9722.554,1,1,268.46,39,537.12,27.75,21.03,0.004088,0.005,0.0227139,0,25.91,0.09,6.9994,2.7595,0.163,0.037,0.116,0.031,0.701,0.02,100,92.73,64.7366,0.19,0,0,0.401626,8e-4,0.273,0,0.272,0.161,0,0.43879,134.224,2.0001,12.3601,1.0562,3.1696,0.0054,0.703483,0.0034,0.24,5.854937,0,0.0057,0,0,1.099497,461.98,3.7,0,1.0468,12.935,0.0636,33.77,4.678,140.9,5.473,73.95,424.1015,12.31,1.71,77,153.22,0,97,113,69.1,0,0,0,0,2,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1376,69,69,0,3,84.97,160.04,33.02901,1.89,6,0.056390747,0.67751479,0,3,3,6,2570.198,1,1,254.1,32.94,88.93,32.16,17.93,0.001884,0.0015,0.0296482,1e-5,0.67,0.1,5.39698,2.3403,0.055,0.081,0,0,0,0.355,105,55.4,100.833,0,0,0,0.399574,0,0,0,0.008,0.198,2.949,0.36078,117.2074,3.7996,12.6226,0.0105,1.231713,0.0092,0.822358,0.0021,0.33,3.330382,4.719984,0.024,0.00248,0,0.920262,152.17,4.47,1,0.951,14.533,0,31.07,3.877,132.1,3.412,67.24,240.8455,5.69,1.89,81,160.73,0,89,121,84.84,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Other,Y,Y,F,No,CASA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1377,64,64,0,1,57.02,162.85,20.80461,1.6,7,0.056956979,0.68334916,1,1,3,7,886.965,2,2,317.97,39.08,49.04,12.02,17.74,0,0,6.88e-5,7e-5,30.09,0.001,0,2.2779,0.11,0.157,0.03,0.044,0,0,91.9,65.53,83.9993,0,5e-5,0,0.043097,0.0102,0,0,0.004,0.154,0,0.27692,85.8871,5.4097,12.0103,6.5836,0.625815,0.2226,0.698447,0.1208,0,3.208258,5.737524,0.6558,0,0,0.87074,214.29,3.88,0,0.9999,13.478,0,31.03,2.982,138,6.987,70.07,267.6256,4.6,1.64,69,163.89,0,78,106,58.08,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1379,70,69,0,2,73.41,179.04,23.14671,1.91,7,0.080022014,0.9603109,1,2,6,7,11969.875,2,2,172.12,24.91,0,13.88,17.09,0.001885,0.0016,0,0,27.93,0.099,6.01362,2.075,0.296,0.32,0,0.001,0.5,0.743,94.1,75.87,71.6125,0,2e-5,0.0015,0.040061,0,0.455,0.503,0.067,0.221,0,0.28519,95.862,0,9.0543,0.4227,0.692039,0,0.802142,0,0.52,3.445796,0.076188,0.0073,0.00437,0,0.178463,176.14,3.51,1,0.8775,13.065,0,30.11,3.506,142,3.533,56.07,315.2043,4.79,1.92,83,176.32,0,82,139,72.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,NA,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1380,51,51,0,1,70.01,159.97,27.58883,1.75,6,0.078159932,0.93792673,1,1,3,6,5808.366,2,2,342.94,33.15,97.72,15.1,29.18,5e-6,0.0016,0.0700108,0.01005,28.08,0.11,3.5019,2.2082,0.14,0.152,0.133,0.091,0.967,0.572,0.2,128.54,59.0918,0,0,0,0.299487,0.0427,0.446,0.302,0.45,0.275,0,0.3578,126.8159,1.6546,10.0041,0.3985,1.536197,0.2237,0.480367,0.0203,0.23,4.855461,1.97902,0.5448,0.00238,0,0,194.13,4.14,0,0.9871,10.354,0,25.74,4.047,140.9,5.987,65.71,284.6931,7.39,1.84,71,162.02,0,69,123,70.86,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1382,71,71,0,3,82.95,166.05,29.95414,1.94,6,0.144846709,1.73976896,1,3,6,6,2964.104,NA,1,220.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.72,62,163.81,0,63,131,77.08,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,NA,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,Y,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,NA,Rituximab plus 6 CHOP cycles,NA,NA,N
1383,57,57,0,3,47.74,158.18,18.95111,1.48,8,0.040311898,0.48405475,2,3,1,8,1225.865,2,2,244.84,36.91,173.07,20.9,22.85,3.24e-4,0,0.0099638,0,25.46,0.236,5.37549,2.173,0.076,0.077,0.11,0.112,0.444,0.564,102,99.21,50.5997,0,0,0.0134,0.272809,0,0.231,0.27,0.109,0.223,0.146,0.25112,89.4628,1.2172,7.2855,0.6337,1.397853,0,0.432699,0,0,3.802524,0.449738,2e-4,0,0,1.035339,246.22,3.1,0,1.0772,13.356,0.0016,30.16,3.256,137,5.993,72.02,356.4595,5.61,1.49,80,158.03,0,83,115,49.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1384,74,74,1,4,69.04,165.77,24.60968,1.78,6,0.093842523,1.12721501,2,4,2,6,9395.348,2,2,186.26,28.23,79.13,32.38,28.15,0.00093000000000000005,0.0012,0,0,28.03,0.109,4.51354,1.4659,0.178,0.192,0.001,0.019,0,0,103.9,55.19,98.0148,0,0,0,0.099811,0,0,0,0,0,3.456,0.32718,102.8451,2.2012,11.7971,0.424,1.188633,0.0021,1.122341,0.002,0.14,3.520831,0.363807,0,0.00196,0,0.235895,203.84,4,2,1.2178,15.854,0,33.73,3.941,137,7.995,53.05,368.9321,7.1,1.8,79,164.44,0,54,103,67.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1385,40,39,1,2,60.07,160.13,23.33818,1.6,7,0.050742076,0.61000128,0,2,3,7,11223.868,2,2,1241.1,41.01,223.22,9.93,27.52,8.57e-4,0,0.0198487,0,27.99,0.141,0.05505,2.7383,0.626,0.501,0.156,0.119,1.414,0.774,106.2,83.17,79.5808,0.03,0,0,0.00158,0,1.032,0.592,0.566,0.374,0.38,0.41857,141.3479,0.5123,6.8714,0.461,1.198334,0,0.601825,0,0.33,7.604119,0.2469,0,0.00233,0,1.4538,433.2,4.81,0,0.7677,8.922,0.0045,38.4,4.405,144.8,13.689,72.95,336.8687,9,1.6,68,161.96,0,69,135,62.83,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1386,59,59,1,3,80.91,172.07,27.11484,1.94,8,0.131519328,1.57865935,0,3,6,8,16568.203,1,1,308.01,38.32,288.5,156.8,59.05,0,0,0.0399717,0,19.69,0.101,4.30101,2.228,0.146,0.122,0.134,0.128,0.662,0.637,106.1,83.17,78.2112,0,0,0.0088,0.03003,0,0.668,0.634,0.013,0,1.334,0.34338,109.1883,4.561,11.4718,1.4,0.769632,0,0.368934,0,0.39,4.160248,2.772476,0.0309,0,0,0.925595,303.15,3.69,0,1.0333,12.103,0,29.38,3.96,145.9,16.099,68.92,391.1061,6.3,1.89,0,169.82,0,121,107,77.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1387,64,65,1,2,68.1,170.03,23.92794,1.77,6,0.045138412,0.54105765,0,2,2,6,3984.703,1,1,220.01,42.05,101.55,18.52,21.94,0.001937,0.0011,0,0,28.08,0.117,4.63126,2.3746,0.259,0.238,0.028,0.042,0.494,0.016,101.1,85.66,72.6087,0,9e-5,0.0157,0.014819,0,0.407,0.325,0.132,0.122,0,0.37287,128.0463,1.212,10.6826,0.7302,0.65007,0,0.296419,0,0,2.907516,0.502118,0,0,0,0.993253,149.24,3.9,0,0.8783,0,0.058,32.19,4.243,141,7.993,74.35,297.9035,4.11,1.76,68,171.73,0.1,80,120,67.85,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Other,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1388,70,70,0,3,82.07,169.87,28.54619,1.94,7,0.240342229,2.88035598,1,3,4,7,4313.774,2,2,170.35,39.08,92.04,48.76,20.06,0,0,0,0,30.47,0.181,0,2.4712,0.221,0.29,0.087,0.1,0.695,0.737,107.1,94.83,69.8883,0.05,2.1e-4,0.0129,0.218981,0.021,0.317,0.431,0.353,0.337,2.276,0.38907,130.1156,1.4402,10.7819,0.4697,0.798979,0.1301,0.715763,0.0761,31.9,3.404377,6.183178,0.3655,0,0,1.18703,238.95,4.41,0,1.0541,0.567,0.0648,0,5.04,140,21.235,67.06,611.216,5.09,1.92,61,166.93,0.1,76,119,80.51,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,< 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,Yes,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1389,60,60,0,3,95.92,187.11,27.13695,2.2,7,0.021441846,0.25722475,1,3,4,7,4120.516,1,1,679.42,30.04,67.72,61.73,51.03,0.002829,0.0046,0.0238704,0,2.86,0.121,6.07338,0,0.192,0.243,0.092,0.104,0.091,0.014,101,133.28,50.0894,0.22,0,0.0158,0.030345,0,0.305,0.417,0.007,0.113,0,0.41315,138.8367,1.6977,13.32,0.7019,0.552057,0,0.501116,0.0051,0.5,4.884259,7.421529,0.0294,0,0,1.000261,103.81,4.09,0,1.2915,11.219,0,28.25,4.646,132.6,8.177,61.16,209.9548,6.69,2.1,76,186.44,0,83,120,93.95,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1390,39,38,1,3,46.93,174,16.15788,1.55,8,0.068003791,0.81559701,2,3,6,8,16269.769,2,2,528.72,46.92,271.86,14.04,22.32,0,0,2.533e-4,0,25.38,0.172,6.82557,2.3569,0.001,0.045,0.001,0.032,0,0,96.3,72.26,83.9998,0,0,0.0057,0.007,0,0,0.002,0,0,2.787,0.31249,112.3448,2.5179,23.3685,1.7894,0.685755,0.0051,0.509729,0.0046,0,3.87921,0.564085,0.0166,0,0,1.348088,314.32,3.79,0,1.0924,13.193,0,35.98,4.277,135.9,6.076,76.54,312.5381,4.9,1.63,90,176,0,80,140,53.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,RUS,Russia,< 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,Y
1391,63,63,0,2,72.19,176.72,23.52462,1.9,8,0.045462964,0.54555418,0,2,5,8,2576.179,1,1,156.54,45.95,184.66,26.99,13.75,0.001646,7e-4,0,6e-5,21.01,0.264,4.99879,2.4152,0,0.002,0,0,0.111,0.711,100.9,85.67,80.8671,0,0,0,0.035766,0.0086,0.005,0.13,0.186,0.272,0.443,0.41152,132.9495,1.8628,11.4653,1.7201,1.2432,0.1456,0.400049,0.0041,0,3.109675,0.704756,0.0302,0,0,0.648845,200.96,3.6,0,0.8935,9.079,0.0679,25.06,4.799,140.3,10.429,77.72,143.8705,5.49,1.89,76,178.81,0,78,120,70.35,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Other,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1393,55,55,1,1,70.05,154.92,28.31009,1.7,6,0.061605152,0.74001503,1,1,6,6,18750.47,2,2,223.22,38.98,60.42,34.35,25.87,0,0,0.0690323,0.00508,30.38,0.097,3.48562,2.445,0.126,0.129,0.013,0.008,0.022,0,102.9,96.16,69.3426,0,1.3e-4,0.006,2.946066,0.0301,0.113,0.189,0,0,0,0.34721,116.0332,0.8003,13.3434,2.3947,1.897859,0.076,0.406842,0.0033,0.66,3.592354,4.628374,0.0392,0.02401,0,1.227391,211.92,4.33,0,1.0925,11.821,0.0451,0,4.129,128.2,5.02,68.03,184.9832,6.68,1.71,45,154.49,0,82,100,76.91,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1394,71,71,1,4,57.81,150.06,24.67763,1.53,7,0.188976129,2.26967451,0,4,2,7,9362.699,1,1,562.91,44.54,260.82,11.27,13.76,0,1e-4,3.326e-4,9e-5,30.76,0.199,4.0299,2.9174,0.202,0.19,0.013,0,0.002,0,106.9,59.78,79.593,0,2e-5,0,0.140044,0.0251,0.005,0,0,0,0.388,0.40062,129.1252,2.7401,9.4941,0.689,1.461033,0.2266,1.249257,0.0806,23.64,10.406886,7.665702,0.6454,0,0,0.60393,293.72,4.23,1,1.0017,0.82,0,0,4.362,139.9,7.996,81.58,368.9844,14.7,1.53,62,150.06,0,69,121,57.37,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,NA,158FF,N,Y,N,N,High,High,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1395,56,56,1,1,79.05,175.01,25.3686,1.94,7,0.114962177,1.38220221,0,1,6,7,21271.01,1,1,780.47,39.18,61.08,14.02,25.85,0,0,0,8e-5,28.01,0.078,3.3959,2.0742,0.134,0.006,0.084,0.044,0.918,0.815,101,120.44,56.7913,0,0,0,0.199903,0.0153,0.58,0.471,0.376,0.28,1.267,0.28708,100.0478,1.0884,7.9951,0.4242,1.429768,0.1629,0.448279,0.04,0,2.011869,0.424724,0.0206,0,0,1.03062,195.16,4.5,0,1.1961,0.551,0.0234,30.08,3.936,137.8,6.499,62.68,141.5645,4.38,1.93,73,176.12,0,80,101,73.45,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,>1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1397,65,65,0,4,94.13,184,27.17794,2.15,8,0.062110048,0.7462174,1,4,6,8,6490.057,1,1,296.75,43.93,101.92,22.18,44.98,0.002903,0.0022,0.0901138,0.00228,26.19,0.14,0,2.377,0,0,0.042,0.056,0.059,0.735,0,97.19,75.114,0.59,2.5e-4,0.1114,0.033956,6e-4,0.014,0.386,0.109,0.266,2.002,0.37524,131.7416,5.4244,19.9504,3.0924,1.100562,0.0765,0.580182,0.0018,23.93,3.643313,3.999086,0.0021,0,0,0.991732,168.92,4.03,0,2.3143,13.561,0,31.95,3.974,134.7,19.18,70.61,334.1786,5.76,2.37,67,186.12,0.1,79,109,109.84,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1398,34,34,1,1,66.43,177.85,20.81429,1.82,6,0.038520586,0.46258277,0,1,3,6,4811.694,1,1,226.05,43.9,61.07,25.33,15.42,0.134956,0.0034,2.415e-4,0,24.93,0.083,0,2.3493,0.226,0.231,0.032,0.033,0.585,0.805,103,100.44,74.8646,0.37,1e-5,0.0153,0.066335,2e-4,0.41,0.481,0.207,0.299,1.37,0.43875,138.151,2.6025,15.7624,1.4257,0.699304,0,0.476969,0.0774,0.6,6.326874,2.703557,0.5596,0.00412,0.001,1.148696,354.29,4.69,0,1.204,13.966,0.0447,38.65,4.797,140,10.224,75.81,246.0829,6.15,1.78,86,178.99,0,85,110,68.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1399,74,74,1,3,83.2,155.24,34.60489,1.83,7,0.052880596,0.634031,1,3,5,7,3430.878,2,2,673.44,38.71,351.35,28.5,43.08,0,1e-4,0.0217695,0.00365,0.63,0.001,3.04163,2.3925,0.199,0.28,0,0,0.561,0.815,99,72.29,82.0525,0.25,5e-5,0.0223,0.068082,0.0194,0.095,0.256,0.315,0.477,0,0.38048,125.0553,0.002,0,0,1.319956,0.2047,0.488847,0.0893,0.59,11.803362,6.072771,0.7398,0.00678,0,1.06155,269.61,5.11,1,1.0462,12.807,0,0.24,4.826,135.9,101.222,72.06,344.9931,11.79,1.93,78,156.2,0,88,120,89.66,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,Yes,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1400,45,44,3,4,88.13,175.65,28.36279,2.06,7,0.036984988,0.44319531,0,4,3,7,24526.358,1,1,2677.12,38.3,72.59,49.61,58.38,0,0,0.0297199,0,29.45,0,16.88459,2.2246,0,0.101,0,0,0,0.398,101.2,94.54,90.0883,0.29,0,0,0.169828,2e-4,0,0,0,0.286,5.197,0.3746,120.1762,2.6195,9.3061,0.7002,0.544259,0,0.40368,9e-4,0,3.096014,0.674321,0.5609,0.00135,0.001,1.02666,175.21,4.44,0,1.0388,13.529,0.0194,31.11,4.322,135,11.501,70.08,439.9665,4.31,2.27,56,176.47,0,79,107,88.76,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1401,43,43,0,2,58.42,170.14,20.69129,1.69,7,0.089465994,1.07366751,0,2,2,7,156.779,1,1,231.25,36.84,133.51,28.81,19.97,0.001727,0.0037,0.0200394,5e-5,26.09,0.027,3.18139,2.2992,0.172,0.303,0.064,0.066,0.16,0.666,100.1,107.16,66.2637,0.13,0,0.0112,0.060879,7e-4,0.142,0.36,0.009,0.24,0,0.37325,115.8918,2.89,8.497,0,1.23172,0.1805,0.819083,0.0701,0.35,3.879588,5.608317,0.6825,0,0,1.067263,189.42,4.3,0,0.9722,15.108,0,29.07,3.749,142.1,11.958,66.16,313.4927,6.23,1.65,50,169.43,0,78,93,59.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1402,70,70,1,4,78.21,171.92,25.92037,1.91,6,0.119993166,1.43911415,0,4,6,6,5656.364,2,2,344.07,26.01,82.49,100.57,36.21,0,0,2.517e-4,0,0,0,8.98487,2.1279,0.189,0.328,0,0.001,0.032,0.718,96.5,65.32,92.5659,0.49,1.7e-4,0.0311,0.109921,0,0,0.196,0.24,0.484,0,0.33723,107.9366,0.9946,5.6457,0.7255,0.296242,0,0.498511,0,0.44,5.552208,5.000079,0.0308,3.1e-4,0,0.067357,303.48,4.09,0,1.0303,0.343,0.0343,21.8,3.866,125.7,18.298,51.92,309.1474,5.8,1.95,72,170.12,0,101,115,78.16,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1403,35,35,1,3,99.21,182.97,28.99908,2.21,6,0.020836433,0.25068746,2,3,3,6,18349.888,1,1,1081.85,31.52,61.85,14.02,21.94,0.130704,0.0049,0.0200259,0.00226,0,0.211,4.10103,2.2729,0.04,0.101,0.073,0.089,0.63,0.723,100.1,131.22,66.7808,0.36,1e-4,0.0055,0.129438,0.0067,0.545,0.462,0.18,0.199,0.302,0.40902,135.78,2.2889,11.2955,2.351,1.002755,0.0093,0.672381,0.0505,0.46,12.923912,5.173967,0.57,0.00151,0,0.744533,196.44,3.89,0,1.0233,0,0.0022,30.57,5.091,138.7,5.062,64.77,224.1851,12.32,2.03,90,181.42,0,65,120,93.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,N,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1404,66,66,1,2,104.78,182.98,30.85886,2.28,6,0.046514567,0.55818493,1,2,4,6,11012.621,2,2,188.45,39.81,47.46,49.41,41.54,0,0,0.0299716,8e-5,28.26,0.139,5.32066,2.4258,0.116,0.125,0.092,0.074,0.808,0.727,102.1,61.61,123.8222,0,6e-5,0,0.059706,0,0.441,0.434,0.316,0.248,0,0.42066,139.9902,1.5541,10.5387,0.5816,1.558469,0.0082,1.332873,0.0026,12.36,6.515778,2.404334,0,0,0,0,230.87,3.58,0,0.9314,0,0.049,0,4.701,142,6.815,70.07,270.0965,10.55,2.15,64,182.98,0,77,118,104.2,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1405,47,47,0,2,41.81,152.1,17.92877,1.34,7,0.064171311,0.76860801,0,2,5,7,1058.236,2,2,191.51,40.38,72.66,8.11,16.01,7.92e-4,1e-4,0.1281618,0.00935,25.98,0.001,3.75048,2.3205,0.343,0.169,0.051,0.015,0.849,0.677,101.9,104.08,47.0366,0,4e-5,0,0.87798,0.0655,0.384,0.241,0.38,0.25,0.058,0.41047,130.0329,1.4916,8.9322,0,2.487247,0.2152,0.698134,0.0904,17.52,3.874119,0.546516,0.0029,0,0,1.825795,355.76,3.99,0,1.2078,0,0.0347,26.08,4.523,139,8.536,78.02,279.5838,8.68,1.34,73,152.03,0,76,111,41,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1406,68,68,0,2,104.76,185.06,30.85936,2.32,6,0.094529091,1.135009,0,2,1,6,3989.216,1,1,350.68,49.95,141.2,34.47,17.01,0.001408,7e-4,0.0270837,0.00227,25.02,0.178,6.20988,2.4944,0.189,0.157,0.067,0.051,0.755,0.021,102.9,91.42,81.9703,0.22,0,0.0218,0.109863,0.0023,0.502,0.388,0.148,0,0.286,0.45661,145.1854,2.5073,8.5214,1.1008,1.433419,0.1535,0.369905,0.0051,30.77,4.505493,5.064423,0.6558,9.5e-4,0,0.712755,387.55,4.28,0,1.0604,11.026,0.0014,24.76,5.228,144.3,8.652,76.06,394.168,6.81,2.09,91,180.15,0,83,160,93.93,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,NA,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,NA,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1407,24,24,0,1,58.8,159.71,23.0022,1.6,6,0.053727971,0.64514817,1,1,1,6,1005.263,1,1,254.29,25.97,48.57,18.73,23.84,3.37e-4,0.0016,0.0605212,0.001,24,0.06,5.5339,2.0383,0.24,0.179,0.215,0.137,1.369,0.79,106,117.17,67.0433,0.2,0,0,0.100088,0.0093,0.442,0.005,1.302,0.699,0,0.36056,112.1889,3.1235,14.1609,1.2195,1.440885,0.0075,0.329015,0.0032,0.51,3.917343,5.694115,0.6992,0.00347,0.001,1.086924,116.47,4.05,1,1.066,12.499,0.0249,23.06,4.446,142.4,10.145,60.95,282.0821,6.3,1.63,80,159.9,0,92,119,58.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1408,43,43,0,1,96.4,190.91,25.57089,2.24,6,0.033940597,0.40714532,0,1,1,6,677.664,1,1,305.18,30.99,61.81,15.06,26.81,0.29204,0.0968,0.019839,2e-5,0.55,0.156,10.41848,2.0744,0.239,0.089,0.143,0.064,1.808,0.777,106.8,101.89,86.9866,0.05,3e-5,0.017,0.363456,5e-4,0.867,0.369,0.687,0.321,1.127,0.3981,126.668,0,10.7795,0.4242,4.399441,0.2364,0.398669,0.0483,10.74,2.199992,0,0,0.00565,0.001,1.220296,173.64,4.34,0,1.0668,11.104,0,26.72,4.039,143.9,5.151,68.37,196.08,5.51,2.21,54,190.07,0,72,114,96.62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1409,28,28,0,1,64.01,172.92,21.75273,1.75,7,0.046037525,0.55307016,1,1,3,7,4524.619,2,2,354.84,36.06,63.26,13.96,56.5,0,0,0.0515755,0.00298,24.47,0,6.06346,2.2529,0.198,0.227,0.281,0.237,1.017,0.772,98,112.61,66.1721,0.16,0,0,0.031098,0.0032,0.417,0.323,0.582,0.561,2.639,0.35156,120.1836,2.5668,11.1391,1.4747,0.390079,0.0095,0.444388,0.0052,0,6.770905,0,0.5326,9.7e-4,0.001,0.113569,342.75,4.5,0,0.9888,0,0.0041,33.89,4.566,137.4,6.693,70.53,262.1652,7.2,1.77,90,170.18,0,135,124,58.08,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,>1,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1410,59,59,0,4,75.02,174.9,24.72916,1.91,6,0.02746044,0.32967517,1,4,1,6,1410.259,2,2,1914.53,43.11,92.05,15.03,16.91,4.6e-4,0,0.0377315,8e-5,19.86,0.171,1.36043,2.1773,0.005,0,0.117,0.084,1.11,0.844,97.9,68.91,100.0671,0,3e-5,0,0.061003,6e-4,0.364,0.27,0.63,0.492,0,0.42674,132.7421,0.4451,0.0339,0.0019,3.125927,0.1392,0.761259,0.0052,15.35,3.800317,3.684076,0.0032,0,0.001,1.160428,355.76,5.07,0,1.0012,10.974,0.0204,25.41,4.816,137,3.415,64.04,190.1173,7.49,1.94,86,176.36,0,94,108,75.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158FF,Y,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1411,58,58,0,3,77.37,164.97,28.21951,1.86,6,0.073062334,0.87554608,0,3,6,6,6876.993,2,2,335.45,34.06,63.33,10.34,28.01,0,0,0.100618,0.01003,30.93,0,8.95091,2.2099,0.195,0.292,0,0,0,0,101.9,101.87,66.6904,0.33,0,0.0086,0.120487,0.0098,0,0,0,0.002,0,0.38962,116.0271,1.2814,6.1154,0.2554,0.798171,0.1166,0.93005,0.0796,26.09,5.809051,10.210859,0.7588,0.00567,0.001,1.571981,289.39,4.79,0,1.0051,14.454,0.0105,0.96,4.29,138.6,3.438,57.07,212.5123,8.28,1.97,80,165.05,0.1,85,119,79,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1412,82,82,1,4,42.16,153.66,18.16799,1.36,7,0.100015723,1.1991125,0,4,3,7,9035.754,2,2,317.9,25.19,130.14,5.74,17.71,0.004056,0.007,2.579e-4,7e-5,2.26,0.169,5.00728,2.4224,0,0,0,0,0.004,0.009,101,36.38,79.8592,0.46,9e-5,0.0308,0.340352,0.0243,0.054,0.261,0,0,1.411,0.28359,111.0512,1.3273,11.3988,0.6596,1.040161,0.2192,0.449326,0.0815,0.33,1.574491,4.882269,0.6226,0,0,0,202.78,4.13,0,0.9117,11.383,0.0519,29.63,3.427,140,6.877,73.96,247.9372,3.11,1.26,72,153.22,0,69,121,41.16,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,N,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1413,71,71,1,2,88.03,158.28,35.59007,1.92,8,0.077915064,0.93456225,1,2,3,8,8204.802,2,2,340.04,43.14,62.38,28.08,26,0,4e-4,0.0200081,1e-4,1.52,0,4.92177,2.4647,0.134,0.096,0.096,0.052,0.881,0.647,100,60.34,101.766,0,1.3e-4,0.0114,0.234428,9e-4,0.453,0.402,0.319,0.208,0,0.41165,139.3926,0.0015,5.7863,0.6788,0.853688,0.0096,0.460261,4e-4,26.5,3.563332,4.330547,0,0,0,1.146905,326.83,4.71,0,1.0051,7.342,0,0,4.549,135.8,8.563,60.05,446.0641,5.69,1.9,82,160.03,0,57,136,91.36,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,>= 75,I,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1414,55,55,0,2,57.09,160.19,22.4966,1.6,7,0.095801925,1.14966306,0,2,2,7,2637.548,1,1,128.15,42.04,163.92,18.85,17.06,2.46e-4,5e-4,0.0399098,0.00791,25.95,0.081,0.09373,2.4968,0.321,0.131,0.19,0.073,2.08,0.831,101.1,94.06,62.8818,0.27,0,0.0101,0.300073,0.0684,1.749,0.616,0.509,0.157,0.388,0.40816,140.8385,2.6615,7.2667,0,2.023735,0.2819,0.102005,0.0893,0.41,2.108479,4.404945,0.5901,3.4e-4,0.001,1.099586,356.37,4.13,0,0.9008,7.312,0,0,4.931,143,8.579,76.98,362.6551,4.3,1.8,70,162.8,0,80,109,62.46,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1415,56,56,1,3,99.06,172.98,32.89309,2.1,6,0.022391267,0.26859014,0,3,3,6,10801.603,1,1,428.14,38.28,259.03,20.28,33.74,0.198883,0.0043,4.02e-5,0,29.96,0.055,9.878,2.2926,0.107,0.026,0.034,0.018,1.002,0.735,96.1,112.85,69.596,0,7e-5,0,0.166407,1e-4,0.34,0,0.634,0.361,1.223,0.3681,127.9744,1.7905,5.9933,1.2974,2.243119,0.1184,0.899198,0.0044,0.8,14.140081,9.613829,0.6894,0,0,1.396156,672.5,4.5,0,1.1069,13.73,0.0161,38.62,4.491,137,3.412,71.9,196.8771,15.87,2.06,69,171.94,0,93,129,95.88,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1416,47,47,0,3,74.72,180.77,22.23762,1.95,7,0.040260697,0.48277723,0,3,6,7,594.702,1,1,267.6,37.91,96.82,51.39,39.57,0.003356,0.0029,0,0,1.38,0.05,6.37507,2.6011,0.107,0.087,0.067,0.046,0.344,0.004,91.9,71.28,102.7996,0.39,4e-5,0.0158,0,0,0.097,0,0.196,0.141,1.478,0.44084,140.3451,0.0131,0.1123,0.397,2.225627,0.172,0.598902,0.0017,0,10.059307,5.834618,0.7304,0.00156,0,1.055453,224.44,5.13,0,0.9079,10.271,0,0.45,4.754,138,8.112,64.02,531.3259,14.2,1.87,73,180.24,0.1,64,104,70,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,Yes,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1417,73,73,0,3,59.26,169.51,20.69354,1.66,6,0.122345945,1.46875655,0,3,2,6,518.837,1,1,202.66,39.91,88.28,4.47,12.97,3.69e-4,6e-4,0.0099547,7e-5,26.96,0.14,6.79423,2.479,0.146,0.239,0.022,0.054,0.289,0.806,107,43.33,95.7814,0.44,1e-4,0.0172,0.150177,4e-4,0.023,0.394,0.204,0.359,0,0.44966,136.6868,2.7907,11.1961,0.6382,0.741691,0.0969,0.14953,0.0607,0,2.500811,0.538614,0.0388,0.00583,0,1.058775,149.33,5.76,0,0.992,11.768,0.0218,47.46,4.574,136,15.5,75.85,339.8645,4.2,1.65,76,169.82,0,63,125,57.91,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1419,70,70,0,3,62.03,165.02,22.72109,1.68,6,0.06221806,0.74681276,1,3,1,6,1006.216,2,2,169.49,32.04,75.03,13.91,14.68,0.002343,0.0023,0,0,22.43,0.052,4.9914,2.3007,0.156,0.191,0.112,0.094,0.917,0.751,0,121.71,41.5997,0.22,1.9e-4,7e-4,0.076376,0,0.578,0.414,0.292,0.287,0.554,0.36193,116.0167,2.5783,9.235,0.3694,1.06485,0,0.460628,0,0,5.09935,0,0,0.00378,0,0,295.56,3.26,1,1.3708,9.619,0.085,33.58,4.234,137.9,5.111,56.23,200.0098,6.13,1.67,69,165.09,0,72,127,63.26,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
1420,76,76,0,3,87.26,164.02,32.48214,1.95,7,0.071371057,0.85559188,0,3,4,7,5315.567,2,2,276.05,25.43,65.55,21.55,21.07,1.76e-4,0.0014,0.0516382,0.00507,25.6,0.081,24.73129,2.1997,0.236,0.162,0.11,0.099,0.931,0.784,101.9,72.45,79.521,0,2.3e-4,0.0128,0.090166,0.0197,0.751,0.591,0.258,0.269,3.454,0.41968,140.9393,3.4327,8.7815,1.5163,1.556406,0.0759,0.698155,0.0763,0.7,4.980954,0.646001,0.4872,8.8e-4,0,1.095571,99.42,3.06,1,1.0368,0.782,0.0323,0,4.692,137.1,9.223,55.02,151.8059,7.72,2.02,69,165.04,0,79,127,94.57,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1421,73,73,0,4,106.32,168.22,38.7797,2.15,6,0.054798853,0.6570852,0,4,1,6,2205.473,2,2,560.41,44.09,146.65,67.21,37.17,0,4e-4,0.044606,0.00688,0,0,9.68515,2.258,0.286,0.241,0.252,0.24,1.065,0.911,102.9,95.53,70.9453,0.09,8e-5,0,0.100288,0.0319,0.74,0.669,0.292,0.285,1.098,0.46362,153.224,1.1148,0.1313,0.2986,1.401912,0.2581,1.068062,0.0675,0.76,9.716478,3.523618,0.653,0.00113,0,1.099561,354.83,4,0,1.0054,9.902,0,28.52,6.015,135.1,6.977,73.95,273.283,12.94,2.3,93,169.99,0,86,156,104.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1422,67,67,0,2,65.46,145.98,31.13417,1.6,8,0.045870468,0.55052007,2,2,4,8,1681.175,2,2,638.46,34.8,99.33,16.14,31.16,6.1e-4,2e-4,0.0300144,0.00368,2.19,0.06,0.05468,2.0544,0.273,0.27,0.095,0.108,0.599,0.123,103.9,69.59,84.5525,0,1.5e-4,0.0043,0.231934,0.0438,0.263,0.281,0.226,0.207,2.7,0.2662,95.3313,4.5965,24.4607,2.681,1.000016,0.1661,1.160776,0.1202,0.53,10.78877,3.90724,0.7077,0.00162,0.001,0.021751,147.85,3.5,1,1.0012,12.446,0,21.69,3.35,138.4,8.361,72.93,261.9316,12.25,1.56,78,144.79,0,103,125,64.87,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1423,69,69,1,3,80.71,162.62,31.19498,1.88,6,0.042076467,0.50472169,1,3,2,6,5665.33,1,1,401.82,44.04,96.97,18.46,12.96,0.08864,0.0187,0.0260474,1e-4,1.93,0.17,11.05266,2.3043,0,0,0.018,0.017,0.038,0.581,100,96.89,53.3313,0.17,1.8e-4,0.0065,0.099351,0.0231,0.005,0.008,0.042,0.158,0,0.36212,128.9329,0.0072,9.4309,1.9538,2.395535,0.3466,0.41111,0.088,0.1,5.27056,4.207786,0.7305,0,0,1.141975,322.81,4.51,0,0.9919,10.635,0.0527,23.95,3.997,140,5.176,73,247.6633,8.55,1.86,76,162.87,0,66,136,78.13,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1424,71,70,1,3,70.83,159.19,27.86222,1.73,6,0.036197883,0.43489071,0,3,5,6,5656.833,2,2,277.06,35.98,80.17,12.09,21.99,9.9e-5,0,0.0300094,5e-5,27.89,0.088,0.11997,2.3717,0.028,0.078,0,0,0,0,98,74.2,78.9033,0,0,0,0.50011,1e-4,0,0.329,0,0,5.632,0.47197,147.898,1.7135,7.7157,0.2114,1.699595,0,1.096755,0,0,6.031562,0.110444,0,0,0,1.243603,450.44,5.24,0,1.1169,13.177,0,32.12,4.856,137,10.968,73.07,385.6703,9.19,1.84,69,161.81,0,69,116,78.06,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1425,55,56,0,2,72.56,161.47,28.00662,1.78,7,0.115272011,1.38315071,1,2,2,7,524.632,2,2,212.2,40,224.52,18.87,25.98,0.00168,0.0016,0.0120793,0.00702,3.56,0.081,3.13197,2.2085,0.118,0.295,0.065,0.139,0,0.018,104.1,125.85,56.0324,0.34,1.5e-4,0.0316,0.453684,0.0495,0.167,0.384,0,0.002,0,0.33061,112.2729,3.1107,7.3066,0.9478,0.540793,0.0118,0.238049,0.0643,0.61,3.627414,4.432714,0.627,0,0,1.097203,242.09,3.9,1,1.065,11.317,9e-4,29.05,4.017,142,8.969,70.02,288.5545,5.01,1.78,66,160.98,0,93,109,75.08,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,1,131HH,158VF,Y,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1426,62,62,0,1,52.84,160.1,20.51869,1.53,7,0.074928895,0.89933387,0,1,4,7,4752.843,1,1,263.06,41,396.64,12.27,33.61,0.002412,0.0017,0.0421448,0.00295,21.45,0.165,4.00739,2.2944,0.228,0.131,0.2,0.151,2.08,0.882,102,66.63,71.3916,0.01,1.7e-4,0.0077,0.049971,9e-4,1.314,0.527,1.102,0.513,3.146,0.41062,138.0828,1.896,13.0231,0.3367,1.009847,0.1387,0.459456,0.0905,0.26,4.063579,4.417273,0.5966,0.00253,0,1.096592,207.36,4.31,0,1.1587,16.946,0.0267,30.87,4.507,135.9,52.624,59.22,196.9458,6.04,1.46,71,160.15,0,73,103,50.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1427,70,70,1,2,78.08,172.02,25.51406,1.92,7,0.105591779,1.26580485,0,2,2,7,2758.891,2,2,377.95,36.18,98.58,18.86,28.83,0.001918,0.0025,0.0348549,8e-5,27.95,0.132,12.91563,2.3931,0.049,0.096,0.024,0.066,0.528,0.748,99.3,78.21,70.7148,0,0,0,0.003996,4e-4,0.232,0.422,0.191,0.223,1.311,0.32578,117.7916,1.1801,9.499,0.8925,1.530832,0.2231,2.182264,0.076,0.65,7.119511,0,0.0136,0,0,1.259619,214.15,4.5,0,0.924,0.745,0.0143,29.89,3.504,137.9,9.013,73.92,329.8031,10.82,1.94,62,171.99,0,59,124,80.3,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1428,61,61,1,2,59,164.91,21.56397,1.64,8,0.100307275,1.20347669,1,2,5,8,9011.972,1,1,494.6,35.04,85.98,65.14,176.49,0,0,0.0199244,0,26.04,0.132,4.28424,2.3941,0.149,0.153,0.133,0.097,1.07,0.72,100,70.98,93.8568,0,5e-5,0.0047,0.011134,0,0.481,0.325,0.481,0.299,0.605,0.40141,128.4559,2.9019,15.9488,0.001,1.130147,0.0084,0.910111,0.0014,0,3.607473,0.15645,0.0189,0,0,1.269951,158.6,4.11,0,1.1895,0.586,0.0145,1.05,4.718,136,20.538,77.77,273.8349,6.92,1.72,79,163.01,0,91,115,61.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1429,75,75,1,4,68.22,163.04,25.0089,1.73,6,0.017971785,0.21576894,1,4,1,6,7380.615,1,1,222.31,36.08,67.62,15.89,19.94,0.001561,0.002,0.118032,0.0074,28.33,0.002,7.87952,2.3366,0.14,0.118,0.106,0.077,0.737,0.585,101.9,60.63,83.0895,0,0,0.0014,0.041019,6e-4,0.404,0.279,0.273,0.207,1.116,0.31776,97.7391,5.1836,23.6002,2.9815,1.551133,0.0609,0.680399,0.0469,1.09,5.894342,0.679759,0,0,0,0.937981,267.94,4.5,0,1.4917,22.714,0,38.13,3.436,136.9,13.269,67.06,214.1856,8.43,1.74,61,163.18,0,90,110,70.07,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,High,Q3 ITT,High,Normal,N,NA,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,NA,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1430,61,61,2,5,67.03,168.05,24.02583,1.77,8,0.059666583,0.71647456,0,5,4,8,16673.38,1,1,524.46,41.51,158.94,20.87,31.64,0,0,2.891e-4,0,27.04,0.12,10.29987,2.3104,0.053,0.136,0,0,0.414,0.682,101.9,51.42,132.5516,0,0,0,0.140602,0,0.372,0.461,0.004,0.117,5.818,0.36341,122.4169,2.5809,14.6089,0.6841,0.487782,0,0.616722,0,0,10.596036,5.555032,0.0046,0.00152,0,1.304205,329.76,3.79,0,1.0626,11.911,0.0497,35.87,3.905,138,5.5,73.07,289.6527,10.13,1.72,71,164.98,0,74,135,66.71,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1431,61,62,0,2,57.05,150.38,24.76724,1.52,7,0.063963988,0.76847608,1,2,4,7,5054.653,2,2,208.47,23.87,43.96,25.81,20.49,0.001978,3e-4,0.0200317,2e-5,1.61,0,8.89955,2.352,0.084,0.063,0.044,0.058,0.363,0.668,99.1,86.44,49.0609,0.68,1.1e-4,0.303,0.039309,0,0.168,0.41,0.175,0.21,0,0.37802,128.9847,1.0047,0.0994,1.2082,0.773882,8e-4,0.688721,0.0019,0,12.086958,6.432428,0.4976,0.0082,0.001,1.192178,240.08,4.55,0,0.9804,10.669,0,24.7,4.287,144.9,6.958,48.15,113.3371,13.9,1.69,57,152.87,0.1,65,116,62.54,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1432,51,51,0,2,58.98,172.98,20.54531,1.69,7,0.106124457,1.27213299,0,2,2,7,1988.962,2,2,390.29,47.51,80.75,58.16,21.98,0.001165,0.0017,0.069757,8e-5,22.49,0,4.60041,2.2182,0.265,0.219,0.079,0.017,1.291,0.792,97.8,67.4,93.3608,0,0,0,0.139826,0.0034,0.647,0.426,0.406,0.261,0,0.4173,144.9505,1.0714,7.0054,0.0099,2.797243,0.1935,1.093599,0.1108,23.2,8.843186,7.853466,0.7267,0,0,1.295924,336.29,4.99,1,0.9987,13.329,0,32.02,4.741,138.1,14.742,77,362.9501,15.37,1.62,67,175,0.1,88,120,58,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NA,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1433,43,43,1,2,34.57,148.34,16.2148,1.21,7,0.078231588,0.93966557,1,2,5,7,16193.655,1,1,300.66,33.13,59.85,16.92,21.22,0,0,6.73e-5,0.01077,28.46,0.116,3.70805,1.9087,0.213,0.241,0.209,0.211,0.535,0.698,99,70.12,70.6921,0.18,3e-5,0.0012,0.089719,0.0782,0.256,0.318,0.283,0.307,0,0.33303,115.8076,0,8.4534,0.8769,1.655973,0.4599,0.174811,0.0958,0.43,3.772926,6.201078,0.821,0,0,1.000489,208.52,3.89,0,0.9925,0,0.0538,23,4.015,141,0.062,58.02,161.5092,5.2,0,59,147.96,0,68,101,0,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,2,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1434,49,49,0,2,66.82,175.1,21.79847,1.83,6,0.047747173,0.57257645,2,2,5,6,2612.076,1,1,193.26,34.09,45.82,11.9,16.11,0,0,0.0099083,0.00287,27.23,0.118,0.12038,2.3482,0.194,0.124,0.336,0.199,0.828,0.778,101,104.24,54.5795,0.16,5e-5,0.0195,0.157442,0.0666,0.425,0.374,0.409,0.363,0,0.35076,115.9062,2.5175,16.3386,1.4918,1.344724,0.0078,0.800083,0.0895,16.04,5.543537,0.003015,0.0164,0,0,1.075147,530.98,3.78,0,0.9883,12.408,0,25.71,3.681,137,6.91,66,363.0145,7.21,1.77,70,175.6,0,84,121,67.85,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1435,77,77,1,2,60.08,160.08,23.53021,1.62,6,0.015986168,0.19193852,1,2,5,6,8333.063,1,1,429.24,34.48,43.97,13.97,17.97,0.002148,9e-4,0.0680811,0.01268,0,0.111,5.33652,1.9297,0.126,0.203,0.134,0.16,0.333,0.31,101,50.18,79.1419,0,0,0,0.078847,0.0495,0.453,0.522,0,0.001,4.695,0.27299,87.0641,0.3369,9.0909,0.5328,1.301802,0.3351,0.400155,0.1207,30.32,2.134604,3.496688,0.6306,0,0.001,0.959236,281.84,3.91,0,1.0433,0,0.0532,0,2.479,135.9,8.422,52.53,286.8159,3.95,1.65,64,162.97,0,69,136,66.67,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1436,27,27,0,1,50.29,160.14,19.29858,1.51,7,0.044743328,0.53671644,1,1,3,7,2098.722,1,1,397.04,30.91,106.46,11.96,29.08,0,0,2.945e-4,9e-5,0,0,6.55978,2.2095,0.279,0.244,0.163,0.149,0.843,0.649,94,95.45,69.9704,0.03,0,5e-4,0.05988,3e-4,0.177,0,0.629,0.556,1.561,0.3658,125.2533,3.0961,14.4147,0.4487,0.819665,0.0061,0.800723,0.0032,0,10.063365,7.62251,0.6442,0,0,1.090979,476.86,3.81,1,1.0778,11.934,0,33.68,4.604,137.1,6.844,70.03,311.3402,9.48,1.51,87,163.8,0,87,138,50.86,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1437,77,77,0,2,112.51,197.7,27.75934,2.49,6,0.05253448,0.63024457,1,2,1,6,2265.31,1,1,220.12,39.94,165.03,77.15,40.03,0,0,0.0190173,1e-5,29.06,0.11,5.53716,2.0983,0.182,0.196,0.085,0.075,0.83,0.711,103.1,47.37,149.6404,0.4,2.2e-4,0.0102,0.199895,2e-4,0.636,0.556,0.213,0.002,0,0.39368,134.5068,2.0937,12.3083,0.5193,1.394182,0.0073,0.370135,4e-4,0,3.327873,0,0,7e-4,0,1.151547,100.65,4.51,1,0.984,0,0.0077,31.21,3.874,139,17.807,58.9,297.9232,5.8,2.4,85,197.46,0,79,120,106.3,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1438,67,67,0,3,62.06,178.01,19.88605,1.75,6,0.034846629,0.41855309,0,3,2,6,2497.36,1,1,160.9,35.5,90.96,13.9,13.75,0,0.0011,2.367e-4,2e-5,0,0.1,7.17723,2.2479,0.089,0.073,0.074,0.08,0.856,0.798,101.9,65.27,85.3875,0.52,0,0.0094,0.016368,0,0.577,0.528,0.245,0.243,0.293,0.37137,122.7698,0.0093,0.106,0.7192,1.100868,0.0097,0.532652,5e-4,0.03,6.652713,0,0,5.5e-4,0,0.839795,213.48,4.5,0,0.9908,0,0.026,31.35,3.777,137.9,3.415,61.03,275.7599,9.82,1.63,58,178.77,0,77,100,59.6,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1439,68,68,0,3,48.59,146.63,22.94258,1.41,6,0.146020646,1.75207468,0,3,6,6,2143.748,1,1,170.06,38.96,64.66,13.91,20.95,0.002233,0.0011,0.0099342,0.00985,0.02,0.054,0.0685,2.1136,0.004,0.103,0.003,0.045,0.504,0.84,106.3,76.11,60.1065,0.11,3e-5,0.0018,0.069504,0.0327,0.295,0.563,0.134,0.258,0,0.29932,109.5947,1.4988,12.1983,1.9899,0.718,0.3421,0.220221,0.1197,28.87,2.703217,6.857486,0.5312,0.004,0,1.138552,153.38,4.09,0,1.0929,10.236,0.0271,28.97,3.843,135.8,20.811,70.04,232.452,3.86,1.52,46,148.26,0,73,112,53.76,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,3,>1,131HH,158VF,Y,Y,N,N,High,High,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1440,70,70,0,3,129.39,186.97,37.8644,2.49,6,0.265832313,3.18927568,1,3,4,6,1848.021,2,2,188.19,39.91,64.87,20.52,19.89,2.5e-5,0,6.76e-5,4e-5,26.06,0.415,4.75684,2.1929,1.726,0.552,0.415,0.118,4,0.864,100,107.21,67.1917,0.31,0,0.0163,0.200562,0.0154,2.249,0.517,2.656,0.607,0,0.46841,151.1642,2.8998,10.3852,2.1461,3.574986,0.1735,0.686643,0.0033,11.18,2.306253,0,0,0,0,0.931474,145.03,4.13,0,0.9406,0.543,0,29.83,5.455,143,193.832,65.99,473.6968,4.98,2.63,69,190.05,0,67,109,130.48,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,NA,NA,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1441,63,63,1,1,88.02,185.53,25.10137,2.12,6,0.05487177,0.65921273,1,1,2,6,4042.716,1,1,268.68,42.01,61.93,10.97,13.78,0,0,0.0199324,7e-5,28.34,0,7.74413,2.5062,0.699,0.273,0.578,0.2,1.88,0.737,95.3,59.03,117.497,0.03,1.6e-4,0.0122,0.201557,5e-4,1.194,0.473,0.54,0.275,0,0.40914,138.968,0.0149,0,1.0125,1.519858,0.0017,0.862536,8e-4,0,5.812116,0.013136,0.0026,0,0,0.96089,398.93,5.02,0,1.0089,0,0.0524,32.82,4.874,143.2,5.99,70.32,315.4915,7.46,2.08,65,182.8,0,63,111,83.24,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1442,63,63,1,4,74.09,172,25.07062,1.9,6,0.098247641,1.17854154,0,4,6,6,11032.588,2,2,168.85,35.07,43.97,26.72,21.07,0,0.0018,0.0296233,0.00403,22.59,0.001,3.52586,2.0923,0.157,0.229,0.077,0.06,0.643,0.62,104.1,80.23,90.1907,0.11,0,2e-4,0.370311,0.0089,0.296,0.312,0.181,0.165,0,0.28711,94.2206,1.964,1.7654,0,1.039762,0.1298,0.359491,0.0861,0.15,4.455242,0.595036,0.0413,0.00475,0,1.245392,145.66,4.19,0,1.1838,12.93,0,27.29,3.391,141.9,5.709,3.35,362.1986,7.79,2.01,51,170.57,0,89,122,79.02,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,< 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,High,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
1443,50,50,1,3,54.54,162.04,20.96717,1.57,6,0.044057544,0.52830255,0,3,6,6,3943.686,1,1,778.53,40.2,93.67,9.97,24.81,0.00153,0.0014,0.0296058,0,28.03,0.072,6.79027,4.7525,0.328,0.419,0.048,0.015,0.694,0.021,106.1,91.22,73.6884,0,1.2e-4,0,0.234695,0,0.159,0,0.339,0.251,0,0.39643,127.9746,1.83,10.7957,0.6286,2.030127,0,1.263063,0,29.98,7.521406,0.278421,0,0.00264,0,0.997147,302.31,4.49,0,1.1054,0.459,0.0319,29.99,4.654,137,7.976,75.88,292.3518,13.96,1.51,67,164.16,0,84,109,56.99,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1444,49,49,0,4,56.93,159.71,22.6208,1.58,6,0.058241178,0.69905479,1,4,4,6,357.69,1,1,146.39,41.45,377.42,34.06,21.11,0,0,3.548e-4,8e-5,22.15,0.101,4.68869,2.0989,0,0,0.031,0.032,1.293,1.091,106,122.46,46.4388,0.05,3.4e-4,0.0061,0.169993,0.0069,0.48,0.464,0.722,0.68,0,0.40146,125.4395,1.7234,10.4092,0.681,1.705176,0.0104,0.808651,0.005,17.92,4.904484,5.196424,0.6632,1.4e-4,0.001,1.042657,274.89,4.14,0,0.9533,12.562,2e-4,26.01,4.39,136,13.32,73.05,195.079,7,1.5,80,155.96,0,101,137,50.32,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1445,72,72,0,1,63.01,152.08,26.70819,1.58,6,0.062357062,0.7483005,0,1,6,6,2181.023,1,1,491.16,41.11,112.04,12,61.19,0.003149,0.0028,0.0995525,2e-5,30.47,0.208,4.89391,2.3253,0.288,0.375,0,0,0.051,0.545,106.2,76.11,64.3395,0.12,0,0,0.319891,6e-4,0.002,0.122,0.1,0.228,0,0.34025,99.115,0.9213,0.0249,0.5025,1.193719,0.128,1.985103,0.0806,26.04,2.701087,5.007114,0.0161,0,0,1.955955,136.1,4.23,0,1.2851,14.54,0.0333,49.81,3.949,137.1,6.828,75.85,472.5502,5.21,1.61,80,152.83,0,78,141,63.1,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,Yes,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1446,61,61,1,4,72.93,177.96,23.66202,1.91,6,0.054522397,0.65429628,0,4,4,6,18320.613,2,2,729.8,39.1,353.16,19.06,25.19,0,0,0.0198904,0.00115,29.99,0.294,4.87756,2.2633,0.042,0.007,0,0,0.457,0.552,0.4,70.65,87.2745,0.01,0,0.0051,0.189954,0.0304,0.156,0.006,0.209,0.18,1.278,0.37456,123.3387,0,13.0088,0,1.566342,0.2708,0.509749,0.0534,0.71,2.39414,0,0,0,0,1.333644,199.47,3.99,0,0.9995,0.178,0,24.69,4.341,139,6.172,59.03,340.6041,3.72,1.92,70,177.82,0,99,119,69.15,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,158FF,N,Y,N,N,Low-Intermediate,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,NA,Y,M,Yes,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1447,58,58,0,2,46.08,158.7,18.74349,1.45,6,0.016003315,0.19162971,0,2,4,6,1259.875,2,2,936.61,28.54,51.75,16.82,21.96,0.003728,0.0039,0.018499,0.00219,24.95,0.1,4.9953,2.199,0.268,0.268,0.098,0.127,0.941,0.81,97.9,74.45,70.6957,0,0,0,0.071192,9e-4,0.573,0.526,0.469,0.317,1.815,0.36108,120.955,1.3798,9.3311,0.7175,1.46011,0.2152,0.603968,0.0683,0,3.620475,0,0.0261,0.00461,0.001,1.224226,226.74,4.4,0,0.9153,11.158,0,26.17,3.989,138,10.248,58.99,309.0667,7,1.34,68,155.14,0,75,104,43.93,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,High-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1448,74,74,1,5,59,171.42,20.69819,1.69,8,0.180335078,2.15933402,0,5,3,8,6065.279,2,2,375.05,27.98,105.34,32.96,24.12,6.6e-5,4e-4,0.0297558,6e-5,26.02,0.085,4.60111,2.4472,0,0,0.038,0.034,1.066,0.739,98,36.23,111.7307,0,0,0.0029,0,0,0.442,0.328,0.36,0.256,0,0.26188,85.7109,0.5608,7.3073,0.4456,1.905165,0.0059,0.70986,0.003,0.64,6.104846,3.002908,0.039,0.00325,0,1.378616,387.72,4.62,0,0.9465,0,0,33.36,3.066,138.1,2.928,67.06,196.1152,10.06,1.7,65,168.01,0,79,107,58.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,< 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,3,0,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1449,81,80,0,3,94.26,165.09,34.58809,2.03,6,0.122827158,1.47152357,0,3,5,6,9371.181,2,2,1007.34,39.34,264.81,53.93,82.05,0.002377,0.002,0.0300059,9.2e-4,29.98,0.051,13.53801,2.493,0.247,0.224,0.068,0.08,0.248,0.005,104.4,70.63,82.249,0.34,9e-5,0.0118,0.040413,7e-4,0.144,0.325,0.071,0.001,2.561,0.41274,138.8454,2.901,11.5935,1.2951,1.107718,0.0131,0.37222,0.0526,0.42,2.801311,5.696689,0.7987,0.00608,0.001,1.352447,235.62,4.51,1,1.1919,13.375,0.0286,26.33,4.41,137,18.034,74.97,462.8229,4.6,2.03,61,167.93,0,75,110,97.64,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,1,131HH,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1450,73,73,1,2,78.98,184.96,23.23231,2.02,6,0.068576038,0.82330925,0,2,1,6,9389.227,2,1,137.39,32.26,49.1,40.16,28.07,0,0,0,0.00151,23.85,0.101,13.75264,2.3023,0.242,0.238,0.093,0.09,0.704,0.738,101.9,73.06,84.9834,0,0,0,0.201046,0.0353,0.424,0.446,0.294,0.258,1.464,0.43041,142.3784,2.6432,15.6864,0.3546,0.703436,0.2113,0.589942,0.0894,0.83,3.21047,5.393024,0.0114,4.9e-4,0.001,1.006492,167.82,3.39,0,1.1939,0,0.0732,32.46,4.768,136,12.357,67.08,231.9854,6.03,2.05,71,186.08,0.1,67,118,78.86,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1451,59,60,0,0,73.03,180.23,23.06673,1.94,7,0.142939558,1.71516765,0,0,1,7,1060.129,1,1,387.26,44.99,123.17,79.01,34.95,0.002182,4e-4,0.0400073,8.7e-4,26.59,0,10.36955,2.2768,0.503,0.53,0.054,0.077,0.482,0.589,99.9,75.09,91.0615,0.06,1e-5,0.0116,0.009818,6e-4,0.184,0.244,0.297,0.398,0,0.45237,159.2783,0.007,0.0365,0.0062,0.687127,0.0685,0.119101,0,0,5.023186,6.748158,0.7762,0,0,1.109984,146.67,4.8,1,1.0952,0,0.0152,27.13,4.938,140.9,17.906,69.13,386.2684,6.21,1.79,80,176.64,0.1,65,129,67.88,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,>= 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1452,32,32,1,3,42.05,163.05,15.68115,1.4,8,0.018040058,0.21645164,1,3,2,8,7370.541,1,1,511.79,26.92,205.07,16.08,33.99,0,0,1.313e-4,0,31,0.095,0.07293,1.9935,0.088,0.076,0.065,0.09,0.212,0.006,98.1,141.62,39.1042,0.04,8e-5,0.0054,0.04574,2e-4,0.014,0,0.215,0.233,2.519,0.32944,99.5625,3.0915,14.6238,0.7895,0.678589,0.0041,0.212128,0,0.2,2.502041,3.692001,0.0231,0,0.001,1.420541,348.72,3.3,0,1.0686,11.718,0,27.31,4.508,137,48.698,68.41,165.6577,3.68,1.37,71,160.14,0,109,120,37.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1453,58,58,0,1,60.57,171.18,21.31369,1.71,6,0.037607284,0.45179322,0,1,1,6,199.726,2,2,142.09,47.51,64.13,16.61,17.78,0.002418,0.0016,2.377e-4,5e-5,27.57,0.167,2.87481,2.3247,0.283,0.166,0.127,0.073,1.575,0.76,106,98.8,62.1136,0,0,0,0.096355,0.0309,0.843,0.393,0.686,0.311,1.815,0.37768,127.3957,3.8706,18.5515,0.9618,2.00675,0.0116,0.172039,0.0035,15.34,2.659381,0,0.0309,0.00275,0,0.831312,146.42,4.21,0,1.0529,13.603,0.0052,30.39,4.365,140.9,11.962,79.01,290.0992,3.9,1.82,81,170.05,0,83,115,59.95,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1454,77,77,2,2,87.01,170.17,30.488,2,6,0.015154747,0.18179659,0,2,2,6,24694.316,1,1,247.99,26.8,76.85,13.99,11.96,0.002935,0.0023,0,0,20.41,0.07,Inf,2.0835,0.163,0.057,0.126,0.064,0.812,0.56,98.1,91.69,70.8294,0,0,0,0.006551,0,0.642,0.398,0.196,0,0,0.32004,116.95,1.284,0,0.3384,2.502469,0,1.007445,0,0,6.992024,0,0,0.00391,0.001,0.969388,146.63,3.89,0,1.0012,0.269,0.0344,23.1,3.405,132.5,7.03,3.02,285.0396,10.68,1.98,75,172.91,0,89,111,94.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1455,60,60,0,3,73.94,181.91,22.41498,1.98,6,0.042861235,0.5145443,1,3,4,6,1034.212,1,1,366.99,32.01,160.38,14.04,23,0.001145,0.0014,1.106e-4,5e-5,25.35,0.268,0,2.0764,0.21,0.318,0.092,0.111,0.866,0.814,112.1,119.32,54.8014,0.21,0,0.0061,0.36747,0.01,0.561,0.56,0.264,0.291,0.722,0.3732,109.3293,2.844,9.6382,0.6994,0.509818,0.105,0.313432,0.0759,28.07,2.393744,0,0.0288,0,0,0.349048,197.81,3.79,0,1.1005,10.25,0.0439,38.02,3.943,138.1,127.443,66,353.7646,3.69,1.92,70,175.82,0,80,126,68.03,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1456,75,75,0,2,64.9,175.9,21.61283,1.79,6,0.082714902,0.99365857,1,2,2,6,180.429,1,1,229.71,45.03,82.6,7.3,10.04,0.003073,0.0032,0.0099314,0.0022,0,0.12,5.68815,2.3921,0.247,0.23,0.187,0.116,0.902,0.753,94.3,82.61,65.043,0.35,9e-5,0,0.201235,0.0195,0.504,0.402,0.347,0.305,1.859,0.45238,141.0333,2.1806,7.6618,0.477,2.243277,0.2022,0.300971,0.0842,21.43,2.583244,3.963096,0.641,0.00446,0,0,351.98,4.6,0,1.0566,11.328,0,30.99,4.909,142.9,6.039,69.94,346.2091,4.77,1.73,82,176.19,0,62,119,63.89,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1457,77,77,0,5,75.03,177.23,24.22008,1.93,6,0.066368969,0.79544056,1,5,3,6,5183.243,2,2,294.68,35.36,67.46,17.86,16.17,0.002649,0.0021,0.0198755,0,22,0.089,4.18694,2.0046,0.34,0.185,0.107,0.093,0.885,0.775,102.1,74.6,67.0701,0.35,0,0.0069,0.004148,0,0.56,0.476,0.346,0.287,0,0.43951,146.9132,3.2195,11.9904,0.7786,1.116727,0.0091,0.566274,0.0492,0,4.212897,1.77522,0.041,0,0,1.432186,193.14,3.89,0,1.0338,0,0.086,28.99,5.163,140,9.612,59.13,191.4519,6.43,1.83,70,176.36,0.1,82,116,76.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,M,Yes,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1458,73,73,1,3,109.43,168.02,39.75264,2.2,8,0.212410217,2.54704916,1,3,5,8,16890.111,2,2,298.07,44.97,96.63,9.03,13.14,0,0,0.0999906,4e-5,3.07,0.011,3.74994,2.5837,0.268,0.348,0.073,0.062,0.508,0.415,98,73.93,83.0616,0.02,5e-5,0,0.371579,8e-4,0.406,0.348,0.151,0.129,0,0.39546,128.6309,6.0288,14.335,1.3286,1.211056,0,1.469673,7e-4,0.27,10.879503,4.062112,0.0149,0.00591,0,0.844239,527.8,4.51,1,1.0059,13.076,0,27.35,4.824,136.9,11.488,76.97,363.6664,14.1,2.31,81,167.98,0,92,140,113.12,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
1459,61,61,0,2,68.08,179.4,21.73928,1.88,7,0.185078137,2.22358773,0,2,1,7,570.14,2,2,191.35,36.05,94.82,20.5,20.94,9.12e-4,0.0022,0.0300073,0,20.43,0.197,16.41996,2.2254,0.092,0.003,0.166,0.084,1.317,0.638,104.1,80.36,78.605,0,0,0.006,0.009938,0,0.454,0,0.648,0.355,1.843,0.34987,118.701,0,0,0,4.34896,0.1303,1.163173,0.0459,24.09,9.058602,3.016601,0.0235,0.00165,0,0.967761,217.2,3.8,0,1.0844,0.51,0.0384,26.95,3.88,140.9,10.672,65.1,93.6468,15.09,1.8,63,180.01,0,69,117,68.85,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,< 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1460,51,51,1,2,45.28,149.81,20.64897,1.38,6,0.116101046,1.3931331,0,2,2,6,3035.936,1,1,357.27,42.13,258.34,37.22,30.95,0.001539,0.0017,3.086e-4,0.00687,28.07,0.108,3.24916,2.0741,0.114,0.051,0.217,0.199,0.907,0.71,100,100.68,50.1906,0.33,0,0.0202,0,0.0109,0.487,0.401,0.394,0.286,0,0.30062,107.9961,1.782,5.9025,1.2273,1.001415,0.2542,0.413859,0.1071,10.7,3.642846,0.56646,0.0233,3.4e-4,0.001,1.340116,232.43,3.49,0,0.9596,0,0.0494,30.08,3.307,141,10.202,72.96,186.3809,6.94,1.24,67,149.21,0,79,123,44.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1461,78,78,2,4,129.3,172.91,47.64825,2.34,6,0.030034311,0.36032944,1,4,4,6,22775.113,1,1,391.94,39.1,62.92,22.19,29.09,0.001467,0.0015,0.0199459,0.00407,26.72,0.033,7.03965,2.3189,0.502,0.277,0.06,0.032,1.336,0.84,99,64.96,91.0037,0,0,0,0.158514,0.0444,0.731,0.503,0.581,0.479,0,0.35325,127.8605,1.4323,5.9416,0.0032,1.107844,0.2912,0.498736,0.1365,26.99,5.084057,4.175989,0.5743,0,0,1.352212,196.34,3.31,0,1.0804,11.619,0,0.71,4.267,139.1,10.24,68.99,407.907,6.49,2.39,69,169.78,0,85,136,117.37,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1462,69,69,0,4,45.75,149.73,20.63025,1.39,7,0.035745483,0.42932395,1,4,1,7,579.328,2,2,348.64,36.01,198.91,9.92,28.96,0.002327,0.0028,0.1230021,0.02081,34.35,0.193,0.10648,0,0.521,0.2,0.201,0.113,1.509,0.8,101,65.91,67.6721,0.11,0,0.0096,0.199902,0.041,1.568,0.704,0.338,0.133,2.462,0.25189,83.7743,1.3659,8.1877,0.4092,3.147501,0.4318,0.573955,0.1844,29.33,0.850678,0.269805,0.7183,0,0.001,1.028613,218.73,4.42,0,0.9351,12.82,0.0161,31.9,3.388,137.9,6.994,63.02,231.1021,3.37,1.33,48,150.35,0,102,105,48.12,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1463,67,67,0,2,66.89,164.51,24.60966,1.74,7,0.059998706,0.71950242,0,2,1,7,2309.592,2,2,174.25,43.98,76.89,15.74,15.52,0,0,0.0300227,0,29.93,0.083,6.96579,2.934,0.038,0.037,0.04,0.025,0.458,0,106.2,86.99,72.8273,0.02,2e-4,0.0103,0.20081,0,0.042,0,0.172,0.002,0,0.49582,172.2175,1.2393,8.8634,1.4874,1.705005,0,1.070995,0,0.57,7.300766,0.632496,0.0126,0.00239,0,0.969749,346.24,4.8,0,0.9983,13.148,0.0138,35.81,5.75,140.1,8.035,70.07,439.3074,11.6,1.69,81,167.91,0,86,122,73.75,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1464,61,61,1,4,68.02,163.05,25.27849,1.73,6,0.016703184,0.20039962,1,4,5,6,20160.913,1,1,537.53,28.95,401.78,26.01,42.05,0.00259,0.0025,0.0314907,9.8e-4,0,0.001,5.35082,2.2894,0.002,0.163,0.029,0.057,0.034,0.423,0.3,70.06,87.9989,0.1,0,0,0.100333,1e-4,0.012,0.003,0.082,0.251,3.6,0.3357,110.6337,1.1879,0.1058,0,0.598478,0,0.568192,0.0054,0.1,7.822097,4.160225,0.7407,4.7e-4,0,0.511544,303.2,3.11,1,1.1033,11.009,0,33.06,3.819,135,3.494,58.82,327.8194,8.73,1.76,73,164.96,0,87,121,67.18,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1465,51,51,1,1,71.41,173.44,23.80873,1.86,7,0.158648042,1.90464705,1,1,1,7,1001.787,2,2,277.81,43.02,54.09,38.57,20.05,0,0,0.0300295,9e-5,28.75,0.161,0.10756,2.3265,0.516,0.269,0.292,0.138,1.649,0.694,98,71.7,97.5906,0,6e-5,0.0077,0.010107,4e-4,0.78,0.281,0.863,0.427,0,0.45063,162.8285,1.2394,11.931,0.5591,3.997056,0.2546,0.398989,0.0472,0.71,2.043444,0.016763,0,0.00132,0.001,0.925593,46.29,3.3,0,0.9915,0.428,0.0488,28.9,4.612,140,10.264,70.43,324.7733,4.92,1.86,91,175.92,0,81,138,78.17,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1466,57,57,1,2,77.78,174.95,25.2526,1.93,6,0.013980969,0.16783303,0,2,5,6,4381.572,1,1,569.36,41.77,61.86,7.18,13.01,0.003655,0.004,0.0099914,9e-5,0,0.031,2.91758,2.3485,0.146,0.005,0.061,0.001,1.863,0.858,103.8,83.05,75.4517,0,0,0,0.005031,8e-4,0.838,0.41,1.079,0.644,0,0.42619,144.9036,3.508,13.5025,1.7562,1.306047,0.2019,0.220205,0.0524,23.16,2.497648,4.383581,0.5124,0,0,1.089743,167.94,4.01,0,0.9819,11.268,0.0393,29.1,5.232,143.5,7.001,75.13,344.405,4.9,1.91,80,174.15,0,84,134,77.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1467,30,30,1,1,82.34,173.54,27.59146,1.99,7,0.119915211,1.4391394,2,1,5,7,8246.305,2,2,572.22,39.99,90.31,74.06,30.03,0,0,0.079657,5.5e-4,23.41,0.116,5.71042,2.2492,0.102,0.005,0.075,0.049,0.599,0.586,102,104.41,84.5634,0.21,0,0.0167,0.099531,3e-4,0.117,0,0.31,0.311,0.665,0.34888,116.189,3.3204,12.6871,0.7667,1.900116,0.006,0.501109,0.0019,0,4.104457,0.550576,0,0.0025,0,1.244639,288.47,4.2,0,1.0223,14.058,0,30.14,4.101,135.1,10.698,78.01,335.2992,6.9,2.05,76,173.97,0,100,117,83.89,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1468,66,66,0,3,54.69,174.09,18.22183,1.64,7,0.155108553,1.85984192,2,3,2,7,2601.954,1,1,511.53,31.94,94.13,14.83,30.03,0.00417,0.0044,0.0470404,0,29.73,0.05,6.378,2.3284,0,0,0,0,0,0,101,101.92,56.9146,0.3,0,0,0.069936,0,0,0,0,0,0,0.37509,133.1944,2.4185,10.196,0.6989,1.183382,0,1.10045,0,0,6.741893,0,0,0.00286,0,1.383009,259.8,3.51,1,1.0095,0.546,0.0187,39.2,4.458,137,8.75,68.82,267.955,9.34,1.64,60,176.04,0,87,88,55.67,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1469,59,59,0,2,70.1,154.11,29.35666,1.68,6,0.118057843,1.41612802,1,2,2,6,192.657,1,1,204.6,43.09,172.74,35.21,30.28,0,0,0.0470493,0.00358,25,0.149,5.70858,2.4467,0.169,0.253,0.022,0.042,0.271,0.615,103.1,90.69,82.7628,0,0,0,0.27007,0.0141,0.19,0.437,0.114,0.222,0.204,0.39078,126.9795,0.9222,7.8374,0,1.078882,0.1711,0.299531,0.0314,0,2.272693,0,0.0248,0.00443,0.001,0.930303,134.09,5.14,0,0.8802,8.624,0.0219,0,4.792,141,13.506,68.06,373.5561,4.5,1.79,81,157.07,0,87,145,76.05,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1470,63,63,0,3,67.04,168.04,23.60568,1.76,6,0.080340409,0.96350962,0,3,2,6,1791.102,2,2,199,42.97,71.3,15.03,16.01,0,1e-4,0.0133417,0.00179,20.34,0.19,16.6517,2.375,0.396,0.248,0.164,0.092,2.46,0.913,103,86.7,72.5177,0,1.1e-4,0.0053,0.279039,5e-4,1.372,0.64,1.145,0.517,0,0.43786,142.0224,0.9185,0.0178,0.2362,1.702301,0.0012,0.602838,0.0044,0,3.525265,0,0,0.00293,0,1.380524,190.29,4.21,0,0.9073,9.097,0.0386,26.59,4.901,136.9,15.973,65.1,419.1619,6.21,1.9,79,171.95,0.1,61,125,74.85,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,Yes,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1471,49,49,0,2,84.82,155.13,35.37066,1.85,6,0.049033448,0.58810838,0,2,1,6,8492.75,1,1,219.29,43.15,206.62,23.28,16.98,0,0,0.0205858,0,31.12,0.094,6.9996,2.3621,0.251,0.124,0.227,0.135,1.146,0.662,102.1,106.88,72.0241,0.06,1.3e-4,0.0013,0.052454,0,1.06,0.566,0.151,0,0,0.37564,116.9545,1.0399,10.2051,0.2485,2.14033,0,0.399514,0,0,3.595202,4.370995,0.6001,0.0067,0.001,1.611861,430.03,5.15,0,0.9933,13.483,0.0374,31.95,4.435,144.8,5.995,75.07,256.89,5.88,1.93,80,157.11,0,81,118,82.35,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1472,72,72,1,4,110.78,174.71,37.56035,2.25,7,0.099198519,1.19080883,1,4,5,7,11563.918,1,1,149.95,45.91,55.88,18.81,9.99,0,0,0.0364476,0.00594,28.08,0,13.69087,2.424,0.421,0.375,0,0,0.574,0.006,101.9,90.81,79.1657,0.01,1.6e-4,0.0185,1.532883,0.0234,0.389,0.238,0.177,0.123,5.225,0.51767,170.0215,1.202,11.1265,0.3984,1.455895,0.0496,1.000111,0.0491,0,4.004957,5.447335,0.6563,0.00872,0.001,0.086693,324.16,4.01,0,0.9683,9.767,0.0351,34.94,5.652,139.1,12.142,69.99,403.9469,6.8,2.36,80,177.83,0,80,136,117.13,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1473,50,50,0,2,66.05,175.02,21.72646,1.8,7,0.148513398,1.78102514,1,2,2,7,5361.934,2,2,455.23,26.55,83,29.68,32.84,0.002032,0.0026,1.168e-4,0.003,25.24,0,5.24374,2.319,0.176,0.145,0.097,0.077,1.172,0.772,101.9,100.65,62.1223,0.28,1.9e-4,0.0242,0.197432,0.021,0.442,0.291,0.749,0.511,0,0.30956,97.3271,0.8176,9.3741,0.9016,1.726517,0.2362,0.509803,0.095,0,3.409468,3.960055,0.699,0.00526,0.001,1.030874,282.01,4.6,0,1.1287,12.689,0.0475,30.24,3.976,138.1,8.942,73.94,344.9255,6.8,1.68,71,173.92,0.1,95,116,62,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1474,60,60,0,2,61.1,172.07,20.70172,1.72,6,0.028895486,0.34648624,0,2,3,6,516.706,2,2,163.04,23.92,49.15,25.41,14.02,0.004213,0.004,0.0200069,0,0,0.237,4.29623,2.1557,0.348,0.241,0.23,0.119,1.794,0.799,101.1,98.07,62.7457,0,2e-4,0.0178,0.029723,0,0.928,0.392,0.847,0.421,0,0.36144,109.1464,1.7946,9.3256,0.6521,1.293974,0,0.459453,0,0.61,14.379175,0.269333,0,0.00214,0,0,387.23,4,1,0,11.411,0,32.02,3.91,134.3,5.101,57.72,255.6039,13.58,1.67,69,171.11,0,69,116,59.29,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1475,60,60,0,1,79.05,162.27,29.35638,1.87,6,0.053562797,0.64329656,1,1,2,6,186.197,2,2,226.26,44.58,53.18,17.07,22.87,0.002607,2e-4,0,8e-5,30.01,0.002,2.39645,2.4704,0.088,0.063,0.081,0.078,0.493,0.427,103.9,93.12,74.5834,0.34,1.3e-4,0.0201,0.100077,0.0117,0.212,0.23,0.201,0.146,0,0.41884,144.9292,2.501,13.9047,1.3058,1.662714,0.0123,0.279817,0.0694,25,1.901892,2.687785,0.0248,0.00247,0,1.517876,121.43,5.08,0,1.0045,11.251,0,23.19,4.08,144.9,8.202,81.61,416.0497,3.39,1.96,89,164,0.1,87,120,85.37,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,Y,N,High-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,Yes,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1476,68,68,1,4,48.95,161.61,19.03297,1.51,6,0.060851695,0.73049013,1,4,1,6,1620.143,1,1,378.81,35.66,176.02,10.48,13.73,0.00143,0.0034,0.0300202,0.00598,21.85,0.07,7.98544,2.283,0.218,0.193,0.068,0.066,0.696,0.647,101,53.19,80.7528,0,0,0,0.099507,0.0194,0.447,0.406,0.193,0.133,0.138,0.37488,126.6758,0.5772,9.2612,0.441,0.900438,0.1821,0.220503,0.0022,0.03,3.418998,0.702154,0.7672,0,0.001,0.169099,263.89,3.9,1,1.1044,0.172,0.0206,25.16,4.404,142,6.888,82.37,360.0386,5.61,1.46,77,160.12,0,92,150,48.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1478,58,59,0,3,51.34,148.14,23.41853,1.43,6,0.024002293,0.28821162,1,3,2,6,3001.9,2,2,563.97,27.39,70.23,15.87,18.08,3.01e-4,1e-4,9.12e-5,0,0,0.175,5.30337,1.2384,0.174,0.185,0.213,0.346,0.404,0.015,98.9,108.61,49.046,0.22,1e-4,0.0133,0.08007,0,0.272,0.44,0.097,0.001,1.806,0.22315,69.4147,0,0,0,0.913828,0.0094,0.75359,0.0016,0,4.827139,0.23516,0.0024,0.00296,0,0.873325,218.26,2.81,0,0.9965,11.224,0.0143,31.88,3.204,140.1,5.495,0,215.5966,7.32,1.43,67,147.37,0,78,120,50.92,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,N,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1479,72,71,1,3,70.46,160.1,27.55135,1.75,7,0.118839309,1.42505757,0,3,2,7,6585.576,2,1,219.04,23.13,82.2,9.01,18.43,0,0,0.0401288,0.00503,3.91,0.085,0,2.2807,0.351,0.313,0.123,0.114,0.431,0.002,0.4,67.79,83.8345,0.18,0,0.01,0.160443,0,0.358,0.247,0.008,0.002,0,0.35246,114.5612,2.0471,9.9746,0.8949,1.001444,0,1.157986,0.0055,0.27,7.22954,3.317507,0.0396,0.00241,0,0.191311,190.46,4.1,0,1.1424,11.601,0,39.11,4.355,134.1,8.564,50.99,249.3859,9.2,1.77,80,162.53,0,78,131,69.01,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1480,57,57,0,4,67.98,158.58,26.94857,1.71,6,0.049099051,0.58962387,2,4,1,6,575.323,2,2,236.77,39.19,41.2,9.93,12.36,0,0,4e-5,4e-5,26.08,0.17,7.01628,2.3964,0,0,0.007,0,0.691,0.716,101.9,70.51,96.0474,0.24,1.7e-4,0.0249,0.099374,9e-4,0.446,0.394,0.158,0.122,0,0.42992,144.9442,1.0791,0.1076,1.0731,1.397712,0.0041,1.039896,0.0052,22.75,6.305345,2.820669,0.0102,0,0,1.149575,460.98,4.41,0,0.9713,12.247,0,24.22,4.445,139,9.911,58,249.7831,8.73,1.66,80,157.81,0.1,113,120,66.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158VF,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1481,73,73,1,3,95,183.36,27.34302,2.2,6,0.047666961,0.57111577,0,3,4,6,6936.655,2,2,144.75,43.95,261.25,21.83,20.77,0,0,0.0300114,0,26.7,0.001,6.88077,2.5766,0.004,0.145,0,0,0,0,0.5,42.76,157.5907,0.4,0,0.0062,0.099731,0,0.008,0.294,0,0,3.401,0.43076,141.63,1.4323,9.0919,0.3468,0.689081,0,0.498287,0,0,8.384936,0.452324,0,0,0,1.021143,175.68,4.59,1,1.0459,0.306,0.0365,30.41,5.003,133,20.732,82.1,389.0803,8.4,2.04,85,182.16,0.1,71,142,89.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1482,68,68,0,4,51.14,150.19,22.94237,1.45,7,0.042558321,0.51093347,2,4,6,7,4696.46,1,1,297.76,30.03,125.07,16.85,40.71,0.003175,5e-4,2.997e-4,5e-5,30.35,0,5.19214,2.2288,0,0.004,0,0,0,0.437,96,76.4,54.8441,0.21,4e-5,0.0163,0.010048,1e-4,0,0.003,0,0.132,0.872,0.24481,86.8958,2.4705,12.098,0.7675,0.843123,0.0686,0.436852,0.0024,0,3.602593,6.4197,0.6864,0,0.001,1.042272,304.12,4.61,1,0.9934,10.462,0,42.08,3.507,132.8,8.55,56.82,309.3271,4.19,1.41,65,151,0,100,125,48.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,Y,Y,Y,N,Low-Intermediate,High,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,N,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1483,48,48,0,3,72.94,175.01,24.09288,1.89,6,0.057319824,0.68858169,1,3,3,6,1007.149,1,1,749.41,38.98,180.34,17.08,19.06,0,0,2.852e-4,0.00103,25.47,0.138,6.77296,2.8778,1.134,0.474,1.077,0.199,2.965,0.772,104,81.45,90.1977,0,1.3e-4,0.0028,0.099452,8e-4,1.664,0.45,1.438,0.406,1.223,0.42439,137.8843,4.6761,10.9199,1.0209,2.666617,0.1889,0.599966,0.0033,0.51,6.205093,0.416262,0.642,0.00781,0.001,1.199863,309.57,4.22,0,0.8999,10.035,0,23.21,4.558,139,10.253,75.42,539.9465,11.75,1.74,85,172.9,0,69,120,69.92,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1484,59,59,0,2,75.97,173.94,24.85478,1.91,6,0.070989055,0.85343926,1,2,5,6,3740.667,2,2,1062.63,37.98,87.78,25.35,20.02,4.8e-4,6e-4,0,4e-5,26.78,0.228,0.11163,0,0.055,0,0.213,0.112,1.369,0.837,93.3,136.21,53.9576,0,0,0.0118,0.006921,9e-4,0.722,0.482,0.561,0.303,0,0.33601,121.5793,0.7412,6.2093,1.1981,1.976202,0.2291,0.641821,0.0774,12.03,10.394675,7.531062,0.5592,0.00141,0,1.178063,153.65,3.81,1,1,13.471,0,29.36,3.569,140.7,1.787,59.33,249.9869,12,1.98,75,172.09,0,69,114,79.36,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1485,65,65,0,3,60.91,149.44,26.66941,1.56,7,0.062149207,0.74596608,0,3,6,7,1634.835,2,2,594.53,39.08,169.48,9.04,18.99,4.13e-4,9e-4,0.0781135,0.00289,28.01,0.085,5.37548,2.7146,0.271,0.147,0.13,0.08,0.865,0.709,106.9,129.9,34.0929,0,4e-5,0,1.474673,0.0024,0.504,0.408,0.413,0.271,0,0.35409,112.423,1.9295,12.1386,1.7973,1.327924,0.0081,1.124617,0.0015,0,4.695887,4.327091,0.0309,0.00389,0,1.065423,246.89,3.5,0,0.9701,13.209,0.0603,39.7,3.781,143,9.276,71.21,362.5434,7.11,1.58,79,149.27,0.1,87,129,62.16,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1486,74,74,1,3,74,170.13,25.30671,1.87,6,0.01758191,0.21062731,0,3,3,6,19283.681,1,1,432.64,41.38,67.84,16.88,23.11,0,0,0.018668,0,28.24,0.12,23.85186,2.2006,0.374,0.241,0.198,0.112,1.614,0.844,106,59.82,91.9672,0.2,1e-5,0.0031,0.095434,0,0.601,0.351,0.953,0.55,5.955,0.40596,139.0436,2.5653,9.5591,0.6133,1.501348,0,0.380169,0,0.33,3.822383,0,0,0,0,1.161607,189.1,4.4,0,1.0896,10.233,0.9237,25.03,3.96,140,17.089,55.88,356.906,6.79,1.79,92,171.96,0.1,86,146,77.13,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1487,65,65,0,1,58.23,154.96,23.50515,1.57,7,0.088422494,1.06213085,1,1,3,7,2341.041,2,2,325.79,43.05,108.04,8.44,11.26,0.00274,0.0037,0.0594803,0.00381,1.96,0.002,3.52599,2.0641,0.094,0.11,0.118,0.116,0.596,0.694,102.9,68.75,72.5048,0,0,0,0.098239,0.0198,0.185,0.008,0.39,0.396,1.246,0.36099,120.128,2.3838,12.7451,0.7724,1.095239,0.3049,0.199597,0.1112,0.25,5.847844,0,0.7494,5.6e-4,0,1.22138,434.15,4.01,0,0.9665,15.432,0.0188,31.98,4.532,137.8,5.49,72.97,193.6053,8.1,1.6,75,155.88,0,70,120,61.65,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,< 60,< 65,>= 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1488,74,74,0,2,59.23,157.23,24.03891,1.6,8,0.08629006,1.03545341,0,2,1,8,1332.64,1,1,441.3,41.94,85.96,8.96,38.14,0.001281,0.0014,0.1509742,0.00243,29.94,0.111,5.33035,2.4214,0.667,0.131,1.749,0.137,4.132,0.83,105,72.23,64.5532,0,3e-5,0,1.605023,0.0595,3.037,0.702,0.964,0.182,0,0.37456,131.7807,4.092,17.9395,4.4311,12.156036,0.2714,0.635103,0.0732,0.53,3.401539,3.486167,0.0301,0.00331,0,1.092237,235.79,4.59,1,1.0133,0.254,0.0524,22.38,4.517,142.1,6.962,78.68,440.9105,7.21,1.63,0,156.9,0,61,90,59,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,Yes,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1489,72,72,0,4,75.06,170.43,26.12632,1.89,7,0.07658403,0.91968071,0,4,6,7,1153.389,1,1,537.32,35.97,80.5,28.13,30.25,7.7e-4,1e-4,0,1e-5,26.04,0.023,4.26112,2.5737,0.074,0.114,0,0.007,0.23,0.681,103,87.56,65.0298,0.21,1.6e-4,0.0119,0.476928,6e-4,0.176,0.469,0.008,0.154,0,0.35369,113.3178,1.0385,10.5114,0.5442,1.218948,0.0035,0.599992,0.0021,0.43,3.213368,0.565908,0.0412,0,0,1.09946,304.08,4.81,0,1.1026,0,0.0837,0.43,3.982,137.9,2.232,64.02,352.5752,5.6,1.83,72,170.05,0,88,113,79.96,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,>= 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1490,37,36,0,0,69.02,168.06,24.78316,1.78,6,0.047485375,0.56920532,0,0,4,6,1006.237,1,1,444,40.91,57.03,18.3,21,8.7e-4,0.0011,0.0218639,7e-5,0,0.191,4.29659,2.3018,0.702,0.516,0.154,0.075,1.243,0.72,107.1,114.82,56.5548,0.23,0,0.0033,0.179888,0,0.783,0.432,0.413,0.258,3.524,0.36227,117.9232,2.5085,9.7896,0.7147,1.098924,0,0.312396,0.0033,0.81,1.640677,0,0,0,0,1.277955,119.91,4.4,0,0.9957,13.788,0,28.01,3.876,146,6.045,72,231.9944,3.22,1.95,88,169.35,0,70,143,69.97,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,NA,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,CASA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1491,69,69,0,1,58.09,158.07,23.07861,1.58,7,0.06963541,0.83514659,0,1,4,7,4691.583,NA,2,598.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,Outside-China,THA,Thailand,NA,NA,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,ASIAN,Asia,NA,Y,M,No,ASIA,NA,GA101 plus 8 CHOP cycles,NA,NA,N
1492,30,30,0,3,47.07,159.74,19.12418,1.47,6,0.047040053,0.56468402,1,3,3,6,2002.059,2,2,334.78,36.08,89.89,5.58,11.66,7.98e-4,0,0.0320111,6e-5,26.68,0.096,3.10587,2.3065,0.253,0.266,0.078,0.06,1.014,0.815,101,127.02,53.9738,0.02,8e-5,0.0112,0.19316,2e-4,0.515,0.446,0.425,0.383,3.685,0.40607,126.219,3.4032,16.8511,2.8205,2.178499,0.1132,0.499329,0.0599,0,2.050476,0.562677,0.036,0,0,1.420545,104.5,4,1,0.9749,10.65,0.0392,30.87,4.497,143.9,10.602,68.96,309.8382,4.39,1.64,91,162.1,0,95,146,54.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1493,76,75,0,3,89.51,154.96,37.00934,1.91,6,0.078490509,0.94219192,1,3,1,6,1505.464,1,1,247.62,45,140.67,29.14,21.92,0.001705,5e-4,0.0399389,7.5e-4,30.03,0.111,5.90792,2.484,0,0.002,0,0,0.404,0.006,104.9,64.84,86.004,0,1e-5,0,0.069953,0.0022,0.15,0.081,0.051,0.001,0,0.47464,156.2524,2.1337,9.5746,1.7295,1.556214,0.2029,0.296383,0.0391,19.96,6.542624,4.960235,0.0355,0,0,1.10222,237.59,4.28,0,1.0089,0.031,0.019,0,5.3,142,11.999,78.18,425.9372,8.2,1.93,86,155.01,0,77,147,89.67,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,N,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1495,58,58,1,3,69.45,181.86,21.34255,1.9,7,0.086393328,1.03650051,0,3,2,7,7208.312,1,1,272.46,49.93,114.72,36.15,31.1,0.001507,0.0013,0.1026985,0.0099,25.04,0.15,5.2651,4.5149,0.352,0.232,0.006,0,0.83,0.467,104.9,77.85,88.3307,0,0,0,2.770961,0.0566,0.405,0.325,0.33,0.185,1.586,0.45033,140.9069,1.9047,6.0234,0.6268,1.982908,0.2634,0.795974,0.08,0,3.003382,3.616844,0.0309,0.00702,0,0.905913,321.51,4.19,0,1.0023,0.246,0,25.34,5.103,144,6.891,72.97,933.9017,6.48,2,72,184,0,88,126,72.77,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1496,72,72,1,4,65.01,164.97,23.62608,1.71,6,0.02119158,0.2543635,2,4,2,6,5841.402,2,2,1083.7,31.97,154.19,16.16,25.95,0,0.0029,0.0645408,5e-5,2.61,0.101,11.78144,2.2088,0,0,0,0,0.05,0.703,0.4,64.6,81.3724,0.26,0,0.0093,0,0,0.019,0.336,0.004,0.197,2.254,0.25161,79.2327,0.7009,9.0793,0.4458,0.939845,0,1.232344,0.0026,0.07,6.794703,3.132704,0.0254,0,0.001,1.389956,162.94,4.41,1,1.1308,10.714,0.052,30.99,3.293,136,3.401,67,368.2707,12.21,1.64,68,162.93,0,59,113,64.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,High,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
1497,53,52,0,3,65,167.92,22.46923,1.74,7,0.04084377,0.4899636,1,3,5,7,9720.063,2,2,674.4,31.52,973.07,8.17,15.65,0.001607,2e-4,0.0297215,0.01241,30,0.051,4.28769,2.3258,0.004,0.116,0,0.001,0,0.014,102.9,99.22,68.9786,0.17,0,0.0094,0.16443,0.0601,0,0,0,0.166,0,0.37022,113.7201,5.1983,20.9565,3.3724,1.098774,0.2377,0.270259,0.1045,0,10.725097,3.526631,0.7798,0,0,1.648471,308.45,4.09,0,0.9964,11.858,0,35.1,5.07,139.1,11.986,75.08,399.9274,8.54,1.88,67,168.03,0,90,103,68.45,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,Y,Y,ASIAN,Asia,NA,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1498,58,58,0,4,80.2,172.99,27.20773,1.95,6,0.081613982,0.97952508,0,4,4,6,19343.262,1,1,289.13,36.53,61.96,10.2,12.47,0,0,0.0499784,0,0,0.101,0,2.3019,0.066,0.117,0.001,0.001,0.705,0.745,100.1,114.25,69.1109,0,0,0,0.16981,9e-4,0.375,0.387,0.247,0.287,1.337,0.31049,106.3346,2.041,7.8912,3.7849,1.32588,0,0.96265,0.0444,0.51,5.14283,1.98639,0.6412,0.00352,0.001,0.998075,274.76,3.89,0,0.9802,14.119,0,30.23,3.844,140,5.175,51.99,249.2468,7.58,2.01,88,172.03,0,81,110,83.81,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1499,36,37,1,2,59.92,159.91,23.03926,1.61,8,0.007780208,0.09358759,0,2,4,8,12573.283,1,1,171.31,25.52,96.28,34.32,30.03,0,0,3.54e-5,0,23.92,0.065,0.08801,2.2246,0.213,0.154,0.156,0.137,1.436,0.83,101.9,94.6,79.0399,0.06,8e-5,0.0256,0.19997500000000001,9e-4,0.809,0.557,0.644,0.362,0,0.39443,121.1276,0.9501,11.2413,0.2991,2.70025,0.0458,1.96103,0.079,0.6,7.010502,0,0,0.00264,0.001,1.198331,250.02,4.29,0,0.9619,12.465,0,25.47,4.356,136,14.527,54.93,408.6517,12.76,1.6,69,160.09,0.1,71,116,57.86,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1500,70,70,1,2,81.01,175.12,26.07197,1.98,6,0.039721589,0.47600503,1,2,3,6,6296.335,2,2,369.79,41,69.83,20.81,31.01,0,0,0.0294963,0.00225,31.31,0,5.48127,2.3543,0.098,0.081,0.012,0,0.444,0.129,93.6,65.25,90.8031,0.07,0,0,0.473342,0.001,0.252,0.006,0.091,0.19,2.605,0.34118,124.8096,2.1126,9.2189,0.471,1.658651,0.0094,0.722905,0.0493,0.45,2.699462,4.337168,0.02,0.00151,0,0.870602,283.5,3.79,1,1.0344,0.902,0.023,0.5,3.887,136,7.464,66.98,440.7064,4.61,1.96,93,178.07,0.1,70,138,82.19,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1501,67,67,1,2,77.91,170.15,27.10876,1.91,6,0.039323718,0.47258234,1,2,1,6,4941.722,1,1,1052.88,31.93,62.05,54.86,59.28,0,0,0.0503795,0,1.41,0,7.88213,2.1684,0.103,0.072,0.198,0.162,0.899,0.838,99.9,50.82,109.1572,0.12,2e-5,0,0.054887,0,0.403,0.443,0.471,0.468,0.029,0.32211,115.6804,0.994,0.077,0,1.766735,0,0.956562,0,0.52,5.790213,2.738043,0,0,0,1.197561,220.49,4.1,0,1.1095,0,0.074,0,3.81,136,4.461,74.01,142.238,7.94,1.9,95,170.08,0,83,139,75.94,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1502,74,74,1,3,77.91,166.97,28.23007,1.85,8,0.065833824,0.78978254,2,3,4,8,6102.025,2,2,446.6,35.5,66.16,23.31,33.44,0.00117,0.0022,2.655e-4,2e-5,32.01,0.02,4.4992,2.5768,0.037,0.219,0,0.011,0,0.581,98.9,72.39,78.5125,0,0,0,0.189975,0.0084,0,0.32,0,0.142,4.275,0.39331,141.8463,2.3805,7.0245,0.2274,0.309779,0,0.599068,0.0016,32.04,10.593311,4.89057,0.5711,0.00493,0,1.50182,322.7,4.19,0,1.0885,0.59,0,0,4.701,132.1,18.269,42.81,362.0444,9.47,1.83,89,168,0,98,139,74.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,High-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1503,63,63,1,4,54.98,154.94,22.86237,1.53,7,0.119355411,1.43241949,0,4,3,7,5180.768,1,1,314.24,43.54,92.62,5.12,3.67,1.45e-4,6e-4,0.0997598,0.00117,21.77,0.221,0.04595,2.0759,0.273,0.274,0.138,0.116,0.834,0.015,101.9,97.15,55.9164,0,5e-5,0,0.01324,0.001,0.228,0,0.398,0.25,6.16,0.39623,129.3172,0,0,0,2.359509,0.1702,1.415523,0.0805,0.38,5.509861,0.167905,0.024,0.00499,0.002,1.072922,392.94,4.8,0,0.4605,10.763,0,24.79,4.605,137,6.124,68.93,203.733,10.3,1.63,60,154.98,0,79,105,58.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1504,65,65,0,3,83.56,171.09,28.38553,1.97,6,0.045536842,0.54725772,1,3,5,6,3870.984,2,1,441.37,42.86,313.61,27.27,26.31,2.07e-4,0,1.707e-4,4e-5,23.51,0.034,15.36062,2.323,0.035,0.083,0,0,0,0.406,0,101.93,60.6085,0.65,0,0.0074,0.101213,4e-4,0,0.162,0,0.001,0,0.39245,122.5779,0.0088,0,0.4319,0.939087,0.0044,1.107828,0.0687,0.39,13.003869,3.840612,0.0103,0.00655,0,1.320428,520.24,4.51,0,1.0031,12.814,0.0311,0,4.44,140,6.936,67.04,251.8657,12.29,1.79,70,170.99,0,96,144,81.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1505,75,75,0,1,45.78,146.71,21.45327,1.38,6,0.016933543,0.20308641,0,1,1,6,4317.335,1,1,183.51,39.99,80.3,17.01,20.11,0.001013,0.0019,0,0,25.06,0.099,5.89047,2.1988,0.174,0.289,0.041,0.034,0.853,0.707,109.8,52.57,78.4557,0,0,0.0149,0.012269,0,0.487,0.42,0.313,0.301,1.232,0.36116,122.7911,2.6863,7.0084,0.435,0.60431,0,0.055767,0,0,3.212762,2.4821,0.026,4e-4,0,1.079153,416.74,4.2,0,0,0.821,0.0281,34.58,3.599,170.4,11.998,68.37,69.9598,3.69,1.37,71,145.99,0,58,120,47.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1506,70,70,1,3,65.13,165.89,23.65995,1.73,7,0.12272674,1.47178964,1,3,5,7,12154.198,2,2,270.72,39.3,106.3,15.93,16.02,0,0,0.0400002,0,28.25,0.03,7.22928,2.3327,0.238,0.28,0.051,0.048,0.506,0.483,104.1,78.22,70.6758,0.03,0,0.0116,0.214668,8e-4,0.327,0.207,0.253,0.294,3.899,0.35963,108.5394,0.6935,9.2153,3.7044,1.269286,0,0.742146,0.0012,0.25,3.913189,0,0,0.00252,0,1.097948,349.79,4.31,1,0.9373,12.709,0,33.38,4.463,137.1,5.087,66.81,147.9113,5.95,1.76,67,165.87,0,86,113,65.6,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1507,67,67,0,3,49.52,157.82,19.6721,1.49,7,0.033190372,0.39879521,1,3,5,7,2640.196,1,1,248.62,44.17,90.66,15.04,16.92,0,0,0.1347047,4e-5,25.02,0.002,5.36565,2.4281,0.075,0,0.08,0.028,1.341,0.775,98.1,68.59,69.3417,0.4,1e-5,0,0.501069,0.001,0.524,0.006,0.617,0.359,0,0.37057,111.0171,4.3155,13.7397,2.4037,2.481301,0.0063,0.799603,6e-4,0,6.203403,0,0,0.00551,0,0.969563,364.79,4.4,0,0.909,8.733,0,36.35,3.906,139.9,4.099,71.94,145.6967,9.97,1.49,72,158.92,0,84,135,49.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1508,61,62,1,4,66.54,157.94,26.23977,1.66,7,0.038525406,0.46248435,1,4,5,7,10980.392,1,1,233.04,36.96,63.57,7.9,16.88,2.3e-5,0,2.943e-4,3e-5,23.04,0.195,0.00693,2.5216,0.003,0.005,0.018,0.066,0.388,0.738,99,97.03,50.0184,0,6e-5,0.0127,0.066945,0,0.394,0.492,0.113,0.175,0.629,0.38573,129.1962,4.1637,11.0591,2.9042,1.326484,6e-4,0.132366,0,0.82,1.655256,0,0,0,0,1.064161,204.12,4,0,1.095,0.379,0.0533,28.89,4.738,143,8.561,63.01,321.8442,2.73,1.61,60,159.87,0,81,97,69.02,0,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1509,50,50,1,2,69.9,152.52,30.09385,1.67,6,0.04526189,0.54302882,0,2,4,6,12990.197,2,1,464.89,41.37,161.57,19.03,14.06,0,0,0,0,0,0.089,0.0585,2.179,0.091,0,0.367,0.234,1.421,0.667,101,141,44.9763,0,2.4e-4,0.0207,0.049634,1e-4,1.072,0.482,0.471,0.131,4.952,0.29889,100.3732,0,0.039,0.3784,2.300477,0.2106,0.501365,0.004,0,3.922272,0.207473,0.0076,0.00581,0,0,188.41,4.14,0,0.8936,0,0,23.17,3.539,143,1.038,59.91,116.0468,6.5,1.68,70,152.92,0,63,118,70.13,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1511,62,62,0,2,62.94,165.08,23.12065,1.7,6,0.067617786,0.80961884,0,2,1,6,246.723,2,2,216.4,37.94,223.77,41.09,37.06,0.002899,0.0046,0,0,17.82,0.024,10.40915,2.4368,0.004,0.079,0.028,0.017,0.183,0.615,108.1,96.78,64.448,0.23,1.5e-4,0.0183,0.048356,0,0.181,0.327,0.007,0.111,0,0.35147,120.9776,1.1422,7.4176,2.3443,0.394564,0.1501,0.38661,0.039,0,3.125538,2.339755,0.0135,0,0,1.19503,221.55,4.81,1,1.0875,11.345,0,28.7,3.284,143.1,8.463,70.05,93.2859,5.09,1.76,92,166.35,0,84,140,63.14,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1512,47,46,0,1,54.85,173.84,18.5971,1.64,8,0.165081123,1.98036469,0,1,3,8,3242.598,2,2,223.96,42.59,108.55,22.9,23.97,0.002133,0.0014,0.0597047,0.00282,29.03,0,2.42393,2.2604,0.084,0.1,0.015,0.025,0.56,0.687,0.3,97.11,62.8072,0.02,0,0.0249,0.210201,0.001,0.283,0.275,0.287,0.313,6.173,0.37418,136.4082,1.0321,12.1996,0.999,1.7808,0.247,0.399342,0.0639,0.38,2.228284,0,0.0086,0.00648,0,0.927237,313.44,3.67,1,0.971,0.418,0,26,4.355,142.5,6.166,79.17,160.5328,4.36,1.66,90,175.62,0,76,142,57.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1513,74,74,0,2,44.71,157.74,18.18348,1.42,7,0.060284944,0.72309897,0,2,3,7,706.089,1,2,282.92,40.9,79.96,21.95,29.13,0,0,0.0297727,0.00145,26.91,0.001,3.74419,2.0994,0.167,0.099,0.074,0.042,1.31,0.889,102.3,78.58,56.3042,0.21,1.2e-4,0.002,0.160251,0.0504,0.483,0.371,0.724,0.704,0,0.40326,132.8514,7.1272,14.1441,1.2094,1.681467,0.1502,0.235064,0.0048,0.75,2.732453,5.12212,0.7258,0,0,0.969119,143.67,3.6,1,0.9613,11.206,0.0405,26.04,4.102,139,5.989,66.08,249.8305,4.3,1.45,80,155.21,0,90,130,46.63,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1514,71,71,0,0,74.16,161.51,28.06886,1.79,7,0.056483554,0.67810792,1,0,3,7,6745.134,2,2,702.3,31.01,46.14,16.24,20.06,1.47e-4,0,1.802e-4,1e-5,19.92,0.1,6.38637,2.3852,0.002,0.007,0.05,0.035,0.506,0.532,96,65.87,81.3128,0,0,0,0.126123,0,0.231,0.226,0.224,0.218,2.767,0.33041,115.1939,3.5094,8.7104,2.7406,0.601727,0,0.24847,0,0.39,7.241599,6.160623,0.0154,0.00153,0.001,0,176.37,0.72,1,1.0551,0.197,0,32.2,3.65,143.1,8.22,43.69,315.065,8.3,1.71,77,162.04,0.1,74,124,71.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1515,51,51,0,2,100.13,185.41,28.88477,2.24,6,0.057266106,0.68743051,0,2,2,6,1427.623,1,1,339.76,39.34,62.98,15.72,15.99,0,0,9.93e-5,0,21.06,0.001,22.18473,2.3002,0.163,0.086,0.357,0.199,1.407,0.824,102.1,81.72,103.2604,0,2.1e-4,0.0153,0,0,0.953,0.614,0.526,0.241,0.875,0.41249,130.1648,0,0,0.4191,1.091121,0.0032,0.200275,2e-4,0,6.793256,4.99998,0.5371,0.00355,0,0,147.58,4.09,0,1.028,0,0,0.01,4.678,141,4.999,67.1,129.0555,8.01,2.15,72,183.16,0,3,122,91.89,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1516,48,48,0,2,52.27,163.9,19.92532,1.55,6,0.088710492,1.06464733,0,2,4,6,2735.18,2,2,52.09,41.03,59.84,24.95,15.64,0.271002,0.0168,2.714e-4,6e-5,25.07,0.164,5.3281,2.0538,0.002,0,0.105,0.031,1.804,0.887,100,120.5,47.4733,0.08,1.3e-4,0.0076,0.019929,0.0236,0.775,0.441,0.95,0.395,2.025,0.41922,148.7522,0,0.0731,2.3471,1.579095,0.3023,0.239296,0.0877,0,2.666102,0,0,0,0,0.968909,201.11,4.9,0,0.9815,10.673,0.0562,34.81,3.904,144.1,8.594,68.06,157.8705,4.9,1.58,85,164.17,0,89,151,48.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1517,57,57,1,1,79.96,169.83,27.75097,1.89,7,0.058249959,0.69903155,1,1,6,7,8341.286,1,1,347.12,34.94,85.1,18.33,14.99,0.002082,0.0011,0.0518841,8.2e-4,25.42,0.089,0,2.4252,0.075,0.002,0.199,0.113,0.844,0.651,101.1,104.04,63.8691,0.09,0,0.001,0.624758,0.0596,0.525,0.416,0.223,0.064,0,0.27518,86.7994,1.3091,8.8069,1.4809,1.680605,0.1858,0.641255,0.0096,30.96,9.205012,3.149071,0.0287,0,0,0.968714,722.77,3.6,1,1.0256,0.341,0,22.35,3.658,142.3,2.352,67.93,327.0331,12.23,1.93,69,169.82,0,86,119,79.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1518,76,76,0,2,90.91,179.08,27.92612,2.1,6,0.074725143,0.89720522,1,2,2,6,147.917,1,1,177.23,45.93,107.49,14.1,11.59,3.03e-4,0,0.0300104,0.00197,31,0.13,5.48997,2.3477,0.078,0.126,0,0,0.159,0.407,100.6,70.46,84.0206,0,0,0,1.208121,0.022,0.136,0.317,0.066,0.001,0,0.41886,137.3476,3.4311,12.7221,0.7997,1.341884,0.053,0.299751,0.0013,0.6,3.276846,4.352255,0.6292,0,0,0.118885,88.61,4,0,0.9982,13.044,0.0387,28.27,4.499,139.9,7.813,85.14,359.5292,5.97,1.98,88,177.81,0,81,133,93.58,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1519,79,79,1,5,57.89,152.04,24.93874,1.55,6,0.126883388,1.52506054,2,5,3,6,8532.229,2,2,495.64,33.08,161.4,16.04,28.88,0,0.0016,0,0,28,0.06,2.93963,2.4765,0.055,0.056,0.001,0,0.231,0,105,41.13,89.0999,0,0,0,0,0,0.107,0,0.008,0,1.334,0.34574,114.0395,3.0571,9.0135,0.5341,1.343793,0.0038,0.774341,0,0.63,4.295226,3.601734,0.0409,0,0,1.091243,367.65,3.4,0,1.2882,14.667,0,28.39,4.412,142.1,14.87,82,355.2309,6.52,1.62,81,151.42,0,86,147,57.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1520,63,63,0,3,103.71,171.21,35.2323,2.11,6,0.141764911,1.70184005,1,3,2,6,4820.133,2,2,429.24,41.97,76.87,15.54,28.06,0,0,0,7e-5,0,0,3.85183,2.4932,0,0.004,0.047,0.092,0.027,0.588,103.1,85.58,78.0155,0,1e-5,0.0024,0.201207,9e-4,0.105,0.447,0.003,0.123,0,0.38488,130.4262,1.1517,9.363,0.576,0.995352,0.0036,0.699213,0.0023,0.49,4.791479,0.184906,0.0097,0.00284,0,0.490083,125.13,3.43,0,1.2832,14.506,0,38.29,4.408,143.1,8.584,62.94,371.4126,9.1,2.15,79,172.71,0.1,64,120,109.54,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NA,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1521,71,71,1,3,60.96,174.7,20.63689,1.74,6,0.045025479,0.53975044,2,3,3,6,7303.735,2,2,402.28,33.13,76.9,43.13,35.38,9.51e-4,0,0.0163236,9e-5,0.81,0.053,4.92271,2.1593,0,0,0.003,0.04,0.051,0.703,0,80.74,62.1969,0,0,0,0,2e-4,0.003,0.317,0.154,0.279,0,0.268,90.5714,3.7379,4.1398,0.4206,0.77348,0.0529,0.239515,0.0036,0.42,3.956186,0,0,8.1e-4,0.001,0,146.4,3.61,0,1.0092,0,0.0127,27.51,3.03,140,21.502,63.94,237.9248,4.97,1.7,94,172.91,0,109,160,58.07,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),<18.5,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1522,42,41,0,2,64.24,174.17,21.03558,1.76,6,0.115826047,1.38857964,0,2,2,6,867.734,1,1,446.85,41.03,203.47,21.65,21.32,0.001409,0.002,0,6e-5,32.53,0.125,3.1535,2.323,0.124,0.041,0.157,0.128,0.85,0.792,106.9,109.71,66.6579,0,2e-5,0,0.139659,0.0294,0.491,0.44,0.308,0.298,2.631,0.42934,143.9778,1.4124,13.6082,1.1016,1.000427,0.255,0.196977,0.1197,0,1.703104,0.347039,0.6421,0.005,0,0.925379,190.57,4.71,0,0.9555,12.675,0,24.46,4.624,143.1,8.759,70.01,330.5308,3.17,1.83,62,174.93,0,78,120,65.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1523,40,40,1,3,54,158.04,21.48446,1.54,7,0.058665266,0.70379061,2,3,5,7,6216.474,1,1,681.84,35.04,233.09,30.94,41.61,0.001434,7e-4,0.1736732,0.00342,1.89,0.001,2.99822,2.7119,0.176,0.116,0.082,0.053,0.758,0.64,97.3,109.66,60.6302,0.21,1.2e-4,0.0026,0.201104,0.0151,0.381,0.241,0.294,0.227,0,0.34281,108.5485,4.3294,13.6011,1.4417,1.437453,0.0048,0.995305,0.0024,0.28,7.822335,0.53318,0,0.00806,0.001,1.014294,450.72,4.81,0,0.9983,12.113,0.0531,33.71,4.366,135.8,22.974,69.09,237.9633,12.44,1.48,70,160.04,0.1,76,111,50.35,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High,High,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1524,49,49,2,3,82.3,181.47,25.28239,2.02,7,0.056702495,0.6803495,1,3,2,7,21828.019,1,1,203.36,39.96,75.16,9.66,11.3,0,0,0.0400202,7e-5,28.05,0.06,0.05774,2.1445,0.289,0.213,0.202,0.124,1.229,0.726,102,113.14,67.5913,0,0,0,0.0997,3e-4,0.491,0.3,0.522,0.292,3.17,0.37163,117.7481,2.1846,12.2601,0.0094,5.887752,0.1027,0.618431,0.0027,0,3.527026,3.533017,0.0346,0,0,1.184558,304.52,4.61,0,1.0855,11.716,0,29.98,4.395,141.9,3.676,65.06,233.1292,7.63,2.16,79,183.35,0,88,125,85.27,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1525,56,57,0,2,93.94,180.12,28.27666,2.12,7,0.075089773,0.90206365,0,2,5,7,1520.564,1,1,187.16,48.92,141.17,27.63,15.7,0.001233,5e-4,0.0498091,3e-5,2.81,0.065,7.83445,2.305,0.33,0.237,0.001,0,0.907,0.712,103,109.7,74.2169,0,9e-5,0,0.400674,0.0067,0.66,0.497,0.248,0.111,4.981,0.49544,157.1108,3.8709,11.25,0,1.520124,0.0045,0.697106,0.0018,0,2.49666,0.562106,0.0269,0.0026,0,0.930774,192.78,4.2,0,1.1506,11.75,0.0018,27.32,5.653,140.7,8.574,71.09,412.2821,5,2.05,99,181.91,0,80,149,90.12,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1526,68,69,1,5,70.29,175.04,23.4204,1.87,7,0.019921225,0.23909703,1,5,6,7,6543.249,1,1,1980.14,38.04,64.11,33.69,33.83,0.001954,0,0.050097,1e-5,30.41,0.001,4.30041,2.3216,0.09,0.279,0,0.033,0.028,0.699,0,71.02,73.2686,0.11,4e-5,0,0.039334,5e-4,0,0.32,0.14,0.282,0,0.38624000000000003,123.0563,3.9467,10.915,0.7761,0.532788,0,0.713042,0.0012,0,14.766033,0.618532,0.0165,0.00335,0.001,1.251447,300.33,3.11,0,1.0569,0.229,0,31.02,3.764,130,12.724,62.13,312.2043,16.52,1.78,78,176.04,0.1,87,130,73.09,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,Yes,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1527,48,48,2,2,67.92,174.79,22.60834,1.79,7,0.03108435,0.37357438,1,2,6,7,29340.731,2,2,391.69,36.99,48.86,10.12,19.11,0.002544,0.0018,0.019958300000000002,0.00118,26.46,0.001,2.96987,2.4236,0.11,0.087,0.028,0.028,0.881,0.855,93.2,83.77,79.5889,0.29,9e-5,0.0241,0.692426,0.0378,0.452,0.449,0.353,0.373,0.688,0.31225,106.3241,3.8267,13.8358,0.7717,1.190645,0.104,1.197279,0.0838,0.71,11.038221,3.529886,0.684,0,0,1.099405,500.83,4.15,1,0.9662,11.716,0,26.1,3.999,135.2,9.498,67.09,306.9843,10.61,1.81,80,179.02,0,71,129,70.05,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1528,58,57,0,2,55.08,164.48,20.00339,1.59,6,0.022992231,0.27606787,1,2,3,6,2046.483,2,2,120.59,32.55,71.81,11.91,11.8,0.00153,0.0014,1.655e-4,0,17.87,0.209,4.12557,2.1954,0.087,0.149,0.129,0.113,0.7,0.696,100,98.97,47.945,0,1e-5,0.013,0.394239,9e-4,0.402,0.429,0.316,0.341,2.392,0.39997,126.1779,0,3.2284,0.6467,0.873936,0.0095,0.35098,0.0043,0.37,1.639224,0,0,0.00661,0,0.676708,442.45,4.13,0,1.0096,11.505,0,33.07,4.598,137.1,2.018,68.14,129.0403,2.75,1.54,69,163.06,0,93,120,54.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1529,35,35,1,1,43.98,151.41,18.50878,1.37,8,0.11883529600000001,1.42703518,0,1,2,8,732.374,1,1,257,43,47.31,12.18,19.66,0,0,0.0599626,0.01009,32.91,0.28,6.50931,2.727,0,0.004,0,0,0.079,0.559,100,100.81,50.3292,0,1.8e-4,0.0088,0.19996,0.066,0.002,0,0.159,0.224,0,0.46758,151.391,1.2979,7.0487,0.5611,1.31154,0.3533,0.295546,0.0925,0.26,3.229596,3.060813,0.671,0.00324,0,0.178432,244.11,4.01,0,0.8583,0,0.0722,0,5.652,141.2,3.45,72.98,434.9144,5.5,1.37,67,150.93,0,84,113,43.97,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,Y,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1530,75,75,0,2,70.09,161.54,26.941,1.73,7,0.119129166,1.43109567,1,2,4,7,1687.979,1,1,162.4,35.93,511.12,17.06,17.88,0.021408,0.0041,0,0.00407,24.06,0.201,5.90048,2.7745,0,0,0,0,0.509,0.733,104,58.7,81.312,0,1.3e-4,0.0031,0.503046,0.083,0.097,0.374,0.261,0.278,0,0.37404,114.6214,3.7572,11.4351,0.9611,3.675854,0.4531,0.249088,0.083,57.41,4.062498,6.004088,0.6989,0,0,1.231894,398.34,3.5,0,1.0754,0.821,0.0493,0,4.131,141.9,5.146,72.93,195.4774,8.81,1.65,57,158.32,0,54,115,68.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1532,77,77,0,2,83.17,176.87,26.21723,2.02,6,0.171158008,2.05537696,0,2,1,6,177.937,2,2,NA,45.06,97.85,23.89,20.96,2.82e-4,0,0.0300075,0.00227,25.99,0.111,16.09411,2.4733,0.143,0.162,0.051,0.09,0.051,0.493,0,60.28,86.7016,0,9e-5,0.0073,0.099309,0.0182,0.164,0.309,0.008,0.195,0,0.38642,113.6893,0,0,0,1.620472,0.1952,0.719821,0.093,0,5.573314,3.602592,0.5112,0.00403,0,1.155184,384.86,4.65,1,0.9029,11.656,0.048,34.73,4.262,131,10.011,64.08,395.0327,7.18,1.96,95,178.17,0,74,118,81.27,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,NA,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1534,70,70,0,1,58.12,165.04,21.48451,1.65,7,0.099999872,1.19984194,0,1,1,7,1027.825,1,1,650.57,43.27,100.13,17.91,22.92,2.52e-4,1e-4,0.0996579,9e-5,0,0.079,1.78205,2.917,0.324,0.115,0.273,0.098,1.921,0.655,102.1,42.55,100.8862,0,6e-5,0,0.16106,0,1.118,0.454,0.616,0.211,1.115,0.41848,138.9785,3.2107,20.0704,8.776,4.462858,0.0697,0.700262,3e-4,25.07,4.297009,0.586733,0.0192,0,0,0.31074,317.68,3.88,0,0.9942,0,0,26.93,4.792,139.1,8.489,87.09,166.6581,8.52,1.71,66,168.09,0,70,117,67,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1535,45,45,0,2,91.9,164.91,34.74266,1.99,6,0.125656753,1.508136,1,2,5,6,9749.338,1,1,263.09,46.99,54.66,18.75,45.68,0,0,0.0315456,3e-5,26.9,0,2.17627,2.4741,0.611,0.535,0.17,0.156,0.698,0.661,106.7,116.57,71.3989,0.06,5e-5,0,1.638142,0.0216,0.435,0.374,0.309,0.366,3.764,0.4081,136.0325,2.726,12.0871,0.8024,0.895927,0.0028,0.779785,0.004,0.77,4.034292,0.603771,0.0061,0,0,1.321327,289.45,3.94,1,1.0053,13.628,0.0551,37.87,4.705,140.3,8.548,72.73,408.0572,5.72,2,89,164.92,0,81,127,92.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1536,48,48,1,2,98.06,171.35,33.52694,2.07,7,0.080260047,0.96213228,0,2,6,7,22428.474,1,1,395.39,39.93,17.8,306.73,74.7,0,0,0.0597488,0.00108,3.43,0.11,4.30119,2.2756,0.172,0.008,0.229,0.111,2.155,0.873,97.9,183.51,45.8962,0,0,0,0.07923,4e-4,0.98,0.439,1.24,0.579,4.489,0.39804,128.9692,1.9525,15.7514,1.0848,3.031711,0.0029,1.407497,0.0435,0,6.808048,4.010428,0.67,0,0,1.030042,147.74,3.23,1,0.7936,0.089,0.0037,27.2,4.427,142.1,5.3,84.29,213.2254,10.79,2.17,72,170.16,0,54,137,98.13,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1537,66,66,0,2,81.03,161.03,30.44417,1.85,7,0.114970633,1.37815566,0,2,3,7,7838.722,2,2,1152.92,37.92,57.2,30.51,22.04,0,0,0.0198411,9e-5,30.44,0.111,11.91532,1.9888,0.319,0.186,0.107,0.046,1.6,0.835,98.1,106.89,60.4706,0,0,0,0.874629,0.0168,0.66,0.386,0.857,0.494,1.024,0.3906,125.5858,2.3219,8.3574,0.0107,1.394561,0.0387,0.602517,0.0528,0.67,1.571389,0,0.0094,3.8e-4,0,0.87973,218.03,3.54,0,1.1171,10.816,0.0037,30.95,4.838,139,9.361,66.97,163.1252,3.29,1.95,78,161.74,0,90,120,82.62,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,< 55,>= 60,< 65,>= 70,>= 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1538,63,63,0,2,48.56,159.96,19.3776,1.51,6,0.159396253,1.91200896,0,2,4,6,203.082,1,1,239.22,41.97,61.94,18.91,17.03,0.002033,0.0026,0.0099842,6e-5,26.74,0.182,4.9981,2.3806,0.093,0.06,0.141,0.107,1.771,0.848,102.2,73.9,65.7938,0,1.4e-4,0.0034,0.002914,9e-4,0.783,0.404,0.795,0.487,0.553,0.36533,125.8618,1.5876,12.0817,0.6966,1.653421,0.2505,0.229309,0.085,0.68,4.255952,0.547268,0.5309,0.0015,0,1.047538,209.38,4.21,1,0.9016,0,0.0144,23.5,4.636,138,9.092,65.98,253.0573,6.47,1.52,95,162.08,0,91,152,48.29,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,NA,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1539,51,51,0,3,67.07,156.16,27.36858,1.64,6,0.070568885,0.84537424,1,3,3,6,5035.918,1,1,257.44,38.85,106.7,14.9,16.03,3.57e-4,0,0.0399863,0.00221,31.05,0.168,3.08329,2.4371,0,0.007,0.066,0.105,0.054,0.752,105,120.11,56.1499,0,2.6e-4,0.0077,2.515263,0.0353,0.136,0.487,0.009,0.221,2.766,0.39854,140.8701,1.2896,0.0412,1.0474,1.403659,3e-4,0.993183,0.0034,0,3.283769,0,0,0.00482,0,1.132477,194.5,4,1,0.9287,12.926,0,29.98,4.003,141.9,15.613,64.96,398.8382,6.25,1.69,65,160.11,0,62,105,68.96,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,NA,NA,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,NA,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1540,36,36,1,1,78.23,186.32,22.79304,2.05,6,0.034635394,0.41623251,0,1,3,6,9211.239,1,1,353.7,34.88,77.07,17,24.06,0,6e-4,0.10156,7e-5,26.76,0.145,0,2.1242,0.005,0.007,0.038,0.056,0.5,0.686,100.9,131.28,61.944,0.01,1e-5,0.0196,0.340301,6e-4,0.412,0.47,0.086,0.169,0.278,0.27584,80.1709,1.6693,8.7939,0.6171,0.80104,0.0034,1.000283,0.0048,0.52,3.95151,4.328614,0.0064,0,0,0,244.32,3.9,0,1.102,11.374,0,31.2,2.95,137,8.494,54.99,398.979,5.8,1.97,81,184.81,0,109,119,72.16,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,GBR,United Kingdom,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1541,56,56,0,3,66.52,174.81,21.80629,1.79,6,0.176720804,2.11990791,1,3,5,6,3018.874,1,1,211.52,0,278.04,21.88,16.93,0.001516,0.0019,1.089e-4,0,25.27,0.096,6.73258,2.0497,0.116,0.007,0.182,0.101,0.941,0.765,103.9,129.92,48.6956,0,2.7e-4,0,0.099551,9e-4,0.489,0.349,0.328,0.3,0,0.40611,132.612,2.0915,12.1932,0.593,2.794897,0.0134,1.792595,0.0046,32.32,12.966616,3.629614,0.0156,0,0,1.026865,568.11,4.21,0,0.9344,8.929,0.0093,0.56,5.221,141.1,7.45,67.07,184.6025,16.73,1.77,67,171,0,68,11,60.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,NA,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1543,59,59,0,2,63.17,169.15,22.41309,1.71,8,0.044559128,0.53480517,2,2,6,8,5668.061,1,1,185.95,31.02,45.78,13.9,16.8,0.002466,0.0012,0,8e-5,28.2,0,0.0476,2.2965,0.047,0.107,0.004,0.001,0.601,0.819,101.1,116.24,48.233,0,1.5e-4,0.0239,0.100604,7e-4,0.401,0.499,0.206,0.273,0,0.34406,115.0479,0.017,10.4042,0.3289,1.340148,0.2018,0.474825,0.0026,0.33,2.19877,3.567774,0.0235,0.00352,0,0,243.66,3.5,1,0.9968,11.589,0,30.18,3.816,140.9,11.911,61.04,263.6876,4.39,1.6,71,168.74,0,68,120,61.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1544,67,67,0,3,69.86,166.94,25.14346,1.76,6,0.048428538,0.58178036,1,3,5,6,2797.678,2,2,261.87,32.93,219.72,20.23,25.92,0,5e-4,0.1022767,0.00599,28.04,0.071,3.92532,2.4051,0.089,0.057,0.092,0.06,0.738,0.567,0,72.69,79.5969,0.37,7e-5,0.0316,0.177218,0.0173,0.299,0.003,0.297,0.256,0.539,0.31335,101.261,1.1572,9.0264,0.6439,1.387566,0.2736,1.307827,0.123,0.11,2.695865,0.36636,0.6407,0.00701,0.001,1.158844,189.82,3.97,0,0.996,0,0.0144,29,3.786,71.3,16.566,62.88,395.4467,4.91,1.78,61,167.98,2,76,117,70.46,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,Y,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,Yes,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1545,65,65,1,3,56.93,162.17,21.78651,1.58,8,0.07861653,0.94282114,0,3,5,8,6072.229,2,2,239.4,42.05,209.45,10.85,20.05,0.00187,0.0022,0.0700012,0.00231,29.98,0.141,6.79476,1.754,0.173,0.156,0.056,0.019,1.367,0.916,107.9,83.18,70.9787,0.14,4e-5,0.0126,0.548033,0.0286,0.659,0.452,0.707,0.628,0,0.36768,132.2425,0.4465,6.7342,0.4605,1.864273,0.2686,0.500424,0.06,0.74,4.506455,3.208933,0.0383,0.00321,0,1.610448,580.92,5.09,0,0.8041,12.982,0,24.29,4.807,138.1,4.083,59.58,355.753,6.87,1.63,78,162.79,0,90,132,57.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1546,63,63,1,4,46.97,165.03,17.01863,1.5,7,0.037935361,0.45586668,1,4,4,7,13500.08,1,1,254.09,27.94,106.22,18.3,12.2,0.001972,6e-4,0,0,0.73,0.09,3.99517,2.3315,0.237,0.223,0.266,0.184,0.725,0.555,102.9,88.06,60.1196,0,0,0,0.034231,0,0.75,0.566,0.111,0.001,0,0.37095,106.9237,0,0.0414,0,1.677135,0,1.05215,0,0.14,14.121368,0,0,1.8e-4,0,1.190572,316.96,3.9,0,0.9993,12.118,0.0709,34.88,4.43,140.1,8.586,65.99,134.1555,20.37,1.54,72,167.43,0.1,60,115,49.5,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,Yes,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1547,71,71,2,4,82.03,159.02,32.72143,1.85,6,0.077946066,0.93364222,1,4,6,6,32176.213,1,1,216.95,41.08,754.07,34.92,36.3,0.004308,0.0043,0,0,28.66,0.135,17.74636,2.3462,0.04,0.097,0,0.008,0,0,99.1,68.28,88.1169,0,2.4e-4,0,0.082726,0,0,0,0,0.142,0,0.41503,140.9909,5.5977,16.3333,5.6527,0.704909,0.0076,0.699613,0.0306,0.82,3.600966,4.83634,0.3763,0,0,1.358992,143.62,4.01,0,1.0328,11.914,0.0273,26.02,4.711,137.1,20.734,74.98,465.5701,4.87,1.78,8,158.11,0,74,101,76.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,1-3,2-3,ABNORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,NA,N,Y,N,N,Low-Intermediate,High,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,N,N,Y,OTHER,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1548,50,49,0,2,45.62,154.94,19.06471,1.42,6,0.040505749,0.48585138,0,2,6,6,6562.221,1,1,343.54,41.79,223.42,30.59,24.98,0.496303,0.0529,3.681e-4,0,22.32,0.149,4.4144,2.2119,0.116,0.129,0.189,0.127,0.696,0.002,109,122.1,44.2181,0,0,0,0.012075,6e-4,0.449,0.336,0.204,0,0,0.40951,142.4128,1.802,12.8601,1.3095,1.119234,0.1787,0.489991,0.0745,27.5,2.693035,0,0.0068,0.00776,0.001,0,187.73,3.69,0,1.0909,0,0,23.08,4.219,145.3,8.731,71.08,237.7479,4.89,1.51,89,154.95,0,72,141,50.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,0,NA,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1549,26,26,1,1,53.03,158.14,21.72359,1.54,8,0.061622457,0.73917679,0,1,6,8,9868.256,2,2,314.74,11.74,139.11,23.95,35.37,0,0,3.91e-5,8e-5,24.54,0.053,4.08139,2.3207,0.132,0.171,0.05,0.07,1.343,0.88,105,113.67,61.8784,0.23,9e-5,0.0164,0.100672,0.0294,0.717,0.565,0.58,0.493,1.173,0.3138,118.697,1.2223,12.4143,0.8634,0.71899,0.1877,0.400011,0.0633,0.82,3.691717,0.062811,0.0092,0,0,1.256785,567.04,4.31,0,0.9022,0,0.0191,23.98,4.383,142,5.135,58.83,163.4296,4.97,1.53,79,156.01,0,93,109,53.2,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1550,44,44,0,2,80.33,173.99,26.75441,1.96,6,0.042315849,0.50773907,1,2,1,6,3570.509,2,2,202.48,39.02,205.12,11.96,17.31,0.740831,0.0191,1.804e-4,4e-5,31.01,0.104,6.07653,2.392,0.034,0.096,0.018,0.047,0.037,0,99.2,91.97,81.0776,0.23,5e-5,6e-4,0.003823,0,0.074,0.165,0.067,0.135,0,0.32723,113.1842,2.881,15.219,1.8271,0.540183,0,0.850631,0.0591,0.05,7.146023,7.30593,0.4292,0.00198,0.001,1.63514,460.46,3.32,0,1.032,16.58,0,32.99,4.005,124.9,7.197,77,243.9849,8.4,1.9,64,168.94,0,90,103,69.86,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1551,59,59,1,3,64.97,174.02,22.43264,1.77,8,0.085441412,1.02533996,0,3,2,8,2554.395,1,1,952.5,41.05,97.85,29.14,30.03,0.002603,0.0032,0.0401165,0.00971,29.48,0.155,8.97343,2.2487,0.533,0.25,0.111,0.047,0.873,0.657,102.1,87.4,71.4111,0,4e-5,0.0224,0.399994,0.1007,0.434,0.118,0.455,0.374,0,0.41895,141.1593,0.009,11.7898,0,2.700201,0.3859,0.229908,0.1179,29.11,2.949373,6.752162,0.7603,0.00189,0.001,1.067796,351.81,3.59,1,0.9213,0,0.0917,31.97,4.753,140.1,3.012,69.95,221.5773,5.74,1.7,71,174.02,0,70,130,64.34,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1552,51,52,0,1,72.94,169.82,25.87028,1.85,6,0.120766807,1.45219115,1,1,3,6,6536.893,2,2,430.43,37.09,313.68,89.4,87.63,0,0,0.0296226,0,2.5,0,7.99835,2.7595,0.23,0.148,0.001,0,0.775,0.655,100,75.16,86.0231,0.05,0,0,0,0,0.478,0.367,0.277,0.162,0,0.36221,114.623,4.8723,16.2839,1.526,1.100777,0,0.498484,0,0.6,7.10726,4.415365,0,0,0,1.516572,344.35,4.62,0,0.8157,0.4,0.0449,27.01,4.779,140.1,15.321,76.95,379.8481,8.49,1.79,62,166.03,0.1,72,110,67.2,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1553,62,62,0,2,68.08,172.03,22.95141,1.81,6,0.021166708,0.25379296,0,2,4,6,2564.327,1,1,261.51,28.96,53.95,15.05,17.8,0.003312,0.0031,0,0,0,0.174,9.99311,2.3194,0,0.001,0.033,0.055,0.026,0.641,103.9,90.42,65.0404,0,7e-5,0.0253,0.00658,0,0.117,0.355,0.005,0.159,3.008,0.33606,99.6642,0,0,0,0.718428,0,0.539144,0,0.35,5.101556,0.192197,0.0173,0.00806,0,0.06373,573.09,4.2,1,1.0149,11.126,0.013,27.26,3.82,143,3.996,49.38,214.0197,7.33,1.9,70,172.03,0,70,112,71.12,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1554,61,61,0,2,54.08,153.93,22.6232,1.51,6,0.059138192,0.70899959,0,2,6,6,2240.444,1,1,428.24,37.05,67.7,12.95,22.97,0,1e-4,0,4e-5,23.08,0.001,14.98902,4.7871,0.087,0.281,0,0.011,0.022,0.824,102.9,72.13,67.803,0.73,1.2e-4,1.53,0.043465,5e-4,0.023,0.479,0.002,0.293,3.212,0.38585,135.1634,1.9052,7.6907,1.4617,0.222408,0.1191,0.234478,0.057,17.18,6.633096,0.315101,0.0094,5.5e-4,0,1.465646,334.92,4.2,0,0.9046,0.635,0.0511,26.03,4.098,140,10.09,64.72,368.786,6.79,1.41,73,152.76,0,75,109,52.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1555,69,69,1,3,98.05,181.63,28.99891,2.2,6,0.108269422,1.30062896,0,3,1,6,7499.992,2,2,271.94,43.98,202.98,39.17,29.48,0,0,0.0999939,0.01002,23.45,0.088,5.29833,2.5296,0.25,0.197,0.14,0.13,0.887,0.532,99,91.13,73.5476,0,8e-5,0,0.159526,0.03,0.512,0.338,0.354,0.304,1.92,0.43682,146.7057,3.047,1.6865,0.0087,1.601923,0.239,0.39963,0.065,23.92,3.401134,4.048739,0.718,0.0079,0.001,1.294336,496.84,4.52,1,1.1974,10.076,0.024,0,5.068,144.2,5.153,67.04,397.62,5.69,2.03,79,177.99,0,92,144,91.72,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1558,66,66,0,2,75.55,174.97,24.80347,1.91,7,0.052565518,0.63118312,0,2,1,7,302.361,2,2,336.32,46.2,92.98,63.04,18.09,0.001935,0.0025,0.0995449,0.00273,0,0,4.88095,2.4233,0.172,0.041,0.206,0.071,2.58,0.917,95.9,93.54,69.8929,0.29,1.8e-4,0.0325,0.013811,4e-4,1.563,0.581,0.956,0.43,0.462,0.42999,143.9221,2.9037,14.2842,1.0338,2.258796,0.159,0.698636,0.003,29.18,6.609911,0.509686,0.0354,0,0,1.144664,347.54,4.67,1,1.1125,14.323,0,26.32,4.615,136.9,9.042,70.06,354.6972,9.96,1.93,87,173.39,0,76,121,78.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1559,73,74,0,5,72.96,156.6,29.67419,1.72,6,0.010653083,0.12777329,1,5,2,6,3311.653,1,1,369.29,44.9,87.88,14.01,22.99,3.53e-4,0,0,0,0,0.002,0,2.5364,0.028,0.007,0.347,0.249,1.066,0.863,96.3,76.85,61.9626,0,1.9e-4,0.0145,0.069662,0,0.653,0.577,0.401,0.428,0,0.42925,139.9343,1.0507,4.9146,0.4018,1.799953,0.0092,0.341653,0,19.79,5.628312,7.089289,0.0257,0,0,1.183592,224.04,3.3,0,1.0597,0,0.0284,1,3.991,135.9,10.002,72.06,243.955,8.41,1.63,75,154.95,0.1,96,130,62.92,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1560,44,45,0,1,100.06,191.3,26.14297,2.31,8,0.182094144,2.18956676,0,1,4,8,3093.565,2,2,260.07,34.85,81.33,23.87,32.53,6.03e-4,0,2.29e-5,7e-5,1.71,0.002,2.84947,2.2913,0.183,0.191,0.022,0.001,0.81,0.849,106.8,137.88,68.0296,0.31,1.7e-4,0.0184,0.314066,0.005,0.463,0.486,0.306,0.368,0,0.35562,130.7112,1.6861,7.9126,0.6594,0.340097,0.195,0.18909,0.0035,0.48,2.406328,0.524893,0.655,0.00322,0,0.95519,170.6,4.83,1,0.9044,11.401,0,26.95,4.39,138,10.24,49.66,267.1003,3.81,2.38,93,192.08,0,76,149,100.38,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1563,65,65,0,2,51.7,166.96,18.72926,1.57,7,0.039419048,0.47329701,1,2,2,7,2745.89,1,1,429.07,36.21,29.66,9.71,29.43,0,0,0.0204096,0.006,0,0,6.34015,2.5428,0.152,0.241,0.049,0.079,0.013,0,100,55.17,88.5616,0.2,4e-5,0.0063,0.208564,0.0097,0.069,0.231,0.003,0.002,0,0.25856,93.1165,2.9562,13.5975,0.7338,0.49917,0.1257,0.532391,0.0595,0,12.506116,4.637315,0.0392,0.00488,0,0.779483,395.07,3.66,0,1.0933,10.167,0.0064,26.69,3.67,132.3,4.251,67.02,321.026,10.12,1.57,96,165.1,0.1,115,151,49.93,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1564,34,34,1,1,51.48,169.4,18.55986,1.58,6,0.070228488,0.84226632,1,1,4,6,10626.013,1,1,400.68,38.21,65.25,72.44,34.8,0.001861,0.0028,0.0081108,4e-5,0.21,0.05,5.71135,2.3234,0.153,0.093,0.22,0.134,1.956,0.814,99.7,91.43,70.9998,0.16,0,0,0.071445,0.0041,0.634,0.291,1.333,0.511,0,0.29962,97.4001,1.0056,10.1731,0.3076,2.131354,0.3039,0.398733,0.0734,0,5.104854,0,0.0318,0.00162,0,1.06622,309.12,4.49,0,1.062,11.883,0.0298,31.59,3.257,140.7,9.962,67.05,197.6451,9.2,1.54,79,170.81,0.1,79,103,51.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1565,59,59,0,2,80.42,170.18,27.74047,1.95,6,0.067686939,0.81205054,2,2,2,6,4821.663,2,2,88.32,34.86,67.58,23.22,16.05,0,0,0,0,25.01,0.111,13.3333,2.0437,0.184,0.252,0.362,0.318,0.057,0.575,104.5,111.92,64.0133,0,5e-5,0,0.19577,0,0.016,0.195,0.183,0.309,2.374,0.4081,133.8765,1.4101,0,1e-4,0.552918,0,0.303536,0,0,5.345148,0.002983,0,0,0,0.960661,173.35,4.4,0,0.9681,0.846,0,31.76,4.704,144.2,10.778,67.01,180.9477,6.43,1.89,63,169.93,0,75,123,81.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1566,78,78,0,4,69.03,152.08,30.41948,1.66,6,0.182638857,2.19129957,0,4,3,6,10507.556,1,1,431.39,27.24,513.07,17.98,24.05,7e-6,0,0.0995388,8e-5,0,0.099,5.26658,2.2341,0.312,0.236,0.117,0.081,1.195,0.683,100,47.01,95.7621,0.13,0,0.0225,0.019594,9e-4,0.782,0.368,0.364,0.224,0,0.40624,128.9346,0,0.0093,0,1.398593,0.0048,0.498405,0.0452,0,9.616532,0.41939,0.0198,0.00102,0,0.034059,414.3,4.1,0,0.9454,0,0.0604,0.69,4.792,139.1,13.629,65.98,243.878,12.21,1.6,74,152.81,0,100,110,69.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,Y,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1567,64,65,1,2,88.76,175.03,28.31152,2.06,6,0.133424465,1.60233086,0,2,4,6,6719.296,2,2,196.68,38.1,88.53,14.87,16.03,0,0,0.0099794,0.00294,27.04,0.103,4.63976,2.3194,0.162,0.105,0.113,0.112,0.936,0.849,103,81.93,81.3745,0,0,5e-4,0.30074,0.0054,0.523,0.51,0.377,0.419,6.062,0.41281,151.3087,1.8145,7.6618,0.6668,0.906002,0.0109,0.500595,0.0526,28.94,3.27936,3.352958,0.0135,0.00838,0,0,185.81,4.11,0,1.0925,10.346,0.0632,0.72,4.672,137,11.978,69.1,273.8937,4.79,1.99,68,173.87,0,82,145,88.12,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1568,43,43,0,2,68.06,171.74,23.06711,1.8,7,0.057182695,0.68594968,1,2,5,7,461.528,2,2,167.77,42.05,179.85,16.11,14.03,0.003704,0.0017,0.0237573,4e-5,3.34,0.125,4.23377,2.0747,0.102,0.09,0,0,0.055,0.113,97.8,85.81,83.9991,0.24,5e-5,0,0.001422,0,0.004,0.005,0.142,0.216,0,0.37933,124.4565,4.2266,11.4294,0.4225,0.71935,0.1097,0.288782,0.0608,17.22,3.009631,2.410761,0.0364,5.8e-4,0,1.108116,381.73,4.5,1,1.0088,13.144,0,35.7,4.552,137,23.226,60.03,297.7952,4.21,1.74,78,170.08,0,72,111,67.85,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1569,61,61,1,2,48.13,165.03,17.9997,1.53,6,0.022591856,0.27107952,1,2,6,6,7904.505,1,1,340.19,37.86,210.4,31.01,43.17,0.002479,0.002,0.0395893,0,22.46,0,6.3117,2.3263,0.314,0.255,0.082,0.062,0.499,0.603,96.7,99.9,54.1658,0,0,0,0.1058,9e-4,0.392,0.43,0.086,0.001,0,0.30225,99.3585,0.0146,7.6509,0,0.881183,0,1.431152,0.0398,0.15,5.822691,0,0.0048,0.00284,0,0.344683,201.04,4.38,0,1.2006,0.585,0.033,33.01,4.004,134.3,15.016,63.97,161.5339,8.82,1.58,80,168.05,0,78,113,54.22,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1570,60,60,1,2,75.92,169.2,26.21858,1.9,7,0.151035256,1.8112145,0,2,3,7,8290.563,2,1,725.41,42.9,202.56,11.09,17.95,0.004286,0.01,0.0103972,0,26.92,0.039,10.12573,3.3047,0.274,0.157,0.005,0.001,0.846,0.561,0,72.76,93.6615,0.17,0,0.0151,0.100525,0,0.464,0.335,0.236,0.001,5.114,0.41549,133.1019,1.692,8.6459,1.0249,2.700467,0.0071,1.508503,0.0606,32.38,14.224836,6.080602,0.6109,0.00775,0.001,1.207235,427.67,4.51,0,1.3061,11.263,0.0257,1.05,4.694,136.1,6.67,81.56,426.439,23.17,1.93,71,167,0.1,81,102,75.07,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1571,39,39,1,2,67.05,155.91,27.98036,1.65,7,0.060839701,0.73032295,1,2,3,7,15165.042,2,2,166.01,41.1,52.84,15.15,21.46,8.4e-4,4e-4,0.009919,7e-5,27.94,0.118,3.91564,2.3448,0.059,0.004,0,0,0.813,0.682,100,135.57,49.0655,0.1,1.3e-4,0.0108,0.02021,6e-4,0.413,0.27,0.316,0.242,0,0.39079,128.2593,1.6843,10.9291,2.4055,1.912147,0.2692,0.409554,0.0093,0.09,2.795327,0.007059,0.017,0.00209,0,1.143471,291.06,4,0,0.9023,0.568,0,28.25,4.737,138.1,8.511,74.02,358.8051,5,1.66,91,155.71,0,94,134,64.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1572,69,69,1,2,78.01,156.2,31.19249,1.77,6,0.034515071,0.41383539,0,2,1,6,3641.167,1,1,216.27,28.31,59.38,13.11,17.12,0.001304,8e-4,0,9e-5,25.07,0.101,6.64032,2.3751,0.24,0.193,0.208,0.128,0.923,0.022,106.1,105.46,51.242,0,0,0.0013,0.077593,6e-4,0.563,0.388,0.244,0.159,0,0.38318,128.8538,2.3654,9.6472,0.4243,1.390609,0.0042,0.311486,0.0032,0.53,3.601716,0.214754,0,0,0,1.334931,126.33,4.5,0,0.9783,11.905,0.0086,28.44,4.393,140.9,11.267,54.91,393.1425,5.41,1.79,80,155.09,0,79,140,75.09,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1573,67,67,0,3,74.94,157.51,29.59956,1.74,7,0.197107622,2.36497253,0,3,5,7,3180.942,2,2,198.43,40.94,62.93,31.12,17.05,0.001129,4e-4,0,2e-5,28.93,0.077,6.21664,1.9954,0.627,0.42,0.154,0.067,1.635,0.749,107.1,127.13,44.2035,0,1e-5,0,0.20173,7e-4,0.659,0.338,0.83,0.373,0,0.46261,147.0727,1.9046,10.4055,1.2366,2.057001,0.0044,0.378886,0.0013,17.38,3.998898,0.130816,0,0.00161,0,1.458945,240.99,4.3,0,0.983,13.129,0,31.55,4.614,140.1,5.016,67.02,201.9352,6.59,1.8,65,160.08,0.1,67,111,78.12,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1574,36,36,0,2,54.01,154.24,22.8624,1.52,6,0.11468002,1.37470334,1,2,2,6,2985.885,1,1,865.78,47.03,97.33,15.08,23.89,8.42e-4,0,0.0211645,0,2.33,0.072,4.19911,2.198,0.144,0.176,0.214,0.233,0.738,0.644,106.1,78.44,91.9912,0.06,5e-5,0.0079,0.039277,0,0.342,0.297,0.336,0.365,1.572,0.37916,124.6861,1.4342,10.2925,1.0138,1.801869,0.0116,0.312449,0,0,4.320031,0,0.0055,0.00437,0,0.925516,218.54,4.28,0,1.1807,12.335,0,40.8,4.502,142,16.729,69.08,239.1526,5.59,1.54,94,155.12,0,87,126,57.03,0,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1575,45,46,1,3,85.48,169.86,30.26814,1.98,6,0.089601854,1.07548217,1,3,5,6,29075.825,2,2,350.7,48.81,55.8,36.39,20.92,6.8e-4,0,0.029786,0,25.03,0.031,6.78418,2.5206,0.095,0.03,0.12,0.094,1.095,0.85,100,88.58,89.155,0.08,2e-4,0.0192,0.180108,0,0.676,0.504,0.393,0.303,0,0.41085,127.9646,0.4037,0,0.8172,1.800586,0,0.479692,0,0,6.096089,0.70898,0,0,0,0.937736,256.17,4.16,0,0.9405,10.403,0,27.24,4.608,136,11.919,72.95,229.993,8.9,2,72,170.99,0,97,126,84.94,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1577,60,60,1,1,79.26,164.96,28.89208,1.89,6,0.023846271,0.28607122,0,1,3,6,13325.957,2,2,168.61,45,68.71,33.74,17.01,0,5e-4,0.1004819,6e-5,23.68,0.001,6.49628,2.4721,0,0.003,0,0,0,0.513,0.4,61.6,123.8906,0.16,0,0,0.099558,0,0,0.003,0.005,0.002,2.859,0.48044,168.5818,1.9305,14.7853,0.8405,1.519866,0.007,0.624248,9e-4,0,9.95539,2.306728,0.0118,0.00112,0,1.222328,328.37,4.11,0,1.1714,13.507,0.0259,34.24,5.252,142,10.864,66.38,393.5136,13.51,1.9,80,163.96,0,87,110,74.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1578,55,55,0,4,38,144.43,19.11583,1.24,8,0.081287663,0.97659251,1,4,3,8,2679.634,1,1,1658.31,18.93,81.95,21.01,20.06,0.001738,0,0.0670282,8.7e-4,3.86,0,6.00207,2.3113,0.454,0.295,0.249,0.131,0.914,0.537,101,61.47,70.8425,0,4e-5,0,0.050058,6e-4,0.46,0.22,0.487,0.337,0,0.26615,90.8929,0,8.2961,0.2138,1.16537,0.0013,0.697277,0,0,13.810133,4.236381,0.0271,0.00212,0,1.063858,535.2,3.48,0,0.9946,10.412,0.0629,18.59,2.817,136.9,6.066,67.13,160.3038,12.4,0.7,50,139.35,0,76,110,34.74,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,>4,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1580,63,64,0,2,58.09,149.87,26.6705,1.54,7,0.150347137,1.80706256,1,2,3,7,1001.725,1,1,127.67,40.92,99.56,15.74,16.97,0,0,0.039989,0.00294,28.38,0.002,7.78033,2.2423,0.446,0.243,0.02,0.001,1.298,0.738,101,82.19,63.6021,0.38,1e-4,0,0.040856,8e-4,0.744,0.407,0.473,0.255,1.49,0.34088,106.5486,2.1869,15.1968,0.2009,1.356298,0.0064,0.305839,0,17.3,2.951104,0.569812,0.0176,6.2e-4,0,1.51927,187.59,4.1,1,0.9958,12.665,0.0211,0.45,3.951,137.7,6.139,74.39,337.5752,4.79,1.51,62,148.34,0.1,79,109,55.19,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1581,73,73,1,3,73.93,145.7,35.36147,1.64,7,0.026938161,0.32327711,1,3,1,7,1383.635,1,1,277.26,37.03,188.94,11.98,19.18,0,0,0.0200071,3e-5,28.02,0.152,5.62935,2.1073,0.176,0.144,0.001,0.001,0.245,0,103.4,97.1,56.0886,0.7,8e-5,0.0224,0.030596,0,0.017,0,0.086,0,1.586,0.34771,112.5313,1.4691,5.673,0.4776,1.598843,0.011,0.480083,0,10.85,17.867404,7.418469,0.5686,0,0,1.647743,574.96,4.41,0,1.0384,13.044,0.0017,27.66,3.626,140.1,3.483,58.04,355.931,20.35,1.6,81,144.31,0,108,123,73.09,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1583,73,73,0,3,55.88,165.04,20.62188,1.6,6,0.050622194,0.60839481,0,3,5,6,3896.918,2,2,291.18,30.68,293.03,15.08,17.83,0,5e-4,0.0116329,0.00216,3.87,0.255,7.5181,2.093,0.273,0.159,0.117,0.092,0.946,0.64,100,83.18,53.0125,0.33,0,0.2601,0.006268,6e-4,0.649,0.426,0.293,0.091,6.053,0.33143,111.532,2.8717,12.935,0.9368,1.429411,0.1542,0.550027,0.0042,28.13,7.390772,3.177884,0.5162,0.00655,0.001,0,273.76,3.51,0,0.9605,0,0.0314,0,3.848,135.1,5.104,62.05,273.5962,10.59,1.62,67,166.93,0,86,123,56.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,Low,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1584,73,73,0,4,80.1,173.37,26.23664,1.95,6,0.11637337,1.39566219,0,4,2,6,5967.228,2,2,593.26,23.96,58.09,31.87,22.15,0,0,0.0377808,0,26.48,0.049,4.68853,2.5007,0.397,0.296,0.059,0.021,0.705,0.007,96,64.19,89.8016,0.23,3e-5,0.0131,0.050094,0,0.522,0.301,0.229,0.124,2.066,0.36053,119.8164,2.659,13.8295,0.652,0.984942,0,1.301009,0,0,17.412101,0.65119,0,0,0,0.892174,130.21,4.4,1,0.9725,8.981,0,29.49,4.688,134.5,8.008,58.12,292.3592,15.41,2.04,90,174.92,0,73,121,82.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1585,66,66,0,1,74.06,162.01,27.70532,1.78,7,0.076964523,0.92242941,0,1,5,7,1900.904,2,2,776.73,40.94,68.94,10.01,12.11,0.002306,0,0.036689,5e-5,28.1,0.214,5.1914,2.4918,0.22,0.233,0.171,0.225,0,0,101,86.34,67.9449,0.13,2e-5,0,0.05973,4e-4,0.027,0.134,0,0.111,0,0.41283,131.3168,3.245,11.4262,0.8045,0.630305,0.0018,0.251361,0,0.32,2.816801,6.798283,0.0342,0,0,0,249.03,4.09,0,1.1374,10.913,0.0437,22.55,4.299,145,4.102,81.34,352.4642,3.97,1.91,62,162.13,0,91,114,79.38,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,CHE,Switzerland,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Other,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1588,61,61,0,2,84.6,180.18,26.69909,2.05,8,0.119442007,1.43187063,0,2,4,8,1078.824,1,1,271.63,40.07,71.85,23.24,27.27,0.002431,0.0025,0,8e-5,26.93,0.051,0,2.3729,0.076,0.22,0,0,0,0.6,103.9,105.53,70.9002,0.08,0,0.0016,0.060221,0.0431,0.002,0.259,0.008,0.271,0,0.41097,133.8541,1.0059,7.2001,0.5162,0.121588,0.1997,0.330941,0.08,27.4,3.823961,2.597491,0.49,0,0,0.16346,181.06,3.99,0,1.1095,0.356,0.0042,29.41,4.651,136.9,20.692,64.89,355.4545,4.7,1.94,90,178.47,0,103,133,79.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1589,60,60,0,4,87.85,172.09,29.35436,2.01,6,0.032791979,0.39416471,1,4,5,6,6288.115,1,1,295.46,42.07,47.47,40.87,35.36,0.002916,0.0027,0.0099233,6e-5,0,0,4.71049,2.4265,0.117,0.08,0.093,0.074,0.824,0.704,100,52.47,123.9834,0.12,1e-4,0.0239,0.131745,0.0155,0.491,0.363,0.293,0.304,4.894,0.36517,135.0007,0,0.0917,1.2068,1.553793,0.2101,0.400021,0.1161,28.32,2.580123,0,0,0,0,1.161128,106.5,3.74,0,0.9618,0.724,0.0384,24.52,4.13,138.1,7.523,70.06,254.8954,5.2,1.91,72,171.99,0,70,144,83.23,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,NA,NA,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1590,86,86,0,4,61.81,153.26,25.6958,1.59,6,0.071417162,0.85765412,1,4,4,6,1382.902,2,2,229.57,41.64,106.98,15.01,41.99,0.002875,0.0039,9.87e-5,0.00735,26.66,0.182,13.64493,2.2043,0.181,0.228,0.032,0.086,0.033,0.004,103,39.75,77.8354,0.06,6e-5,0.0152,0.099742,0.0391,0.051,0.321,0.032,0.119,0.642,0.32901,105.6569,0,7.8276,0.3927,1.091926,0.4311,0.498356,0.2321,0.52,1.505268,2.122329,0.6671,0.00356,0.001,1.330028,107.89,4,1,0.9969,10.873,0.0195,23.08,3.425,138,11.178,66.07,407.848,3.53,1.58,62,149.02,0,81,121,59.98,1,1,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,2-3,ABNORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1591,66,66,0,3,81.92,164.21,30.65683,1.91,7,0.193448695,2.32140457,0,3,4,7,2411.344,1,1,234.04,36.12,325.67,18.95,21.01,0.00264,0.0045,1.123e-4,0.005,2.13,0.108,5.2014,2.2264,0.141,0.005,0.292,0.185,1.345,0.761,105.9,100.16,61.0076,0.16,0,0.0144,0.090097,0.0396,0.878,0.517,0.39,0.174,0.448,0.45979,150.5881,0,6.3054,0.6468,1.835265,0.3921,0.336777,0.0906,0.35,3.009645,2.898381,0.6703,0,0,1.03981,257.74,4.76,0,0.9909,11.197,0,35.03,5.984,139,10.283,63.9,208.3119,4.97,1.9,77,163.91,0,29,140,86.81,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1592,81,81,0,2,52.04,153.2,22.46132,1.47,7,0.227576389,2.7340893,0,2,1,7,779.298,1,1,177.19,33.97,134.48,13.83,20.52,5.6e-4,0.001,0.0099261,2e-5,3.15,0.122,5.35394,2.2811,0.162,0.145,0.083,0.064,0.884,0.751,104.9,50.81,62.0853,0,3.1e-4,0,0.029034,3e-4,0.561,0.486,0.376,0.316,0,0.26665,88.633,2.8746,6.6647,0.8823,0.480265,0.0041,0.359423,0.0088,0.71,2.86346,3.015477,0.6998,6.3e-4,0,0,237.04,4.8,0,1.0156,0.864,0.0427,27.4,3.205,137.9,4.029,57,284.3299,3.57,1.47,61,153.2,0,72,129,49.96,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,Y
1593,77,77,1,3,101.51,183.84,29.41098,2.22,6,0.067591127,0.81072644,0,3,2,6,18623.847,2,2,363.15,38.81,175.86,45.07,25.93,0.002229,6e-4,1.551e-4,0,27.94,0.002,5.20539,2.3016,0,0.066,0,0.014,0.027,0.716,101.2,84.44,67.6185,0,1e-4,0.0117,0.100796,0,0.015,0.324,0.062,0.318,0.571,0.38038,117.7506,4.4221,13.7421,0.2141,0.513524,0,0.719423,0,31.3,10.719934,0,0,5.2e-4,0,0.929419,394.63,3.61,0,1.0928,13.671,0.0318,30.06,4.705,138,10.266,70.69,363.3898,10.08,2.13,95,180.02,0,99,140,96.04,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1594,64,64,0,2,74.96,179.85,23.67437,1.94,6,0.056637904,0.67989895,0,2,3,6,2368.062,2,2,240.82,35.07,84.26,14.86,20.01,0,0,0.099628,5e-5,30.04,0.155,5.71889,2.2183,0,0,0,0,0.574,0.79,100.1,119.13,51.8132,0,5e-5,0.0027,0.288355,4e-4,0.395,0.485,0.105,0.138,1.645,0.39994,132.4585,1.1733,7.7172,0.3655,1.451174,0,0.699038,0.0022,0.38,6.910822,2.895087,0.0261,0,0,1.185174,379.8,3.42,0,1.0032,10.274,0.0359,36.02,4.505,140,15.621,67.01,190.0198,9.99,2.1,87,181.24,0,68,140,77.27,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1595,57,57,1,3,41.96,149.54,19.07452,1.34,6,0.133533739,1.60072067,0,3,5,6,5488.341,1,1,2060.96,39.45,77.9,22.47,29.08,0,0,0.059931,0,25.92,0.141,5.29031,2.4042,0.429,0.208,0.306,0.187,1.203,0.681,99.6,61.36,79.8618,0.45,0,0.0057,0.100211,0,0.717,0.475,0.47,0.221,2.155,0.47556,155.9329,6.5974,17.9255,2.4524,1.802158,0,0.358753,0,0.02,5.193089,2.583196,0,0.00551,0,1.389576,340.82,3.25,0,0.9989,0.015,0.0192,23.36,4.606,137,8.445,82.07,226.0062,9.5,1.23,75,147.08,0,82,129,41.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1596,53,53,0,1,54.91,153,23.37278,1.52,7,0.03292735,0.39505871,0,1,3,7,2432.448,2,2,775.69,35.05,51.68,10.83,19.8,0.00382,0.0029,8.54e-5,3e-5,29.02,0,4.40929,2.5255,0.583,0.295,0.026,0.001,0.799,0.011,102.3,106.17,61.9153,0,6e-5,0.0091,0,1e-4,0.315,0.001,0.381,0.207,3.69,0.36855,115.3702,1.2789,11.0392,0.8769,1.250399,0.1803,0.571113,0.0693,0.52,12.950855,7.090677,0.0356,0.00179,0,0.948541,643.45,4.16,0,1.0342,0.188,0.0537,27.33,3.838,142,5.177,54.05,273.6549,12.29,1.52,54,153.64,0,69,95,54.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1597,43,43,0,2,76.22,170.93,26.71175,1.89,8,0.142998726,1.71520298,0,2,6,8,2640.52,2,2,285.38,45.94,62.95,15.72,10.04,5.86e-4,0,0.029944,0.00363,30.34,0,5.24446,2.3937,0.745,0.318,0.36,0.135,2.446,0.724,105.1,100.1,75.0457,0.03,0,0.0057,0.124778,0.014,1.605,0.567,0.726,0.199,0,0.45114,140.8477,5.4332,25.351,1.0049,4.520487,0.1502,1.035457,0.0594,20.03,5.047558,5.787074,0.5922,0,0,1.610614,356.51,3.7,1,0.9743,14.07,0,27.75,5.876,138,5.807,84.18,273.059,9.91,1.84,86,168.94,0,89,120,74.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1598,39,39,0,3,70.08,165.03,25.217,1.81,6,0.094417872,1.13397209,1,3,2,6,884.761,1,1,219.11,30.94,63.93,9,16.11,5.7e-4,0.0016,3.168e-4,0,23.21,0.14,15.23491,2.294,0.061,0,0.105,0.076,0.815,0.699,107.9,72.45,107.4776,0.02,0,0,0.059739,0,0.383,0.306,0.273,0.199,0,0.41854,146.9665,2.8303,15.1024,0.7265,3.093454,2e-4,0.670009,0.0022,0.49,6.86645,0.500066,0,0,0,1.033852,131.91,4.2,0,1.6085,10.877,0.0085,32.9,4.206,140.7,3.976,67.04,220.7555,11.59,2.03,71,168.09,0,99,116,80.67,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,Y,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1599,73,73,0,2,59.93,148.4,27.76833,1.54,6,0.01812216,0.21760685,0,2,4,6,5271.668,2,1,168.98,34.74,69.03,8.77,16.81,0,0,0,0,25.78,0.08,13.11525,2.3816,0.031,0.154,0.072,0.115,0.522,0.659,103,68.21,68.0872,0.13,1.6e-4,0.0102,0,0,0.502,0.614,0.006,0.002,2.926,0.28432,100.1018,0,0,0,0.602483,0,0.398802,0,0.48,3.876956,7.091708,0.0251,0.00669,0,0.88605,234.74,4.1,1,1.0071,11.363,0.0084,0.13,3.211,135.2,3.053,49.96,561.4589,5.39,1.5,59,147.17,0,70,104,58.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1600,37,37,1,2,70.35,169.94,24.33525,1.82,7,0.105434749,1.26541111,1,2,5,7,21097.286,2,2,490.19,0,73.96,18.89,19.13,0,5e-4,0.020031,0,0,0.038,13.48358,2.2756,0.002,0,0.06,0.014,1.199,0.688,101.9,91.77,85.2998,0.12,1.6e-4,0.0204,0,0,0.453,0.083,0.491,0.265,0.81,0.2961,88.6012,0,9.5687,1.1808,1.179358,0,0.997232,0,0.69,20.515607,4.179399,0.0073,0.00594,0,1.000709,247.32,4.85,0,1.1118,11.93,0.047,24.69,3.81,135.8,6.853,58.73,291.0044,23.83,1.9,51,171.96,0,76,32,74.98,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1601,39,39,0,1,72.09,166.9,26.14269,1.81,6,0.050846086,0.61034495,0,1,1,6,308.211,1,1,168.46,48.05,77.03,15.07,17.04,0.002218,0.0012,0.0597381,0,27.12,0.198,4.64081,2.4266,0.214,0.167,0.372,0.159,1.714,0.74,101,99.67,79.5803,0.11,2e-4,0.0185,0.127305,9e-4,1.015,0.471,0.618,0.242,0,0.51028,167.57,1.7117,11.7514,0.756,1.8776,0.0048,0.799789,5e-4,0,7.809703,0,0,0.00387,0,0,245.97,4.77,0,1.0026,0.239,0.0262,38.05,5.598,140.1,20.055,76.99,215.2893,11.26,1.92,96,169.91,0,64,141,73.03,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,POSITIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1602,38,38,0,0,59.96,186.61,17.91928,1.82,7,0.111254739,1.33595117,0,0,2,7,2205.127,2,2,224.02,37.72,155.28,23.14,101.73,0.002782,0.0026,2.201e-4,3e-5,23.7,0.109,5.18213,2.1957,0.175,0.213,0.109,0.15,0.55,0.631,98.4,95.14,79.2977,0,0,0,0.100192,8e-4,0.344,0.402,0.15,0.181,3.814,0.38502,133.9597,0.006,10.1076,0.6808,0.997909,0.0059,0.450633,0.001,0,2.995243,0.325097,0.0057,0.00399,0.001,0.849225,154.1,3.81,1,1.1389,12.588,0,37.75,4.328,135.2,8.381,65.99,321.403,4.49,1.82,54,187.1,0,57,54,65.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1603,72,72,0,4,71.62,163,26.63544,1.76,6,0.066840443,0.80286948,1,4,1,6,1804.953,1,1,350,33.98,90.37,29.86,23.88,0.00127,2e-4,0.0899134,0.00695,0,0.099,0.04912,2.301,0.126,0.003,0.135,0.041,1.38,0.728,0,72.36,69.9988,0.58,3.9e-4,22.8215,0.045037,0.0153,0.824,0.389,0.317,0.13,2.725,0.26763,78.6544,2.3546,14.3867,1.6226,3.06005,0.2161,0.711492,0.0783,11.96,14.550453,7.660188,0.7735,0.00136,0.001,1.269876,727.67,4.6,0,1.0571,11.77,0,34.13,3.301,135.2,3.968,63.06,208.258,20.78,1.79,80,164.98,0,81,121,68.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1604,60,60,1,3,68.8,165.1,24.60954,1.75,7,0.085821003,1.03122821,1,3,3,7,1494.714,2,2,168.82,44.01,138.38,19.1,10.02,0,0,0.0401235,0.0022,29.67,0.096,0,2.2032,0.103,0.058,0.006,0.042,0.868,0.886,99,137.58,44.2452,0.3,0,0.0011,0.300708,0.0309,0.532,0.564,0.245,0.311,3.817,0.38225,131.3186,6.0829,12.0172,0.7291,1.662026,0.2338,0.859407,0.0895,15.1,3.003545,0,0,0,0,1.105887,293.04,4.81,0,0.9911,11.882,0.0228,0,4.202,135.2,11.027,70.99,339.5686,5.69,1.69,70,168.74,0.1,80,113,70.01,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1605,41,41,1,1,66.88,185.39,19.63949,1.9,7,0.04973496,0.59738795,0,1,1,7,4222.956,2,2,241.86,56.7,117.01,10.67,5.73,0,0,0.01003,8.5e-4,3.47,0.002,0,2.5737,0.321,0.186,0.056,0.046,0.472,0,98.8,90.86,80.319,0,0,0.0189,0.083459,0.0245,0.085,0.003,0.224,0.136,1.859,0.56294,173.6537,3.5392,8.9707,0.0061,1.428314,0.1764,1.106264,0.0879,17.62,6.297474,0.681418,0.6407,0.00211,0,0.085395,353.43,4.92,0,0.9559,11.252,0,25.1,7.917,133.2,9.004,91.88,307.3344,9.32,1.81,90,184.64,0,77,122,67.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
1606,71,71,1,2,87.67,160.03,34.57251,1.91,7,0.045114119,0.54165701,1,2,4,7,11237.064,1,1,267.1,38.71,176.12,23.92,30.25,3.87e-4,0,0.0429925,7e-5,25.14,0.119,2.97761,2.6254,0.094,0.041,0.209,0.135,0.771,0.739,98.1,68.91,91.9761,0,2e-5,0,0.82921,0,0.363,0.389,0.347,0.338,0.185,0.31809,109.8281,4.0932,11.2922,2.8895,1.326538,0,0.622768,7e-4,0.71,4.826221,2.478734,0,0,0,0.02907,366.92,4.96,1,1.1573,0.401,0.0383,23.37,3.659,138.3,10.07,68.09,481.877,8.18,2.03,74,160.05,0,88,128,88.8,0,0,1,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1607,66,66,0,2,51.97,160.09,20.36011,1.54,7,0.161174644,1.92736154,0,2,3,7,308.199,1,1,277.41,41.32,111.14,40.74,36.74,0.001776,0.0024,0.0198928,0.00967,27.06,0,4.49941,2.4004,0.172,0.135,0.17,0.147,1.006,0.692,99.1,68.94,66.9596,0,0,0,0,0.0101,0.611,0.347,0.407,0.306,1.489,0.44072,152.8246,3.7442,11.7094,2.6696,1.398299,0.2265,0.398567,0.091,0.44,4.296255,6.050207,0.7407,0,0.001,0.990357,86.11,3.8,1,1.1381,14.358,0,32.64,4.803,140.2,36.06,50.99,350.9698,6.89,1.56,94,159.86,1.4,70,151,52.54,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,Yes,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1608,69,69,0,3,86.35,175.06,28.69373,2.01,6,0.019225973,0.23091638,1,3,2,6,12468.346,2,2,375.84,39.92,55.98,12.98,20.83,0,0,0.0376492,3e-5,0.66,0.154,7.88335,2.339,0.11,0.002,0.118,0.064,1.604,0.763,0,75.11,77.8446,0,0,0,0.373896,3e-4,0.669,0.265,0.706,0.331,1.729,0.37382,134.4549,2.9043,9.9763,0.4063,3.828643,0.0085,0.549631,9e-4,0,3.38407,0,0,0.00477,0,0.073834,267.35,4.21,0,0.9927,0,0.0879,28.95,4.165,141,6.805,72.9,208.1164,7.63,1.89,88,174.91,0,89,160,81.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,I,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1609,50,50,0,3,64.83,170.17,22.32553,1.75,6,0.114120444,1.36945031,0,3,1,6,4229.209,2,2,545.04,43.09,213.99,21.09,87.95,8.95e-4,4e-4,0.0646149,0.00403,27.06,0.105,8.63701,2.346,0.246,0.211,0.057,0.046,1.164,0.806,105.1,68.74,94.1385,0.55,0,0.0289,0.165596,0.0224,0.472,0.39,0.542,0.344,0,0.39276,131.0922,1.897,12.529,2.7843,1.898136,0.2517,0.199444,0.0057,0.54,1.704682,0,0,0,0,1.259736,174.13,3.79,1,0.8971,11.524,0.0028,25.97,5.01,140.8,19.154,69.07,404.0084,3.84,1.78,80,170.01,0.1,78,124,64.41,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HR,158FF,N,Y,Y,N,High,High,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1610,26,26,0,3,75,177.99,23.45892,1.93,7,0.070336145,0.84490885,1,3,5,7,3144.1,2,2,7150.57,42.01,81.25,33,43.09,0.001617,0.0041,0.1005546,0.00607,2.74,0.178,3.24239,2.2605,0.455,0.32,0.047,0.012,1.109,0.317,101,116.57,72.522,0.44,2.2e-4,0.0278,0.489958,0.0487,0.588,0.307,0.341,0.131,0,0.3904,132.0847,4.3015,13.5785,1.366,1.183321,0.2667,0.997252,0.1417,29.23,5.04593,0.588485,0.7008,0.0051,0.001,1.490474,285.88,4.2,0,1.1773,18.842,0.0108,28.94,4.677,138.9,7.888,72.98,237.4367,7.8,1.96,89,178.19,0,92,136,78.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1611,70,70,1,1,94.42,168.1,33.21257,2.01,7,0.064585579,0.77499235,1,1,6,7,16249.348,2,2,354.09,36.08,84.26,75.12,26.19,0,0,0.0300162,4e-5,1.68,0,4.2794,2.3561,0.033,0,0.067,0.036,0.702,0.606,100.1,119.31,53.9879,0.11,0,0.0017,0.109114,0.0132,0.264,0.172,0.279,0.243,0,0.35656,121.6412,0.0163,6.7624,0.6263,1.912048,0.0853,0.81775,0.0055,0.61,9.523928,0.521366,0.5594,0.00148,0,0.77322,337.38,4.78,0,0.9986,0.293,0,0.08,4.34,138,6.845,66.29,269.1683,14.23,1.96,68,168.64,0,84,119,90,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1612,62,62,0,2,55.89,159.84,21.72083,1.57,6,0.137458822,1.64749113,0,2,6,6,213.216,1,1,1436.65,38.91,169.92,15.07,28.05,0,0,0.0200269,0.00347,28.03,0.234,4.60239,2.3983,0.217,0.244,0.117,0.123,0.731,0.668,101,119.27,44.2098,0,0,0,0.006404,3e-4,0.448,0.37,0.284,0.295,4.02,0.31497000000000003,89.5357,3.5781,9.432,0,1.001258,0,0.499917,0.0046,0,1.096747,0,0,0.00409,0.001,0.143745,103.25,3.49,0,1.0387,12.274,0.0039,30.93,4.337,137.9,32.561,66.12,460.024,2.11,1.59,60,158.05,0,85,107,58.09,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Other,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1613,67,68,1,3,83.07,158,34.40439,1.84,6,0.08578975,1.02981004,0,3,4,6,9579.478,2,1,493.27,41.01,128.53,21.66,16.05,4.43e-4,7e-4,0.0296532,0.00234,23.02,0.07,7.49751,2.4981,0.371,0.235,0.136,0.084,1.368,0.718,102.9,78.19,70.9534,0,8e-5,0.0084,0.160368,0.0163,0.633,0.375,0.665,0.334,1.823,0.42896,140.9017,1.3352,12.9633,2.1431,1.436659,0.2106,0.579092,0.0775,0.42,3.283751,0.475159,0.5303,0,0,1.212949,285.94,5.07,0,0.8424,10.766,0.0395,0.18,4.541,144,12.671,76.94,247.188,6.2,1.89,78,159.05,0,87,145,85.79,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1614,71,71,0,2,81.1,169.56,28.27159,1.93,6,0.075910354,0.91019556,1,2,3,6,3099.677,1,1,203.87,41.98,239.03,15,18.05,0.002178,0.0022,0.0499447,0,27.01,0.2,7.6421,2.3494,0.386,0.169,0.198,0.108,1.308,0.562,104.1,104.35,59.0768,0,3e-5,0,0.302433,4e-4,1.02,0.41,0.391,0.18,0,0.41867,136.8397,2.3556,12.8042,0.7729,2.475847,0.0043,2.414288,0.0219,17.5,3.152815,3.0032,0,0.0064,0,0.909925,182.26,4.09,0,1.0717,13.337,0.0076,35.66,4.917,140.1,13.602,83.23,297.3957,7.28,1.91,69,166.9,0,85,113,85.78,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,POL,Poland,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1615,75,75,0,2,74.7,171.96,25.49868,1.89,7,0.037186464,0.44705183,1,2,4,7,3495.551,1,1,465.51,42.07,48.32,11,11.87,0,0,0.0498813,1e-5,1.21,0.08,3.99992,2.2596,0.562,0.309,0.23,0.151,2.208,0.849,37.2,78.88,68.3134,0.18,2e-5,0.011,0.110071,8e-4,1.31,0.613,0.95,0.367,2.163,0.32015,104.9988,5.1331,12.2589,0.8153,1.182291,0.013,0.398974,4e-4,0.14,5.268459,6.038866,0.0187,0,0,0,270.27,3.9,0,0.9866,11.827,0,29.28,3.698,138,5.155,69.08,139.071,8.7,1.89,79,171.98,0,86,130,77.15,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1616,54,54,1,1,87.32,170.45,29.7014,2.01,6,0.044578508,0.53511838,0,1,2,6,3790.77,1,1,143.92,41.93,87.62,41.77,20.22,0,0,0.0300155,0.00217,24.67,0.176,4.68964,2.3494,0.072,0.096,0.633,0.64,1.065,0.785,105,111.37,63.709,0.04,2e-4,0,0.084723,7e-4,0.847,0.616,0.277,0.239,0,0.38653,139.064,0.9801,7.0748,1.303,1.317075,0.1793,0.322251,0.0048,16.26,4.329599,3.980401,0,2.7e-4,0,0.115468,109.28,4,0,1.0496,0,0.0963,28.16,3.413,138.6,21.24,65.99,297.9052,7.67,1.94,69,172.04,0,70,122,92.41,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1617,27,26,0,1,72.92,162.86,27.12547,1.79,7,0.035938772,0.43083809,0,1,1,7,12323.451,2,2,230.54,37.02,91.87,40.1,20.96,0.004282,0.0034,0,0,0,0.229,9.29974,2.3983,0.096,0.131,0.107,0.073,0.523,0,105,144.66,54.0296,0,6e-5,0.0118,0.13409,5e-4,0.448,0.421,0.008,0,2.345,0.38414,139.04,0.4799,9.6118,1.2367,0.802942,0.0062,0.969541,0.0448,0,12.177792,3.786658,0,0,0,1.332788,277.36,3.6,0,1.124,13.637,0.0021,28.95,4.219,144,3.409,59.98,195.0228,12.22,1.73,77,161.64,0,70,110,69.57,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,N,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1618,55,54,1,4,63.1,163.98,23.22752,1.69,8,0.05020803,0.60173745,1,4,6,8,32552.416,2,2,424.57,37.47,106.34,31.43,89.01,4.37e-4,0.0011,0.0097999,5e-5,27.1,0.141,9.62215,2.4452,0.074,0.073,0.06,0.063,0.586,0.688,104.2,78.78,79.7899,0.2,0,0.0115,0.039347,7e-4,0.33,0.328,0.209,0.2,0,0.29268,105.8142,3.0179,13.725,0,1.096034,0.0139,0.771322,0.0648,0.79,5.592877,5.264901,0.0334,7.6e-4,0,1.060034,295.49,4.28,0,1.0993,13.651,0,25.16,3.545,137,6.312,69.9,481.5484,8.09,1.82,53,163.87,0,99,104,60.26,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1619,69,69,1,2,73.89,157.99,28.73187,1.76,7,0.061081399,0.73263935,0,2,6,7,8237.614,1,1,625.76,30.04,79.09,9.64,13.16,0.001708,0,0.0296021,0.0037,28.86,0,3.89921,2.1849,0,0.044,0,0,0,0.595,102.9,99.25,53.8484,0,1.7e-4,0,0.201361,6e-4,0,0.005,0,0.259,1.329,0.31047,108.3225,0.3942,0,0,0.393982,0,1.060074,7e-4,0,5.490528,0,0,0.00817,0.001,1.248646,273.96,3.81,0,1.0967,11.041,0,28.14,3.493,140.1,4.093,2.57,90.0173,5.91,1.75,64,159.8,0,75,105,72.94,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1620,44,45,1,1,98.88,183.37,28.61568,2.21,6,0.13368782,1.60405632,1,1,4,6,7222.742,2,2,179.22,35.88,52.71,15.87,14.06,0,0,0.0197781,0,27.05,0.06,5.34819,2.3005,0.186,0.246,0.11,0.161,0.615,0.706,103.1,176.71,48.2185,0,0,0,0.300492,0,0.312,0.365,0.28,0.369,1.623,0.46626,155.1193,2.6524,7.6595,0.3908,0.704251,0,0.698158,0,0.74,6.419892,3.953115,0,0.0012,0,0.911719,353.87,3.88,0,1.0524,0,0.0522,28.52,5.416,137.9,10.229,67.99,146.5622,7.57,2.3,90,185.81,0,81,121,105.37,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1621,64,65,0,4,90.6,184.96,26.66989,2.15,6,0.04591267,0.55028263,1,4,6,6,5148.69,2,2,572.85,20.78,113.29,103.7,45.23,0.001387,0.0019,0.0199421,0,0,0,8.76811,0,0.238,0.305,0.092,0.12,0.406,0.638,103.9,85.62,84.5445,0,0,0,0.099279,3e-4,0.077,0.058,0.314,0.405,0,0.37895,116.9662,2.0054,7.2346,0.4234,0.581755,0,0.697763,0.0049,0,4.598169,0,0.3761,0.05401,0,0.858043,150.12,4.19,1,1.0774,14.068,0,29.65,3.983,135.2,22.229,54.61,95.3175,6.32,2.06,80,186.75,0,135,130,89.5,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1622,54,54,1,2,93.01,164.07,34.28234,2,8,0.025874253,0.31044322,2,2,3,8,6838.545,1,1,285.53,44.52,108.22,32.5,33.84,0,0,0.0099075,1e-5,31.36,0.097,4.81766,2.4514,0.178,0.151,0.006,0,0.983,0.633,102.9,98.49,80.3189,0,1e-5,0.0075,0.540483,0.0163,0.307,0.232,0.522,0.278,3.127,0.39022,142.7682,2.6381,11.6205,1.5324,1.685794,0.2023,0.413916,0.0038,0.61,5.208215,5.081148,0.0113,0.00422,0,1.519328,233.58,4.7,0,1.2649,14.749,0,24.46,4.167,140.7,8.343,76.09,190.7604,8.6,2.08,75,165.99,0,80,140,100.2,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1623,49,49,1,3,93.44,179.01,29.05472,2.14,7,0.059242547,0.71101937,1,3,1,7,1948.7,2,2,184.17,35.92,72.56,19.37,18.68,0.002632,0.0035,0.0213485,4e-5,29.03,0.119,4.68976,2.1911,0.196,0.123,0.158,0.079,1.649,0.709,96,137.44,59.2197,0.19,8e-5,0.013,0.110053,0.0198,0.753,0.341,0.61,0.255,4.106,0.37224,130.7524,2.2918,13.0362,0.5763,2.737304,0.2298,0.399536,4e-4,28.86,2.893475,0,0,0.00273,0,1.225606,119,3.89,0,0.9927,11.388,0,22.97,4.362,141.1,7.777,73.95,303.1398,6.73,2.18,77,179.01,0.1,80,130,100.6,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1624,61,61,0,1,69.9,159.09,27.11023,1.72,8,0.078468658,0.94171082,0,1,1,8,2667.777,1,1,392.18,30.79,158.16,11.03,13.83,2.34e-4,0,0.0255271,0.00697,26.75,0.112,0.11308,2.4275,0.217,0.238,0.11,0.091,0.614,0.717,104.4,73.86,83.9995,0,1.7e-4,0.0108,0.058108,6e-4,0.45,0.475,0.248,0.25,2.309,0.33668,106.7838,2.7305,9.3567,0.7071,0.635116,0.0098,0.40116,0.0687,0.69,5.067178,5.195053,0.866,8.3e-4,0.001,1.039641,392.25,4.2,0,1.0171,11.12,0,33.09,3.823,146.1,15.26,67.78,202.0116,6.3,1.73,89,162.83,0,63,137,70.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1625,72,71,1,1,69.04,157.99,27.05785,1.72,8,0.166778559,2.00215144,1,1,1,8,6288.908,2,2,111.59,41.99,50.45,18.84,10.05,0.002736,0.0034,2.727e-4,0.00227,24.17,0.001,4.42094,2.2242,0.116,0.183,0,0.001,0,0,104,60.51,87.792,0,0,0.0057,0.279009,0.0208,0.012,0,0.004,0.001,0.196,0.42652,147.9654,2.5352,17.5071,0.6672,0.727315,0.1576,0.399018,0.047,0,3.658724,3.842448,0.6407,0.00124,0,1.008599,243.39,4.2,0,1.0292,13.335,0,36.07,4.489,143.2,16.689,69.04,464.5962,5.32,1.78,79,155.26,0,66,131,68.98,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1626,68,68,2,4,66.59,178.09,21.1008,1.84,7,0.057812877,0.6937992,1,4,2,7,14862.881,1,1,459.76,25.89,199.32,34.61,48.16,0,0,0,1e-5,27.7,0,7.642,2.3008,0,0.049,0.021,0.059,0.372,0.807,0,98.03,52.1562,0.13,2.3e-4,0.0111,0,8e-4,0.09,0.375,0.174,0.378,2.621,0.31655,111.2625,1.8961,0,0.0062,0.196689,0.1191,0.701227,0.0929,0.48,8.199063,7.098074,0.8084,0.00124,0.001,0,383.6,4.5,0,1.0453,11.042,0.0097,38.24,3.476,125.6,5,0,178.7536,8.19,1.84,72,179.45,0,36,128,69.82,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1627,38,38,1,3,77.19,180.07,23.36472,1.99,7,0.072811281,0.87419224,1,3,3,7,7149.344,2,2,359.37,39.27,45.64,36.58,41.94,0,1e-4,0.0312427,0.00191,2.65,0.111,5.20529,2.2983,0.109,0.164,0.148,0.141,0.62,0.715,101,126.33,61.8065,0,0,0.0021,0.230424,0.01,0.425,0.517,0.224,0.267,0,0.40543,139.9871,3.5727,14.2949,0.7592,0.598127,0.0117,0.82654,0.0851,29.47,3.480707,5.561092,0.5448,0.00402,0.001,1.133348,317.76,4,0,0.999,0,0,21.48,4.633,138,10.073,70.06,592.6695,5.19,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1628,62,62,0,2,102.38,187.07,28.13181,2.32,7,0.050198042,0.6031453,1,2,2,7,5475.464,2,2,218.79,36.52,64.17,4.75,2.06,2.17e-4,0,0.0597505,0.01004,26.59,0.177,0,2.3013,0.48,0.346,0.129,0.044,2.234,0.867,101.1,116.63,68.0089,0.08,8e-5,0,3.104636,0.0632,1.18,0.495,0.904,0.509,0,0.4128,138.6874,2.0902,12.1004,0.7241,3.604539,0.1847,2.808411,0.1218,0.44,6.426805,3.389517,0.6093,6.6e-4,0.001,1.130094,526.37,4.89,0,1.0776,13.428,0.0183,29.86,4.898,135.2,3.014,68,392.8138,11.58,2.13,89,182.97,0,97,141,95.15,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1629,59,58,2,3,67,164.91,24.03445,1.73,6,0.088841102,1.06698456,0,3,5,6,24225.802,2,2,597.3,0,165.01,90.14,59.76,0.001161,0.0021,2.545e-4,4e-5,20.57,0.154,3.5347,0,0.136,0.065,0.128,0.084,1.182,0.772,101,133.26,49.4318,0.23,0,0.0265,0.192972,0.0172,0.648,0.425,0.47,0.311,0,0.26177,94.4501,2.0979,8.8934,0.1737,1.391484,0.01,0.624396,0.0792,0.49,3.016392,3.000585,0,0.00363,0.001,0,87.14,0,0,1.2162,10.98,0,28.23,3.915,138.3,5.199,0.88,243.1491,4.71,1.82,80,165.84,0,77,111,67.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),<18.5,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158VF,Y,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,NA,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1630,76,76,0,4,62.91,165.08,22.75915,1.7,7,0.036778549,0.44170432,0,4,3,7,9719.602,1,1,235.64,46.07,76.13,9.02,18.05,0,0,0.0300091,0.00403,0,0.133,6.6792299999999996,2.2772,0.234,0.276,0.056,0.09,0.461,0.647,98.8,65.29,64.2667,0,0,0.0046,0.200355,0.0201,0.288,0.356,0.162,0.273,0,0.3558,119.599,2.7401,12.6987,1.0291,0.798333,0.0889,0.228608,0.0493,0.56,5.103362,4.379903,0.6091,7.1e-4,0,1.187029,152.74,4.3,0,1.0924,11.53,0.0158,23.02,4.35,141.9,18.297,59.99,285.6687,6.21,1.62,79,166.05,0,101,130,58.49,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1631,31,31,0,2,75.99,169.29,26.73272,1.87,7,0.068312203,0.81966198,1,2,2,7,1739.456,2,2,625.68,44.17,172.26,173.58,55.08,0,0,0.0788296,8e-5,26.34,0,8.75609,2.3306,0.066,0.006,0.27,0.217,0.869,0.703,96.5,124.16,66.5813,0.03,0,0.0033,0.199934,0,0.714,0.469,0.243,0.161,0,0.38425,126.2229,0.4108,0.1317,1.4948,1.19035,0,0.299856,0,0,5.9248710000000004,0,0,0.00394,0,1.140937,723.87,4.19,0,0.9704,0,0.0866,31.92,4.393,138,11.055,65.25,220.0397,7.92,1.73,71,168.94,0,112,120,75.44,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1632,29,29,0,3,64.83,162.07,24.21909,1.69,7,0.013302411,0.15949268,0,3,4,7,8889.531,1,1,216.82,46.09,92.44,15.07,20.82,7.33e-4,7e-4,0.0499786,0.00201,0,0,3.28193,2.2525,0.312,0.219,0.133,0.104,1.004,0.688,104.9,121.88,48.7948,0.07,1.3e-4,0.0284,0.010018,9e-4,0.66,0.428,0.327,0.3,0,0.38548,126.7605,0,7.8754,0.9501,1.260133,0.0543,0.499614,0.0053,0.45,6.505898,4.644803,0.0358,0,0,1.131093,131.63,4.19,0,0.9101,0,0.0507,28.02,4.567,141,3.996,70.02,324.6966,7.74,1.71,64,163.03,0.1,65,119,64.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1633,64,64,0,3,67.96,165.09,25.43516,1.74,6,0.079601725,0.95586831,1,3,5,6,2703.293,1,1,314.2,32.01,73.13,15.02,30.01,0.002439,0.003,0.0194126,0.00113,0,0.001,11.01061,2.3679,0,0,0.079,0.09,1.097,0.807,101.1,90.41,61.9719,0.17,0,0,0.059753,0.0263,0.448,0.31,0.521,0.423,0,0.3576,131.9088,0.8515,0.0867,0.0093,1.370133,0.0845,0.55216,0.0906,19.66,9.225488,3.850471,0.0366,0,0,0.407241,305.41,4.01,0,0.8996,9.768,0.0578,28.63,4.662,134.9,7.389,60.09,208.459,12.24,1.7,76,165.01,0,73,123,64.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,Y,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1634,41,41,1,3,66.83,175.8,21.48457,1.82,7,0.069680287,0.83775791,0,3,6,7,2152.298,2,2,163.03,31.55,80.55,11.07,9.8,0.002538,0.0011,2.52e-5,7e-5,25.99,0.036,5.14222,2.3023,0.084,0.072,0,0,0.641,0.798,101.1,141.63,50.6894,0.34,3.8e-4,0.1305,0.039811,0.0139,0.429,0.516,0.176,0.18,4.18,0.41888,131.2336,1.923,14.1421,0.1167,0.603047,0.0114,0.200406,0.0057,0.84,3.883062,0,0.0024,0.00439,0.001,1.335536,165.37,4.1,0,0.9746,10.684,0.0527,27.89,4.507,138,18.85,69.02,266.3133,5.53,1.84,86,175.01,0,80,125,69,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1635,41,41,1,1,83.55,169.99,28.60774,1.95,7,0.063955291,0.76717986,1,1,3,7,2583.803,1,1,262.22,44.03,78.65,54.6,24.18,0.004105,0.0025,0.0300253,0,24.16,0,8.14662,2.202,0.394,0.452,0.138,0.119,0.919,0.706,104.4,100.31,80.9244,0,1.1e-4,0,0.109978,2e-4,0.557,0.396,0.415,0.343,0,0.4642,153.4791,1.2576,7.4681,0.6443,0.704747,0.0014,0.82607,0.0042,0,6.900605,0.199061,0.0054,0.00127,0,1.038245,212.83,4.07,2,1.0755,11.191,0,34.32,4.908,136.9,32.453,61.94,330.1162,9.2,1.99,78,171.43,0,95,135,86.52,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NA,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1636,56,56,0,2,75.95,164.97,27.91697,1.84,6,0.09730445,1.16893874,1,2,3,6,1782.855,2,2,580.43,36.08,140.51,16.97,14.87,0.002785,0.003,4.45e-5,2e-5,25.74,0.065,9.37694,2.0939,0.099,0.067,0.134,0.136,0.778,0.644,101.1,98.93,68.0155,0.44,1e-4,0.327,0.09018,6e-4,0.333,0.251,0.319,0.259,3.371,0.37288,127.7174,1.7276,8.9679,0,1.900715,0.2355,0.259758,0.0811,0.52,8.314451,3.754035,0.7509,0.00667,0,0.160547,246.19,3.23,1,1.0097,0.179,0.0573,32.35,4.256,140.7,3.062,59.24,0,11.89,1.78,96,162.15,0,77,161,74.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HH,158VF,Y,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1637,67,67,0,3,72.07,169.93,24.52349,1.84,7,0.084488178,1.01541808,1,3,3,7,174.757,2,2,148.12,37.08,68.15,19.1,19.04,0,0,0.0300145,4e-5,27.82,0.06,0,2.2338,0.129,0.134,0.349,0.327,0.612,0.005,101,69.9,83.8926,0,0,0.0018,0.300785,0,0.441,0.373,0.144,0.001,2.725,0.3242,114.8242,1.5215,10.2914,0.3244,1.304641,1e-4,0.504937,0,12.81,6.008153,3.208987,0.5268,0,0,1.073894,324.52,4.32,0,1.0057,13.132,0,28.94,4.251,140.7,10.662,66,168.3743,8.81,1.77,70,169.15,0,75,121,73.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1638,72,73,0,3,84.55,170.17,28.60313,1.98,6,0.034678758,0.41633893,0,3,1,6,255.258,2,2,323.36,41.01,0,18.65,26.15,0.002418,0.0017,0.1046123,0,29.01,0.074,6.29448,2.2935,0.349,0.229,0.081,0.064,0.944,0.643,101,64.5,86.0705,0.04,1.3e-4,0.0155,0.100645,0,0.256,0.009,0.664,0.443,1.14,0.3836,138.0572,0,0,0.0103,1.954799,0,0.60005,0,0.58,8.848506,0.162104,0,0,0,1.215064,247.3,4.25,1,1.0178,0.057,0.0436,30.7,4.175,134,3.794,61.97,291.3321,13.1,1.99,81,170.09,0,68,124,81.04,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1639,20,20,0,0,111.14,185.75,32.11729,2.34,8,0.017708876,0.21257872,0,0,3,8,680.096,1,1,445.71,42.9,128.06,29.73,23.89,0.002352,5e-4,0.0399097,3e-5,27.39,0.208,5.90715,2.4216,0.435,0.407,0.221,0.146,1.814,0.832,102.9,158.45,75.0471,0,1.5e-4,0.0013,0.070003,0,0.898,0.496,0.717,0.408,2.392,0.40878,140.9674,2.2287,13.4354,0.7423,0.825966,0.0063,0.30012,0.003,33.06,2.610889,3.128559,0.0168,0.00295,0,1.440181,206.84,4.51,0,1.0021,18.085,0,27.27,4.604,138,15.193,78.82,344.9896,5.08,2.29,79,186.48,0,65,104,107.06,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,Y,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1640,62,62,1,2,111.88,182.43,34.93046,2.33,6,0.087958872,1.05576372,2,2,3,6,9125.427,1,1,268.78,44,79.05,46.36,57.43,8.34e-4,0.0011,0.0698787,0.00277,28.95,0,6.06753,2.3364,0.058,0.105,0.078,0.075,0.396,0.016,98.1,93.93,89.884,0.14,7e-5,0.0209,0.201133,0.0105,0.18,0.217,0.119,0.143,0,0.39263,128.9277,2.7575,7.1565,0.3162,1.319452,0.0753,0.763549,0.005,0,8.351079,4.821181,0,0.00691,0.001,1.02477,268.17,4.1,1,1.2294,13.093,0,21.95,4.721,137.1,12.127,70.8,481.2208,12.09,2.14,71,183.26,0,80,136,111,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1642,79,79,0,3,50.69,150.53,21.94297,1.44,8,0.125747017,1.50817332,1,3,5,8,4990.873,1,1,306.46,36.11,133.69,5.1,10.96,0.181594,0.0042,2.242e-4,0,26.08,0.125,2.85605,2.0796,0.24,0.168,0.019,0.019,0.308,0,101.1,68.63,61.7567,0.05,0,0,0.0352,2e-4,0.364,0.17,0,0,0.443,0.29361,95.6142,2.9482,10.0157,0.9362,1.190572,0,0.697881,0.004,0,4.006011,0.642865,0.0154,1.1e-4,0,1.423705,244.3,4.5,0,0.9872,12.858,0,37.03,3.531,144,17.962,68.06,267.3162,5.51,1.36,60,150.98,0,66,113,49.94,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1643,62,62,0,3,52.13,158.71,20.56098,1.52,8,0.079282411,0.95270743,2,3,3,8,2837.756,2,2,374.56,40.08,105,10.91,14.96,0.002045,0.0026,0.0199444,0.0018,24.42,0.08,15.39438,2.3608,0.307,0.268,0.2,0.103,0.918,0.567,103.1,94.73,56.3387,0.2,5e-5,0.0101,0.099696,0.0093,0.635,0.472,0.18,0,0.925,0.32071,104.8097,0.4843,0.0651,0,2.091671,0.1843,1.3728070000000001,0.1223,0,5.787248,3.451705,0.0335,0.00103,0,1.198027,139.66,4.43,1,0.9342,13.541,0.0276,32.9,3.318,140,10.222,52.93,341.4794,9.59,1.54,80,159.86,0,111,141,57.06,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,>= 70,>= 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1645,59,59,1,2,55.11,153.12,23.14702,1.51,7,0.084311336,1.01177461,1,2,1,7,4482.503,2,2,629.64,40.99,91.12,22.05,17.12,8.54e-4,0,0.1002165,0.01008,24.56,0.12,4.98073,2.2485,0.124,0.181,0.118,0.148,0.058,0.021,101,102.28,53.5867,0,1.4e-4,0.0297,0.139982,0.0291,0.008,0.004,0.125,0.211,2.217,0.39328,133.0622,1.4568,8.0643,0.4789,0.59892,0.1855,0.70637,0.093,16.86,2.701625,0.431257,0.0037,4.4e-4,0,1.017871,104.73,4,0,1.0377,11.327,0,33.07,4.264,140,9.961,69.66,161.4701,4.41,1.59,80,153.55,0,69,123,57.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1646,55,55,0,5,79.17,179.28,25.28073,1.98,6,0.022469239,0.2698373,1,5,5,6,2315.776,2,2,768.9,38.07,96.19,11.99,17.05,0,0,0.1057275,0.00279,25.42,0.001,4.27685,2.1213,0.879,0.491,0.492,0.158,2.081,0.737,97.1,137.95,53.9564,0,1.2e-4,0,0.159887,6e-4,1.109,0.303,1.175,0.512,0.698,0.43485,135.8668,2.296,15.9759,1.4374,1.310884,0,0.870034,0,0.16,5.202177,0,0,0,0,1.120325,323.14,4.2,0,1.0327,14.057,0,38.94,4.872,141.1,10.238,67.09,220.1042,8.11,1.8,96,178.51,0.1,89,167,74.88,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1647,68,68,0,2,52.19,155.27,20.79522,1.5,7,0.05953294,0.71419873,0,2,6,7,1029.673,2,2,177.39,35.94,66.83,7.8,8.94,0.001644,0.0031,0.0699496,0.006,25.95,0.211,3.60038,2.1246,0.126,0.027,0.077,0.055,0.504,0,108.1,90.06,51.5728,0.08,0,0,0.168678,0.0506,0.446,0.293,0.006,0,0,0.29186,93.3228,3.1968,14.9259,1.2394,1.133881,0.1365,0.269932,0.0898,0.41,5.040459,3.568283,0.6613,0.00426,0,1.514016,167.56,3.98,1,0.8796,18.021,0,32.96,3.794,143.2,4.057,54.96,327.0395,6.19,1.56,72,154.98,0,69,129,54.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,G,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1648,67,67,0,3,57.87,148.22,25.90826,1.5,8,0.014836099,0.17832045,1,3,6,8,10352.203,1,1,478.65,35.56,101.72,7.89,20.8,0.001108,0.0011,0.021298,0,22.98,0.196,5.467,2.2212,0.448,0.268,0.345,0.164,1.571,0.76,103,103.22,49.7028,0,0,0,0.076382,5e-4,0.75,0.254,0.894,0.546,0.236,0.30292,99.9626,3.5229,15.4962,3.8246000000000002,2.004113,0,0.700441,0,0.07,5.704513,0,0,0.00734,0.001,1.25379,308.69,4,1,1.0608,15.991,0.0212,37.92,3.756,142.1,9.415,68.58,273.0087,9.31,1.44,52,146.79,0,79,103,54.73,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,NA,N,Y,N,N,Low,High,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1650,62,61,2,3,60.06,160.99,23.1191,1.64,6,0.05933085,0.71276212,0,3,2,6,7936.702,2,2,479.58,42.05,108.62,36.81,22.07,0,0,0.0997456,0.01007,23.14,0,7.79934,2.3855,0.684,0.534,0.091,0.099,0.563,0.703,99.5,59.81,107.3123,0.32,4e-5,0.0104,0.299602,0.0258,0.281,0.335,0.348,0.46,0,0.40506,137.7327,2.4631,7.0998,0.3,1.640436,0.1387,0.499033,0.0602,0,2.50459,0.574692,0.0203,0,0,0.015576,127.74,4.4,0,0.9616,0,0.0413,33.07,4.592,133.4,20.514,77.05,321.7933,4.8,1.65,70,167,0.1,66,135,69.85,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NA,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1651,66,66,0,1,61.92,168.25,21.78859,1.7,7,0.060003727,0.7203339,0,1,1,7,867.621,1,1,203.6,43.9,38.32,16,21.76,0.001944,7e-4,0.0100751,0,0,0.208,7.1804,2.4652,0.269,0.128,0.279,0.16,0.885,0.449,98.1,52.64,92.1461,0,0,0,0,0,0.533,0.252,0.299,0.134,2.681,0.39991,135.7477,2.5702,8.2974,1.8117,1.755135,0.1519,0.308422,3e-4,0.23,5.62287,0,0,0,0,1.039001,247.23,4.49,0,0.8984,11.515,0,32.83,4.524,138.1,10.73,68.78,246.976,8.41,1.76,88,165.06,0,63,155,58.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1652,64,64,NA,3,83.1,159.92,32.79645,1.89,6,0.042487,0.5097609,0,3,NA,6,NA,2,2,438.28,36.28,81.08,28.04,32.12,0.001202,0.0019,0.0296394,0.00979,26,0.11,0.08878,2.3358,0.272,0.167,0.019,0,1.213,0.762,100,103.99,69.019,0.11,4e-5,0,0.423808,0.0315,0.644,0.364,0.349,0.273,4.919,0.36922,124.6046,2.473,12.7748,1.0155,0.910623,0.2289,0.500626,0.1248,0.54,3.839187,3.685304,0.6266,0,0.001,1.121153,303.71,4.28,0,0.8737,12.358,0,0.45,4.71,137,8.507,75.26,408.6286,4.65,1.92,92,161.83,0,107,145,86.88,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,NA,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1653,76,76,1,3,70.14,166.93,25.50064,1.8,6,0.082416436,0.98886046,1,3,2,6,9752.886,2,1,1115.89,38.95,88.22,31.02,52.48,0,0,0.0198394,8e-5,24.98,0.072,9.64083,2.501,0.222,0.179,0.038,0.045,0.475,0.611,0.3,63.94,79.384,0.3,0,0.0171,1.579598,0.0047,0.212,0.255,0.185,0.2,0,0.38662,129.2604,1.6721,4.7981,0.4807,1.311282,0.0037,0.603332,0.0017,0.36,2.394671,0,0,0.00639,0,1.060414,242.3,3.88,0,0.9311,0,0.0092,26.12,4.233,140.8,13.037,61.11,398.1508,4.37,1.8,92,165.07,0,77,170,68.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1654,67,67,1,3,57.1,167.94,21.03532,1.64,6,0.014216288,0.17040039,1,3,2,6,3063.86,1,1,1015.09,20.61,217.5,14.01,21.92,0,0,0.0163109,5e-5,2.84,0.185,6.68227,2.2579,0.078,0.003,0.135,0.1,0.852,0.753,97.2,68.63,81.348,0.39,1e-5,0.0118,0.039762,0,0.515,0.387,0.27,0.214,3.961,0.29372,90.5466,2.7341,12.8519,1.8711,2.064036,0.0096,0.500275,0,0,7.607727,0.025266,0,0.00396,0,0,367.25,4.21,1,0.9986,0.036,0.0422,35.52,3.449,134.4,8.564,68.95,153.3455,10.62,1.63,66,168.5,0,83,131,58.33,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1655,24,24,0,2,75.07,178.16,23.70473,1.95,6,0.058974908,0.70700213,0,2,5,6,7943.996,1,1,1089.89,48.06,298.34,48.88,21.94,0.002741,0.0025,0.0080885,0.00199,2.18,0.1,5.57627,2.4804,0.179,0.058,0.14,0.04,0.991,0.7,106.1,105.85,95.3848,0.42,1e-5,0.02,0.184163,0.0291,0.529,0.179,0.353,0.211,0,0.48633,161.748,2.1191,14.2812,1.9249,3.284981,0.2292,0.599799,0.1173,0,5.101395,7.079017,0.8228,1.1e-4,0,0.050769,86.77,4.3,1,1.1194,11.774,0.0334,26.18,5.198,141.9,14.453,93.53,653.3596,8.8,2.1,85,183.01,0.1,62,113,86.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,NA,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,Yes,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1657,52,52,0,4,59.97,155.07,24.91212,1.6,6,0.102547926,1.23187098,1,4,3,6,1603.739,2,2,210.94,44.43,206.55,17.05,13.01,0.001926,0.0011,2.685e-4,1e-5,26.97,0.05,0,2.4474,0.482,0.256,0.154,0.086,1.522,0.715,103.1,115.66,52.1572,0,0,0,0.079657,0.0097,0.821,0.415,0.657,0.279,2.384,0.42301,132.6801,1.675,9.1767,0.422,1.597741,0.1898,0.43187,0.0407,10.6,3.596595,0.679438,0.0287,4e-5,0.001,1.300519,463.92,5.51,0,0.8871,0.302,0.0018,0,4.1,143,11.907,72.02,315.5241,5.98,1.61,58,154.98,0,70,111,60.21,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1658,65,65,1,2,58.02,152.5,23.36251,1.56,7,0.099690039,1.19658541,1,2,5,7,7934.911,2,2,327.14,39.35,99.48,29.3,15.18,0,2e-4,0.0999435,8e-5,24.58,0.079,8.9469,2.4524,0.002,0,0.122,0.123,0.693,0.567,105,65.25,77.6441,0.11,0,0.0109,0.300892,0.0019,0.493,0.417,0.158,0.118,0,0.3699,122.903,1.2946,6.1465,0.9963,1.676362,0.0811,0.475291,9e-4,0.77,5.544624,5.321114,0.6368,0.00594,0,1.000969,354.21,4.6,1,0.9357,0.392,0.0263,0,3.707,143,6.107,65.46,219.3171,9.08,1.67,61,153.99,0,72,144,64.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,Yes,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1659,61,61,0,3,71.42,160.14,27.89741,1.76,6,0.05323703,0.63787508,0,3,1,6,119.578,1,1,445.88,44.93,71.8,63.54,40.24,0.033806,0.0043,8.99e-5,5e-5,29.86,0.035,4.59661,2.324,0.215,0.275,0.048,0.08,0.12,0.017,0.1,112.81,48.9223,0,8e-5,0.0146,0.00525,2e-4,0.288,0.378,0.002,0,0.032,0.34081,122.183,0,0.0095,0.3259,0.699324,0.078,0.638048,0.0593,21.85,3.087207,3.870091,0.0355,0,0,1.35423,254.64,3.37,1,1.1332,12.751,0,23.03,3.457,139.9,7.522,67.94,181.355,4.68,1.7,90,162.76,0,70,147,67.1,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,Yes,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1660,74,73,0,2,55.9,178.13,17.9369,1.68,7,0.047801092,0.57443301,1,2,5,7,1771.297,2,2,108.82,47.35,88.23,31.98,31.48,0,0,0.0297672,9e-5,31.09,0.119,6.79834,2.3571,0.453,0.518,0.053,0.048,0.588,0.63,104.8,52.36,83.0435,0.11,2.3e-4,0,0.370093,0.0101,0.478,0.352,0.163,0.225,4.112,0.41627,147.0422,1.7155,9.2057,1.8431,1.122511,0.0106,0.299553,0.0023,0,1.882746,0,0.0078,0.00442,0,1.290169,84.49,4.71,1,1.0286,12.248,0.0154,32.51,4.7,136.1,19.56,73.03,660.8756,3.11,1.65,70,175.51,0,61,110,52.91,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1661,59,59,0,2,69.47,174.92,22.92056,1.84,6,0.056980427,0.68367485,0,2,3,6,1855.349,2,2,282.54,39.05,125.91,14.03,21.06,0,0,0.040055,8.5e-4,26.71,0.159,5.12074,2.3242,0.172,0.094,0.025,0.001,1.619,0.843,105,100.32,66.9278,0,1.4e-4,2e-4,0.200418,8e-4,0.656,0.386,0.701,0.405,0.87,0.29535,101.5379,2.7584,8.1752,0.4097,3.149878,0.2244,0.413907,0.03,23.19,3.208405,0.021232,0,0,0.001,1.487055,221.87,4.59,0,1.0079,13.222,0.0059,35.96,2.996,143.8,6.263,58.08,279.323,6.4,1.73,83,175.03,0,74,99,72.98,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1662,69,69,0,3,65.01,157.03,26.35191,1.66,7,0.020756015,0.24874991,0,3,3,7,3278.757,2,2,381.11,39.07,88.68,16.09,15.48,8.3e-4,0.0022,0.0103575,0,26.99,0.002,6.58631,2.5003,0.213,0.181,0.052,0.055,1.197,0.82,96.4,69.89,81.3303,0.17,1.5e-4,0.0243,9.77e-4,0,0.608,0.463,0.578,0.401,1.657,0.45744,146.9104,3.5191,22.8954,2.1103,1.300379,0,0.491167,0.0027,0.05,8.57244,2.590652,0.0224,3.3e-4,0,1.064183,214.49,5.1,0,1.0925,0.618,0.0514,26.1,4.806,142,13.139,76.57,285.5782,10.4,1.67,70,152.15,0,68,114,62.58,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1663,63,63,0,2,55.12,151.8,23.16279,1.5,7,0.070864514,0.85208242,1,2,2,7,3366.554,1,1,2086.07,28.97,285.13,20.88,23.98,0.004254,0.0033,1.31e-5,1e-5,23.45,0.228,4.99864,2.1545,0.469,0.211,0.279,0.122,2.005,0.679,94.3,84.69,57.9411,0,0,0,0.100528,6e-4,0.783,0.302,1.149,0.378,5.466,0.31269,97.2162,1.0951,20.1652,1.671,2.582072,0.2154,0.60203,0.0554,17.92,5.102548,0.089001,0.0331,0,0,1.312691,556.97,3.7,1,1.0779,10.604,0.0622,32.03,3.848,139.1,5.2,69.07,351.9798,9.38,1.51,71,154.92,0,72,115,58.99,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,NA,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1664,45,45,0,1,62.94,158.07,24.60943,1.63,8,0.035966962,0.43125947,0,1,2,8,693.616,2,2,320.9,38.03,100.51,24.36,37.03,0,8e-4,0.0996839,0.01198,28.22,0.001,12.27976,2.3705,0.112,0.214,0,0.017,0,0,99,118.29,54.4822,0.44,0,0.0052,0.056233,0.031,0,0.003,0,0,0,0.44024,143.9153,0,0,0.0075,0.819997,0.2531,0.300237,0.0694,0,7.999761,3.010494,0.7234,0,0,1.190954,312.58,4.09,0,0.967,9.325,0.0321,29.59,5.25,140.1,4.709,67.03,208.0319,6.87,1.49,75,158.01,0,87,117,59.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,N
1665,65,66,1,4,50.96,148.08,23.24391,1.43,6,0.110600306,1.32638996,1,4,4,6,5747.919,1,1,881.52,35.07,170.88,13.07,36.21,9.06e-4,0.002,0,4e-5,21.86,0.071,24.9955,2.2467,0.125,0.236,0.083,0.116,0.451,0.739,101,83.69,57.5771,0.06,0,0,0.079106,0.0401,0.278,0.446,0.187,0.349,0,0.38994,133.0753,1.8065,7.5359,0.86,0.893829,0.2586,0.469094,0.0947,0,10.032514,2.947456,0.5593,0.00556,0.001,1.148447,201.64,3.94,1,0.9841,0.693,0.0431,29.8,4.786,137.9,6.173,51.22,240.5537,11.34,1.46,62,146.47,0,97,100,50.95,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1666,46,46,0,2,85.68,165.01,30.50596,1.94,6,0.122522005,1.47055525,0,2,5,6,4033.008,1,1,217.71,39.04,39.16,16.18,23.89,0,0.0011,0.0400114,0,26.96,0.026,4.3981,1.9358,0.016,0.003,0.197,0.124,1.492,0.877,104.9,140.55,51.0082,0,0,0.0291,0.193732,0.0014,0.623,0.524,0.616,0.35,3.247,0.4072,138.9864,0.4891,6.5554,0.2258,1.601447,0.0524,0.599097,0.0047,0.83,4.630121,0.233726,0,0,0,1.291314,233.63,4.19,0,1.0057,11.973,0,0,3.958,141,8.008,62.1,196.2412,7.03,1.9,75,166.96,0,99,140,86.41,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1667,57,57,0,1,78.09,170.1,26.12973,1.93,7,0.036588507,0.43938741,2,1,3,7,1607.367,1,1,488.45,26.94,73.8,142.34,33.92,0.001093,0.0012,0.0470434,1e-4,2.82,0.166,3.88795,2.2232,0.209,0.141,0.084,0.065,0.615,0,99,86.88,79.585,0.03,8e-5,0.0123,0.009788,4e-4,0.35,0.232,0.289,0.195,0.916,0.30836,105.488,2.6049,13.1189,13.1873,1.748182,0.0096,1.197296,0.0731,0.49,13.219371,5.266854,0.563,4.9e-4,0,0,505.98,3.8,0,1.1537,10.65,0.0312,26.14,3.915,139,5.113,68.99,226.0039,15.82,1.94,69,171.01,0,87,110,81.93,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NA,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1668,70,70,2,4,110.89,173.92,38.70653,2.25,8,0.106015426,1.2731511,1,4,6,8,29305.827,1,1,475.77,40.02,147.02,28.99,26.11,0.001433,0.0013,6.89e-5,0.00403,26.38,0.157,0.07598,2.3205,0.314,0.319,0.215,0.198,0.919,0.757,94.2,100.05,76.986,0,1e-5,0.0148,0.019116,0.0124,0.487,0.379,0.472,0.444,4.031,0.42297,145.1741,1.4512,11.2043,0.7704,0.799505,0.1317,0.360151,0.0132,33.89,5.776551,5.828467,0.7364,0,0,1.576627,244.69,3.89,0,1.0093,10.915,0,23.57,5.329,137.1,12.001,72.96,313.236,5.71,2.19,80,174.95,0.1,95,135,108.12,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1669,67,67,0,1,59.93,160.96,22.9423,1.63,7,0.135148412,1.62186146,1,1,2,7,2072.332,1,1,417.52,43.04,101.11,15.02,25.92,8.42e-4,7e-4,1.02e-5,2e-5,26.3,0.002,0.03925,2.3679,0.299,0.294,0.111,0.079,0.868,0.725,102,88.51,62.3103,0,0,0.0054,0.040258,0,0.446,0.105,0.468,0.408,0,0.33777,110.6439,2.8231,11.0932,2.4469,1.301685,0.0138,0.800847,0.0039,0.77,5.5872,4.936258,0.0212,0.00721,0.001,0.936712,329.55,4.31,0,1.1771,8.814,0.0304,32.12,3.893,137.8,6.884,72.92,253.7325,8.4,1.57,78,160.13,0.1,63,131,55,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,>= 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1670,67,67,1,4,69.02,170.16,24.08912,1.79,6,0.038156687,0.45801774,0,4,5,6,36180.463,2,2,333.09,40.87,82.96,18.1,30.76,5.81e-4,0.0015,0.0073117,2e-5,23.71,0,2.61432,2.4255,0.158,0.19,0.185,0.17,0.914,0.831,100.1,73.7,72.5708,0,1.4e-4,0.0057,0.270947,7e-4,1.149,0.782,0.075,0.012,0,0.31888,113.6395,1.2224,6.9752,1.3457,0.663751,8e-4,0.600453,0.0036,12.91,3.002026,0.395055,0.011,8e-4,0,1.259779,136.34,4.39,0,1.0263,0,0.0233,0.12,3.943,137.1,2.998,64.8,231.972,4.1,1.79,74,170.99,0,79,145,68.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1671,58,58,1,3,77.91,170.02,27.41303,1.9,6,0.073502069,0.88103071,0,3,5,6,3564.073,1,1,227.08,44.32,104.22,12.33,12.94,0,0,0.0680098,0.00335,25.73,0.171,6.46103,2.7659,0.166,0.268,0.041,0.088,0.215,0.352,97.1,108.83,63.9083,0.11,0,0.0152,0.100558,0,0.176,0.34,0.144,0.234,1.223,0.33224,109.2731,2.2348,9.8514,1.2928,1.203424,0.0134,0.399625,0.0035,0.33,4.539496,0,0,0.00541,0,1.131865,334.59,4.97,0,1.2332,14.419,0.0243,24.18,4.236,137.9,10.067,80.02,337.3552,5.59,1.88,61,170.13,0,77,114,78.01,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1672,38,38,1,2,54.92,150.47,24.1514,1.5,7,0.037378562,0.44842126,0,2,6,7,6477.925,1,1,488.64,41.28,80.95,9.88,21.9,0.001282,1e-4,0.0613343,0.00269,20.7,0.141,3.923,2.2981,0,0,0.043,0.063,0.008,0,102,103.3,61.009,0.17,0,0.0062,0.088834,9e-4,0,0,0.005,0.001,0,0.37487,121.6221,3.1714,12.4187,3.563,2.401704,0.2097,0.451484,0.0045,0.23,7.486084,2.316605,0.0015,0,0,1.420985,245.38,4.15,0,0.9666,11.308,0.0232,24.78,4.093,135,6.458,62.85,333.1265,9.59,1.39,60,149.87,0,94,100,54.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
1673,53,54,0,3,58.41,169.82,20.85323,1.67,6,0.03758391,0.45109487,0,3,3,6,2053.748,1,2,292.13,34.05,207.18,16.12,22.84,0.001811,0.0029,0.0198694,0.00392,0,0,4.95967,2.0749,0.111,0.148,0.124,0.126,0.809,0.831,106.9,100.68,56.0301,0.17,3.2e-4,0.0066,0.43093,0.0401,0.374,0.391,0.328,0.327,3.018,0.36154,114.6601,1.8085,9.0042,0.0091,1.309568,0.2593,0.602068,0.1303,0,3.108659,3.287845,0.6309,0,0.001,1.039456,259.54,4.07,0,1.056,15.389,0.0253,45.33,4.212,143,6.831,66,537.5185,5.3,1.64,68,167.93,0,74,101,57.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1674,66,67,1,4,77.43,157.49,32.18737,1.78,6,0.116720131,1.40097328,2,4,4,6,5869.172,2,2,1608.14,35.84,67.88,19.78,50.98,0,3e-4,0.009977,7e-5,3.95,0.001,3.49893,2.2764,0.196,0.169,0.037,0.039,0.581,0.736,102.1,87.55,69.9003,0.75,2e-5,0.0114,0.070008,6e-4,0.488,0.5,0.126,0.13,3.858,0.35008,121.5567,1.7559,3.9981,0.7384,0.580534,6e-4,0.398969,0.0049,0.52,5.40538,1.955358,0.579,0.00208,0,1.032893,154.24,4.29,1,0.9944,0.375,0,28.48,4.092,138.1,7.996,50.88,223.1233,8.1,1.78,70,157.91,0,81,92,75.02,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,2-3,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Other,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1675,60,60,1,2,79.99,174.93,26.2715,1.94,7,0.313229899,3.76493386,1,2,2,7,4684.49,1,1,472.46,33.2,178.79,183.84,85.61,0.003308,0.0026,2.09e-4,0.00505,26.08,0,0.0115,2.4905,0.124,0.081,0.005,0.028,0.644,0.769,102,82.25,89.9399,0.12,1.7e-4,0.0056,0.124504,0.0126,0.23,0.355,0.328,0.27,0,0.43194,148.6329,3.8889,12.4732,1.0147,0.700856,0.1199,0.748508,0.0493,30.58,6.149442,4.139793,0.0074,0,0,0.972594,232.36,4.3,0,1.0073,12.75,0,26.91,5.719,139.1,8.383,79.99,194.3905,7.62,1.93,89,173.92,0,70,113,77.65,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1676,31,31,1,1,114.91,178.03,36.70478,2.32,7,0.043546084,0.52347613,2,1,3,7,20000.354,1,1,343.27,42.02,71.8,15.07,20.92,0,0,0.0200071,9e-5,25.15,0.12,2.90505,2.2165,0.024,0.008,0,0,0.459,0.699,95.8,175.14,70.6429,0,0,0,0.099941,6e-4,0.072,0.009,0.299,0.288,4.108,0.41995,142.5241,2.4076,7.244,0.3636,1.319685,0.2083,0.007215,0,30,3.608397,6.04444,0.5655,0.00535,0,1.061206,220.35,3.7,0,1.0385,0,0.0338,0,4.825,142.4,5.996,66.99,273.3639,4.82,2.39,76,180.28,0,76,123,126.21,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1677,75,76,0,3,32.5,139.87,17.80489,0.95,7,0.118907389,1.42587665,0,3,3,7,277.467,1,1,157.1,34.09,359.37,18.44,16.91,0.003937,0.0047,0,2e-5,27.52,0,4.99965,2.1252,0.08,0.002,0.129,0.142,0.705,0.651,105,61.73,49.7645,0.48,0,0.0235,0.201495,8e-4,0.439,0.368,0.226,0.188,0,0.36951,119.3276,0.246,14.0753,1.3427,1.803238,0.1566,0.479115,0.029,0.16,4.099955,3.950665,0.0316,0.00425,0.002,1.002559,327.39,4.2,1,0.3912,0.073,0.0484,28.05,4,140,3.42,63.09,208.8085,7.36,0,80,142.22,0,98,129,0,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1678,65,64,0,2,51.3,164.96,18.7293,1.55,6,NA,NA,1,2,3,6,633.6,1,1,174.98,21.83,53.28,11.91,24.17,0,0,0,1e-5,27.92,0,5.4988,2.2143,0.05,0.074,0.089,0.091,0.372,0.702,106.3,83.44,61.8205,0.09,0,0.0015,0.117847,0.0198,0.236,0.361,0.098,0.205,0,0.3032,104.2928,1.9962,9.563,0.4159,1.259015,0.0078,1.079085,0.0054,0.02,3.348423,0,0,0.00526,0,1.2945,192.9,3.61,0,1.0306,14.632,0.0105,30.51,3.603,138.9,8.566,67.02,248.4111,6.42,1.64,65,163.08,0,76,100,53.45,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,NA,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1679,59,59,2,4,73.08,170.61,24.7244,1.85,6,0.089215186,1.06970234,1,4,6,6,19361.707,2,2,144.31,31.05,47.86,15.06,18.04,0.00143,0.0021,2.907e-4,0,26.21,0.105,5.6753,0,0.005,0.001,0.019,0.065,0.476,0.738,104,80.25,76.0007,0.31,0,0,0.040217,7e-4,0.236,0.485,0.12,0.188,0,0.26252,89.6075,2.0963,11.8713,0.9221,0.70093,0.0084,0.498763,0.0661,28.55,4.528269,0.308956,0.0169,4.5e-4,0,1.233457,90.54,4.3,0,0.9683,12.24,0.0279,30.61,3.013,141.9,5.109,56.98,236.6615,5.9,1.78,53,170.05,0.1,55,97,70.23,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1680,73,73,0,2,64.04,170.04,21.87653,1.73,6,0.056464223,0.67732312,0,2,2,6,631.973,1,1,1424.86,26.96,261.07,10.09,18.84,0.001566,0.0025,9.58e-5,8e-5,26.04,0,6.20522,2.4272,0.27,0.399,0.059,0.104,0.335,0.661,105.1,54.36,91.0574,0,1.6e-4,0,0.100481,9e-4,0.375,0.483,0.007,0.186,6.27,0.32058,91.6244,2.1731,13.441,1.8323,0.299274,0.0445,0.477801,0.0907,20.96,6.099514,1.991835,0.7152,0.00503,0,1.388985,218.91,4.01,0,1.0496,13.129,0,29.86,3.31,136.9,13.648,63.01,231.9606,4.98,1.65,81,170.95,0,79,119,66,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1681,61,61,0,4,75.06,164.23,28.02185,1.82,7,0.037992962,0.45574927,1,4,1,7,637.919,1,1,938.81,43.76,75.14,27.17,25.81,0.002882,0.0021,2.775e-4,1e-5,27.73,0.027,5.53454,2.2951,0.488,0.202,0.455,0.171,2.248,0.878,100,65.05,86.7344,0.23,2.6e-4,0.0327,0,3e-4,1.215,0.477,1.035,0.568,0,0.44305,145.3056,0.7058,0.1367,0.4801,3.373163,0.2352,0.498994,0.0413,0,5.808246,5.490346,0.6696,0,0,0.936962,212.61,4.23,1,1.0729,0.141,0.0499,28.02,5.242,134.5,32.308,66.86,255.9712,8.01,1.83,100,164,0.1,99,164,74.08,1,1,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158FF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,NA,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1682,62,62,1,4,41.5,157.06,16.98904,1.37,8,0.127199986,1.53017984,2,4,5,8,2640.409,1,1,612.15,36.08,81.36,10.98,27.53,0,0,0.1034315,2e-5,2.36,0.07,3.57862,2.1846,0.434,0.288,0.418,0.252,1.357,0.749,0,76.38,51.7433,0,1.6e-4,0.0201,0.040561,0,0.753,0.446,0.566,0.364,5.141,0.21261,82.9838,3.6064,26.928,0.5235,1.493499,0,2.495699,0.0032,0,6.911343,3.350486,0,0,0,1.279011,256.63,3.48,0,1.2488,0.628,0.0437,31.97,3.493,129.6,8.412,72.9,0.2007,11,1.33,80,157.03,0,88,110,35.19,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,Y,Y,N,Y,High,High,Q1 ITT,High,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,Y
1683,78,78,1,3,65.06,165.03,24.22013,1.73,7,0.104286606,1.25034366,0,3,5,7,9840.153,2,2,420,0,86.05,16.01,16.89,0,0,0.0400771,6e-5,0,0.002,6.09632,2.2299,0.201,0.192,0.239,0.194,1.204,0.851,97.1,41.15,98.4472,0,0,0.0066,0.256501,1e-4,0.615,0.441,0.615,0.576,0,0.30752,106.6692,1.5015,11.1206,0.401,0.816459,0,0.277707,1e-4,0,3.603412,0,0,0.00369,0,0.999632,672.93,4.1,0,1.0214,7.865,0.0245,33.32,4.053,134.8,10.894,67.71,363.3238,4.58,1.69,72,164.9,0,69,135,64.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1684,56,57,0,2,65.86,160.12,25.24712,1.69,7,0.071916079,0.86375725,1,2,1,7,779.943,2,2,193.42,40.5,64.11,12.92,19.16,0,0,1.85e-4,0,3.33,0.064,10.4206,1.9763,0.466,0.316,0.347,0.247,1.238,0.745,103,116.72,46.378,0.04,0,0,0.019395,0,1.131,0.639,0.288,0.131,0,0.32901,107.7064,0.0026,0.0509,0.0066,1.834745,0.0051,0.409001,0,0.07,5.404359,0,0,0.0054,0,0.935621,207.91,3.25,0,1.1828,10.83,0.0493,30.1,3.795,140.9,7.998,72.98,161.9859,7.59,1.77,80,157.23,0,80,150,64.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1685,50,50,1,0,78.8,177.81,24.93196,1.97,6,0.02848145,0.34177532,1,0,2,6,2918.041,1,1,149.15,36.97,89.94,25.85,13.99,7.02e-4,0,0.1059973,0.0019,24.53,0.12,4.41333,2.2366,0.113,0.231,0.086,0.135,0.251,0.537,99,95.39,91.978,0,0,0,0.049922,4e-4,0.216,0.414,0.077,0.185,0,0.40091,135.7539,4.419,14.6043,1.1492,0.996395,0.0044,1.139439,0.0055,0.4,6.925956,5.481295,0.2812,0.0904,0.001,1.066355,359.74,3.89,0,1.6898,12.788,0,34.71,5.098,135.2,11.984,78.8,374.7732,10.09,2,64,175.61,0.1,83,119,74.21,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1686,69,69,1,2,55.95,156.99,22.59274,1.55,6,0.097995972,1.17711849,0,2,5,6,3957.692,1,1,130.79,35.51,72.01,21.83,25.88,0,2e-4,0.0198695,0.00976,26.14,0.237,0.09655,1.9739,0.162,0.153,0.062,0.085,0.213,0.019,109.4,93.73,50.6243,0,9e-5,0,0.11006,0.0197,0.051,0.009,0.163,0.21,0,0.36758,126.5263,1.472,9.0754,0,0.784937,0.2573,0.280817,0.0334,0.3,2.672293,0,0,0.00596,0,1.23221,108.15,2.76,0,1.105,11.874,0.044,30.81,4.285,140,6.101,53.81,169.0499,4.39,1.58,71,159.73,0,84,131,60.13,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1687,28,29,0,3,59,152.71,25.33325,1.55,7,0.036958421,0.44342849,0,3,6,7,9408.198,1,1,652.79,46.06,178.39,44.94,186.39,0,3e-4,1.215e-4,1e-4,31.07,0.149,0.05363,2.4459,0.06,0.113,0,0,0.16,0.679,106.2,116.01,70.9306,0.02,4e-5,0.0123,0.049403,5e-4,0,0,0.196,0.324,0.718,0.39922,122.2019,2.4033,11.8217,1.849,1.030376,0.2191,0.69896,0.0041,0,3.004803,0,0.6249,5.7e-4,0,1.227766,188,4.21,0,1.0008,14.696,0,33.97,5.238,143.1,9.738,70.13,391.3598,4.94,1.6,70,154.03,0.1,86,107,60.22,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1689,69,69,0,3,61.92,159.73,24.72896,1.65,7,0.024986253,0.30009229,0,3,1,7,1381.569,2,2,197.83,43.03,136.92,17.94,12.55,0.002387,0.0024,1.015e-4,0,0,0.16,5.50091,2.1337,0.364,0.219,0.062,0.025,1.614,0.689,103.1,98.88,53.9885,0.14,0,0.0052,0.341786,0,1.04,0.461,0.415,0.207,0,0.35333,124.7244,4.352,12.0501,0.6524,2.259813,0.0031,0.26982,0,0.04,4.531221,0.058233,0,0,0,1.388719,346.46,4,0,0.9774,10.844,0,32.01,3.76,144.1,8.43,73.62,291.9033,7.01,1.65,67,159,0,84,106,63.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1690,58,59,0,2,64.96,169.79,22.84599,1.74,6,0.09966668,1.1956159,0,2,4,6,990.403,2,1,409.94,33.99,62.55,4.72,11,0.001299,0.0023,0.0995121,0.00602,26.79,0.128,9.3966,2.3924,0.897,0.142,5.872,0.286,4.046,0.697,93.8,94.69,72.5766,0.63,2e-5,0.0133,0.255922,0.0235,2.313,0.428,2.342,0.158,0.66,0.40757,132.1702,2.341,0.1098,2.7818,6.069862,0.2292,0.862276,0.0561,0,6.074891,0.263389,0,0.00359,0,0.835332,332.48,3.81,0,0.9785,11.862,0.0285,31.97,4.498,140,17.16,67.97,196.2151,13.43,1.71,111,167.67,0,106,137,59.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1691,36,36,1,3,51.36,172.01,17.8871,1.61,6,0.063162082,0.75822732,2,3,5,6,3889.774,2,2,1116.47,37.92,55.01,30.53,25.99,5.09e-4,8e-4,0.0298529,0.00272,2.4,0.25,8.92952,2.0252,0.426,0.087,14.159,0.56,3.821,0.895,92.1,85.63,73.7235,0.12,2e-5,0,0,5e-4,1.55,0.445,2.95,0.595,2.368,0.30992,111.0796,2.4117,11.8721,1.8509,3.634172,0.2383,0.388994,0.0514,17.04,5.701618,6.031358,0.7029,0.00112,0,0.928202,235.84,3.9,0,0.6549,0.044,0.0335,0.24,3.983,135.7,4.096,71.93,148.8255,10.14,1.56,74,170.98,0,100,116,47.8,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,NA,Y,Y,N,N,Low-Intermediate,High,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1692,65,65,0,2,81.06,187.21,23.1419,2.09,6,0.059837072,0.71784326,1,2,2,6,4351.959,2,2,217.95,36.55,56.3,21.55,13.17,0,0,1.986e-4,0,23.21,0.08,0,2.4759,0,0.001,0,0.008,0,0.657,0,70.45,90.0809,0,0,0,0.00215,0,0.003,0.244,0.005,0.241,0,0.4039,125.6964,2.2151,6.8038,0.0051,0.662253,0,0.907456,0,0.58,14.128296,0,0.0013,0,0,0,521.48,4.01,0,1.1039,8.699,0,32.1,4.739,71.4,6.659,70.91,5.3356,13.82,1.99,68,189.53,0,62,127,84.57,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1693,49,49,0,2,86.33,164.98,31.61609,1.95,7,0.027479527,0.32969168,1,2,5,7,5021.538,1,1,NA,37.09,81.25,12.38,29.56,8.62e-4,0,0.0099422,0.00193,30.06,0.111,0,2.1978,0.103,0.176,0.068,0.084,0,0.009,103.1,107.26,62.3061,0.16,0,0.0114,0.010087,3e-4,0.017,0.309,0,0,0,0.41967,147.8432,2.7611,15.4908,8.1347,0.305094,0.2088,0.312347,0.0033,0.73,3.461411,5.166654,0.5685,0,0,1.030021,278.74,4.74,0,1.0122,10.063,0,30.32,4.71,135.9,6.837,67.97,255.205,3.89,1.83,83,162.11,0,89,130,76.33,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,NA,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1694,74,75,1,1,71.59,157.97,28.95184,1.72,7,0.038964687,0.46737648,1,1,1,7,886.595,1,1,174.5,44.04,62.2,56.88,24.18,0,0,0.0596391,1e-5,27,0.012,0.07442,2.8621,0,0.007,0.051,0.068,0.109,0.706,0.3,75.97,61.9972,0.17,5e-5,0,0.100122,0,0.345,0.496,0.006,0.147,0,0.46384,166.1316,0,0,0.4781,0.892467,0.0107,0.182571,0,17.55,3.459559,0,0,0.00857,0.001,1.294921,314.37,4.67,0,1.0124,0.145,0,0,4.698,138.9,10.88,71.03,297.9839,4.94,1.62,73,156.05,0,69,116,65.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1696,76,76,0,2,82.17,164.92,31.51038,1.92,8,0.106386267,1.27742126,0,2,1,8,763.756,1,1,215.23,37.02,176.61,54.33,31.46,7.74e-4,0.0012,0.0996836,0,0,0.191,3.13382,1.8744,0.302,0.271,0.143,0.126,0.577,0.646,103,77.54,70.7946,0.23,0,0,0.025988,0,0.77,0.582,0.004,0.001,2.553,0.40764,134.9732,0.0038,5.7913,0.4528,1.08002,0,0.314259,0,0.15,4.406668,3.427504,0.0334,0,0,0.969037,220.56,4.19,0,0.9948,0.212,0,25.91,5.102,138.1,6.235,74.02,246.9078,4.82,2.03,96,164.19,0,80,119,79.75,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1697,26,27,0,2,87.18,167.31,32.40162,1.98,6,0.0386459,0.46314239,1,2,3,6,1928.977,1,2,383.07,39.34,87.08,20.38,12.95,0,0,0.0435739,0,0,0.159,7.96405,2.3052,0.143,0.005,0.091,0.028,1.224,0.75,101,117.4,79.7234,0,0,0,0.12977,0,0.439,0.001,0.618,0.36,4.313,0.43055,133.08,1.556,0.0261,0,3.311493,0,0.987427,0,0.28,4.845223,0.67705,0.0212,9.2e-4,0,1.13008,380.45,4.41,1,1.0262,14.625,0,33.87,5.309,134.1,13.502,71.75,248.0214,9.4,1.99,61,165.04,0,80,109,84.56,0,0,0,1,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1698,56,56,0,0,71.04,152.84,29.85019,1.7,8,0.091803108,1.10240802,1,0,1,8,2506.968,2,2,181.58,40.93,103.8,12.17,32.35,0.002364,0.0019,0.0389062,0.00127,29.94,0.12,4.29076,2.1843,0.117,0.006,0.351,0.183,0.92,0.012,104,87.34,74.299,0.13,6e-5,0,0.031069,5e-4,0.537,0.291,0.248,0,0.978,0.39757,134.1035,1.5518,9.3218,0.674,1.18102,0.105,0.560596,0.0048,0,5.00055,5.202233,0.0215,0,0,1.269852,313.72,3.56,1,1.0262,12.296,0,25.55,4.465,143.9,3.41,71.07,321.6476,6.61,1.66,72,152.03,0,72,134,70.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1699,70,70,0,3,65,164.1,24.21924,1.71,6,0.014946829,0.17958701,0,3,5,6,396.06,1,1,175.33,35.09,56.77,62.95,28.07,0.001371,1e-4,0.049903,8e-5,24.3,0.164,6.68277,2.0782,0.3,0.161,0.016,0,1.605,0.817,101,99.2,52.05,0.32,4e-5,0.0024,0.11722,0,0.782,0.464,0.594,0.291,2.128,0.41795,136.6956,1.282,7.1684,0,2.498233,8e-4,0.591638,3e-4,0,2.367064,0.244655,0,0.00287,0,1.02174,319.04,4.06,1,1.4959,11.886,0.0313,32.07,4.814,132.2,9.15,63.08,234.138,5.6,1.67,68,162.74,0,90,118,62.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1700,70,70,0,4,93.2,184.37,27.51707,2.19,7,0.079209246,0.95079199,1,4,2,7,2294.916,1,1,775.76,43.92,71.24,12.12,16.83,3.35e-4,1e-4,1.346e-4,6e-5,29.05,0.155,6.58866,2.525,0.314,0.225,0.12,0.098,1.413,0.809,102.9,56.6,127.0673,0,1.3e-4,0.0024,0.089274,0.0102,0.736,0.512,0.611,0.369,1.402,0.40927,131.3162,1.9799,10.199,0.2476,1.449024,0.1468,1.235111,0.08,0.16,5.418668,6.419428,0.7309,0,0,1.263885,271.36,5.06,0,1.0094,13.379,0.0194,30.31,4.552,136,15.674,76.01,244.1516,7.91,2.2,72,180.28,0,71,126,87.39,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1701,29,28,0,1,45.63,159.81,18.15094,1.44,7,0.029820735,0.35674853,1,1,6,7,1566.277,2,2,187.58,24.38,206.13,15.1,9.93,0.001424,9e-4,0.0119055,0.00595,2.25,0.181,0.08728,2.2041,0.234,0.213,0.222,0.159,0.494,0.006,99.1,126.36,47.8557,0.17,0,0.0127,0.139838,0.0853,0.253,0.007,0.211,0.273,1.766,0.2939,98.5383,1.9024,8.3375,1.1516,0.485852,0.1363,0.469488,0.1083,0.41,3.629546,1.541099,0.5614,0,0.001,1.062443,305.97,3.01,0,0.9371,9.872,0.0532,27.41,3.544,140.9,7.993,69.49,105.8456,5.26,1.4,61,158.96,0,70,7,45.41,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1702,49,49,1,3,63.39,157.73,25.70998,1.64,7,0.066588167,0.79931351,2,3,5,7,6033.226,1,2,692.36,39,290.44,22.84,23.93,0,0,0.0114977,0.00719,1.38,0.05,0.0711,2.4979,0.274,0.197,0.131,0.094,0.874,0.738,102.9,105.59,65.1923,0,0,0,0.120279,0.0349,0.381,0.232,0.469,0.41,0,0.3903,128.9637,3.0915,16.8956,7.2195,1.342737,0.3014,0.390032,0.0985,0,3.600653,4.06235,0.0343,0,0,1.130059,269.72,4.4,1,1.1024,10.428,0.0263,37.39,4.92,139.1,7.997,82.83,833.1928,5.59,1.66,80,159.71,0.1,94,112,68.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1703,62,62,0,1,45.2,169.83,16.18764,1.52,7,0.126046393,1.51149474,2,1,5,7,4675.533,2,2,221.31,40.69,55.96,13.9,28.09,8.99e-4,2e-4,0,0,23.04,0,15.37296,2.3176,0.046,0.124,0.014,0.036,0.527,0.82,100.1,65.54,76.9456,0,0,0.0097,0.001193,0,0.089,0.358,0.24,0.317,2.475,0.39773,130.8291,2.9973,13.4887,0.4807,1.118907,0.0047,0.697819,0.003,0.27,3.704066,4.206263,0.4975,0,0,1.218583,313.88,4.68,0,0.9939,10.963,0.029,25.67,4.286,137,6.89,62.2,85.5153,6.3,1.47,79,169.98,0,81,114,47.14,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1704,66,66,1,3,70.07,167.93,25.15326,1.79,6,0.050960459,0.61053323,0,3,2,6,3005.678,2,2,259.83,44.24,92.13,21.97,16.13,0,0,0.0317853,0,26.45,0.201,5.93693,2.2774,0.35,0.249,0.066,0.053,0.287,0,104.3,114.88,61.8681,0.05,0,0,0.159509,0,0.015,0,0.171,0.222,0,0.39291,129.3242,4.1742,13.9983,0.9161,2.207238,0,0.559032,0,0,7.195265,0.48418,0.5881,0.00301,0,1.279236,325.59,4.12,0,0.9369,11.412,0.0198,26.85,4.533,136.9,10.206,74.8,279.8058,9.39,1.83,87,166.92,0,96,135,71.07,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,I,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High,High,Q3 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1705,54,53,2,3,82.3,167.93,29.16933,1.94,6,0.041272404,0.49537186,1,3,3,6,9833.149,2,2,212.98,35.51,107.62,28.93,21.98,3.1e-5,0,0.0199149,1e-5,25.44,0.148,7.98212,1.9239,0.085,0.235,0.22,0.323,0.912,0.871,105,105.6,70.2479,0.07,0,0.0093,0.018827,0,0.526,0.592,0.302,0.45,4.174,0.3585,121.1775,0.7176,4.8297,0.9293,0.430916,0,0.13972,0,26.65,8.1616320000000009,0.437033,0,0.00333,0,1.479334,140.61,4.23,1,1.111,10.605,0,33.86,4.153,139.9,10.29,49.22,171.1467,7.93,1.87,83,164.98,0,77,149,78.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1706,52,52,0,2,82.83,162.86,30.95438,1.89,6,0.093045518,1.11773251,1,2,2,6,1219.952,2,2,128.95,46.03,107.58,90.58,31.84,0.00197,4e-4,0.067345,0,30.95,0,9.97548,2.3705,0.239,0.197,0.001,0.001,0.215,0,102.2,93.08,76.9851,0,1.2e-4,0,0.129515,0,0.19,0.008,0.004,0,0,0.43603,144.9757,1.0052,7.6571,0.6587,1.239098,0.0071,0.600287,0,0,4.54303,3.270264,0,0,0,1.227487,327.27,4.59,1,1.0023,12.038,0.032,30.71,4.805,144.1,5,73.97,169.902,6.92,1.83,81,161.12,0,66,161,81.4,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1707,65,65,0,1,68,170.58,23.66328,1.79,8,0.096537573,1.15736792,2,1,3,8,2521.402,1,1,272.2,42.13,50.35,4.64,11.65,0.001723,0.0011,0.0389608,0.005,25.38,0.101,0,2.3493,0.096,0,0.133,0.063,0.973,0.624,100.9,86.01,62.783,0,1e-4,0,0.464873,0.0104,0.646,0.341,0.239,0,1.05,0.35085,127.7824,1.4782,12.2735,1.4768,2.500257,0.1032,0.408049,0.0049,0,3.1842,0,0.0332,0.0052,0.001,1.134783,352.81,3.7,1,0.9929,8.974,0,29.59,4.123,141,2.045,74.39,321.1699,6.88,1.78,81,168.2,0,72,123,64,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,<1,2-3,NORMAL,HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Other,Y,Y,F,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1708,66,66,1,4,62.07,172.09,20.9705,1.72,7,0.03208288,0.38479326,1,4,1,7,3973.205,1,1,220.44,41.99,82.34,101.4,21.07,0.003249,0.0039,0.0157129,9e-5,25.09,0.305,3.20865,2.3799,0.162,0.037,0.293,0.16,1.127,0.572,103,50.83,123.988,0,2.5e-4,0.0046,0.049826,0.0102,0.496,0.251,0.448,0.192,7.275,0.45297,146.559,1.5991,12.0868,2.5064,6.045576,0.3536,0.539074,0.073,32.58,5.704965,4.12401,0.5396,0,0.001,1.032637,378.52,3.58,0,0.957,0,0.0328,0.07,4.743,141.1,10.295,75.03,368.1734,12.54,1.61,49,170.13,0,75,115,57.5,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,China,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,High,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1709,59,59,0,1,63.07,170.86,22.37538,1.76,8,0.067607232,0.81226106,0,1,1,8,1248.8,1,2,959.86,44.05,108.62,40.85,28.14,0.001841,0.0019,0.0998652,0.007,29.09,0,5.34233,2.3245,1.365,0.608,0.181,0.095,1.07,0,103,73.13,98.1245,0,0,0,0.08201,0.0089,0.997,0.415,0.27,0.127,1.898,0.43705,154.7621,3.606,9.401,1.276,2.048768,0.2909,0.801674,0.0815,0.66,13.143985,7.891075,0.7692,0.00226,0.001,1.051193,313.95,3.88,0,0.9838,13.449,0.0031,0.15,4.69,138.1,12.107,78.18,237.9603,12.57,1.72,85,171.99,0,80,130,66.88,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,>= 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1710,59,58,1,5,61,163.85,22.54712,1.66,7,0.064104225,0.77007992,0,5,6,7,20625.547,2,2,1202.94,33.09,129.8,16.01,19.18,0.001979,0.0022,2.112e-4,8e-5,22.69,0,8.39701,2.3019,0.077,0.071,0.001,0.005,0.408,0.669,91.8,70.62,78.3932,0.37,6e-5,0.0256,0.098825,0.0409,0.332,0.419,0.117,0.161,3.467,0.37398,122.0691,1.9038,10.2078,1.022,1.402632,0.2696,0.939098,0.123,0.68,5.705235,0,0.4266,0.00157,0,0.801332,190.84,4.1,1,1.0899,0.044,0.0385,24.59,4.295,140,25.915,63.92,279.8691,8.08,1.66,57,164.08,0,72,117,62.9,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1711,40,40,0,2,110.16,173.77,37.19739,2.29,7,0.106815746,1.28003989,0,2,5,7,4407.636,1,1,397.3,37.88,63.03,15.08,10.89,4.01e-4,2e-4,0.0239877,0,29.02,0.001,7.66064,2.3786,0.003,0,0.217,0.164,1.214,0.757,92.6,117.84,81.1639,0,0,0,0,0,0.765,0.416,0.471,0.362,0.496,0.43064,140.4221,2.1721,9.8665,2.6134,1.900196,0,1.426086,0,0,14.231647,0.055938,0,0.00123,0,1.123206,174.91,4.09,0,0.9906,0,0.0012,32.17,5.174,144.1,5.113,72.86,285.8185,17.21,2.37,85,170.16,0,82,132,111.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,N,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1713,70,70,0,2,68.96,170.11,23.33068,1.8,6,0.027214654,0.32668185,0,2,2,6,894.505,1,1,NA,45.05,131.64,53.8,15.06,0.002961,0,0,0,26.96,0.125,4.96103,2.3489,0.573,0.167,1.763,0.319,2.02,0.662,102.3,70.99,76.4682,0,7e-5,0,0.200449,1e-4,0.978,0.443,0.894,0.235,1.374,0.39818,124.6704,3.8142,15.1992,2.0876,12.129584,0.0377,0.399396,0,24.58,4.275733,0,0,7.6e-4,0,0.804388,467.47,4.7,0,0.9739,10.788,0.0213,31.6,3.988,143,9.059,76,249.9365,9.1,1.79,70,170.92,0,79,121,69.9,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,NA,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1714,56,56,0,2,79.96,169.99,27.0639,1.91,6,0.054681563,0.6566511,1,2,3,6,1811.834,1,1,692.53,38.99,47.62,23.94,17.02,0.003012,0.0025,0.0399027,0.00497,28.75,0.002,5.29256,2.2798,0.128,0.086,0.066,0.053,1.609,0.888,102,81.3,87.0651,0.16,7e-5,0.0107,0.216087,0.0154,0.657,0.467,0.814,0.546,3.294,0.39312,134.8654,2.8601,7.293,0.6664,1.347012,0.1892,0.863328,0.0772,0,3.803111,0.458471,0.0299,0.00181,0.001,1.160561,86.46,3.24,0,0.8843,0.079,0.0099,22.46,4.614,141.1,3.516,69.1,243.8685,6.88,1.84,79,168.05,0,84,134,76.07,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,AUS,Australia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1715,55,55,1,4,62.13,159.85,24.24081,1.64,7,0.057300899,0.68754097,2,4,5,7,27447.555,2,2,1247.64,37.9,251.6,13.54,17.93,0,0,1.262e-4,0,0,0.143,0.11626,2.4593,0.815,0.53,0.15,0.093,1.253,0.82,96.1,92.64,66.8072,0.15,1e-5,0.0109,0.039443,3e-4,0.568,0.299,0.746,0.626,5.074,0.33022,99.8979,1.9746,12.8809,0.3761,1.402353,0.0104,0.98438,0.0636,0.65,13.202488,3.59753,0.0231,0,0,1.130026,383.94,5.24,0,1.0787,13.715,0,37.85,4.402,141.1,8.925,69.01,231.3815,13.79,1.61,73,162.89,0,97,113,66.58,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1716,64,64,0,2,64.56,170.84,22.06772,1.75,7,0.12147404,1.4579566,1,2,3,7,174.656,1,1,200.92,42.61,110.12,28.75,20.07,0.001769,0.003,0.0998634,7e-5,29.12,0.151,8.17776,2.1738,0.341,0.224,0.083,0.08,0.577,0,105,71.12,84.9064,0.07,0,0.0251,0.070016,8e-4,0.398,0.274,0.157,0.002,0,0.4454,144.4703,6.3798,16.9889,4.4713,1.69775,0.2406,0.540962,0.0852,0.69,3.474588,3.978619,0.6715,0.0047,0.001,1.13747,232.61,4.06,1,1.121,12.362,0.0556,0,5.046,144.9,5,70.03,388.996,6.3,1.71,72,166.95,0,69,136,62.11,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1717,65,66,1,4,53.9,145.8,25.63497,1.43,7,0.061774786,0.74181645,1,4,6,7,20279.916,1,1,2878.87,37.97,183.93,14.93,20.89,0.065499,0.0221,3.12e-4,0,1.46,0.106,17.05663,2.2081,0,0.006,0.111,0.152,0,0,103.9,101.51,50.1325,0.17,0,3e-4,0,0,0,0.005,0,0,2.605,0.31188,96.5238,2.9077,9.3614,0.4531,0.598407,0.0369,0.399602,0.0038,0.04,8.415546,0.53337,0.6527,0.00802,0.001,1.269111,276.71,4.19,0,0.915,11.314,0.0224,27.77,4.261,142.1,4.999,2.17,226.0055,8.76,1.35,69,141.81,0,80,112,47.52,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1718,70,70,1,1,78.81,168.98,27.51266,1.9,6,0.043074155,0.51605572,1,1,5,6,13026.197,1,1,237.55,41.64,63.78,7.94,9.96,0,0,0.0092696,2e-5,29.43,0.148,7.60437,2.433,0.052,0.046,0.081,0.103,0.524,0.704,103,57.34,104.8774,0.31,0,0.0132,0.199951,0,0.331,0.293,0.243,0.328,0,0.3951,133.416,1.8813,6.4218,0.6924,1.647063,0,0.602097,0,0.61,5.534108,2.406393,0.0052,0,0,1.391843,251.82,3.81,0,1.0264,11.405,0,0,5.001,138.9,11.967,64.96,341.1735,6.91,1.78,46,169.92,0,93,127,78.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1719,61,61,1,2,59.94,154.92,25.24093,1.6,8,0.09349231,1.12151909,1,2,6,8,20664.278,1,1,716.57,25.13,225.35,16.89,34.03,6.3e-4,0,3.37e-5,1e-4,28.01,0.042,13.47719,2.2729,0.128,0.18,0.014,0.072,0.004,0,101,87.53,73.1455,0.08,8e-5,0.0072,0,8e-4,0.011,0.007,0,0,1.895,0.32437,113.2236,0,1.7011,0,1.050598,0.0666,0.29956,0.0233,29.98,5.490133,6.218423,0.8146,0.00611,0.001,0.752003,194.33,4.29,0,0.9522,11.774,0,0,3.711,136,10.209,54.93,297.873,7.18,1.67,70,153.23,0,90,116,60.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1720,54,53,0,1,69.43,180.77,21.63158,1.88,6,0.325850395,3.90549462,1,1,2,6,191.299,2,2,181.01,37.94,91.93,23.93,17.94,0.601505,0.0358,1.296e-4,9e-5,26.96,0.237,5.1772,2.2262,0.084,0.003,0.025,0.002,0.55,0.537,103.1,82.49,79.5887,0,7e-5,0,6.34e-4,0.0043,0.332,0.211,0.216,0.203,0.763,0.4534,154.3598,0,0.0394,0.2273,1.170946,0.2574,0.400101,0.0908,25.99,4.004485,4.491242,0.6471,0,0.001,0.936518,220.81,3.6,1,0.996,6.851,0.0601,27.79,4.937,140.1,5.471,61.96,190.9559,6.14,1.7,79,178.51,0,70,120,63,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1721,41,41,0,2,55.19,162.75,20.77499,1.58,6,0.084171876,1.01009062,0,2,6,6,26210.987,1,1,410.56,38.85,729.26,25.9,38.12,0.002868,0.0042,0.0499917,1e-5,29.24,0.113,15.37242,2.4258,0.007,0.086,0.037,0.074,0.366,0.719,101,118.73,57.4568,0,0,0,0.090136,2e-4,0.206,0.363,0.133,0.269,0,0.297,93.1508,1.9421,12.8024,0.9231,1.299976,0.1361,0.909085,0.0394,0.51,5.89497,3.600883,0.0256,0.0018,0.001,1.259516,253.74,4.1,1,1.2055,11.828,0.0526,28.92,4.521,139,9.03,66.91,362.2091,8.31,1.48,70,158.9,0,87,120,48.19,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1722,55,55,0,1,83.16,178.59,25.96571,2,6,0.115255802,1.38352263,0,1,3,6,10358.011,2,2,378.06,34.35,62.54,12,24.19,0,0,0.0470361,0,32.06,0.05,4.60045,2.0918,0.133,0.117,0.247,0.157,1.029,0.769,104,109.58,61.9875,0,0,0,0.099295,0,0.523,0.391,0.494,0.347,2.299,0.32965,105.069,2.8463,10.8922,2.5792,1.030285,0.0107,0.601402,0,0.58,3.4379,0.263052,0,0,0,1.357579,93.8,3.79,0,0.9882,12.945,0,28.09,4.113,137,10.968,69.23,374.4114,5.87,1.97,60,176.32,0.1,69,114,80.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,NA,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,OTHER,North America,Y,Y,M,NA,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
1723,48,48,1,2,NA,185.42,NA,NA,7,0.072061877,0.8656604,1,2,3,7,10314.228,2,2,538.32,43.92,104.17,40,35.99,0.001027,0.0013,0,8e-5,19.95,0.146,12.45533,2.3249,0.11,0.144,0.001,0.031,0.047,0.67,101.9,115.42,64.5503,0,0,0,0.071562,0.005,0.024,0.262,0.101,0.27,1.355,0.37064,128.9039,2.0917,9.8206,0.2814,0.846575,0.1894,0.430254,0.0799,0.49,3.545838,2.895018,0.5377,0.00705,0,1.076566,285.99,3.69,0,1.1549,13.033,0.0057,28.67,4.454,143.9,10.271,73.94,330.4132,4.68,1.9,97,185.41,0,70,141,70.57,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),NA,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,Low-Intermediate,NA,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1725,34,34,0,1,73.14,167.93,25.6271,1.84,8,0.138530911,1.66125302,0,1,6,8,2758.989,1,1,190.91,44.99,991.93,28,25.07,1.76e-4,0,0.0219954,8e-5,25.85,0.002,6.84167,2.5062,0.275,0.224,0.115,0.071,1.413,0.749,104.1,102.62,72.4458,0.08,0,0,0.07153,7e-4,1.003,0.539,0.398,0.207,2.655,0.3818,120.8755,0,0.0912,0.6329,1.632768,0.1528,0.300242,0.0297,0.61,5.78189,8.035354,0.7309,0,0,1.501009,405.82,5.51,0,0.9956,0,0.0379,27.44,4.581,138.1,7.01,74.28,338.4208,9.36,1.9,78,170.03,0.1,71,135,79.59,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1726,57,57,0,2,60.54,169.9,20.81477,1.67,7,0.040390621,0.48484741,0,2,1,7,740.059,2,2,157.19,44.03,47.71,11.93,13.79,0,0,0.0077649,9e-5,31.08,0.106,5.61973,2.3446,0.219,0.104,0.203,0.119,1.138,0.672,104,83.74,83.3273,0.59,0,0.015,0.002209,3e-4,0.809,0.383,0.314,0.175,2.292,0.4005,133.189,1.8349,9.7916,0.6209,1.687281,0.2092,0.308656,0.0684,15.26,4.643588,0.089514,0.4594,0,0,1.199015,347.97,4.21,0,0.9321,7.463,0,34.83,4.408,140.1,8.267,71,393.666,5.36,1.59,88,171.92,0,79,109,58.55,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,< 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1727,76,76,0,3,72.03,163.01,26.929,1.8,6,0.075885288,0.91224453,0,3,5,6,6635.506,2,2,451.81,43.07,50.04,39.61,29.09,0.002076,0.0019,0.0463098,0.00179,28.02,0,5.90038,2.3216,0.447,0.345,0,0,0.757,0.021,98,51.25,96.3285,0,0,0,0.099754,0.001,0.343,0.291,0.311,0.204,0,0.42991,139.08,1.475,0,0.1167,0.809889,0.1224,0.520011,0.0608,0.4,5.090015,4.060822,0.6783,0.00464,0.001,1.000278,426.12,4.5,1,1.0379,0.416,0,27.66,4.668,137.1,10.225,65.06,480.0492,6.54,1.77,68,165,0,83,121,73.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,DEU,Germany,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1728,62,62,0,2,70.04,174.78,23.37609,1.85,6,0.134974886,1.62029518,0,2,5,6,15805.218,1,1,430.79,40.92,64.12,43.93,61,0.186028,0.0039,8e-6,5e-5,25.24,0.072,13.45094,2.3808,0.361,0.335,0.11,0.13,0.756,0.706,104.9,100.62,60.1061,0,1e-5,0,0.029728,0.0174,0.466,0.503,0.263,0.22,3.343,0.40764,137.2816,0.0108,6.909,0.3102,1.220207,0.2523,0.60327,0.0513,0.21,3.427923,3.121768,0.6705,0.00316,0.001,1.257922,391.45,3.31,1,1.1118,14.35,0.0618,34.97,4.601,144.1,5.092,59.03,113.4177,6.21,1.89,79,172.98,0,53,122,66.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Other,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1729,68,68,1,3,78.59,171.03,26.69802,1.92,6,0.027111635,0.32494584,0,3,5,6,15839.811,1,1,165.96,34.91,90.04,24.93,32.98,0.003418,0.004,0,3e-5,23.91,0.06,5.4379,2.4007,0.382,0.306,0.09,0.051,1.126,0.881,95.9,80.74,84.9393,0.45,0,0.0158,0.300924,0.0111,0.789,0.59,0.351,0.32,0,0.36026,119.0596,1.1104,4.9466,0.7661,0.867961,0.0105,0.520019,0.0604,0,6.00462,4.550101,0.5693,0.00565,0.001,0,254.77,3.8,1,1.2112,16.402,0.0174,40.23,3.309,138,7.006,58.99,388.9993,8.49,1.92,69,170.12,0,63,121,73.98,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131RR,158FF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1730,63,64,1,3,60.84,170.35,20.94628,1.7,7,0.02479831,0.29726397,1,3,5,7,4072.141,2,2,4037.58,46.07,74.08,22.08,21.56,6.9e-4,0,0.0198285,0.00592,0,0.098,3.58263,2.3791,0.359,0.186,0.207,0.128,0.915,0.723,96,78.14,69.9687,0.18,0,0,0.030095,9e-4,0.503,0.318,0.36,0.322,0,0.33589,115.2978,3.5717,14.6292,1.8508,1.138895,0.205,1.026046,0.0977,0,7.500947,8.576866,0.6293,0.00149,0,0.247176,204.56,4.3,0,0.9299,11.172,0,38.56,3.565,139,7.887,72.93,243.2907,7.82,1.77,77,172.05,0,64,145,64.04,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1731,62,62,1,3,61.65,162.12,23.00451,1.66,6,0.030083108,0.36008303,1,3,5,6,8543.871,2,2,226.49,38.99,122.42,15.04,22.04,0,5e-4,0.0177461,7e-5,27.03,0.002,4.92193,2.5018,0.093,0.02,0.168,0.138,0.452,0.406,95.8,91.07,59.3145,0.09,0,0.0222,0.069727,6e-4,0.257,0.26,0.164,0.163,0,0.3371,115.102,1.7372,6.4231,0.3944,0.949995,0.0137,0.289743,0.0036,0.44,6.041355,6.798427,0.0032,0,0,0,145.22,3.71,0,1.269,0.47,8e-4,30.08,3.831,142.1,4.054,70.02,267.7191,6.8,1.67,63,165.68,0,95,121,62.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,Y,Y,N,N,High,Low-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1732,73,73,1,3,77.58,164.26,28.02463,1.84,7,0.13557012,1.62570734,1,3,1,7,6965.03,NA,1,246.82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,NA,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,3,0,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,NA,Rituximab plus 6 CHOP cycles,NA,NA,N
1733,72,72,1,2,72.91,165.55,26.56957,1.81,6,0.054572295,0.65504724,1,2,5,6,27016.247,2,2,835.04,39.92,104.97,25.33,29.06,0.002685,0.0031,0.0399633,6e-5,0,0,0.09478,2.2964,0.078,0.124,0.049,0.054,0.643,0.759,0,62.59,80.2996,0.12,0,0.0214,0,1e-4,0.515,0.522,0.145,0.201,2.403,0.37285,117.114,2.0666,15.1999,1.5947,1.439254,0.251,0.232028,0.0744,0.03,3.933556,0,0.0328,0.00345,0.001,1.032595,267.16,3.99,0,1.0001,0.324,0.0395,29.78,4.386,134.2,15.362,74.71,147.1408,5.34,1.79,70,164.93,0,80,120,70.96,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1734,38,38,1,2,94.92,177.16,30.28135,2.1,6,0.1048598,1.25790154,1,2,2,6,4841.243,1,1,280.97,14.04,92.36,24.42,41.55,0.140714,0.0041,2.318e-4,8e-5,0.59,0,4.32062,2.6535,0.001,0.087,0.009,0.031,0.225,0.545,103,118.22,75.2895,0.16,1.9e-4,0.0028,0.200407,0.0097,0.105,0.281,0.009,0.002,0,0.26171,89.668,0,6.728,1.1673,1.147353,0.1999,0.409317,0.0761,0,3.207527,3.226468,0.6094,0.00258,0,0.855312,279.6,4.68,1,1.0919,0.414,0,0,3.551,141,8.464,57.97,805.7054,6.41,2.13,65,176.42,0.1,77,119,95.1,0,0,0,1,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,NA,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1735,61,61,0,2,69.09,175.05,22.86766,1.83,7,0.041808734,0.50112888,0,2,6,7,8452.146,2,2,478.99,33.72,84.17,20.24,29.02,0.003629,0.0028,3.006e-4,0.00218,32.91,0.084,3.295,2.278,0.34,0.198,0.081,0.065,0.875,0.739,104,65.89,84.906,0.33,1.5e-4,0.0207,0.052423,0.0046,0.629,0.473,0.246,0.199,0,0.33008,119.1934,2.7665,11.6434,0.915,0.772653,0.1901,0.59935,0.1004,17.32,5.090663,6.205243,0.4993,0,0.001,1.230646,272.42,3.5,0,1.0895,11.887,0.0015,25.42,4.02,139.3,6.826,55.09,321.0107,7.55,1.79,78,178.12,0,84,122,64.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1736,72,72,0,2,56.02,156.76,22.77623,1.56,6,0.051902437,0.62252307,1,2,2,6,2433.758,2,2,1061.25,36.98,64.64,36.44,31.12,0.001164,0.0016,0.0238108,8e-5,24.33,0.2,33.09285,2.4082,0.23,0.173,0.093,0.083,0.809,0.672,99,46.07,103.1546,0.31,0,0.0073,0.002392,4e-4,0.253,0.004,0.5,0.372,0,0.3769,137.9296,2.8228,10.4377,0.9854,1.891689,0.0772,1.07031,0.0604,0.43,10.597891,0.177571,0.0211,0,0,1.384898,245.84,3.05,0,1.041,12.009,0.0172,29.01,4.268,139,5.237,65.06,165.3973,14.71,1.69,80,156.97,0,73,129,60.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1738,65,65,0,2,86.11,172.72,29.4084,2,6,0.064122766,0.76920366,0,2,1,6,2719.765,2,2,431.67,41.05,50.22,17.98,18.68,0,0,0.0300027,7e-5,0,0,7.80021,2.2273,0.68,0.403,0.042,0.03,1.414,0.717,100,105.93,66.0477,0.21,0,0.01,0.099781,0,0.71,0.358,0.627,0.344,2.45,0.4156,127.7156,3.7706,7.2938,0.6201,1.80559,0.0078,0.882842,0.0039,0,6.127309,3.331097,0.538,3.6e-4,0,0.502912,273.94,4.37,0,1.0433,0,0.084,37.81,5.424,141.9,6.823,68.47,305.8171,9.78,1.9,89,173.45,0,80,112,86.68,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1739,55,55,1,0,69,173,22.95526,1.82,6,0.102464537,1.22966892,0,0,3,6,2515.612,2,2,210.8,47.92,70.61,26.06,16.03,0.00177,0.001,0.1008769,7e-5,23.82,0.105,0,2.5003,0.151,0.085,0.037,0.001,0.941,0.676,103,115.43,61.9514,0,0,0,0.069939,6e-4,0.488,0.343,0.339,0.233,2.47,0.39269,133.1513,5.4272,12.595,0.7111,2.230713,0.0088,0.769678,0.0032,21.64,7.220401,4.605011,0.0131,0,0,0.961173,288.47,3.87,0,1.117,13.29,0.0143,28.82,4.71,143.1,6.829,83.75,189.1766,12,1.79,73,173.95,0,86,99,69.96,1,0,0,0,0,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1740,59,59,0,2,65.03,154.91,27.11023,1.64,6,0.110724653,1.32753843,1,2,2,6,107.629,1,1,28.79,43.2,73.62,5.69,1.85,0.003718,0.0041,0.0200387,0,24.35,0.2,3.89671,2.3523,0.219,0.121,0.152,0.121,0.865,0.746,104.1,77.43,77.8025,0,2.6e-4,0.4257,0.11008,6e-4,0.621,0.369,0.305,0.299,0,0.41143,128.3338,4.1419,14.9556,1.3775,2.299529,0.0099,0.531551,0.0033,0.36,4.508352,0,0,0.00799,0.001,1.003532,274.9,3.48,0,0.8915,10.597,0.029,32.28,4.222,142,14.81,79.28,376.6492,6.95,1.57,57,152.78,0,86,115,59.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1741,72,72,0,3,68.97,164.98,25.16856,1.74,6,0.096668767,1.160668,1,3,3,6,5421.322,2,2,346.79,39.02,63.41,22.04,31.35,0,0,0.0415484,4e-5,27.52,0.081,6.22434,2.1376,0.228,0.272,0.034,0.06,0.86,0.787,106.8,72.1,78.4404,0.48,5e-5,0.0098,0.09939,0,0.402,0.393,0.48,0.449,4.638,0.36255,123.2546,1.7304,10.9252,0.3292,0.913848,0,0.949854,0.0021,15.63,5.428478,0,0,0.00194,0,1.196726,167.35,3.41,0,1.0467,0.235,6e-4,30.13,4.112,145,7.002,67.03,303.1504,7.02,1.92,68,164.03,0,0,127,74.04,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1742,33,33,0,2,51.48,156.05,21.09049,1.52,6,0.061998126,0.74374374,0,2,3,6,624.551,1,1,407.18,46.09,144.02,21.5,11.89,0.002349,0.0025,0.0200255,0.01264,0,0.149,15.03117,2.3638,0.216,0.092,0.116,0.044,1.3,0.806,108,97.1,65.2228,0.13,2e-5,0.0042,0.200752,0.0228,0.495,0.239,0.894,0.514,0,0.4658,150.5845,0.018,7.0992,0.4016,2.13595,0.3729,0.601136,0.0955,0,2.677732,0.648153,0.6211,0,0,1.156039,175.69,4.28,0,0.8455,0.324,0.0425,19.53,5.169,141.9,5.057,61.42,190.1836,5.09,1.47,71,157.17,0.1,79,110,54.9,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),<18.5,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,Yes,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1743,57,58,0,2,74.84,176.39,24.21618,1.92,7,0.040586599,0.48680754,2,2,1,7,6067.245,2,2,916.94,38.84,74.93,5.72,16.89,0.002402,0.0022,1.223e-4,0.00598,25.96,0.058,4.08691,2.31,0.114,0.078,0.031,0.004,0.613,0.738,0,116.28,58.0332,0.09,0,0.007,0.1101,0.0451,0.533,0.482,0.097,0.002,0,0.32458,104.8904,4.0187,5.7123,1.3667,0.599281,0.2325,0.347582,0.125,30.59,5.320577,0.12729,0.6308,0,0.001,1.036828,304.44,4.1,1,0.9049,0,0.0441,33.73,3.938,138.1,7.346,59.09,204.795,6.2,1.88,95,178.53,0,71,156,71.09,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1744,79,79,0,4,101.86,180.06,30.87007,2.2,6,0.054391733,0.65314025,0,4,5,6,17952.16,NA,1,792.86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,1,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,NA,NA,1-3,2-3,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,NA,Y,M,No,WE,NA,Rituximab plus 6 CHOP cycles,NA,NA,Y
1745,69,69,1,3,82.43,171.91,27.69984,1.95,7,0.021609611,0.25973728,0,3,3,7,2089.854,2,2,236.69,28.95,36.02,31.01,23.16,0,0,0.050252,0,28.99,0.001,5.38665,2.275,0.268,0.23,0.262,0.251,0.766,0.597,101,67.73,89.1581,0.24,1.9e-4,0.2914,0.011955,0,0.487,0.4,0.271,0.251,0,0.43198,144.8249,1.8747,9.7001,3.3644,0.919777,0,0.545698,0,33.75,5.502162,0.006917,0.0052,0,0,0.931849,195.77,3.89,1,1.1975,11.531,0,0,4.79,137,10.285,62.21,297.6123,6.72,1.9,81,172.04,0,91,129,86.7,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1746,80,80,1,3,63.17,176.05,20.73407,1.77,7,0.096175073,1.15344888,1,3,3,7,13205.499,1,1,377.11,41.91,331.19,23.23,14.97,0.003045,0.0028,0.0081299,0,1.65,0.002,10.9967,2.4446,0.537,0.434,0.079,0.089,0.683,0.716,0,33.49,130.7506,0.17,0,0,0.005647,0,0.444,0.524,0.251,0.238,0.001,0.28195,98.2573,0.3182,0,0.001,0.70066,0.1627,0.601426,0.0653,0,12.963299,8.810901,0.7737,0.00675,0.001,0.874835,480.14,3.7,0,1.1923,12.855,0,33.7,3.504,138,3.31,67.05,237.1475,13.09,1.67,83,175.08,0,85,132,58.79,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,NA,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,M,NA,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1747,80,80,0,3,44.96,152.64,19.37704,1.41,6,0.024655714,0.2956062,0,3,4,6,2436.97,2,2,786.39,27.25,111.77,7.85,24.19,0.001678,0.0017,0.0200268,0.00296,1.12,0,4.99968,1.9763,0.131,0.158,0.001,0.001,0.43,0.738,100.9,45.75,81.3811,0.08,1e-4,0,0.401995,0.0093,0.059,0.162,0.158,0.258,0,0.32943,108.5919,2.0408,15.1068,0.5919,0.801311,0.0094,0.599278,0.0403,0.06,13.097724,4.61345,0.4395,0.0038,0,0.954198,722.86,4.2,1,0.931,13.552,0.0143,42.02,3.695,137.1,2.962,62.22,174.0639,14.08,1.38,60,154.18,0,89,104,44.84,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1748,37,38,0,1,76.8,159.83,29.06668,1.79,7,0.083411466,1.00194885,0,1,2,7,1105.639,2,2,165.23,41.07,108.7,32.31,23.9,0.001797,0.0019,0.0312011,0,23.79,0.279,0,2.1136,0.004,0.006,0.052,0.06,0.322,0.702,100,157.61,48.3423,0,0,0,0.140466,0,0.02,0.009,0.261,0.322,4.148,0.42087,139.062,1.6902,13.0029,7.8293,1.795357,0,0.300146,0,0.74,4.0951,0,0,0.00786,0.001,1.130078,334.13,3.5,1,1.0524,10.508,0,34.21,4.902,143,5.489,69.99,247.3463,6.6,1.78,79,158.72,0.1,90,131,71.44,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,N,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1750,61,61,1,3,48.23,171.08,17.60398,1.54,8,0.113209951,1.35567832,1,3,6,8,1817.617,1,1,210.46,32.99,75.64,13.12,21.08,0.17666,0.043,0,5e-5,30.05,0.078,3.95758,2.6011,0.111,0.134,0.032,0.028,0.511,0.712,103,82.59,61.0036,0,1.2e-4,0.0109,0.074542,0.016,0.364,0.413,0.157,0.185,0,0.33215,114.6045,1.9948,25.9065,1.0705,0.882301,0.157,0.346467,0.0706,16.57,2.786384,5.57564,0.0265,0,0.001,1.51387,324.97,3.39,1,0.9932,10.607,0,0.73,4.158,143.2,3.966,74.23,260.9353,4.6,1.6,65,169.83,0,80,131,47.79,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,HMS,Y
1751,72,73,1,3,67.01,164.28,24.21922,1.74,7,0.057334636,0.68804977,0,3,3,7,4374.475,2,2,557.97,42.03,165.05,36.8,25.96,0.003752,0.0037,0.0300089,7.3e-4,30.88,0.072,16.38508,2.4382,0.285,0.272,0.041,0.034,0.622,0.019,103,56.54,109.0247,0.03,1.7e-4,0.0134,0.004036,9e-4,0.441,0.443,0.216,0.001,0,0.40042,129.6567,1.4124,12.6012,1.1481,1.489991,0.2114,0.482009,0.081,0.66,4.879952,6.284508,0.6992,4e-4,0,1.352042,154.14,5.07,0,1.1543,12.11,0,29.06,4.793,139,8.963,69.1,333.3412,6.8,1.79,79,167.95,0,62,107,72.9,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1752,73,73,2,3,60.91,155.19,24.68645,1.6,6,0.05085223,0.60999399,0,3,4,6,13666.097,2,2,381.71,27.05,56.23,20.32,20.95,0.001466,0.0016,0,0,0,0,5.81596,2.375,0,0.001,0,0.001,0.059,0.719,103.9,72.84,63.6281,0,0,0,0.010804,0,0.042,0.289,0.135,0.228,4.214,0.30073,107.6942,2.8917,7.7109,13.0275,0.969968,0,0.469611,0,0.1,13.142211,0,0,0.00101,0,0,513.61,4.67,1,0.9915,8.961,0,28.88,3.215,137.9,3.409,0.26,286.9788,16.6,1.5,79,151.97,0,67,142,56.06,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HH,158VF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1753,68,68,0,4,94.33,159.73,38.79616,1.95,8,0.078574477,0.94258495,1,4,2,8,3079.369,1,1,197.15,43.98,50.57,53.91,30.11,0,0,0.0983507,0.00335,28.07,0.255,3.89802,2.1971,0.198,0.004,0.293,0.123,1.613,0.591,99.9,91.65,75.8623,0.03,8e-5,0.0081,0.010266,8e-4,0.831,0.396,0.483,0.002,3.377,0.46269,158.83690000000001,1.9837,10.7779,1.4138,5.96553,0.2109,1.284694,0.0641,23.38,7.107771,4.271303,0.0218,0,0,0.960186,153,4.11,0,1.0082,0.075,0,0.03,4.793,136.9,10.345,72.31,218.3065,13.41,1.92,71,158.84,0,61,119,87.22,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1754,50,50,1,2,93.8,172.02,31.60187,2.06,6,0.059494688,0.71337588,0,2,5,6,16891.144,1,1,438.72,45.1,68.6,40.11,34.9,0.001687,0.0014,0.0200139,0.00997,28.84,0.152,1.91854,2.6242,0.079,0.132,0.19,0.17,0.93,0.727,102,113.4,70.8529,0.27,0,0.0087,0.099237,0.0301,0.643,0.501,0.379,0.299,1.748,0.48715,156.5802,2.4982,12.1979,0.9305,1.320836,0.3031,0.477557,0.1282,26.86,4.190822,7.03191,0.7041,1.5e-4,0.001,1.064671,257.39,3.29,0,1.0294,0.251,0.0799,32.88,5.044,142.5,7.523,78.01,612.84760000000006,5.23,1.9,80,174.47,0,97,125,90.15,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1755,51,51,1,2,45.17,155.03,19.14059,1.41,6,0.092526708,1.11171458,1,2,2,6,5310.612,1,1,509.29,37.99,49.14,18.46,13.9,0.003217,0.0046,0.0198789,7e-5,28,0,5.1829,1.1876,0.25,0.164,0.332,0.251,1.614,0.845,101.1,115.35,46.9506,0.12,0,0,0.20163,0.0181,1.036,0.555,0.549,0.422,1.5,0.31769,118.2754,1.4028,8.9117,0.904,0.939335,0.2115,0.32333,0.0908,0.3,2.546865,3.602922,0.0301,0.04955,0.002,0.092438,120.55,3.6,0,1.2118,0.927,0.0422,33.18,3.706,142.1,5.128,69.06,160.1546,3.91,1.46,79,155.16,0,61,132,45.77,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1756,68,69,0,2,63.17,160.05,25.13168,1.66,7,0.058489006,0.70180598,1,2,4,7,848.322,1,1,161.42,36.06,352.87,29.84,35.92,0.002092,0.0034,0.0792565,9e-5,24.09,0.148,7.48738,2.2374,0.005,0,0.064,0.06,0.756,0.59,102,73.9,70.9607,0.08,0,0.0015,0.2154,0.017,0.657,0.51,0.118,0,0,0.29959,97.1597,2.2102,14.3832,1.851,1.500822,0.1586,0.527287,0.0493,0,3.704082,3.605121,0.0329,0,0.001,1.134749,205.61,4.1,0,1.0797,12.76,0,31.01,3.743,138,8.389,64.42,243.2781,6.2,1.65,71,156.16,0,72,115,61.64,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1757,77,77,1,4,68.38,156.02,27.57356,1.66,7,0.315456143,3.779205,1,4,3,7,5550.538,2,2,441.43,29.86,163.89,43.13,16.9,0,0,0,0,1.95,0,15.62782,2.4966,0.217,0.175,0.094,0.109,0.3,0.021,103.1,47.52,91.6255,0.22,7e-5,0.0198,0.089851,0,0.256,0.282,0.067,0.2,0,0.34023,109.8202,1.2397,6.4974,0.6633,1.010335,0,0.31787,0,16.09,4.322375,0.504803,0.0103,0.00183,0,1.094705,282.54,4.53,0,1.0194,11.621,0.0132,27.37,3.894,135.2,15.049,56.1,244.6389,5.5,1.63,70,156.04,0,91,136,67.78,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1758,65,65,0,4,65.66,164.17,24.14465,1.72,7,0.053172139,0.63872647,1,4,6,7,1750.694,2,2,189.01,37.09,219.27,9.79,16.82,0,0,0.0199531,8e-5,27.66,0.123,1.08505,2.3254,0.203,0.144,0.057,0.016,1.115,0.659,105.1,76.22,75.0974,0,8e-5,0.0131,0.199922,0.0248,0.449,0.007,0.471,0.283,3.35,0.43284,144.5217,3.3913,12.5564,2.0885,1.842896,0.0135,0.384979,0.0549,0.46,3.603979,2.886903,0.0201,0.00155,0.001,1.194592,98.84,4.7,1,1.0886,12.391,0.0446,34,4.342,143,12.102,66.95,446.2655,6.1,1.8,81,161.88,0,77,139,64.72,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Eastern Europe,NA,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1759,70,70,0,1,56.96,172.06,19.46342,1.66,7,0.039204724,0.47046012,1,1,1,7,598.265,2,2,329.8,40.01,74.92,47.4,45.32,0,0,0.0585222,0.00595,26.02,0.291,2.89921,2.072,0.143,0.104,0.021,0.044,0.602,0.776,101,89.71,54.3582,0,0,0,0.039251,0.0306,0.165,0.32,0.31,0.345,2.52,0.44452,146.9597,2.3374,5.6826,0.4997,1.798927,0.1542,0.856055,0.0744,0,3.102385,0.322108,0,0,0,1.098522,223.51,3.49,0,1.0913,10.626,0,26.58,5.593,140.8,17.966,57.95,364.3544,5.4,1.61,57,170.14,0,57,106,56.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,NA,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,NA,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1760,35,35,0,2,58.04,160.15,22.48905,1.61,6,0.030184284,0.36205456,0,2,1,6,5437.466,2,2,194.68,36.93,144.51,22.07,15.81,0.001186,0,0.0277156,0.01002,24.05,0.169,4.69076,2.1571,0.218,0,0.102,0.033,1.948,0.772,101.9,112.84,65.0723,0,0,0,1.65033,0.0518,0.754,0.288,1.047,0.276,2.435,0.40862,133.9995,1.7718,9.3647,0.5187,4.519072,0.3107,0.752939,0.0915,0,3.780808,6.870157,0.7002,0,0,1.229849,206.46,3.61,0,0.9545,0.748,0.0106,30.24,4.604,142,10.91,67.05,214.0615,8.72,1.66,79,160.19,0,89,126,59.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1761,67,67,2,2,69.85,167.91,24.41464,1.79,7,0.173441431,2.0836549,1,2,5,7,12118.263,2,2,210.39,36.86,67.77,14.72,12.9,1.7e-4,0,2.482e-4,0,3.81,0.001,4.99445,2.4138,0.179,0.087,0.061,0.036,1.801,0.88,99,68.19,81.3749,0,0,0,0.273182,7e-4,1.046,0.614,0.555,0.362,3.098,0.42962,142.7485,2.9422,9.1929,1.2997,2.063209,0.0019,0.799962,0.0436,17.83,2.609193,3.595792,0.0014,0,0,1.320551,289.15,4.89,0,1.1182,13.85,0,25.84,5.09,140.8,4.831,71.02,190.3948,4.48,1.85,64,167.42,0,0,127,70.09,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,HMS,N
1762,32,32,1,0,68.04,162.99,25.60596,1.74,6,0.079599736,0.95497486,2,0,2,6,4417.325,2,2,429.74,42.01,116.11,87.83,87.18,0,0,0.0198448,3e-5,23.94,0,0,2.3752,0.141,0.166,0.184,0.154,0.681,0.788,100.4,320.73,31.7356,0.1,3e-5,0,0.046607,0,0.242,0.336,0.333,0.407,0,0.39092,139.0994,3.5208,16.2026,5.3806,0.627821,0,0.662326,0,16.17,7.957735,0.084814,0,0,0,1.097981,240.2,4.4,0,0.8916,10.029,0,34.98,4.125,138.9,9.975,83.01,403.3151,9.31,1.8,84,164.05,0,108,149,72.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1764,69,68,0,1,48.09,153.28,20.57231,1.43,6,0.043131488,0.51779736,0,1,2,6,1533.924,1,1,194.61,36,199.87,18.29,20.05,0.033807,0.0031,3.2e-4,2e-5,25.31,0.069,4.11129,2.2265,0.221,0.248,0.074,0.072,0.831,0.807,105.1,62.74,73.0246,0.08,6e-5,0.0104,0.004891,2e-4,0.448,0.566,0.207,0.2,3.617,0.39431,128.977,2.5082,12.195,0.6145,1.868466,0.1598,0.958082,0.0599,0,5.099193,3.902532,0,0,0,0.159879,235,3.61,1,1.1153,11.967,0.0023,31.16,4.706,135.9,12.514,72.96,199.3491,7.61,1.47,69,153.75,0,79,141,48.18,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1767,76,76,3,3,107.53,175.71,34.37947,2.22,6,0.038210312,0.45846229,0,3,5,6,26134.552,2,2,353.34,34.19,157.99,34.19,29.32,0.002707,0.0022,3.688e-4,0,28.14,0,5.30828,2.2064,0.168,0.209,0.045,0.063,0.598,0.743,103.1,106.41,61.968,0,4e-5,0.0033,0.409667,0,0.37,0.45,0.211,0.268,0,0.50147,166.5288,1.3941,0.0113,0.6992,0.998311,0,1.701969,0,33.12,7.936058,6.459218,0.0366,0.00284,0,0.478212,189.69,3.99,0,0.9816,0.277,0,0,5.468,141.1,10.277,44.32,138.2615,9.9,2.26,66,175.1,0,61,130,102.94,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131RR,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1768,53,53,0,2,74.93,153.72,32.7358,1.72,7,0.086763148,1.04022167,0,2,6,7,1083.062,1,1,460.54,47.08,58.9,13.09,14.91,0,0,0.030003,5e-5,21.95,0.039,0,2.2547,0.163,0.086,0.082,0.058,1.326,0.705,102.1,118.42,53.0358,0.12,9e-5,0.0068,0.200131,3e-4,0.614,0.324,0.546,0.245,0.679,0.39968,131.8539,1.0011,0.0237,1.0975,2.037632,0.0045,0.652323,0.0089,0.67,3.906758,6.07326,0.039,0,0,1.389813,296.14,3.91,0,0.8304,0,0,26.21,4.423,140.9,5.167,74.99,275.0694,6.82,1.72,94,153.77,0,51,145,72.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1769,73,73,0,3,60.11,170.95,21.345,1.69,7,0.116732138,1.39980323,0,3,2,7,2038.636,2,2,220.14,38.98,81.22,14.93,13.08,0,0,0.0499368,0.00504,25.65,0.053,4.60189,2.4292,1.335,0.524,0.15,0.047,1.803,0.717,104.9,70.21,71.0121,0,0,0,0.220035,0.0339,1.073,0.46,0.665,0.263,3.47,0.31718,114.234,2.1509,5.7085,0.3302,1.892536,0.2795,0.829831,0.0892,23.19,6.752861,4.517081,0.03,0.00143,0,0.901534,433.34,4.39,1,0.9688,12.017,0.002,24.32,3.418,137.1,7.998,65.99,183.7128,10.91,1.69,75,172.72,0,91,120,61.06,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,NA,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1770,56,56,0,3,60.05,159.09,23.66133,1.61,6,0.025429551,0.30479192,1,3,6,6,4117.052,2,2,1155.62,32.13,242.66,18.57,20.06,0.003594,0.0046,3.593e-4,0,23.01,0.024,8.21399,2.2752,0.063,0.095,0.039,0.048,0.152,0,103.1,100.66,67.1696,0,0,0,0.191019,0.0162,0,0,0.209,0.184,4.769,0.34321,100.2321,1.9574,9.6736,0.5767,1.327652,0.1374,0.739309,0.0709,0,5.809544,0.097165,0.0228,0.00139,0,1.227077,239.7,4.68,0,1.0222,16.959,0,31.99,4.379,140.1,8.028,63.91,208.9207,8.81,1.63,76,160.24,0,74,95,59.93,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1771,66,66,1,2,55.46,163.89,20.9785,1.6,6,0.072722118,0.87410679,0,2,5,6,15943.854,2,2,238.62,36.01,62.13,8.95,10.11,0,0,0.0300024,0,27.09,0,12.73905,2.3376,0.334,0.2,0.221,0.124,1.927,0.819,0,72.29,74.794,0.09,1.6e-4,0.0155,0.099486,0,1.16,0.523,0.59,0.289,0,0.32932,97.6628,2.3296,11.3827,1.1122,1.600562,0,0.901428,0,0.06,8.884938,0,0,0.00161,0,0.984342,359.8,4.3,0,0.994,0,0.0278,27.76,4.01,139.9,3.006,76.97,166.1978,10.06,1.53,80,166.04,0.1,78,139,56.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1774,50,50,1,0,88.2,170.03,30.55559,2,8,0.04370539,0.52451516,2,0,5,8,10542.384,1,1,202.9,40.98,56.98,37.06,45.51,0,0,0,0,29.09,0.105,9.96491,2.3707,0.312,0.037,0.161,0.043,2.1,0.814,98,175.76,45.0156,0.34,3.4e-4,0.0233,0.208292,1e-4,1.312,0.449,0.685,0.239,0,0.36006,127.9842,2.8653,11.9414,1.8439,1.593829,0.0097,0.2746,0.0032,12.83,2.795384,0,0,0.00472,0,1.195868,186.32,4.5,1,1.0959,0.686,0.0415,32.01,4.521,141,8.986,61.23,343.8027,4.95,2.06,83,174.06,0,77,119,95.84,0,1,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VF,Y,Y,N,N,Low,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1775,51,50,0,2,71.47,178.03,22.48382,1.89,6,0.162903399,1.95207447,1,2,1,6,241.466,1,1,244.88,37.04,74.38,14.06,24.18,0,0,0.0821325,0.00214,27.12,0.11,2.70836,2.5022,0.05,0.106,0.113,0.113,0.348,0,101,101.27,64.6842,0,1e-5,0.0017,0.099832,9e-4,0.268,0.3,0.008,0,0,0.40708,129.8548,2.3519,0,0.505,1.549218,0.004,0.770591,0.0026,19.93,5.608162,0.505933,0.0172,0,0,0.961534,345.38,3.79,0,1.0536,0,0.058,0.69,3.991,140,8.572,55.7,267.3854,9.32,1.89,81,179.44,0,78,111,77.57,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,< 55,< 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),<18.5,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,NORMAL,HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1776,64,64,1,4,67.98,166.1,24.15023,1.75,7,0.071391475,0.85504306,1,4,6,7,5964.476,1,1,448.79,25.98,156.43,72.32,114.7,0.003691,0.0017,0.0081393,8e-5,2.08,0.002,7.09641,2.2105,0.198,0.225,0.162,0.14,0.816,0.683,0,85.83,63.5657,0,0,0,0.085739,0.01,0.731,0.509,0.172,0.162,0,0.28739,93.6427,1.2226,3.3032,0.6692,0.769627,0.0098,0.484289,0.0643,0,9.154959,11.191332,0.7691,0.00135,0,1.162846,405.27,4.2,0,1.104,0,0.0714,28.98,2.95,138.9,4.964,51.51,176.6106,8.39,1.66,70,165.01,0,85,148,65.02,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1777,58,57,2,3,62.91,183.91,18.59741,1.84,7,0.018604011,0.22334616,1,3,4,7,21406.698,NA,2,514.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,KOR,"Korea, Republic of",NA,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,NA,GA101 plus 6 CHOP cycles,NA,NA,N
1778,68,68,1,2,94.25,171.03,32.44845,2.05,6,0.080104854,0.96182211,1,2,3,6,1541.906,1,1,228.03,44.98,176.77,11.96,19.24,7.78e-4,0,0.0200221,2e-5,25.91,0.001,5.61572,2.4577,0.115,0.08,0.008,0.001,0.578,0.654,103,98.65,61.9599,0.44,0,0.0062,0.393841,0.0199,0.426,0.417,0.133,0.107,1.494,0.33487,107.8669,5.5132,10.6265,0.7388,1.093127,0.0045,0.46236,0.0607,0,3.11384,4.991036,0.6408,0.0026,0.001,1.13004,222.09,4.48,0,0.9952,0.475,0.0027,27.96,4.309,143,6.816,69.19,597.6537,5.53,1.95,68,171.12,0,94,120,86.98,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1779,66,66,1,3,51.56,152.07,22.33525,1.48,7,0.162741734,1.95206006,2,3,5,7,18729.714,1,1,1003.1,15.71,300.34,49.99,74.17,0.00318,0.0032,0,2e-5,26.49,0.156,6.55583,2.2365,0.154,0.148,0.11,0.098,1.069,0.798,102,81.22,57.7676,0.31,0,0.018,0.009795,1e-4,0.373,0.304,0.623,0.447,2.036,0.29734,109.9762,2.1181,13.5914,1.094,0.870945,0.1301,0.970193,0.0618,0,5.140213,3.801265,0,0,0,1.035256,328.61,3.7,0,1.0936,10.662,0.0407,29.09,3.61,142,15.321,65.09,122.273,7.39,1.53,71,154.91,0,79,136,54.09,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1780,67,67,1,4,77.69,171.94,26.21828,1.92,6,0.061766999,0.74134017,0,4,2,6,9345.082,1,1,3453.47,41.57,169.59,34,59.02,0,0,0.0665234,0.02045,0,0,0.10601,2.6341,0.55,0.419,0.176,0.089,1.492,0.851,99.1,91.21,70.6539,0.12,4e-5,0,0.428303,0.1285,0.793,0.555,0.556,0.362,0,0.40761,126.6599,2.1067,4.7275,1.4193,0.881404,0.2269,1.344559,0.1346,31.15,4.243345,0.490819,0.0131,0,0,1.030819,307.34,4.31,0,1.0089,11.93,0,30.05,4.762,138,10.991,65.1,262.3149,7.51,1.9,101,171.28,0.1,96,169,76.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1781,68,69,1,3,75.07,158.06,29.75571,1.78,6,0.061684457,0.74040258,0,3,6,6,6778.049,1,1,893.16,46.02,82.49,12.99,19.12,0.003884,0.0016,0.0236585,0.00172,0,0.079,0,2.3209,0.238,0.322,0.001,0,0.134,0,102.2,68.78,84.5862,0.16,9e-5,0,0.230272,0.0227,0.013,0,0.16,0.199,2.503,0.39089,120.7489,2.3477,15.7538,1.2999,2.381379,0.2473,0.504181,0.0899,16.14,1.936916,3.059856,0.02,0.00115,0,1.384828,218.81,4.09,0,1.1651,12.826,0,27.85,4.304,142.9,4.299,71.1,264.0461,3.84,1.8,78,155.98,0,81,111,67.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,High,Q2 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1782,69,69,0,2,46.06,150.66,19.91824,1.4,7,0.178426695,2.13427984,1,2,1,7,3178.645,2,2,437.63,36.95,72.8,6.21,16.06,0.001348,1e-4,0.0279658,8e-5,26.99,0.002,0.00123,2.2586,0.322,0.449,0,0.001,0,0.011,102.3,64.74,61.0021,0.2,0,0.0023,0.501055,0.0295,0,0.249,0,0.002,2.487,0.33614,114.3295,2.5048,16.3865,0.6677,0.737321,0.0696,0.337392,0.0593,24.25,2.744161,3.60907,0.4895,0,0,1.17265,253.98,4.29,0,1.0257,0.583,0.009,0,3.275,145.1,5.47,74.81,214.1741,4.55,1.44,79,152.57,0.1,84,127,46.19,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,Y,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1783,50,50,0,2,50.69,176.24,16.41449,1.62,6,0.175816783,2.10920916,1,2,5,6,3833.688,2,2,254.31,41.66,89.73,18.91,12.99,0.001423,0.0016,0.1736003,0.0032,2.49,0.001,6.42296,2.2205,0.097,0.135,0.044,0.057,0.575,0.712,103.9,101.68,59.1033,0,0,0,1.252989,8e-4,0.251,0.358,0.34,0.418,0,0.46802,149.9421,1.8065,9.2866,0.2994,0.997057,0.0094,0.727705,0.0022,25.95,7.361571,4.485481,0.0017,9.4e-4,0.001,0.772173,502.16,3.81,0,0.9864,12.69,0.0529,28.52,5.157,137.9,5.875,73.91,209.8626,8.72,1.72,86,175.4,0,82,115,56.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1784,71,70,0,2,80.85,176.18,26.02715,1.98,6,0.141459988,1.69918684,1,2,6,6,5980.863,2,2,452.33,3.37,50.58,8.39,16.98,0,2e-4,0,0,23.25,0.074,3.61156,2.1858,0.004,0.199,0,0,0,0.546,99,69.15,84.0759,0.04,0,0.0128,0.001817,0,0,0.21,0,0.24,0,0.35949,126.4926,1.0855,12.8456,1.2318,0.429649,0,0.636561,0.0056,17.02,5.560965,0.290628,0.0029,0,0,0,247.43,4.11,0,0.9732,0,0.0141,31.74,4.011,136.7,14.138,73.56,413.954,7.1,2.1,70,175.87,0,59,114,87.6,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NA,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1786,70,70,1,4,68.96,175.34,22.65546,1.83,6,0.059491273,0.71442994,0,4,2,6,3555.328,2,1,417.41,40.4,80.76,76.82,28.94,1.41e-4,5e-4,0.0499739,9e-5,24.1,0.152,5.29269,2.3481,0.517,0.345,0.062,0.023,1.374,0.822,103.9,94.6,54.9708,0,0,0,0.061319,6e-4,0.728,0.409,0.622,0.459,0,0.40253,143.2191,2.8191,13.2827,0.7924,1.841067,0.1536,0.30122,0.0796,0,3.29416,5.203099,0.5621,0,0,1.161456,168.07,4.43,1,1.0998000000000001,16.457,0.0423,29.6,4.706,142,Inf,69.92,255.1857,5.66,1.71,69,169.97,0,64,131,59.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158FF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1787,53,53,1,2,69.88,174.87,22.74672,1.83,6,0.062203734,0.74662212,1,2,4,6,4041.19,2,2,479.78,41.02,98,15.79,31.23,0,0,3.308e-4,8.9e-4,27.96,0.14,0.08741,2.2966,0.537,0.336,0.296,0.146,2.089,0.799,100,106.42,66.3648,0.1,1.1e-4,0.007,0.040305,0.0077,0.811,0.417,1.378,0.518,0,0.41217,139.8019,2.8623,13.6958,0.9418,2.251518,0.2703,0.928896,0.0778,32.72,3.71288,6.039559,0.6996,0,0.001,0,182.78,4.28,1,1.0967,10.943,0,1.02,4.517,134.8,15.39,66.44,243.9474,8.61,1.85,61,174.84,0,86,111,69.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1788,78,78,0,3,52.16,154.91,21.93288,1.49,6,0.139457875,1.6726447,1,3,3,6,6602.099,2,2,196.06,25.87,90.73,14.79,16.06,0.003896,0.0176,0,0,0,0.156,10.02003,2.2533,0.168,0.136,0.067,0.051,0.722,0.702,106.2,54.68,70.6022,0.39,2e-5,0.0035,0.049703,6e-4,0.341,0.261,0.257,0.237,3.25,0.39015,118.4638,1.282,10.4899,0.7546,1.158403,0.1262,0.620854,0.0633,0,6.40172,4.165117,0.825,0.00138,0.001,1.452437,363.13,4.92,1,1.0312,12.521,0,22.99,4.544,134.6,9.284,69.92,163.2104,9.77,1.47,66,152.59,0,97,108,48.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1789,67,67,0,5,72.33,165.86,25.71111,1.8,7,0.037920159,0.45543987,1,5,2,7,982.482,1,1,359.65,29.58,67.2,12.24,15.96,0.003407,0.0029,0,0,28.92,0.182,0.06105,2.2042,0.163,0.107,0.15,0.123,0.999,0.785,93.7,75.21,84.7682,0.22,1.9e-4,0.0235,0.089575,0,0.357,0.278,0.649,0.426,1.233,0.33379,108.8221,2.3558,10.7975,1.5807,1.000257,0.0103,0.617443,0.0056,10.95,3.595137,0.133035,0.0091,0,0,0.871711,99.72,3.54,0,0.9987,10.233,0,28.33,3.783,139,17.016,62.19,87.5392,6.14,1.8,80,169.82,0.1,64,113,75.72,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131RR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,Yes,< 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1791,62,63,1,1,44.99,159.71,17.88764,1.44,6,0.062226525,0.74682966,0,1,1,6,NA,1,1,141.88,41.3,58.03,12.94,6.09,0.001536,0.0019,3.1e-4,0,25,0.135,6.48425,2.4059,0.047,0.002,0.031,0.014,0.644,0.013,103.4,64.98,70.9561,0,0,0,0.189461,1e-4,0.399,0.243,0.112,0,3.862,0.39621,125.0329,2.093,9.5421,1.4028,1.240508,0,0.238871,0.0027,0,7.325033,0,0.0303,0,0,1.239737,319.41,4.31,0,0.9725,0.189,0.0033,0.28,4.059,141.5,9.844,71.94,446.0668,7.52,1.49,67,159.88,0,66,103,47.86,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1792,36,36,0,2,67.29,165.1,24.47474,1.74,7,0.038075569,0.45682925,1,2,2,7,7799.364,1,1,509.7,28.07,76.97,15.64,60.18,6.96e-4,0,2.739e-4,2e-5,23.16,0.097,1.92637,2.1653,0.134,0.2,0.163,0.235,0.482,0.786,101,124.49,58.7752,0.14,0,0,0.110026,1e-4,0.276,0.341,0.231,0.395,0,0.00407,76.6455,1.5681,9.4609,3.24,0.538716,0,0.947957,0,0.27,3.648794,0,0,0.00158,0,1.304106,85.39,3.89,0,1.0952,17.082,0.0076,28.9,2.482,140,7.515,46.54,255.5817,3.9,1.72,90,167.27,0.1,94,128,64.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1793,28,28,1,3,49.86,150.69,21.69759,1.45,6,0.040632679,0.48784406,1,3,6,6,7451.505,1,1,1265.18,36.96,53.83,25.96,54.87,0.0025,0.0013,3.587e-4,2e-5,30.95,0,6.20586,2.3014,0.323,0.36,0.134,0.153,0.9,0.764,97.9,100.44,75.1311,0.11,1.1e-4,0.0235,0.059916,2e-4,0.6,0.524,0.354,0.359,2.34,0.22346,75.9422,1.612,9.7069,0.5573,1.46097,0.0106,1.430358,0.06,0,6.772867,0.117779,0.0155,0.00244,0,1.117814,276.87,3.87,2,1.0007,10.98,0.0856,28.9,2.917,137,8.575,56.97,314.9893,9.87,1.43,58,150.98,0.1,123,110,51.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1795,29,29,0,1,80.86,189.15,22.15766,2.08,6,0.050958159,0.61014363,0,1,2,6,2975.249,1,1,131.01,46.82,54.82,22.85,14.98,0.105514,0.0048,0.0199537,3e-5,28.26,0.18,7.33611,2.2418,0.304,0.123,0.346,0.16,1.949,0.842,101.9,92.37,100.8868,0.02,2.4e-4,0.0278,0.010356,0,1.292,0.634,0.707,0.329,0,0.49487,170.1735,2.9033,9.9376,1.0929,2.566963,0.0109,0.501123,0,0.93,16.079763,2.087448,0.0324,0.0026,0,0.808441,277.56,3.81,0,0.8117,0,0.0755,0.09,5.056,141.9,7.879,72.51,148.8094,18.79,1.98,80,186.71,0,67,113,80.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1796,64,64,0,2,80.93,169.82,27.69935,1.92,6,0.061154956,0.73354304,0,2,2,6,5640.073,2,2,962.82,34.97,122.72,20.44,24.18,0.001681,7e-4,0.0416428,0,3.63,0.089,10.66505,2.2497,0.024,0,0.018,0.017,1.178,0.862,102,94.76,67.1321,0.2,1e-4,0.0031,0.189996,0,0.713,0.517,0.502,0.366,3.261,0.29992,98.0249,0.0159,4.7111,0,0.859602,0,0.40624,0,0.03,7.092455,0.326108,0,0.00193,0,1.221959,457.69,3.8,1,1.1332,12.09,0.004,33.92,3.318,138,7.003,66.95,185.8051,8.4,1.92,63,170.86,0,69,110,84.01,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1797,35,34,1,3,62.96,175.02,20.5259,1.75,6,0.020779777,0.24933569,0,3,3,6,16452.453,1,1,390.55,36.02,731.64,25.18,22.92,0.147903,0.0029,1.533e-4,0,26.09,0.071,5.32239,2.3214,0.061,0.416,0,0.048,0,0.798,104.9,106.89,74.2405,0,6e-5,0,0.201079,0,0,0.323,0.112,0.55,2.859,0.3075,89.5522,1.7151,8.8368,0.5589,0.10358,0,0.51245,0,0.74,4.998033,0.290273,0,0.00676,0.001,1.227563,195.14,3.89,1,1.1082,11.079,0.1049,24.34,3.303,137.9,51.895,61.34,274.2926,5.6,1.73,62,176.01,0,101,89,65.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1798,36,36,0,2,80.65,166.96,28.81338,1.9,7,0.0296279,0.35538128,1,2,3,7,6301.22,1,1,170.66,35.93,228.47,36.32,16.04,0,0,1.246e-4,4e-5,33.92,0.11,5.18448,2.1457,0.146,0.004,0.213,0.057,1.357,0.547,105.8,182.17,53.1056,0.15,2.5e-4,0.0208,0.099848,0,0.835,0.348,0.295,0,0,0.35336,111.0979,1.3699,12.6271,1.4983,1.908196,0.0044,0.649694,0,0.38,13.100922,7.353966,0.0418,0,0,1.209625,618.82,4.41,0,0.9025,11.844,0,30.58,3.98,143.2,5.994,67.1,265.1705,18.65,1.78,60,168.06,0,85,88,75.17,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1799,70,70,1,4,97.72,162.08,37.28846,2.01,7,0.098034317,1.17634219,2,4,5,7,33440.483,1,1,869.54,39.99,84.21,43.36,30.7,0.001956,0.0018,0.0239266,0.01002,24.94,0.146,3.58279,2.297,0.145,0.101,0.03,0.001,0.521,0.652,101,79.91,81.8226,0.05,1.6e-4,0.024,0.169877,0.0491,0.248,0.266,0.204,0.25,0,0.3334,108.3491,2.4336,7.4064,0.0017,0.628887,0.2282,0.543463,0.0903,0,3.40104,3.807601,0.6078,0.00673,0.001,0.402047,319.41,4.59,0,1.1073,0.336,0.0062,29.6,3.816,139,10.275,58.99,368.966,4.7,2.08,68,161.75,0,76,120,98.13,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,NA,1-3,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Western Europe,NA,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
1800,70,69,1,5,51.81,152.84,21.82837,1.48,8,0.04646956,0.55752757,0,5,4,8,2637.05,2,2,739.69,33.94,108.24,20.81,33.68,0,0,4.53e-5,0,32.97,0.079,2.92275,2.4743,0.057,0.078,0.005,0,0.918,0.891,98.6,78.19,51.5866,0.25,5e-5,0.0303,0.079635,0.001,0.549,0.504,0.294,0.356,0,0.29946,93.3598,2.5135,10.0207,0.0104,0.798484,0.0755,0.61812,0.0291,0.03,6.889973,5.224889,0.6241,0.00434,0,1.003149,178.36,4.6,1,0.9953,0,0.0179,0.3,3.78,137,10.271,70.44,135.6917,7.6,1.48,68,152.44,0,81,121,51.8,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,S,S,Y
1801,76,76,0,3,43.58,167,15.63884,1.45,8,0.088089603,1.0567677,1,3,3,8,2270.456,2,2,172.96,39.09,81.2,11.04,16.92,0,0,0.0388985,4e-5,29.39,0.161,0.00914,2.4714,0.12,0.005,0.164,0.102,0.901,0.809,98.9,39.76,76.9316,0.57,7e-5,0.0213,0.139827,0.0038,0.884,0.601,0.149,0.155,0,0.37372,136.5713,4.1711,18.3331,0.8082,0.946141,0.1488,0.578973,0.0048,24.07,4.059603,5.001547,0.592,0.00134,0,0.121925,195.06,3.66,0,0.9742,10.75,0.024,28.12,3.858,141.1,10.221,67,245.5047,5.6,1.52,65,168.09,0,71,130,44.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High,High,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1802,73,73,1,3,54.9,157.03,21.92721,1.54,7,0.107439801,1.29039525,1,3,1,7,9754.311,1,1,2335.23,40.38,171.27,36.35,37.19,0,0,0.0204214,1e-5,0,0,6.40716,2.3378,0.492,0.344,0.138,0.072,1.961,0.888,95,58.36,80.0906,0.34,1.7e-4,0.0258,0.189972,0,1.177,0.621,0.568,0.379,0,0.39089,122.3823,0.009,6.4153,0.9215,1.020334,0,0.450353,0,0.22,3.506793,1.510057,0,4e-4,0,0.476495,212.71,4.35,1,0.9403,0.419,0,24.5,4.579,135.2,5.006,68.94,243.2138,5.88,1.6,76,157.41,0,80,116,56.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1803,70,70,1,0,84.77,174.74,28.00011,1.99,6,0.116524825,1.39896461,1,0,5,6,6578.482,2,2,206.23,38.99,55.9,23.4,19.97,0,0,2.53e-5,0,27.43,0.068,9.61244,2.1137,0.802,0.368,0.648,0.222,3.307,0.862,111.7,92.71,70.8948,0,0,0.0101,0.199885,0.0123,2.391,0.589,1.171,0.427,3.776,0.31676,118.6181,0,5.7648,0.2626,1.879149,0.1419,0.825483,0.0329,24,2.603041,2.743557,0,0.00804,0.001,1.109339,108.02,4.19,0,0.9629,11.403,0.0417,0.63,3.257,142,9.481,51.82,360.4359,5.79,2.02,76,174.86,0,74,151,81.96,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1804,59,59,0,3,83.2,191.18,22.71729,2.15,8,0.036663499,0.44026305,2,3,6,8,16423.736,1,1,1338.24,39.44,73.92,44.13,45.62,0,0,0.0099449,0,26.92,0.172,6.94394,2.3296,0.001,0.045,0.087,0.105,0.84,0.843,0,80.55,119.9004,0.4,2e-4,0.0195,0.0778,0,0.437,0.46,0.493,0.451,0.822,0.41634,143.6388,3.8212,13.3201,1.6207,0.309728,0,0.601197,0,0,4.528888,0,0,0.00579,0,0.924711,182.56,4.1,0,1.0226,10.605,0.0184,26.38,5.073,137.9,10.227,56.96,821.2038,6.13,2.1,96,190.4,0,112,128,82.43,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,POSITIVE,Y,China,CHN,China,>= 50 ml/min,NA,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,NA,NA,N,Y,N,N,High,High,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,NA,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,Y
1805,65,65,0,3,53.45,155.83,22.48275,1.52,8,0.037785103,0.45310291,1,3,3,8,2764.545,2,2,429.7,44.68,94.37,14.09,23.82,4.5e-5,0,9.45e-5,8.3e-4,26.55,0,3.89905,2.3661,0.151,0.153,0.02,0.027,0.04,0.002,106.1,60.75,91.9822,0.13,8e-5,0.0045,0.128078,0.0128,0.044,0.009,0.004,0.002,2.068,0.41377,132.3068,1.53,10.1512,1.3699,1.055391,0.0134,0.371189,0.005,0.05,7.109236,3.729748,0.5683,0,0,1.137994,291.24,4.23,0,0.9758,12.039,0.0203,31.29,4.929,139.9,9.969,59.54,267.0087,8.75,1.6,71,155.07,0,91,118,54.95,0,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1806,68,68,0,3,71.2,153.11,30.71798,1.69,6,0.036013417,0.43223114,1,3,3,6,1512.263,1,1,791.98,44.3,82.72,10.51,19.83,0,0,1.684e-4,3e-5,25.06,0.14,13.55231,2.5259,0.81,0.46,0.078,0.034,1.178,0.662,102,66.9,82.2069,0.05,5e-5,0,0.09978,0.026,0.742,0.441,0.355,0.2,2.493,0.38239,116.9923,3.5402,9.8049,1.4474,1.579809,0.1489,0.699641,0.0774,0.05,3.355227,5.541982,0.0363,0.00291,0,1.450179,193.71,5.67,0,0.918,0,0.0442,0.62,4.506,138,7.004,67.22,439.0433,6,1.64,65,154.03,0,96,115,71.44,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1807,68,68,0,3,86.25,175.3,28.04675,2.02,7,0.072621299,0.87156148,0,3,3,7,7293.715,1,1,185.3,30.61,67.92,20.5,21.01,0.003568,0.0039,0.0882708,8e-5,23.8,0.11,7.60201,0.8249,0.048,0.074,0.102,0.115,0.754,0.764,106.2,72.46,79.5823,0.18,1.9e-4,0.0282,0.109867,1e-4,0.34,0.294,0.316,0.359,0.58,0.3315,111.5603,0,0.0216,0.3655,0.90422,0.1033,0.360095,0.0453,30.44,3.923684,0.375287,0.0107,0.00134,0.001,1.141459,89.84,3.98,1,1.106,13.129,0.0035,25.75,3.593,138.1,12.803,44.67,289.0931,6.18,1.92,78,172.06,0,79,148,79.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Normal,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Other,Y,Y,F,No,OTH,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1808,23,23,1,3,94.87,175.03,31.6023,2.13,7,0.024504569,0.29356938,0,3,1,7,6327.107,1,1,1583.74,46,68.16,44.86,40.79,0.002307,9e-4,0.0816421,0.00532,24.96,0.366,0.02599,2.2787,0.303,0.321,0.106,0.12,0.845,0.773,107.1,136.44,79.4964,0.28,1.8e-4,0.0091,0.299691,0.001,0.55,0.454,0.347,0.364,2.256,0.42077,138.102,1.4045,10.6553,0.3529,1.500619,0.1581,0.58022,0.0048,0.71,2.045629,0,0,9.9e-4,0,0.90898,185.94,4.2,0,0.1296,12.384,0.0457,34.21,4.581,143.8,8.422,80.69,393.9168,4.38,2.12,65,175.06,0,59,130,96.18,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1809,57,58,2,3,75.98,176.24,24.74072,1.94,6,0.102759862,1.23353791,1,3,3,6,19555.307,2,2,306.59,35.06,221.94,8.94,22.9,0,0,2.713e-4,5e-5,28.94,0.015,3.83439,2.1956,0.174,0.212,0.149,0.151,0.564,0.676,100,72.45,98.8659,0,0,0,0.090412,7e-4,0.214,0.335,0.197,0.219,7.298,0.27948,90.4555,2.1151,7.8934,0.0088,1.01092,0,0.700916,0.0034,0.18,3.680941,5.435001,0.6679,0.00288,0.001,0,166.12,5.04,1,1.0968,10.764,0,24.7,2.998,140.9,7.6,73.07,371.0846,6.21,1.91,60,176.36,0,60,104,77.84,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1811,77,77,0,3,82.91,173.97,27.31351,1.99,6,0.188538315,2.26324044,0,3,2,6,286.926,2,2,239.93,40.06,198.18,34.83,24.02,0.088896,0.0055,3.012e-4,6e-5,3.34,0.122,11.47035,2.4321,0.194,0.163,0.226,0.237,0.786,0.657,104.9,103.01,55.8704,0,5e-5,0,0.34013,0.0402,0.494,0.48,0.203,0.183,0,0.42928,147.9236,0,0,0,1.840432,0.2864,0.90028300000000006,0.0804,31.13,5.383309,3.808485,0.5309,0,0.001,0.711287,215.51,3.8,1,1.1017,0.569,0.0359,0.26,4.271,139.9,5.189,66,303.5533,8.71,1.98,79,174.8,0,72,140,84.61,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1812,51,51,0,2,58.99,155.09,24.29111,1.59,7,0.041656676,0.49904,0,2,4,7,3455.248,1,1,281.34,41.44,113.45,16.95,14.05,0,0,0.0769115,9e-5,0,0.21,1.79121,2.0195,0.207,0.287,0.151,0.162,0.918,0.815,103.1,91.66,62.8873,0,0,0.002,0.102719,7e-4,0.313,0.291,0.697,0.717,0,0.36479,118.0259,1.6073,0.0235,0.6484,1.020623,5e-4,0.599006,0.032,0.36,4.265187,0.14852,0.007,0,0,1.116723,133.2,4.1,1,0.9833,0.457,0.0124,39.39,3.886,144.1,13.96,64.09,228.2395,5.49,1.61,72,154.18,0,66,111,56.98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,NA,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,NA,Y,F,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1813,65,64,1,3,55.75,162.72,20.70225,1.58,7,0.01791055,0.21489809000000001,1,3,2,7,1821.362,1,1,160.48,41.98,264.57,7.4,18.95,0.001329,0.0014,8.65e-5,8e-5,28.45,0.233,0,2.3817,0.267,0.163,0.017,0,0.742,0.612,102,73.88,74.6364,0.06,1.8e-4,0.0234,0.150126,0.0281,0.301,0.219,0.277,0.196,0,0.36001,108.2697,0.3589,4.7791,0.4204,1.630962,0.0028,0.499138,0.0046,0.02,3.491695,4.393169,0.029,0.00505,0.001,1.088527,323.93,3.99,0,0.8461,0.359,0.0046,0.18,3.94,140.1,13.908,61.95,258.9846,5.37,1.63,62,161.8,0,65,120,56.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1814,56,56,0,1,66.8,169.91,23.04594,1.76,7,0.099008608,1.1882433,0,1,2,7,1213.868,2,2,162.97,49.57,162.59,119.44,17.71,0.001563,0.0044,0.0198851,1e-5,2.37,0.075,3.96805,2.4672,0.103,0.146,0.005,0,1.09,0.887,102,86.15,74.9012,0,0,0,0.019592,0,0.764,0.618,0.274,0.26,2.646,0.46742,159.5247,2.5703,11.3908,1.1041,0.710215,0.002,0.700919,3e-4,0.43,9.819086,4.169455,0.0219,8.2e-4,0.001,1.130057,468.07,3.8,1,1.1485,0.697,0.0043,29.5,5.936,135.8,8.458,77.75,408.9124,9.56,1.7,89,171.01,0,64,140,71.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1816,38,38,1,0,50.99,164.99,18.96288,1.55,6,0.071645093000000007,0.85986238,0,0,1,6,8066.687,1,1,235.81,39.01,155.05,12.97,14.81,0.002887,0.0031,0.0185199,0.00218,0,0.109,4.00586,2.0897,0,0.069,0,0.001,0.036,0.56,100.9,137.97,42.337,0.36,0,0.0026,0.163214,0.0264,0,0,0.055,0.242,7.001,0.40026,132.783,0.0169,5.9367,11.5226,0.870002,0.09,0.369919,0.0709,17.44,8.052605,7.497277,0.5919,0,0,1.052606,351.55,4.15,0,1.0306,13.192,0,24.55,5.068,139.9,3.409,62.92,130.8976,9.49,1.42,80,161.89,0,81,114,46.41,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VV,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1818,50,50,1,4,97.01,175.54,30.93248,2.15,6,0.088747512,1.06607937,2,4,4,6,10291.022,2,2,568.38,38.22,71.53,30.36,21.54,8.56e-4,0,0.0399057,0,26.01,0,3.67744,2.4452,0,0,0,0.001,0,0,95,108.82,75.1221,0.04,1e-5,0,0.359375,3e-4,0,0,0,0,0.797,0.36875,123.0331,1.4836,9.2021,0.8158,0.772125,0,0.476917,0,15.37,6.499535,0.038156,0,0,0,1.266436,292.25,3.5,1,1.0181,11.408,0.0106,22.99,4.472,140.1,10.256,71,301.6322,8.1,2.16,81,175.07,0,84,125,99.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,Y
1819,69,69,0,3,78.07,179.77,24.382930000000002,1.99,7,0.044025593,0.5276075,1,3,6,7,6548.325,1,1,898.7,24.92,292.3,107.4,102.06,0,0,0.1333079,0.00365,0,0,7.15211,2.2614,0.016,0.04,0.083,0.093,0.379,0.427,0,73.91,79.5905,0.14,0,0,0.22934,0.0261,0.331,0.364,0.006,0.001,0,0.27561,85.7308,1.4541,0,0,1.001434,0.0076,0.599816,0.0329,0.49,8.111017,1.798136,0.5474,0.00511,0,0,188.85,3.59,0,1.369,11.591,0,23.93,3.262,137,20.206,49.46,255.667,12.18,1.92,70,177.8,0,96,122,77,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,No,0,0,131HR,158VV,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1820,75,75,2,3,59,NA,23.50032,1.58,7,0.067899631,0.81697035,0,3,5,7,15724.746,1,1,251.95,38.98,203.84,22.01,18.68,0.003797,0.0034,0.0107656,0.00335,0,0.001,6.2741,2.7505,0.272,0.125,0.067,0.072,1.196,0.806,101.9,58.99,79.5952,0,1.1e-4,0.011,0.209128,0.0295,0.867,0.594,0.234,0.128,0,0.41739,133.89940000000001,3.2871,12.8627,1.005,2.09279,0.1799,0.938812,0.0858,0.31,8.543051,7.681347,0.6708,3e-4,0,1.161696,368.1,4.49,0,0.9717,12.688,0.0052,0.6,5.011,145,29.782,73.02,339.2852,11.65,1.66,84,156.54,0,67,137,60.12,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,>1,131HH,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1821,80,80,1,3,102.21,162.15,39.15938,2.02,8,0.08762916,1.05145664,1,3,3,8,6040.958,2,2,234.97,35.03,68.7,23.38,25.81,0,0,0.0499096,6e-5,17.86,0.001,7.60012,2.3424,0.231,0.223,0.057,0.049,0.473,0.005,100,68.83,80.8591,0,3e-5,4e-4,0.140891,5e-4,0.293,0.311,0.09,0.001,3.816,0.38571,123.5491,1.9056,10.2834,0.5974,1.199492,0.0495,1.019042,0.0604,0,3.651569,3.420389,0,3e-5,0,0.965155,169.26,4.1,1,1.2903,14.182,0,34.68,4.344,137.9,15.346,61.32,697.0869,5.4,1.93,75,161.63,0,85,125,96.39,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,I,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,1,131RR,158VF,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,Y
1822,42,42,0,0,67.41,158.47,26.5542,1.71,7,0.096622022,1.15849776,0,0,6,7,2300.099,1,1,219.43,38.02,100.01,22.14,20.95,0,3e-4,0.050261,0.004,27.06,0.125,5.03245,2.2508,0.214,0.162,0.451,0.448,1.462,0.856,104,188.14,35.5475,0.04,0,0.007,0.179462,9e-4,0.767,0.489,0.658,0.482,0,0.37574,128.6078,1.9108,5.1204,0.8994,2.670838,0.2293,1.063577,0.1024,0,3.997679,0.469821,0.0284,0,0,0.193754,83.1,0,0,0.9927,12.354,0,26.55,4.807,144.1,17.008,70.07,175.6515,7.8,1.8,76,157.83,0.1,71,130,69,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1823,63,63,0,4,75.98,165.05,26.89732,1.85,6,0.027333314,0.32796154,1,4,4,6,10761.63,2,2,876.84,27,56.9,18.53,66.78,0,0,1.902e-4,0,27.98,0.071,11.68848,2.2918,0.157,0.197,0.529,0.672,1.181,0.882,96.9,60.91,84.3655,0,3e-5,0.0046,0.070019,0,0.98,0.691,0.407,0.383,0,0.251,64.3351,0.7482,9.3182,0.861,0.799144,0,0.199746,0,0.55,3.466188,0,0,0.03291,0,1.003972,304.26,3.29,0,1.0297,0,0.0369,27.32,2.548,139,5.173,70.06,178.4911,4.98,1.73,75,165.01,0.1,114,120,71.5,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VV,N,Y,N,N,High,High,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,F,Yes,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1824,67,68,1,2,54.02,156.76,21.66764,1.52,6,0.05453492,0.65468123,1,2,5,6,6162.298,1,1,310.33,38.39,79.18,15.68,26.95,0,0,0.0814169,0.00409,26.04,0.124,5.38992,2.2994,0.288,0.302,0.015,0.037,0.423,0.369,100.9,73.88,70.1231,0.07,1e-5,0.0085,0.65482,0.0322,0.23,0.308,0.105,0.172,2.038,0.35081,107.8175,2.9901,13.008,0.8573,1.319779,0.1634,0.603624,0.0656,15.03,4.095701,0,0,0.00173,0.001,1.069861,155.96,4.39,0,0.9947,0.567,0.0533,26.33,4.085,140.7,16.075,64.96,465.7172,6.43,1.43,80,155.91,0,83,104,49.89,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1825,79,79,1,5,72.93,158.65,28.30778,1.75,7,0.157082876,1.88644051,2,5,1,7,6175.472,1,1,241.31,24.87,161.24,14.55,12.92,0,0,0.0200185,2e-5,26.06,0,9.62824,2.0944,0.656,0.309,0.296,0.124,2.47,0.8,100,89.23,53.9525,0,5e-5,0,0.20996,2e-4,1.457,0.498,1.139,0.43,0,0.35342,109.0532,2.1308,8.3002,0.8853,2.006617,0.0092,1.352579,0.0039,0.02,11.898371,0.513374,0.0179,0,0,0.993256,344.37,4,1,1.2964,0.561,0.009,26.99,4.302,133.1,11.03,60.99,135.2096,16.27,1.77,70,160.06,0,61,145,72.93,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Other,Y,Y,F,No,OTH,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1826,40,39,1,3,64.81,174.95,21.72749,1.8,7,0.055048142,0.66082038,1,3,6,7,15264.613,1,1,638.85,41.39,145.87,31.13,23.81,0,0,0.043873,0.00401,0,0.17,6.066,2.2555,0.003,0,0.138,0.081,0.834,0.021,104,115.33,59.7478,0.25,7e-5,0.0164,0.04332,7e-4,0.498,0.362,0.185,0,0.745,0.42411,137.2432,1.1621,9.3276,0.6809,1.701573,0.0113,1.145599,0.0788,21.98,16.279148,7.950931,0.5456,0.00567,0.001,1.290082,323.73,3.53,1,1.1944,11.418,0.0059,0.14,5.294,137,4.294,78.13,356.9285,21.07,1.83,69,172.07,0,93,106,65.78,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1827,36,35,1,1,77.68,183.21,23.61368,2,7,0.045465351,0.5456278,1,1,3,7,11044.197,1,1,302.71,42.87,180.82,40.25,24.13,0,0,3.267e-4,9e-5,30.09,0.13,6.68246,2.2294,0,0.007,0,0,0,0.571,107,85.63,98.1845,0.33,6e-5,0.0212,0,0,0.001,0.336,0,0,0,0.41942,140.8037,0.733,8.1921,0.1493,0.121126,0,0,0,0.45,2.815355,0.706205,0.0182,2.2e-4,0,1.069956,73.27,3.03,1,0.9404,0.202,0.0345,0.17,4.64,143.1,8.469,62.77,315.0303,2.99,1.99,67,182.94,0.1,80,116,78.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1828,82,82,0,5,87.17,170.1,30.26896,1.99,6,0.014286176,0.17091306,1,5,5,6,4844.296,2,2,256.87,39.92,129.36,17.07,16.91,0,0,2.097e-4,0,28.13,0.112,9.90274,2.5799,0.123,0.139,0.02,0.001,0.704,0.432,97,51.94,95.2397,0,7e-5,0,0.061683,0,0.211,0.166,0.263,0.186,1.148,0.5013,163.8775,2.4076,10.4002,0.9216,1.520303,0.0104,0.599951,0.0042,0.24,6.372199,4.190367,0,0.00518,0,1.087524,314.91,4.2,0,1.0335,10.077,0,24.53,4.616,144.1,23.962,68.99,359.0223,8.47,1.98,61,170.82,0,98,130,87.37,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1829,28,28,0,1,86.57,196.46,22.31158,2.22,6,0.02619555,0.31455866,0,1,3,6,1678.27,2,2,549.09,42.38,52.21,12.95,16.15,7.25e-4,5e-4,0.0198734,0.00321,29.04,0.256,0,2.4719,0.377,0.366,0.064,0.035,0.866,0.66,0,104.23,89.2892,0,0,0,0.19996,0.01,0.341,0.231,0.441,0.301,0,0.49097,158.0047,2.4042,6.6097,0.7894,1.331249,0.004,0.667062,0.0566,0.81,4.017701,0,0,0,0,0.908539,232.08,4.45,0,0.9908,11.326,0,30.26,5.644,139.3,10.281,72.92,1562.4163,7.22,2.14,76,195.24,0,63,110,85.7,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,NA,NA,Y,Y,N,N,Low,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1830,47,46,2,4,75.09,179.19,23.46412,1.95,7,0.050498337,0.60582536,2,4,6,7,12613.616,2,2,588.74,44.91,71.66,16.16,18.74,0,6e-4,0.0363695,0.00402,0,0.061,5.98715,2.2766,0.072,0.122,0.04,0.068,0.643,0.801,84.1,107.03,65.9779,0,0,0.0022,0.170348,0.0083,0.336,0.384,0.357,0.445,5.272,0.39779,139.0071,1.5566,7.5673,0.4805,0.801792,0.0063,0.356624,0.0056,17.35,5.293029,0,0.0384,0.0045,0,1.002146,309.72,3.3,1,1.0011,12.987,0,25.84,4.629,137,11.969,73.04,294.1417,6.45,1.84,85,176.18,0,71,140,71.85,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1831,71,71,0,4,60.04,181.09,19.04286,1.76,6,0.033476919,0.40134749,1,4,5,6,1635.046,2,2,321.1,2.73,101.61,22.08,19.8,3.65e-4,0,0.0105459,0,23.51,0.09,4.53948,2.1062,0.127,0.24,0.057,0.105,0.75,0.821,99.3,65.55,74.0946,0,5e-5,0,0.160998,0,0.436,0.499,0.273,0.417,2.939,0.28365,96.9885,1.4115,8.2821,0.3383,0.56178,0,0.701233,0,0,6.748596,1.642702,0,0.0016,0,1.228849,235.17,3.21,0,1.1083,11.272,0.0409,36.84,3.624,136,0.225,3.37,163.3541,7.8,1.69,70,179.66,0,100,111,59.64,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,High,High,Q3 ITT,High,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1832,68,68,0,2,69.83,162.75,26.39312,1.75,7,0.057121629,0.68571738,0,2,5,7,9409.818,1,1,596.46,36.13,118.25,10.07,15.05,0.001884,0.0021,2.397e-4,0.0018,24.62,0.07,0,2.4492,0.017,0.019,0,0.001,0.287,0.779,100.9,87.26,60.0347,0,8e-5,0,0.07174,0.0376,0.338,0.527,0.009,0.172,0.202,0.39683,129.3977,1.8083,5.2341,1.0905,0.415262,0.1295,0.16627,0.0943,0.11,2.507338,5.445708,0.7561,0,0,0.901568,261.03,4.09,0,1.2447,11.34,0.0221,33.66,4.292,143,6.824,57.19,213.6564,2.79,1.75,76,160.08,0,55,136,67.87,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1833,35,34,1,1,96.28,184.74,27.19502,2.21,6,0.096397682,1.15720194,2,1,6,6,14205.22,2,2,406.12,40.06,103.11,60.68,26.96,0,9e-4,0.012059,1e-5,24.08,0,12.15299,2.3111,0.14,0.157,0.06,0.048,0.021,0,101,95.13,94.2501,0,1.1e-4,0.0065,0.019962,0.0132,0.214,0.32,0,0,0.62,0.35181,112.9667,3.4599,14.8286,0.7864,0.551965,0.0779,0.665229,0.0851,0,5.974701,4.25777,0,0.00361,0,1.09062,121.1,4.18,1,1.1141,12.82,0.0389,28.38,4.116,142,7.998,74.96,303.4555,7.82,2.22,57,183.15,0,86,110,98,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1834,62,62,1,5,52.06,150.95,22.66377,1.48,6,0.02440207,0.29330944,1,5,2,6,3784.22,1,1,671.73,28.17,48.24,12.04,20.85,1.593712,0.0336,7.083e-4,3e-5,0,0.135,5.39877,2.3383,0,0,0.063,0.087,0,0,101.9,92.65,44.2379,0.11,5e-5,0.0147,0,3e-4,0,0.166,0,0,0,0.22432,69.7904,1.1918,12.5351,1.6003,0.649824,0.0093,0.859803,0.0789,0.1,4.76935,2.304877,0.002,0.00733,0,1.062622,327.11,3.31,0,1.0122,4.354,0.0209,29.08,0,140,5,62.18,90.0706,6.31,1.57,61,152.08,0.1,87,117,54.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
1835,62,62,0,1,74.96,179.31,22.75263,1.93,6,0.04203662,0.50509133,0,1,1,6,4794.381,1,1,269.39,40.91,159.67,18.2,18.09,0,0,3.015e-4,0.00219,28.33,0.071,0,2.4556,0.605,0.331,0.087,0.012,0.889,0.006,101,65.47,96.4244,0.17,1e-5,0.0076,0.085559,7e-4,0.531,0.219,0.254,0.121,2.399,0.40014,128.6625,2.8668,12.2839,0.6507,2.051623,0.115,0.569892,0.0016,28.07,3.20435,3.813065,0.0328,7e-5,0,0,273.97,4.2,1,1.055,11.596,0,0,4.452,141.9,7.002,72.02,457.9973,6.07,1.97,80,182.96,0.1,63,127,80.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,I,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,NA,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,M,NA,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1836,45,45,0,1,93.06,174.82,31.32381,2.08,7,0.052441426,0.62924463,0,1,6,7,8107.263,1,1,501.43,50.66,241.31,57.81,34.84,0.001708,0.0022,0.0399544,6e-5,31.32,0,33.84174,2.5004,0.11,0.14,0.037,0.061,0.482,0.737,101.1,100.71,82.8927,0,0,0,0.036841,0.001,0.241,0.42,0.256,0.276,0,0.4223,149.953,0.738,3.8709,1.608,1.356661,0.1967,0.276782,0.0054,22.11,6.204274,4.001701,0.7205,0,0,1.608774,170.5,3.88,0,1.101,0.66,0.0779,23.37,5.982,135.1,6.926,90.42,284.6181,8.3,2.24,66,176.57,0.1,56,115,100.45,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,Yes,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1837,60,60,0,2,59.91,157.98,24.09566,1.61,6,0.056424896,0.67799758,0,2,4,6,1365.344,1,1,324.75,41.95,61.81,11.94,13.55,0,7e-4,0.0399568,0.00957,3.84,0.08,9.26867,2.3388,0.244,0.19,0.138,0.125,1.03,0.796,101.1,76.47,79.1697,0,0,0.0024,0.190056,0.0596,0.464,0.259,0.514,0.436,2.748,0.41415,132.509,3.3339,12.3512,0.8327,1.399776,0.2573,0.474352,0.1051,32.15,3.032994,0.252003,0.6363,0.00166,0.001,0.969174,462.09,4.15,1,0.9285,12.115,0.0252,23.31,5.098,144,11.948,76.28,195.0588,5.22,1.45,83,155.03,0,82,111,54.02,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1838,67,67,2,3,86.46,187.34,25.03167,2.15,6,0.041474144,0.49718026,1,3,6,6,24831.416,1,1,1397.19,33.96,112.17,44.67,113.16,0,0,0.0199375,3e-5,3.85,0.21,13.8832,2.2329,0.246,0.282,0.026,0.057,0.505,0.804,98.8,65.35,95.7651,0,0,0,0,0,0.135,0.387,0.319,0.456,0,0.34608,109.3111,0.0302,0,0,0.702849,0.0069,1.486383,0.0308,0,7.32446,3.296961,0.0176,0,0,0,317.78,4.34,0,1.0625,10.563,0.033,32.06,4.158,131,10.982,67.98,142.9959,9.27,2,75,185.42,0,115,118,76.25,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1839,82,82,0,3,NA,159.79,NA,NA,7,0.029058168,0.34977893,2,3,1,7,3314.216,2,2,198.16,27.01,129.88,19.14,26.23,2.22e-4,0,0.0268958,0,22.98,0.071,0.01901,2.5297,0.142,0.222,0.049,0.061,0.613,0.713,101,74.37,53.1767,0,0,0.0024,0.200619,0,0.491,0.516,0.098,0.113,0,0.42027,131.5451,1.8791,8.6055,0.3976,1.100639,0,0.489786,0,0.22,6.300616,3.124387,0.0197,0.00423,0,0.02805,379.35,4.21,1,0.898,0,0.0233,1.02,4.95,138.9,6.9,52.8,211.6793,7.53,1.61,86,157.11,0,86,160,59,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,NA,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,I,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),NA,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,NA,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1840,51,52,1,2,83.56,170.08,28.69607,1.99,6,0.035721021,0.42939443,1,2,1,6,3965.547,2,2,931.37,36.01,73.94,38.6,83.87,0,0.0019,0.0399196,7e-5,3.19,0,5.68211,2.1591,0.068,0.067,0.105,0.111,0.59,0.655,0.3,93.11,79.5874,0.27,1e-4,0,0.015085,5e-4,0.203,0.325,0.316,0.282,0.441,0.31104,103.5668,0.9547,10.5011,0.0045,0.488637,0.1864,0.400136,0.0924,12.12,3.998146,2.417706,0.6652,5.2e-4,0,0.024051,263.02,3.79,0,1.1118,11.624,0.0017,25.21,4.14,139.8,7.046,69.07,280.3476,6.6,1.94,66,170.08,0,63,120,76.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,< 40,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,< 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1841,41,42,0,5,57.07,165.08,20.44675,1.62,7,0.057618427,0.69221893,0,5,6,7,5435.033,1,1,790.22,29.94,125.99,21.2,67.65,0,0,0.0518223,0.0084,0,0.096,4.96701,2.0511,0.065,0.3,0.064,0.143,0,0.702,100.2,121.85,53.0182,0,1.3e-4,0,0.11008,0.0063,0,0.229,0.126,0.44,3.193,0.38951,118.7211,1.4141,6.9262,0.7043,0.390844,0.0084,1.026565,0.0761,0.08,6.008809,0,0.01,8e-5,0,1.161425,201.58,4,0,1.0905,13.615,0.0096,47.91,4.334,136.1,10.102,61.57,226.082,6.79,1.57,67,164.9,0.1,91,111,55.21,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1842,47,46,1,2,66.02,173.19,22.22794,1.8,6,0.055491935,0.66534018,1,2,5,6,6286.605,1,1,363.66,25.92,90.55,39.45,28.09,0.001643,0.0022,0.0473806,8e-5,27.31,0.177,4.54972,2.1957,0.075,0.008,0.133,0.095,1.424,0.811,104.9,94.74,68.9861,0,0,0.004,0.189688,0.0098,0.754,0.452,0.597,0.285,0,0.34482,115.5129,1.8704,11.2184,0.3752,1.803745,0.174,0.839757,0.0896,0,3.124566,0,0.0086,5e-4,0,0,85.18,3.8,1,1.2157,0.896,0.0061,28.99,3.49,141,20.7,62.43,496.331,6.39,1.83,77,174.01,0,95,123,69.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1843,64,64,0,3,70.13,168.09,25.37261,1.8,6,0.063965708,0.76603268,0,3,4,6,4335.298,1,1,211.76,40.11,52.16,12.92,17.96,0.001398,8e-4,0.0498177,1e-4,21.19,0.159,4.60338,2.3913,0.469,0.42,0.088,0.105,1.412,0.857,100,95.2,64.9687,0,0,0.0019,0.100313,0,0.838,0.622,0.592,0.424,0,0.36271,112.9032,2.1584,13.2094,2.0934,0.93627,0,1.033209,0,0.68,4.307518,0,0,0.00204,0.001,1.130045,292.46,3.9,0,1.0364,10.725,0.0273,30.43,4.09,133.7,6.858,77.05,190.2218,5.95,1.79,76,166.97,0.1,87,122,66.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1844,56,56,0,2,67,174.96,21.48454,1.82,7,0.12710918,1.52577264,0,2,5,7,1227.322,2,2,205.33,36.47,85.95,53.74,51.68,2.33e-4,0.0013,0.0100584,5e-5,25.99,0,12.44419,2.2933,0.215,0.162,0.001,0,1.008,0.7,96,71.63,96.1777,0,1.7e-4,0,0.1595,4e-4,0.571,0.344,0.55,0.372,0,0.36034,127.0417,2.0422,7.7405,0.011,0.515041,0.0029,0.421278,0.0016,0.66,9.758059,3.277081,0.6307,0.00106,0,1.178769,253.3,3.11,0,1.0085,0.203,0.048,25.84,3.939,136.8,6.817,70.91,354.9867,9.67,1.84,80,174.86,0,72,120,71.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1845,65,65,0,2,85.94,179.95,26.35216,2.07,7,0.031951753,0.38309537,1,2,6,7,3851.882,1,1,129.24,39.01,57.39,8.98,0.08,0,0,0.0408528,0.01928,3.52,0.1,3.4999,2.1083,0.077,0.004,0.23,0.13,1.519,0.803,102,70.14,104.8631,0,2.9e-4,0.0039,0.500911,0.127,0.66,0.431,0.727,0.337,0,0.3755,135.6386,2.9474,13.0101,0.5061,2.396178,0.2775,1.314032,0.1242,0.3,3.601347,0.498728,0.0241,0,0,0,247.73,3.71,0,0.9962,0,0,26.99,3.991,134,7.999,66.07,362.9402,7.8,2.21,80,180.01,0,87,135,95.5,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1846,55,55,0,2,51.95,160.2,20.05013,1.53,8,0.022341286,0.26833689,1,2,6,8,2280.227,1,1,308.71,30.98,64.1,10.15,15.72,0.001875,4e-4,0.0081258,5e-5,22.93,0.166,2.14987,2.4634,0.155,0.119,0.24,0.172,0.822,0.394,102.1,61.38,84.6784,0,5e-5,0.0077,0.040345,0,0.712,0.465,0.224,0.002,0,0.32291,108.3127,0.1951,10.98,1.2264,0.998263,0.0012,0.250535,0,27.77,3.195872,4.23633,0,0.00109,0,1.190977,154.26,4.8,0,1.1097,0,0,30.28,3.839,141.2,5.99,65.49,291.4285,5,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,R,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 8 CHOP cycles,HMS,HMS,Y
1847,49,49,1,4,63,175.09,19.91802,1.78,7,0.055787728,0.66965162,1,4,6,7,20970.221,1,1,2288.7,31.57,73.04,26.89,41.69,0,0,1.459e-4,9e-5,26.92,0,4.9849,0,0.172,0.227,0.08,0.115,0,0,106.9,112.6,61.0001,0.44,0,0,0.005434,0.0099,0,0,0.043,0.155,1.937,0.35647,121.2797,2.3215,10.9108,1.4831,0.700169,0.1944,0.459057,0.0764,19.89,4.097213,4.709936,0.6559,0,0,1.301171,189.67,3.91,0,1.1452,14.266,0.0258,28.02,4.159,140,5.116,1.79,273.0054,5.78,1.79,71,175.06,0,78,126,65,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,HMS,N
1848,54,54,1,2,73.94,156.83,29.17957,1.73,6,0.046140404,0.55351316,2,2,5,6,3173.715,1,2,461.52,38.15,126.4,22.01,11.62,0.002594,0.0017,0.020012,0.00407,27.39,0.002,12.86809,2.756,0.198,0.184,0.001,0,0.85,0.82,98.1,74.08,92.9736,0,8e-5,0,0.089282,0.025,0.396,0.363,0.38,0.418,0.442,0.35648,107.9079,2.1756,13.7064,0.0037,1.253356,0.2186,0.873336,0.0641,0,10.968134,3.224651,0.7116,0.00842,0,1.224847,576.62,3.59,0,0.8709,10.898,0.0122,25.26,4.734,137.9,13.044,70.94,231.3225,15.09,1.67,98,155.98,0,112,133,69.88,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1849,68,67,1,3,70.43,170.4,24.4871,1.82,7,0.156287053,1.87612805,1,3,3,7,16357.422,2,2,477.82,33.98,93.86,37.53,61.05,0.001912,0.003,0.0995211,0.005,23.13,0.001,17.11222,2.3018,0.105,0.094,0.098,0.068,0.664,0.644,103,90.64,61.0087,0.28,0,0.0031,0.200283,0.0136,0.416,0.285,0.188,0.156,2.368,0.38525,125.0876,5.0714,12.109,2.774,1.000237,0.0103,0.399091,0.0794,0.83,12.597807,0.165317,0.0264,0.00552,0,1.223604,268.85,3.74,1,1.0308,0.793,0.0261,25.41,4.512,137,5.99,64.9,315.1221,12.42,1.71,76,171.43,0,84,120,66.15,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,Y
1850,67,68,0,2,70.12,182.99,21.40201,1.93,6,0.03277468,0.39317463,0,2,3,6,5896.754,1,1,232.87,47.15,57.16,16.18,10.1,0,0,0.1296777,0.00405,2.85,0.12,3.88889,2.2523,0.247,0.132,0.2,0.133,1.202,0.652,100.9,81.47,74.1615,0.13,4e-5,0,0.234197,0.0235,0.727,0.437,0.492,0.199,0,0.49098,164.616,2.7063,7.4019,0.6185,1.304935,0.1966,0.539968,0.0767,0,4.469661,0,0.0097,0,0,0,358.84,3.49,0,0,7.306,0.0403,26.68,5.651,141,8.583,72.04,113.8341,6.99,1.85,70,179.43,0,77,106,66.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1851,55,55,2,4,79.91,169.94,27.54404,1.93,6,0.016606263,0.19921841,2,4,5,6,27722.186,2,2,318.96,39.76,63.83,10.98,17.14,0.001408,0.0018,0.0300163,0,25.3,0.001,6.06191,2.3269,0.165,0.165,0.064,0.052,0.77,0.248,96.5,76.44,94.8225,0,0,0,0.032548,0,0.261,0,0.473,0.341,1.252,0.31419,105.1935,0.7252,7.7417,0.0024,1.682668,0.0121,0.681334,0.0044,0.66,3.030252,0,0.0079,0,0,1.053642,203.65,4.3,0,1.0665,12.221,6e-4,29.27,4.133,141,13.053,59.35,350.9917,6.5,1.92,86,169.68,0,81,132,77.17,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1853,25,25,1,2,102.39,179.27,30.99032,2.21,6,0.038279697,0.45910967,1,2,6,6,16369.704,2,2,359.1,28.25,97.52,49.21,35.43,0,0,0.0433412,0,24.23,0.071,8.23638,2.2227,0.004,0.084,0.036,0.039,0.407,0.679,107.1,116.84,87.6759,0.28,0,0,0.300357,1e-4,0.012,0,0.24,0.326,0,0.34412,107.8666,1.5244,1.4425,0,0.704814,0,0.72324,0.0015,0,3.908899,0.638911,0,0.00995,0.002,1.301981,414.47,3.8,1,1.0549,0.147,0.055,33.55,3.767,142.9,10.227,66.97,258.859,5.6,2.36,72,181.77,0,83,130,106.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,131HR,158FF,Y,Y,N,N,High,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Other,Y,Y,M,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1854,46,46,0,2,54.08,174.02,18.18631,1.63,8,0.10563932,1.26746603,1,2,2,8,2988.87,1,1,1186.98,34.02,202.28,13.19,25.8,0,0,0.0304907,1e-4,29.97,0.144,0,2.3739,0.104,0.025,0.093,0.052,0.476,0.008,101.9,78.58,85.4761,0.27,6e-5,0,0.098103,0.0109,0.187,0.006,0.11,0,0,0.35642,128.9992,1.4169,12.098,0.7799,1.786423,0.3366,0.907033,0.0941,0,7.251787,8.357128,0.7084,0,0,1.458645,224.8,4.16,0,1.1293,12.631,0,25.08,4.04,137.9,5.1,76.07,307.7332,9.35,1.58,60,174.86,0,108,109,53.39,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,NA,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1855,43,42,0,2,59.13,169.97,20.76681,1.67,6,0.173483999,2.08059519,1,2,2,6,1990.884,1,1,183.66,35.96,67.28,17.91,18.98,0.003218,0.0025,0.0102464,1e-4,1.66,0,3.98503,1.494,0.179,0.179,0.355,0.318,1.621,0.882,106.1,69.94,97.471,0,8e-5,0.0044,0.099489,0.0304,0.773,0.486,0.729,0.632,0,0.31035,105.7726,1.749,13.4265,0.3407,1.787572,0.1493,1.250644,0.0858,0.4,6.411045,3.526222,0.7054,7.6e-4,0.001,1.139853,183.55,3.89,1,1.0987,12.059,1e-4,29.62,3.755,141.1,7.993,71.08,249.321,8.5,1.7,64,170.92,0,89,113,59.92,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1856,86,86,1,3,86.84,176.68,27.76656,2.04,6,0.095897532,1.15093613,1,3,1,6,6216.104,1,1,185.93,44.59,65.83,32.11,33.93,0.001994,5e-4,0,0,2.97,0.171,21.0801,2.4564,0.294,0.49,0.217,0.235,0.758,0.738,100.4,33.27,116.0551,0.17,1.2e-4,0.0101,0.003362,0,0.518,0.417,0.296,0.407,2.045,0.38755,131.7741,0,0.0554,0,0.560527,0.0067,0.380032,0.0018,14.08,3.776474,0,0,2.3e-4,0,0,206.12,3.99,0,1.0055,0,0.0419,29.1,4.067,140.9,9.733,65.49,288.2505,4.28,2.03,77,176.17,0,64,131,83.11,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,Y,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1857,71,71,1,2,62.9,153.31,26.02729,1.61,6,0.050990321,0.61194609,1,2,6,6,2432.632,1,1,255.55,35.79,75.54,23.36,18.01,0.001064,0,0.0400612,0,0.96,0,4.80058,2.2312,0.074,0.154,0.032,0.074,0.025,0,107,91.69,58.4624,0.03,0,0.0016,0.110083,0,0.09,0.322,0,0,0,0.41578,130.4249,1.1066,6.1616,1.335,0.603376,0.0023,0.360087,0,0.15,6.806742,0,0,0.00279,0,1.258735,242.07,3.9,0,0.9184,0.16,0,27.18,4.391,141.1,6.059,66.15,397.8388,8.8,1.61,57,152.03,0,72,89,64.82,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,>= 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1858,73,73,0,3,53.09,157.91,21.13588,1.53,7,0.070461439,0.84588328,1,3,4,7,3272.36,2,2,542.39,36.81,71.29,17.31,43.09,0.002249,0.0012,0.0685661,0.01155,28.94,0.152,4.7704,2.1902,0.06,0.049,0.018,0.013,0.524,0.799,102.1,65.83,71.6088,0,0,0,0.120166,0.0508,0.185,0.384,0.24,0.293,2.578,0.3678,136.0752,1.725,12.0191,0.5797,0.996914,0.3162,0.355704,0.09,0,1.391104,0.302781,0.0281,0.00196,0.001,1.042083,66.59,3.49,1,1.0555,0.406,0.0296,24.48,3.819,138,11.361,65.08,599.6409,2.36,1.47,0,157.05,0,75,88,48.1,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,<LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1859,74,75,0,2,59.08,152.9,25.33681,1.57,6,0.103029219,1.23594504,1,2,3,6,588.887,1,1,384.98,38.06,93.02,26.66,97.47,0,0,2.735e-4,9e-5,2.86,0.1,6.42834,2.3016,0.755,0.478,0.154,0.104,1.286,0.759,96.1,69.63,73.4516,0,2.1e-4,0.0061,0.040152,3e-4,0.646,0.361,0.738,0.51,0.949,0.26317,87.654,2.6412,9.9841,1.0907,0.939074,0.0046,0.458891,0.0521,0,1.991255,4.194961,0.5704,0.00131,0.001,1.135637,267.02,4.41,1,1.0947,11.052,0,35.06,2.814,136.4,5.3,62.28,433.9823,3.6,1.47,96,149.97,0,98,129,57.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158FF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1860,55,55,1,0,59.98,180.02,18.70754,1.74,6,0.101165733,1.21448528,0,0,2,6,14458.677,2,2,291.27,40.02,53.4,16.19,26.91,4.1e-4,0,0.0300173,9e-5,29.93,0.089,4.67654,2.4818,0.304,0.397,0.025,0.037,0.324,0.02,101,98.74,70.6398,0.03,2.1e-4,0.0167,0.218851,0.023,0.27,0.348,0.003,0,2.462,0.43188,144.9432,0.2096,11.1155,1.5608,1.092726,0.1365,0.500548,0.0712,0.33,7.359133,3.551041,0.0378,0,0,0.968734,108.6,4,0,0.9773,0,0,0.41,4.423,139.1,14.894,67.18,436.7312,10.43,1.9,70,181.65,0,76,116,66.45,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1861,37,37,0,3,45.01,147.95,20.55336,1.37,8,0.050890744,0.61081447,2,3,2,8,312.622,1,1,699.55,42.06,92.2,16.16,13.97,0.001736,0.0013,7.37e-5,7e-5,0,0.002,5.77668,2.4227,0.121,0.008,0.212,0.1,1.364,0.8,0,98.64,56.8318,0.12,1.6e-4,0.0219,0,0.0043,0.821,0.483,0.522,0.335,0.602,0.35657,115.8934,1.7901,9.8591,1.3166,2.093249,0.0853,0.539091,0.0706,0,5.200367,3.009246,0.4974,0,0,0.939595,253.39,4.49,0,0.9898,0.638,0,27.02,4.036,139,4.476,70.9,202.4982,8.11,1.46,69,146.12,0,57,119,44.93,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158FF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1862,36,36,1,5,60.08,170.81,20.84248,1.7,6,0.039926666,0.47885848,1,5,6,6,15804.623,2,2,609.07,32.22,207.67,16.83,44.5,0.001661,0.0015,0.0102021,8.2e-4,2.68,0.157,4.87572,2.3439,0.1,0.1,0.12,0.135,0.732,0.765,95,124.07,58.3914,0.14,0,0,0.059746,0.001,0.391,0.366,0.282,0.293,1.799,0.38433,118.361,1.562,12.6765,0.594,0.760949,0.0132,1.011035,0.0789,0,7.435688,0,0.0332,0,0.001,0,167.07,3.62,0,0.9551,10.809,0.1042,33.95,4.388,136.9,26.021,69,243.975,9.5,1.74,66,170,1.9,75,108,59.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Elevated,N,Yes,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1863,40,41,1,1,88.26,176.2,27.91559,2.03,7,0.098795254,1.18506123,1,1,3,7,3236.36,1,1,366.54,39.47,106.75,18.2,21.01,0.001557,0.0014,0.0243358,8e-5,26.41,0.179,4.98163,2.3948,0.15,0.116,0.231,0.131,0.844,0.414,107.9,120.17,72.476,0.1,1.1e-4,0,0.068591,9e-4,0.502,0.304,0.222,0.001,3.455,0.37563,132.4445,3.0832,19.6462,1.1059,2.291654,0.0668,0.619518,0.0043,18.02,4.82419,0.270252,0.0169,0,0,1.102248,205.92,4.23,1,0.9312,12.085,0,28.85,4.186,141.1,4.999,78.84,344.9846,8.21,2.1,64,175.07,0,61,112,89.07,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1864,66,66,1,4,75.63,169.97,26.19385,1.89,6,0.020317679,0.24369032,1,4,1,6,2577.65,1,1,425.55,35.94,49.67,20.33,18.94,0.001073,0.0021,0.0300242,0,20.88,0.001,5.29508,1.0135,0.292,0.202,0.221,0.142,1.125,0.704,103.9,80.65,78.8599,0,0,0,0.040114,0,0.781,0.446,0.344,0.302,0,0.33202,106.2231,2.9934,14.2167,0.8561,1.003026,0,1.349432,0.0033,16.71,8.576189,0.549494,0,0.00547,0.001,1.278164,226.52,3.9,1,1.0099,15.673,0,43.42,3.924,140.1,11.048,65.08,190.1367,9.94,1.78,78,165.84,0,65,119,68.99,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CZE,Czech Republic,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,Y,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1865,41,41,0,1,52.1,166.02,19.37807,1.56,6,0.037274516,0.44709107,1,1,5,6,5421.793,1,1,314.03,46.05,68.6,24.42,20.18,4.98e-4,0,0,5e-5,27.93,0.001,0,2.3229,0,0,0,0,0,0.748,100.1,111.93,62.8315,0.14,1.3e-4,0,0.00332,0,0,0.146,0.002,0.272,4.061,0.33562,114.0154,1.09,0.1226,1.4217,0.804906,0.0037,0.569563,0.0245,30.44,4.566859,4.936341,0.3401,0.00118,0,0.199641,274.83,4.2,0,1.0048,0.318,0.0211,28.97,3.662,132.2,6.909,64.15,0,5.71,1.54,72,166.05,0,71,115,50.84,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,Y,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,OTHER,Other,Y,Y,M,No,CASA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1866,65,65,0,1,50.95,156.05,20.55575,1.49,7,0.077793351,0.93441935,0,1,1,7,483.07,1,1,151.64,46.84,71.68,12.75,9.97,0.003756,0.0031,0.0103646,7e-5,26.02,0.05,0.0681,2.4024,0.2,0.224,0.074,0.08,0.404,0,104.1,64.19,73.0862,0,0,0.0089,0.151913,0.0122,0.238,0.269,0.174,0.182,0,0.42287,131.3254,1.3502,14.1967,0.589,1.206858,0.1121,0.58141,0.0306,0.41,2.736111,3.563431,0.0052,0.003,0.001,1.062805,218.98,4.66,0,0,11.859,0,28.9,4.532,141.6,6.9,75.07,243.2541,4.99,1.39,104,155.82,0,73,149,49.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1868,73,74,0,2,70.38,164.08,26.51419,1.76,6,0.060623235,0.72763041,1,2,3,6,413.816,1,2,216.57,27.06,91.45,10.99,14,0.002093,0.0019,0,8e-5,26.1,0.234,7.99091,2.321,0.074,0.021,0.001,0,0.721,0.756,105.1,82.27,64.5287,0,2.6e-4,0.0129,0.229962,0.0062,0.251,0.184,0.348,0.364,2.95,0.38404,124.2641,3.2993,15.8919,1.1856,2.502629,0.2579,0.60573,0.0734,28.99,3.520443,2.722243,0.0291,0,0,1.230059,243.98,5.03,0,0.9952,12.83,0.0052,24.7,3.805,142.9,3.46,67.02,204.9164,6.7,1.83,68,165.05,0,81,104,75.82,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,POSITIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1869,43,43,0,2,66.97,177.92,21.65755,1.84,6,0.071379399,0.85599789,1,2,5,6,3868.454,1,1,160.08,35.9,90.38,8.95,11.08,0.001859,7e-4,0.0238147,3e-5,27.21,0.154,17.35823,2.3498,0.248,0.194,0.081,0.032,0.758,0.016,104.1,104.28,77.1808,0,1e-5,0,0.119989,0,0.428,0.182,0.257,0.107,1.577,0.42427,133.0634,1.4687,0,0.281,2.476445,0.0021,4.552053,0.0022,0,7.253826,3.962529,0.0042,0,0,1.176095,329.41,4.2,0,1.1057,10.353,0,26.53,4.511,139.1,17.996,50.97,226.4039,12.59,1.84,68,178.08,0,87,107,70.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1870,69,69,0,4,98.99,169.39,35.02692,2.06,6,0.030547496,0.36657787,0,4,4,6,4156.157,2,2,681.04,43.67,231.25,20.55,37.97,0.001986,0.0022,0.0998773,0.00594,29.09,0.091,4.49987,2.5803,0.305,0.3,0.014,0.004,0.345,0.626,95.3,157.76,44.2071,0.17,1.6e-4,0,0.156783,6e-4,0.459,0.458,0.004,0.002,1.479,0.45008,153.2612,7.0518,13.2962,4.3964,0.757256,0.0068,0.468723,0,0.03,8.812595,2.237097,0.0166,0.0036,0,1.340005,284.81,3.49,0,1.1705,12.266,0.0753,33.17,5.253,138.1,18.079,75.99,371.4315,9.52,1.91,88,168.05,0,107,131,91.69,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1871,57,58,0,2,113.1,190.44,31.45184,2.43,6,0.023012915,0.27645142,1,2,4,6,2999.906,1,1,367.88,32.79,67.26,27.93,34.68,5.65e-4,6e-4,1.11e-4,0,0.4,0.001,6.42165,2.2975,0.089,0.044,0.185,0.092,1.105,0.775,95,119.29,70.9333,0.12,3e-5,0.01,0.003745,3e-4,0.512,0.415,0.425,0.243,0,0.39036,127.0054,0.0129,7.0743,0.6747,1.600259,0.0792,0.500979,0.0019,0.66,4.243555,0.318503,0.4893,0,0,0.038238,227.8,3.69,1,1.0931,13.388,0.006,25.47,4.704,138,13.218,70.04,261.8564,6.41,2.38,92,189.96,0.1,98,148,114.53,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1872,65,65,0,3,67.86,160.13,26.14787,1.7,6,0.118196097,1.41757314,0,3,3,6,1624.308,1,1,158.14,32.9,96.94,10.39,15.35,0.003525,0.0036,0.0225802,7e-5,23.98,0.124,6.50849,2.2375,0.491,0.216,0.073,0.028,1.552,0.727,98.1,105.47,48.4358,0.6,5e-5,0.0254,0.09278,0.012,0.77,0.364,0.649,0.269,3.732,0.31174,96.3328,1.9593,12.2456,0.1138,2.142367,0.2377,0.480445,0.0826,0,3.799744,0,0.0211,0.00854,0.002,1.130094,245.64,4.2,0,0.946,13.34,0.0304,36.22,4.142,143.9,6.464,68.54,224.1745,6.29,1.71,72,160.15,0,79,112,68.09,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,Y,Y,N,N,Low-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1873,66,67,0,3,61.33,156.02,25.21732,1.6,7,0.096428652,1.15782054,0,3,2,7,747.435,2,2,777.64,34.04,307.43,16.7,23.95,0,0.0012,0.0297766,4e-5,23.14,0.037,5.3755,2.152,0.089,0.005,0.117,0.063,0.929,0.778,99,99.19,58.9891,0.13,0,0.0027,0.089361,0,0.482,0.335,0.324,0.286,1.533,0.42312,133.8288,1.8952,0.0175,0.0108,2.540143,0.0367,0.836753,0.0019,0.83,3.068608,0,0,1e-4,0,1.000104,408.47,4.66,1,0.9549,11.575,0,27.4,4.919,133.9,13.435,63.05,211.5899,6.79,1.46,64,155.92,0,78,104,60.04,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,N
1875,69,69,0,3,57.34,161,21.96699,1.59,7,0.083995314,1.00889653,0,3,4,7,3052.941,1,1,169.33,5.43,231.18,43.13,36.13,0.002251,0.0022,0,0,22.01,0.088,7.48714,2.1901,0.457,0.378,0.18,0.134,0.971,0.755,103.9,62.26,79.5898,0.05,0,0,0.099976,0,0.498,0.428,0.468,0.332,0,0.28628,99.7309,1.5543,5.6664,0.6793,1.130207,0.0038,0.599695,0.0025,0,6.194045,2.919929,0.0366,0,0,1.446657,360.55,4.3,0,1.1556,11.934,0,28.68,3.701,141.9,7.485,66.69,277.1719,8.5,1.63,77,162.08,0,76,141,60.45,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,High,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1876,72,73,0,2,69.02,172.95,23.30033,1.82,8,0.21976038,2.63595419,1,2,2,8,4483.693,1,1,345.13,46.94,305.78,5.34,16.13,0.003141,0.0047,0.0502244,0.00208,26.58,0.1,2.92454,2.7577,0.281,0.104,0.138,0.03,2.204,0.841,104.1,67.32,79.5877,0.15,0,0,0.201299,0.0177,1.001,0.498,1.064,0.346,0,0.35984,126.7081,2.0554,11.1715,1.4985,3.091932,0.3063,0.752542,0.0709,0,3.423465,3.331996,0.5375,0,0,1.295497,396.69,4.1,0,0.8924,0,0.0047,0.96,4.424,141,3.023,84.84,308.6112,7.58,1.81,60,173.71,0,71,115,67.13,0,0,0,0,0,0,0,0,1,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,Yes,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1877,56,56,1,1,66.55,168.03,23.23129,1.75,8,0.040151969,0.48232297,1,1,3,8,6796.358,1,1,211.41,47.11,58.91,17.88,17,0.001841,0.0017,3.62e-4,9e-5,22.49,0.101,0,2.5927,0.075,0,0.1,0.066,0.755,0.689,100,83.18,72.5358,0,0,0.0033,0.199984,0.0242,0.489,0.374,0.189,0.165,0,0.45973,156.7864,3.6016,20.0787,0.7316,2.489877,0.3134,0.375207,0.0032,0,2.216281,0.37609,0.5242,0,0,0,220.41,3.79,0,0.9941,0.156,0.0428,30.88,5.26,136.9,15.023,80.09,303.2993,4.4,1.65,63,167.35,0,72,127,65.76,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1878,53,53,0,3,61.34,168.01,22.05119,1.67,7,0.047007668,0.56424013,1,3,3,7,9335.125,1,1,606.75,35.93,192.95,23.81,25.21,0.001203,0.0017,0.0200032,3e-5,26.91,0.279,6.13034,2.4748,0.247,0.127,0.053,0.018,0.692,0.559,105,125.39,47.9186,0,0,0,0.049715,0,0.392,0.285,0.214,0.122,2.075,0.37399,111.07,2.0148,8.2196,1.1252,3.277043,0.0081,2.11769,0.003,0.29,5.583658,0.014258,0,0.00367,0,1.423374,421.98,4.3,0,1.04,12.244,0,28.76,4.494,142.9,4.146,65,359.4961,9.68,1.64,69,169.9,0,82,111,58.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,High,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1879,56,56,1,3,65.45,152.05,28.67361,1.62,8,0.059011363,0.70841831,1,3,4,8,9344.752,2,2,701.57,44,265.6,32.08,38.78,0.001343,0.0019,0,1e-5,33.03,0.108,4.89632,2.5226,0.165,0.187,0,0,0.374,0.669,102,82.87,86.1365,0.12,2.1e-4,0.0118,0,0.0101,0.022,0.005,0.255,0.292,1.912,0.36064,115.6489,1.0124,10.5672,0.0089,0.526506,0.1552,0.18912,0.082,22.21,4.393087,5.561252,0.785,0,0,1.202883,291.09,4.01,0,1.0408,12.67,0,25.99,4.598,140,18.051,69.15,473.4977,4.85,1.61,90,151.14,0,123,130,62.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,G,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1880,58,58,0,1,53.12,174.1,18.18601,1.62,6,0.078022464,0.93756891,1,1,1,6,563.65,1,1,540.64,36.07,76.87,14.04,27.97,0,0.0017,2.062e-4,7e-5,0,0.074,4.68898,2.2732,0.229,0.194,0.203,0.179,0.618,0.665,102.2,72.37,72.5889,0.29,0,0.007,0.005424,8e-4,0.371,0.362,0.293,0.278,0.069,0.37509,132.2446,0.9571,9.405,1.0898,1.010829,0.1911,0.419781,0.0856,0,3.52363,0,0,0.00745,0.001,0,154.94,4.06,0,0.9016,0.726,0.0137,29.5,4.293,142,10.601,71.93,136.8353,6.12,1.56,93,170.15,0,112,140,51.12,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1881,68,68,2,4,104.38,185.83,29.92433,2.29,7,0.099166875,1.18958221,0,4,5,7,16903.552,1,1,517.04,38.01,155.04,21,19.92,0.001135,0.0029,0.0401179,0.00199,26.62,0.06,6.13227,2.226,0.357,0.289,0.047,0.057,0.771,0.763,103.1,87.82,84.0759,0.5,0,0.0135,0.002581,0.0019,0.547,0.531,0.226,0.24,0,0.3935,131.5508,1.3583,9.6194,0.2232,0.874911,0.1375,0.600012,0.0815,16.71,17.135039,7.081793,0.7784,0,0,1.115162,209.72,3.79,0,1.0092,11.385,0,25.71,5.097,133.1,6.881,66.56,297.8331,15.4,2.29,78,183.49,0,69,124,94.16,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1882,62,62,1,4,52.74,164.91,19.268,1.55,6,0.029916769,0.35910938,1,4,2,6,9874.475,2,2,284.78,31.91,85.84,11.97,23.83,0,0,0.0101354,7e-5,27.94,0.16,3.79939,2.2552,0.272,0.221,0.065,0.045,0.949,0.773,106,98.29,52.6237,0.3,0,0.0293,0.066938,1e-4,0.49,0.452,0.347,0.295,0.178,0.35981,108.3764,1.041,6.4319,0.8054,0.987432,0.0101,0.499794,0,0.23,7.5487,4.062292,0.029,0,0,1.142034,304.08,4.8,0,1.0016,12.236,0,31.03,4.713,140,21.659,64.92,388.5155,9.74,1.55,63,166.98,0,90,113,55.05,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,< 60,< 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,2-3,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158FF,N,Y,N,N,High,High,Q1 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1883,48,48,2,1,77.71,187,22.06925,2.02,7,0.026866371,0.32269808,1,1,6,7,75518.68,2,2,1621.77,41.99,61.05,23.26,28.86,0,0,0.0297397,7e-5,22.79,0.001,0.01838,2.4582,0.043,0.06,0.091,0.071,0.752,0.775,0,91.63,74.1184,0,1.3e-4,0,0.110026,0.0164,0.354,0.328,0.368,0.411,0,0.40855,137.6413,1.3928,0,0.422,0.798379,0.1613,0.603127,0.0607,0.63,7.201042,7.836259,0.7663,0,0,0,387.68,4.39,0,1.0235,0.068,0.0091,20.92,4.567,136.1,4.999,70.6,273.8747,9.1,2.01,84,185.72,0,87,152,77.61,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,POL,Poland,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1884,71,71,0,2,49.41,152.01,21.66937,1.44,7,0.054078022,0.64890623,0,2,2,7,1421.213,1,1,216.1,42.05,81.91,13.14,24.07,0.07328,0.0031,0.0219187,2e-5,25.13,0.105,9.24623,2.4323,0.214,0.199,0.057,0.025,1.078,0.934,0.3,75.32,61.8413,0.38,6e-5,0.0044,0.009998,6e-4,0.66,0.616,0.452,0.491,1.304,0.38001,119.5087,0.0016,8.1973,0,1.075051,0.0964,0.281954,0.0029,0.72,2.620653,2.628221,0.028,0.00328,0.001,0.11308,155.07,4.71,1,1.0386,10.621,0.0321,24.55,4.391,138.9,5.113,63.04,223.8209,3.76,1.53,70,152.5,0,63,117,51.14,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1885,58,57,0,2,81.96,174.08,26.63935,1.98,6,0.086512104,1.03845877,1,2,6,6,8605.378,2,2,242.53,29.51,62.17,19.01,18.33,0.002407,0.0021,9.85e-5,8e-5,29.92,0.111,16.61265,2.1394,0.126,0.051,0.214,0.154,1.464,0.849,103,94.41,92.8689,0.19,0,0.0132,0.050036,0.0121,0.671,0.441,0.631,0.458,1.664,0.41304,146.4935,4.3418,12.23,1.0717,1.589591,0.1574,1.157986,0.1049,32.52,29.695517,5.435376,0.6013,0.0023,0.001,1.208969,226.64,3.21,0,1.033,11.239,0.0273,0.13,4.671,135,8.58,61.98,302.0996,30.61,1.99,79,172.09,0,93,125,78.58,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1886,59,59,0,3,59.16,158.16,23.63453,1.6,7,0.0718664,0.86339645,1,3,3,7,1771.868,2,2,226.04,33.99,118.32,45.4,63.81,0,3e-4,0.0502251,0.01009,27.73,0.071,0.08692,2.2287,0.218,0.09,0.141,0.074,1.614,0.808,104.1,92.41,70.6759,0.31,0,0,0.489681,0.0666,0.872,0.415,0.679,0.324,0,0.29946,110.6535,1.7617,12.5964,1.1856,1.436722,0.3792,0.511414,0.1027,0,4.020941,4.966635,0.0254,0,0.001,1.3213,173.67,4.21,1,1.0327,10.277,0,22.72,3.89,138,9.964,64.95,413.8952,6.16,1.54,72,157.07,0,84,115,54.41,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1887,56,56,0,3,65.2,164.98,23.28365,1.71,8,0.010209479,0.12272778,0,3,4,8,1455.065,1,1,553.61,39.95,80.47,21.53,26.32,0.003755,0.0046,0.0595476,0,27.56,0.2,4.49958,2.3927,0.005,0.049,0.008,0.043,0,0,104.8,99.83,58.125,0.23,0,0.0019,0.078881,5e-4,0,0,0,0,1.038,0.30003,100.9577,5.2102,19.9863,12.8498,0.616443,0.051,0.30059,0.0748,0,2.167892,0.357573,0,0.00161,0.001,1.350815,309,4.59,0,1.0429,12.827,0,30.95,3.388,141.8,9.708,70.23,243.9449,3.4,1.71,72,164.94,0,70,102,64.25,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1889,71,71,1,3,65.04,154.3,27.05446,1.63,6,0.082072182,0.98387756,0,3,1,6,9677.032,2,2,1097.99,5.44,86.63,26.69,23.97,0.003822,0.0028,0.0250967,4e-5,25.96,0.07,20.07745,2.0818,0.128,0.128,0.061,0.067,0.564,0.609,100.4,106.82,48.2798,0.2,1.8e-4,0,0.129769,1e-4,0.455,0.417,0.108,0.001,0,0.3224,98.2163,2.7324,9.5501,1.2958,1.341335,0,0.770231,0,0.51,4.053755,3.618132,0.0186,0.00254,0,0.937115,313.89,3.49,1,1.2056,12.558,0.0456,25.69,3.873,140.2,3.405,60.83,219.8,6.69,1.72,79,153.14,0,97,136,61.3,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1890,46,46,2,2,73.04,151.43,32.68644,1.7,6,0.006542092,0.07840458,2,2,1,6,8833.432,2,2,8391.72,46.95,72.2,25.05,20.94,0.002219,0.0012,1.47e-4,5e-5,23.62,0.15,2.75613,2.5005,0.283,0.2,0.009,0.008,0.139,0,93.6,131.32,54.9537,0.6,3e-5,0.0238,0.100081,7e-4,0.014,0,0.074,0,2.47,0.35989,114.8832,0.8657,0.0673,0.5091,1.49829,0.1999,0.449904,0.021,0.24,2.900268,0.46482,0.011,0.00732,0,1.284269,228.86,4.88,0,0.9242,0.828,0.011,23.73,4.166,139,13.365,70.98,337.2874,5.58,1.61,90,149.9,0,82,145,66.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Other,Y,Y,F,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1891,63,64,0,2,64.41,178.18,20.33211,1.81,7,0.119127716,1.42922648,0,2,4,7,12279.745,2,2,561.73,35.84,62.9,10.39,18.98,0,0,0,0,24.95,0.044,4.99861,2.148,0.1,0.103,0.037,0.043,0.919,0.912,101.1,64.32,90.2213,0,0,0,0.099317,3e-4,0.44,0.462,0.508,0.521,2.617,0.40682,133.109,2.091,9.5663,0.5507,1.344251,0.0528,0.478086,0.0036,0.83,1.790234,0.218092,0.0144,0,0,0.202425,144.13,3.34,0,0.9047,0.336,0,32.91,4.05,140,14.701,67.02,305.7595,3.32,1.83,86,175.02,0,92,161,64,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,Y,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1892,61,61,0,2,73.9,168.02,25.48662,1.85,6,0.048448828,0.58009236,0,2,3,6,1673.324,2,2,297.98,50.18,62.95,7.06,17,0.001604,0.0011,0.0198713,6e-5,30.88,0.002,0.06868,2.5224,0.089,0.103,0,0,0.025,0,103,92.17,70.7261,0,0,0,0.125323,6e-4,0.022,0.232,0.001,0,0,0.37281,127.1488,2.2761,11.3777,0.2033,1.660027,0.1133,0.300187,0.0042,0,1.555242,0,0.0013,0.00385,0,1.069126,87.38,4.31,0,0.9862,12.075,0,28.01,4.094,143.9,17.953,71.08,433.1807,3.44,1.8,58,167.49,0,72,110,74.44,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1893,53,54,1,3,72.93,174.1,24.16615,1.88,6,0.057955436,0.69565631000000006,1,3,5,6,16180.244,2,2,1201.21,40.77,51.36,15.02,20.87,0,0,0.0515054,8e-5,3.89,0,4.0167,2.1168,0.244,0.252,0.072,0.051,0.755,0.663,100,71.62,88.5242,0.12,3e-5,0.0089,0.039534,5e-4,0.426,0.431,0.248,0.24,3.217,0.34242,117.4703,0.7469,0,0.1472,0.970039,0,0.459774,0,0.79,5.152561,0.124958,0,0.00144,0,1.031051,214.75,3.91,0,1.1016,0.635,0,16.97,4.439,139,3.537,60.08,410.1614,6.8,1.91,64,172.28,0,88,101,70.54,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1894,43,43,0,2,85.05,174.04,27.90216,2.01,7,0.104159633,1.2495334,1,2,6,7,7632.787,1,2,657.68,38.07,56.28,24.46,31.69,0,0,0.0698829,0.00408,32.04,0,4.99969,2.3586,0.159,0.212,0.105,0.123,0.552,0.017,102,95.24,98.0109,0,6e-5,0,0.27884,0.026,0.194,0.042,0.268,0.223,0,0.46239,163.3296,1.9842,10.0046,0.0113,0.595067,0.0079,0.428918,0.0551,11.05,3.920451,4.141121,0.6299,0.00686,0.001,1.388785,155.97,3.69,0,0.956,12.703,0,0.29,5.922,133.8,5.159,65.98,273.0666,6.4,2.09,66,175.7,0,86,97,94.91,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,>= 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1895,42,42,1,0,82.3,185.39,23.87739,2.07,7,0.088490545,1.0626702,0,0,5,7,4696.506,1,1,639.27,41.95,50.35,9.04,16.91,0.00119,4e-4,0,4e-5,27.77,0,0,2.3765,0.11,0.178,0.028,0.018,0.761,0.87,103,125.95,70.1957,0,1.5e-4,0,0.099478,0.0132,0.422,0.457,0.389,0.49,0.25,0.35744,109.6929,1.8769,10.1967,0.3415,1.546056,0.0915,0.70008,0.0909,0.55,3.411865,0,0.4555,0.0055,0,0.935533,434.44,4.92,0,1.2293,14.647,0.0052,30.99,4.645,137,3.037,70.99,481.9825,5.14,2.1,92,186.26,0,99,130,84.73,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,Y
1896,61,62,0,4,62.92,160.11,24.03615,1.65,7,0.058889291,0.70675342,1,4,3,7,2916.403,1,1,791.85,43.09,66.49,10,13.99,0.004161,0.0045,0.0255261,7e-5,28.31,0.07,4.3903,2.526,0.101,0.141,0,0,0,0,100.1,105.46,53.0157,0.23,0,0,0.167806,6e-4,0,0,0,0,0,0.40981,129.4576,0.9268,2.1715,0.5937,1.759154,0.0756,0.528713,0.0056,26.94,3.12937,4.028139,0.0058,0.00389,0.001,1.244246,235.35,4.69,1,1.1998,11.908,0.0111,27.43,4.983,139,15.329,72.93,312.4614,6.12,1.66,80,159.05,0,85,140,64.06,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1897,60,60,0,2,56.9,156.35,22.82458,1.56,7,0.059758625,0.7173058,0,2,3,7,1682.834,1,1,758.52,36.24,179.7,12.32,33.71,0.002458,0.0029,0.050784,0.00201,27,0.286,4.30012,2.4947,0.117,0.07,0.087,0.091,0.247,0.009,104.1,88.24,56.0688,0,2e-5,0,0.299679,0.0305,0.236,0.298,0.008,0,0,0.36071,115.6851,2.5359,9.5043,0.4102,1.000841,0.1955,0.98486,0.0991,17.15,5.598214,0.53368,0.034,0.00514,0,0.969152,267.6,4.28,0,1.0914,11.912,0.0249,32.59,4.413,140.1,5.996,74.12,249.9799,9.31,1.56,75,153.26,0,84,129,51.99,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,Y,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1898,63,63,0,3,28.01,145.96,15.10537,1.02,6,0.040310118,0.48357975,1,3,3,6,4836.346,1,1,131.57,28.43,108.86,7.74,16.9,0.001563,0.0014,0,3e-5,1.12,0.254,0.10526,2.1379,0.065,0.1,0.153,0.158,0.495,0.629,103,98.88,35.1261,0.19,0,8e-4,0.137869,0.0052,0.243,0.251,0.173,0.208,0,0.11061,71.7501,2.8875,10.3218,1.207,1.256616,0.0522,0.601431,5e-4,0,4.325672,0,0,0,0.001,1.343792,434.09,4.13,0,0.9931,12.043,0,30.32,1.464,141.9,6.052,55,210.0011,8.19,0,63,146.7,0,76,132,0,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,>1,NA,NA,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1899,55,55,1,2,55.01,164.97,20.57414,1.58,7,0.044254343,0.53144636,0,2,1,7,1479.974,2,2,372.47,43.03,71.92,26.73,24.1,0,0,0.0499742,7e-5,1.51,0.1,1.86039,2.3177,0.438,0.116,0.346,0.162,2.25,0.87,102.3,101.93,48.0332,0,0,0,0.344857,0.0038,1.307,0.591,0.896,0.347,1.813,0.37205,124.0924,1.7366,8.7923,1.5572,3.078846,0.0139,1.831404,0.0301,0.1,6.503793,0.481743,0.0063,0,0,1.180384,556.61,3.9,0,1.0424,12.036,0,28.59,4.421,142.1,5.981,70.05,267.5696,10.75,1.58,90,164.06,0,75,141,53.9,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,F,No,EE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1900,69,69,0,3,70.01,172.14,23.87541,1.84,6,0.097452056,1.16946173,1,3,1,6,2910.436,1,1,384.26,42.86,118.19,13.83,19.17,0,0,0,0,27.03,0.05,7.49925,2.1436,0.003,0.073,0.134,0.137,0.415,0.791,101.1,73.1,73.5666,0.45,4e-5,0.0232,0.061245,0,0.226,0.414,0.157,0.257,2.191,0.32544,107.9866,1.1507,6.2318,0.0089,0.699778,0,0,0,0.08,3.640016,0,0,0.00684,0.001,1.166386,68.61,4.69,0,0.9196,0.25,0.0406,25.08,3.129,136.9,11.998,69.98,301.1208,4.7,1.75,71,169.95,0,79,122,64.32,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,WHITE,Western Europe,N,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1901,65,65,0,3,70.81,155.25,28.97238,1.71,6,0.06826219,0.81914505,1,3,5,6,9049.328,2,2,355.78,37.95,72.78,14.95,18.1,0,0,0.0399684,3e-5,27.96,0.124,7.15037,2.3435,0.089,0.189,0.001,0.002,0.526,0.841,102.9,115.8,53.0024,0.28,0,0.0108,0.13998,0,0.176,0.387,0.263,0.443,0,0.40607,127.7825,1.4454,0.0615,1.5953,0.655433,0,1.318369,0.0043,0,17.756413,7.497701,0.5704,0,0,1.172495,386.45,4.6,0,1.0742,15.002,0,27.01,4.675,140.1,9.011,67.07,0,15.37,1.69,73,154.51,0,85,113,64.61,0,0,0,0,0,0,0,1,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,POSITIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1902,32,31,1,1,51.15,163.83,19.11699,1.55,6,0.054599059,0.65528851,0,1,3,6,9388.364,2,2,358.1,35.96,71.02,61.83,40.15,0.002414,0.0018,0.0199084,9e-5,0,0.05,0.0459,2.4396,0,0,0.008,0.066,0,0.706,97.7,146.19,38.7526,0.17,0,0.019,0.069579,1e-4,0,0.233,0.007,0.261,3.246,0.38565,132.2339,0.9573,4.9935,0.6767,0.959353,0.0058,0.500699,0.0038,0,4.356621,0,0,0.00313,0,0.944854,226.09,3.88,0,1.1277,11.661,0,37.87,4.998,137.1,9.976,69.4,32.2971,6.79,1.59,80,163.94,0,88,110,52.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1904,78,78,0,3,80.44,172.97,26.50396,1.93,6,0.086882842,1.0411389,1,3,6,6,5213.232,1,1,338.81,31.06,55.09,12.09,41.56,0,1e-4,0.0228162,0.00303,29.07,0.141,4.99508,2.2997,0.086,0.176,0.054,0.121,0.759,0.825,104,39.98,104.043,0.18,0,0.0085,0.338624,0.0099,0.341,0.393,0.501,0.563,0.991,0.33059,115.1666,0.3841,5.7089,0.0023,1.002434,0.2387,0.301491,0.0025,10.79,2.501876,0,0.602,0,0,1.414641,126.93,3.49,1,1.2025,0.753,0.001,27.29,3.656,139.5,3.786,53.09,333.5412,4.11,2.03,94,171.09,0,127,154,76.1,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,>= 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,Outside-China,KOR,"Korea, Republic of",>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,2,0,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,OTH,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1905,73,73,1,1,112.29,185.07,32.88108,2.34,6,0.031123474,0.37341195,0,1,3,6,7839.958,1,1,132.86,39.24,260.85,79.47,23.86,0.356979,0.0043,3.503e-4,2e-5,2.31,0.078,6.78666,2.2635,0.121,0.128,0.105,0.094,0.642,0.668,101.9,103.43,60.9103,0.12,0,0,0.247785,3e-4,0.572,0.499,0.121,0.108,0,0.4098,128.9317,3.8665,7.0255,0.4909,0.837936,0.0043,0.50066600000000006,0.0049,0.05,2.006061,3.959034,0.0088,0.00144,0,1.065267,125.49,5.24,0,1.0948,8.236,0,27.14,4.491,137.6,32.597,62.13,461.4032,3.9,2.11,59,183.92,0.1,77,101,110.18,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1906,38,37,1,0,77.07,170.08,26.35175,1.9,7,0.16174982,1.94522244,2,0,1,7,7638.905,2,2,488.75,43.97,108.27,24.92,27.04,0,0,0.0996198,0.00947,24.56,0,4.60402,2.4986,0.195,0.073,0.082,0.026,1.112,0.711,90.9,96.63,84.5537,0,0,0,0.123285,0.0308,0.637,0.332,0.383,0.294,5.748,0.39377,134.3789,4.1977,12.2303,0.2792,1.0008,0.2179,0.561195,0.0747,15.71,7.684963,6.852604,0.8261,0,0,1.229708,673.94,4.29,0,1.0631,0.039,0,22.16,5.547,136.9,3.094,90.51,380.7851,8.4,1.86,70,170.17,0,88,110,75.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1907,74,73,0,1,45.74,152.1,19.47425,1.41,6,0.102595131,1.23109414,1,1,1,6,521.562,2,2,288.64,34.08,41.36,15.14,9.97,0.146466,0.0226,0.0200264,2e-5,0,0.151,3.49958,2.302,0.823,0.543,0.078,0.031,1.813,0.724,97.9,55.76,72.7229,0.12,0,0.0065,0.905117,0.0181,0.837,0.421,0.86,0.448,0,0.34453,114.7546,1.2088,10.3907,0.861,1.401559,0.1891,0.666724,0.0767,31.18,4.296417,3.369087,0.0267,0.00543,0,0.086653,303.39,3.43,0,0.9273,0,0.0149,26.1,3.494,140,9.047,73.06,267.5778,7.79,1.38,81,151.62,0,81,148,46.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1908,63,63,0,1,42.69,153.14,17.90957,1.36,7,0.096903095,1.16233755,1,1,1,7,120.752,1,1,180.09,46.95,115.6,6.17,12.84,0,0.001,0.0365979,0.00599,28.74,0.118,4.26221,2.4196,0.203,0.147,0.014,0.002,0.72,0.656,101.1,79.42,61.8836,0.23,1.1e-4,0,0.007485,0.0192,0.465,0.393,0.21,0.172,0,0.35618,124.3214,2.0989,11.3501,0.6996,1.854349,0.4545,0.300227,0.1377,0.69,4.160946,8.949997,0.8601,2.3e-4,0,1.357411,376.13,4.91,0,1.0058,14.694,0,30.27,4.276,141,5.471,76.06,446.3673,7.55,1.27,95,152.14,0,84,142,42.21,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,< 65,>= 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1909,70,70,0,4,67.17,173.4,22.47694,1.8,6,0.021842666,0.26225036,1,4,6,6,6260.042,2,2,673.09,26.71,64.9,15.07,16.13,0.002699,0.0021,0.0099662,7e-5,0,0,6.14047,2.3006,0.066,0.105,0.057,0.075,0.87,0.799,0.3,73.88,76.825,0.01,1e-4,0.0157,0.159308,0.0106,0.364,0.33,0.501,0.514,0,0.29894,91.6869,0.7854,7.0789,0.3445,0.737587,0.15,0.498495,0.068,0.32,4.894652,0.221968,0,0.00166,0,1.067161,386.09,4,1,0.9462,11.066,0.0177,1.07,3.701,140,8.571,61.92,317.9637,6.3,1.72,88,171.02,0.1,76,131,64.96,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1910,59,59,1,2,106.11,175.06,34.10567,2.23,6,0.045547978,0.54658708,0,2,5,6,4368.551,1,1,835.57,28.54,54.18,128.45,62.19,7.01e-4,0,0.0181325,9e-5,25.07,0.055,11.03186,2.2767,0.485,0.267,0.139,0.086,1.279,0.575,94.3,97.11,86.0799,0.07,1e-4,0.0108,0.007547,3e-4,0.714,0.36,0.58,0.287,0,0.41475,139.0108,2.1233,8.9004,0.5201,1.450679,0.0038,0.813635,0.024,0.8,11.893784,3.455444,0.0139,0,0,0.205209,708.13,3.08,0,1.1624,10.59,0.028,33.01,4.704,132.5,2.991,65.09,135.9813,14.96,2.11,73,175.93,0,75,119,105.27,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,ABNORMAL,HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1911,58,58,0,2,58.94,162.72,22.25475,1.63,6,0.025874194,0.31035651,2,2,4,6,2003.152,2,2,132.75,31.99,226.74,18.29,15.52,0.0029,0.002,2.293e-4,0,3.65,0.208,0.07425,2.1541,0.191,0.124,0.094,0.096,0.79,0.614,0.2,91.53,54.0109,0.33,1.8e-4,0.0309,0.130214,0,0.616,0.522,0.1,0,3.238,0.28111,95.0256,1.06,0.1064,0.5736,1.648535,9e-4,0.850612,0.0503,0.4,5.067961,0.191167,0,0.00524,0.001,1.329463,388.72,5.29,0,1.1086,12.535,0,23.8,3.171,128.3,8.559,59.42,166.9034,8.21,1.66,50,161.78,0,64,93,60.29,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1912,22,22,0,1,60.02,165.13,21.936,1.66,6,0.199899009,2.39900622,1,1,2,6,6967.031,2,2,397.86,41.06,69.09,110.87,26.22,0,0,0.0101205,0.00599,23.96,0.043,5.60955,2.0736,0.435,0.252,1.082,0.255,2.191,0.723,98.9,101.82,87.5038,0,1.3e-4,0.0055,0.098076,0.0302,1.1,0.385,1.171,0.46,1.411,0.35828,114.2529,3.6057,11.0147,1.1087,2.464272,0.313,0.380612,0.1303,0,7.789473,9.808868,0.7803,0,0,1.413682,325.08,4,1,1.2032,12.833,0,39.34,4.349,140.1,7.008,64.03,240.0222,11.89,1.65,77,165.09,0,88,107,62.96,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1914,73,73,0,3,67.92,169.91,24.02775,1.76,6,0.021170035,0.25381547,0,3,2,6,1410.682,1,1,288.37,42.51,67.03,8.81,13.85,0,0,0.0254657,6e-5,25.38,0.09,7.85077,2.477,0.209,0.153,0.046,0.022,0.544,0.532,103.1,62.67,80.9594,0,0,0,0.21931,2e-4,0.391,0.349,0.082,0.001,0,0.39237,130.2661,1.7981,8.4774,0,2.210383,0.0123,0.599351,0,0,6.601578,4.013004,0.3179,0,0,0.913511,325.9,4.84,0,0.9063,0.958,0.089,0.62,4.489,134.5,3.966,79.05,349.5349,10.99,1.72,81,169.5,0,96,148,65.07,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1915,41,41,0,1,109.84,174.92,35.62167,2.26,6,0.035098735,0.42022122,0,1,4,6,2683.148,2,2,297.27,43.94,79.95,43.66,22.06,0,0,0.0201241,8e-5,27.97,0.17,0,2.4154,0.122,0.116,0.001,0.001,0.471,0.02,93.4,142.34,76.9562,0.18,2e-5,0.0156,0.404262,0.0125,0.203,0.278,0.124,0.161,0.384,0.48889,160.3561,3.0354,12.1988,1.1934,0.785913,0.0081,1.09801,0.0047,13.42,3.753662,0.531235,0,4.1e-4,0,1.229781,272.89,4.2,0,0.905,10.676,0,23.93,5.79,140,8.573,70.78,221.0801,6.11,2.4,95,175.81,0,85,120,114.39,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1916,65,66,0,2,65.08,164.95,24.05877,1.71,7,0.136129521,1.63292747,0,2,3,7,1189.303,1,1,245.29,40.07,31.51,10.21,20,0.072659,0.0038,0.0540679,0.00791,25.78,0.04,5.43944,2.242,0.175,0.127,0,0,0.495,0.739,101,67.41,76.9934,0.22,2.3e-4,0.0278,0.100365,0.0622,0.048,0.211,0.27,0.326,0.402,0.41578,131.5316,1.2071,6.8311,0.4991,0.699231,0.3307,0.116603,0.0843,23.9,2.299034,0.509993,0.6294,0.00173,0.001,1.139758,191.37,4.41,0,0.941,12.086,0.0161,26.07,4.804,137.7,8.949,67.07,149.8399,3.45,1.83,91,163.02,0,75,139,63,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1917,73,73,0,3,114.26,178,35.44494,2.32,6,0.125898519,1.51030193,2,3,4,6,2909.159,2,2,179.13,36.12,178.4,16.16,24.16,9.4e-5,0,0.0101314,3e-5,32.93,0.155,4.39608,2.2282,0.042,0.076,0,0,0.021,0.469,104.9,88.22,78.6549,0.34,4e-5,0.0088,0.220006,5e-4,0.008,0.007,0.003,0.001,0,0.35734,116.0068,0,0.136,0.2796,0.741172,0.0129,0.654077,0.047,17.03,5.919867,7.489489,0.6476,0.00537,0.001,1.098065,538.32,4.88,0,1.0214,0.24,0,0.68,4.065,138.6,9.981,51.02,253.7507,9.22,2.31,67,178.39,0,74,121,111.16,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1918,46,47,0,3,46.21,155.97,19.3689,1.44,8,0.107441497,1.28992642,1,3,1,8,1000.482,1,1,757.42,34.85,136.43,20.58,19.99,6.88e-4,9e-4,0.0122505,4e-5,32.02,0.001,0.07775,2.5016,0.051,0,0.074,0.049,0.771,0.712,98.9,107.03,60.1041,0,5e-5,0,0.201202,6e-4,0.555,0.434,0.152,0.056,1.657,0.28929,96.1473,3.306,11.1913,2.5019,1.660047,0.0098,0.899146,1e-4,0,9.894207,7.394199,0.0275,0.00226,0,1.369259,274.14,4.61,1,1.2035,10.448,0,28.61,3.982,142,3.951,58.77,301.0083,12.32,1.49,95,157.25,0.1,89,116,47.34,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,NA,NA,Y,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Western Europe,N,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1919,70,70,1,2,51.66,147.91,23.81042,1.43,7,0.086698573,1.04074326,1,2,4,7,16911.343,2,2,186.37,0,163.97,18.08,26.78,0.001409,4e-4,0.0600558,0.00111,23.4,0,5.53452,2.0986,0.208,0.252,0.069,0.087,0.904,0.842,102.9,78.87,54.1399,0.44,4e-5,0.0079,0.160327,0.0059,0.449,0.464,0.392,0.49,3.304,0.25243,82.4971,1.6278,8.6297,0.6992,1.11087,0.2114,0.480701,0.0487,0.22,5.539562,0.146385,0.0283,0,0,1.518492,254.39,4.11,0,1.1114,13.758,0,32.95,3.933,134.5,14.313,53.9,315.7894,7.58,1.44,72,150.12,0,87,117,51.35,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,ESP,Spain,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158VF,Y,Y,N,N,High,Low-Intermediate,Q1 ITT,High,Normal,Y,No,< 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
1920,26,26,2,2,65.05,163.81,23.92549,1.71,7,0.078882512,0.94779755,0,2,5,7,33402.954,1,1,342.99,40.51,91.58,15.07,10.22,0,0,0.0200287,3e-5,26.58,0.001,4.53587,2.2289,0.101,0.119,0.129,0.125,0.539,0,102.9,147.52,57.0557,0,0,0,0.156685,4e-4,0.236,0.001,0.224,0.156,0.032,0.40112,128.1263,2.4999,14.3849,1.6237,0.831601,0.0053,0.781078,0,0,17.327868,5.298034,0.5012,0,0,1.034598,346.35,3.07,0,1.0675,12.01,0.0237,28.02,5.301,138.9,15.171,78.02,267.9524,15.09,1.78,75,162.8,0,115,130,66.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1921,37,37,0,2,54.95,153.99,22.64488,1.52,8,0.041924461,0.50313776,0,2,5,8,1462.396,1,1,469.93,49.23,112.51,29.3,27.38,0.003403,0.0011,0.0422338,0.00405,26.04,0.11,0.01387,2.5292,0.153,0.098,0.001,0,0.756,0.687,93.5,121.22,46.4226,0.13,1.4e-4,0.0012,0.167715,0.0305,0.549,0.478,0.151,0.002,0.566,0.37759,123.3842,0,10.1348,0.3943,1.426892,0.3162,0.295715,0.0583,0,3.584201,0.309491,0.0412,0,0,1.228778,427.18,4.39,0,0.9711,13.214,0.0146,25.54,4.786,139.3,6.812,79.2,362.2661,5.6,1.56,74,151.99,0,79,116,51.12,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1922,44,44,0,2,95.89,177.68,30.895,2.12,6,0.026187775,0.31456677,0,2,5,6,9744.166,1,1,177.04,44.04,358.09,17.92,14.1,0,0,0.0767232,4e-5,1.63,0.089,5.55301,2.2974,0.145,0.128,0.088,0.082,0.927,0.781,103.9,166.13,48.1798,0.51,0,0.0021,0.10038,0,0.644,0.477,0.304,0.311,6.059,0.40726,124.7097,1.9633,12.3173,1.1295,0.997623,0,0.25159,0,0,5.130457,0,0,0,0,1.207746,213.04,3.92,0,1.0929,12.379,0.074,53.66,4.831,141.3,52.312,72.09,231.3431,5.9,2.05,76,176.06,0,73,130,91.8,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,POSITIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131RR,158VV,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1923,82,82,1,5,66.19,158.06,25.71894,1.66,7,0.050534745,0.6056164,2,5,2,7,10674.701,2,2,595.41,28,107.78,9.37,19.18,0,0,0.0300288,8.7e-4,0.7,0.091,5.13805,2.2261,0.376,0.157,0.12,0.057,0.857,0.601,0.1,49.97,79.2287,0,0,0,0.039282,8e-4,0.478,0.355,0.384,0.218,0,0.39998,131.2813,2.3574,0.0576,0.3251,1.662617,0.1775,1.159916,0.0745,24.92,7.186378,0.131237,0.0037,0.00414,0.001,0,269.72,5.34,1,0.9543,0,0.0182,0.53,4.25,136.3,8.553,56.06,231.9782,9.5,1.61,71,158.05,0,72,123,63.81,1,0,0,0,1,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
1924,68,67,0,2,60.2,163.25,22.374,1.64,7,0.105315687,1.26202734,1,2,2,7,4423.725,2,2,162.81,21.98,61.17,29.33,22.1,0.002307,0.0023,0.0298476,6e-5,26.04,0,7.93793,1.9518,0,0.087,0,0,0.247,0.782,97.8,73.9,75.7891,0,0,0,0.08956,8e-4,0.11,0.441,0.189,0.27,0,0.39165,132.6868,0.7137,8.1969,0,0.800238,0.0669,0.449311,0.0036,0.65,4.19163,5.167225,0.0406,0.00468,0,0.910578,292.21,3.6,0,1.2509,0.502,0.0469,23.94,4.17,137,0.468,63.03,0,6.5,1.73,80,164.91,0,81,130,60.95,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,< 55,< 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131HH,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1925,73,73,1,3,50.61,154.1,21.56003,1.47,6,0.031463827,0.37889515,1,3,1,6,4136.783,2,2,307.62,36.08,40.9,8,18.07,0.001124,1e-4,0.0464289,0.00999,26.95,0.207,2.89055,2.23,0.519,0.186,0.277,0.145,1.493,0.772,99,67.59,56.504,0.41,0,0.0092,0.199989,9e-4,0.791,0.389,0.767,0.439,0,0.32029,112.0034,1.6026,8.2111,1.3797,2.172829,0.0827,0.839965,0.0849,17.28,2.695129,0,0,0,0,1.222452,171.5,4.28,0,0.9724,0.688,0.001,23.69,3.21,139.9,0.661,73.95,255.1551,4.81,1.4,68,152.69,0,80,134,48.07,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,0,0,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,Yes,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1926,58,59,1,2,59.05,167.11,21.64925,1.66,7,0.052394807,0.62951714,1,2,4,7,11652.184,1,1,248.61,32.29,81.56,15.87,36.75,0.001799,5e-4,0.0288309,6e-5,27.38,0.211,10.74819,2.0475,0.029,0.073,0.166,0.167,0.85,0.85,100,76.13,70.9568,0.11,0,0.0045,0.100828,7e-4,0.42,0.474,0.318,0.388,2.08,0.21342,84.3937,1.8715,13.9143,11.8711,0.696528,0,0.359242,8e-4,31.36,9.257151,5.555176,8e-4,0.00335,0.001,1.491278,400.71,4.11,0,1.1453,12.732,0,39.95,3.201,130.5,21.398,68.02,0,9.14,1.68,75,165.07,0,84,124,59.07,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1927,72,73,0,2,79.08,172.91,27.04798,1.93,7,0.114288232,1.36948792,2,2,1,7,1848.582,2,2,210.86,48.03,94.5,51.45,51.51,0,4e-4,0.0297921,8e-5,30.33,0,10.73326,4.4422,0.057,0.158,0,0.01,0.054,0.61,104,94.4,61.0054,0.18,1.4e-4,0.0284,0.010007,0.0259,0.235,0.428,0.005,0.128,0,0.40992,140.6842,2.895,17.0996,1.7916,0.994739,0.2391,0.499077,0.0999,0.41,4.054389,3.121586,0.6713,6.4e-4,0,1.388908,271.91,4.57,0,1.1095,11.969,0.0301,31.04,5.007,140.9,12.282,76.81,267.9791,5.8,1.82,71,170.05,0,71,120,75.68,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,< 60,>= 65,>= 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,Low,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1928,69,69,0,3,50.76,160.19,19.38773,1.53,6,0.021628317,0.25927826,2,3,3,6,4916.203,2,2,2045.53,41.09,73.88,12.17,20.07,0.001246,3e-4,0.0498335,7e-5,0,0.162,4.7106,2.157,0.23,0.218,0.083,0.045,1.084,0.601,100,43.91,97.8238,0.02,1.3e-4,0,0.11005,7e-4,0.488,0.21,0.468,0.28,3.307,0.36036,118.7249,1.1877,12.1887,1.0154,1.100295,0.1604,0.399565,0.0035,0.79,4.663486,4.458385,0.5889,0,0,1.329201,250.86,3.5,1,1.2116,16.207,0.0016,28.12,4.615,138,32.752,69.91,286.1585,7.23,1.53,77,158.19,0,81,117,50.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HH,158VF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1929,51,51,1,2,53.09,152.03,22.66182,1.5,7,0.173887668,2.08747222,1,2,5,7,6030.87,2,2,640.27,42.06,56.19,7.86,9.99,5.98e-4,6e-4,0.060783,0.00379,0.37,0.09,5.00739,2.3356,0.266,0.157,0.142,0.086,0.967,0.708,108.7,94.91,71.7139,0,3e-5,0,0.643086,0.0025,0.489,0.422,0.317,0.153,1.532,0.41096,136.5388,1.8913,6.6216,1.3762,1.541443,0.0118,0.48036,0.0017,29.01,2.408503,0,0,0.0057,0,1.387369,164.65,4.19,0,0.6777,0,0.0262,0,4.518,137.1,8,56.11,327.1162,4.58,1.57,80,155.9,0,79,118,59.55,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1930,61,61,2,3,79.29,182.91,23.62148,2.01,6,0.022385697,0.26892581,1,3,5,6,18548.252,2,2,1006.91,32.1,62.96,28.92,49.34,0.002437,0.0027,1.578e-4,6e-5,16.97,0.09,6.01924,2.3495,0.176,0.216,0.047,0.065,0.309,0.661,0,78.36,85.7151,0,0,0,0.300392,0.0083,0.294,0.441,0.086,0.222,2.838,0.35086,112.112,0.0303,7.0559,0.8501,1.218141,0.1342,1.608695,0.1,0.8,4.32989,3.162307,0.0251,0.00564,0.002,1.097159,218.1,4.21,1,1.6277,14.59,0.0267,32.57,4.23,137,15.24,57.43,315.1009,8.22,1.96,71,182.63,0,76,111,75.06,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,Y,N,High,High,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,HMS,HMS,N
1931,58,58,0,1,60.08,167.99,21.94833,1.65,6,0.073717198,0.8853358,0,1,4,6,2603.329,1,1,276.78,29.84,100.46,24.28,42.06,0,0,3.608e-4,0.00222,23.94,0.116,4.23199,2.236,0.247,0.357,0.161,0.224,0.58,0.698,104.4,119.25,44.9077,0.02,7e-5,0.0059,0.150528,0.0283,0.487,0.465,0.182,0.246,1.199,0.33028,112.8865,0.7249,0,0.2923,0.478465,0.0016,0.9893,0.0793,0,6.095384,2.524312,0.5396,0,0,0,205.51,4.01,1,0.9926,10.803,0.0131,34.51,3.569,143.9,2.178,61.07,0,7.24,1.69,85,169.27,0,60,159,58.08,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1933,57,57,0,2,67.39,161.69,25.89562,1.72,8,0.078580871,0.94338826,1,2,6,8,4280.198,2,2,204.58,35.56,62.81,22.15,21.95,0.001223,0.0014,0,5e-5,29.22,0,3.78504,1.8672,0.102,0.106,1.184,0.868,1.811,0.841,106.9,65.05,100.8672,0.31,2.3e-4,0.0321,0.199893,0.0409,1.004,0.522,0.91,0.561,6.766,0.28679,115.6218,2.0808,14.2836,2.7384,0.800203,0.1887,0.215905,0.0903,30.25,2.395799,0,0.0081,0.00334,0.001,1.16063,235.35,4.35,0,0.8063,0,0,28.83,2.865,139.9,3.026,62.89,285.0727,3.29,1.81,71,160.97,0,64,100,66.85,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,>= 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,Y,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1934,65,65,0,4,54.95,NA,21.04922,1.57,7,0.061858612,0.74230199,2,4,6,7,2294.788,2,2,511.85,32.03,119.76,112.51,41.44,0.003807,0.0031,0,9e-5,24.03,0.052,4.02826,2.2489,0,0.006,0.001,0.053,0,0.512,99.1,91.2,56.8266,0,1e-5,0.0146,0.019438,0.0162,0,0.239,0,0.163,0.219,0.34537,114.8905,1.7081,6.2115,0.5385,0.197858,0.2344,0.200539,0.0901,0.71,4.196051,3.678247,0.5144,0.00461,0,1.493993,180.92,4.19,0,1.059,12.368,0,28.24,3.295,136.8,51.499,0,224.4163,4.4,1.47,69,156.12,0,85,113,54.43,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,High,High,Q2 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,NA,Y,N,Y,ASIAN,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1935,72,72,0,2,102.38,175.03,33.08042,2.14,7,0.054443271,0.65386122,0,2,2,7,1105.643,2,2,246.43,42.03,180.97,17.07,13.75,0,0,0.0501672,0.00329,24.96,0.145,5.02888,2.4541,0.122,0.002,0.06,0,1.572,0.698,101,75.79,87.9849,0.27,1.2e-4,0,0.399413,0.001,0.61,0.006,0.53,0.132,0.701,0.50633,162.6839,1.6028,11.5905,0.4943,3.76516,0.0112,0.638276,0,0,11.863111,2.155529,0.0202,0.00269,0,1.285967,673.14,4.77,0,1.0495,15.944,0,29.04,5.731,142.2,8.567,74.28,243.9204,21.54,2.26,83,177.95,0.1,66,157,105.04,1,0,0,0,1,0,0,0,0,0,2,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,>= 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Other,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1936,56,57,0,2,74.01,168.95,26.06321,1.87,6,0.087821281,1.05422984,0,2,4,6,1442.964,2,2,269.34,42.01,61.81,21.99,23.92,0,0,0,0,21.64,0.141,3.89887,2.2574,0.351,0.33,0.169,0.096,1.419,0.845,104.1,130.16,51.0437,0.07,1.9e-4,0.0167,0.0080510000000000009,4e-4,0.85,0.542,0.544,0.33,0,0.40908,138.3989,1.7936,11.8693,0.3397,1.520232,0.0116,0.558438,0,0.68,3.70976,0,5e-4,0,0,1.096124,149.09,3.6,0,0.924,0.505,0.0166,27.62,4.015,139,13.69,66.89,244.3788,6.23,2,76,171.12,0,77,120,82.88,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1937,71,71,0,1,90.79,181.91,26.56974,2.1,6,0.105895563,1.27212763,1,1,3,6,1315.615,1,1,163.16,37.91,102.37,15.01,16.11,0,0,0.0203275,0,30.9,0.145,5.44619,2.9386,0.112,0.041,0.307,0.142,1.389,0.78,105.1,103.75,61.9913,0.05,3e-5,0.0056,2.98392,2e-4,0.838,0.46,0.443,0.232,0,0.39097,127.9301,1.3501,5.28,0.5184,1.370366,0,0.859316,0,0.32,3.020269,0.133177,0,0.0012,0,0.114406,290.11,3.51,0,1.0014,0.47,0.0175,26.22,4.399,142,5.64,61.9,180.6654,6.8,2.03,58,183.96,0,82,130,95.73,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1939,60,60,1,3,45.05,164.06,16.47791,1.47,6,0.044982898,0.5398078,1,3,3,6,5174.434,2,2,251.1,41.05,103.05,10.2,13.76,0,0,0,8e-5,26.93,0.499,5.62776,2.2181,0.181,0.109,0.196,0.101,1,0.718,100,61.63,70.9767,0,0,0,0.070009,7e-4,0.479,0.256,0.521,0.337,0,0.40227,141.7434,1.0957,9.7828,0.0107,0.905518,0.0817,0.624502,0.1158,0,5.0998,3.360902,0.7151,0.00441,0,1.144438,320.69,4.4,0,0.904,12.474,0.0039,34.48,4.516,140.8,10.1,79.92,133.3647,6.4,1.42,77,167.18,0,97,121,44.42,1,1,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,NA,NA,N,60 - 69,< 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,3,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,NA,N,<LLN,Y,Y,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1941,69,69,0,2,69.96,169.05,25.08449,1.8,6,0.027562977,0.33113936,0,2,1,6,298.408,2,2,221,47.5,69.95,15.74,19.2,0.001664,0.0028,2.125e-4,6e-5,27.01,0.063,7.01442,2.4022,0.467,0.323,0.001,0.001,1.001,0.85,100.9,89.04,73.6787,0,0,0,0.028232,7e-4,0.445,0.428,0.574,0.444,1.988,0.43089,148.6174,3.3249,8.6356,0,1.248064,0.1691,0.398576,0.005,17.09,2.769612,0,0,0.00145,0,1.093387,195.91,4.71,0,1.0099,9.011,0.0201,27.25,4.323,139.5,3.415,73.92,393.6504,4.39,1.78,90,171.03,0,58,168,74.83,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,Rituximab plus 6 CHOP cycles,S,S,Y
1942,64,64,1,0,NA,NA,NA,NA,7,0.104287998,1.25171327,0,0,2,7,4667.528,2,2,155.66,43.15,70.88,20.16,15.47,2.39e-4,0,0,1e-5,30.31,0.001,6.43313,2.6793,0.532,0.29,0.252,0.162,1.734,0.748,100.4,60.28,93.8467,0.09,0,0,0.299758,9e-4,1.23,0.546,0.474,0.262,0,0.26375,105.0242,1.2572,0.8978,0.7209,1.61937,0.0021,0.750223,0.0491,0.78,6.523401,8.782373,0.0297,0.00243,0.001,1.515275,450.99,4,0,1.0944,0,0.0474,21.97,3.274,143.1,5.11,73.04,321.0637,11.48,1.57,63,158.35,0,84,112,55.89,0,0,0,1,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,NA,NA,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,>= 65,< 70,>= 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),NA,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,NA,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,Y,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1943,48,49,1,2,71.77,164.48,26.03039,1.82,6,0.037811395,0.45356396,1,2,1,6,7798.754,2,2,409.93,42.47,74.01,25.82,21.01,0,0,0,0,28.42,0.15,4.98653,2.354,0.444,0.343,0.133,0.093,1.261,0.734,100.1,87.47,73.6255,0,8e-5,0.0042,0.159818,0,0.606,0.419,0.623,0.318,0,0.44376,155.141,0.0095,8.7561,1.3581,1.429437,0.0016,0.328771,0,17.08,4.990248,0.199773,0,0,0,1.394318,188.31,4.8,0,0.994,12.045,0.0069,0,5.214,136.9,15.812,69.11,184.2487,5.85,1.97,86,166.01,0,78,121,72.93,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,Yes,2,>1,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1944,24,24,1,1,65.67,162.99,25.22393,1.71,6,0.126191279,1.51248175,0,1,3,6,3081.153,2,2,228.17,41.61,33.12,9.81,15.99,1.45e-4,0,0.0488388,0.00501,23.03,0.002,0.00222,2.1768,0.166,0.105,0.372,0.242,1.172,0.772,100,158.29,54.9088,0.02,9e-5,0.0088,0.049836,0.0205,0.492,0.38,0.597,0.332,3.26,0.36151,120.7697,2.65,9.1698,1.1751,1.832352,0.1718,0.36015200000000003,0.0028,0,3.926046,3.903375,0.0126,0.0068,0.001,1.130945,189.91,3.7,0,1.1229,11.736,2e-4,1.06,4.261,144.1,10.817,67.98,168.9469,7.8,1.7,49,164,0,79,0,65.06,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1945,52,52,0,2,79.96,175.79,25.50405,1.99,7,0.150955241,1.80919779,1,2,1,7,758.518,1,1,858.51,38.98,118.16,69.07,87.05,0.001476,0.0011,0.0795405,7e-5,2.71,0.104,7.94136,2.2482,0.231,0.037,0.298,0.155,1.821,0.732,98,86.66,88.8854,0.05,5e-5,0,0.039913,6e-4,0.921,0.357,0.596,0.232,0.413,0.41063,136.9056,1.8257,11.3949,0.6288,2.156532,0.0096,0.598933,0.002,24.99,4.315143,3.829751,0.0374,0,0.001,0,259.08,4.72,0,1.0432,10.715,0.0043,0,4.697,141,5,76.53,323.076,8.5,2,81,175.71,0,64,121,81.99,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,>= 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,4,>1,131HR,158VF,Y,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,Yes,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1946,46,46,0,1,73.95,171.13,25.61799,1.88,7,0.1390452,1.66875705,1,1,2,7,578.811,1,1,539.75,49.97,338.37,19.7,18.85,0.002243,0.0027,4.94e-4,1e-5,28.96,0.029,4.28327,2.3251,0.268,0.17,0.111,0.053,1.084,0.639,102,95.18,82.1826,0.23,1.6e-4,0.0219,0.099941,0,0.867,0.436,0.228,0,0.77,0.41104,141.6553,5.1079,13.5542,0.6497,2.098705,0.007,1.686295,0.0036,0.31,17.059442,6.284357,0.6404,0,0,1.381252,149.38,4.51,0,0.9975,8.591,0.0079,30.94,4.708,144.3,15.718,75.66,422.5072,21.11,1.92,96,172.98,0,72,150,77.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1947,42,42,1,4,64.86,152.48,28.38014,1.6,6,0.077172655,0.92705369,0,4,6,6,12532.349,1,1,674.29,41.94,84.35,21.69,24.08,0.001072,0.0015,0.0199189,2e-5,23.9,0.062,2.49937,2.3356,0.153,0.051,0.588,0.268,1.15,0.635,103,114.38,60.1128,0.38,0,0.0121,0.231873,7e-4,0.71,0.437,0.384,0.136,2.671,0.38961,131.1606,0,0.053,1.1192,1.432915,0.0033,0.73014,0.0049,19.77,18.274327,0.705313,0.0255,2.5e-4,0,0.969372,724.8,4.07,0,1.099,0.704,0.0026,26.34,4.393,139.3,8.409,61.39,161.6022,23.02,1.64,79,154.52,0,88,129,66.83,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,>4,>1,131HR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1948,50,50,1,4,54.98,149.93,24.24296,1.5,6,0.111598527,1.33799211,1,4,6,6,12890.805,2,2,683.37,31.04,66.03,14.94,18.81,0,0.0017,0,0,29.07,0,12.96758,1.9936,0.032,0.139,0.001,0.059,0,0,103,132.99,44.2667,0.08,0,0,0.128074,0,0,0.009,0,0.001,0,0.2436,82.7231,0.0134,4.9178,0.1496,0.602836,0,1.29922,0.0033,0.3,2.071999,0.273864,0.0084,0.0044,0,1.34635,116.41,3.46,0,1.0559,11.872,0.0085,22.95,2.993,140.9,5,51.2,165.9411,4.31,1.57,81,150.31,0,80,120,56.07,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,G,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,POSITIVE,N,Outside-China,CHN,China,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Western Europe,Y,Y,F,No,WE,G-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1949,61,61,1,2,75.8,160.02,28.98163,1.78,7,0.096619686,1.15921961,1,2,2,7,11221.69,1,1,570.15,42.04,81.21,18.98,16.8,0,0,0.0199638,1e-5,31.9,0.031,0.05684,2.3238,0.089,0.189,0.096,0.141,0.238,0.626,98,77.84,78.6586,0.14,0,0,0.130554,4e-4,0.261,0.465,0.008,0.183,3.878,0.26827,92.4452,2.4988,11.5907,1.9977,0.809553,0,0.350305,0,0,5.816734,10.209269,0.6919,0,0,1.321858,494.97,4.19,0,1.0332,0.116,0.0021,25.95,3.039,142.5,3.012,71.98,387.1072,8.11,1.78,86,159.92,0,86,159,74.97,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1950,48,48,0,3,78.04,172.71,26.1818,1.92,6,0.054728965,0.65687307,0,3,6,6,12272.934,2,2,545.01,42.03,179.63,17.87,22.13,0.001822,0.0016,7.2e-6,4e-5,26.37,0.075,6.87787,2.4279,0.303,0.344,0.055,0.044,0.721,0.679,101,83.9,102.0828,0.16,1e-5,0.004,0.29993,0.0137,0.352,0.263,0.328,0.358,0,0.45059,138.9935,2.5703,11.463,0.2776,0.95939,0.0754,1.151545,0.1037,0,7.606925,5.09485,0.7085,0,0,1.361099,475.77,4.61,0,1.1323,14.622,0.0067,34.71,4.833,138,9.405,73.01,362.6372,10.72,1.95,80,175.45,0,87,98,77.56,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,0,0,NA,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1951,66,66,0,5,119.56,182.9,35.56069,2.35,6,0.162623376,1.94875301,1,5,3,6,15403.952,2,2,907.57,34.21,78.53,28.01,29.01,0,0,0.0495087,0,26.93,0,8.98613,2.3798,0.108,0.112,0.091,0.056,1.124,0.821,98.8,93.58,96.8616,0,0,0,0.165216,0,0.782,0.526,0.307,0.231,0,0.43347,150.13,2.6086,5.4289,0.6644,1.023958,0,1.298507,0,0.39,7.230822,0.619006,0,0.00435,0,1.162414,198.76,4.43,0,0.9998,10.082,0,28.53,5.662,137.9,15.823,67.91,369.0882,9.16,2.38,88,182.93,0,105,145,113.77,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,N,1-3,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q4 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1952,71,71,0,3,49.5,162.43,19.04213,1.51,7,0.009327515,0.11222085,0,3,4,7,1035.768,2,2,640.79,42.06,88.99,51.27,41.53,0,0.0011,0.0473345,0.00884,23.6,0.251,0.03643,2.1962,0.955,0.474,0.09,0.035,1.941,0.841,103.5,102.07,45.0603,0.08,0,0.0065,0.039264,0.0324,0.868,0.387,0.949,0.515,0,0.39479,132.5758,2.5082,12.8766,0.3761,1.319319,0.3554,0.498223,0.1352,0,2.959568,0.304436,0.6481,0,0,0.938814,111.35,3.7,0,0.9542,10.57,0,28.81,4.176,140,15.378,70.01,294.4519,4.66,1.41,62,160.96,0,106,111,45.11,1,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,High,High,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1953,19,19,0,0,73.96,161.67,28.28608,1.79,7,0.037953201,0.45554049,0,0,1,7,389.227,1,1,117.86,44.04,62.15,14.85,13.82,0,0,0.0099836,1e-5,28.09,0.125,0,2.3002,0.221,0.098,0.007,0,0.944,0.752,98.5,212.3,48.4055,0.34,8e-5,0.0054,0.128001,3e-4,0.527,0.324,0.36,0.273,0,0.45106,142.1796,2.1085,16.3884,0.7935,2.373453,0.0032,0.61284400000000006,0,0,3.17133,4.605291,0.016,0,0,1.03326,232.46,3.51,0,0.9531,11.219,0.0429,33.78,5.757,140.8,22.965,79.23,189.7673,5.69,1.83,69,163.05,0,78,108,75.03,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1954,57,58,0,4,69.01,164.81,25.7026,1.76,6,0.041979477,0.5038404,1,4,4,6,3923.943,2,2,3018.39,38.02,238.64,12.17,27.39,0.002107,0.0012,0.0400462,0.00618,23.52,0.002,4.81874,2.0068,0.086,0.1,0.021,0.043,0.041,0.005,106.1,92.06,65.6221,0.05,1.4e-4,0.0115,0.069892,0.0295,0.015,0.215,0.001,0,0.858,0.40366,123.0295,1.9144,10.02,2.024,0.801432,0.2516,0.689583,0.0938,0,4.040776,5.291273,0.7379,0,0,1.300838,351.29,4.07,0,0.9579,10.64,0,31.85,4.345,139,9.222,53.09,408.2339,6.24,1.69,78,163.89,0,96,120,68.05,0,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,POSITIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,< 1 x 10^9/L,N,NA,N,N,N,WHITE,Eastern Europe,Y,Y,F,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1956,68,68,2,3,65.1,170.19,22.31283,1.75,7,0.12203608,1.46437786,0,3,5,7,16133.1,1,1,2739.18,38.02,92.6,23.27,49.62,8.7e-5,9e-4,0.0099264,0,0,0.064,6.28371,2.2278,0.193,0.211,0.079,0.076,0.88,0.706,101,70.07,79.7116,0.19,0,0.0077,0.109833,8e-4,0.465,0.375,0.231,0.25,3.216,0.39074,133.1753,0.9985,9.8093,1.0215,0.782814,0.1051,0.700281,0.0042,12.69,5.529252,4.834584,0.0129,0.00167,0.001,1.142227,233.81,4.31,0,1.0636,11.97,0.0142,35.3,4.406,141,6.789,61.92,379.2948,8.1,1.95,65,172.09,0,67,120,70.05,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,II,GA101 plus 6 CHOP cycles,R,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,HUN,Hungary,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,NA,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1958,58,58,1,2,108.31,179.01,33.14361,2.28,8,0.06020548,0.72240767,1,2,6,8,10916.208,1,1,877.19,40.99,248.06,14.88,17.9,0,0.0013,0,0,23.51,0.001,8.93419,2.2931,0.087,0.007,0.011,0,0.914,0.732,100.9,103.23,83.0624,0.12,0,0.0066,0.062551,0,0.589,0.399,0.276,0.242,1.03,0.37636,126.7531,0,0.0265,0.1519,1.521435,0.008,0.709361,0.0044,0,9.450172,4.507367,0.6004,0.00214,0,1.290903,212.19,4.41,0,1.137,14.76,0,33.11,4.987,137.9,9.506,63.98,387.305,13.12,2.32,65,179.04,0,79,121,109.51,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,Y,Outside-China,HUN,Hungary,< 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HH,NA,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1959,54,55,0,4,82.56,162.77,30.95426,1.9,6,0.08713742,1.04567399,0,4,3,6,4693.761,2,2,346.13,39.33,111.98,28.18,17.12,0.001857,0.0016,2.148e-4,0,27.02,0.165,13.54136,2.3384,0.197,0.106,0.066,0.034,1.012,0.652,106.2,98.24,77.9711,0.02,0,0.0047,0.208837,0,0.583,0.367,0.31,0.146,0,0.34903,108.5064,1.6268,5.3488,0.6481,2.625516,3e-4,1.000545,0,0,7.9974,1.793609,0,0.00266,0.001,1.039333,473.91,4.51,2,0.9878,11.856,0,28.65,4.042,144,9.782,65.03,447.0253,14.67,1.86,80,162.77,0,72,121,79.9,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131RR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,North America,Y,Y,F,No,NAM,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1960,68,68,0,1,86.02,179.61,26.91524,2.04,8,0.061428089,0.73740084,1,1,6,8,15485.33,1,1,256.09,43.4,123.1,14.05,19.81,0.003219,0.0016,0.0199816,8e-5,42.49,0.05,0.08731,2.5642,0.301,0.121,0.159,0.101,0.933,0.649,102.9,99.1,70.9128,0.36,1.3e-4,0.0114,0.810782,0.0279,0.561,0.396,0.367,0.224,0,0.41081,147.8136,3.2551,16.4343,1.1352,2.258278,0.0053,0.972362,0.0506,0.58,4.20137,8.565736,0.5337,0.00486,0.001,1.391529,201.28,4.49,0,1.1054,13.816,0.0074,25.05,4.755,136,8.376,81.52,309.372,7.69,2.06,67,181.93,0,74,110,85.77,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,I,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,0,0,131HH,158VF,Y,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,N
1961,71,71,0,3,66.6,170,23.14257,1.75,7,0.118909966,1.42737559,1,3,2,7,315.528,1,1,197.37,38.06,89.4,21.99,28.81,2.11e-4,8e-4,0.0099954,0.0028,25.12,0,0,2.2613,0.215,0.331,0.032,0.03,0.58,0.752,101.9,76.25,70.6505,0.23,1e-5,3e-4,0.010385,9e-4,0.191,0.292,0.309,0.355,0,0.36457,119.4993,2.3658,15.2867,1.4413,0.83051,0.1586,0.28667,0.0024,0.57,2.748138,0.29016,0.0052,0,0,1.064679,73.73,3.91,1,1.0517,13.471,0,30.11,4.466,138,15.394,72.99,387.6252,3.89,1.69,80,168.01,0,74,116,66.82,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q4 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1962,65,65,1,4,73,169.85,25.39347,1.83,6,0.070449324,0.84467736,0,4,4,6,11265.218,1,1,564.65,41.54,69.63,48.84,24.17,3.81e-4,0,0.0499268,0.00356,28.94,0,0,2.294,0.263,0.419,0.026,0.041,0.509,0.695,95.2,94.19,60.7315,0.66,1.9e-4,0.0203,0.100666,0.0196,0.318,0.389,0.175,0.271,0.603,0.39402,128.9172,2.8962,12.4512,1.043,0.575579,0.0018,0.414849,0.0054,20.09,4.05876,0.666842,0.0415,0.00485,0,1.021224,308.19,4.58,1,0.9238,13.125,0,23.46,4.67,142,19.685,73.07,178.6197,5.8,1.94,98,171.18,0,113,140,70.04,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CAN,Canada,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,North America,Y,Y,F,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1963,65,65,1,3,59.23,156.91,23.92293,1.59,8,0.104742647,1.25778283,2,3,3,8,18577.831,2,2,197.03,40.08,196.23,15.92,17.12,0.002857,0,0.0177595,0.00272,25.93,0.151,3.28579,2.3745,0,0.003,0,0.001,0,0.415,99,84.66,67.1422,0.14,0,0,0.010374,5e-4,0,0,0.082,0.204,0,0.39404,133.1075,1.2438,9.0372,0.7259,1.360874,0.0903,0.380278,0,0,12.000453,5.983191,0.0305,0,0,1.338094,261.04,4.61,0,0.9478,0.887,0,28.22,4.716,138,22.103,59.22,398.8011,13.23,1.59,79,157.49,0.1,84,111,58.55,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,0,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,NA,N,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,Y
1965,75,74,0,1,52.08,150.29,22.70565,1.45,7,0.130332225,1.56509864,0,1,1,7,2206.31,2,2,261.38,41.13,125.89,8.8,13.97,1.597296,0.2021,6.1e-6,0,26.94,0.395,13.00212,2.2719,0.069,0.097,0,0,0.364,0.267,103,68.65,61.8491,0,6e-5,0.0096,0.240151,0.0256,0.009,0,0.202,0.153,0,0.42022,144.9443,0,0,0,1.84281,0.3358,0.313717,0.0791,24.91,4.007797,0.323831,0.0029,0.00626,0.001,1.160252,296.23,4.28,1,0.8494,13.156,0,28.05,4.898,143.2,10.282,54.98,249.2275,6.71,1.45,81,149.07,0,61,130,52.1,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131RR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1966,38,38,0,1,48.51,165.44,17.92836,1.53,6,0.042422506,0.50958379,2,1,2,6,2264.552,1,1,350.56,36.94,0,8.35,27.61,0.00102,4e-4,0.0099672,4e-5,25.94,0.06,0,2.2094,0.358,0.345,0.011,0.001,0.405,0.004,97.8,74.78,86.776,0.24,2e-4,0.022,0.219212,0.0127,0.011,0,0.278,0.275,0,0.38603,133.781,1.6167,9.2056,2.2145,1.38676,0.1951,0.181442,0.0529,0.11,10.58043,4.410465,0.7395,0.00185,0,0.088871,504.18,4.39,0,0.9434,0.486,0.007,24.95,4.628,142.1,7.032,64.76,296.4002,9.87,1.63,69,166.92,0,76,95,55.08,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,Y
1967,53,53,0,2,71.5,169.97,25.02674,1.83,6,0.05747632,0.68976496,0,2,4,6,4198.822,1,1,622.28,34.03,27.09,5.7,10.06,0.001995,0.0015,0.0401302,0,25.99,0.091,0.10593,2.459,0.18,0.208,0.004,0.013,0.48,0.546,100.1,82.61,79.3712,0.35,5e-5,0.0154,0.199908,0,0.367,0.387,0.134,0.11,0.142,0.39335,131.5054,0,5.916,0.3715,1.156602,0,0.870537,0,0.49,6.809409,0,0,0.00261,0,1.388547,333.56,3.59,1,0,0.823,0.0463,26.89,3.477,134.2,11.907,61.35,237.529,13.08,1.93,80,168.97,0.1,80,129,74.02,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,N,<1,0-1,NA,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,Low,High,Q4 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1968,28,28,1,1,57.9,169.98,20.57495,1.66,7,0.160443107,1.92737412,0,1,3,7,18228.931,1,1,220.56,40.14,48.5,19.95,15.48,0,0,0.0300013,5e-5,29.27,0.177,6.4447,2.3317,0.376,0.18,0.16,0.093,1.605,0.758,107,120.12,68.9704,0.1,0,5e-4,0.10993700000000001,3e-4,0.804,0.41,0.621,0.313,0,0.30665,108.5289,0,0.1166,0.3943,2.005988,0.0604,0.898008,0.005,0.13,6.678854,7.032445,0.0399,0,0,1.228415,180.69,3.7,1,1.0289,11.684,0,23.67,3.791,139.9,6.829,71.09,321.2316,11.09,1.84,71,174.75,0,84,123,64.49,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,NA,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1969,73,73,0,2,55.21,168.98,19.60883,1.64,6,0.047027015,0.56401643,0,2,4,6,314.077,2,2,488.83,31,115.94,17.84,26.98,0.001186,8e-4,1.2e-6,4e-5,3.54,0.131,2.85426,2.2494,0.202,0.159,0.139,0.116,1.23,0.848,97.2,55.66,85.8733,0,0,0,0.099767,0.0043,0.632,0.464,0.525,0.438,0,0.33083,109.274,3.254,12.8822,0.6143,1.441757,0.0077,0.689372,0.0598,0.65,8.053313,5.222615,0.6675,0,0,0,267.76,4.82,0,0.9009,10.657,0.0295,30.84,3.462,137,8.799,72.08,279.9222,9.44,1.55,74,164.29,0,80,112,54.9,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,1,1,131HR,158VV,N,Y,N,N,High-Intermediate,Low-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,< 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1970,63,63,1,2,60.86,172.17,20.5662,1.73,7,0.135918005,1.63095041,0,2,5,7,7917.437,1,1,201.39,44.1,222.7,16.83,18.94,0.001064,0,0.07574,0.00973,20.86,0.246,5.70219,2.4165,0.275,0.359,0.221,0.283,0.513,0.017,103,66.63,94.971,0,0,0.0078,0.010445,8e-4,0.357,0.324,0.159,0.224,0.75,0.37087,128.2283,2.9851,15.8948,1.946,0.719776,0.1096,0.290293,0.0545,0.83,4.361814,2.992637,0.0151,0.00169,0,1.429811,255.32,4.11,0,1.01,13.904,0.0231,32.82,4.37,140.9,20.33,67.97,494.4641,5.6,1.59,61,172.92,0,75,106,59.92,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,1,131HH,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,Y,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,Y
1974,73,73,0,4,70.99,172.01,24.68633,1.86,6,0.0406518,0.48728066,1,4,6,6,2344.558,1,1,790.19,34.53,63.51,16.1,23.88,9.23e-4,0,0.0099397,1e-4,23.68,0.069,4.63022,2.0639,0.003,0.078,0,0,0.002,0.666,100.3,111.27,53.0276,0.3,2e-5,0.0033,0.09019,0.001,0,0.007,0.004,0.24,0,0.38428,116.0201,1.41,0.8887,0.3791,0.769975,0.0081,0.692393,0.047,0.68,6.122733,3.708732,0.0058,0.00838,0,1.195385,242.02,5,0,1.0972,11.517,0.046,33.96,3.792,136.1,10.281,51.82,262.8023,6.56,1.77,69,170.95,0,90,107,68.26,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,No,2,>1,131HR,158VF,N,Y,N,N,High,High,Q4 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,NA,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1975,78,79,1,3,104.28,185.35,29.75337,2.28,8,0.091480182,1.09932421,1,3,4,8,11973.264,2,2,298.38,33.02,72.65,9.89,20.81,9.78e-4,0.0025,3.197e-4,5e-5,75.26,0.139,4.39876,2.2604,0.297,0.26,0.069,0.049,0.562,0.362,106.3,56.71,89.9355,0.26,3e-5,0.0077,0.099572,4e-4,0.255,0.181,0.243,0.208,0,0.38602,133.1573,2.815,10.7366,0.0086,1.003048,0.1801,0.722769,0.0942,0,6.535813,5.041906,0.7718,0.00789,0.001,1.149937,304.34,4.88,1,1.1629,18.532,0,34.81,4.355,139.9,5,62.53,371.1378,6.89,2.18,72,183.22,0.1,79,126,96.24,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,>= 75,III,GA101 plus 8 CHOP cycles,G,G8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),>=30,POSITIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,N,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,Y,N,Low-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,G-CHOP,GA101 plus 8 CHOP cycles,HMS,S,N
1976,61,61,0,2,70.15,152.01,31.00582,1.66,7,0.123454942,1.48158289,1,2,2,7,5663.657,1,1,948.4,38.08,78.71,15.01,23.87,0,0.0016,0.0194324,0,23.9,0.001,17.48033,2.4269,0.108,0.113,0.034,0.072,0.045,0,105.6,88.82,61.3437,0,0,0,0.039038,1e-4,0.016,0.007,0.102,0.1,0.116,0.34085,105.6117,1.0656,10.4393,0,0.87385,8e-4,0.398487,0.0027,0.42,14.619549,4.450951,0.5006,0.00333,0,1.29261,479.77,4.29,1,0.9995,0.618,0.0057,25.88,4.017,141.9,3.416,74.97,106.5588,14.21,1.64,80,150.09,0,72,126,68.02,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,NA,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158FF,Y,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,NA,Y,N,N,WHITE,Western Europe,NA,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1977,42,42,2,3,78.16,179.05,24.44752,2,6,0.016530578,0.19838744,1,3,4,6,10628.134,2,2,1423.47,30.6,59.41,48.29,98.69,0,0,0.1080099,2e-5,28.36,0,5.32165,2.125,0.235,0.133,0.077,0.056,0.818,0.002,97.7,110.71,73.3565,0,0,0,0.110068,5e-4,0.466,0.009,0.201,0,2.528,0.36189,106.4725,3.964,8.5488,0.5886,1.971323,0,1.285545,0.0041,0,10.039644,0,0,0.00658,0.001,0.041231,301.72,3.88,0,1.0896,11.876,0.0317,27.49,4.036,135,5.34,61.93,273.4871,14.05,1.92,79,175.74,0,61,121,77.16,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1978,69,70,0,3,65,171.98,22.37186,1.74,7,0.050065874,0.6014276,0,3,6,7,3308.548,2,2,639.96,39.42,82.92,22.07,21,0.003577,0.0036,2.814e-4,2e-5,31,0.14,5.56709,2.4366,0.238,0.194,0.081,0.044,1.499,0.773,101,98.79,57.6779,0.19,0,0,0.091526,0.0038,0.703,0.374,0.663,0.313,0,0.31048,111.7953,2.4039,10.0141,0.4154,3.037717,0.2101,0.529868,0.066,0,4.800526,4.640264,0.0077,0.00492,0,1.223129,154.38,4,0,1.0434,12.677,0.0286,36.47,3.534,138,6.016,68.08,362.4422,8.4,1.72,87,172.7,0,89,110,67.11,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,RUS,Russia,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,1,1,131HH,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,High,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1979,44,44,1,3,75.06,175.5,24.21874,1.91,7,0.099568093,1.19404152,1,3,3,7,2682.13,1,1,376.58,40.01,89.36,22.02,21.97,0.001973,0.003,0.0099697,7e-5,26.41,0.119,6.22081,2.2272,0.348,0.193,0.151,0.096,1.355,0.653,100.4,110.99,79.2365,0.33,2e-4,0.0119,0.001416,0.0148,0.717,0.395,0.394,0.195,0,0.41091,130.0676,1.596,12.0464,1.3327,2.555392,0.2457,0.304738,0.0051,0.73,7.365611,5.006319,0.72,0.00957,0.001,0.823654,326.42,4.01,0,1.0778,12.948,0.0342,31.36,5.244,140,5.07,55.88,208.053,11,1.87,75,174,0.1,68,113,72.81,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,N,1-3,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131HR,158VF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1980,72,71,0,4,38.53,160.01,14.52504,1.34,6,0.041735884,0.50166537,0,4,3,6,2268.97,2,2,345.88,44.11,164.37,16.13,51.44,0.001502,0.0022,0.0995899,8e-5,29.38,0.117,3.3948,2.9392,1.033,0.353,0.392,0.238,0.889,0.014,101,55.67,69.5158,0.14,2e-4,0.0215,0,0,0.589,0.365,0.31,0.115,0.962,0.3925,116.01,4.1748,17.8631,2.6631,1.741399,0.2076,1.307881,0.0904,0,8.720664,6.711442,0.6613,0,0,1.397599,335.21,4.78,0,1.092,13.071,0,30.94,3.975,136,17.052,75.82,273.6974,9.91,1.33,70,160.09,0,72,103,37.94,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,N,Outside-China,JPN,Japan,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131RR,158FF,N,Y,N,N,Low-Intermediate,High-Intermediate,Q1 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,HMS,S,Y
1981,60,59,0,3,48.32,167.16,18.12175,1.52,8,0.065677634,0.79139098,2,3,6,8,1990.856,1,1,633.89,34.09,83.58,30.41,21.03,9.89e-4,9e-4,0.0099648,7e-5,31.93,0.227,9.63736,2.3734,0,0,0,0,0.048,0.664,104,85.32,61.8849,0.58,0,0.0302,0.033984,8e-4,0,0.252,0.008,0.13,0,0.38122,139.0969,1.7238,15.9363,1.2983,1.635033,0.189,0.6021,0.0647,0.63,7.507089,0,0,0,0,1.38859,374.54,4.2,0,1.0655,11.401,0,30.21,4.306,137.9,6.948,67.06,237.9262,10.46,1.61,90,165.79,0,83,144,51.71,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,1,1,131HR,158FF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Normal,N,No,< 1 x 10^9/L,N,NA,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1982,58,58,0,0,66.59,157.83,27.30963,1.68,6,0.041887811,0.50198102,0,0,1,6,481.179,1,1,166.26,40.08,695.09,16.93,28.94,6.59e-4,0,0.0200016,0.006,26.88,0.08,3.91917,2.4243,0.088,0.094,0.009,0.037,0.356,0.738,103,185.32,34.1222,0,2e-5,0,0.05008,0.0203,0.146,0.387,0.169,0.272,0,0.35994,118.7952,3.5421,7.663,0.0112,0.4872,0.3064,0.150176,0.0735,0.47,3.066145,0,0,7e-4,0,1.081482,320.24,4.31,0,1.1094,12.419,0.0549,43.47,4.347,135.1,7.697,71,138.2319,4.4,1.78,55,158.19,0,97,110,70.12,1,1,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HH,158VV,N,Y,N,N,Low,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,HMS,N
1983,55,55,1,1,67.15,175.41,21.96449,1.83,6,0.078221494,0.93926879,1,1,1,6,5071.018,2,2,359.44,46.9,100.88,8.21,17.93,0.001906,0.0017,0.0507082,0.00829,0,0.162,2.99972,2.1961,0,0,0.068,0.095,0.645,0.693,106.7,91.2,83.0296,0,6e-5,0,0.085582,9e-4,0.424,0.418,0.228,0.201,2.353,0.43763,144.2105,1.1997,12.5343,0.86240000000000006,1.32845,0.1552,0.197046,0.0511,0.55,1.836257,0.660769,0.041,0.00396,0,1.134145,177.52,4.49,0,0.9627,11.537,0.0198,32.57,4.225,141.1,10.953,72.47,279.0777,3.28,1.76,80,174.74,0.1,70,127,66.89,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Eastern Europe,Y,Y,M,No,EE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1984,74,74,0,4,85.31,164.94,32.29212,1.93,7,0.044896391,0.53881356,1,4,4,7,2688.232,1,1,5951.9,40.09,206.15,15.07,34.08,0.001143,3e-4,0.0199493,0.00226,28.58,0.08,4.99622,2.9545,0.214,0.131,0.15,0.138,0.562,0.017,95.7,51.73,108.7856,0.08,1.4e-4,0.0061,0.329495,0.0039,0.282,0.273,0.221,0.161,0,0.47908,155.0659,2.4428,9.3652,1.1933,1.390845,0.0975,0.467328,0.0037,0.77,4.200143,4.736238,0.5175,0.00419,0.001,1.193721,253.35,3.9,0,0.8491,0,0.0223,31.53,4.709,132.5,16.996,75.93,455.6108,6.58,1.95,85,165.09,0,106,131,89.77,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,>= 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),>=30,NEGATIVE,N,Outside-China,ESP,Spain,>= 50 ml/min,N,<1,2-3,NORMAL,HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HH,158VF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,N,N,N,WHITE,Western Europe,Y,Y,M,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,S,N
1985,74,74,0,4,53.56,163.08,20.23562,1.57,6,0.08242852,0.98895877,2,4,3,6,623.938,1,1,219.21,33.06,122.15,4.41,20.82,0,3e-4,3.63e-4,3e-5,23.77,0.139,4.68581,2.043,0.265,0.317,0.219,0.283,0.356,0.575,99.9,60.86,71.6023,0.07,0,0,0,0,0.388,0.427,0.008,0.117,0.321,0.25186,86.5446,1.1343,0,0.3189,0.42999,0.1096,0,0.0027,0.25,0.584816,0,0.0238,0.00809,0.001,0.212333,57.15,3.7,0,1.0785,0,0.0428,35.69,3.021,136.4,10.232,2.1,279.9205,1.92,1.56,56,167.92,0,70,109,55.8,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,N,<1,2-3,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,1,1,131RR,158VV,Y,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,High,Elevated,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1986,60,60,1,2,76,160.07,28.517,1.82,7,0.056559598,0.67871971,1,2,3,7,7496.391,1,1,192.57,45.24,109.29,15.09,26.75,4e-4,1e-4,0.09967,0.00103,2.37,0,4.40948,2.759,0.28,0.27,0.04,0.033,0.892,0.763,100.9,89.18,79.2129,0.1,8e-5,0,0.150565,7e-4,0.669,0.497,0.281,0.257,6.015,0.39045,132.0654,2.6216,14.607,0.0103,1.45049,0.1375,0.680257,0.0659,27.29,12.15787,7.450032,0.6572,0,0,1.193659,579.04,4.49,0,0.9996,9.395,0.043,27.41,4.495,135.8,3.554,79.27,226.701,14.21,1.98,78,162.9,0,71,121,84.43,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),25 -<30,NEGATIVE,Y,Outside-China,USA,United States,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and No Extranodal Involvement,No,0,0,131HR,158FF,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q2 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1988,66,66,1,3,51.34,154.09,21.87381,1.48,6,0.057857646,0.69367767,0,3,5,6,5162.223,1,1,348.5,37.9,79.99,14.42,26.79,0,0.0014,0,0,28.09,0.096,24.994,2.3184,0,0.004,0.049,0.059,0.643,0.831,103,97.91,48.0569,0,0,0,0.100182,0,0.34,0.443,0.218,0.351,0,0.36252,107.9237,2.5098,10.1744,0.7082,0.821595,0.0033,0.398531,0,0,3.997675,0.252909,0,0.00228,0,1.35407,209.79,3.91,0,1.1179,0,0.0518,43.07,3.3,144.1,10.121,66.19,365.3608,5.3,1.44,64,153.28,0,71,113,51.12,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,>= 75,IV,GA101 plus 6 CHOP cycles,R,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),25 -<30,NEGATIVE,Y,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,High-Intermediate,High-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,<LLN,Y,N,Y,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1989,48,48,1,2,44.93,157.87,17.91122,1.43,7,0.018402123,0.2209358,1,2,6,7,5476.153,2,2,333.92,41.03,46.94,20.12,20.08,0.002961,0.0025,0.0200319,9e-5,27.72,0.152,4.17797,2.1379,0.131,0.225,0.027,0.062,0,0,103,104.3,51.2685,0,4e-5,0.0068,0.099151,6e-4,0.002,0.008,0.004,0.002,4.395,0.34118,110.5963,1.9393,10.0753,0,0.602192,0.0128,0.698806,0.0044,0.48,7.506679,0.398686,0.0111,0.00926,0,1.480351,147.75,3.3,0,1.0827,11.679,0,28.93,4.405,138,4.586,56.96,136.3909,9.22,1.51,80,159.71,0,92,109,48.01,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,< 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),<18.5,NEGATIVE,Y,Outside-China,THA,Thailand,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and No Extranodal Involvement,Yes,2,>1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q1 ITT,Low-Intermediate,Elevated,N,No,< 1 x 10^9/L,Y,NA,Y,N,Y,WHITE,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,S,Y
1990,43,43,1,4,54.92,161.06,20.96744,1.55,6,0.026818905,0.32161257,0,4,3,6,4817.945,2,2,309.62,40.93,72.92,29.54,48.42,0,0,0.0400716,7e-5,23.32,0.101,0,2.238,0.251,0.189,0.226,0.123,1.415,0.745,99,121.31,49.4603,0.08,1e-4,0.0131,0.119363,0,0.624,0.279,0.863,0.512,2.67,0.38862,122.0689,2.5439,13.3404,1.1803,2.323947,0.0029,0.66995,0.0024,24.4,3.945089,0,0.0139,0,0,0.829605,340.17,4.41,0,1.0373000000000001,10.389,0.0232,32.92,3.572,143,4.919,71.07,0,7.8,1.51,80,159.79,0,68,110,52.2,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),18.5 -<25,POSITIVE,N,China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,3,>1,131HR,158VF,N,Y,N,N,High,High,Q3 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,<LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,G-CHOP,GA101 plus 6 CHOP cycles,S,S,N
1991,64,64,0,1,57.04,172.95,19.27157,1.66,6,0.189165181,2.26913242,0,1,1,6,563.19,1,1,190.16,42.92,204.21,15.64,10.54,8.89e-4,5e-4,0.045111,0.00403,26.93,0.149,4.6026300000000004,2.2722,0.161,0.287,0.145,0.212,0.045,0,103.9,68.91,76.015,0.05,3e-5,0.0063,0.023589,0.0092,0.125,0.352,0.009,0.134,0,0.38707,122.0368,0,0,0,1.018907,0.2396,0.451344,0.075,10.77,6.77061,13.174224,0.7629,0.00445,0.001,0.12185,368.56,3.96,0,1.0088,11.692,0.025,27.86,4.562,136,2.168,74.73,285.2835,8.51,1.73,72,170.97,0,78,120,58.85,1,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),>=30,NEGATIVE,N,Outside-China,CZE,Czech Republic,>= 50 ml/min,Y,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and No Extranodal Involvement,No,2,0,131HH,158FF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Eastern Europe,Y,Y,M,No,EE,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1992,52,51,1,2,58.81,165.09,21.82846,1.64,6,0.077599731,0.93029273,1,2,5,6,5967.839,1,1,226.11,41.9,69.32,26.39,20.9,0.002536,0.0036,0.0198362,6e-5,26.91,0.002,24.35755,2.3594,0.03,0.061,0.616,0.738,0.821,0.769,99.5,78.61,76.0206,0,0,0.0024,0,0.0175,0.592,0.563,0.243,0.266,0.418,0.35436,119.5022,2.1462,13.01,1.1526,0.932733,0.013,0.669928,0.1302,19.71,2.768616,5.220023,0.7189,0,0,1.421833,140.76,4.43,0,1.1958,12.421,0.0789,24.45,3.979,140,6.944,72.93,192.6944,5.21,1.63,71,168.82,0,79,116,58.53,0,0,0,0,0,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,40 - 59,>= 55,< 60,< 65,< 70,< 75,II,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NA,N,Outside-China,ITA,Italy,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,2,>1,131HH,158VV,N,Y,N,N,Low-Intermediate,Low-Intermediate,Q3 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,<LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,HMS,N
1993,75,75,1,4,47.6,148.91,22.32398,1.41,7,0.030521708,0.36685328,0,4,2,7,18811.845,1,1,878.49,44.97,654.58,14,45.04,0.003195,0.0043,0.0204042,0.0084,27.94,0.821,7.85183,2.5466,0.559,0.339,0.107,0.048,1.864,0.85,103.9,66.75,66.0396,0.01,1.8e-4,0.0208,0.052989,0.011,1.226,0.581,0.899,0.44,0,0.28127,90.8589,4.5458,17.4983,1.5151,0.906103,0.3103,0.299657,0.0895,0.34,2.991282,3.804865,0.6198,0.00384,0.001,0.833542,223.59,3.6,0,0.9386,14.967,0,34.68,2.892,136,11.996,69.99,270.6298,5.59,1.37,68,149.25,0.1,79,110,47.13,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,>= 65,>= 70,< 75,IV,Rituximab plus 8 CHOP cycles,R,R8,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,Y,Outside-China,RUS,Russia,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HR,158FF,N,Y,N,N,High,High,Q2 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,N,N,Y,WHITE,Eastern Europe,Y,Y,F,No,EE,R-CHOP,Rituximab plus 8 CHOP cycles,S,S,Y
1994,60,60,0,3,84.09,175.94,27.18211,2.02,6,0.041446753,0.49699872,0,3,5,6,592.19,2,2,398.3,43.6,96.68,25.97,58.84,0,0,0.051955,0.0036,27.51,0.002,13.10807,2.3496,0.134,0.158,0,0,0.848,0.712,103.1,73.79,103.1237,0,1.9e-4,0,0.19996,0.066,0.418,0.385,0.293,0.205,7.887,0.40268,137.8815,0.9995,9.9908,0,2.718347,0.3161,0.799327,0.1175,16.83,1.524872,0,0.0211,0,0,1.06584,87.85,3.59,0,1.1417,12.043,0,19.3,4.213,142.7,8.434,70.12,344.9032,3.61,2.17,62,176.35,0,69,109,89.29,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,NA,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,60 - 69,>= 55,>= 60,< 65,< 70,< 75,IV,GA101 plus 6 CHOP cycles,G,G6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW-INTERMEDIATE RISK (2 POINTS),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,<1,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,2,>1,131HH,NA,N,Y,N,N,Low-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,Y,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,ASIAN,Asia,Y,Y,M,No,ASIA,G-CHOP,GA101 plus 6 CHOP cycles,S,HMS,N
1995,66,66,0,1,67.27,157.36,26.67435,1.67,8,0.150245368,1.80340151,2,1,3,8,417.535,1,1,168.07,40.09,83.03,10.85,16.86,5.05e-4,7e-4,0.0515154,1e-5,0,0.058,8.90499,2.2943,0.303,0.19,0.093,0.032,1.093,0.723,104.3,72.1,76.0197,0.16,1.5e-4,0.0249,0.343721,0,0.488,0.328,0.594,0.444,0,0.35911,130.5344,2.5672,11.8881,1.0933,1.198257,0,0.413856,0,0.11,6.765759,0.523844,0,1.8e-4,0,1.300249,313.06,3.53,0,1.2623,12.478,0,31.87,4.606,132,5.989,53.07,273.4312,8.5,1.74,96,160.11,0,79,140,70.35,0,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,Y,40 - 59,>= 55,>= 60,< 65,< 70,< 75,III,Rituximab plus 8 CHOP cycles,R,R8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,Y,Outside-China,CHN,China,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q1 ITT,High,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,WHITE,Western Europe,Y,Y,F,No,WE,R-CHOP,Rituximab plus 8 CHOP cycles,HMS,HMS,N
1996,61,61,0,4,89.56,180.56,27.55136,2.09,6,0.016979962,0.20365735,1,4,2,6,10403.299,1,1,474.47,43.84,230.01,27.19,26.83,7.23e-4,0.0013,0.0383528,0,29.92,0.17,3.68698,2.321,0.284,0.199,0.144,0.082,1.418,0.661,103.1,70.05,95.1513,0,5e-5,0.0088,0.07283,0,1.175,0.539,0.299,0.175,0,0.42791,129.0018,1.8799,10.1969,0.9612,1.482491,0,1.431483,0.0022,0,7.996689,3.985097,0.0182,0,0,1.176887,139.95,3.87,1,1.142,12.295,0,34.24,4.782,139,10.037,69,277.7586,11.36,2.05,75,181.77,0.1,94,140,89.24,0,0,0,0,1,0,0,0,0,0,1,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,>= 70,>= 55,>= 60,< 65,>= 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH RISK (4 OR 5 POINTS),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,<1,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage IV and Extranodal Involvement,Yes,0,>1,131HH,158VV,N,Y,N,N,High,High,Q4 ITT,Low-Intermediate,Elevated,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,Y,N,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,HMS,S,N
1997,51,51,1,3,73.02,170.8,24.97212,1.88,6,0.08361155,1.00265993,2,3,2,6,5638.513,1,1,228.42,39.99,76.09,14.08,20.92,0,0,0.0199285,9e-5,28.26,0.18,0.10806,2.2278,0.027,0,0.147,0.111,1.064,0.728,95.9,116.01,61.0085,0,0,0.0055,0.199986,0.0171,0.532,0.348,0.375,0.274,7.241,0.36422,131.8579,4.0439,16.529,1.937,1.744926,0.1048,0.277698,0.0056,30.17,2.769522,0.427917,0,0.00101,0,1.058952,189.19,3.81,0,1.0482,10.125,0.0673,30.24,3.897,137.9,11.13,71.98,249.3707,4.14,1.93,94,170.07,0,78,154,73.03,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,< 60,< 65,< 70,< 75,IV,Rituximab plus 6 CHOP cycles,R,R6,Y,DIFFUSE LARGE B-CELL LYMPHOMA,HIGH-INTERMEDIATE RISK (3 POINTS),>=30,NEGATIVE,N,Outside-China,USA,United States,>= 50 ml/min,Y,1-3,2-3,ABNORMAL,NOT HISPANIC OR LATINO,Stage III and Extranodal Involvement,Yes,1,1,131RR,158VF,N,Y,N,N,High-Intermediate,High-Intermediate,Q2 ITT,High-Intermediate,Elevated,N,No,>= 1 x 10^9/L,N,>=LLN,Y,N,Y,WHITE,North America,Y,Y,M,No,NAM,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1998,42,42,0,1,58.99,162.9,22.81184,1.63,7,0.043110849,0.51735958,1,1,4,7,3417.19,1,1,446.8,40.9,113.06,11.09,16.83,0.003879,0.0045,0,3e-5,25.03,0,4.6012,0,0.12,0.052,0.147,0.119,0.884,0.77,107.9,113.68,51.5896,0,0,0,0.100298,0.0051,0.48,0.453,0.384,0.313,0,0.28727,103.8225,1.8544,15.1085,3.8129,1.557689,0.1371,0.459306,0.0043,0.14,3.996658,6.754001,0.0312,0,0.001,1.25977,450.44,4.11,0,0.981,11.551,0,27.81,3.504,141.1,5.987,74.11,125.0884,5.21,1.46,71,161.05,0,95,119,53.91,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,< 40,< 55,< 60,< 65,< 70,< 75,III,Rituximab plus 6 CHOP cycles,R,R6,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),25 -<30,NEGATIVE,N,Outside-China,CAN,Canada,>= 50 ml/min,N,1-3,0-1,NORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,No,1,1,131HR,158VF,Y,Y,N,N,Low,Low-Intermediate,Q1 ITT,Low-Intermediate,Normal,N,No,>= 1 x 10^9/L,Y,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,R-CHOP,Rituximab plus 6 CHOP cycles,S,S,N
1999,66,66,0,1,77.32,163.81,28.23363,1.81,7,0.180968737,2.17169039,0,1,2,7,649.391,2,2,132.34,37.9,115.05,18.24,10.87,1.37e-4,0.0029,0.0133226,6e-5,25.09,0.228,12.31751,1.9982,0.041,0.056,0.112,0.091,0.578,0.681,104,94.58,64.8532,0,0,0,0.322492,0.0294,0.147,0.008,0.342,0.356,0,0.37713,120.8789,0,0.1253,0.5105,1.039963,0.2299,0.199142,0.0679,0.29,3.004759,0,0.0175,0.00135,0,1.24538,195.01,4.36,0,0.865,0.054,0.0074,27.1,4.116,143.7,7.018,68.67,104.1998,5.48,1.78,91,159.98,0,83,155,70.97,1,0,0,0,0,0,0,0,0,0,0,YEARS,YEARS,Y,N,Y,Y,kg,cm,< 25 x 10^9/L,< 100 x 10^9/L,N,60 - 69,>= 55,>= 60,< 65,< 70,< 75,II,GA101 plus 8 CHOP cycles,G,G8,N,DIFFUSE LARGE B-CELL LYMPHOMA,LOW RISK (0 OR 1 POINT),18.5 -<25,NEGATIVE,N,China,CHN,China,>= 50 ml/min,Y,1-3,0-1,ABNORMAL,NOT HISPANIC OR LATINO,Stage I-II and Extranodal Involvement,Yes,2,>1,131HR,158VF,N,Y,N,N,Low,Low-Intermediate,Q4 ITT,Low-Intermediate,Normal,N,No,< 1 x 10^9/L,N,>=LLN,Y,N,N,ASIAN,Asia,Y,Y,F,No,ASIA,G-CHOP,GA101 plus 8 CHOP cycles,S,S,N
